Citrus Sinensis ID: 013927
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RXC8 | 460 | Receptor-like cytosolic s | yes | no | 0.990 | 0.934 | 0.591 | 1e-150 | |
| Q8H1D6 | 467 | Receptor-like cytosolic s | no | no | 0.958 | 0.890 | 0.453 | 1e-103 | |
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.647 | 0.485 | 0.557 | 2e-89 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.744 | 0.495 | 0.426 | 1e-65 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.744 | 0.510 | 0.436 | 4e-63 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.725 | 0.496 | 0.430 | 4e-63 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.735 | 0.444 | 0.417 | 2e-62 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.721 | 0.440 | 0.418 | 3e-62 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.741 | 0.632 | 0.425 | 3e-62 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.732 | 0.474 | 0.429 | 6e-62 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 532 bits (1371), Expect = e-150, Method: Compositional matrix adjust.
Identities = 266/450 (59%), Positives = 332/450 (73%), Gaps = 20/450 (4%)
Query: 5 FLYVNNGSLDASSPRGVLDSCFR--------------GSESEASFKENTTQSESPSKSRA 50
L V+ D SPRG L++C EA + RA
Sbjct: 11 LLEVDKEKQDPKSPRGALEACLTRCSISSASSSSDDPPPNREAIDNADADTDVQCKNHRA 70
Query: 51 LTNWSRFFKLWKKKSTKHLRTFHPL---AMPKLSREKSRSTREDPDLTH-IYNYRSSLKE 106
+NW +FFKLWK++S K L +F PL A P + + KS + + H IY+++SSL+
Sbjct: 71 SSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSLQN 130
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
F++S+++ AT NFS EN+IG+GGYA+VY+G L +G L+AVKRLTKGT DE+T FL E+G
Sbjct: 131 FSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSELG 190
Query: 167 IIAYVDHPNTAKLVGCDSDG-IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTAN 224
IIA+VDHPNTAK +GC +G +HLVF+LSPLGSL S+LHG SK K WS+RY +ALGTA+
Sbjct: 191 IIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTAD 250
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL YLHEGCQ+RIIHRDIKADNILLTED++PQICDFGLAKWLP+Q THHNVSKFEGTFGY
Sbjct: 251 GLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGY 310
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344
FAPEYFMHGIVDEKTDV++FGVLLLELITG A+D QQS+V+WAKPLL+ I+ELVDP
Sbjct: 311 FAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELVDP 370
Query: 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRT 404
SLGD Y+ EE+ R TASLCI+QS +LRP+MSQVV LL G ED + +E++ + +RT
Sbjct: 371 SLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAKIKMMQRT 430
Query: 405 YSEELFDAQEYNSTRYLSDISRFKEIALGS 434
YSEEL D+ EYNST+YL D+ R +E+AL S
Sbjct: 431 YSEELLDSVEYNSTKYLGDLDRIREVALAS 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 203/448 (45%), Positives = 278/448 (62%), Gaps = 32/448 (7%)
Query: 11 GSLDASSPRGVLDSCFRGSESEASFKENTTQS-------------ESPSKSRALTNWSRF 57
G D+SSPRGVL S +S ++ ++ S S W++
Sbjct: 25 GLEDSSSPRGVLGMVSDSDNSSSSCSSCSSDDKSSSTSSPFSNTTKTVSSSHHGLQWNKM 84
Query: 58 FKLWKKKSTKHLRTFHPLAMPKLSREKSRSTREDPDLT---------HIYNYRSSLKEFT 108
+ KKKS + LA +L+R+ R R+ P LT + + S + FT
Sbjct: 85 IESIKKKSMRRFSVIPLLASYELTRKNLR--RKQPKLTPSESAFTCEAFFMAKPSWRNFT 142
Query: 109 LSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE--KTCGFLCEIG 166
EL AT F+ EN+IGKGG+AEVYKG L +G VA+K+L +E + FL E+G
Sbjct: 143 YEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDFLSELG 202
Query: 167 IIAYVDHPNTAKLVGCDSD-GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG 225
IIA+V+HPN A+L G SD G+H V + +P GSLAS+L GS++ +W RY++ALG A+G
Sbjct: 203 IIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIRYKVALGIADG 262
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L+YLH C +RIIHRDIKA NILL DYE QI DFGLAKWLP W HH V EGTFGY
Sbjct: 263 LSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEGTFGYL 322
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL-QQSVVIWAKPLLDSNDIRELVDP 344
APEYFMHGIVDEK DV++FGVLLLE+IT RRAVD +QS+V WAKP L+ N + ++VDP
Sbjct: 323 APEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEKNSMEDIVDP 382
Query: 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRT 404
LG+ ++ E+ R +LTAS+C+ +RP M+++V LLRG++ A E Q++ RT
Sbjct: 383 RLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRGEDGPA----ELQQKAGERT 438
Query: 405 YSEELFDAQEYNSTRYLSDISRFKEIAL 432
S D Q++ S+ YL+++ R +++ +
Sbjct: 439 MSVNACDLQDHTSSSYLNELRRHRQLLM 466
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 159/285 (55%), Positives = 210/285 (73%), Gaps = 4/285 (1%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEI 165
FT +E+ AT +F N++G GGY+EVY+G L DG +AVKRL K + D K FL E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 166 GIIAYVDHPNTAKLVGCDSD-GIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTA 223
GII++V HPNTA L+GC + G++LVF+ S G+L S LH +++ DW RY+IA+G A
Sbjct: 315 GIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGVA 374
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG 283
GL YLH+ C RIIHRDIK+ N+LL DYEPQI DFGLAKWLP +WTHH V EGTFG
Sbjct: 375 RGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343
Y APE M G +DEKTD+Y+FG+LLLE+ITGRR V+ Q+ +++WAKP +++ + ELVD
Sbjct: 435 YLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGNTSELVD 494
Query: 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL-RGDE 387
P L D YD +++++ VLTAS C++QSPILRP M+QV+ LL G+E
Sbjct: 495 PKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNE 539
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 145/340 (42%), Positives = 205/340 (60%), Gaps = 17/340 (5%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
FT EL AT FS NL+G+GG+ V+KG L G VAVK+L G+ + F E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGS-GQGEREFQAEVE 326
Query: 167 IIAYVDHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGT 222
II+ V H + L+G G+ LV++ P +L LHG K +P +WS R +IALG+
Sbjct: 327 IISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-KGRPTMEWSTRLKIALGS 385
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL+YLHE C +IIHRDIKA NIL+ +E ++ DFGLAK TH + ++ GTF
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVMGTF 444
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD----HLQQSVVIWAKPLLD---- 334
GY APEY G + EK+DV+SFGV+LLELITGRR VD ++ S+V WA+PLL+
Sbjct: 445 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 504
Query: 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVK 394
D L D +G+ YD EE+ R V A+ C+ S RP+MSQ+V L G+ + +
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV-SLSDLN 563
Query: 395 ESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
E + H YS + +Y++++Y D+ +F+++ALG+
Sbjct: 564 EGMRPGHSNVYS-SYGGSTDYDTSQYNDDMIKFRKMALGT 602
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 148/339 (43%), Positives = 201/339 (59%), Gaps = 16/339 (4%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
FT EL AT F+ NL+G+GG+ V+KG L G VAVK L G+ + F E+
Sbjct: 272 FTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGS-GQGEREFQAEVD 330
Query: 167 IIAYVDHPNTAKLVG-CDSDGIH-LVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGT 222
II+ V H LVG C +DG LV++ P +L LHG K+ P ++S R RIALG
Sbjct: 331 IISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHG-KNLPVMEFSTRLRIALGA 389
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL YLHE C RIIHRDIK+ NILL +++ + DFGLAK TH + ++ GTF
Sbjct: 390 AKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVS-TRVMGTF 448
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDH---LQQSVVIWAKPL----LDS 335
GY APEY G + EK+DV+S+GV+LLELITG+R VD+ + ++V WA+PL L+
Sbjct: 449 GYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARALED 508
Query: 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKE 395
+ EL D L NY+ +E+ R V A+ I S RPKMSQ+V L G E + ++ E
Sbjct: 509 GNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEG-EVSLDALNE 567
Query: 396 SQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
K H Y L + +Y+ T Y +D+ +F++IAL S
Sbjct: 568 GVKPGHSNVYG-SLGASSDYSQTSYNADMKKFRQIALSS 605
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 143/332 (43%), Positives = 194/332 (58%), Gaps = 17/332 (5%)
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL 162
+L+ F ELQ+AT NFSS+NL+GKGG+ VYKGCL DG+++AVKRL F
Sbjct: 296 NLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQ 355
Query: 163 CEIGIIAYVDHPNTAKLVG-CDSDGIHL-VFQLSPLGSLASILHGSKDKP--DWSKRYRI 218
E+ +I+ H N +L G C + L V+ GS+AS L K KP DW R RI
Sbjct: 356 TELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRL---KAKPVLDWGTRKRI 412
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278
ALG GL YLHE C +IIHRD+KA NILL + +E + DFGLAK L + +H +
Sbjct: 413 ALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHV-TTAV 471
Query: 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD-----HLQQSVVIWAKPLL 333
GT G+ APEY G EKTDV+ FG+LLLELITG RA++ + + +++ W K L
Sbjct: 472 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGAILDWVKKLQ 531
Query: 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSV 393
+ ++VD L NYD E++ V A LC + PI RPKMS+VV +L GD +
Sbjct: 532 QEKKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKWE 591
Query: 394 KESQKQTHRRTYSEELFDAQEYNSTRYLSDIS 425
SQ+ R+YS+ E++S+ SD++
Sbjct: 592 ASSQRAETNRSYSK----PNEFSSSERYSDLT 619
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 142/340 (41%), Positives = 202/340 (59%), Gaps = 21/340 (6%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
F EL AT FS NL+G+GG+ V+KG LR+G VAVK+L +G+ + F E+G
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGS-SQGEREFQAEVG 400
Query: 167 IIAYVDHPNTAKLVG-CDSDGIHL-VFQLSPLGSLASILHGSKDKP--DWSKRYRIALGT 222
II+ V H + LVG C +D L V++ P +L LHG K +P +WS R +IA+G+
Sbjct: 401 IISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG-KGRPTMEWSSRLKIAVGS 459
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL+YLHE C +IIHRDIKA NIL+ +E ++ DFGLAK TH + ++ GTF
Sbjct: 460 AKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVMGTF 518
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD----HLQQSVVIWAKPLLDSNDI 338
GY APEY G + EK+DV+SFGV+LLELITGRR +D H S+V WA+PLL N +
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLL--NQV 576
Query: 339 REL------VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQS 392
EL VD L + YD EE+ R V A+ C+ + RP+M QV +L G+ +
Sbjct: 577 SELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN-ISPSD 635
Query: 393 VKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIAL 432
+ + H Y + +Y+S++ +++F+++ L
Sbjct: 636 LNQGITPGHSNVYGSS-GGSTDYDSSQDNEGMNKFRKVGL 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 146/349 (41%), Positives = 203/349 (58%), Gaps = 36/349 (10%)
Query: 102 SSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGF 161
S FT EL T+ FS N++G+GG+ VYKG L DG LVAVK+L G+ + F
Sbjct: 336 SGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGS-GQGDREF 394
Query: 162 LCEIGIIAYVDHPNTAKLVG-CDSDGIHL-VFQLSPLGSLASILHGSKDKP--DWSKRYR 217
E+ II+ V H + LVG C +D L +++ P +L LHG K +P +W++R R
Sbjct: 395 KAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG-KGRPVLEWARRVR 453
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277
IA+G+A GL YLHE C +IIHRDIK+ NILL +++E Q+ DFGLAK TH + ++
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TR 512
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ----QSVVIWAKPLL 333
GTFGY APEY G + +++DV+SFGV+LLELITGR+ VD Q +S+V WA+PLL
Sbjct: 513 VMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLL 572
Query: 334 ----DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL-----R 384
++ D ELVD L +Y E+ R + TA+ C+ S RP+M QVV L
Sbjct: 573 HKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDM 632
Query: 385 GDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALG 433
GD N V +S Y+S +Y +D +F+++A G
Sbjct: 633 GDISNGNKVGQSSA----------------YDSGQYNNDTMKFRKMAFG 665
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 145/341 (42%), Positives = 201/341 (58%), Gaps = 19/341 (5%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
FT +L AT NFS+ NL+G+GG+ V++G L DGTLVA+K+L G+ + F EI
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGS-GQGEREFQAEIQ 189
Query: 167 IIAYVDHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGT 222
I+ V H + L+G G LV++ P +L LH K++P +WSKR +IALG
Sbjct: 190 TISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLH-EKERPVMEWSKRMKIALGA 248
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL YLHE C + IHRD+KA NIL+ + YE ++ DFGLA+ TH + ++ GTF
Sbjct: 249 AKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVS-TRIMGTF 307
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ-----QSVVIWAKPL----L 333
GY APEY G + EK+DV+S GV+LLELITGRR VD Q S+V WAKPL L
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSV 393
+ + LVDP L +++D E+ R V A+ + S RPKMSQ+V G+ + +
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNI-SIDDL 426
Query: 394 KESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
E YS L + +Y+ST+Y D+ +FK++A S
Sbjct: 427 TEGAAPGQSTIYS--LDGSSDYSSTQYKEDLKKFKKMAFES 465
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 146/340 (42%), Positives = 199/340 (58%), Gaps = 22/340 (6%)
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
FT EL AT+ F+ NL+G+GG+ V+KG L G VAVK L G+ + F E+
Sbjct: 300 FTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGS-GQGEREFQAEVD 358
Query: 167 IIAYVDHPNTAKLVG-CDSDGIHL-VFQLSPLGSLASILHGSKDKP--DWSKRYRIALGT 222
II+ V H + LVG C S G L V++ P +L LHG K +P DW R +IALG+
Sbjct: 359 IISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHG-KGRPVLDWPTRVKIALGS 417
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL YLHE C RIIHRDIKA NILL +E ++ DFGLAK +TH + ++ GTF
Sbjct: 418 ARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVS-TRVMGTF 476
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD---HLQQSVVIWAKPLL----DS 335
GY APEY G + +K+DV+SFGV+LLELITGR +D ++ S+V WA+PL
Sbjct: 477 GYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAAQD 536
Query: 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD---EDNAQS 392
D +L DP L NY +E+ + A+ I S RPKMSQ+V L GD +D ++
Sbjct: 537 GDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSEG 596
Query: 393 VKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIAL 432
+ Q TY + EY+++ Y +D+ +FK++AL
Sbjct: 597 TRPGQS-----TYLSPGSVSSEYDASSYTADMKKFKKLAL 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | ||||||
| 224123254 | 439 | predicted protein [Populus trichocarpa] | 0.965 | 0.954 | 0.689 | 1e-174 | |
| 356574920 | 490 | PREDICTED: receptor-like cytosolic serin | 0.960 | 0.851 | 0.661 | 1e-165 | |
| 449442863 | 456 | PREDICTED: receptor-like cytosolic serin | 0.967 | 0.921 | 0.672 | 1e-164 | |
| 449482896 | 456 | PREDICTED: receptor-like cytosolic serin | 0.967 | 0.921 | 0.672 | 1e-164 | |
| 357441549 | 520 | Cysteine-rich receptor-like protein kina | 0.951 | 0.794 | 0.632 | 1e-157 | |
| 356533605 | 504 | PREDICTED: receptor-like cytosolic serin | 0.963 | 0.829 | 0.649 | 1e-156 | |
| 297833220 | 469 | kinase family protein [Arabidopsis lyrat | 0.988 | 0.914 | 0.608 | 1e-150 | |
| 22330852 | 460 | ROP binding protein kinase 2 [Arabidopsi | 0.990 | 0.934 | 0.591 | 1e-148 | |
| 359487962 | 433 | PREDICTED: receptor-like cytosolic serin | 0.903 | 0.905 | 0.643 | 1e-145 | |
| 147797625 | 479 | hypothetical protein VITISV_028676 [Viti | 0.928 | 0.841 | 0.622 | 1e-144 |
| >gi|224123254|ref|XP_002319033.1| predicted protein [Populus trichocarpa] gi|222857409|gb|EEE94956.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 296/429 (68%), Positives = 357/429 (83%), Gaps = 10/429 (2%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFH 73
D SSPRGV+++C G ES + F N+T +S+A +NWSRFFK WK+ S KHL +
Sbjct: 13 DGSSPRGVIEACLTGLESNSDFTRNSTAESEVPRSKAHSNWSRFFKSWKRFSLKHLTS-- 70
Query: 74 PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV 133
P +PK + KSRSTRE+ L ++YN++S+L+ FT +EL+ AT NF+ ENLIGKGG+AEV
Sbjct: 71 PPPVPKEPKRKSRSTRENTVLRNLYNFKSTLQHFTFAELKMATNNFNHENLIGKGGFAEV 130
Query: 134 YKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLVFQ 192
YKGCL DG LVA+K+LTKGT+DEKT GFL E+GIIA+VDHPNTAKL+GC DG +HLVF+
Sbjct: 131 YKGCLPDGRLVAIKQLTKGTLDEKTAGFLNELGIIAHVDHPNTAKLLGCGIDGGMHLVFE 190
Query: 193 LSPLGSLASILHG-----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247
LSPLGSL S LHG S+ + DWSKRY+IALG A+GL YLHE C++RIIHRDIKADNI
Sbjct: 191 LSPLGSLGSALHGLVLICSQVELDWSKRYKIALGAADGLLYLHENCRRRIIHRDIKADNI 250
Query: 248 LLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVL 307
LLT+++EPQICDFGLAKWLP QWTHHNVSKFEGTFGYFAPEY+MHGIVDEKTD+Y+FGVL
Sbjct: 251 LLTKNFEPQICDFGLAKWLPTQWTHHNVSKFEGTFGYFAPEYYMHGIVDEKTDIYAFGVL 310
Query: 308 LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIE 367
LLELITGRR VD LQQS+V+WAKPLLD+ND +EL DPSLGDNYD EE+DR VLTASLCIE
Sbjct: 311 LLELITGRRPVDRLQQSLVVWAKPLLDNNDTKELADPSLGDNYDLEEMDRVVLTASLCIE 370
Query: 368 QSPILRPKMSQ--VVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDIS 425
QSP+LRP+MSQ VVILLRGDE ++ K+ + + RTYSEE+FDAQ+YNSTRYL+D+
Sbjct: 371 QSPVLRPRMSQASVVILLRGDEYVSERAKKGKGRALLRTYSEEIFDAQDYNSTRYLNDLK 430
Query: 426 RFKEIALGS 434
R+KE+ALGS
Sbjct: 431 RYKELALGS 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574920|ref|XP_003555591.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 280/423 (66%), Positives = 352/423 (83%), Gaps = 6/423 (1%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFH 73
+ +SPRGVL++C + +S E+ + S +RA ++WS+FFK+W+KKS K L +
Sbjct: 71 NIASPRGVLEACMKDFDSHDQSHESKA---TCSTTRARSHWSKFFKIWRKKSFKRLGSLP 127
Query: 74 PL-AMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAE 132
PL ++PK+ + KS+S+RE+ L+ +YN+RSS F+LSEL+ AT NFS EN+IG+GG+AE
Sbjct: 128 PLISVPKIPKWKSKSSRENQVLSKLYNFRSSWVTFSLSELRNATNNFSDENIIGRGGFAE 187
Query: 133 VYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLVF 191
VYKGCL+DG L+AVK+L+KGT DEKT GFLCE+G+IA+VDHPNTAKLVGC +G + LVF
Sbjct: 188 VYKGCLQDGQLIAVKKLSKGTTDEKTAGFLCELGVIAHVDHPNTAKLVGCCVEGEMQLVF 247
Query: 192 QLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250
+LS LGSL S+LHGS K K DWSKRY+IALG A+GL YLHE C +RIIHRDIKA+NILLT
Sbjct: 248 ELSTLGSLGSLLHGSDKKKLDWSKRYKIALGIADGLLYLHECCHRRIIHRDIKAENILLT 307
Query: 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
E++EPQICDFGLAKWLP QWTHH+VSKFEGTFGYFAPEYFMHGIVDEKTDV+SFGVLLLE
Sbjct: 308 ENFEPQICDFGLAKWLPEQWTHHSVSKFEGTFGYFAPEYFMHGIVDEKTDVFSFGVLLLE 367
Query: 311 LITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSP 370
+ITGR AVDH+QQSVVIWAKPLLD+N I++LVDPSLGD+Y E++ VLTAS+CIE SP
Sbjct: 368 IITGRPAVDHMQQSVVIWAKPLLDANHIKDLVDPSLGDDYKREQMGCVVLTASMCIEHSP 427
Query: 371 ILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEI 430
ILRP+MSQVV LLRG++ ++ K S+++ +R YSEEL DAQEYNST++L D+ RF++I
Sbjct: 428 ILRPRMSQVVTLLRGEDHVLKATKSSRRRPLQRAYSEELLDAQEYNSTKHLRDLKRFEQI 487
Query: 431 ALG 433
ALG
Sbjct: 488 ALG 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442863|ref|XP_004139200.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/425 (67%), Positives = 350/425 (82%), Gaps = 5/425 (1%)
Query: 14 DASSPRGVLDSCFRGSESEA-SFKENTTQSES-PSKSRALTNWSRFFKLWKKKSTKHLRT 71
D SPRGVL++ + SE +A S ++T + E+ PS+S AL +W FFKLWKK+S + L +
Sbjct: 33 DGLSPRGVLEASLQSSEFDADSLNDSTPEPENQPSQSGALFHWKNFFKLWKKRSFRRLAS 92
Query: 72 FHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYA 131
F PL + K+SR +RS RE+P L+ +Y ++SSL FT SELQTAT FS ENLIGKGGYA
Sbjct: 93 FPPLGVLKISRRGNRSGRENPGLSDLYKFKSSLGNFTFSELQTATNKFSHENLIGKGGYA 152
Query: 132 EVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLV 190
EVYKG L DG L+AVKRLTKG D++T FL EIGIIA++DHPNTAKL+GC DG +HLV
Sbjct: 153 EVYKGRLHDGQLIAVKRLTKGAPDDRTACFLSEIGIIAHIDHPNTAKLIGCGIDGGMHLV 212
Query: 191 FQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
F+LSP GSL S LHG + +K DWSKRY+IALGTA+GL YLH+ CQ+RIIHRDIKADNILL
Sbjct: 213 FKLSPNGSLGSFLHGPNANKLDWSKRYKIALGTADGLLYLHDHCQRRIIHRDIKADNILL 272
Query: 250 TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL 309
TED+ PQICDFGLAKWLP+QWTH++VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL
Sbjct: 273 TEDFVPQICDFGLAKWLPKQWTHYSVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL 332
Query: 310 ELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQS 369
EL+TGRRA+D L QS+V+WAKPLLD+N+ E++DP+L ++YD EE++R +LTASLCIEQS
Sbjct: 333 ELVTGRRALDELCQSLVLWAKPLLDNNNHEEVIDPALKESYDLEEVERMILTASLCIEQS 392
Query: 370 PILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKE 429
PILRP+MSQVV+LLRGD+ A+ K S + +RTYSEEL DAQEYN TRYLSD+ + ++
Sbjct: 393 PILRPRMSQVVVLLRGDKYVAECEK-STRVPLQRTYSEELLDAQEYNKTRYLSDLKKHRQ 451
Query: 430 IALGS 434
+A GS
Sbjct: 452 LAFGS 456
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482896|ref|XP_004156435.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 286/425 (67%), Positives = 350/425 (82%), Gaps = 5/425 (1%)
Query: 14 DASSPRGVLDSCFRGSESEA-SFKENTTQSES-PSKSRALTNWSRFFKLWKKKSTKHLRT 71
D SPRGVL++ + SE +A S ++T + E+ PS+S AL +W FFKLWKK+S + L +
Sbjct: 33 DGLSPRGVLEASLQSSEFDADSLNDSTPEPENQPSQSGALFHWKNFFKLWKKRSFRRLAS 92
Query: 72 FHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYA 131
F PL + K+SR +RS RE+P L+ +Y ++SSL FT SELQTAT FS ENLIGKGGYA
Sbjct: 93 FPPLGVLKISRRGNRSGRENPGLSDLYKFKSSLGNFTFSELQTATNKFSHENLIGKGGYA 152
Query: 132 EVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLV 190
EVYKG L DG L+AVKRLTKG D++T FL EIGIIA++DHPNTAKL+GC DG +HLV
Sbjct: 153 EVYKGRLHDGQLIAVKRLTKGAPDDRTACFLSEIGIIAHIDHPNTAKLIGCGIDGGMHLV 212
Query: 191 FQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
F+LSP GSL S LHG + +K DWSKRY+IALGTA+GL YLH+ CQ+RIIHRDIKADNILL
Sbjct: 213 FKLSPNGSLGSFLHGPNANKLDWSKRYKIALGTADGLLYLHDHCQRRIIHRDIKADNILL 272
Query: 250 TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL 309
TED+ PQICDFGLAKWLP+QWTH++VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL
Sbjct: 273 TEDFVPQICDFGLAKWLPKQWTHYSVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL 332
Query: 310 ELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQS 369
EL+TGRRA+D L QS+V+WAKPLLD+N+ E++DP+L ++YD EE++R +LTASLCIEQS
Sbjct: 333 ELVTGRRALDELCQSLVLWAKPLLDNNNHEEVIDPALKESYDLEEVERMILTASLCIEQS 392
Query: 370 PILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKE 429
PILRP+MSQVV+LLRGD+ A+ K S + +RTYSEEL DAQEYN TRYLSD+ + ++
Sbjct: 393 PILRPRMSQVVVLLRGDKYLAECEK-STRVPLQRTYSEELLDAQEYNKTRYLSDLKKHRQ 451
Query: 430 IALGS 434
+A GS
Sbjct: 452 LAFGS 456
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357441549|ref|XP_003591052.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355480100|gb|AES61303.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 265/419 (63%), Positives = 342/419 (81%), Gaps = 6/419 (1%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFH 73
D +SPRGVL++C +G +++ + T S S SRA ++W +FFKLWK+KS K L + H
Sbjct: 52 DEASPRGVLEACVKGFDAQQLPEPET----SCSNSRARSHWGKFFKLWKRKSVKRLTSIH 107
Query: 74 PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV 133
+ +PK+ + KSRSTRE+ +++YN+RSSL F+LS+L+ AT +FS ENLIG+GG++EV
Sbjct: 108 SIGVPKIPKWKSRSTRENFVTSNLYNFRSSLVTFSLSDLRNATNHFSHENLIGRGGFSEV 167
Query: 134 YKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLVFQ 192
YKGCL+DG L+AVK++T G+ DEKT GFL E+G+IA+VDHPNTAKLVGC +G +HLVF+
Sbjct: 168 YKGCLQDGQLIAVKKMTTGSTDEKTAGFLSELGVIAHVDHPNTAKLVGCCVEGEMHLVFE 227
Query: 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251
LS LGSL +LHGS K K DWSKRY++ALG A+GL YLHE CQ+RIIHRDIKA+NILLTE
Sbjct: 228 LSTLGSLGYVLHGSDKTKLDWSKRYKVALGIADGLLYLHENCQRRIIHRDIKAENILLTE 287
Query: 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
+++PQICDFGLAKWLP Q THHN+S FEGTFGY +PEY MHGIVDEKTDVYSFGVLLLE+
Sbjct: 288 NFDPQICDFGLAKWLPEQLTHHNMSTFEGTFGYLSPEYCMHGIVDEKTDVYSFGVLLLEI 347
Query: 312 ITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPI 371
ITGR+A+D +Q SVV WAKPLLD+N+I+++VDPSLG NYD ++ LTAS+C+EQSPI
Sbjct: 348 ITGRKALDRMQTSVVTWAKPLLDANNIKDVVDPSLGGNYDQGQMGCVSLTASICVEQSPI 407
Query: 372 LRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEI 430
LRP+MSQ+V LLRG++ + S+++ +RTYSEEL DAQEYNST+YL D++R K+I
Sbjct: 408 LRPRMSQIVTLLRGEKSVMYARACSKRRNLQRTYSEELLDAQEYNSTKYLRDLNRHKKI 466
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356533605|ref|XP_003535352.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-156, Method: Compositional matrix adjust.
Identities = 274/422 (64%), Positives = 342/422 (81%), Gaps = 4/422 (0%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFH 73
D+SSPR VL++ F ++ +++ + S ++ +W++FFKLWKKKS K L +
Sbjct: 82 DSSSPREVLEA-FMKDFVDSHHEQSHESETTSSTTKTHYHWTKFFKLWKKKSFKRLGSIP 140
Query: 74 PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV 133
PL++PKL + KS+S+RE+ L+ +YN+RSS F+LS+L+ AT NFS+EN+IG+GG+AEV
Sbjct: 141 PLSVPKLPKWKSKSSRENQALSKLYNFRSSWVTFSLSKLRHATNNFSAENIIGRGGFAEV 200
Query: 134 YKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLVFQ 192
YKGCL++G L+AVK+LTKGT DEKT GFLCE+G+IA+VDHPNTAKLVGC +G + LVFQ
Sbjct: 201 YKGCLQNGQLIAVKKLTKGTTDEKTAGFLCELGVIAHVDHPNTAKLVGCCVEGEMLLVFQ 260
Query: 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251
LS LGSL S+LHGS K+K DWSKRY+I LG A+GL YLHE C +RIIHRDIKA+NILLTE
Sbjct: 261 LSTLGSLGSLLHGSDKNKLDWSKRYKICLGIADGLLYLHECCHRRIIHRDIKAENILLTE 320
Query: 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
++EPQICDFGLAKWLP QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV+SFGVLLLE+
Sbjct: 321 NFEPQICDFGLAKWLPEQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFSFGVLLLEI 380
Query: 312 ITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPI 371
ITGR AVDH+QQSVVIWAKPLLD N I++LVDPSLGD+Y+ ++ VLTAS+CIE SPI
Sbjct: 381 ITGRPAVDHMQQSVVIWAKPLLDKNHIKDLVDPSLGDDYERGQLSCVVLTASMCIEHSPI 440
Query: 372 LRPKMSQVVILLRG-DEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEI 430
RP+MSQVV LLRG D ++ +RTYSEEL DAQEYNST++L D+ RF+++
Sbjct: 441 FRPRMSQVVTLLRGEDHVLKAKKSSQSSRSLQRTYSEELPDAQEYNSTKHLRDLKRFEQL 500
Query: 431 AL 432
L
Sbjct: 501 TL 502
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297833220|ref|XP_002884492.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297330332|gb|EFH60751.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 270/444 (60%), Positives = 329/444 (74%), Gaps = 15/444 (3%)
Query: 6 LYVNNGSLDASSPRGVLDSCFR------------GSESEASFKENTTQSESPSKSRALTN 53
L V D SPRG L++C EAS + RA +N
Sbjct: 26 LEVEKEKQDPKSPRGALEACLTRSSISSSSSDDPPPNREASDNADADTDAQCKNHRASSN 85
Query: 54 WSRFFKLWKKKSTKHLRTFHPLAMPKLSREKSRSTREDPDLTH-IYNYRSSLKEFTLSEL 112
W +FFKLWK++S K L +F PL+ S KS T D + H IY+++SSL F++S++
Sbjct: 86 WGKFFKLWKRRSMKRLSSFPPLSGAAPSISKSNKTHIDGMVLHDIYDFQSSLHNFSISDI 145
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD 172
+ AT NFS EN+IG+GGYAEVY+G L +G L+AVKRLTKGT DE+T FL E+GIIA+VD
Sbjct: 146 EIATDNFSPENIIGRGGYAEVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSELGIIAHVD 205
Query: 173 HPNTAKLVGCDSDG-IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLH 230
HPNTAK +GC +G +HLVF+LSPLGSL S+LHG SK K WS+RY +ALGTA+GL YLH
Sbjct: 206 HPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTADGLVYLH 265
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
EGCQ+RIIHRDIKADNILLTED++PQICDFGLAKWLP+Q THHNVSKFEGTFGYFAPEYF
Sbjct: 266 EGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGYFAPEYF 325
Query: 291 MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350
MHGIVDEKTDV++FGVLLLELITG A+D QQS+V+WAKPLL+ IRELVDPSLGD Y
Sbjct: 326 MHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLEKKAIRELVDPSLGDEY 385
Query: 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELF 410
+ EE+ R TASLCI+QS +LRP+MSQVV LL G E + +E++ + +RTYSEEL
Sbjct: 386 NREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEGVVMTPREAKIKMMQRTYSEELL 445
Query: 411 DAQEYNSTRYLSDISRFKEIALGS 434
D+ EYNST+YL D+ R +EIAL S
Sbjct: 446 DSVEYNSTKYLGDLDRIREIALAS 469
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22330852|ref|NP_187165.2| ROP binding protein kinase 2 [Arabidopsis thaliana] gi|75330746|sp|Q8RXC8.1|RBK2_ARATH RecName: Full=Receptor-like cytosolic serine/threonine-protein kinase RBK2; AltName: Full=Protein ROP BINDING PROTEIN KINASES 2 gi|19698987|gb|AAL91229.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|22136306|gb|AAM91231.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332640669|gb|AEE74190.1| ROP binding protein kinase 2 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1371), Expect = e-148, Method: Compositional matrix adjust.
Identities = 266/450 (59%), Positives = 332/450 (73%), Gaps = 20/450 (4%)
Query: 5 FLYVNNGSLDASSPRGVLDSCFR--------------GSESEASFKENTTQSESPSKSRA 50
L V+ D SPRG L++C EA + RA
Sbjct: 11 LLEVDKEKQDPKSPRGALEACLTRCSISSASSSSDDPPPNREAIDNADADTDVQCKNHRA 70
Query: 51 LTNWSRFFKLWKKKSTKHLRTFHPL---AMPKLSREKSRSTREDPDLTH-IYNYRSSLKE 106
+NW +FFKLWK++S K L +F PL A P + + KS + + H IY+++SSL+
Sbjct: 71 SSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSLQN 130
Query: 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
F++S+++ AT NFS EN+IG+GGYA+VY+G L +G L+AVKRLTKGT DE+T FL E+G
Sbjct: 131 FSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSELG 190
Query: 167 IIAYVDHPNTAKLVGCDSDG-IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTAN 224
IIA+VDHPNTAK +GC +G +HLVF+LSPLGSL S+LHG SK K WS+RY +ALGTA+
Sbjct: 191 IIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTAD 250
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL YLHEGCQ+RIIHRDIKADNILLTED++PQICDFGLAKWLP+Q THHNVSKFEGTFGY
Sbjct: 251 GLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGY 310
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344
FAPEYFMHGIVDEKTDV++FGVLLLELITG A+D QQS+V+WAKPLL+ I+ELVDP
Sbjct: 311 FAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELVDP 370
Query: 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRT 404
SLGD Y+ EE+ R TASLCI+QS +LRP+MSQVV LL G ED + +E++ + +RT
Sbjct: 371 SLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAKIKMMQRT 430
Query: 405 YSEELFDAQEYNSTRYLSDISRFKEIALGS 434
YSEEL D+ EYNST+YL D+ R +E+AL S
Sbjct: 431 YSEELLDSVEYNSTKYLGDLDRIREVALAS 460
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487962|ref|XP_002264044.2| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 256/398 (64%), Positives = 309/398 (77%), Gaps = 6/398 (1%)
Query: 27 RGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFHPLAMPKLSREKSR 86
R S + F + + ES +SRA ++W F + K S + P+ M K SR KS+
Sbjct: 35 RDKISGSRFPSSVSAQES-KRSRARSHWRSFLNRFTKNSVIRFPSLTPV-MSKRSRGKSQ 92
Query: 87 STREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAV 146
S RE+ + +N SS K F+L ELQ ATKNF ENLIGKGGYAEVYKG L+DG +A+
Sbjct: 93 SARENVLAVNTFN--SSWKNFSLVELQNATKNFHHENLIGKGGYAEVYKGRLKDGQFIAI 150
Query: 147 KRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGIHLVFQLSPLGSLASILHG 205
KRLT+GT +E+ FL E+GIIA+V+HPNTAKL+G G+HLV QLSPLGSL S+LH
Sbjct: 151 KRLTQGTPEERVMSFLHELGIIAHVNHPNTAKLIGYGVQGGLHLVLQLSPLGSLGSLLHV 210
Query: 206 SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265
+K K +WS RY+IALGTA+GL YLHE CQ+RIIHRDIKADNILLTED+EPQICDFGLAKW
Sbjct: 211 TKSKLEWSSRYKIALGTADGLRYLHEHCQRRIIHRDIKADNILLTEDFEPQICDFGLAKW 270
Query: 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV 325
LP+QWTH NV+KFEGTFGYFAPEYFMHGIVDEKTD++SFGVLLLELITGRRAVDH++QS+
Sbjct: 271 LPKQWTHFNVTKFEGTFGYFAPEYFMHGIVDEKTDIFSFGVLLLELITGRRAVDHMKQSL 330
Query: 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385
V+WAKPLL N + ELVDP+L D YD EE+DR +LTASLCIEQSP+LRP+M+QVV+LLRG
Sbjct: 331 VVWAKPLLYKNSVAELVDPAL-DEYDEEEMDRMLLTASLCIEQSPVLRPRMNQVVVLLRG 389
Query: 386 DEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSD 423
DE N +ESQ +RTYS E+ DA EYNST+ L +
Sbjct: 390 DEYNPDGAQESQNHMPKRTYSNEILDAAEYNSTKCLDE 427
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147797625|emb|CAN71781.1| hypothetical protein VITISV_028676 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 519 bits (1337), Expect = e-144, Method: Compositional matrix adjust.
Identities = 261/419 (62%), Positives = 317/419 (75%), Gaps = 16/419 (3%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSK-SRALTNWSRFFKLWKKKSTKHLRTF 72
D +P+G+L+ C +ES + + S SK SRA ++W F + K S +
Sbjct: 62 DEHTPKGILEFC---AESFVPEMQTSCLGSSESKRSRARSHWRSFLNRFTKNSVIRFPSL 118
Query: 73 HPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAE 132
P+ M K SR KS+S RE+ + +N SS K F+L ELQ ATKNF ENLIGKGGYAE
Sbjct: 119 TPV-MSKRSRGKSQSARENVLAVNTFN--SSWKNFSLVELQNATKNFHHENLIGKGGYAE 175
Query: 133 VYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGIHLVF 191
VYKG L+DG +A+KRLT+GT +E+ FL E+GIIA+V+HPNTAKL+G G+HLV
Sbjct: 176 VYKGRLKDGQFIAIKRLTQGTPEERVMSFLHELGIIAHVNHPNTAKLIGYGVQGGLHLVL 235
Query: 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251
QLSPLGSL S+LH +K K +WS RY+IALGTA+GL YLHE CQ+RIIHRDIKADNILLTE
Sbjct: 236 QLSPLGSLGSLLHVTKSKLEWSSRYKIALGTADGLRYLHEHCQRRIIHRDIKADNILLTE 295
Query: 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
D+EPQICDFGLAKWLP+QWTH NV+KFEGTFGYFAPEYFMHGIVDEKTD++SFGVLLLEL
Sbjct: 296 DFEPQICDFGLAKWLPKQWTHFNVTKFEGTFGYFAPEYFMHGIVDEKTDIFSFGVLLLEL 355
Query: 312 ITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPI 371
ITGRRAVDH++QS+V+WAKPLL N + ELVDP+L D YD EE+DR +LTASLCIEQSP+
Sbjct: 356 ITGRRAVDHMKQSLVVWAKPLLYKNSVAELVDPAL-DEYDEEEMDRMLLTASLCIEQSPV 414
Query: 372 LRPKMSQ-------VVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRYLSD 423
LRP+M+Q VV+LLRGDE N +ESQ +RTYS E+ DA EYNST+ L +
Sbjct: 415 LRPRMNQASTNFRKVVVLLRGDEYNPDGAQESQNHMPKRTYSNEILDAAEYNSTKCLDE 473
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | ||||||
| TAIR|locus:2096209 | 460 | RBK2 "ROP binding protein kina | 0.976 | 0.921 | 0.602 | 5.8e-137 | |
| TAIR|locus:2144970 | 511 | AT5G18910 [Arabidopsis thalian | 0.880 | 0.747 | 0.587 | 1.5e-122 | |
| TAIR|locus:2162848 | 429 | AT5G35960 [Arabidopsis thalian | 0.898 | 0.909 | 0.527 | 1.6e-104 | |
| TAIR|locus:2155700 | 456 | AT5G65530 [Arabidopsis thalian | 0.970 | 0.923 | 0.481 | 8.8e-102 | |
| TAIR|locus:2142514 | 467 | RBK1 "ROP binding protein kina | 0.951 | 0.884 | 0.453 | 6.8e-95 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.741 | 0.821 | 0.5 | 1.7e-84 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.861 | 0.645 | 0.462 | 6.4e-83 | |
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.744 | 0.406 | 0.45 | 2.4e-67 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.753 | 0.501 | 0.424 | 1.4e-62 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.755 | 0.506 | 0.419 | 1.5e-60 |
| TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 5.8e-137, P = 5.8e-137
Identities = 262/435 (60%), Positives = 333/435 (76%)
Query: 11 GSLDASSPRGVLDSCFRGSESEASFKENTTQSESPS-----KSRALTNWSRFFKLWKKKS 65
G+L+A R + S S+ +E +++ + RA +NW +FFKLWK++S
Sbjct: 26 GALEACLTRCSISSASSSSDDPPPNREAIDNADADTDVQCKNHRASSNWGKFFKLWKRRS 85
Query: 66 TKHLRTFHPL---AMPKLSREKSRSTREDPDLTH-IYNYRSSLKEFTLSELQTATKNFSS 121
K L +F PL A P + + KS + + H IY+++SSL+ F++S+++ AT NFS
Sbjct: 86 MKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSLQNFSISDIEIATDNFSP 145
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
EN+IG+GGYA+VY+G L +G L+AVKRLTKGT DE+T FL E+GIIA+VDHPNTAK +G
Sbjct: 146 ENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSELGIIAHVDHPNTAKFIG 205
Query: 182 CDSDG-IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
C +G +HLVF+LSPLGSL S+LHG SK K WS+RY +ALGTA+GL YLHEGCQ+RIIH
Sbjct: 206 CCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTADGLVYLHEGCQRRIIH 265
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT 299
RDIKADNILLTED++PQICDFGLAKWLP+Q THHNVSKFEGTFGYFAPEYFMHGIVDEKT
Sbjct: 266 RDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKT 325
Query: 300 DVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359
DV++FGVLLLELITG A+D QQS+V+WAKPLL+ I+ELVDPSLGD Y+ EE+ R
Sbjct: 326 DVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELVDPSLGDEYNREELIRLT 385
Query: 360 LTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTR 419
TASLCI+QS +LRP+MSQVV LL G ED + +E++ + +RTYSEEL D+ EYNST+
Sbjct: 386 STASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAKIKMMQRTYSEELLDSVEYNSTK 445
Query: 420 YLSDISRFKEIALGS 434
YL D+ R +E+AL S
Sbjct: 446 YLGDLDRIREVALAS 460
|
|
| TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1205 (429.2 bits), Expect = 1.5e-122, P = 1.5e-122
Identities = 231/393 (58%), Positives = 301/393 (76%)
Query: 53 NWSR-FFKLWKK-KSTKHLRTFHPL-AMPKLSREKSRSTRED--P-----DLTHIYNYRS 102
+W R FF+L KK S TF PL +PKL+R KS+ R++ P D H++ ++
Sbjct: 116 HWRRGFFRLLKKGSSAMPFNTFTPLKGVPKLTRRKSKRIRDNMVPVIPALDTDHLFYFKP 175
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL 162
S + F+L ++QTAT ++S ENLIG+GGYAEVYKG + DG +VA+K+LT+G+ +E T +L
Sbjct: 176 SWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMTMDYL 235
Query: 163 CEIGIIAYVDHPNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALG 221
E+GII +VDHPN AKL+G C G+HLV +LSP GSLAS+L+ +K+K +WS RY++A+G
Sbjct: 236 SELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEKLNWSMRYKVAMG 295
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT 281
TA GL YLHEGCQ+RIIH+DIKA NILLT+++E QI DFGLAKWLP QWTHH VSK EGT
Sbjct: 296 TAEGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTVSKVEGT 355
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341
FGY PE+FMHGIVDEKTDVY++GVLLLELITGR+A+D Q S+V+WAKPL+ N I++L
Sbjct: 356 FGYLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQHSIVMWAKPLIKENKIKQL 415
Query: 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTH 401
VDP L D+YD EE+DR V ASLCI Q+ + RP+MSQVV +LRGD+ + ++E +
Sbjct: 416 VDPILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEILRGDKCSLDKLRERENSKL 475
Query: 402 RRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
+RTYSEEL D +EYNSTRYL+DI+R E LG+
Sbjct: 476 QRTYSEELLDNEEYNSTRYLNDINRHMETVLGT 508
|
|
| TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 212/402 (52%), Positives = 283/402 (70%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRT-F 72
D+SSP GVL+ FR E +S T ++ S S+ R + + + KKS ++++ F
Sbjct: 30 DSSSPTGVLEEFFRTEEFNSS--SETVKNPSSSRFRKMV---QLLRSKSKKSLENVKIPF 84
Query: 73 HPLAMPKLSREKSRSTRED----PDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKG 128
H + K S + S RE+ + +H + S + FT S+L++AT NFS ENLIGKG
Sbjct: 85 HNNGVIKSSFRRCSSMRENLRFSSNDSH-FLLHSPRRIFTFSDLKSATNNFSLENLIGKG 143
Query: 129 GYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG-I 187
GYAEVYKG L +G +VA+KRL +G +E FL E+GI+A+V+HPN AKL+G +G +
Sbjct: 144 GYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAKLLGYGVEGGM 203
Query: 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247
HLV +LSP GSLAS+L+ SK+K WS RY+IALG A GL YLH GC +RIIHRDIKA NI
Sbjct: 204 HLVLELSPHGSLASMLYSSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRIIHRDIKAANI 263
Query: 248 LLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVL 307
LLT D+ PQICDFGLAKWLP WTHH VSKFEGTFGY APEY HGIVDEKTDV++ GVL
Sbjct: 264 LLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGTFGYLAPEYLTHGIVDEKTDVFALGVL 323
Query: 308 LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIE 367
LLEL+TGRRA+D+ +QS+V+WAKPL+ N IREL+DPSL Y+ +I +L A+L I+
Sbjct: 324 LLELVTGRRALDYSKQSLVLWAKPLMKKNKIRELIDPSLAGEYEWRQIKLVLLAAALSIQ 383
Query: 368 QSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEEL 409
QS I RP+MSQVV +L+G+ + + + + + +R+ + +E+
Sbjct: 384 QSSIERPEMSQVVEILKGNLKDLKCIMKCRVPFYRKAFRDEV 425
|
|
| TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
Identities = 214/444 (48%), Positives = 293/444 (65%)
Query: 6 LYVNNGSLDASSPRGVLDSCFRGSESEASF--------KENTTQSESPSKSRALTNWSRF 57
L+ N+ S++ SPR VL+ S+S+ S K ++ S +P + W++
Sbjct: 18 LHKNDLSIEDPSPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSPLSTTPPNVSSFHQWNKM 77
Query: 58 FKLWKKKSTKHLRTFHPLAMPKLSREK-----SRSTREDPDLTHIYNYRSSLKEFTLSEL 112
+ KKKS + LA +L+R+K S + D D I + S + FT EL
Sbjct: 78 IESIKKKSIRRFSVIPLLASYELTRKKKQPKLSPCSENDFDCDQILVAKPSWRNFTFDEL 137
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGT--VDEKTCGFLCEIGIIAY 170
AT NF+ EN+IGKGG+AEVYKG L DG VA+K+LT+ V+E+ FL E+GIIA+
Sbjct: 138 VAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAH 197
Query: 171 VDHPNTAKLVGCDSD-GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
V+HPN A+L G D G+H V + S GSLAS+L GS++ DW KRY++A+G A+GL+YL
Sbjct: 198 VNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWKKRYKVAMGIADGLSYL 257
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
H C +RIIHRDIKA NILL++DYE QI DFGLAKWLP W HH V EGTFGY APEY
Sbjct: 258 HNDCPRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTFGYLAPEY 317
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVD-HLQQSVVIWAKPLLDSNDIRELVDPSLGD 348
FMHGIVDEKTDV++FGVLLLE+ITGRRAVD +QS+V+WAKPLL+ N++ E+VDP LG+
Sbjct: 318 FMHGIVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEKNNMEEIVDPQLGN 377
Query: 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEE 408
++D E+ R + TAS+CI +RP M+++V LLRGD+ A+ QK RT S +
Sbjct: 378 DFDETEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGDDQLAE-----QKPGGARTVSLD 432
Query: 409 LFDAQEYNSTRYLSDISRFKEIAL 432
D ++ S+ YL+D++R +++ +
Sbjct: 433 DCDL-DHTSSSYLNDLTRHRQLLM 455
|
|
| TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 196/432 (45%), Positives = 274/432 (63%)
Query: 14 DASSPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFH 73
D+ + SC +S ++ + +++ S S W++ + KKKS +
Sbjct: 41 DSDNSSSSCSSCSSDDKSSSTSSPFSNTTKTVSSSHHGLQWNKMIESIKKKSMRRFSVIP 100
Query: 74 PLAMPKLSREKSRSTREDPDLTH---------IYNYRSSLKEFTLSELQTATKNFSSENL 124
LA +L+R+ R R+ P LT + + S + FT EL AT F+ EN+
Sbjct: 101 LLASYELTRKNLR--RKQPKLTPSESAFTCEAFFMAKPSWRNFTYEELAVATDYFNPENM 158
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLVGC 182
IGKGG+AEVYKG L +G VA+K+L +E + FL E+GIIA+V+HPN A+L G
Sbjct: 159 IGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDFLSELGIIAHVNHPNAARLRGF 218
Query: 183 DSD-GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
SD G+H V + +P GSLAS+L GS++ +W RY++ALG A+GL+YLH C +RIIHRD
Sbjct: 219 SSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIRYKVALGIADGLSYLHNACPRRIIHRD 278
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
IKA NILL DYE QI DFGLAKWLP W HH V EGTFGY APEYFMHGIVDEK DV
Sbjct: 279 IKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEGTFGYLAPEYFMHGIVDEKIDV 338
Query: 302 YSFGVLLLELITGRRAVDHL-QQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVL 360
++FGVLLLE+IT RRAVD +QS+V WAKP L+ N + ++VDP LG+ ++ E+ R +L
Sbjct: 339 FAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEKNSMEDIVDPRLGNMFNPTEMQRVML 398
Query: 361 TASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQEYNSTRY 420
TAS+C+ +RP M+++V LLRG++ A E Q++ RT S D Q++ S+ Y
Sbjct: 399 TASMCVHHIAAMRPDMTRLVQLLRGEDGPA----ELQQKAGERTMSVNACDLQDHTSSSY 454
Query: 421 LSDISRFKEIAL 432
L+++ R +++ +
Sbjct: 455 LNELRRHRQLLM 466
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 164/328 (50%), Positives = 227/328 (69%)
Query: 101 RSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDE--K 157
R K F+ E+ AT FSSENL+G+GG+AEVYKG L ++G +AVKR+T+G D+ +
Sbjct: 50 RPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDERR 109
Query: 158 TCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLSPLGSLASILHGSKDKP-DWSKR 215
FL EIG I +V HPN L+GC D G++LVF S GSLAS+LH P +W R
Sbjct: 110 EKEFLMEIGTIGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWETR 169
Query: 216 YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275
Y+IA+GTA GL YLH+GCQ+RIIHRDIK+ N+LL +D+EPQI DFGLAKWLP QW+HH++
Sbjct: 170 YKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHSI 229
Query: 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS 335
+ EGTFG+ APEY+ HGIVDEKTDV++FGV LLELI+G++ VD QS+ WAK ++
Sbjct: 230 APIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIKD 289
Query: 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVK- 394
+I +LVDP +G+ +D +++ R ASLCI S + RP M +V+ +L+G++ + K
Sbjct: 290 GEIEKLVDPRIGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEVLQGEDIEKEKWKM 349
Query: 395 ESQKQTHRRTYSEELFDAQEYNSTRYLS 422
E +++ + E + E +S+ LS
Sbjct: 350 EEEEEVKEEFWGYEDLEDCECDSSISLS 377
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
Identities = 181/391 (46%), Positives = 250/391 (63%)
Query: 17 SPRGVLDSCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFHPLA 76
SPR VL++ R S S + ++ S S A + K KS + L
Sbjct: 175 SPRSVLNTLSRDSLSSSGDDASSFNGSMVSSSFASPSDKP-----KHKSISPYKFISSLI 229
Query: 77 MPK-LSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYK 135
M L + + T+ P + ++ FT +E+ AT +F N++G GGY+EVY+
Sbjct: 230 MNSPLRKWRGSETKNKPKPQPL------IQCFTYNEISKATNDFHQGNIVGIGGYSEVYR 283
Query: 136 GCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQL 193
G L DG +AVKRL K + D K FL E+GII++V HPNTA L+GC + G++LVF+
Sbjct: 284 GDLWDGRRIAVKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRF 343
Query: 194 SPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
S G+L S LH +++ DW RY+IA+G A GL YLH+ C RIIHRDIK+ N+LL D
Sbjct: 344 SENGTLYSALHENENGSLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPD 403
Query: 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELI 312
YEPQI DFGLAKWLP +WTHH V EGTFGY APE M G +DEKTD+Y+FG+LLLE+I
Sbjct: 404 YEPQITDFGLAKWLPNKWTHHAVIPVEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEII 463
Query: 313 TGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPIL 372
TGRR V+ Q+ +++WAKP +++ + ELVDP L D YD +++++ VLTAS C++QSPIL
Sbjct: 464 TGRRPVNPTQKHILLWAKPAMETGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPIL 523
Query: 373 RPKMSQVVILL-RGDE-DNAQSVKESQKQTH 401
RP M+QV+ LL G+E + A+S + + T+
Sbjct: 524 RPTMTQVLELLTNGNEAEIAKSWRMPKDMTN 554
|
|
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 684 (245.8 bits), Expect = 2.4e-67, P = 2.4e-67
Identities = 153/340 (45%), Positives = 212/340 (62%)
Query: 87 STREDPD-LTHIYN-YRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLV 144
S R+ P+ L +Y + S+ + F EL + T NFS++N IGKGG + V++GCL +G +V
Sbjct: 411 SPRKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVV 470
Query: 145 AVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSD-GIHLVFQLSPLGSLASI 202
AVK L K T D F+ EI II + H N L+G C D + LV+ GSL
Sbjct: 471 AVKIL-KQTEDVLN-DFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEEN 528
Query: 203 LHGSKDKP---DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259
LHG+K P WS+RY++A+G A L YLH + +IHRD+K+ NILL++D+EPQ+ D
Sbjct: 529 LHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSD 588
Query: 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319
FGLA+W TH S GTFGY APEYFM+G V++K DVY+FGV+LLEL++GR+ +
Sbjct: 589 FGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPIS 648
Query: 320 HL----QQSVVIWAKPLLDSNDIRELVDPSLGDNYDA--EEIDRAVLTASLCIEQSPILR 373
Q+S+V+WAKP+LD +L+DPSL DN + +++ R L A+LCI +SP R
Sbjct: 649 SGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQAR 708
Query: 374 PKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEELFDAQ 413
PKMS V+ LL+GDED + + + SE L D Q
Sbjct: 709 PKMSIVLKLLKGDEDTLEWAMQQVNSSSEE--SEMLKDEQ 746
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 639 (230.0 bits), Expect = 1.4e-62, P = 1.4e-62
Identities = 146/344 (42%), Positives = 206/344 (59%)
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL 162
S FT EL AT FS NL+G+GG+ V+KG L G VAVK+L G+ + F
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER-EFQ 322
Query: 163 CEIGIIAYVDHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKP--DWSKRYRI 218
E+ II+ V H + L+G G+ LV++ P +L LHG K +P +WS R +I
Sbjct: 323 AEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-KGRPTMEWSTRLKI 381
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278
ALG+A GL+YLHE C +IIHRDIKA NIL+ +E ++ DFGLAK TH + ++
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRV 440
Query: 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD----HLQQSVVIWAKPLL- 333
GTFGY APEY G + EK+DV+SFGV+LLELITGRR VD ++ S+V WA+PLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 334 ---DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390
+ D L D +G+ YD EE+ R V A+ C+ S RP+MSQ+V L G+ +
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV-SL 559
Query: 391 QSVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
+ E + H YS + +Y++++Y D+ +F+++ALG+
Sbjct: 560 SDLNEGMRPGHSNVYSS-YGGSTDYDTSQYNDDMIKFRKMALGT 602
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
Identities = 144/343 (41%), Positives = 202/343 (58%)
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL 162
S FT EL AT FS NL+G+GG+ V+KG L G VAVK+L G+ + F
Sbjct: 259 SKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGER-EFQ 317
Query: 163 CEIGIIAYVDHPNTAKLVG-CDSDGIHL-VFQLSPLGSLASILHGS-KDKPDWSKRYRIA 219
E+ II+ V H + LVG C + L V++ P +L LHG + +WS R +IA
Sbjct: 318 AEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
LG+A GL+YLHE C +IIHRDIKA NIL+ +E ++ DFGLAK TH + ++
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVM 436
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD----HLQQSVVIWAKPLL-- 333
GTFGY APEY G + EK+DV+SFGV+LLELITGRR VD ++ S+V WA+PLL
Sbjct: 437 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 496
Query: 334 --DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391
+ D L D + + YD EE+ R V A+ C+ S RP+MSQ+V L G+ +
Sbjct: 497 ASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV-SLS 555
Query: 392 SVKESQKQTHRRTYSEELFDAQEYNSTRYLSDISRFKEIALGS 434
+ E + YS + +Y+S++Y D+ +F+++ALG+
Sbjct: 556 DLNEGMRPGQSNVYSS-YGGSTDYDSSQYNEDMKKFRKMALGT 597
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8RXC8 | RBK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5911 | 0.9907 | 0.9347 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 434 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 69/192 (35%), Positives = 98/192 (51%), Gaps = 10/192 (5%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+G+GG+ VY + G VA+K + K L EI I+ ++HPN KL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
D + ++LV + GSL +L ++ K + RI L GL YLH IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 242 IKADNILLTED-YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKT 299
+K +NILL D + ++ DFGL+K L + GT Y APE + G EK+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 300 DVYSFGVLLLEL 311
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 68/199 (34%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 125 IGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G+G + EVYKG L+ VAVK L + +++ FL E I+ +DHPN KL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
+G + + +++V + G L S L ++ K S AL A G+ YL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KNF 123
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT---FGYFAPEYFMHGI 294
IHRD+ A N L+ E+ +I DFGL+ R + + G + APE G
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLS----RDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 295 VDEKTDVYSFGVLLLELIT 313
K+DV+SFGVLL E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
+ +G+G + +VY + G LVA+K + K + + L EI I+ + HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKD-KPDWSKRYRIALGTANGLTYLHEGCQ 234
+L D D ++LV + G L +L D ++ Y + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLH---S 115
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
K I+HRD+K +NILL ED ++ DFGLA+ L GT Y APE +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKG 172
Query: 295 VDEKTDVYSFGVLLLELITGR 315
+ D++S GV+L EL+TG+
Sbjct: 173 YGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 38/211 (18%)
Query: 125 IGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G+G + EVYKG L+ T VAVK L +G +E+ FL E I+ + HPN +L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
+G + +++V + P G L L +K ++AL A G+ YL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNF 123
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTHHNVSKFEGTFG 283
+HRD+ A N L+TE+ +I DFGL++ LP +W
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------------ 171
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
APE G K+DV+SFGVLL E+ T
Sbjct: 172 --APESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 74/197 (37%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTK-GTVDEKTCGFLCEIGIIAYVDHPNTAKLVG- 181
+G G + VYK + G +VAVK L K +K EI I+ + HPN +L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 182 -CDSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRIIH 239
D D ++LV + G L L S+ P + +IAL GL YLH IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHS---NGIIH 121
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-VDEK 298
RD+K +NILL E+ +I DFGLAK + +++ F GT Y APE + G K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 299 TDVYSFGVLLLELITGR 315
DV+S GV+L EL+TG+
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 67/198 (33%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 125 IGKGGYAEVYKGCLRDG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G+G + EVYKG L+ VAVK L + +++ FL E I+ +DHPN KL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKR 236
+G + + + +V + P G L L ++ K S AL A G+ YL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAK-WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
IHRD+ A N L+ E+ +I DFGL++ + K + APE G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKF 181
Query: 296 DEKTDVYSFGVLLLELIT 313
K+DV+SFGVLL E+ T
Sbjct: 182 TSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 71/201 (35%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F IGKGG+ EVYK R G VA+K + K EK + EI I+ HPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
K G D + +V + GSL +L + S+ + GL YLH
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---N 117
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
IIHRDIKA NILLT D E ++ DFGL+ L + + GT + APE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMAPEVINGKP 173
Query: 295 VDEKTDVYSFGVLLLELITGR 315
D K D++S G+ +EL G+
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 79/300 (26%), Positives = 122/300 (40%), Gaps = 76/300 (25%)
Query: 123 NLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + EVYKG L+ T VAVK L + +E+ FL E ++ + HPN +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASIL--------HGSKDKPDWSKRYRIALGTANGLTY 228
L+G + + ++LV + G L L K A+ A G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTHHN 274
L K+ +HRD+ A N L+ ED +I DFGL++ LP +W
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG----------RRAVDHLQQS 324
APE GI K+DV+SFGVLL E+ T +++L++
Sbjct: 175 -----------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
Query: 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ KP +++ EL+ C + P RP S++V L
Sbjct: 224 YRL-PKPEYCPDELYELM--------------------LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 123 NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNTAKLV 180
L+G+G + VY +D G L+AVK + E+ EI I++ + HPN +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 181 GCDSD----GIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
G + D +++ + GSL+S+L K ++Y GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLHS---N 120
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
I+HRDIK NIL+ D ++ DFG AK L T GT + APE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 296 DEKTDVYSFGVLLLELITGRR 316
D++S G ++E+ TG+
Sbjct: 181 GRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 123 NLIGKGGYAEVYKGC---LRDGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
+G+G + +V L D T VAVK L ++ F EI I+ +DH N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 178 KLVG-CDSDG---IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
K G C+ G + L+ + P GSL L +D+ + + + G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-- 127
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV-SKFEGTFGYFAPEYFMH 292
+R IHRD+ A NIL+ + +I DFGLAK LP ++ V E ++APE
Sbjct: 128 -QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 293 GIVDEKTDVYSFGVLLLELIT 313
+DV+SFGV L EL T
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-- 181
IGKG + +VYKG L+ T VAVK + FL E I+ DHPN KL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 182 CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
I++V +L P GSL + L K++ K +++L A G+ YL K IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 242 IKADNILLTEDYEPQICDFGLA--------------KWLPRQWTHHNVSKFEGTFGYFAP 287
+ A N L+ E+ +I DFG++ K +P +WT AP
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT--------------AP 164
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELITG 314
E +G ++DV+S+G+LL E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 125 IGKGGYAEVYKGCLR-DGTL----VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G G + VYKG +G VA+K L + T + L E ++A VDHP+ +L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 180 VG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
+G C S + L+ QL PLG L + KD + A G++YL E KR++
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLV 131
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
HRD+ A N+L+ +I DFGLAK L ++ + + A E +H I K
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191
Query: 299 TDVYSFGVLLLELIT-GRR 316
+DV+S+GV + EL+T G +
Sbjct: 192 SDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 118 NFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPN 175
N+ +LIG+G + VYKG L G VA+K+++ + E+ + EI ++ + HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEG 232
K +G SD ++++ + + GSL I+ P Y + GL YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY-VY-QVLQGLAYLHE- 117
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
Q +IHRDIKA NIL T+D ++ DFG+A L + + GT + APE
Sbjct: 118 -QG-VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEM 173
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
+D++S G ++EL+TG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 70/202 (34%), Positives = 98/202 (48%), Gaps = 32/202 (15%)
Query: 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
L+GKG + EV+KG L+D T VAVK + E FL E I+ DHPN KL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
I++V +L P G S L KD+ + + AL A G+ YL K IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 242 IKADNILLTEDYEPQICDFGLA-------------KWLPRQWTHHNVSKFEGTFGYFAPE 288
+ A N L+ E+ +I DFG++ K +P +WT APE
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT--------------APE 164
Query: 289 YFMHGIVDEKTDVYSFGVLLLE 310
+G ++DV+S+G+LL E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+G+G VYK + G + A+K++ +E L E+ + + P K G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 183 DSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQKRIIH 239
+G I +V + GSLA +L K + IA GL YLH ++ IIH
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIH 123
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT 299
RDIK N+L+ E +I DFG++K L T + F GT Y +PE
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 300 DVYSFGVLLLELITGR 315
D++S G+ LLE G+
Sbjct: 182 DIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 39/208 (18%)
Query: 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAYVDHPNTAKLVG 181
IGKG + +V G R G VAVK L D+ T FL E ++ + HPN +L+G
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLK----DDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI--ALGTANGLTYLHEGCQKRI 237
+ +++V + GSL L S+ + + ++ AL G+ YL E K
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAK---------WLPRQWTHHNVSKFEGTFGYFAPE 288
+HRD+ A N+L++ED ++ DFGLAK LP +WT APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------------APE 169
Query: 289 YFMHGIVDEKTDVYSFGVLLLELIT-GR 315
K+DV+SFG+LL E+ + GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 65/176 (36%), Positives = 86/176 (48%), Gaps = 12/176 (6%)
Query: 144 VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGIHLVFQLSPLGSLASI 202
VAVK L + + FL E I+ +DH N +L G + + +V +L+PLGSL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDR 85
Query: 203 LHGSKDKPDW---SKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259
L KD S A+ ANG+ YL KR IHRD+ A NILL D + +I D
Sbjct: 86 LR--KDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGD 140
Query: 260 FGLAKWLPRQWTHHNVSKFEGT--FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
FGL + LP Q H V + F + APE +DV+ FGV L E+ T
Sbjct: 141 FGLMRALP-QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 123 NLIGKGGYAEVYKGCLRD----GT---LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
N +G G + EVY+G D G+ VAVK L KG D++ FL E +++ +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 176 TAKLVG-C-DSDGIHLVFQLSPLGSLASILHGSKDKPDW------SKRYRIALGTANGLT 227
KL+G C ++ +++ +L G L S L ++ + + I L A G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 228 YLHEGCQKRIIHRDIKADNILLTE-DYEP----QICDFGLAKWLPRQWTHHNVSKFEGTF 282
YL Q IHRD+ A N L++E Y+ +I DFGLA+ + + + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ APE + G ++DV+SFGVL+ E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 88/274 (32%), Positives = 118/274 (43%), Gaps = 33/274 (12%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-----TAK 178
IG G A VY CL + VA+KR+ E+ ++ +HPN T+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 179 LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLHEGCQK 235
+VG D + LV GSL I+ S IA GL YLH Q
Sbjct: 69 VVG---DELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL--PRQWTHHNVSKFEGTFGYFAPEYF--M 291
IHRDIKA NILL ED +I DFG++ L T F GT + APE +
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 292 HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351
HG D K D++SFG+ +EL TG V+ L ND PSL D
Sbjct: 182 HG-YDFKADIWSFGITAIELATGAAPYSKYPPMKVLM---LTLQND-----PPSLETGAD 232
Query: 352 AEEIDRAVLT-ASLCIEQSPILRPKMSQVVILLR 384
++ ++ SLC+++ P RP + LL+
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEE---LLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 12/196 (6%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--VGC 182
+G G + EV+ G T VAVK L GT+ + FL E I+ + H +L V
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 183 DSDGIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+ + I++V + GSL L G K + +A A G+ YL + IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 242 IKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTD 300
+ A NIL+ E+ +I DFGLA+ + ++T +KF + APE +G K+D
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSD 186
Query: 301 VYSFGVLLLELIT-GR 315
V+SFG+LL E++T GR
Sbjct: 187 VWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (251), Expect = 1e-23
Identities = 75/214 (35%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHP- 174
++ +G+G + EVY RD LVA+K L K + FL EI I+A ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGTANGLTYLH 230
N KL D ++LV + GSL +L K S+ I + L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 231 EGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQWTHHNV----SKFEGTFGYF 285
K IIHRDIK +NILL D ++ DFGLAK LP + ++ S GT GY
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 286 APEYFMHGI---VDEKTDVYSFGVLLLELITGRR 316
APE + +D++S G+ L EL+TG
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 2e-23
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 123 NLIGKGGYAEVYKG-CLRDGTLVAVKR--LTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
IGKG + +VY DG L +K L+ + E+ L E+ I+ ++HPN K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-DALNEVKILKKLNHPNIIKY 64
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILH--GSKDKP-------DWSKRYRIALGTANGLTY 228
+ + +V + + G L+ + + KP DW ++ L L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA----LKY 118
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK---FEGTFGYF 285
LH ++I+HRDIK NI LT + ++ DFG++K L V GT Y
Sbjct: 119 LHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVVGTPYYL 170
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRA 317
+PE + + K+D++S G +L EL T +
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 125 IGKGGYAEVYKGCLR--DGTL--VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
+G G + V KG G VAVK L + + FL E ++A +DHP +L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 181 G-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
G C + + LV +L+PLG L L ++ P S +A A G+ YL K +H
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLES---KHFVH 118
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG-----YFAPEYFMHGI 294
RD+ A N+LL ++ +I DFG+++ L + + T G ++APE +G
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALG---AGSDYYRAT-TAGRWPLKWYAPECINYGK 174
Query: 295 VDEKTDVYSFGVLLLELIT 313
K+DV+S+GV L E +
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 68/230 (29%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCL--RDGTL----VAVKRLTKGTVDEKTCGFLCEIG 166
+ + + +G G + EVY+G RDG VAVK L + ++ FL E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 167 IIAYVDHPNTAKLVGCDSDGI--HLVFQLSPLGSLASILHGSKDKPDWSKRYR------I 218
I++ +H N +L+G + + ++ +L G L S L ++ +P+
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAK----------- 264
A A G YL E IHRDI A N LLT +I DFG+A+
Sbjct: 122 ARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 265 ---WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
LP +W PE F+ GI KTDV+SFGVLL E+
Sbjct: 179 GRAMLPIKWM--------------PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 9e-23
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKLV 180
+GKG + +V +D G L A+K L K + E E I++ ++HP KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 181 GC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRY--RIALGTANGLTYLHEGCQK 235
+ ++LV + +P G L S L + ++ Y I L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHS---L 112
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
II+RD+K +NILL D ++ DFGLAK L + F GT Y APE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 296 DEKTDVYSFGVLLLELITGR 315
+ D +S GVLL E++TG+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F +G+G Y VYK G +VA+K + V+E + EI I+ D P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61
Query: 178 KLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
K G ++D + +V + GS++ I+ + + I T GL YLH
Sbjct: 62 KYYGSYFKNTD-LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK--FEGTFGYFAPEYFMH 292
+ IHRDIKA NILL E+ + ++ DFG++ Q T + GT + APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP 331
+ K D++S G+ +E+ G+ + I+ P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP 212
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNTAKL 179
IG+G Y +VYK + G LVA+K++ ++ + GF + EI ++ + HPN +L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 180 ----VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
I++VF+ L +L + K S+ GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SN 119
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG---TFGYFAPEYFMH 292
I+HRDIK NIL+ D ++ DFGLA R +T N + + T Y PE +
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLA----RPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 293 GIV-DEKTDVYSFGVLLLELITGR 315
+ D++S G +L EL G+
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 122 ENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
E +IG G + EV +G L + VA+K L G+ D++ FL E I+ DHPN
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+L G S + ++ + GSL L + K + + G A+G+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL--------------PRQWTHHNVSKFEGT 281
+HRD+ A NIL+ + ++ DFGL++ L P +WT
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT---------- 175
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
APE + +DV+SFG+++ E+++
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIA-YVDHPNTAKLVG 181
+IG+G Y +VYK + G LVA+K + DE+ E I+ Y +HPN A G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYG 70
Query: 182 C--------DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLH 230
+ D + LV +L GS+ ++ G + K K IA T GL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE-- 288
E ++IHRDIK NILLT++ E ++ DFG++ L T + F GT + APE
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRNTFIGTPYWMAPEVI 185
Query: 289 ---YFMHGIVDEKTDVYSFGVLLLELITG 314
D ++DV+S G+ +EL G
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 36/208 (17%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--VGC 182
+G G + EV++G + T VAVK L GT+D K FL E I+ + HP +L V
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+ I++V +L GSL L G + + +A A+G+ YL + IHRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 242 IKADNILLTEDYEPQICDFGLAKWL-------------PRQWTHHNVSKFEGTFGYFAPE 288
+ A N+L+ E+ ++ DFGLA+ + P +WT APE
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT--------------APE 174
Query: 289 YFMHGIVDEKTDVYSFGVLLLELIT-GR 315
++ K+DV+SFG+LL E++T GR
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 125 IGKGGYAEVYKGCL---RDGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G+G + +V C DGT +VAVK L + + T G+ EI I+ + H N K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 180 VGCDSD----GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
GC S+ G+ L+ + PLGSL L K K + ++ A G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYFMHGI 294
IHRD+ A N+LL D +I DFGLAK +P ++ V + + ++A E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 295 VDEKTDVYSFGVLLLELIT 313
+DV+SFGV L EL+T
Sbjct: 187 FSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 8e-22
Identities = 72/250 (28%), Positives = 109/250 (43%), Gaps = 31/250 (12%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTC--------GFLCEIGIIAYVDHP 174
LIG G + VY G G L+AVK++ +V + EI ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 175 NTAKLVGCDSDGIHLVFQLS--PLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLH 230
N + +G D HL L P GS+A++L +G+ ++ R L GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLH 123
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK----FEGTFGYFA 286
+ IIHRDIK NIL+ +I DFG++K L + +G+ + A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
PE K D++S G L++E++TG+ Q I+ I E P +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK--------IGENASPEI 232
Query: 347 GDNYDAEEID 356
N +E ID
Sbjct: 233 PSNISSEAID 242
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 72/262 (27%), Positives = 111/262 (42%), Gaps = 31/262 (11%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-C 182
+G G V K R G ++AVK + + L E+ I+ + P G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 183 DSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
++G I + + GSL IL + + +IA+ GLTYLHE + +IIHRD
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRD 126
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
+K NIL+ + ++CDFG++ L + F GT Y APE K+D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 302 YSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD-------PSL-GDNYDAE 353
+S G+ L+EL TGR + + I EL+ P L + +
Sbjct: 183 WSLGLSLIELATGR----------FPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232
Query: 354 EIDRAVLTASLCIEQSPILRPK 375
D +LC+ + P RP
Sbjct: 233 FQD----FVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F+ IGKG + EVYK R +VA+K + +++ EI ++ P
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 178 KLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
K G G L + + GS +L K D + I GL YLHE +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL--DETYIAFILREVLLGLEYLHE---E 117
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
IHRDIKA NILL+E+ + ++ DFG++ L + N F GT + APE
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGY 175
Query: 296 DEKTDVYSFGVLLLELITG 314
DEK D++S G+ +EL G
Sbjct: 176 DEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 1e-21
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 35/214 (16%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDE---KTCGFLCEIGIIAYVDHP 174
+ +G+G Y VYK + G +VA+K++ +E T L EI ++ + HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 175 NTAKL--VGCDSDGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLH 230
N KL V ++LVF+ + L L P+ K L GL Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL--LRGLAYCH 115
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYFAP 287
RI+HRD+K NIL+ D ++ DFGLA+ R +TH V T Y AP
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAP 167
Query: 288 EYFMH------GIVDEKTDVYSFGVLLLELITGR 315
E + + D++S G + E+ITG+
Sbjct: 168 EILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK-GTVDEKT---CGFLCEIGIIAY 170
NF E IGKG ++ VYK CL DG +VA+K++ +D K C L EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC--LKEIDLLKQ 58
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLAS-ILHGSKDK---PD---WSKRYRIALG 221
+DHPN K + +++ +++V +L+ G L+ I H K K P+ W ++
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC-- 116
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT--HHNVSKFE 279
+ L ++H KRI+HRDIK N+ +T ++ D GL ++ + T H V
Sbjct: 117 --SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---- 167
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
GT Y +PE + K+D++S G LL E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLC-EIGIIAYVD- 172
+F +IG+G ++ V + A+K L K + EK ++ E ++ ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTY 228
HP KL D + ++ V + +P G L + GS D+ R+ A L Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC--TRFYAAE-ILLALEY 117
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR------------------QW 270
LH K IIHRD+K +NILL +D +I DFG AK L +
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
+ F GT Y +PE + +D+++ G ++ +++TG+
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-21
Identities = 77/257 (29%), Positives = 123/257 (47%), Gaps = 33/257 (12%)
Query: 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC-----GFLCEIGIIAYVDHPNTA 177
++GKG Y VY G G L+AVK++ T + E+ ++ + H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 178 KLVG-CDSDGIHLVF-QLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGC 233
+ +G C D +F + P GS++SIL+ G +P + K + L +G+ YLH C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC 122
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK---WLPRQWTHHNVSK-FEGTFGYFAPEY 289
++HRDIK +N++L + ++ DFG A+ W+ TH N+ K GT + APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
K+D++S G + E+ TG+ ++D L I A R L+ P L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH--------RGLM-PRL 230
Query: 347 GDNYDAEEID--RAVLT 361
D++ A ID + LT
Sbjct: 231 PDSFSAAAIDFVTSCLT 247
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 68/200 (34%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 124 LIGKGGYAEVYKGC---LRDGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+GKG + V L+D T +VAVK+L T + F EI I+ + H N K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNIVK 69
Query: 179 LVG-CDSDG---IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
G C S G + LV + P GSL L +++ D K A G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS--- 126
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYFMHG 293
KR +HRD+ NIL+ + +I DFGL K LP+ ++ V + E ++APE
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 294 IVDEKTDVYSFGVLLLELIT 313
+DV+SFGV+L EL T
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ F+ E +G G + EV++G ++ VA+K L K K F E+ + + H +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 177 AKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGC 233
L V + ++++ +L GSL + L + + + +A A G+ YL E
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-- 122
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWL------------PRQWTHHNVSKFEGT 281
+ IHRD+ A NIL+ ED ++ DFGLA+ + P +WT
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---------- 171
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
APE HG K+DV+SFG+LL E+ T
Sbjct: 172 ----APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 62/209 (29%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 123 NLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC---EIGIIAYVDHPNTAK 178
N IG G + +VY L G L+AVK + D E+ ++ + HPN
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPN--- 60
Query: 179 LVGCDSDGIH----LVFQ-LSPLGSLASILHGSKDKPD-WSKRYRIALGTANGLTYLHEG 232
LV +H +F G+L +L + + + Y + L GL YLH
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHS- 117
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT--HHNVSKFEGTFGYFAPEYF 290
I+HRDIK NI L + ++ DFG A L T V GT Y APE
Sbjct: 118 --HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 291 MHGIVDEK---TDVYSFGVLLLELITGRR 316
G D++S G ++LE+ TG+R
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 9e-21
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLV----AVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
++G G + VYKG + +G V A+K L + T + F+ E I+A +DHP+ +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 179 LVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
L+G C S I LV QL P G L +H KD + A G+ YL E +R+
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
+HRD+ A N+L+ +I DFGLA+ L +N + + A E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190
Query: 298 KTDVYSFGVLLLELIT 313
++DV+S+GV + EL+T
Sbjct: 191 QSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 65/205 (31%), Positives = 88/205 (42%), Gaps = 14/205 (6%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK--TCGFLCEIGIIAYVDHP 174
+F +IGKG + +V RD + A+K + K EK L E I+ ++HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 175 NTAKL--VGCDSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
L D + ++LV L G L + K + K + + A L YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA--LEYLHS 118
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
K IIHRDIK DNILL E I DF +A + + S GT GY APE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLC 172
Query: 292 HGIVDEKTDVYSFGVLLLELITGRR 316
D +S GV E + G+R
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 62/195 (31%), Positives = 103/195 (52%), Gaps = 11/195 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC-D 183
+G G + EV+ G T VA+K L +G++ + FL E ++ + HP +L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE--AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 184 SDGIHLVFQLSPLGSLASILHGSKD-KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ I+++ + GSL L + K +K +A A G+ ++ +K IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 243 KADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
+A NIL++E +I DFGLA+ + ++T +KF + APE +G K+DV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIKSDV 186
Query: 302 YSFGVLLLELIT-GR 315
+SFG+LL E++T GR
Sbjct: 187 WSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC----EIGIIAYVDHPNTAK 178
L+G G + VY+G L DG AVK ++ + + EI +++ + HPN +
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+G + D +++ +L P GSLA +L +GS +P R L GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL---LGLEYLHD--- 120
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-G 293
+ +HRDIK NIL+ + ++ DFG+AK + F+G+ + APE G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQG 177
Query: 294 IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353
D++S G +LE+ TG+ L+ ++ R P + D+ E
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-------KIGRSKELPPIPDHLSDE 230
Query: 354 EIDRAVLTASLCIEQSPILRPKMSQ 378
A C+++ P LRP ++
Sbjct: 231 ----AKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 119 FSSENLIGKGGYAEVYKGC-LRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
F ++G G + VYKG + +G VA+K L + T + L E ++A VD+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 174 PNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
P+ +L+G C + + L+ QL P G L + KD + A G+ YL E
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+R++HRD+ A N+L+ +I DFGLAK L ++ + + A E +H
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 293 GIVDEKTDVYSFGVLLLELIT 313
I ++DV+S+GV + EL+T
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 48/220 (21%)
Query: 125 IGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + VY+G + T VA+K + + + FL E ++ + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 179 LVGCDSDGIH--LVFQLSPLGSLASILHGSK---------DKPDWSKRYRIALGTANGLT 227
L+G S G +V +L G L S L + P K ++A A+G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTHH 273
YL K+ +HRD+ A N ++ ED +I DFG+ + LP +W
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW--- 187
Query: 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
APE G+ K+DV+SFGV+L E+ T
Sbjct: 188 -----------MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH---PNTAKL 179
LIG+G Y VY+G + G +VA+K + T D+ E+ +++ + PN K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 180 VGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLHEGCQ 234
G G L + + + GS+ +++ +++Y I++ L Y+H +
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKY-ISVIIREVLVALKYIH---K 119
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+IHRDIKA NIL+T ++CDFG+A L S F GT + APE G
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 295 V-DEKTDVYSFGVLLLELITG 314
D K D++S G+ + E+ TG
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-19
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC-- 182
IG G + V+ G + VA+K + +G + E+ F+ E ++ + HP +L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED--FIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ I LVF+ G L+ L + K + L G+ YL +IHRD+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 243 KADNILLTEDYEPQICDFGLAKW-LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
A N L+ E+ ++ DFG+ ++ L Q+T +KF + +PE F K+DV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDV 184
Query: 302 YSFGVLLLELIT-GRRAVDHLQQSVVI--------WAKPLLDSNDIRELVD 343
+SFGVL+ E+ + G+ ++ S V+ KP L S + EL+
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVK-----RLTKGTVDEKTCGFL----CEIGIIAYVDH 173
LIGKG Y VY + G ++AVK G D + + EI + +DH
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 174 PNTAKLVGCDS--DGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYL 229
N + +G ++ + + + + P GS+ S L +G ++ L GL YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLAYL 124
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE- 288
H K I+HRD+KADN+L+ D +I DFG++K + + +G+ + APE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 289 -YFMHGIVDEKTDVYSFGVLLLELITGRR 316
+ K D++S G ++LE+ GRR
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 29/274 (10%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKR--LTKGTVDEKTCGFLCEIGIIAYVDHP 174
+F N IGKG + V+K + D + A+K+ L+K E+ + E ++A +D
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA-IDEARVLAKLDSS 59
Query: 175 NTAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHE 231
+ D +++V + + G L +L + +P + +R + GL +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH- 118
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYF 290
K+I+HRDIK+ N+ L +I D G+AK L + N + GT Y +PE
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS---DNTNFANTIVGTPYYLSPELC 173
Query: 291 MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350
+EK+DV++ GV+L E TG+ D Q +I I V P + Y
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI--------LKIIRGVFPPVSQMY 225
Query: 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ C+ + RP Q LLR
Sbjct: 226 SQQLAQ----LIDQCLTKDYRQRPDTFQ---LLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 34/203 (16%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
IG+G + EV+ G LR D T VAVK + + FL E I+ HPN +L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
I++V +L G + L + + ++ A G+ YL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119
Query: 242 IKADNILLTEDYEPQICDFGLA--------------KWLPRQWTHHNVSKFEGTFGYFAP 287
+ A N L+TE +I DFG++ K +P +WT AP
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT--------------AP 165
Query: 288 EYFMHGIVDEKTDVYSFGVLLLE 310
E +G ++DV+SFG+LL E
Sbjct: 166 EALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 28/293 (9%)
Query: 95 THIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGT 153
++ + S K T++++ ++ K EN+I +G YKG +++G VK +
Sbjct: 672 LQFFDSKVS-KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIND-- 725
Query: 154 VDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSD-GIHLVFQLSPLGSLASILHGSKDKPD 211
V+ + ++G + HPN KL+G C S+ G +L+ + +L+ +L
Sbjct: 726 VNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS---- 778
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271
W +R +IA+G A L +LH C ++ ++ + I++ EP + L L
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837
Query: 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD---HLQQSVVIW 328
S Y APE + EK+D+Y FG++L+EL+TG+ D + S+V W
Sbjct: 838 CFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891
Query: 329 AKPLLDSNDIRELVDPSLGDN--YDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
A+ + +DPS+ + + EI + A C P RP + V
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 58/243 (23%)
Query: 122 ENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNT 176
+G+G YA VYK G +VA+K++ G E G L EI ++ + HPN
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 177 AKLVGCDS--DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYR------IALGTANGLTY 228
L+ I+LVF+ L ++ KDK S L T GL Y
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVI---KDK---SIVLTPADIKSYMLMTLRGLEY 117
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYF 285
LH I+HRD+K +N+L+ D ++ DFGLA+ R+ TH V+++ Y
Sbjct: 118 LHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YR 169
Query: 286 APEYFM------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD-SNDI 338
APE G+ D++S G + EL+ P L +DI
Sbjct: 170 APELLFGARHYGVGV-----DMWSVGCIFAELLLR---------------VPFLPGDSDI 209
Query: 339 REL 341
+L
Sbjct: 210 DQL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 105 KEFTLSELQTA---TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCG 160
+ L ++ + + + + IG+G EVYK R G VA+K++ +++
Sbjct: 4 LKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE--L 61
Query: 161 FLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI 218
+ EI I+ HPN D + +V + GSL I+ + + + + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VS 276
GL YLH + +IHRDIK+DNILL++D ++ DFG A L ++ + N V
Sbjct: 122 CREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV- 177
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
GT + APE K D++S G++ +E+ G
Sbjct: 178 ---GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF-LCEIGIIAYVDHPNTAKL--V 180
IG+G Y VYK G +VA+K++ E L EI ++ ++HPN KL V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 181 GCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240
++LVF+ L ++ + S GL + H I+HR
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 241 DIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYFAPE-YFMHGIVD 296
D+K +N+L+ + ++ DFGLA+ R +TH+ V+++ Y APE
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLGDKGYS 177
Query: 297 EKTDVYSFGVLLLELITGR 315
D++S G + EL++ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 32/204 (15%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD- 183
IG+G + V +G G VAVK + D FL E ++ + H N +L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 184 SDGIHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+G+++V +L G+L + L + + + +L A G+ YL K+++HRD+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 243 KADNILLTEDYEPQICDFGLAK---------WLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
A NIL++ED ++ DFGLA+ LP +WT APE H
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------------APEALKHK 172
Query: 294 IVDEKTDVYSFGVLLLELITGRRA 317
K+DV+S+GVLL E+ + RA
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CD 183
+G G + V+ G R VA+K + +G + E F+ E ++ + HPN +L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD--FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 184 SDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
I +V + G L + L K K + + YL IHRD+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 243 KADNILLTEDYEPQICDFGLAKW-LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
A N L+ ED ++ DFGLA++ L Q+T +KF + PE F + K+DV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSDV 184
Query: 302 YSFGVLLLELITG 314
+SFGVL+ E+ +
Sbjct: 185 WSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182
++GKG Y VY L +A+K + + EI + +Y+ H N + +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 183 DSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTAN---GLTYLHEGCQKRI 237
DS+ + + P GSL+++L SK P I T GL YLH+ +I
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 238 IHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-- 294
+HRDIK DN+L+ T +I DFG +K L + F GT Y APE G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 295 VDEKTDVYSFGVLLLELITGR 315
D++S G ++E+ TG+
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 9/194 (4%)
Query: 124 LIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
IG+G + +VY+G VAVK T FL E I+ DHP+ KL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 180 VG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
+G + + +V +L+PLG L S L +K D + + + L YL KR +
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
HRDI A N+L++ ++ DFGL+++L + +++ SK + + APE
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPESINFRRFTSA 188
Query: 299 TDVYSFGVLLLELI 312
+DV+ FGV + E++
Sbjct: 189 SDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 125 IGKGGYAEVYK-GCLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNTAKL--V 180
IG+G + V+K G VA+K++ ++ L EI + HP KL V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 181 GCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240
G LV + P L+ +L + ++ G+ Y+H I+HR
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHR 123
Query: 241 DIKADNILLTEDYEPQICDFGLAKWL----PRQWTHHNVSKFEGTFGYFAPE-------Y 289
D+K N+L++ D +I DFGLA+ PR ++H +++ Y APE Y
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW-----YRAPELLYGARKY 178
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGR 315
D D+++ G + EL+ G
Sbjct: 179 ------DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC-EIGIIAYVDHPNTAKLVGC 182
IGKG + V K DG ++ K + G + EK L E+ I+ + HPN +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 183 DSD----GIHLVFQLSPLGSLASILHGSK---DKPDWSKRYRIALGTANGLTYLHEGCQK 235
D +++V + G LA ++ K + +RI L H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 236 --RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
++HRD+K NI L + ++ DFGLAK L + GT Y +PE H
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHM 185
Query: 294 IVDEKTDVYSFGVLLLELITGR---RAVDHLQ 322
DEK+D++S G L+ EL A + LQ
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 124 LIGKGGYAEVYKGCLRD---GTLVAVK-----RLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+G G ++ Y+ RD GTL+AVK R T +E EI ++A ++HP+
Sbjct: 7 QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 176 TAKLVG--CDSDGIHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEG 232
+++G C+ +L + GS++ +L K Y GL+YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLLRGLSYLHE- 121
Query: 233 CQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHNVSK--FEGTFGYFAPEY 289
+IIHRD+K N+L+ + +I DFG A L + T + GT + APE
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGR 315
DV+S G +++E+ T +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 124 LIGKGGYAEVYKGC-LRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
++G G + VYKG + DG VA+K L + T + L E ++A V P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 179 LVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
L+G C + + LV QL P G L + +KD+ + A G++YL E R+
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
+HRD+ A N+L+ +I DFGLA+ L T ++ + + A E +H
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190
Query: 298 KTDVYSFGVLLLELIT-GRRAVDHLQ 322
++DV+S+GV + EL+T G + D +
Sbjct: 191 QSDVWSYGVTVWELMTFGAKPYDGIP 216
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-18
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS 184
+G+G + EV+ G T VA+K L GT+ + FL E ++ + H +L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 185 DG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRI------ALGTANGLTYLHEGCQKRI 237
+ I++V + GSL L G + K R+ A A+G+ Y+ +
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
+HRD++A NIL+ E+ ++ DFGLA+ + ++T +KF + APE ++G
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 181
Query: 297 EKTDVYSFGVLLLELITGRR 316
K+DV+SFG+LL EL T R
Sbjct: 182 IKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 9e-18
Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+G+G V K L++ G + A+K +T + L E+ I P K G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 183 --DSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRY---RIALGTANGLTYLHEGCQKR 236
+S I + + GSL SI K + +IA GL+YLH ++
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RK 125
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG----YFAPEYFMH 292
IIHRDIK NILLT + ++CDFG++ L V+ GTF Y APE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFTGTSFYMAPERIQG 177
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
+DV+S G+ LLE+ R
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 8/180 (4%)
Query: 139 RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSDG---IHLVFQLS 194
G VAVK L + EI I+ + H N K G C DG I L+ +
Sbjct: 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254
P GSL L +K+K + ++ + A+ G+ YL ++ +HRD+ A N+L+ +++
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147
Query: 255 PQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+I DFGL K + ++ V + ++APE + +DV+SFGV L EL+T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--VGC 182
+G G + EV+ G + T VAVK L GT+ + FL E ++ + H +L V
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 183 DSDGIHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+ I+++ + GSL L + K K + A G+ Y+ +K IHRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 242 IKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTD 300
++A N+L++E +I DFGLA+ + ++T +KF + APE G K+D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSD 186
Query: 301 VYSFGVLLLELIT 313
V+SFG+LL E++T
Sbjct: 187 VWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 122 ENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGT--VDEKTCGFLCEIGIIAYVDHPNTAK 178
++ +G G Y EVY+G + VAVK L + T V+E FL E ++ + HPN +
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQ 66
Query: 179 LVG-CDSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGT--ANGLTYLHEGCQ 234
L+G C + +++ + G+L L ++ + + + + T ++ + YL +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLE---K 122
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-WTHHNVSKFEGTFGYFAPEYFMHG 293
K IHRD+ A N L+ E++ ++ DFGL++ + +T H +KF + APE +
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYN 180
Query: 294 IVDEKTDVYSFGVLLLELIT 313
K+DV++FGVLL E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 28/201 (13%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVK--RLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G Y +VYK + G LVA+K +L G E EI ++ HPN G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPNIVAYFG 67
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLHEGCQKR 236
D + +V + GSL I ++ +IA T GL YLH +
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLH---ETG 121
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK---FEGTFGYFAPEYF--- 290
IHRDIK NILLTED + ++ DFG++ L ++K F GT + APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 291 MHGIVDEKTDVYSFGVLLLEL 311
G D K D+++ G+ +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 125 IGKGGYAEVYKGCL-----RDG-TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + +V K R G T VAVK L + + L E ++ V+HP+ K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 179 LVG-CDSDG-IHLVFQLSPLGSLASILHGSK------------------DKPD-----WS 213
L G C DG + L+ + + GSL S L S+ D PD
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 214 KRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273
A + G+ YL E +++HRD+ A N+L+ E + +I DFGL++ + + ++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
SK + A E I ++DV+SFGVLL E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 42/277 (15%)
Query: 118 NFSSENLIGKGGYAEVYK-GCLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPN 175
+F +GKG Y VYK L D A+K + G++ +K + EI I+A V+HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 176 T-----AKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKR---YRIALGTANGLT 227
A L G + +V + +P G L+ + K K +RI + GL
Sbjct: 61 IISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
LHE ++I+HRD+K+ NILL + +I D G++K L + + GT Y AP
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAP 170
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELITGR-----RAVDHLQQSVVIWAKPLLDSNDIRELV 342
E + K+D++S G LL E+ T R++ L+ V P + ++L
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+ ++ P LRP ++
Sbjct: 231 N-----------------FIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS 184
+G+G + EV+ G T VA+K L GT+ + FL E I+ + H L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE--AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 185 DG-IHLVFQLSPLGSLASIL-HGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ I++V + GSL L G + +A A+G+ Y+ + IHRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 243 KADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
+A NIL+ ++ +I DFGLA+ + ++T +KF + APE ++G K+DV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186
Query: 302 YSFGVLLLELITGRR 316
+SFG+LL EL+T R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIG----IIAYVDHPNTAK 178
L+G G + V+KG + +G + + K D EI + +DH +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 179 LVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
L+G C + LV QLSPLGSL + +D D + + A G+ YL E R+
Sbjct: 74 LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
+HR++ A NILL D QI DFG+A L + S+ + + A E + G
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 298 KTDVYSFGVLLLELIT 313
++DV+S+GV + E+++
Sbjct: 191 QSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 34/276 (12%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHP 174
NF E IG+G ++EVY+ CL DG VA+K++ + + C EI ++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASIL-HGSKDK---PD---WSKRYRIALGTANG 225
N K + + +++V +L+ G L+ ++ H K K P+ W +Y + L +A
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA-- 118
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L ++H +R++HRDIK N+ +T ++ D GL ++ + T GT Y
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS--NDIRELVD 343
+PE + K+D++S G LL E+ QS K L S I +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--------LQSPFYGDKMNLYSLCKKIEQCDY 225
Query: 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
P L ++ +EE+ + V ++CI P RP ++ V
Sbjct: 226 PPLPSDHYSEELRQLV---NMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS 184
+G G + EV+ G T VAVK L GT+ ++ FL E I+ + H +L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 185 D-GIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ I++V + GSL L G +A A G+ Y+ + IHRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 243 KADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
++ NIL+ + +I DFGLA+ + ++T +KF + APE ++G K+DV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186
Query: 302 YSFGVLLLELITGRR 316
+SFG+LL EL+T R
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 75/265 (28%), Positives = 116/265 (43%), Gaps = 22/265 (8%)
Query: 119 FSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F+ IGKG + EV+KG R +VA+K + +++ EI +++ D P
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 178 KLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
K G L + LG +++ D ++ I GL YLH ++
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKK 122
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
IHRDIKA N+LL+E E ++ DFG+A L N F GT + APE D
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDS 180
Query: 298 KTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA--EEI 355
K D++S G+ +EL G L V++ L+ N+ P+L NY +E
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLF---LIPKNN-----PPTLEGNYSKPLKEF 232
Query: 356 DRAVLTASLCIEQSPILRPKMSQVV 380
A C+ + P RP +++
Sbjct: 233 VEA------CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 125 IGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDEKTCG--FLCEIGIIAYVDHPNTAKLVG 181
+G GG+ V + A+K + K + E E I+ +HP KL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
D I+++ + G L +IL +++ R+ IA YLH + II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHN---RGIIY 116
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
RD+K +N+LL + ++ DFG AK L + WT F GT Y APE I+
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT------FCGTPEYVAPE-----IIL 165
Query: 297 EK-----TDVYSFGVLLLELITGR 315
K D +S G+LL EL+TGR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 75/257 (29%), Positives = 113/257 (43%), Gaps = 41/257 (15%)
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF 161
SL + LS L+ F ++G G Y +VYKG ++ G L A+K + +E+
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL 61
Query: 162 LCEIGIIA-YVDHPNTAKLVGC--------DSDGIHLVFQLSPLGSLASILHGSKD---K 209
EI ++ Y H N A G D + LV + GS+ ++ +K K
Sbjct: 62 --EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 210 PDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269
DW I GL +LH ++IHRDIK N+LLTE+ E ++ DFG++ L R
Sbjct: 120 EDWIAY--ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 270 WTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS 324
N F GT + APE D ++D++S G+ +E+ G
Sbjct: 175 VGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG---------- 222
Query: 325 VVIWAKPLLDSNDIREL 341
A PL D + +R L
Sbjct: 223 ----APPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAY-VDHPNTAKLV 180
I KG + VY R G A+K L K + K E I+ + P AKL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 181 GC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRI 237
D ++LV + G AS++ P DW+K+Y G+ LH Q+ I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRGI 118
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
IHRDIK +N+L+ + ++ DFGL++ + KF GT Y APE +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK--------KFVGTPDYLAPETILGVGD 170
Query: 296 DEKTDVYSFGVLLLELITGRR 316
D+ +D +S G ++ E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYV 171
F N IG+G Y VY+ G +VA+K++ +D + G L EI ++ +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR---MDNERDGIPISSLREITLLLNL 63
Query: 172 DHPNTAKL----VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLT 227
HPN +L VG D I LV + LAS+L S+ + L GL
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGY 284
YLHE IIHRD+K N+LLT+ +I DFGLA+ + T V T Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-----TLWY 174
Query: 285 FAPEYFMHGIV-DEKTDVYSFGVLLLELITGR 315
APE + D+++ G +L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 123 NLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+IGKG + VY G L D AVK L + T E+ FL E I+ HPN
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 179 LVGC--DSDGI-HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
L+G S+G +V G L + + P L A G+ YL K
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
+ +HRD+ A N +L E + ++ DFGLA+ + ++ HN + + + A E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 294 IVDEKTDVYSFGVLLLELIT 313
K+DV+SFGVLL EL+T
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 87/290 (30%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLT---KGTVDEKTCGFLCEIGIIAYVD 172
K F+ IG G + VY +R +VA+K+++ K + EK + E+ + +
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQQLR 73
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
HPNT + GC LV + LGS + IL K + I G GL YLH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEY 289
+ IHRDIKA NILLTE ++ DFG A + P F GT + APE
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMAPEV 182
Query: 290 FM---HGIVDEKTDVYSFGVLLLEL---------ITGRRAVDHLQQSVVIWAKPLLDSND 337
+ G D K DV+S G+ +EL + A+ H+ Q+ P L SND
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLSSND 238
Query: 338 ----IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
R VD L ++I + ++ ++ +LR + V+I L
Sbjct: 239 WSDYFRNFVDSCL------QKIPQDRPSSEELLKHRFVLRERPPTVIIDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 76/239 (31%), Positives = 107/239 (44%), Gaps = 28/239 (11%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYK-GCLRDGTLVAVKRLTK- 151
L ++ Y SS+ L L T + IGKG Y +VYK +DG+L AVK L
Sbjct: 1 LYGLFPYNSSM--LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI 58
Query: 152 GTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG-------CDSDGIHLVFQLSPLGSLASIL 203
VDE+ E I+ + +HPN K G + LV +L GS+ ++
Sbjct: 59 SDVDEE---IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV 115
Query: 204 HG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260
G + D + I G GL +LH RIIHRD+K +NILLT + ++ DF
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITG 314
G++ L N S GT + APE D + DV+S G+ +EL G
Sbjct: 173 GVSAQLTSTRLRRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+G G + +VYK ++ G A K + + +E F+ EI I++ HPN L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+ + ++ + G+L SI+ + + + L +LH ++IHRD
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRD 128
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY-----FMHGIVD 296
+KA NILLT D + ++ DFG++ F GT + APE F D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 297 EKTDVYSFGVLLLELITGR 315
K D++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 56/194 (28%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC-- 182
+G G + +VYK ++ ++A ++ +E+ ++ EI I+A DHPN KL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ + ++ + G++ +++ + + + T L YLHE +IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDL 129
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-----VDE 297
KA NIL T D + ++ DFG++ R T F GT + APE M D
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 298 KTDVYSFGVLLLEL 311
K DV+S G+ L+E+
Sbjct: 188 KADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 75/264 (28%), Positives = 112/264 (42%), Gaps = 20/264 (7%)
Query: 119 FSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F+ IGKG + EVYKG R +VA+K + +++ EI +++ D P
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 178 KLVGCDSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKR 236
+ G G L + LG S L K P + + I GL YLH +R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGG-GSALDLLKPGPLEETYIATILREILKGLDYLH---SER 121
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
IHRDIKA N+LL+E + ++ DFG+A L N F GT + APE D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYD 179
Query: 297 EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356
K D++S G+ +EL G L V++ P + P+L Y +
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP--------KNSPPTLEGQYSKPFKE 231
Query: 357 RAVLTASLCIEQSPILRPKMSQVV 380
C+ + P RP +++
Sbjct: 232 ----FVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 72/241 (29%), Positives = 108/241 (44%), Gaps = 41/241 (17%)
Query: 119 FSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIA-YVDHPNT 176
F L+G G Y +VYKG ++ G L A+K + +E+ EI ++ Y H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQEINMLKKYSHHRNI 65
Query: 177 AKLVGC--------DSDGIHLVFQLSPLGSLASILHGSKD---KPDWSKRYRIALGTANG 225
A G D + LV + GS+ ++ +K K +W I G
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRG 123
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L++LH Q ++IHRDIK N+LLTE+ E ++ DFG++ L R N F GT +
Sbjct: 124 LSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWM 178
Query: 286 APEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340
APE D K+D++S G+ +E+ G A PL D + +R
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG--------------APPLCDMHPMRA 224
Query: 341 L 341
L
Sbjct: 225 L 225
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 124 LIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNT 176
+G+G + +V K + VAVK L ++ + E+ ++ + H N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 177 AKLVG-CDSDG-IHLVFQLSPLGSLASILH-----GSKDKPDWSKRYR----------IA 219
L+G C +G +++V + + G+L L G PD + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
A G+ +L K+ IHRD+ A N+L+TED+ +I DFGLA+ + HH +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYYRK 190
Query: 280 GTFG-----YFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
T G + APE + ++DV+SFGVLL E+ T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 74/251 (29%), Positives = 109/251 (43%), Gaps = 35/251 (13%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKG--TVDEKTCGFLCEIGIIAYVDH 173
K FS IG G + VY +R+ +VA+K+++ +EK + E+ + + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
PNT + GC LV + LGS + +L K + + G GL YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+IHRD+KA NILL+E ++ DFG A + + F GT + APE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVIL 184
Query: 292 ---HGIVDEKTDVYSFGVLLLEL---------ITGRRAVDHLQQSVVIWAKPLLDSND-- 337
G D K DV+S G+ +EL + A+ H+ Q+ P L S
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSGHWS 240
Query: 338 --IRELVDPSL 346
R VD L
Sbjct: 241 EYFRNFVDSCL 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 49/224 (21%)
Query: 122 ENLIGKGGYAEVYKGCLR-DGTLV--AVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTA 177
E++IG+G + +V + ++ DG + A+K L + + F E+ ++ + HPN
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 178 KLVG-CDSDG-IHLVFQLSPLGSLASILHGSK---DKPDWSKRY------------RIAL 220
L+G C++ G +++ + +P G+L L S+ P ++K + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-----------LPRQ 269
A G+ YL E K+ IHRD+ A N+L+ E+ +I DFGL++ LP +
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
W A E + + K+DV+SFGVLL E+++
Sbjct: 184 W--------------MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 14/198 (7%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPNTAKLVG 181
+GKGG+ EV ++ G + A K+L K + ++ L E I+ V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 182 CDSDGIHLVFQLSPL--GSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
L ++ + G L + G P+ + A GL +LH Q+RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLH---QRRI 116
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
++RD+K +N+LL + +I D GLA L GT GY APE + D
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEVYDF 173
Query: 298 KTDVYSFGVLLLELITGR 315
D ++ G L E+I GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 81/272 (29%), Positives = 120/272 (44%), Gaps = 38/272 (13%)
Query: 99 NYRSSLKEFTLSEL---QTATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKG-- 152
+ SLK+ ++EL + K F+ IG G + VY +R +VA+K+++
Sbjct: 4 SRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 63
Query: 153 TVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP 210
+EK + E+ + + HPN+ + GC LV + LGS + +L K
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL 122
Query: 211 DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270
+ I G GL YLH +IHRDIKA NILLTE + ++ DFG A
Sbjct: 123 QEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--- 176
Query: 271 THHNVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLEL---------ITGRRAV 318
+ F GT + APE + G D K DV+S G+ +EL + A+
Sbjct: 177 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233
Query: 319 DHLQQSVVIWAKPLLDSND----IRELVDPSL 346
H+ Q+ P L SN+ R VD L
Sbjct: 234 YHIAQN----ESPTLQSNEWSDYFRNFVDSCL 261
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 63/243 (25%)
Query: 101 RSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG------CLRDGTLVAVKRLTKGTV 154
RS+L+E T +G+G + EV+ TLV VK L K T
Sbjct: 4 RSNLQEITT---------------LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TK 47
Query: 155 DEKTC-GFLCEIGIIAYVDHPNTAKLVG-C-DSDGIHLVFQLSPLGSLASILHGSKDKPD 211
DE F E+ + + H N +L+G C +++ +++ + + LG L L +K K +
Sbjct: 48 DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDE 107
Query: 212 WSK------RYRIALGT--ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263
K + ++AL T A G+ +L R +HRD+ A N L++ E ++ L+
Sbjct: 108 KLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS 164
Query: 264 K-------------WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
K +P +W APE K+DV+SFGVL+ E
Sbjct: 165 KDVYNSEYYKLRNALIPLRW--------------LAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 311 LIT 313
+ T
Sbjct: 211 VFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 49/223 (21%)
Query: 123 NLIGKGGYAEVYKGCLRDGTL---VAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAK 178
++IG+G + +V K ++ L A+KR+ + + F E+ ++ + HPN
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 179 LVG-CDSDG-IHLVFQLSPLGSLASIL---------------HGSKDKPDWSKRYRIALG 221
L+G C+ G ++L + +P G+L L + + + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-----------LPRQW 270
A G+ YL + K+ IHRD+ A NIL+ E+Y +I DFGL++ LP +W
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
A E + + +DV+S+GVLL E+++
Sbjct: 178 --------------MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHP 174
NF E IG+G ++EVY+ CL D VA+K++ + + C EI ++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLAS-ILHGSKDK---PD---WSKRYRIALGTANG 225
N K + + + +++V +L+ G L+ I + K K P+ W +Y + L +A
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW--KYFVQLCSA-- 118
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
+ ++H +R++HRDIK N+ +T ++ D GL ++ + T GT Y
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYM 173
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS--NDIRELVD 343
+PE + K+D++S G LL E+ QS K L S I +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--------LQSPFYGDKMNLFSLCQKIEQCDY 225
Query: 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
P L + +E++ V S+CI P RP + V
Sbjct: 226 PPLPTEHYSEKLRELV---SMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 119 FSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
F+ IGKG + EV+KG R +VA+K + +++ EI +++ D P
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 178 KLVGCDSDGIHLVFQLSPLG---SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
K G G L + LG +L + G D+ + + L GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLH---S 119
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
++ IHRDIKA N+LL+E + ++ DFG+A L N F GT + APE
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSA 177
Query: 295 VDEKTDVYSFGVLLLELITG 314
D K D++S G+ +EL G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 78/270 (28%), Positives = 116/270 (42%), Gaps = 32/270 (11%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKG--TVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G + VY +VAVK+++ +EK + E+ + + HPNT + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
C LV + LGS + +L K + I G GL YLH +IH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM---HGIVD 296
RDIKA NILLTE + ++ DFG A + F GT + APE + G D
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 297 EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356
K DV+S G+ +EL + + ++ ++ DS P+L N +
Sbjct: 199 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--------PTLQSNEWTDSFR 250
Query: 357 RAVLTASLCIEQSPILRPKMSQVVILLRGD 386
V C+++ P RP ++ LLR D
Sbjct: 251 GFV---DYCLQKIPQERPASAE---LLRHD 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 26/201 (12%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC-- 182
+G G + +VYK ++ +A ++ + +E+ ++ EI I+A +HP KL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 183 DSDGIHLVFQLSPLGSLASI---LHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ ++ + P G++ +I L +P R L L YLH +IIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLH---SMKIIH 133
Query: 240 RDIKADNILLTEDYEPQICDFGLA----KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
RD+KA N+LLT D + ++ DFG++ K L R+ F GT + APE M +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR------DSFIGTPYWMAPEVVMCETM 187
Query: 296 -----DEKTDVYSFGVLLLEL 311
D K D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 48/185 (25%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 136 GCLRDGTL--------VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSDG 186
GC++ G VA+K L + E I+ +D+P +++G C+++
Sbjct: 9 GCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA 68
Query: 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246
+ LV +++ G L L G KD+ S + + G+ YL K +HRD+ A N
Sbjct: 69 LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARN 125
Query: 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF-EGTFGYFAPEYFMHGIVDEKTDVYSFG 305
+LL + +I DFGL+K L +++ + ++APE ++DV+S+G
Sbjct: 126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 185
Query: 306 VLLLE 310
+ + E
Sbjct: 186 ITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDE---KTCGFLCEIGIIAYVDHPNTAKL 179
++G+G Y V K + G +VA+K+ + DE KT L E+ ++ + H N L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 180 V-GCDSDG-IHLVFQLSPLGSLASILHGSKDKP-----DWSKRYRIALGTANGLTYLHEG 232
G ++LVF+ ++L + P D + Y L + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCH-- 117
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE---- 288
IIHRDIK +NIL++E ++CDFG A+ L + ++ + T Y APE
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLVG 175
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGR 315
+G + DV++ G ++ EL+ G
Sbjct: 176 DTNYG---KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 52/224 (23%)
Query: 125 IGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + +V+ G D LVAVK L + ++ F E ++ H N K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASIL--HG----SKDKPD-------WSKRYRIALGTA 223
G + D +VF+ G L L HG PD S+ +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQ 269
+G+ YL + +HRD+ N L+ D +I DFG+++ LP +
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
W PE M+ ++DV+SFGV+L E+ T
Sbjct: 190 W--------------MPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 125 IGKGGYAEVY---KGCLRDGTLVAVKRLTKGTVDEK--TCGFLCEIGIIAYVDHPNTAKL 179
I KG Y V+ K D + A+K + K + K L E I++ P KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
++LV + P G LAS+L GS D+ D ++ Y IA L YLH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVARIY-IA-EIVLALEYLH---SN 112
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKW-LPRQWTHHNV-----SKFEGTFGYFAPEY 289
IIHRD+K DNIL+ + ++ DFGL+K L R+ + N + GT Y APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 290 FM---HGIVDEKTDVYSFGVLLLELITG 314
+ H + D +S G +L E + G
Sbjct: 173 ILGQGHS---KTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
E +G G + EV+ T VAVK + G++ FL E ++ + H KL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 182 C-DSDGIHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I+++ + GSL L + K K + A G+ ++ Q+ IH
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
RD++A NIL++ +I DFGLA+ + ++T +KF + APE G K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIK 183
Query: 299 TDVYSFGVLLLELITGRR 316
+DV+SFG+LL+E++T R
Sbjct: 184 SDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 124 LIGKGGYAEVYKGCLRDG--TLVAVK---------RLTKGTVDEKTCGFLCEIGII-AYV 171
+G G + VYK ++ L+A+K K D+ + E+ II +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 172 DHPNTAKL--VGCDSDGIHLVFQL---SPLGSLASILHGSKDKPDWSKRYRIALGTANGL 226
HPN + ++D +++V L +PLG + L K + + + I + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
YLH+ +KRI+HRD+ +NI+L ED + I DFGLAK ++ ++ GT Y
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELIT 313
PE + EK DV++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 41/219 (18%)
Query: 122 ENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
E +IG G + EV +G L + VA+K L G +++ FL E I+ DHPN
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
L G S + ++ + G+L S L + + + + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL-----------------PRQWTHHNVSKF 278
+HRD+ A NIL+ + ++ DFGL+++L P +WT
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT------- 178
Query: 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE + +DV+S+G+++ E+++ G R
Sbjct: 179 -------APEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
K IGKG + +V G R G VAVK + D FL E ++ + H N
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 61
Query: 177 AKLVGC---DSDGIHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEG 232
+L+G + G+++V + GSL L + + +L + YL
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 119
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKW---------LPRQWTHHNVSKFEGTFG 283
+HRD+ A N+L++ED ++ DFGL K LP +WT
Sbjct: 120 -ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------------ 166
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GR 315
APE K+DV+SFG+LL E+ + GR
Sbjct: 167 --APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
+IA+ GLTYL+ RI+HRDIK NIL+ + ++CDFG++ L +
Sbjct: 107 KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIAD 160
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
F GT Y +PE G K+DV+S G+ ++EL G+
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVD 172
NF IG+G Y VYK G +VA+K++ +D +T G + EI ++ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELN 57
Query: 173 HPNTAKLVGCDSDGIH------LVFQL--SPLGSLASILHGSKDKPDWSKRYRIALGTAN 224
HPN KL+ D IH LVF+ L S K Y L
Sbjct: 58 HPNIVKLL----DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQ 111
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLP-RQWTHHNVSKFEGT 281
GL + H R++HRD+K N+L+ + ++ DFGLA+ +P R +TH V T
Sbjct: 112 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----T 163
Query: 282 FGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAV 318
Y APE + D++S G + E++T RRA+
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 36/222 (16%)
Query: 124 LIGKGGYAEVY----KGCLRDGTLVAVKRLTKGTVDEKTCG--FLCEIGIIAYVDHPNTA 177
LIGKGG EVY C R VA+K++ + + FL E I A + HP
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRR---VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 178 KLVGCDSDGIHLVFQLSPL---GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+ SDG V+ P +L S+L K SK L+ H+ C
Sbjct: 66 PVYSICSDG-DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 235 -------KRIIHRDIKADNILLTEDYEPQICDFGLAKWL-------------PRQWTHHN 274
K ++HRD+K DNILL E I D+G A + R + +
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 275 VS---KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
++ K GT Y APE + E TD+Y+ GV+L +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 7e-14
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV-----DEKTCGFLCEIGIIAYVDHPNTAK 178
+G G + V + G A+K L+K + E E I+ + HP
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLVN 65
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDKP-DWSKRY--RIALGTANGLTYLHEGC 233
L G D ++LV + P G L S L S P ++ Y ++ L L YLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLH--- 118
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMH 292
I++RD+K +N+LL D +I DFG AK + R +T GT Y APE +
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------LCGTPEYLAPEIILS 172
Query: 293 GIVDEKTDVYSFGVLLLELITG 314
+ D ++ G+L+ E++ G
Sbjct: 173 KGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVD 172
+ N I +G Y VY+ + G +VA+K+L ++++ GF L EI I+ +
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQ 62
Query: 173 HPNTAKL----VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
HPN + VG + D I++V + L S++ K S+ + L +G+ +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH--HNVSKFEGTFGYFA 286
LH I+HRD+K N+LL +ICDFGLA R++ ++ T Y A
Sbjct: 122 LH---DNWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVTLWYRA 174
Query: 287 PEYFM-HGIVDEKTDVYSFGVLLLELIT------GRRAVDHLQQ 323
PE + D++S G + EL+T G+ +D L +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 49/224 (21%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTL---VAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTA 177
+++IG+G + +V K ++ L A+KR+ + + F E+ ++ + HPN
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 178 KLVG-CDSDG-IHLVFQLSPLGSLASILHGSK---DKPDWSKRYRIA------------L 220
L+G C+ G ++L + +P G+L L S+ P ++ A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-----------LPRQ 269
A G+ YL QK+ IHRD+ A NIL+ E+Y +I DFGL++ LP +
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 188
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
W A E + + +DV+S+GVLL E+++
Sbjct: 189 W--------------MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNTAKL 179
+G+G + EVYK ++ G +VA+K++ + GF L EI I+ + HPN L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD---GFPITALREIKILKKLKHPNVVPL 72
Query: 180 VGC---DSDGIH----LVFQLSPL--GSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
+ D V+ ++P L+ +L K S+ L G+ YLH
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTH---HNVSKFEG---T 281
E I+HRDIKA NIL+ +I DFGLA+ P K+ T
Sbjct: 133 E---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 282 FGYFAPEYFMHGIVDEK-----TDVYSFGVLLLELITGR 315
Y PE + E+ D++ G + E+ T R
Sbjct: 190 RWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 33/194 (17%)
Query: 144 VAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVG-CDSDG-IHLVFQLSPLGSLA 200
VAVK L D+ + E+ ++ + H N L+G C +G ++++ + + G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 201 SILH-----GSKDKPDWSKRYR----------IALGTANGLTYLHEGCQKRIIHRDIKAD 245
L G D +K A A G+ YL +R IHRD+ A
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163
Query: 246 NILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT------FGYFAPEYFMHGIVDEKT 299
N+L+TED +I DFGLA+ + H++ ++ T + APE + ++
Sbjct: 164 NVLVTEDNVMKIADFGLARGV------HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 300 DVYSFGVLLLELIT 313
DV+SFG+L+ E+ T
Sbjct: 218 DVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 124 LIGKGGYAEV----YKGCLRDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPN 175
++GKG + +V KG L AVK L K + D+ C + E ++A HP
Sbjct: 2 VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVEC-TMTEKRVLALAGKHPF 57
Query: 176 TAKLVGCDSDGIHLVFQLSPL--GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
+L C L F + + G L + S + R+ A GL +LHE
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-YAAEIVLGLQFLHE-- 114
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+ II+RD+K DN+LL + +I DFG+ K L T S F GT Y APE
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFCGTPDYIAPEILS 169
Query: 292 HGIVDEKTDVYSFGVLLLELITGR 315
+ D ++ GVLL E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 122 ENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
E +IG G + EV G L+ VA+K L G +++ FL E I+ DHPN
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
L G S + +V + GSL + L + + + G A+G+ YL +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---M 125
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL---------------PRQWTHHNVSKFEG 280
+HRD+ A NIL+ + ++ DFGL++ L P +WT
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT--------- 176
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329
APE + +DV+S+G+++ E+++ G R + VI A
Sbjct: 177 -----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 72/255 (28%), Positives = 113/255 (44%), Gaps = 36/255 (14%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTK-GTVDEKTCGFLCEIGII-AYVDHPNTAKLVG 181
IGKG Y +V+K ++G+ AVK L +DE+ E I+ A DHPN K G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE---IEAEYNILKALSDHPNVVKFYG 82
Query: 182 C-------DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLHE 231
+ D + LV +L GS+ ++ G + + + IA GL +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF- 290
+ IHRD+K +NILLT + ++ DFG++ L N S GT + APE
Sbjct: 143 ---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIA 197
Query: 291 ----MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA----------KPLLDSN 336
+ D + DV+S G+ +EL G + L ++ +P L SN
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSN 257
Query: 337 DIRELVDPSLGDNYD 351
+ + + L +Y+
Sbjct: 258 EFNDFIRKCLTKDYE 272
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 71/241 (29%)
Query: 123 NLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLV 180
IG G Y V R G VA+K+++ D L EI ++ ++ H N ++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN---II 62
Query: 181 GC-------DSDG---IHLVFQLSPLGS-LASILHGSKDKPDWSKR-----------YRI 218
G + +++V +L + + L ++ S + Y+I
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIK--------SPQPLTDDHIQYFLYQI 112
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK------WLPRQWTH 272
G L YLH +IHRD+K NIL+ + + +ICDFGLA+ T
Sbjct: 113 LRG----LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 273 HNVSKFEGTFGYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQ 322
+ V+++ Y APE Y + D++S G + EL+T + D++
Sbjct: 166 YVVTRW-----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 323 Q 323
Q
Sbjct: 215 Q 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 125 IGKGGYAEVYKG---CLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLV 180
+G G + V KG + VAVK L D L E ++ +D+P +++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 181 G-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
G C+++ LV +L+ LG L L +K + + + G+ YL E +H
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEE---TNFVH 118
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT----FGYFAPEYFMHGIV 295
RD+ A N+LL + +I DFGL+K L N K + ++APE +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 296 DEKTDVYSFGVLLLE 310
K+DV+SFGVL+ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 125 IGKGGYAEVY----KGCLRDG--TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + VY KG ++D T VA+K + + + FL E ++ + + +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDK---------PDWSKRYRIALGTANGLT 227
L+G S G ++ +L G L S L + + P K ++A A+G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
YL+ + +HRD+ A N ++ ED+ +I DFG+ + + + K + +P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELIT 313
E G+ +DV+SFGV+L E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 45/222 (20%)
Query: 120 SSENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+ + +IG G + EV++G L R VA+K L G +++ FL E I+ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 176 TAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKP-DWSKRYRIAL--GTANGLTYLH 230
+L G + ++ + G+L L +D ++S + + G A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---------------PRQWTHHNV 275
+ +HRD+ A NIL+ + E ++ DFGL++ L P +WT
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT---- 177
Query: 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE + +DV+SFG+++ E+++ G R
Sbjct: 178 ----------APEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 35/188 (18%)
Query: 144 VAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG-CDSDG-IHLVFQLSPLGSLA 200
VAVK L + + E+ I++++ +H N L+G C G I ++ + G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 201 SILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259
+ L ++ + A G+ +L K IHRD+ A N+LLT +ICD
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICD 184
Query: 260 FGLAK--------------WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFG 305
FGLA+ LP +W APE + + ++DV+S+G
Sbjct: 185 FGLARDIMNDSNYVVKGNARLPVKW--------------MAPESIFNCVYTFESDVWSYG 230
Query: 306 VLLLELIT 313
+LL E+ +
Sbjct: 231 ILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDE---KTCGFLCEIGIIAYVDHPNTAKL- 179
IG+G Y VYK G +VA+K++ T DE T + EI ++ ++HPN +L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 180 --VGCDSDGIHLVFQLSPLG---SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
V ++ ++LVF+ L + S D P K Y L G+ Y H
Sbjct: 65 DVVHSENK-LYLVFEFLDLDLKKYMDSSPLTGLD-PPLIKSYLYQL--LQGIAYCH---S 117
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW--LP-RQWTHHNVSKFEGTFGYFAPEYFM 291
R++HRD+K N+L+ + ++ DFGLA+ +P R +TH V T Y APE +
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILL 172
Query: 292 HGIVDEKT--DVYSFGVLLLELITGR 315
G T D++S G + E++ R
Sbjct: 173 -GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 77/251 (30%), Positives = 111/251 (44%), Gaps = 33/251 (13%)
Query: 74 PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV 133
PL +P S S S+ + +S LSEL+ N IG G V
Sbjct: 44 PLPLPPPSSSSSSSSSSSASGSAPSAAKS------LSELERV-------NRIGSGAGGTV 90
Query: 134 YKGCLR-DGTLVAVKRLTKGTVDEKTCGFLC-EIGIIAYVDHPNTAKLVGC-DSDG-IHL 189
YK R G L A+K + G ++ +C EI I+ V+HPN K D +G I +
Sbjct: 91 YKVIHRPTGRLYALKVIY-GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149
Query: 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
+ + GSL D+ + R L +G+ YLH ++ I+HRDIK N+L+
Sbjct: 150 LLEFMDGGSLEG--THIADEQFLADVARQIL---SGIAYLH---RRHIVHRDIKPSNLLI 201
Query: 250 TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY----FMHGIVDEKT-DVYSF 304
+I DFG+++ L + N S GT Y +PE HG D D++S
Sbjct: 202 NSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGAYDGYAGDIWSL 259
Query: 305 GVLLLELITGR 315
GV +LE GR
Sbjct: 260 GVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVD---EKTCGFLCEIGIIAYVDHPNTAKL- 179
IG+G Y V+K R+ G +VA+K+ + D +K L EI ++ + HPN L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66
Query: 180 -VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
V +HLVF+ L + + P+ + +I T + + H + I
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH---KHNCI 122
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
HRD+K +NIL+T+ + ++CDFG A+ L + + + T Y APE + D +
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGP--GDDYTDYVATRWYRAPELL---VGDTQ 177
Query: 299 ----TDVYSFGVLLLELIT------GRRAVDHL 321
DV++ G + EL+T G+ VD L
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKL 179
++GKG + +V+ L+ A+K L K V D+ C + + + +HP L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
+L F + L + H S K D + A GL +LH K I+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIV 118
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
+RD+K DNILL D +I DFG+ K F GT Y APE + +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 299 TDVYSFGVLLLELITGR 315
D +SFGVLL E++ G+
Sbjct: 177 VDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 10/192 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-C- 182
+G G + V+ G R VA+K + +G + E+ F+ E ++ + HP +L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED--FIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+++V + G L + L + K + G+ YL + IHRD+
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 243 KADNILLTEDYEPQICDFGLAKW-LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
A N L++ ++ DFG+ ++ L ++T + +KF + PE F K+DV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYSSKSDV 184
Query: 302 YSFGVLLLELIT 313
+SFGVL+ E+ T
Sbjct: 185 WSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 37/282 (13%)
Query: 125 IGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + VY+G RD T VAVK + + + FL E ++ + +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHG---------SKDKPDWSKRYRIALGTANGLT 227
L+G S G +V +L G L S L + P + ++A A+G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
YL+ K+ +HRD+ A N ++ D+ +I DFG+ + + + K + AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
E G+ +D++SFGV+L E+ + + L V+ K ++D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--KFVMD------------ 236
Query: 347 GDNYDAEE--IDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386
G D + +R +C + +P +RP ++V LL+ D
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 74/248 (29%), Positives = 116/248 (46%), Gaps = 36/248 (14%)
Query: 119 FSSENL-----IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG-FLCEI-GIIAY 170
F++E+L IG+G + V K + GT++AVKR+ + TVDEK L ++ ++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRS 59
Query: 171 VDHPNTAKLVGCD-SDG---IHLVFQLSPLGSLASILHGSKDK--PDWSKRYRIALGTAN 224
D P K G +G I + L ++ P+ +IA+ T
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-EILGKIAVATVK 118
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE--GTF 282
L YL E + +IIHRD+K NILL + ++CDFG++ L +++K G
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-----VDSIAKTRDAGCR 171
Query: 283 GYFAPEY---FMHGIVDEKTDVYSFGVLLLELITGR-------RAVDHLQQSVVIWAKPL 332
Y APE D ++DV+S G+ L E+ TG+ D L Q VV P+
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ-VVKGDPPI 230
Query: 333 LDSNDIRE 340
L +++ RE
Sbjct: 231 LSNSEERE 238
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 60/232 (25%)
Query: 125 IGKGGYAEVYK----GCL--RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
IG+G + V++ G L T+VAVK L + + F E ++A DHPN K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHG-------------------SKDKPDWS--KR 215
L+G + G + L+F+ G L L + S ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 216 YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK----------- 264
IA A G+ YL E ++ +HRD+ N L+ E+ +I DFGL++
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 265 ---WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+P +W PE + ++DV+++GV+L E+ +
Sbjct: 190 ENDAIPIRW--------------MPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 33/196 (16%)
Query: 142 TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG-CDSDG-IHLVFQLSPLGS 198
T VAVK L ++ + E+ ++ + H N L+G C DG ++++ + + G+
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 199 LASILHGSKDK-----------PDWSKRYR----IALGTANGLTYLHEGCQKRIIHRDIK 243
L L + P+ ++ A A G+ YL K+ IHRD+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 244 ADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT------FGYFAPEYFMHGIVDE 297
A N+L+TED +I DFGLA+ + H++ ++ T + APE I
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDI------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221
Query: 298 KTDVYSFGVLLLELIT 313
++DV+SFGVLL E+ T
Sbjct: 222 QSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CD 183
+G G + V G R VA+K + +G++ E F+ E ++ + H +L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 184 SD-GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
I++V + G L + L + S+ + G+ YL K+ IHRD+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 243 KADNILLTEDYEPQICDFGLAKW-LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
A N L+ + ++ DFGL+++ L ++T SKF + PE ++ K+DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKSDV 184
Query: 302 YSFGVLLLELIT-GRRAVDHLQQSVVI 327
++FGVL+ E+ + G+ + S +
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFNNSETV 211
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 125 IGKGGYAE--VYKGCLRDGTLVAVKRLTKGTVDEKTCGF-LCEIGIIAYVDHPNTAKLVG 181
+GKG + E +Y+ D +LV K + + EK L EI I++ + HPN
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 182 CDSDGIHLVFQLSPL--GSLASILHGSKDKPDWSKRYRIAL--GTANGLTYLHEGCQKRI 237
D L+ ++ G+L + K + + + + + ++Y+H + I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
+HRDIK NI LT+ ++ DFG++K L +++ GT Y +PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNF 180
Query: 298 KTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357
K+D+++ G +L EL+T +R D ++ ++ N V Y +E I
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVK--IVQGN--YTPVV----SVYSSELI-- 230
Query: 358 AVLTASLCIEQSPILRPKMSQVVILLR 384
+++ + ++Q P RP +V+
Sbjct: 231 SLVHS--LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 10/155 (6%)
Query: 184 SDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
SDG I + + GSL +L +K P+ ++++ GL YL E + +I+HRD+
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLRE--KHQIMHRDV 130
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVY 302
K NIL+ E ++CDFG++ Q + F GT Y +PE ++D++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 303 SFGVLLLELITGRRAV--DHLQQSVVIWAKPLLDS 335
S G+ L+EL GR + ++ I+ +P++D
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG 221
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 25/159 (15%)
Query: 123 NLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGF----LCEIGI---IAYVDHP 174
IG+G Y VYK L G VA+K++ +E G L EI + + +HP
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHP 61
Query: 175 NTAKL----VGCDSDG---IHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANG 225
N +L G +D + LVF+ LA+ L P + + + G
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264
+ +LH RI+HRD+K NIL+T D + +I DFGLA+
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 16/105 (15%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H IIHRD+K NI + ED E +I DFGLA R T ++ + T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA----RH-TDDEMTGYVATRWY 181
Query: 285 FAPE---YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
APE +MH ++ D++S G ++ EL+TG+ DH+ Q
Sbjct: 182 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 118 NFSSENLIGKGGYAEVYKGC--LRDGTLVAVKRLTKGTVDEKTCGFL----CEIGIIAYV 171
N+ L+G+G + VY C + G +AVK++ +T + CEI ++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 172 DHPNTAKLVGCDSDGIHL-VF-QLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLT 227
H + GC D L +F + P GS+ L +G+ + K R L G+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGVE 118
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-VSKFEGTFGYFA 286
YLH I+HRDIK NIL ++ DFG +K L + + GT + +
Sbjct: 119 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELIT 313
PE K DV+S G ++E++T
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
+I++ GLTYL E + +I+HRD+K NIL+ E ++CDFG++ Q +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMAN 156
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
F GT Y +PE ++D++S G+ L+E+ GR
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 124 LIGKGGYAEVYKGCLR--DGTL--VAVKRL-TKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
++G+G + V +G L DG+ VAVK + + FL E + DHPN K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 179 LVGC-----DSDGIH---LVFQLSPLGSLASILHGSK--DKPDW---SKRYRIALGTANG 225
L+G I ++ G L S L S+ P+ + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFG 283
+ YL + IHRD+ A N +L ED + DFGL+K + + ++K
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVK 180
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ A E + K+DV++FGV + E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+GKG Y VYK R G +A+K + + K + E+ I+ P G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+++ + GSL + G RI GL +L E + IIH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE-- 297
RD+K N+L+ + + ++CDFG++ L N+ G Y APE G ++
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQNP 182
Query: 298 ----KTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD---PSLGDNY 350
++DV+S G+ +LE+ GR + I+A+ + +VD P+L Y
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQ-------LSAIVDGDPPTLPSGY 234
Query: 351 DAEEIDRAVLTASLCIEQSPILRPKMSQ------VVILLRGDEDNAQSVKESQKQ 399
+ D + C+ + P RP +Q +V D D A+ V + K+
Sbjct: 235 SDDAQD----FVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALKR 285
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 61/202 (30%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 125 IGKGGYAEV----YKGCLRDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVD---HP 174
+G+G + +V YK G L A+K L KG + DE +CE I + HP
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVE-SLMCEKRIFETANSERHP 62
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
L C D + V + + G L ++H D + A GL YLHE
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHE- 119
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+I++RD+K DN+LL + +I DFGL K S F GT + APE
Sbjct: 120 --NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 293 GIVDEKTDVYSFGVLLLELITG 314
D + GVL+ E++ G
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 22/155 (14%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNTAKL 179
IG+G + EV+K + +VA+K++ ++ + GF L EI I+ + H N L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 180 VG-CDSDG---------IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
+ C + +LVF+ LA +L K S+ ++ NGL Y+
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI 135
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264
H + +I+HRD+KA NIL+T+D ++ DFGLA+
Sbjct: 136 H---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
+IA+ L YLH + +IHRD+K N+L+ + + ++CDFG++ +L +V+
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-----DSVA 159
Query: 277 KFE--GTFGYFAPEYF-----MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329
K G Y APE G D K+DV+S G+ ++EL TGR D W
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDS-------WK 211
Query: 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
P + E P L + E V + C++++ RP ++
Sbjct: 212 TPFQQLKQVVEEPSPQLPAEKFSPEFQDFV---NKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 65/299 (21%)
Query: 119 FSSENLIGKGGYAEVYKGCLRDGTL-----VAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
+ +L+ +G + ++ G L D V VK + + + L E ++ + H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 174 PNTAKLVGCDSDGIHLVFQLSP---LGSLASILHGSKDKPDWSKR-------YRIALGTA 223
N ++ + F L P G+L L + + + +A+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL--------------PRQ 269
G++YLH ++ +IH+DI A N ++ E+ + +I D L++ L P +
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329
W A E ++ +DV+SFGVLL EL+T L Q+
Sbjct: 185 W--------------MALESLVNKEYSSASDVWSFGVLLWELMT-------LGQT----- 218
Query: 330 KPLLDSNDIRELVDPSLGDNYD-AEEI---DRAVLTASLCIEQSPILRPKMSQVVILLR 384
P ++ D E+ L D Y A+ I D + C P RP SQ+V L
Sbjct: 219 -PYVEI-DPFEMAA-YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 7e-12
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKG--TVDEKTCGFLCEI-GIIAYVDHPNTAKL- 179
+G G + VY ++ G LVA+K++ K + +E C L E+ + +HPN KL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNEHPNIVKLK 64
Query: 180 -VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYR-IALGTANGLTYLHE-GCQKR 236
V ++D ++ VF+ G+L ++ K KP R I GL ++H+ G
Sbjct: 65 EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---- 119
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-----FEGTFGYFAPEYFM 291
HRD+K +N+L++ +I DFGLA+ S+ + T Y APE +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAPEILL 171
Query: 292 H-GIVDEKTDVYSFGVLLLELIT------GRRAVDHLQQ 323
D+++ G ++ EL T G +D L +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 142 TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG-CDSDG-IHLVFQLSPLGS 198
VAVK L D+ + E+ ++ + H N L+G C DG ++++ + + G+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 199 LASILHGSKDK-----------PDWSKRYR----IALGTANGLTYLHEGCQKRIIHRDIK 243
L L + P+ ++ A A G+ YL ++ IHRD+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 244 ADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT------FGYFAPEYFMHGIVDE 297
A N+L+TED +I DFGLA+ + HN+ ++ T + APE +
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDV------HNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215
Query: 298 KTDVYSFGVLLLELIT 313
++DV+SFGVLL E+ T
Sbjct: 216 QSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 59/224 (26%), Positives = 88/224 (39%), Gaps = 57/224 (25%)
Query: 125 IGKGGYAEVYKGCLRDGTLVA---VKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G + +V G G A VK L ++ FL E+ ++HPN + +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 182 -C-DSDGIHLVFQLSPLGSLASILHGSKD----KPDWSKRYRIALGTANGLTYLHEGCQK 235
C +S LV + PLG L + L ++ R+A A+GL +LH Q
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLA--------------KWLPRQWTHHNVSKFEGT 281
IH D+ N LT D +I D+GLA +P +W
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL---------- 169
Query: 282 FGYFAPEYFMHGIVDE------------KTDVYSFGVLLLELIT 313
APE +V+ K++++S GV + EL T
Sbjct: 170 ----APE-----LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 122 ENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
E ++G G + E+ +GCL + VA+ L G D++ GFL E + DH N
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 178 KLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+L G + G + +V + G+L S L + + + + G A+G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG--TFGYFAPEYFMHG 293
+H+ + A +L+ D +I F L + + G + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 294 IVDEKTDVYSFGVLLLELIT-GRR 316
+DV+SFG+++ E+++ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 61/197 (30%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 124 LIGKGGYAEVYKGCLRDGT-LVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKL 179
++GKG + +V L+ A+K L K V D+ C + + +HP L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
HL F + L + H S + D ++ A GL +LH +K II
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGII 118
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
+RD+K DN+LL +D +I DFG+ K S F GT Y APE +E
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 299 TDVYSFGVLLLELITGR 315
D +SFGVLL E++ G+
Sbjct: 177 VDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPN 175
F ++GKGG+ EV +R G + A K+L K + ++ L E I+ V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
L D + LV L G L I H + + + A GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
Q+RI++RD+K +NILL + +I D GLA +P T + GT GY APE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKN 175
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
D ++ G LL E+I G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 118 NFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKG----TVDEKTCGFLCEIGIIAYVD 172
+ IG G Y V R G VA+K++ T+ ++T L E+ I+ +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFK 62
Query: 173 HPNTAKLV------GCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY------RIAL 220
H N + G D +++V L L I+H + + RY R
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLR--- 118
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VSKF 278
GL Y+H +IHRD+K N+L+ ED E +I DFG+A+ L T H ++++
Sbjct: 119 ----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 279 EGTFGYFAPE--YFMHGIVDEKTDVYSFGVLLLELITGRRAV 318
T Y APE + D++S G + E++ GRR +
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 61/243 (25%)
Query: 106 EFTLSELQTATKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTC 159
E LS ++ F E +G+G + +VYKG L T VA+K L + +
Sbjct: 1 EIPLSAVR-----FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 160 GFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASIL-------------- 203
F E +++ + HPN L+G ++F+ G L L
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 204 -HGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262
K D S IA+ A G+ YL +HRD+ A N L+ E +I DFGL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 263 AK--------------WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
++ LP +W PE ++G ++D++SFGV+L
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRW--------------MPPEAILYGKFTTESDIWSFGVVL 216
Query: 309 LEL 311
E+
Sbjct: 217 WEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 9/103 (8%)
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
++ + L YL E + +IHRD+K NILL ++CDFG++ L +
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172
Query: 277 KFEGTFGYFAPEYF----MHGIVDEKTDVYSFGVLLLELITGR 315
+ G Y APE + D + DV+S G+ L+EL TG+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 60/197 (30%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKL 179
++GKG + +V L+ G AVK L K V D+ C + + + ++P L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILH-GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
HL F + L + H K + D + A GL +LH K II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGII 118
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
+RD+K DN++L D +I DFG+ K + + S F GT Y APE
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 299 TDVYSFGVLLLELITGR 315
D +SFGVLL E++ G+
Sbjct: 177 VDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 141 GTLVAVKR--LTKGTVDEKTCGFLCEIGIIAYVDHPNTAK-----LVGCDSDGIHLVFQL 193
G VAVK+ L K E E+ I+ HPN + LVG D + +V +
Sbjct: 44 GRQVAVKKMDLRKQQRREL---LFNEVVIMRDYQHPNIVEMYSSYLVG---DELWVVMEF 97
Query: 194 SPLGSLASIL-HGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
G+L I+ H ++ + L L++LH + +IHRDIK+D+ILLT D
Sbjct: 98 LEGGALTDIVTHTRMNEEQIATVCLAVLK---ALSFLH---AQGVIHRDIKSDSILLTSD 151
Query: 253 YEPQICDFG----LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
++ DFG ++K +PR+ GT + APE + D++S G+++
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 309 LELITG 314
+E++ G
Sbjct: 206 IEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 35/200 (17%)
Query: 139 RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG-CDSDG-IHLVFQLSP 195
++ VAVK L ++ + E+ ++ + H N L+G C DG ++++ + +
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 104
Query: 196 LGSLASILHGSKDKPDWSKRYRIA----------------LGTANGLTYLHEGCQKRIIH 239
G+L L ++ P Y IA A G+ YL ++ IH
Sbjct: 105 KGNLREYLR-ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIH 160
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT------FGYFAPEYFMHG 293
RD+ A N+L+TE+ +I DFGLA+ + +N+ ++ T + APE
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDV------NNIDYYKKTTNGRLPVKWMAPEALFDR 214
Query: 294 IVDEKTDVYSFGVLLLELIT 313
+ ++DV+SFGVL+ E+ T
Sbjct: 215 VYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 42/133 (31%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 184 SDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
SDG I + + GSL +L + P+ ++++ GLTYL E + +I+HRD+
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMHRDV 130
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVY 302
K NIL+ E ++CDFG++ Q + F GT Y +PE ++D++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 303 SFGVLLLELITGR 315
S G+ L+E+ GR
Sbjct: 187 SMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 13/102 (12%)
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
RIA+ GLTYL +I+HRD+K N+L+ + ++CDFG++ Q +
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAK 151
Query: 277 KFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGR 315
+ GT Y APE +GI +DV+S G+ +EL GR
Sbjct: 152 TYVGTNAYMAPERISGEQYGI---HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L +H K +IHRDIK+ NILL + ++ DFG +K + F GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345
APE + +K D++S GVLL EL+T +R D ++ E++ +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP---------------FDGENMEEVMHKT 257
Query: 346 LGDNYD--AEEID---RAVLTASLCIEQSPILRPKMSQVV 380
L YD I + ++TA L + P RP S+++
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAYVDHPNTAKLVG 181
+GKGG+ EV +R G L A K+L K + ++ G + E I+A V H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 182 C---DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTAN---GLTYLHEGCQ 234
+ LV + G L I + ++ P + + R TA GL +LH Q
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFYTAQIISGLEHLH---Q 115
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+RII+RD+K +N+LL D +I D GLA L + + GT G+ APE
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE 173
Query: 295 VDEKTDVYSFGVLLLELITGR 315
D D ++ GV L E+I R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 61/228 (26%), Positives = 90/228 (39%), Gaps = 46/228 (20%)
Query: 124 LIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTA 177
+IG+G + EV L G + A+K L K + + E I+A D P
Sbjct: 8 VIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 178 KLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE-GC 233
KL D + ++LV + P G L ++L P+ + R+ IA L +H+ G
Sbjct: 65 KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL-ALDSVHKLGF 122
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK---------------------------WL 266
IHRDIK DNIL+ D ++ DFGL K
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
+ + GT Y APE + D +S GV+L E++ G
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 37/253 (14%)
Query: 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAK 178
++GKG + +V L+ G L AVK L K + D+ C + E I++ +HP +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQ 60
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQK 235
L C D + V + G L + H K + R R A + L +LH+ K
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD---K 115
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV--SKFEGTFGYFAPEYFMHG 293
II+RD+K DN+LL + ++ DFG+ K + + S F GT Y APE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 294 IVDEKTDVYSFGVLLLELITGRRAV-----DHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348
+ D ++ GVLL E++ G D L ++++ ND E+V P+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---------ND--EVVYPTW-L 219
Query: 349 NYDAEEIDRAVLT 361
+ DA +I +A +T
Sbjct: 220 SQDAVDILKAFMT 232
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 34/246 (13%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRL-TKGTVDEKTCGFLCEIGIIAYVDHP 174
+ ++G+G + V+ C R D LV +K++ + ++ E ++ + HP
Sbjct: 1 KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 175 NTAKLVG--CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY---- 228
N + + + +V + +P G+LA + KR L L +
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ---------KRCNSLLDEDTILHFFVQI 110
Query: 229 ---LHEGCQKRIIHRDIKADNILLTEDYEP-QICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
LH K I+HRD+K NILL + +I DFG++K L + + V GT Y
Sbjct: 111 LLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCY 167
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLD--SN 336
+PE ++K+D+++ G +L EL + +RA + ++ P+ D S
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP 227
Query: 337 DIRELV 342
D+R+L+
Sbjct: 228 DLRQLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A GL +LH K II+RD+K DN++L + +I DFG+ K + F GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTP 165
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319
Y APE + + D ++FGVLL E++ G+ D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 28/226 (12%)
Query: 111 ELQTATKNFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEI 165
EL + F E +G+ + ++YKG L LVA+K L ++ F E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 166 GIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASIL-----HGS-----------K 207
++A + HPN L+G + ++F+ G L L H K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 208 DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267
D IA+ A G+ YL +H+D+ A NIL+ E +I D GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ K + PE M+G +D++SFGV+L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
NF +G+G YA VYKG R G +VA+K + + + EI ++ + H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 177 AKLVGCDSDGIH------LVFQLSPLGSLASIL--HGSKD--KPDWSKRYRIALGTANGL 226
+L D IH LVF+ L + HG + P+ K + L G+
Sbjct: 61 VRL----HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGI 113
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEG---T 281
+ HE R++HRD+K N+L+ + E ++ DFGLA+ +P V+ F T
Sbjct: 114 AFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP-------VNTFSNEVVT 163
Query: 282 FGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGR 315
Y AP+ + D++S G ++ E+ITGR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 142 TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSDGIH-LVFQLSPLGSL 199
LVAVK L D FL E+ I++ + PN A+L+G C D ++ + G L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 200 ASILHGSKDKPDWSKRYR----------IALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
L + +A A+G+ YL +HRD+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163
Query: 250 TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT----FGYFAPEYFMHGIVDEKTDVYSFG 305
++Y +I DFG++ R + + +G + A E + G K+DV++FG
Sbjct: 164 GKNYTIKIADFGMS----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 306 VLLLELIT--GRRAVDHLQQSVVI 327
V L E++T + +HL VI
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 16/105 (15%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H IIHRD+K N+ + ED E +I DFGLA+ T ++ + T Y
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 285 FAPEY---FMHGIVDEKTDVYSFGVLLLELITGRR---AVDHLQQ 323
APE +MH ++ D++S G ++ EL+TGR DH+ Q
Sbjct: 184 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 124 LIGKGGYAEVY---KGCLRD-GTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNTAK 178
++G+G + +V+ K D G L A+K L K T+ + E I+A V+HP K
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 179 LVGCDSDGIHLVFQLSPLGSLASIL----------HGSKD---KPDWSKRYRIALGTANG 225
L H FQ G L IL SK+ + K Y L A
Sbjct: 63 L--------HYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--ALA 110
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VSKFEGTFG 283
L +LH II+RD+K +NILL E+ ++ DFGL+K + H F GT
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVE 163
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
Y APE + D +SFGVL+ E++TG
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 141 GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-----TAKLVGCDSDGIHLVFQLSP 195
G VAVK++ + F E+ I+ H N + LVG D + +V +
Sbjct: 47 GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNSYLVG---DELWVVMEFLE 102
Query: 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255
G+L I+ + + + + + L L+YLH + +IHRDIK+D+ILLT D
Sbjct: 103 GGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 157
Query: 256 QICDFG----LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
++ DFG ++K +P++ GT + APE + D++S G++++E+
Sbjct: 158 KLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 312 ITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQS 369
I G + PL IR+ + P + D++ + R L L E S
Sbjct: 212 IDG--------EPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 37/103 (35%), Positives = 60/103 (58%), Gaps = 12/103 (11%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H IIHRD+K N+ + ED E +I DFGLA+ + T + V+++ Y
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-----Y 181
Query: 285 FAPEYFMHGIVDEKT-DVYSFGVLLLELITGR---RAVDHLQQ 323
APE ++ + +T D++S G ++ E++TG+ + DHL Q
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG---FLCEIGIIAYVDHPNTAKLV 180
+GKGG+ EV +++ G + A K+L K + +K G L E I+ V+ P L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-KKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 181 GCDSDGIHLVFQLSPL--GSLA-SILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
HL +S + G L I + + + + + G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
++RD+K +N+LL + ++ D GLA L T +++ GT GY APE
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173
Query: 298 KTDVYSFGVLLLELITGR 315
D ++ G + E++ GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 12/107 (11%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H ++HRD+K NIL+ E+ + +ICDFGLA+ Q T + +++ Y
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----Y 171
Query: 285 FAPEYFMH-GIVDEKTDVYSFGVLLLELITGR---RAVDHLQQSVVI 327
APE + D + D++S G + E++ G+ DH+ Q +I
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
K ++ IG+G VY + G VA++++ +K + EI ++ +PN
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPN 78
Query: 176 TAK-----LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
LVG D + +V + GSL ++ ++ D + + L +LH
Sbjct: 79 IVNYLDSYLVG---DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 133
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGL-AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
++IHRDIK+DNILL D ++ DFG A+ P Q S GT + APE
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEV 187
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341
K D++S G++ +E+I G P L+ N +R L
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE--------------PPYLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 124 LIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVDEKTCGFLC-----EIGIIAYVDHPNT 176
+IG+GG+ EVY GC + G + A+K L K + K L + +++ D P
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP-- 57
Query: 177 AKLVGCDSDGIH----LVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHE 231
+ C + H L F L + H S+ K R A GL ++H
Sbjct: 58 --FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH- 114
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+ +++RD+K NILL E +I D GLA ++ H +V GT GY APE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168
Query: 292 HGIV-DEKTDVYSFGVLLLELITG 314
G D D +S G +L +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
K ++ IG+G VY + G VA+K++ +K + EI ++ +PN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKNPN 77
Query: 176 TAK-----LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
LVG D + +V + GSL ++ ++ D + + L +LH
Sbjct: 78 IVNYLDSYLVG---DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGL-AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
++IHRDIK+DNILL D ++ DFG A+ P Q S GT + APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEV 186
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341
K D++S G++ +E++ G P L+ N +R L
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE--------------PPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 35/98 (35%), Positives = 48/98 (48%), Gaps = 17/98 (17%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA-KWLPRQ---WTHHNVSKFEG 280
GL YLH I+HRDIK N+L+ + +ICDFGLA P + T V+++
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-- 169
Query: 281 TFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGR 315
Y APE M H D++S G + EL+ R
Sbjct: 170 ---YRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 25/204 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGF-LCEIGIIAYVDHPNTAKLVGC 182
IG+G Y V+K R+ +VA+KR+ DE L EI ++ + H N +L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65
Query: 183 DSDGIH------LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
D +H LVF+ L D GL + H
Sbjct: 66 --DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAK--WLP-RQWTHHNVSKFEGTFGYFAPEYFMHG 293
++HRD+K N+L+ ++ E ++ DFGLA+ +P R ++ V T Y P+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGA 174
Query: 294 -IVDEKTDVYSFGVLLLELITGRR 316
+ D++S G + EL R
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNTAKL--V 180
IG+G Y VYKG + G +VA+K++ + +E + EI ++ + HPN L V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 181 GCDSDGIHLVFQLSPLG---SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
++L+F+ + L S+ G + K Y + G+ + H +R+
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI--LQGILFCH---SRRV 122
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAK--WLP-RQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+HRD+K N+L+ ++ DFGLA+ +P R +TH V T Y APE + G
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVLL-GS 176
Query: 295 VDEKT--DVYSFGVLLLELITGR 315
T D++S G + E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 8e-10
Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNV 275
I L LH + IIH DIK +N+L + +I CD+GL K
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCK------IIGTP 163
Query: 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
S ++GT YF+PE D D ++ GVL EL+TG
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGT--LVAVKRLTKGTV---DEKTCGFLCEIGIIAYVD 172
+F+ ++GKG + +V R GT L A+K L K V D+ C + E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECT-MVEKRVLALSG 58
Query: 173 HPN-TAKLVGC--DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTANGLTY 228
P +L C D ++ V + G L I + K + Y A A GL +
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFF 116
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
LH K II+RD+K DN++L + +I DFG+ K W F GT Y APE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGRRAV-----DHLQQSVV 326
+ + D ++FGVLL E++ G+ D L QS++
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 65/219 (29%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 118 NFSSENLIGKGGYAEVY----KGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
NF ++G G Y +V+ G G L A+K L K T+ +K +H
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKA----------KTAEH 50
Query: 174 PNTAKLV-----GC-----------DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYR 217
T + V C +HL+ G L + L+ + + R
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277
IA L +LH Q II+RDIK +NILL + + DFGL+K + S
Sbjct: 111 IA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS- 165
Query: 278 FEGTFGYFAPEYFMHGIV--DEKTDVYSFGVLLLELITG 314
F GT Y APE G D+ D +S GVL EL+TG
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV 171
K+F ++L+G+G + EV +R+ G + A+K + K + E F E I++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 172 DHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWS--KRYRIALGTANGLT 227
+ P +L D D ++LV + P G L S+L+ +D+ D + Y L A
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA---- 114
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE-GTFGYFA 286
+H Q +HRDIK +N+L+ ++ DFG A L SK GT Y A
Sbjct: 115 -IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--KMVNSKLPVGTPDYIA 171
Query: 287 PEYF---------MHGIVDEKTDVYSFGVLLLELITGR 315
PE +G+ + D +S GV+ E+I GR
Sbjct: 172 PEVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK----- 178
IG+G V ++ G LVAVK++ + F E+ I+ H N +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 179 LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
LVG D + +V + G+L I+ + + + + + L L+ LH + +I
Sbjct: 87 LVG---DELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLH---AQGVI 138
Query: 239 HRDIKADNILLTEDYEPQICDFG----LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
HRDIK+D+ILLT D ++ DFG ++K +PR+ GT + APE
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPELISRLP 192
Query: 295 VDEKTDVYSFGVLLLELITG 314
+ D++S G++++E++ G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 31/105 (29%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPR 268
A G+ +L ++ IHRD+ A NILL+E+ +ICDFGLA+ LP
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+W APE + ++DV+SFGVLL E+ +
Sbjct: 240 KW--------------MAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHP 174
+ ++S +G G Y V R G VA+K+L++ E E+ ++ ++ H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 175 NTAKLV-----GCDSDGIHLVFQLSPL--GSLASI--LHGSKDKPDWSKRYRIALGTANG 225
N L+ D + + P L I S+DK + + G
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCG 129
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L Y+H IIHRD+K N+ + ED E +I DFGLA+ + T + V+++ Y
Sbjct: 130 LKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YR 181
Query: 286 APEY---FMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
APE +MH ++ D++S G ++ E++TG+ + D+L Q
Sbjct: 182 APEVILNWMH--YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 64/239 (26%), Positives = 101/239 (42%), Gaps = 45/239 (18%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK--TCGFLCEIGIIAYVDH 173
+F S +IG+G + EV +D G + A+K+L K + EK E I+A D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
P KL D + ++L+ + P G + ++L + R+ IA T + +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH- 118
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP--------RQWTHHNVSKFE---- 279
+ IHRDIK DN+LL ++ DFGL L R +H S F
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 280 ------------------------GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
GT Y APE F+ +++ D +S GV++ E++ G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
K ++ IG+G VY + G VA+K++ +K + EI ++ HPN
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL-IINEILVMRENKHPN 77
Query: 176 TAK-----LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
LVG D + +V + GSL ++ ++ D + + L +LH
Sbjct: 78 IVNYLDSYLVG---DELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGL-AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
++IHRDIK+DNILL D ++ DFG A+ P Q S GT + APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEV 186
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341
K D++S G++ +E++ G P L+ N +R L
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE--------------PPYLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 33/241 (13%)
Query: 108 TLSELQTATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIG 166
T+ + K ++ IG+G V+ + G VA+K++ +K + EI
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL-IINEIL 68
Query: 167 IIAYVDHPNTAK-----LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALG 221
++ + +PN LVG D + +V + GSL ++ ++ D ++ +
Sbjct: 69 VMKELKNPNIVNFLDSFLVG---DELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRE 123
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL-AKWLPRQWTHHNVSKFEG 280
L +LH ++IHRDIK+DN+LL D ++ DFG A+ P Q S G
Sbjct: 124 CLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVG 177
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340
T + APE K D++S G++ +E++ G P L+ N +R
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE--------------PPYLNENPLRA 223
Query: 341 L 341
L
Sbjct: 224 L 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
ANG+ +L K +HRD+ A N+L+ E +ICDFGLA+ + R + +SK TF
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISK-GSTF 302
Query: 283 ---GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ APE + + +DV+SFG+LL E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 125 IGKGGYAEVYKGCL---RDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNTA 177
IG+G Y VYK +DG A+K+ KG ++ T G EI ++ + H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYT-GISQSACREIALLRELKHENVV 65
Query: 178 KLVGC---DSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTA--------NG 225
LV +D ++L+F + I + +KR I NG
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQILNG 120
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWLPRQWTHHNVSKFEG- 280
+ YLH ++HRD+K NIL+ + + I D GLA R + +
Sbjct: 121 VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLA----RLFNAPLKPLADLD 173
Query: 281 ----TFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELIT 313
T Y APE + H + D+++ G + EL+T
Sbjct: 174 PVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A G+ +L ++ IHRD+ A NILL+E+ +ICDFGLA+ + + +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ APE + ++DV+SFGVLL E+ +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 124 LIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVDEKTCGFLC-----EIGIIAYVDHPNT 176
+IG+GG+ EVY GC + G + A+K L K + K L + +++ D P
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP-- 57
Query: 177 AKLVGCDS------DGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTY 228
+ C S D + + L G L L HG + + + Y A GL +
Sbjct: 58 --FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-MRFY--AAEIILGLEH 112
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
+H + +++RD+K NILL E +I D GLA ++ H +V GT GY APE
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 165
Query: 289 YFMHGIV-DEKTDVYSFGVLLLELITG 314
G+ D D +S G +L +L+ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDH 173
+F+ ++GKG + +V + L A+K L K V D+ C + E ++A D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT-MVEKRVLALQDK 59
Query: 174 PN-TAKLVGC--DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTANGLTYL 229
P +L C D ++ V + G L I K K + Y A + GL +L
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFL 117
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
H + II+RD+K DN++L + +I DFG+ K F GT Y APE
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI 172
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVD 319
+ + D +++GVLL E++ G+ D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC 182
IG+G ++EV K + G A+K + K + L EI + + HPN +L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 183 DSDGIH----LVFQLSPLGSLASILHGSKD--KPDWSKRYRIALGTANGLTYLHEGCQKR 236
D LVF+L + +L ++ G K K Y L L ++H +
Sbjct: 67 LFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQL--LKSLDHMH---RNG 120
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-HGIV 295
I HRDIK +NIL+ +D ++ DFG + + ++ +++ T Y APE + G
Sbjct: 121 IFHRDIKPENILI-KDDILKLADFGSCRGI---YSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 296 DEKTDVYSFGVLLLELIT 313
K D+++ G + E+++
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK-----TCGFLCEIGIIAYVDHPNTAK 178
IGKG + +VY+ +D + A+K L+K + K T G E I+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG---ERNILVRTLLDESPF 57
Query: 179 LVG------CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA-LGTANGLTYLHE 231
+VG DSD ++LV G L L + ++ IA L A L +LH+
Sbjct: 58 IVGLKFSFQTDSD-LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA--LEHLHK 114
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
I++RD+K +NILL +CDFGL+K + + F GT Y APE +
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 292 HGIVDEK-----TDVYSFGVLLLELITG 314
DEK D +S GVL+ E+ G
Sbjct: 170 ----DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK--TCGFLCEIGIIAYVDHP 174
+F S +IG+G + EV +D G + A+K L K + EK E I+ D
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
K+ D ++L+ + P G + ++L + + ++ IA T + +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH-- 118
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP--------RQWTHHNVSKFE----- 279
Q IHRDIK DN+LL ++ DFGL L R TH+ S F
Sbjct: 119 -QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 280 --------------------GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
GT Y APE FM ++ D +S GV++ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 68/253 (26%), Positives = 100/253 (39%), Gaps = 58/253 (22%)
Query: 123 NLIGKGGYAEVYKGC-LRDGTLVAVKR--LTKGTVDEKT-------CGF----LCEIGII 168
+G+G Y +V K G +VA+K+ + + + D CG L E+ I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 169 AYVDHPNTAKLVG--CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGL 226
+ H N LV + D I+LV + L ++ K + S+ I L NGL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGL 132
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG------ 280
LH + +HRD+ NI + +I DFGLA+ +SK E
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 281 ------TFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329
T Y APE M H V D++S G + EL+TG
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELLTG--------------- 230
Query: 330 KPLL-DSNDIREL 341
KPL N+I +L
Sbjct: 231 KPLFPGENEIDQL 243
|
Length = 335 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 51/239 (21%)
Query: 122 ENLIGKGGYAEVYK-GCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
E GK AE Y +D LVAVK L T+ + F E ++ + H + K
Sbjct: 15 EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVKFY 73
Query: 181 GC--DSDGIHLVFQLSPLGSLASIL--HG-------------SKDKPDWSKRYRIALGTA 223
G D D + +VF+ G L L HG +K + S+ IA A
Sbjct: 74 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQ 269
+G+ YL + +HRD+ N L+ + +I DFG+++ LP +
Sbjct: 134 SGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVI 327
W PE M+ ++DV+SFGV+L E+ T G++ L + VI
Sbjct: 191 W--------------MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
G+ Y+H Q+RI+HRD+KA NI L + +I DFG+++ L + + F GT Y
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYY 171
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ-QSVVIWAKPLLDSNDIRELVD 343
+PE H D K+D++S G +L E+ A + SVV+ I E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL---------RIVEGPT 222
Query: 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380
PSL + Y + +++ + L + P LRP ++++
Sbjct: 223 PSLPETYSRQL--NSIMQSML--NKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 69/228 (30%), Positives = 101/228 (44%), Gaps = 69/228 (30%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRL---------TKGTVDEKTCGFLCEIGIIAYVDHP 174
+GKG Y V+K R +VA+K++ + T E FL E+G DHP
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM--FLQELG-----DHP 67
Query: 175 NTAKLVGC-----DSDGIHLVFQL--SPLGSL--ASILHGSKDKPDWSKRYRIALGTANG 225
N KL+ D D I+LVF+ + L ++ A+IL D KRY I
Sbjct: 68 NIVKLLNVIKAENDKD-IYLVFEYMETDLHAVIRANILE------DVHKRY-IMYQLLKA 119
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG-- 283
L Y+H G +IHRD+K NILL D ++ DFGLA+ ++S+ E
Sbjct: 120 LKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR---------SLSELEENPENP 167
Query: 284 ----------YFAPE------YFMHGIVDEKTDVYSFGVLLLELITGR 315
Y APE + G+ D++S G +L E++ G+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 125 IGKGGYAEVYKGCLR--DGTL-VAVKRL-----TKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+G+G + V +G L D L VAVK + T+ +++ FL E + DHPN
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED----FLSEAVCMKEFDHPNV 62
Query: 177 AKLVGCDSDGIHLVFQLSPL--------GSLASILHGSK--DKPDW---SKRYRIALGTA 223
+L+G + SP+ G L S L S+ D P + + A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR--QWTHHNVSKFEGT 281
+G+ YL K IHRD+ A N +L E+ + DFGL+K + + ++K
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--P 177
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ A E + K+DV+SFGV + E+ T
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A L YLHE K I+HRD+K N+ LT ++ D G+A+ L Q S GT
Sbjct: 112 AMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM--ASTLIGTP 166
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342
Y +PE F + + K+DV++ G + E+ T + A + + +++ I E
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR--------IIEGK 218
Query: 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380
P + +Y E + ++ L + P RP + ++
Sbjct: 219 LPPMPKDYSPELGE--LIATMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183
+G+G YA VYKG R +G LVA+K ++ T + + E ++ + H N L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 184 SDGIH----LVFQLSPLGS-LASILHGSKDKPDWSKRYRIAL---GTANGLTYLHEGCQK 235
D IH L F + + LA + P Y + L GL Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIH---GQ 122
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLA--KWLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
I+HRD+K N+L++ E ++ DFGLA K +P Q V T Y P+ + G
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV----TLWYRPPDVLL-G 177
Query: 294 IVDEKT--DVYSFGVLLLELITGRRAV----DHLQQSVVIW 328
D + D++ G + +E++ G+ A D +Q IW
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 57/193 (29%), Positives = 86/193 (44%), Gaps = 13/193 (6%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
IG G Y +VYK + G L A+K + K E EI ++ H N G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIK-VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
D + + + GSL I H + + Y ++ T GL YLH K +HRD
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLH---SKGKMHRD 131
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM---HGIVDEK 298
IK NILLT++ ++ DFG++ + T F GT + APE G ++
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 299 TDVYSFGVLLLEL 311
D+++ G+ +EL
Sbjct: 190 CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 5/89 (5%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
G+ ++HE KR++HRDIK+ NI LT++ + ++ DFG A+ L + + GT Y
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYY 166
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
PE + + + K+D++S G +L EL T
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGT--LVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDH 173
+F +G G + V + GT A+K L K + ++ E I+ + H
Sbjct: 19 DFEMGETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLH 230
P ++ D + ++ + + G L + L + P D +K Y L A YLH
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLH 135
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEY 289
K II+RD+K +N+LL ++ DFG AK +P R +T GT Y APE
Sbjct: 136 S---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------LCGTPEYLAPEV 186
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
+ D ++ GVLL E I G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 42/211 (19%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183
+G+G YA V+KG + LVA+K + + C + E+ ++ + H N L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL---- 68
Query: 184 SDGIH------LVFQ---------LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
D IH LVF+ L G+L S +H K GL+Y
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVK---------IFMFQLLRGLSY 118
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL--AKWLPRQWTHHNVSKFEGTFGYFA 286
H+ ++I+HRD+K N+L+ E E ++ DFGL AK +P + + V T Y
Sbjct: 119 CHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----TLWYRP 171
Query: 287 PEYFMHGIVDEKT--DVYSFGVLLLELITGR 315
P+ + G + T D++ G +L E+ TGR
Sbjct: 172 PDVLL-GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
A G+ +L ++ IHRD+ A NILL+E+ +ICDFGLA+ + + +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+ APE + ++DV+SFGVLL E+ +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 119 FSSENLIGKGGYAEVYKGCLR--DGTL--VAVKRL-----TKGTVDEKTCGFLCEIGIIA 169
F+ ++GKG + V + L+ DG+ VAVK L + ++E FL E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE----FLREAACMK 56
Query: 170 YVDHPNTAKLVGCD-----SDGIHLVFQLSPL---GSLASILHGSK--DKP---DWSKRY 216
DHPN KL+G + + + P G L + L S+ ++P
Sbjct: 57 EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHN 274
R + A+G+ YL K IHRD+ A N +L E+ + DFGL+K + +
Sbjct: 117 RFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
SK + A E + +DV++FGV + E++T
Sbjct: 174 ASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAKL 179
+IG+G YA+V L+ + ++ K + DE E + +HP L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILHGSKDK--PDWSKRYRIALGTANGLTYLHEGCQKRI 237
C L F + + + H + + P+ R+ A + L YLHE + I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
I+RD+K DN+LL + ++ D+G+ K R S F GT Y APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 298 KTDVYSFGVLLLELITGRRAVD 319
D ++ GVL+ E++ GR D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 124 LIGKGGYAEVYKGCLRDGT----LVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNT 176
++GKGGY +V++ G + A+K L K T+ + T E I+ V HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 177 AKLVGCDSDGIHLVFQLSPLGSLASILHGSKDK---PDWSKRYRIALGTANGLTYLHEGC 233
L+ G L L L +H ++ D + Y + A L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA--LEHLH--- 117
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFM 291
Q+ II+RD+K +NILL ++ DFGL K TH F GT Y APE M
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCGTIEYMAPEILM 173
Query: 292 HGIVDEKTDVYSFGVLLLELITG 314
+ D +S G L+ +++TG
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 164 EIGIIAYVDHPNTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIALG 221
E ++ V HP +L + D L + + P G L S L S + + + A
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASE 109
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEG 280
L YLH K I++RD+K +NILL ++ ++ DFG AK L R WT G
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------LCG 160
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
T Y APE ++ D ++ G+L+ E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183
+G+G YA VYKG + +G LVA+K + + + E ++ + H N L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLL---- 68
Query: 184 SDGIH------LVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
D IH LVF+ L + H P+ K + L GL+Y+H Q+
Sbjct: 69 HDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIH---QR 122
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
I+HRD+K N+L+++ E ++ DFGLA+ + H S T Y P+ + G
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL-GST 179
Query: 296 DEKT--DVYSFGVLLLELITGRRAV-------DHLQQSVVIWAKPLLDS 335
+ T D++ G + +E+I G A D L++ ++ P D+
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
+G G Y +VYK L G L AVK + D+ + EI ++ H N G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75
Query: 183 -DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+ + + + GSL I H + + Y + T GL YLH K +HRD
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLH---SKGKMHRD 131
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM---HGIVDEK 298
IK NILLT++ + ++ DFG+A + T F GT + APE +G ++
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 299 TDVYSFGVLLLEL 311
D+++ G+ +EL
Sbjct: 190 CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/239 (24%), Positives = 107/239 (44%), Gaps = 24/239 (10%)
Query: 89 REDPDLTHIYN-YRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV----YKGCLRDGTL 143
R++ ++ + N Y +++ + +LQ +++ +IG+G + EV +K + +
Sbjct: 16 RKNKNIDNFLNRYEKIVRK--IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK---V 70
Query: 144 VAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPNTAKLVGCDSDGIHL--VFQLSPLGSL 199
A+K L+K + +++ F E I+A+ + P +L D +L V + P G L
Sbjct: 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130
Query: 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259
+++ W+K Y TA + L +IHRD+K DN+LL + ++ D
Sbjct: 131 VNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLAD 185
Query: 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH----GIVDEKTDVYSFGVLLLELITG 314
FG + + GT Y +PE G + D +S GV L E++ G
Sbjct: 186 FGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 54/225 (24%)
Query: 125 IGKGGYAEVYKG-CL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + +V+ C +D LVAVK L + + + F E ++ + H + +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTVLQHQHIVR 71
Query: 179 LVGCDSDG--IHLVFQLSPLGSL----------ASILHGSKDKP----DWSKRYRIALGT 222
G ++G + +VF+ G L A IL G +D + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPR 268
A+G+ YL +HRD+ N L+ + +I DFG+++ LP
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+W PE ++ ++D++SFGV+L E+ T
Sbjct: 189 RW--------------MPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 125 IGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVD---HPNT 176
IG+G Y +V+K RD G VA+KR+ T +E + E+ ++ +++ HPN
Sbjct: 9 IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 177 AKLVG-CD------SDGIHLVFQLSPLGSLASILHGSKDK---PDWSKRYRIALGTANGL 226
+L C + LVF+ L + L + + K L GL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL--LRGL 123
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
+LH R++HRD+K NIL+T + ++ DFGLA+ Q +V T Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRA 177
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLE------LITGRRAVDHL 321
PE + D++S G + E L G VD L
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 39/155 (25%)
Query: 181 GCDSDGIHLVFQLSPLGSLASILHGSKD----KPDW----SKRYRIALGTANGLTYLHEG 232
G S G ++ P+ S +S SKD + W R + A G+ +L
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL--- 228
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTHHNVSKF 278
K IHRD+ A N+LLT+ +ICDFGLA+ LP +W
Sbjct: 229 ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW-------- 280
Query: 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
APE + ++DV+S+G+LL E+ +
Sbjct: 281 ------MAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 161 FLCEIGIIAYVDHPNTAKLVG---CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYR 217
F E + A + HPN L+ + VF+ P +L +L P + R
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPA-GETGR 83
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEP--QICDFGLAKWLP-----RQ 269
+ L + L H + I+HRD+K NI++++ P ++ DFG+ LP
Sbjct: 84 LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADV 140
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318
T ++ GT Y APE V +D+Y++G++ LE +TG+R V
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 48/226 (21%)
Query: 119 FSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDH 173
F IG+G Y +VYK +D G LVA+K++ +D + GF + EI I+ ++H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNH 65
Query: 174 PNTAKL---VGCDSDGI---------HLVFQLSP---LGSLAS-ILHGSKDKPDWSKRYR 217
N L V D + +LVF+ +G L S ++H S+D K +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH---IKSFM 122
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL----PRQWTHH 273
L GL Y H +K +HRDIK NILL + ++ DFGLA+ R +T+
Sbjct: 123 KQL--LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 274 NVSKFEGTFGYFAPEYFMHGIVDEK----TDVYSFGVLLLELITGR 315
+ T Y PE + +E+ DV+S G +L EL T +
Sbjct: 178 VI-----TLWYRPPELLLG---EERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 124 LIGKGGYAEVYKGCLRDGT--LVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTA 177
++GKG + +V GT + A+K L K + D+ C + E I+A HP
Sbjct: 2 VLGKGSFGKVMLA-ELKGTDEVYAIKVLKKDVILQDDDVDCT-MTEKRILALAAKHPFLT 59
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
L C D + V + G L + S+ K D + A L +LH +
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
+I+RD+K DNILL + ++ DFG+ K L T + F GT Y APE
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT----TTFCGTPDYIAPEILQEL 171
Query: 294 IVDEKTDVYSFGVLLLELITGR 315
D ++ GVL+ E++ G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 20/95 (21%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQIC--DFGLAKWLPRQWTHHNVSK----- 277
GL YLH +RIIHRD+K +NI + + Q+C D G A++ V
Sbjct: 169 GLRYLH---AQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQF--------PVVAPAFLG 215
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELI 312
GT APE + K D++S G++L E++
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 62/201 (30%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGI-IAYVDHPNTAKLV 180
IGKG + +V + DG AVK L K + +K + E + + V HP LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF---LV 59
Query: 181 GC-----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
G +D ++ V G L L + P+ R+ A A+ L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VSKFEGTFGYFAPEYFMHG 293
II+RD+K +NILL + DFGL K + H+ S F GT Y APE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 294 IVDEKTDVYSFGVLLLELITG 314
D D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H ++HRD+K N+LL + + +ICDFGLA+ ++++ T Y
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174
Query: 285 FAPEYFMHGIVDEKT---DVYSFGVLLLELITGRRAV----DHLQQ 323
APE ++ E T DV+S G + EL+ GR+ + D++ Q
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQ 217
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPN 175
F ++GKGG+ EV +R G + A KRL K + ++ L E I+ V+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTAN---GLTYLH 230
L D + LV + G L ++ + P + + R A GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEE-RALFYAAEILCGLEDLH 119
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
++ ++RD+K +NILL + +I D GLA +P ++ GT GY APE
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVL 173
Query: 291 MHGIVDEKTDVYSFGVLLLELITGR 315
+ D + G L+ E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 74/291 (25%), Positives = 108/291 (37%), Gaps = 67/291 (23%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLV 180
L+GKG V+ L+ G L A+K L K + + K L E I+A +DHP L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 181 GC--DSDGIHLVFQLSPLGSLASILHGSKDK--PDWSKRYRIALGTANGLTYLH-EGCQK 235
+ LV P G L +L K + R+ A L YLH G
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL-------------------PRQWTHHNVS 276
I++RD+K +NILL E + DF L+K S
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 277 K--------FEGTFGYFAPEYFMHGIV-----DEKTDVYSFGVLLLELITGR-------- 315
+ F GT Y APE ++ D ++ G+LL E++ G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 316 -RAVDHLQQSVVIWAKPLLDSNDIRELV------DPS--LGDNYDAEEIDR 357
++ + V + S+ R+L+ DPS LG A EI +
Sbjct: 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 31/105 (29%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPR 268
A G+++L K IHRD+ A NILLT +ICDFGLA+ LP
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+W APE + + ++DV+S+G+LL E+ +
Sbjct: 281 KW--------------MAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
L +LHE + II+RD+K DN+LL + ++ D+G+ K R S F GT Y
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYI 163
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319
APE D ++ GVL+ E++ GR D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 48/236 (20%)
Query: 122 ENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
E GK AE Y C +D LVAVK L K D F E ++ + H + K
Sbjct: 15 EGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFY 73
Query: 181 GC--DSDGIHLVFQLSPLGSLASIL--HG------SKDKP----DWSKRYRIALGTANGL 226
G + D + +VF+ G L L HG ++ S+ IA A G+
Sbjct: 74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM 133
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTH 272
YL + +HRD+ N L+ E+ +I DFG+++ LP +W
Sbjct: 134 VYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW-- 188
Query: 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVI 327
PE M+ ++DV+S GV+L E+ T G++ L + VI
Sbjct: 189 ------------MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 64/236 (27%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK-TCGFL-CEIGIIAYVDH 173
++F S +IG+G + EV +D G + A+K L K + EK G + E I+ D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
K+ D ++L+ + P G + ++L + ++ IA T + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH- 118
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL----------------PRQWTHHNV 275
Q IHRDIK DN+LL ++ DFGL L P +T N+
Sbjct: 119 --QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 276 S---KFE--------------GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
+ K E GT Y APE FM ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183
+G+G YA VYKG + G LVA+K + + + E ++ + H N L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 184 SDGIH------LVFQLSPLGSLASIL------HGSKDKPDWSKRYRIALGTANGLTYLHE 231
D IH LVF+ L + L G + + L GL Y H
Sbjct: 69 HDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCH- 120
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGL--AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
Q+R++HRD+K N+L++E E ++ DFGL AK +P + + V T Y P+
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWYRPPDV 174
Query: 290 FMHGIVDEKT--DVYSFGVLLLELITGR 315
+ G + T D++ G + E+ TGR
Sbjct: 175 LL-GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 59/198 (29%), Positives = 85/198 (42%), Gaps = 14/198 (7%)
Query: 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGII-AYVDHPNTAKL 179
+IGKG + +V + DG+ AVK L K T+ +K + E ++ + HP L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQKRII 238
L F L + H +++ R R A A+ + YLH II
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNII 118
Query: 239 HRDIKADNILLTEDYEPQICDFGLAK--WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
+RD+K +NILL + DFGL K P + T S F GT Y APE D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT----STFCGTPEYLAPEVLRKEPYD 174
Query: 297 EKTDVYSFGVLLLELITG 314
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTL--VAVKRLTKGTV--DEKTCGFLCEIGIIAYVD 172
++F+ +G G + V ++ VA+KR K + ++ E I+ Y++
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
HP L G D ++LV + G + L +K P+ + A + +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-----DVGCFYAAQIVLIF 144
Query: 231 EGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPE 288
E Q I++RD+K +N+LL +D ++ DFG AK + R +T GT Y APE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPE 198
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITG 314
++ + D ++ G+ + E++ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
L +LHE + II+RD+K DN+LL D ++ D+G+ K S F GT Y
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNY 162
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319
APE D ++ GVL+ E++ GR D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 13/94 (13%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
GL Y+H IIHRD+K N+ + ED E +I DFGLA RQ ++ + T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA----RQ-ADDEMTGYVATRWY 181
Query: 285 FAPEY---FMHGIVDEKTDVYSFGVLLLELITGR 315
APE +MH ++ D++S G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 13/94 (13%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG----LAKWLPRQWTHHNVSKFEG 280
L YLH + +IHRDIK+D+ILLT D ++ DFG ++K +P++ G
Sbjct: 129 ALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVG 179
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
T + APE + D++S G++++E++ G
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
L E ++++HRD+K+ NI L ++ DFG +K + S F GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGRRAV------DHLQQSVVIWAK----PLLDSNDI 338
+ +K D++S GV+L EL+T R + +QQ V++ K P S+ +
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ--VLYGKYDPFPCPVSSGM 299
Query: 339 RELVDPSLGDN 349
+ L+DP L N
Sbjct: 300 KALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 30/97 (30%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE----G 280
L ++H+ ++I+HRDIK+ NI LT+D ++ DFG+A+ L ++ + G
Sbjct: 113 ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL------NSTVELARTCIG 163
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA 317
T Y +PE + + K+D+++ G +L E+ T + A
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 22/199 (11%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G+GGY +V+ +D G +VA+KR+ K + + L E I+ KL+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE-GCQKRII 238
D + ++L + P G ++L+ + R+ +A + LHE G I
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALHELG----YI 123
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG---YFAPEYFMHGIV 295
HRD+K +N L+ ++ DFGL+K + V+ G Y APE
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGI--------VTYANSVVGSPDYMAPEVLRGKGY 175
Query: 296 DEKTDVYSFGVLLLELITG 314
D D +S G +L E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 59/200 (29%), Positives = 85/200 (42%), Gaps = 18/200 (9%)
Query: 124 LIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTV--DEKTCGFLCEIGII-AYVDHPNTAKL 179
+IGKG + +V DG AVK L K V ++ + E ++ V HP L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF---L 58
Query: 180 VGC-----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
VG ++ ++ V G L L + P+ R+ A A+ L YLH
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
I++RD+K +NILL + DFGL K Q + F GT Y APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQP 172
Query: 295 VDEKTDVYSFGVLLLELITG 314
D D + G +L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPN 175
F ++GKGG+ EV +R G + A K+L K + ++ L E I+ V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEG 232
L D + LV L G L ++ + +R A GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH-- 119
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
++RI++RD+K +NILL + +I D GLA +P T + GT GY APE +
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKN 175
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
D + G L+ E+I G+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 14/109 (12%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGT 281
GL Y+H ++HRD+K N+L+ D E +ICDFGLA+ P + ++++ T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF-MTEYVAT 172
Query: 282 FGYFAPEYFMHGIVDEKT-DVYSFGVLLLELI------TGRRAVDHLQQ 323
Y APE + K DV+S G +L EL+ G+ VD L Q
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183
+G+G YA VYKG + LVA+K + + C + E+ ++ + H N L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69
Query: 184 SDGIH------LVFQL------SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
D IH LVF+ L + ++ K + R GL Y H
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCH- 121
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGL--AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
+++++HRD+K N+L+ E E ++ DFGL AK +P + + V T Y P+
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----TLWYRPPDI 175
Query: 290 FMHGIVDEKT--DVYSFGVLLLELITGR 315
+ G D T D++ G + E+ TGR
Sbjct: 176 LL-GSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 119 FSSENLIGKGGYAEVYKGCLRDGT--LVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPN 175
F ++G+G Y V K C T +VA+K+ +E+ L E+ ++ + N
Sbjct: 3 FEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASIL-HGSKDKPDWSKRYRIALGTANGLTYLHEG 232
+L ++LVF+ L + + P+ + Y L A +H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----IHWC 116
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+ I+HRDIK +N+L++ + ++CDFG A+ L + ++ N +++ T Y +PE +
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLG 175
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
+ D++S G +L EL G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHN-VSKFEGTF 282
GL Y+H ++HRD+K N+ + TED +I DFGLA+ + ++H +S+ T
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 283 GYFAPEYFMHGIVDEKT-DVYSFGVLLLELITGRR--AVDHL--QQSVVIWAKPLLDSND 337
Y +P + K D+++ G + E++TG+ A H Q +++ + P++ D
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 338 IREL--VDPSLGDNYDAE 353
EL V PS N E
Sbjct: 243 RNELLNVIPSFVRNDGGE 260
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 33/80 (41%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV- 295
II+RDIK +NILL + + DFGL+K S F GT Y AP+ G
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGG 184
Query: 296 -DEKTDVYSFGVLLLELITG 314
D+ D +S GVL+ EL+TG
Sbjct: 185 HDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 124 LIGK----GGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL-CEIGIIAYVDHPNTAK 178
LIGK + K TLVAVK++ + ++ L EI + HPN
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
V +++V L GS +L H + P+ + + I N L Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119
Query: 235 KRIIHRDIKADNILLTEDYEPQICDF----GLAKWLPRQWTHHNVSKF-EGTFGYFAPEY 289
K IHR +KA +ILL+ D + + + K RQ H+ K + +PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 290 F---MHGIVDEKTDVYSFGVLLLELITG 314
+ G +EK+D+YS G+ EL G
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 109 LSELQTATKNFSSENLIGKGGYAEV----YKGCLRDGTLVAVKRLTKGTVDEK--TCGFL 162
+++L+ ++F +IG+G + EV +K + A+K L+K + ++ + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 163 CEIGIIAYVDHPNTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKP-DWSKRYR-- 217
E I+A+ + +L D +L V + P G L +++ + D P W++ Y
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAE 150
Query: 218 --IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275
+AL + + + IHRD+K DN+LL + ++ DFG +
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC- 200
Query: 276 SKFEGTFGYFAPEYFM----HGIVDEKTDVYSFGVLLLELITG 314
GT Y +PE G + D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGY 284
L YLH +++RD+K +N++L +D +I DFGL K + K F GT Y
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
APE D + GV++ E++ GR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGF-LCEIGIIAYVDHPNTAKL-- 179
L+G+G Y V K ++ G +VA+K+ + D+ + EI ++ + H N L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 180 VGCDSDGIHLVFQL---SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
V ++LVF+ + L L +G D S+ + G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGL----DESRVRKYLFQILRGIEFCH---SHN 120
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
IIHRDIK +NIL+++ ++CDFG A+ L + + T Y APE + D
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGEVYTDYVATRWYRAPELL---VGD 175
Query: 297 EK----TDVYSFGVLLLELITG 314
K D+++ G L+ E++TG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 124 LIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAK 178
L+GKG + +V +R+ G A+K L K + ++ L E ++ HP
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 179 LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQKRI 237
L L F + + H S+++ R R + L YLH G +I
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE 297
++RD+K +N++L +D +I DFGL K + F GT Y APE
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 298 KTDVYSFGVLLLELITGR 315
D + GV++ E++ GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 12/203 (5%)
Query: 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPN 175
F ++GKGG+ EV +R G + A K+L K + ++ L E I+ V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
L D + LV + G L I + D + A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
++RI++RD+K +NILL + +I D GLA +P T V GT GY APE +
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINN 175
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
D + G L+ E+I G+
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 141 GTLVAVKRLTKGTVDEKTCGFLC-EIGIIAYVDHPNTAKLVGC--------DSDGIHLVF 191
G VAVK+L++ ++ E+ ++ V+H N L+ + ++LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 192 QLSPLGSLASILHGSKDKPDWSKR-YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250
+L +L ++H D S Y++ G + +LH IIHRD+K NI++
Sbjct: 106 ELMD-ANLCQVIHMELDHERMSYLLYQMLCG----IKHLHSA---GIIHRDLKPSNIVVK 157
Query: 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
D +I DFGLA+ T+ ++ + T Y APE + E D++S G ++ E
Sbjct: 158 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 311 LITGR---RAVDHLQQ 323
L+ G + DH+ Q
Sbjct: 215 LVKGSVIFQGTDHIDQ 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 64/244 (26%), Positives = 90/244 (36%), Gaps = 60/244 (24%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + EV C D L A+K L K V + E I+A D+ KL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR-II 238
D D ++ V P G + S+L + P+ R+ IA LT E K I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-----ELTLAIESVHKMGFI 123
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN------------------------ 274
HRDIK DNIL+ D ++ DFGL +WTH++
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGF--RWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 275 -----------------------VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
GT Y APE + + D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 312 ITGR 315
+ G+
Sbjct: 242 LVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
+ YLHE RIIHRDIKA+NI + + + DFG A + P + + GT
Sbjct: 195 IQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIATN 250
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318
APE D++S G++L E+ T ++
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 47/217 (21%)
Query: 125 IGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G + +V G + G V VK L ++ FL E + H N + +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 182 CDSDGIH--LVFQLSPLGSLASILHGSKD----KPDWSKRYRIALGTANGLTYLHEGCQK 235
++ LV + PLG L L + PD + R+A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLA--------------KWLPRQWTHHNVSKFEGT 281
IH D+ N LLT D +I D+GL+ W+P +W
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW----------- 168
Query: 282 FGYFAPEYF--MHG---IVDE--KTDVYSFGVLLLEL 311
APE +HG +VD+ +++V+S GV + EL
Sbjct: 169 ---IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 63/199 (31%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 125 IGKGGYAEVYKGCLRDGTLV-AVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPNTA--KL 179
IGKG + +V + RD + A+K + K + ++ L E ++A V+ P K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 180 VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA-LGTANGLTYLHEGCQKRII 238
+ ++LV G L L R+ A L A L LH+ +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHK---FNVI 115
Query: 239 HRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-HGIV 295
+RD+K +NILL DY+ I CDFGL K + N F GT Y APE + HG
Sbjct: 116 YRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171
Query: 296 DEKTDVYSFGVLLLELITG 314
+ D ++ GVLL E++TG
Sbjct: 172 -KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VSKFEG 280
A G+ +L K +HRD+ A N+LL + +ICDFGLA R H + VSK
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLA----RDIMHDSNYVSK-GS 298
Query: 281 TF---GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
TF + APE + +DV+S+G+LL E+ +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 14/94 (14%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQWTHHNVSKFE---- 279
GL ++H+ ++I+HRDIK+ NI L+++ ++ DFG+A+ L ++ +
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL------NDSMELAYTCV 163
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
GT Y +PE + + KTD++S G +L EL T
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 63/239 (26%), Positives = 88/239 (36%), Gaps = 54/239 (22%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G + EV D L A+K L K V + E I+A D+ KL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
D D ++ V P G + S+L + R+ IA T + +H + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC-AIESVH---KMGFIH 124
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWT----------HHNVSKFE---------- 279
RDIK DNIL+ D ++ DFGL +WT HH E
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 280 -----------------------GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
GT Y APE + + D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 42/211 (19%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDE----KTCGFLCEIGIIAYVDHPNTAKL 179
IG G Y VYK G VA+K + T ++ T + + + DHPN +L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 180 VG-CDSD------GIHLVFQ------------LSPLGSLASILHGSKDKPDWSKRYRIAL 220
+ C + + LVF+ + P G A + D +++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK------DLMRQF---- 117
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280
GL +LH C I+HRD+K +NIL+T + ++ DFGLA+ ++
Sbjct: 118 --LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVV 169
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
T Y APE + D++S G + E+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 32/82 (39%), Positives = 44/82 (53%), Gaps = 8/82 (9%)
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM----H 292
I++RDIK +NILL + + DFGL+K + S F GT Y APE H
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGH 184
Query: 293 GIVDEKTDVYSFGVLLLELITG 314
G + D +S G+L+ EL+TG
Sbjct: 185 G---KAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 16/184 (8%)
Query: 143 LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG--CDSDGIHLVFQLSPLGSLA 200
LVAVK L FL EI I++ + +PN +L+G D + ++ + G L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 201 SILHGSKDKPDWSKRYRI-----------ALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
L + + ++ I A+ A+G+ YL +HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 250 TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLL 309
Y +I DFG+++ L + + + A E + G +DV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 310 ELIT 313
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 125 IGKGGYAEVYKGCLRD---GTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNTAKL- 179
IG+G Y VYK RD +A+K++ DE + EI ++ + H N +L
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 180 --VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA----LGTANGLTYLHEGC 233
V + ++LVF+ L L + S PD++K R+ G+ Y H
Sbjct: 68 DVVHSEKR-LYLVFEYLDL-DLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 234 QKRIIHRDIKADNILLTEDYEP-QICDFGLAK--WLP-RQWTHHNVSKFEGTFGYFAPEY 289
R++HRD+K N+L+ ++ DFGLA+ +P R +TH V T Y APE
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TLWYRAPEI 174
Query: 290 FMHGIVDEKT--DVYSFGVLLLELITGR 315
+ G T D++S G + E++ +
Sbjct: 175 LL-GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 5/114 (4%)
Query: 203 LHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261
H S+++ R R + L YLH +K +++RD+K +N++L +D +I DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFG 141
Query: 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
L K + + F GT Y APE D + GV++ E++ GR
Sbjct: 142 LCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 117 KNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLT---KGTVDEKTCGFLCEIGIIAYVD 172
+ + + IG+G Y V G VA+K+++ T ++T L EI I+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---LREIKILRRFK 61
Query: 173 HPNTAKLVG-------CDSDGIHLVFQLSP--LGSLASILHGSKDKPDWSKRYRIALGTA 223
H N ++ + +++V +L L L H S D + Y+I
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-YQIL---- 116
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-VSKFEGTF 282
GL Y+H ++HRD+K N+LL + + +ICDFGLA+ + H ++++ T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 283 GYFAPEYFMHGIVDEKT-DVYSFGVLLLELITGR 315
Y APE ++ K D++S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 21/200 (10%)
Query: 133 VYKGCLRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHPNTAKLVG-----CDS- 184
+YKG + V ++ K K + EI + +D N K+ G D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKA 244
+ L+ + G L +L KD + + +A+ GL L++ K ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 245 DNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT---DV 301
+ L+TE+Y+ +I GL K L K YF+ + ++ I E T D+
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYK-MLNDIFSEYTIKDDI 205
Query: 302 YSFGVLLLELITGRRAVDHL 321
YS GV+L E+ TG+ ++L
Sbjct: 206 YSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLT----KGTVDEKTCGFLCEIGIIAYVD 172
N+ L+G+G + VY D G +AVK++ ++ CEI ++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 173 HPNTAKLVGCDSD----GIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGL 226
H + GC D + + + P GS+ L +G+ + K R L G+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL---EGV 119
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-WTHHNVSKFEGTFGYF 285
+YLH I+HRDIK NIL ++ DFG +K L + + GT +
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGR 315
+PE K D++S G ++E++T +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 124 LIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHP--NT 176
L+GKG + +V +R+ G A+K L K + ++ + E ++ HP
Sbjct: 2 LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 177 AKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQK 235
K D + V + + G L H S+++ +R R + L YLH +
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---SR 114
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
+++RDIK +N++L +D +I DFGL K + F GT Y APE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 296 DEKTDVYSFGVLLLELITGR 315
D + GV++ E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
G+ +LH IIHRD+K NI++ D +I DFGLA+ T ++ + T Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQSVVIWAK 330
APE + E D++S G ++ E+I G DH+ Q W K
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ----WNK 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTC----GFLCEIGIIAYVD 172
N+ L+G+G + EVY D G +AVK++ ++T CEI ++ +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 173 HPNTAKLVGCDSD----GIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGL 226
H + GC D + + + P GS+ L +G+ + + ++RY + G+
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYTRQI--LQGV 119
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW-THHNVSKFEGTFGYF 285
+YLH I+HRDIK NIL ++ DFG +K + + + GT +
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELIT 313
+PE K DV+S ++E++T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLT----KGTVDEKTCGFLCEIGIIAYVD 172
N+ L+G+G + VY D G +A K++ ++ CEI ++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 173 HPNTAKLVGCDSD----GIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGL 226
H + GC D + + + P GS+ L +G+ + K R L G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL---EGM 119
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-WTHHNVSKFEGTFGYF 285
+YLH I+HRDIK NIL ++ DFG +K L + + GT +
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGR 315
+PE K DV+S G ++E++T +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 57/198 (28%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKT--CGFLCEIGII-AYVDHPNTAKL 179
+IGKG + +V + + AVK L K + +K + E ++ V HP L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 180 VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLTYLHEGCQKRII 238
L F L + H +++ R R A A+ L YLH I+
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 118
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN--VSKFEGTFGYFAPEYFMHGIVD 296
+RD+K +NILL + DFGL K + HN S F GT Y APE D
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 297 EKTDVYSFGVLLLELITG 314
D + G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 34/207 (16%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL---V 180
+G+G YA V+KG + LVA+K + + C + E+ ++ + H N L V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 181 GCDSDGIHLVFQ---------LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
D + LVF+ + G++ S+ H K Y+I GL Y H
Sbjct: 74 HTDKS-LTLVFEYLDKDLKQYMDDCGNIMSM-HNVK-----IFLYQI----LRGLAYCH- 121
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGL--AKWLPRQWTHHNVSKFEGTFGYFAPEY 289
+++++HRD+K N+L+ E E ++ DFGL AK +P + + V T Y P+
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDV 175
Query: 290 FM-HGIVDEKTDVYSFGVLLLELITGR 315
+ + D++ G + E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 125 IGKGGYAEVYKGCLR---DGTL--------VAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
+G+G + +YKG LR D + V +K L D F +++ + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--FFETASLMSQLSH 60
Query: 174 PNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
+ KL G C D +V + G L LH K+ + +A A+ L YL +
Sbjct: 61 KHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED- 119
Query: 233 CQKRIIHRDIKADNILLT-----EDYEP--QICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
K+++H ++ NIL+ E Y P ++ D G+ + + +
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWI 171
Query: 286 APEYFMHGIV--DEKTDVYSFGVLLLEL 311
APE +G D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 42/233 (18%)
Query: 111 ELQTATKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRL---TKGTVDEKTCGF 161
E+ +T F E +G+ + +VYKG L VA+K L +G + E+ F
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE---F 55
Query: 162 LCEIGIIAYVDHPNTAKLVG--CDSDGIHLVFQLSPLGSLASIL-----H---GSKDKPD 211
E + + + HPN L+G + ++F L L H GS D
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 212 WSKR-------YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264
K I A G+ +L ++H+D+ N+L+ + +I D GL
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLF- 171
Query: 265 WLPRQWTHHNVSKFEGT----FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
R+ + K G + +PE M+G +D++S+GV+L E+ +
Sbjct: 172 ---REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 59/253 (23%), Positives = 109/253 (43%), Gaps = 28/253 (11%)
Query: 73 HPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEF--TLSELQTATKNFSSENLIGKGGY 130
+ L P L + K+ I N+ + K+ + +L+ +++ +IG+G +
Sbjct: 8 YDLDFPALRKNKN-----------IDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAF 56
Query: 131 AEVYKGCLRDGTLV-AVKRLTKGTVDEKT--CGFLCEIGIIAYVDHPNTAKLVGCDSDG- 186
EV + V A+K L+K + +++ F E I+A+ + P +L D
Sbjct: 57 GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116
Query: 187 -IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKAD 245
+++V + P G L +++ W++ Y TA + L IHRD+K D
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPD 171
Query: 246 NILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH----GIVDEKTDV 301
N+LL + ++ DFG + ++ + GT Y +PE G + D
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 302 YSFGVLLLELITG 314
+S GV L E++ G
Sbjct: 231 WSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 15/183 (8%)
Query: 143 LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLA 200
LVAVK L + FL EI I++ + PN +L V SD + ++ + G L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 201 SIL--HGSKDKPDWSKRYRIALGT--------ANGLTYLHEGCQKRIIHRDIKADNILLT 250
L H ++ + + I+ T A+G+ YL +HRD+ N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVG 164
Query: 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
++Y +I DFG+++ L + + + + E + G +DV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 311 LIT 313
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 31/194 (15%)
Query: 143 LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLA 200
LVAVK L FL E+ I++ + PN +L+G D D + ++ + G L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 201 SIL--HGSKDK----------------PDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
L H DK +S +AL A+G+ YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG----TFGYFAPEYFMHGIVDEK 298
N L+ E+ +I DFG++ R + + +G + A E + G
Sbjct: 165 ATRNCLVGENLTIKIADFGMS----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 299 TDVYSFGVLLLELI 312
+DV++FGV L E++
Sbjct: 221 SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 9/102 (8%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
G+ +LH IIHRD+K NI++ D +I DFGLA+ T ++ + T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
APE + E D++S G ++ E+I G DH+ Q
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 20/101 (19%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL----PRQ--WTHHNVSKF 278
L Y+H + HRD+K NIL D + +ICDFGLA+ P WT + +++
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 279 EGTFGYFAPE----YFMHGIVDEKTDVYSFGVLLLELITGR 315
Y APE +F D++S G + E++TG+
Sbjct: 172 -----YRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 207 KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266
KD+P + I + Y+H+ K++IHRDIK +NI L D + + DFG A
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 267 --PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-------GRRA 317
R+ + + GT +PE E TD++S G++LL++++
Sbjct: 318 EKEREAFDYG---WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374
Query: 318 VDHLQQSVVIWAKPLLDSNDIRELVDP--SLGDNYDAEEIDRAVLT 361
Q +I + + D E DP L D D+ EID A +
Sbjct: 375 KPGKQLLKIIDSLSVCD----EEFPDPPCKLFDYIDSAEIDHAGHS 416
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 12/113 (10%)
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
G+ +LH IIHRD+K NI++ D +I DFGLA+ T ++ + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELI------TGRRAVDHLQQSVVIWAKP 331
APE + E D++S G ++ E++ GR +D + + P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 38/214 (17%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAYVDH-PNTAKLV 180
IG+G Y +VYK G LVA+K+ T+ +DE+ L EI ++ + +L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 181 GCD----SDG---IHLVFQL--SPLGSLASILHGSKDKPDWSKR-----YRIALGTANGL 226
+ +G ++LVF+ S L +P +K Y++ G A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH-- 125
Query: 227 TYLHEGCQKR-IIHRDIKADNILLTEDYEP-QICDFGLAKWLP---RQWTHHNVSKFEGT 281
C K ++HRD+K N+L+ + +I D GL + + +TH V T
Sbjct: 126 ------CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----T 174
Query: 282 FGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITG 314
Y APE + D++S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 9/102 (8%)
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277
I L YLH + IIHRD+K +NI L E + DFG A L H + +
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQ 243
Query: 278 ---FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316
+ GT +PE KTD++S G++L E+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 45/262 (17%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV 171
++ K++ N+IG G + VY+ C+ VA+K++ + + E+ I+ +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNL 116
Query: 172 DHPNTAKL--------VGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWS----KRYR 217
+H N L + I L V + P + H +++ K Y
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWL--PRQWTHHN 274
L A L Y+H K I HRD+K N+L+ + + ++CDFG AK L ++ +
Sbjct: 177 YQLCRA--LAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231
Query: 275 VSKFEGTFGYFAPEYFMHGIVDEKT--DVYSFGVLLLELI------TGRRAVDHLQQSVV 326
S+F Y APE M G + T D++S G ++ E+I +G+ +VD L + +
Sbjct: 232 CSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 327 IWAKPLLDSNDIRELVDPSLGD 348
+ P + D + ++P+ D
Sbjct: 286 VLGTP---TEDQLKEMNPNYAD 304
|
Length = 440 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 50/157 (31%), Positives = 67/157 (42%), Gaps = 19/157 (12%)
Query: 125 IGKGGYAEVYKGCLR----DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAK 178
+G G + EV CL L A+K L K V + E I+A D+ +
Sbjct: 9 LGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
L D D ++ V P G + S+L P+ R+ IA LT E K
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-----ELTCAVESVHKM 120
Query: 237 -IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272
IHRDIK DNIL+ D ++ DFGL +WTH
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTH 155
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK-----WLPRQWTHH--- 273
T L YLH I+HRD+K DN+L+T ++ DFGL+K + H
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 274 NVSKFE-----GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
+ +F GT Y APE + + D ++ G++L E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 8/80 (10%)
Query: 187 IHLVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKA 244
++LV + G + S+LH G D+ I+ A L YLH + IIHRD+K
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDEE--MAVKYIS-EVALALDYLH---RHGIIHRDLKP 132
Query: 245 DNILLTEDYEPQICDFGLAK 264
DN+L++ + ++ DFGL+K
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 11/138 (7%)
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
D + ++LV G L ++L +D+ P+ R+ IA + +H Q +HRD
Sbjct: 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA----EMVLAIHSIHQLHYVHRD 127
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVD 296
IK DN+LL + ++ DFG + + T + S GT Y +PE G
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYG 186
Query: 297 EKTDVYSFGVLLLELITG 314
+ D +S GV + E++ G
Sbjct: 187 PECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLV-AVKRLTKGTVDEK--TCGFLCEIGIIAYVDH 173
++F +IG+G + EV L++ V A+K L K + ++ T F E ++ D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 174 P--NTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLH 230
T D + ++LV G L ++L +D+ P+ R+ +A + +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVH 119
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
Q +HRDIK DNIL+ + ++ DFG L T + S GT Y +PE
Sbjct: 120 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEIL 175
Query: 291 M-----HGIVDEKTDVYSFGVLLLELITG 314
G + D +S GV + E++ G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 12/106 (11%)
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277
I G GL YLH Q IHR+IKA +IL++ D + L R V
Sbjct: 106 ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 278 FEGTFG-----YFAPEYF---MHGIVDEKTDVYSFGVLLLELITGR 315
F + +PE ++G + K+D+YS G+ EL TGR
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 46/216 (21%)
Query: 125 IGKGGYAEVYKGCLRDGTLVA---VKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IG G + +V + T VA VK L ++ FL + + HPN + +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 182 CDSDGIH--LVFQLSPLGSLASILHGSKDK---PDWSKRYRIALGTANGLTYLHEGCQKR 236
+ I LVF+ LG L S L + R+A A G+T++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLA--------------KWLPRQWTHHNVSKFEGTF 282
+H D+ N LT D ++ D+G+ K +P +W
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL----------- 168
Query: 283 GYFAPEYF--MHG--IVDEKT---DVYSFGVLLLEL 311
APE HG I E+T +V++ GV L EL
Sbjct: 169 ---APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 19/156 (12%)
Query: 118 NFSSENLIGKGGYAEV-YKGCLRDGTLVAVKRLTKGTVDEKT--CGFLCEIGIIAYVDHP 174
+F + +IGKG + EV G + A+K L K + +K E ++A D P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-----ALGTANGLT 227
L D+ ++L+ + P G L ++L + R+ + A+ + L
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263
+ IHRDIK DNIL+ ++ DFGL+
Sbjct: 122 F---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 22/100 (22%)
Query: 235 KRIIHRDIKADNILLTEDYE-----------------PQICDFGLAKWLPRQWTHHNVSK 277
+R++HRD+K NI L+ +I DFGL+K + + H+
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV- 202
Query: 278 FEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGR 315
GT Y++PE +H D+K+D+++ G ++ EL +G+
Sbjct: 203 --GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 125 IGKGGYAEVYKGCLRDGT---LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT---AK 178
+G+G Y VYK +DG A+K++ + C EI ++ + HPN K
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR---EIALLRELKHPNVIALQK 65
Query: 179 LVGCDSD-GIHLVFQLSP--LGSLASILHGSK--DKPDWSKRYRIA---LGTANGLTYLH 230
+ SD + L+F + L + SK KP R + +G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 231 EGCQKRIIHRDIKADNILLT----EDYEPQICDFGLAKWLPRQWTH-HNVSKFEGTFGYF 285
++HRD+K NIL+ E +I D G A+ ++ TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 286 APEYFMHGIVDEKT-DVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332
APE + K D+++ G + EL+T + H +Q + + P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPF 229
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.35 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.14 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| PLN02236 | 344 | choline kinase | 96.84 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.78 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.67 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.57 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.47 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.32 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.23 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.35 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.34 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.29 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.92 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.63 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.62 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.21 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.15 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=436.51 Aligned_cols=283 Identities=52% Similarity=0.845 Sum_probs=250.3
Q ss_pred cccccCHHHHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
..+.|++.++..+|++|...++||+|+||.||+|...+|..||||++....... ..+|.+|+.++.+++|||+|+++|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 577899999999999999999999999999999999988999999887655432 4459999999999999999999998
Q ss_pred ccC-C--cEEEEEEcCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEe
Q 013927 183 DSD-G--IHLVFQLSPLGSLASILHGSKD-KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQIC 258 (434)
Q Consensus 183 ~~~-~--~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 258 (434)
|.+ + .+||+||+++|+|.+.|+.... .++|..|++||.++|+||+|||+.|...||||||||+|||+|+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 764 2 7999999999999999998666 89999999999999999999999888899999999999999999999999
Q ss_pred ccccccccCCCCcccceecc-ccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc----cchhhhhhcccc
Q 013927 259 DFGLAKWLPRQWTHHNVSKF-EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL----QQSVVIWAKPLL 333 (434)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~----~~~~~~~~~~~~ 333 (434)
|||+|+..+.. ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.. ......|+.+.+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999766541 1112222 7999999999999999999999999999999999999998853 334678888888
Q ss_pred CccccccccCCcCC-CCCCH-HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 334 DSNDIRELVDPSLG-DNYDA-EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 334 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
....+.+++|+.+. ..++. .++.++..++.+|++.+|..||+|.||++.|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88899999999987 66664 689999999999999999999999999999965543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=387.13 Aligned_cols=253 Identities=33% Similarity=0.490 Sum_probs=209.0
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC---CcEEEEEEcCCC
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---GIHLVFQLSPLG 197 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~lv~e~~~~g 197 (434)
.+.||.|+||+||+|.+.....||||++...... .....|.+|+.+|.+++|||||+++|++.+ ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3559999999999999984444999999865432 225689999999999999999999998665 378999999999
Q ss_pred CHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCC-eeecCCCCCcEEecCCC-CeEEeccccccccCCCCcccc
Q 013927 198 SLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKR-IIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 198 sL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~-iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|..+++. .+..+++..++.||.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999987 47899999999999999999999999 77 99999999999999998 99999999998654321 22
Q ss_pred eeccccccccccCCccc--cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 275 VSKFEGTFGYFAPEYFM--HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.+...||+.|||||++. ...|+.|+|||||||+||||+||+.||........... ++....+..++.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~-----------v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA-----------VVVGGLRPPIPK 269 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-----------HHhcCCCCCCCc
Confidence 33467999999999999 56899999999999999999999999998765332211 111222223333
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.....+..++.+||+.||+.||++.+|+..|+.+....
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 35567888899999999999999999999998775433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=366.43 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=204.2
Q ss_pred CCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cC-CcEEEEEEcC
Q 013927 120 SSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SD-GIHLVFQLSP 195 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~-~~~lv~e~~~ 195 (434)
...+.||+|+.|+||++.++ +++.+|+|++..........++.+|+++++..+||+||.+||++ .. ...++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34578999999999999988 78999999997766667777899999999999999999999963 23 3899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+|||+.++... +.+++...-+|+.++++||.|||+ .++||||||||+||||+..|+|||||||.++.+... ..
T Consensus 162 gGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 99999999743 668899999999999999999996 389999999999999999999999999999877554 34
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC---CcCCCCCCH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD---PSLGDNYDA 352 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d---~~l~~~~~~ 352 (434)
..++||..|||||.+.+..|+.++||||||++++|+++|+.||....+....|. .-+..+++ |.+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~------~Ll~~Iv~~ppP~lP~~--- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF------ELLCAIVDEPPPRLPEG--- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH------HHHHHHhcCCCCCCCcc---
Confidence 578899999999999999999999999999999999999999976421111111 11122222 222222
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....++..++..||++||.+||++.|+++
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 24467888999999999999999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=364.67 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=198.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh------hHhhHHHHHHHHhhCCCCCeeeEeeecc--CC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE------KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~ 186 (434)
.+.|.+.+.||.|+||.|-+|..+ +|+.||||++.+..... ......+|+++|++|+|||||+++++.. +.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356888899999999999999865 89999999998754322 2234578999999999999999999844 46
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC---CCeEEeccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---YEPQICDFGLA 263 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGla 263 (434)
.|+||||+.+|.|.+.+-. .+.+.+.....++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 7999999999999998874 4556667778899999999999999 999999999999999766 78999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCC---CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI---VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
+..... ..+.++|||+.|.|||++.... +..++|+||+|||||-+++|.+||...-.... +.+
T Consensus 327 K~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----------l~e 392 (475)
T KOG0615|consen 327 KVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----------LKE 392 (475)
T ss_pred hccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----------HHH
Confidence 987633 4567899999999999998765 33588999999999999999999976332210 111
Q ss_pred cc-CCcCC--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 341 LV-DPSLG--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 341 ~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+ ...+. .....+..++..++|.+||..||++||++.|+++
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11 11110 1111234567888999999999999999999964
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=378.89 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=205.9
Q ss_pred cCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
..|...++||+|||+.||.+.. .+|+.||+|++.+... ....+...+|+++.+.|+|||||+++++++| ++|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588999999999999999997 7899999999987543 2445678999999999999999999999766 799999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+|..++|..++. ....+++..+..++.||+.||.|||+ ++|||||||..|+|++++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999998 67889999999999999999999999 999999999999999999999999999999886442
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...-... +.+... .+.. ++
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-y~~Ik~-----~~Y~-------~P 238 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-YNKIKL-----NEYS-------MP 238 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-HHHHHh-----cCcc-------cc
Confidence 234578999999999999999999999999999999999999999986321110 000000 0000 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+||..+|+.+|.+||++.+|+.
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122345667889999999999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=361.04 Aligned_cols=198 Identities=33% Similarity=0.508 Sum_probs=177.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC-chhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT-VDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
.+|...+.||+|+||+||+|+++ ++..||||.+.+.. .....+.+..|+.+|+.++|||||.++++. .+..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46888889999999999999977 78999999998765 345566788999999999999999999984 457899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC------CCeEEecccccccc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED------YEPQICDFGLAKWL 266 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~------~~~kL~DFGla~~~ 266 (434)
||.+|+|..+++ ..+.+++.....++.|||.||++||+ ++||||||||+|||++.. -.+||+|||+|+.+
T Consensus 90 yC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999998 44578999999999999999999999 999999999999999865 45899999999988
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL 321 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 321 (434)
... ....+.+|++.|||||+++.+.|+.|+|+||+|+|||++++|+.||+..
T Consensus 166 ~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 744 3446789999999999999999999999999999999999999999853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=372.84 Aligned_cols=250 Identities=30% Similarity=0.384 Sum_probs=210.8
Q ss_pred CCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEcCCCC
Q 013927 121 SENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLSPLGS 198 (434)
Q Consensus 121 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~~~gs 198 (434)
..+.||+|-||.||.|.++....||+|.+..... ....|++|+++|++|+|+|||+++|++.. .++||||||+.|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3467999999999999999777999999987543 33469999999999999999999998654 5899999999999
Q ss_pred HHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 199 LASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 199 L~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
|.++|.. ....+...+.+.++.|||+||+||++ +++|||||.+.||||+++..+||+|||+|+......... ...
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-SEG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee-cCC
Confidence 9999986 56788999999999999999999999 999999999999999999999999999999544332211 111
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+.+.....+ -+.++...+...+..++.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev------------~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV------------LELLERGYRLPRPEGCPD 431 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH------------HHHHhccCcCCCCCCCCH
Confidence 122567999999999999999999999999999998 8888877554433 234555555566666778
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.+.+++..||+.+|++|||+..+...|+.+..
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 89999999999999999999999888876644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=343.68 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=205.8
Q ss_pred CCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeee--ccC--CcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGC--DSD--GIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~--~~~lv~ 191 (434)
+|.++++||+|.||+||++.. .+|..||.|.+..+..+ ...+....|+.+|++|+|||||++++. ..+ -+++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477778999999999999974 48999999999865554 345678999999999999999999983 222 388999
Q ss_pred EEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 192 QLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 192 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
|||..|+|..++.. .+..+++..+++++.|++.||..+|+...+ -|+||||||.||+++.+|.|||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998864 567789999999999999999999984433 38999999999999999999999999999887
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.... .....+|||.||+||.+...+|+.||||||+||++|||+.-+.||.+..-... . ..|... ...
T Consensus 180 s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L--~------~KI~qg---d~~ 246 (375)
T KOG0591|consen 180 SKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL--C------KKIEQG---DYP 246 (375)
T ss_pred chhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH--H------HHHHcC---CCC
Confidence 6533 23567899999999999999999999999999999999999999987421111 0 011111 111
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.-.+......+..++..|+..||+.||+...+++.+..
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11123455778889999999999999997666666654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=346.85 Aligned_cols=241 Identities=26% Similarity=0.317 Sum_probs=195.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.++||+|+||+||.++.+ +++.+|+|++.+....+ .......|..+|.+++||+||+++-.+++ .+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 46999999999999999999866 78999999998865533 35578889999999999999999887554 799999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
+|+.||.|...|.. ...+++..+..++..|+.||.|||+ ++||||||||+|||+|.+|+++|+|||+++.....
T Consensus 105 d~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-- 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-- 178 (357)
T ss_pred eccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence 99999999999974 4567777777778899999999999 99999999999999999999999999999854322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.....-. +....+ ...+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~-----------I~~~k~-~~~p 246 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK-----------ILKGKL-PLPP 246 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH-----------HhcCcC-CCCC
Confidence 2334568999999999999999999999999999999999999999987543322211 110000 0001
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.-...+...++...|+.+|.+|..
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcC
Confidence 111235667889999999999964
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=357.69 Aligned_cols=259 Identities=28% Similarity=0.352 Sum_probs=210.6
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEEEEcC
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLSP 195 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~e~~~ 195 (434)
.+.+...||.|.||+||+|.+.. .||||++..... .+..+.|.+|+..+++.+|.||+-+.|++.. ...+|+.+|.
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCe 470 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCE 470 (678)
T ss_pred Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhcc
Confidence 35566789999999999999873 499999986544 4567789999999999999999999998654 6789999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+.+|..+++.....++..+.+.||.|||+|+.|||. ++|||||||..||++.++++|||+|||++............
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 999999999989999999999999999999999999 99999999999999999999999999999755433333344
Q ss_pred eccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 276 SKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
....|...|||||++.. .+|+..+||||||||+|||++|..||........+|..-.. . -..|.. ....
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG---~--l~pd~s---~~~s 619 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG---Y--LMPDLS---KIRS 619 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc---c--cCccch---hhhc
Confidence 55668899999999864 46999999999999999999999999843333333332110 0 001111 1113
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
...+++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 3456788888999999999999999999988776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.05 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=200.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
.|+...++|+|+||.||+++++ +|+.||||++.....+ ......++|+.+|++++|+|+|.++.++.. .++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4677788999999999999987 7999999999754432 334568999999999999999999998654 79999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|+..-|.+ |......++...+.+++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+... ..
T Consensus 83 ~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd 156 (396)
T KOG0593|consen 83 CDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GD 156 (396)
T ss_pred cchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--cc
Confidence 99755544 44456678889999999999999999999 99999999999999999999999999999988642 34
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------------------ccccC
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------------------KPLLD 334 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------------------~~~~~ 334 (434)
.++..+.|.+|+|||.+.+ ..|...+||||+||++.||++|.+.|.+.......+. .|.+.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5677788999999999987 5699999999999999999999999976332211110 11111
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.-.+.+.-++.-....-+....-+++++..||+.||.+|++-+|++
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1111111111111111122234678899999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.11 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=201.3
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccC--CcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSD--GIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~--~~~lv~e 192 (434)
+|...+.||+|+||.||++... +|...|||.+....... .+.+.+|+.+|++++|||||+++|. ..+ .++++||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 5777889999999999999976 58999999987763322 5568899999999999999999995 333 4889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCC-CC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPR-QW 270 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~-~~ 270 (434)
|+++|+|.+++......+++..+..++.||++||.|||+ ++||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998655579999999999999999999998 99999999999999999 79999999999987653 11
Q ss_pred cccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccc-cchhhhhhccccCccccccccCCcCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHL-QQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.......+.||+.|||||++.++. ...++|||||||++.||+||+.||... ........ ...... .+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~--ig~~~~---------~P 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL--IGREDS---------LP 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH--HhccCC---------CC
Confidence 222234578999999999998643 335999999999999999999999863 22111100 000110 11
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.++........+++..|+..+|+.|||+.+++...--
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2223334567778899999999999999999876543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.90 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=201.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC---
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--- 185 (434)
.++|.+.++||+|+||.||+|.. .++..||||++...........+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35688999999999999999974 235689999997654444456789999999999 89999999996432
Q ss_pred CcEEEEEEcCCCCHHHHhccCC----------------------------------------------------------
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------------------------------------------------- 207 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 207 (434)
..+++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 4789999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccccccc
Q 013927 208 ---DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284 (434)
Q Consensus 208 ---~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 284 (434)
..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 236778889999999999999999 99999999999999999999999999999865432222222233456789
Q ss_pred ccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHH
Q 013927 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTAS 363 (434)
Q Consensus 285 ~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 363 (434)
+|||++.+..++.++|||||||++|||++ |..||............ .. .+. ... .+......+..++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~-~~~-----~~~----~~~~~~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR-LK-DGT-----RMR----APENATPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-Hh-cCC-----CCC----CCCCCCHHHHHHHH
Confidence 99999998889999999999999999997 99999764322111110 00 000 000 11122346788999
Q ss_pred hhhccCCCCCCCHhHHHHHhcCCC
Q 013927 364 LCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 364 ~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+||+.+|++||++.+|++.|+...
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.88 Aligned_cols=258 Identities=26% Similarity=0.361 Sum_probs=209.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~ 193 (434)
+.|.+...||.|.-++||+|+.. .+..||||++..+........+.+|+..|+.++||||+.++.+ ....+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 46889999999999999999854 7899999999988777777889999999999999999999985 44579999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|.+||+.+++... ...+++..+..|+.++++||.|||. +|.||||||+.||||+.+|.|||+|||.+-.+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999753 5568999999999999999999998 99999999999999999999999999998766543322
Q ss_pred cce--eccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 273 HNV--SKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 273 ~~~--~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... ..++||++|||||+++. ..|+.|+|||||||+..||.+|..||...++..+...+-.. ....+.-..+..
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn---~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN---DPPTLLTSGLDK 259 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC---CCCCcccccCCh
Confidence 111 56789999999999654 35999999999999999999999999988766554332111 111111001111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
+........+..++..||..||.+|||+++++
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 11122235678899999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.07 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=207.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cC-CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SD-GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~-~~~lv~ 191 (434)
++|.+.++||.|.||.||+|... +|..||||++++....-..+.-++|+..|++|+ |||||++..+. .+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 56888899999999999999965 789999999987665544556788999999999 99999999973 33 689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|||+. .|.+++..++..+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus 90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC--
Confidence 99985 8999999889999999999999999999999999 99999999999999998889999999999987654
Q ss_pred ccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc------cccCcc----cc--
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK------PLLDSN----DI-- 338 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~------~~~~~~----~~-- 338 (434)
...+..+.|.+|+|||++.. +.|+.+.||||+|||++|+.+-++.|.+..+...+|.. |....- .+
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 33456678999999999764 66999999999999999999999999875554444321 111100 00
Q ss_pred ------ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 339 ------RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 339 ------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+....+..-. +....+++.++.+|+.+||++|||+.|+++.
T Consensus 243 ~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 001111111111 1245778899999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=370.62 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=214.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+....+.||+|+||+||+|... +.+.||||.++.........+|.+|++++..++|||||+++|+|. +..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3445577999999999999843 356899999988776667789999999999999999999999865 47999
Q ss_pred EEEEcCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 190 VFQLSPLGSLASILHGS-------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
|+|||..|+|.++|... +.+++..+.+.||.|||.||.||-+ +.+|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 99999999999999631 2237888999999999999999999 9999999999999999999999
Q ss_pred EeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCc
Q 013927 257 ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDS 335 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 335 (434)
|+|||+++.+....+.+......-..+|||||.++.+.|+.+||||||||||||+++ |+.||.+..+..++.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe------- 716 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE------- 716 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-------
Confidence 999999997766555444334444689999999999999999999999999999997 999998866655431
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 336 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
-+-...+ ...+..++.++..|+..||+.+|++||+++||-.+|+.....
T Consensus 717 ----~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 717 ----CIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----HHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1111122 345566778999999999999999999999999999865433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.89 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=202.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec----cCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD----SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~----~~~~~lv 190 (434)
..|+.+.+||+|.||.||+|+.. +|+.||+|++..+.. ++......+|+.||++|+||||+++.++. ...+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 35777889999999999999955 899999999987663 34445688999999999999999999962 2369999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+|||+. +|.-++....-.++..++..++.||+.||+|+|. ++|+|||||.+|||||.+|.+||+|||||+.+....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999996 7888887777789999999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchh---hh-----------hhccccCc
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VI-----------WAKPLLDS 335 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~-----------~~~~~~~~ 335 (434)
....+..+-|++|+|||.+.+. .|+..+|+||.||||.||++|+..|.+..... .+ |....+..
T Consensus 273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 2335667789999999999875 49999999999999999999999997743322 22 22111110
Q ss_pred cccccccCCcCC-CCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDIRELVDPSLG-DNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~~~~~d~~l~-~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+.+.-. ...-. ......+.|+..+|..||.+|.|+.++++
T Consensus 352 ---~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ---ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ---ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 001111100 00000 11245677889999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=346.10 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=205.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~l 189 (434)
.++|..++.||+|+|++|++|... +++.||||++.+... +....-...|-.+|.+| .||.|++||-.++| .+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 357999999999999999999865 789999999987543 22334566788999999 89999999987655 7999
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|+||+++|+|.++|. ..+.+++.+...+|.+|+.||+|||+ +|||||||||+|||+|.|+++||+|||.|+.++..
T Consensus 152 vLe~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999997 44778999999999999999999999 99999999999999999999999999999987643
Q ss_pred Ccc---------cc--eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 270 WTH---------HN--VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 270 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
... .. ...++||..|.+||++..+..+..+|+|+||||||.|+.|.+||...++.+.. .+ |
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-qk-------I 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-QK-------I 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-HH-------H
Confidence 221 11 14589999999999999999999999999999999999999999876554321 11 0
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.. ++-.+...++ +.+.+|+.+.|..||.+|++..+|.+.
T Consensus 300 ~~-l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 QA-LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HH-hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 00 1111222222 567778899999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=349.38 Aligned_cols=259 Identities=29% Similarity=0.429 Sum_probs=215.0
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEcCCCCHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLSPLGSLA 200 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~~~gsL~ 200 (434)
+-||.|+.|.||+|++. ++.||||+++.-. ..++.-|++|+||||+.+.|+|.. .+|+|||||..|-|.
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 45999999999999998 7889999875321 126788999999999999998765 588999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc
Q 013927 201 SILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 201 ~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
.+|.. ...+.-.....+..+||.|+.|||. +.|||||||.-||||+.+..|||+|||-++..... ...-.++|
T Consensus 201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred HHHhc-cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 99984 4566677788899999999999998 99999999999999999999999999999866543 22235789
Q ss_pred ccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHH
Q 013927 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVL 360 (434)
Q Consensus 281 t~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 360 (434)
|..|||||++.+.+.++|+|||||||||||||||.-||...+....+|.- -...+....+..+.+.+..
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-----------GsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-----------GSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-----------cCCcccccCcccCchHHHH
Confidence 99999999999999999999999999999999999999988877766632 1233444556677889999
Q ss_pred HHHhhhccCCCCCCCHhHHHHHhcCCCCcchhhhhhhccccccccchh
Q 013927 361 TASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTHRRTYSEE 408 (434)
Q Consensus 361 l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (434)
|+.+||+..|..||++++|+..|+-...+.-...+++.......|.++
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq~swrEe 390 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQASWREE 390 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHHHHHHHH
Confidence 999999999999999999999998776655444444444444444443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=314.18 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=203.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|...+.||+|.||.||+|+.. +|+.||||++......+ .....++|+..|+.++|+||+.+++++. +++.+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5777789999999999999965 89999999998765432 3346899999999999999999999854 478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++ .+|..++......+....+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 83 m~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 98 68999999888899999999999999999999999 999999999999999999999999999999887553322
Q ss_pred ceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCcccccc---chhhhhh---ccccCc----------c
Q 013927 274 NVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQ---QSVVIWA---KPLLDS----------N 336 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~---~~~~~~~---~~~~~~----------~ 336 (434)
...+-|.+|+|||.+.+.. |+..+||||.|||+.||+-|.+-|.+.. +...++. .|.... .
T Consensus 159 --~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 --THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred --ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 2336799999999998764 9999999999999999999987776532 2222211 111100 0
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.+...-.+.+.. .-+.......+++..+|..||.+|+++.|+++.
T Consensus 237 ~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111111111 223344566899999999999999999999753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.41 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=201.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch----hhHhhHHHHHHHHhhCC-CCCeeeEeee--ccCC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD----EKTCGFLCEIGIIAYVD-HPNTAKLVGC--DSDG 186 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~--~~~~ 186 (434)
..++|.+.+.||+|+||+|+.|... +|..||||++.+.... .....+.+|+.+++.++ ||||++++.+ ....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3467999999999999999999865 7899999977664221 22335668999999999 9999999997 3457
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKW 265 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~ 265 (434)
.++||||+.+|+|.+++.. ...+.+.....++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999986 6778889999999999999999999 999999999999999999 9999999999987
Q ss_pred cCCCCcccceeccccccccccCCccccCC-CC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGI-VD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
.. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.......... .....-.+...+.
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-i~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-IRKGEFKIPSYLL 247 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-HhcCCccCCCCcC
Confidence 64 1223456789999999999999877 86 789999999999999999999987433222111 0000111111110
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
...+..++.+||..+|.+|+++.+|+
T Consensus 248 -----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 248 -----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 35678899999999999999999998
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.02 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=199.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC-----------------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD-----------------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 179 (434)
++|.+.+.||+|+||.||+|.+.+ +..||||.+...........+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 347999999876555555679999999999999999999
Q ss_pred eeecc--CCcEEEEEEcCCCCHHHHhccCC------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeee
Q 013927 180 VGCDS--DGIHLVFQLSPLGSLASILHGSK------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239 (434)
Q Consensus 180 ~g~~~--~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiH 239 (434)
++++. +..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99743 46899999999999999885321 246788899999999999999999 89999
Q ss_pred cCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh--CCCc
Q 013927 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT--GRRA 317 (434)
Q Consensus 240 rDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p 317 (434)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++|||||||++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322222233445788999999988889999999999999999987 5567
Q ss_pred cccccchhhh-hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 318 VDHLQQSVVI-WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
|......... ......... .... ....++.....+.+++.+||+.+|++||++.+|.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQ-GRQV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhc-cccc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7654322211 000000000 0000 00111223357888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=340.92 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=207.3
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~~ 194 (434)
.|+...+||+|+||.||+|... .++.||+|++..+..+....+..+|+.+|..++++||.++||. +...++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4677788999999999999966 7899999999988887888889999999999999999999996 455789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.+|++.+.|.. ...+++..+.-|+.+++.||.|||. .+.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 94 ~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-- 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-- 167 (467)
T ss_pred cCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence 99999999974 3444777777788999999999999 99999999999999999999999999999877654332
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
..+++||+.|||||+++...|+.|+||||||++.+||++|.+|+....+..+.+..|. -..|.+.+.+
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------~~PP~L~~~~---- 235 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------SAPPRLDGDF---- 235 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------CCCCcccccc----
Confidence 2678999999999999988999999999999999999999999988766443332222 1223333322
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+.+++..||+.+|+.||++.+++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 245677889999999999999999973
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.39 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=195.4
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcEEEEEEc
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIHLVFQLS 194 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~lv~e~~ 194 (434)
..||+|++|.||+|.+. |+.||||++....... ....+.+|+.+|.+++||||++++|++.+ ..++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999985 8899999997653322 23568899999999999999999997433 578999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++.. ...+++.....++.+++.||.|||+ ..+++||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 99999999974 3568899999999999999999997 2488999999999999999999999999998654321
Q ss_pred eeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 275 VSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||........... +.........+.
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~-----------i~~~~~~~~~~~ 245 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL-----------IINKNNSLKLPL 245 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH-----------HHhcCCCCCCCC
Confidence 23457899999999976 6799999999999999999999999986543221100 000000111112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.....+.+++.+||+.||++||++.+|++.|+..
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 2345678899999999999999999999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=345.25 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=206.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC--C--cE-EEEEEeeC--CCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD--G--TL-VAVKRLTK--GTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~ 187 (434)
.+-.+.++||+|+||.||+|.++. + .. ||||.... ....+....|++|+++|++++|||||++||+. ...+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455666899999999999998652 2 23 89999875 23456677899999999999999999999974 4589
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++|||+|.+|+|.++|......++...++.++.+.|.||+|||+ +++|||||.++|+|++.++.+||+|||+++.-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999998777779999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.- .... ..-.-...|+|||.+..+.|+.++|||||||++||+++ |..||.+........ .++....
T Consensus 314 ~~-~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-----------kI~~~~~ 380 (474)
T KOG0194|consen 314 QY-VMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-----------KIVKNGY 380 (474)
T ss_pred ce-eecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-----------HHHhcCc
Confidence 11 1111 01123578999999999999999999999999999998 888998765543210 0111122
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
+...+......+..++.+||..+|++||+|.+|.+.|+.......
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 222233445667778889999999999999999999987655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=340.01 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=205.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~ 193 (434)
..|..-.+||+|+.|.||.+... +++.||||++...... ..+-+++|+.+|+..+|+|||.+++. ..+.+++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45777889999999999999854 7899999999876543 33458899999999999999999984 44689999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++. ...+++.++..|+..+++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 352 MEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred cCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999999995 4569999999999999999999999 9999999999999999999999999999987765432
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
..++.+||+.|||||++....|+.|+||||||++++||+-|.+||-..++...+|...... ...+ .....
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng---~P~l-------k~~~k 494 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---TPKL-------KNPEK 494 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC---CCCc-------CCccc
Confidence 4467889999999999999999999999999999999999999997644443333211111 1111 11122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.|+++||++.|+|+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3356778899999999999999999975
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.44 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=204.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
.+|...+.||+|+||.||+|.+. ++. .||||.+...........+..|+.+++.++||||++++|++. +..+++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 35889999999999999999864 343 489999876544455567899999999999999999999754 467899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
++|+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999999998766678899999999999999999999 999999999999999999999999999998765432
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........++..|+|||++.+..++.++|||||||++|||++ |..||+........- .+.......
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~------------~~~~~~~~~ 231 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ILEKGERLP 231 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH------------HHhCCCCCC
Confidence 2222222234678999999999999999999999999999998 999997644322110 000000001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
.+......+..++.+||..+|.+||++.+|+..|......
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1111234677899999999999999999999998766433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.86 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=198.7
Q ss_pred cCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
++|.+.+.||+|+||.||+|.. .++..||||++...........+.+|+.++..+ +||||+++++++. +..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999963 245689999987554344455788999999999 8999999999754 468
Q ss_pred EEEEEEcCCCCHHHHhccCC------------------------------------------------------------
Q 013927 188 HLVFQLSPLGSLASILHGSK------------------------------------------------------------ 207 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 207 (434)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 89999999999999885321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 208 --------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 208 --------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 246788899999999999999998 899999999999999999999999999998664332211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||++.+..++.++|||||||++|||++ |..||.........+.. +........+.
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~-----------~~~~~~~~~~~ 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-----------IKEGYRMLSPE 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH-----------HHhCccCCCCC
Confidence 1222334667999999999999999999999999999998 88898764332211110 00000000111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....++.+++.+||+.+|++||++.+|++.|+.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=321.62 Aligned_cols=258 Identities=24% Similarity=0.288 Sum_probs=201.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEee----eccCCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVG----CDSDGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g----~~~~~~~lv~ 191 (434)
+|...+.|++|+||.||+|+++ +++.||+|+++.+... ...-..++|+.+|.+++|||||.+-. ...+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4777789999999999999977 7899999999865432 22235789999999999999999854 4667899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|||+. +|.++++.-+..+....+..+..|+++|+.|||. +.|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 99985 8999998777788889999999999999999999 999999999999999999999999999999887652
Q ss_pred ccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccc---hhhhhhc---cc------cCc---
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQ---SVVIWAK---PL------LDS--- 335 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~---~~~~~~~---~~------~~~--- 335 (434)
...+..+-|++|+|||.+.+.. |+...|+||+|||+.||+++++.|.+... ...++.. |. +..
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 3456677899999999998765 99999999999999999999999876332 2122111 10 000
Q ss_pred ---cccccccCCcCCCCCCHH-HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 ---NDIRELVDPSLGDNYDAE-EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ---~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
-......-..++..+... ..+.-.+++...|..||++|.|+.|.+.
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000111111122222221 2355677888999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=366.77 Aligned_cols=258 Identities=28% Similarity=0.398 Sum_probs=212.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC--CC----cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR--DG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~l 189 (434)
+......||+|+||.||.|... .| ..||||.+.+........+|++|..+|++++|||||+++|++-+ ..++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4556678999999999999865 33 35999999988777788899999999999999999999998544 6889
Q ss_pred EEEEcCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 190 VFQLSPLGSLASILHGS------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
++|||.+|+|..+|... ...+.....+.|+.|||+|+.||++ +++|||||.++|+|+++...|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876 6678999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccccccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
+.+.............-...|||||.++.+.++.|+|||||||+|||++| |..||....+..+... .+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-----------~~ 918 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-----------VL 918 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-----------HH
Confidence 95443322222222223468999999999999999999999999999998 8889977555433210 11
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
... +.+.+..+.+.+.++|..||+.+|++||++..|++.+..+....
T Consensus 919 ~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 919 EGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred hCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 111 33445566778889999999999999999999999887765444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.28 Aligned_cols=256 Identities=23% Similarity=0.366 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
++|.+.+.||+|+||.||+|... ++..||||++...........+.+|+.+++.+ +|+||+++++++. +..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888999999999999998742 34579999998655445556788999999999 8999999999754 468
Q ss_pred EEEEEEcCCCCHHHHhccCC------------------------------------------------------------
Q 013927 188 HLVFQLSPLGSLASILHGSK------------------------------------------------------------ 207 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 207 (434)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecc
Q 013927 208 ---------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278 (434)
Q Consensus 208 ---------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 278 (434)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 236778889999999999999999 99999999999999999999999999999865433211111223
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
.++..|+|||++.+..++.++|||||||++|||++ |+.||.........+.. .........+......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-----------VKRGYQMSRPDFAPPE 343 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-----------HHcccCccCCCCCCHH
Confidence 35678999999998899999999999999999997 99999764332211110 0000000011112356
Q ss_pred HHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 358 AVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 78899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.74 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=200.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~ 188 (434)
..++|.+.++||+|+||+|+++..+ +++.+|||+++++.+ .+..+..+.|..|+...+ ||.++.++.+++ ++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467999999999999999999987 788999999998765 345567888998888775 999999999854 5899
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+.||++..+ .....+++..+..+|..|+.||.|||+ ++||+||||.+|||+|.+|++||+|||+++.--
T Consensus 446 fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC-
Confidence 99999999993332 245789999999999999999999999 999999999999999999999999999998532
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
+.....++++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+.+... ++|..+.+
T Consensus 520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------------~FdsI~~d 583 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------------VFDSIVND 583 (694)
T ss_pred -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHhcC
Confidence 23345688999999999999999999999999999999999999999998754432 22222211
Q ss_pred --CCCHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 349 --NYDAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 349 --~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
.++.-...+.+.++.++|..+|++|..+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1233344677889999999999999877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=340.09 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=203.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.... .....+.+|+++++.++|||||.+++.++. ++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778888999999999999976 7899999999876553 345678999999999999999999997554 7999999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.+ +|..+|. ..+.+++..+..|+.+++.||.|||+ ++|+|||+||+|||++.+|.+|+||||+|+.+... .
T Consensus 82 ~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--T 154 (808)
T ss_pred hhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--c
Confidence 9986 9999997 56778999999999999999999999 99999999999999999999999999999976543 3
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC--CC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD--NY 350 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~ 350 (434)
...+...||+.|||||++.+..|+..+|+||+|||+||+++|++||-...-. .++...+.+ .+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---------------~Lv~~I~~d~v~~ 219 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---------------QLVKSILKDPVKP 219 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---------------HHHHHHhcCCCCC
Confidence 3446678999999999999999999999999999999999999999642211 111111111 11
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++...|..||.+|.+..+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2244467888999999999999999999863
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.50 Aligned_cols=265 Identities=28% Similarity=0.414 Sum_probs=222.7
Q ss_pred CCCCCCeecccCcEEEEEEEeCC---C--cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRD---G--TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~ 191 (434)
...+..+||+|-||.||+|.+.+ | -.||||..+.+...+..+.|+.|..+|++++||||++++|++.+ ..++||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 34455789999999999998542 2 35899999887777778899999999999999999999998765 799999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+++.|.|..+|..++..++......++.||+.||.|||+ .++|||||...||||.....|||+|||+++++.....
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.+. +...-..-|||||.+.-..++.++|||-|||++||++. |..||.+..+..++.. +...-+...
T Consensus 547 Yka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~------------iEnGeRlP~ 613 (974)
T KOG4257|consen 547 YKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH------------IENGERLPC 613 (974)
T ss_pred hhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE------------ecCCCCCCC
Confidence 332 23334668999999999999999999999999999985 9999998776555432 222223334
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcchhhhhhhc
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQK 398 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 398 (434)
++.++..+..++.+||+.+|.+||.+.++...|..+..+.+....++.
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~ 661 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQL 661 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHH
Confidence 555667888999999999999999999999999888766555544443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=324.44 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+. .+..||+|.+...........+.+|+.++.+++||||++++|++ .+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999753 35789999998765445556789999999999999999999974 3478999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999997656678999999999999999999998 899999999999999999999999999876432211
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
. .......++..|+|||.+.+..++.++|||||||++||+++ |..||.........-.. ... ....
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~----~~~~ 228 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV--------EDG----FRLP 228 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--------HCC----CCCC
Confidence 1 11112234678999999998999999999999999999775 99999764332111000 000 0001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+......+.+++..||+.+|.+||++.+|++.|...
T Consensus 229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122335678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=325.80 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=202.0
Q ss_pred CCCCCCeecccCcEEEEEEEeCC------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+|.+.+.||+|+||.||+|.... ...||+|.+...........+.+|+.++.+++||||+++++++. +..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57888999999999999998642 25799999876554455567899999999999999999999754 36889
Q ss_pred EEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 190 VFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
+|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999986421 457888899999999999999999 89999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhcccc
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLL 333 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 333 (434)
++|+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..........
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~----- 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE----- 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence 99999999976543322222233456788999999988899999999999999999998 999987643322110
Q ss_pred CccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.+........+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 238 -------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 -------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 010011111122334678889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.24 Aligned_cols=255 Identities=26% Similarity=0.330 Sum_probs=201.2
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------------hhHhhHHHHHHHHhhCCCCCeeeEe
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------------EKTCGFLCEIGIIAYVDHPNTAKLV 180 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~ 180 (434)
..++|.+.+.||+|.||.|-+|... +++.||||++.+.... ...+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467999999999999999999976 7999999999764221 1224688999999999999999999
Q ss_pred eec----cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 181 GCD----SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 181 g~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
.+. .+.+|+|+|||..|.+...=. .+..++..+..+++.+++.||+|||. ++||||||||+|+||+++|+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEE
Confidence 983 447999999999887765432 22238999999999999999999999 9999999999999999999999
Q ss_pred EeccccccccCCCC---cccceeccccccccccCCccccCC---C-CCcCcEEehhHHHHHHHhCCCccccccchhhhhh
Q 013927 257 ICDFGLAKWLPRQW---THHNVSKFEGTFGYFAPEYFMHGI---V-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329 (434)
Q Consensus 257 L~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 329 (434)
|+|||.+...+... .........||+.|+|||.+.++. + +.+.||||+||+||.|+.|+.||.+......
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l--- 327 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL--- 327 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH---
Confidence 99999998664331 122234578999999999987643 3 4678999999999999999999965322111
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
...++...+.....++..+.+.+||.++|++||+.|.+..+|....-
T Consensus 328 --------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 --------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 12233333333333345567888999999999999999999976653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.92 Aligned_cols=234 Identities=25% Similarity=0.329 Sum_probs=194.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
+|+..+.||.|+||.|.+++.+ +|..+|+|++.+...- ...+...+|..+|+.+.||+++++++.+.| .+++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5888899999999999999977 7899999999876553 334567889999999999999999987544 7899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|.++|.|.+++.. ...++......+|.+|+.||+|||+ ++|++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred ccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 9999999999974 4567888888899999999999999 99999999999999999999999999999977543
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.-+.|||+.|+|||++....|..++|.|||||++|||+.|..||...+. ..++.+ ++...+ .++.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~K----------I~~~~v--~fP~ 262 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEK----------ILEGKV--KFPS 262 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHH----------HHhCcc--cCCc
Confidence 4578999999999999999999999999999999999999999987554 222222 111111 1122
Q ss_pred HHHHHHHHHHHhhhccCCCCC
Q 013927 353 EEIDRAVLTASLCIEQSPILR 373 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~R 373 (434)
-....+.+|+...|+.|-.+|
T Consensus 263 ~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 263 YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCHHHHHHHHHHHhhhhHhh
Confidence 222456667788899988888
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.77 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=200.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~ 191 (434)
+|.+.+.||+|+||+||+|.+. +++ .|++|.+...........+..|+..+++++||||+++++++.+ ..++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 5778899999999999999874 444 4778877544333334567788889999999999999998644 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 9999999999998666788999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........++..|+|||++.++.++.++|||||||++|||++ |..||.+.......... ..+. ....+. .
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~~~--~~~~~~---~- 235 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---EKGE--RLAQPQ---I- 235 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCC--cCCCCC---C-
Confidence 222334456788999999998899999999999999999998 99999764432211000 0000 000111 1
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
....+..++.+||..+|++||++.++++.|..+.
T Consensus 236 ---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 236 ---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1234567889999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=322.91 Aligned_cols=248 Identities=26% Similarity=0.334 Sum_probs=194.6
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
|...+.||+|+||+||+|... +|+.||||.+...... .....+.+|+.++.+++|+||+.+++++ .+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677789999999999999865 7899999998754322 2234578899999999999999999864 3468899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|..++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999998887543 3468899999999999999999999 999999999999999999999999999998654321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .+...+. .....++.
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--------~~~~~~~-~~~~~~~~ 226 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--------EVDRRVK-EDQEEYSE 226 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--------HHHHHhh-cccccCCc
Confidence 2234568999999999999999999999999999999999999997643211100 0000000 00011112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
.....+..++.+||+.+|.+||+ +.++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22346778999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.85 Aligned_cols=247 Identities=30% Similarity=0.462 Sum_probs=191.9
Q ss_pred CCeecccCcEEEEEEEeC-----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 122 ENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
.+.||.|.||.||+|.+. .+..|+||.+...........+.+|+..+++++||||++++|++. +..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999876 357899999966554555678999999999999999999999854 3689999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.++|... ...+++..+..|+.||++||.|||+ ++++|+||+++||+++.++.+||+|||++..........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999876 6789999999999999999999999 899999999999999999999999999998763322222
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......+...|+|||.+....++.++||||||+++|||++ |+.||........... +.+. .....+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~-----------~~~~-~~~~~~~ 228 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK-----------LKQG-QRLPIPD 228 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH-----------HHTT-EETTSBT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------cccc-ccceecc
Confidence 2233446788999999998889999999999999999999 7789876533321111 0000 0011111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
.....+..++.+||+.+|++||++.+|++.|
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2235678899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=318.29 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=203.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+.. ...||||.+...........|..|+.++++++||||++++++. .+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999998752 4579999987665555556789999999999999999999974 3468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999997666678999999999999999999998 999999999999999999999999999998764221
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||............ .. .....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--------~~----~~~~~ 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--------ED----GYRLP 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH--------Hc----CCCCC
Confidence 1111112334678999999998889999999999999999998 99998654322111000 00 00001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112335678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.71 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=202.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
+-|.+++.||.|+-|.|-+|++. +|+.+|||++.+... ......+-+|+-+|+-+.||||+++|+++.+ .+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999876 899999999987522 2334467789999999999999999998654 799999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|.|.++|- .++.+.+....+++.||+.|+.|+|. .+|+||||||+|+|+|..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 9999999999997 56778888889999999999999999 99999999999999999999999999999764433
Q ss_pred ccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC--
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD-- 348 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-- 348 (434)
....+-||++.|.|||++.+.+|+ .++||||.|||||.||||+.||++.+-... +..--.+
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L---------------LlKV~~G~f 229 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL---------------LLKVQRGVF 229 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCcc
Confidence 345677899999999999999986 789999999999999999999985332211 1111111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+.....++..|+.+||..||+.|.|++||+..
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122233567788899999999999999999764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=337.44 Aligned_cols=257 Identities=21% Similarity=0.344 Sum_probs=200.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeeccC--C
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD--G 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~ 186 (434)
.+.|.+.++||+|+||.||+|.+. .+..||||++...........+.+|+.+++++. ||||+++++++.+ .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999853 234799999976554455567999999999996 9999999998644 6
Q ss_pred cEEEEEEcCCCCHHHHhccCC-----------------------------------------------------------
Q 013927 187 IHLVFQLSPLGSLASILHGSK----------------------------------------------------------- 207 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 207 (434)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 899999999999998875421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 208 ------------------------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 208 ------------------------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 236778888999999999999998 89999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhc
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 330 (434)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999986543222222223446788999999988889999999999999999997 99998754322111110
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.. ......+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 353 -------~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 353 -------IKS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -------Hhc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 000 000111122345678899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=315.62 Aligned_cols=246 Identities=28% Similarity=0.373 Sum_probs=195.2
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHH
Q 013927 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLA 200 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~ 200 (434)
.||+|+||.||+|... +++.||+|.+......+....+.+|+.++++++||||+++++++. +..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999875 789999998876544455567999999999999999999999744 4688999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc
Q 013927 201 SILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 201 ~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++................+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9997655678999999999999999999998 8999999999999999999999999999875443211111111123
Q ss_pred ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 281 t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
+..|+|||.+.++.++.++|||||||++|||++ |..||.......... .+........+......+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~ 226 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE------------AIEQGVRLPCPELCPDAVY 226 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH------------HHHcCCCCCCcccCCHHHH
Confidence 467999999998889999999999999999998 888886543221110 0000111111122235678
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 360 LTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+++.+||+.+|++||++.+|++.|+
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 8999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.92 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=203.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv 190 (434)
.+|.+.++||.|+||+||+|.+. +|. .||+|++...........+.+|+.++..++||||+++++++.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 45888899999999999999854 444 4899998765555555678899999999999999999997544 67899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
++|+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 99999999999997666678999999999999999999999 999999999999999999999999999998765332
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||+......... .+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------------~~~~~~~~~ 231 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD------------LLEKGERLP 231 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------------HHHCCCcCC
Confidence 2211222234678999999988889999999999999999998 899987643321110 000000001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+......+..++.+||+.+|+.||++.+++..|+...
T Consensus 232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11123356778999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=323.58 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=196.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... +++.||+|++...........+.+|+.++++++||||++++++..+ ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999876 7899999999765433334467889999999999999999997443 57899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++ |+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 98 58998887656668889999999999999999998 999999999999999999999999999997653321 1
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---h---hccc------c-Cccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---W---AKPL------L-DSNDIR 339 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~---~~~~------~-~~~~~~ 339 (434)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... . ..+. . ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2234467999999999875 45899999999999999999999999764322111 0 0000 0 000111
Q ss_pred cccCCcCCCCC----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGDNY----DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111110000 0111245778999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.88 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=200.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc---CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS---DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---~~ 186 (434)
++|.+.+.||+|+||.||+|... +++.||+|++...........+..|+.++.++ +|+||+++++++. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999632 35789999987654444445688899999999 8999999999643 35
Q ss_pred cEEEEEEcCCCCHHHHhccCC-----------------------------------------------------------
Q 013927 187 IHLVFQLSPLGSLASILHGSK----------------------------------------------------------- 207 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 207 (434)
.++++||+++|+|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccccccccc
Q 013927 208 -DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286 (434)
Q Consensus 208 -~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 286 (434)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257889999999999999999998 8999999999999999999999999999987643322222233445778999
Q ss_pred CCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhh
Q 013927 287 PEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLC 365 (434)
Q Consensus 287 PE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 365 (434)
||++.+..++.++|||||||++|||++ |..||........... .+........+......+.+++.+|
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR-----------RLKEGTRMRAPEYATPEIYSIMLDC 312 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH-----------HHhccCCCCCCccCCHHHHHHHHHH
Confidence 999999999999999999999999998 9999975332111100 0000000011112235678899999
Q ss_pred hccCCCCCCCHhHHHHHhcCCC
Q 013927 366 IEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 366 l~~~P~~RPs~~evl~~L~~~~ 387 (434)
|+.+|++||++.+|++.|+.+.
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=327.15 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=200.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||++... +|..||+|.+...........+.+|+.++++++||||+++++++ .+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57899999999999999999977 78899999998654444456799999999999999999999974 3468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 157 (331)
T cd06649 85 MDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (331)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence 999999999974 3468889999999999999999997 236999999999999999999999999998765432
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh--hhhccccCccc-----c--------
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV--IWAKPLLDSND-----I-------- 338 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~-----~-------- 338 (434)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ....+...... .
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 12345689999999999988899999999999999999999999965332111 11111100000 0
Q ss_pred ----------------cc----ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 339 ----------------RE----LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 339 ----------------~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.. +................+.+++.+||+.||++||++.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000000001123568889999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=326.04 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=195.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||++++++. .+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 57999999999999999999976 78999999987654333344678899999999999999999974 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. ++|.+++......++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... .
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 96 67888776666678888999999999999999999 999999999999999999999999999987543221 1
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhh-------hccccCc----cccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW-------AKPLLDS----NDIREL 341 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-------~~~~~~~----~~~~~~ 341 (434)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ..+.... .....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 22345689999999998654 58889999999999999999999997643321110 0000000 000000
Q ss_pred cCCcCC--CCCC-------HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 VDPSLG--DNYD-------AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 ~d~~l~--~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...... .... ......+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 0000 001245678999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=327.67 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=191.2
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
+.||+|+||.||++... +|+.||||++..... ......+.+|+.++++++||||+++++++ .+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 789999999976432 22334678899999999999999999864 34688999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence 99998864 4568899999999999999999999 99999999999999999999999999998753221 122344
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. . +.. ++......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-~~--~------~~~----~p~~~~~~ 221 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LM--E------EIR----FPRTLSPE 221 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-Hc--C------CCC----CCCCCCHH
Confidence 67999999999999889999999999999999999999999754322111000 00 0 001 11122356
Q ss_pred HHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 358 AVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 77899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.83 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=196.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv 190 (434)
.++|.+++.||+|+||.||+|+-+ +|..+|+|++.+... .+.....+.|-.+|...++|+||++|..+++ .+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 468999999999999999999866 799999999988654 2445578889999999999999999987655 79999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC--
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR-- 268 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~-- 268 (434)
|||.+||++..+|. ....+++.....++.+++.|+.-||. .|||||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999997 55677777777788899999999999 9999999999999999999999999999853311
Q ss_pred -------------C--------Ccc----c-c-----------------eeccccccccccCCccccCCCCCcCcEEehh
Q 013927 269 -------------Q--------WTH----H-N-----------------VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFG 305 (434)
Q Consensus 269 -------------~--------~~~----~-~-----------------~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlG 305 (434)
. ... . . .-..+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 000 0 0 0124699999999999999999999999999
Q ss_pred HHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC---HhHH
Q 013927 306 VLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPK---MSQV 379 (434)
Q Consensus 306 vil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~ev 379 (434)
||+||||.|-+||....+... |.+..... ..+..........+..+||.+||. ||++|.. +.||
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr--------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQET-YRKIVNWR--------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-HHHHHHHh--------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999977443321 11111000 001111112222677888999999 9999976 4454
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.40 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=198.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+..|+.++..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 6899999999764321 23446888999999999999999998744 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999963 4567888999999999999999999 9999999999999999999999999999976533
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||++.+..++.++|||||||++|||++|..||............... .. .+..+... ...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~---~~~~~~~~-~~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-KE---TLQRPVYD-DPR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-cc---cccCCCCC-ccc
Confidence 223456899999999999889999999999999999999999999764332211000000 00 00001000 000
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......+..++.+||..+|.+||++.+++..
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223567788999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=347.95 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=222.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
....+.++||.|.||+|++|+++ .| ..||||.++....+....+|+.|+.||-+++||||++|.|+.. ....+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567789999999999999976 33 5799999999888888889999999999999999999999743 478899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
.|||++|+|+.+|....+.+.+.+...++.+||.|+.||-+ +++|||||.+.||||+.+..+|++|||+++.+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999999988999999999999999999999999 999999999999999999999999999999886543
Q ss_pred cccceecccc--ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 271 THHNVSKFEG--TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 271 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
....+..-| ..+|.|||.+...+++.++|||||||||||.++ |.+||=.+.+..++ .-+...++
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI------------kaIe~gyR 852 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------------KAIEQGYR 852 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH------------HHHHhccC
Confidence 222333223 468999999999999999999999999999885 99997554443332 12333444
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcchhhh
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVK 394 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~~~~ 394 (434)
...+.+++..|.+|+..||++|-.+||.+.||+..|.++.......+
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 55566777899999999999999999999999999998877665544
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=318.86 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred CCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEE
Q 013927 119 FSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHL 189 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~l 189 (434)
|...+.||+|+||+||++.. .++..||+|.+...........+.+|+.++++++||||+++++++. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47888999999999988753 2578899999976544344557889999999999999999999642 24789
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
+|||+++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+...
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999964 458999999999999999999998 89999999999999999999999999999876543
Q ss_pred Ccccc-eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc---cCccccccccCCc
Q 013927 270 WTHHN-VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL---LDSNDIRELVDPS 345 (434)
Q Consensus 270 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---~~~~~~~~~~d~~ 345 (434)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..||.............. .....+..+++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 22111 1122356679999999888899999999999999999999999865432211111000 0111111222222
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.....+......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222223334567888999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=315.20 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=198.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+.++++++||||+++++++. +..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 34778889999999999999988788899998865432 2346889999999999999999999754 3689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence 9999999997655678999999999999999999998 89999999999999999999999999998765332111 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||.............. .. ....+ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~---~~--~~~~~-------~~ 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR---GF--RLYRP-------KL 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CC--CCCCC-------CC
Confidence 112234568999999988889999999999999999999 8999976433221111000 00 00011 11
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
....+..++.+||+.+|.+||++.++++.|.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2246788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=321.96 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=197.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|..+ +++.||||++..... ......+.+|+.+++.++||||+++++++. +..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 688999999876432 233456788999999999999999998643 46889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|++++.+..+.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 999887765543 44678899999999999999999998 999999999999999999999999999998764321 1
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-----cccc--------Cccccc
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----KPLL--------DSNDIR 339 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-----~~~~--------~~~~~~ 339 (434)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||........... .+.. ......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 122345689999999999988899999999999999999999999976432111100 0000 000000
Q ss_pred cccCCcCCCC------CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGDN------YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..... ........+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000111000 00112356889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=318.10 Aligned_cols=253 Identities=24% Similarity=0.316 Sum_probs=200.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||.||+|... ++..||||.+......+....+.+|+.++++++||||+++++++. +..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778889999999999999864 247899999977655545668999999999999999999999743 4789
Q ss_pred EEEEEcCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 189 LVFQLSPLGSLASILHGS-------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 999999999999998643 2346788899999999999999998 899999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
+|+|||++..+.............+++.|+|||++.++.++.++|||||||++|||++ |..||.............
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence 9999999976533221111223345788999999999999999999999999999998 999986543322211100
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.+. ....+......+.+++.+||+.+|++||++.||++.|+
T Consensus 239 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 000 00111123356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=319.34 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=198.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G 186 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~ 186 (434)
..++|++.+.||+|+||.||+|... .+..||||++...........+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467999999999999999998753 2467999998654333344568899999999999999999997543 6
Q ss_pred cEEEEEEcCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 187 IHLVFQLSPLGSLASILHGSK---------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 889999999999999986422 235788889999999999999998 89999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||............ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~ 237 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---MEG 237 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HcC
Confidence 99999876543322222222345778999999998889999999999999999999 78888654322111000 000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
... ..+......+..++.+||+.+|++||++.++++.|+.
T Consensus 238 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 0111223467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=320.64 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=201.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~ 186 (434)
.++|.+.+.||+|+||.||+|... ....||+|.+...........+.+|+.++.++ +|+||+++++++. +.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 356888899999999999999864 23689999987655444455788999999999 8999999999744 36
Q ss_pred cEEEEEEcCCCCHHHHhcc---------------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 187 IHLVFQLSPLGSLASILHG---------------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~---------------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
.+++|||+++|+|..++.. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 8899999999999999853 23468899999999999999999998 99999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhc
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 330 (434)
++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.........-
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-- 245 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-- 245 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH--
Confidence 99999999999986643322222222335678999999988889999999999999999997 989987543221110
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+........+......+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 246 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 246 ----------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0000111111222345678899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.23 Aligned_cols=243 Identities=22% Similarity=0.231 Sum_probs=195.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||++++++.. +..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888899999999999999976 7899999998754321 23446888999999999999999998744 36889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++.. ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999864 4568888999999999999999999 99999999999999999999999999999865432
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +..... .++.
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-----------i~~~~~--~~~~ 219 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-----------ILAGKL--EFPR 219 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCCc--CCCc
Confidence 1235689999999999988899999999999999999999999976433211100 000000 0111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCC-----HhHHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPK-----MSQVVIL 382 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~~ 382 (434)
.....+.+++.+||+.||.+||+ +.+++..
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12345778999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=326.58 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=194.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++ .+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 689999999975422 12345688999999999999999999974 34689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 99999999999874 3567888888899999999999999 99999999999999999999999999999866432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +....+ .++
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~----------i~~~~~--~~p 235 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-EK----------ILAGRL--KFP 235 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-HH----------HhcCCc--CCC
Confidence 12356899999999999888999999999999999999999999764322111 00 000000 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC-----HhHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK-----MSQVV 380 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl 380 (434)
......+.+++.+||+.||.+||+ +.+++
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 112245678999999999999997 56665
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.29 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=198.7
Q ss_pred CCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
+|.+.+.||+|+||.||+|.. .++..||+|.+...........+.+|+.+++.++||||++++++. .+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 477788999999999999974 246789999997655444556788999999999999999999974 3478999
Q ss_pred EEEcCCCCHHHHhccC----------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 191 FQLSPLGSLASILHGS----------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
|||+++|+|.+++... ...+++.....++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 9999999999998522 2347888899999999999999998 89999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhcccc
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLL 333 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 333 (434)
+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.........-.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM---- 238 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999986543322222233445778999999988889999999999999999998 9889865432211100
Q ss_pred CccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
+........+......+..++.+||+.+|.+||++.+|++.|+.
T Consensus 239 --------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 --------VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00000000111223467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.16 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=196.9
Q ss_pred eecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCCCH
Q 013927 124 LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLGSL 199 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~gsL 199 (434)
.||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++||||+++++++. +..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 355799999876544444567899999999999999999999754 468899999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc-eecc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-VSKF 278 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 278 (434)
.+++......+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..+........ ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 99997666788999999999999999999998 8999999999999999999999999999976543321111 1112
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
.++..|+|||.+.+..++.++|||||||++||+++ |..||.......... .+........+......
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS------------FIEQGKRLDCPAECPPE 226 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH------------HHHCCCCCCCCCCCCHH
Confidence 23578999999988889999999999999999996 999997643322110 00111111122233457
Q ss_pred HHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 358 AVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.+++.+||..+|++||++.+|++.|+..
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 77899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.34 Aligned_cols=241 Identities=24% Similarity=0.297 Sum_probs=190.0
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||+|+||.||+|... +++.||+|++..... ......+..|+.++.+++||||+++++++. +..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 688999999875321 233456788999999999999999988643 468999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 279 (434)
.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 999864 4568899999999999999999998 999999999999999999999999999987543221 1223457
Q ss_pred cccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 280 gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +..... .++......+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-~~----------~~~~~~--~~~~~~~~~~~ 221 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-RK----------ILQEPL--RFPDGFDRDAK 221 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-HH----------HHcCCC--CCCCcCCHHHH
Confidence 899999999999989999999999999999999999999754322111 10 000000 01112234677
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 360 LTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+++.+||+.+|.+||++..+.+.|.
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 8899999999999987655555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=313.14 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=200.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.++||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++|+||++++++.. +..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46888899999999999999988888999998865432 3457899999999999999999998743 4688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999998653 4568889999999999999999998 89999999999999999999999999999866432111
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||++..+.++.++|||||||++|+|++ |..||............. ....... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--------~~~~~~~----~~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ--------RGYRMPR----ME 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH--------cCCCCCC----CC
Confidence 1122345678999999988889999999999999999998 999997543322111100 0000000 11
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.....+.+++.+||+.+|++||+++++++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=311.16 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=197.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCC-eeeEeeeccC--------C
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPN-TAKLVGCDSD--------G 186 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~--------~ 186 (434)
.|...++||+|+||+||+|+.+ +|+.||+|++..... +.......+|+.+++.++|+| |+.++++... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3555567999999999999976 789999999987654 334456889999999999999 9999997332 5
Q ss_pred cEEEEEEcCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSK---DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
+++|+||+. .+|..++.... ..++...+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 779999997 58999998654 357778899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhh---hhh---ccccCc-
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---IWA---KPLLDS- 335 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~~~---~~~~~~- 335 (434)
+.+.-. ....+..++|.+|+|||++.+. .|+...||||+|||+.||++++..|.+...... ++. .|....
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 865422 2234566789999999999887 599999999999999999999999977433221 111 111000
Q ss_pred cccccccCCc--CCCC-----CCHHH---HHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 336 NDIRELVDPS--LGDN-----YDAEE---IDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 336 ~~~~~~~d~~--l~~~-----~~~~~---~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+....+.+-. .... ..... .....+++.+||+.+|.+|.|+..++..
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000010100 0000 00111 1367889999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.31 Aligned_cols=198 Identities=25% Similarity=0.405 Sum_probs=171.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.++||.|+||.||++... ++..+|+|.+...........+.+|+.++++++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57999999999999999999977 688999998876544444567899999999999999999999743 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ...+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 85 MDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 999999999964 3457888999999999999999997 247999999999999999999999999998765332
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL 321 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 321 (434)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346899999999998888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=318.48 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=204.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCC-----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc---CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS---DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~~ 187 (434)
.++|.+.++||+|+||.||+|.... +..||+|.+...........+.+|+.++++++||||+++++++. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999765 68899999876555555667899999999999999999999632 468
Q ss_pred EEEEEEcCCCCHHHHhccCC-------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 188 HLVFQLSPLGSLASILHGSK-------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
+++++|+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 89999999999999986532 458899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
|+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||......... .. +.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~-------~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AY-------LK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HH-------HH
Confidence 99986543322211222345778999999988889999999999999999999 99999764332110 00 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
. .............+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 234 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 D----GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred c----CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0000011112346788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.08 Aligned_cols=241 Identities=23% Similarity=0.289 Sum_probs=191.4
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
+.||+|+||.||++... +|+.||||++.+... ......+.+|+.+++.++||||++++++. .+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 789999999976432 23345688899999999999999998864 34689999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT 154 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence 99988864 4568899999999999999999998 99999999999999999999999999998753221 112234
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..... ....+ +......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~~~--------~~~~~----p~~~~~~ 221 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILM--------EDIKF----PRTLSAD 221 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHhcc--------CCccC----CCCCCHH
Confidence 57999999999999889999999999999999999999999754322111 00000 00011 1122346
Q ss_pred HHHHHHhhhccCCCCCC-----CHhHHHHH
Q 013927 358 AVLTASLCIEQSPILRP-----KMSQVVIL 382 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RP-----s~~evl~~ 382 (434)
+..++.+||+.+|++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 77889999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.58 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=205.3
Q ss_pred HHhcCCCCCCeecccCcEEEEEEE-eCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec-------cC
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-------SD 185 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-------~~ 185 (434)
...++|.+.+.||+|||+-||++. ..++..||+|++.... .+.....++|++..++++|||++++++.. ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 344679999999999999999998 4478899999998776 34556789999999999999999999852 12
Q ss_pred CcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccc
Q 013927 186 GIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl 262 (434)
..|+++.|...|+|.+.+.. .+..+++.+.+.|+.+|++||.+||+.. ..++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 48899999999999998865 3457899999999999999999999832 2499999999999999999999999999
Q ss_pred ccccCCCCccc-------ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc
Q 013927 263 AKWLPRQWTHH-------NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 263 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 332 (434)
+...+-..... ....-..|..|+|||.+. +...++++|||||||+||+|+.|..||+..-+..
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------- 248 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------- 248 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-------
Confidence 98654321111 111233688999999985 3457899999999999999999999998632211
Q ss_pred cCccccc-cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 333 LDSNDIR-ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 333 ~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.+. ....+.+....+....+.+.+++.+||+.||.+||++.+++..+...
T Consensus 249 ---gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 ---GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111 11222222222333557888999999999999999999999888654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.51 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=197.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCC------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~ 187 (434)
+++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........+..|+.+++.++|+||+++++++. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568889999999999999998753 56899998875544444557999999999999999999999643 468
Q ss_pred EEEEEEcCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEe
Q 013927 188 HLVFQLSPLGSLASILHGSK------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQIC 258 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~ 258 (434)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999986532 258899999999999999999999 8999999999999998754 59999
Q ss_pred ccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccc
Q 013927 259 DFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~--------- 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME--------- 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------
Confidence 9999986633211111112233568999999998899999999999999999997 999997633221110
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 338 IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 338 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.+........+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 ---FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000011111222356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=316.04 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=204.9
Q ss_pred cCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCchhh--HhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDEK--TCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.+|++.+.||+|.||+|-++.. ..|+.||||.+.++...+. .-.+.+|++||+.|+||||+.++.+++ +...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577788999999999999985 5899999999998776433 346789999999999999999999865 4788999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||..+|.|.+++. ....+++.....++.||+.|+.|+|. ++++|||||.+|||+|.|+++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-- 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-- 206 (668)
T ss_pred EecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence 9999999999997 45778889999999999999999998 99999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....+++|++.|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+....+.+. -......
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-----------s~GaYrE-- 272 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-----------SRGAYRE-- 272 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-----------hcccccC--
Confidence 345789999999999999998875 7899999999999999999999986654333211 1111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
++..-...-||.+||..||++|.|+.+|...-
T Consensus 273 -P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 12222344578999999999999999997654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.56 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=190.1
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
+.||+|+||.||++... +|+.||+|++..... ......+..|+.+++.++||||+++++++ .+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999876 789999999976422 22344677899999999999999999864 34688999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence 99988864 3568899999999999999999998 99999999999999999999999999998753221 112234
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .++......
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-----------~~~~~~--~~p~~~~~~ 221 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----------ILMEEI--RFPRTLSPE 221 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------HhcCCC--CCCCCCCHH
Confidence 5689999999999988999999999999999999999999975432211100 000000 011122346
Q ss_pred HHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 358 AVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
+..++.+||+.+|++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 77889999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=311.36 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=200.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|...+++.||||.+..... ....+.+|+.++++++||||+++++++. +..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46888899999999999999987778899999875432 2346889999999999999999999743 4688999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999997543 568999999999999999999998 89999999999999999999999999999876532111
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||++.+..++.++||||||+++|||++ |+.||............ ........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~ 227 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV------------DQGYRMPCPP 227 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------------HcCCCCCCCC
Confidence 1111223457999999988889999999999999999999 99999764432211100 0000011112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.....+.+++.+||+.+|.+||++.++++.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 233568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.17 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=201.5
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--C----
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D---- 185 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~---- 185 (434)
...++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++..++|+||++++.... +
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34468999999999999999999865 789999999976543 334456888999999999999999876421 1
Q ss_pred ----CcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEe
Q 013927 186 ----GIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQIC 258 (434)
Q Consensus 186 ----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~ 258 (434)
..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 25799999999999998864 23468889999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 259 DFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~-------~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------L 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------h
Confidence 999998665432222334567999999999999989999999999999999999999999764332111100 0
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..... ..+......+..++..||+.+|.+||++.+++..
T Consensus 259 ~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00001 0112223567889999999999999999999753
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.26 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=197.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+|.+.+.||.|+||.||+|... .++.||||++...........+..|+.++..++||||+++++++. +..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566688999999999999853 257899999986544444456889999999999999999999744 46889
Q ss_pred EEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 190 VFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
++||+.+++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||.||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999998521 2347888889999999999999998 89999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhcccc
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLL 333 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 333 (434)
+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..........
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----- 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE----- 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence 99999999886543322222233445788999999988889999999999999999998 888886543321110
Q ss_pred CccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.+.+.. ....+......+..++..||+.+|++||++.+|++.|+.
T Consensus 238 ------~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ------MIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000100 011112234567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=317.73 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=199.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+|.+.+.||+|+||.||+|... ....+|+|.+...........+.+|+.+++.++||||+++++.+. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778889999999999999753 235799998876554444567899999999999999999999743 46889
Q ss_pred EEEEcCCCCHHHHhccC-----------------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCc
Q 013927 190 VFQLSPLGSLASILHGS-----------------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N 246 (434)
++||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987532 1347788999999999999999998 999999999999
Q ss_pred EEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchh
Q 013927 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSV 325 (434)
Q Consensus 247 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 325 (434)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976543222111223345678999999988889999999999999999998 999997643221
Q ss_pred hhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 326 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+. .+........+......+..++.+||+.+|++||++.+|+..|+.+.
T Consensus 238 -~~~-----------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 -LFN-----------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHH-----------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111 01111111111223356788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=314.50 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=202.0
Q ss_pred cCCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~ 187 (434)
+.|.+.+.||+|+||.||++.. .++..||+|.+...........+.+|+.+++++.||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999974 2578899999876544455567999999999999999999999743 357
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++++|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999997655678999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccc---cccC
Q 013927 268 RQWTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR---ELVD 343 (434)
Q Consensus 268 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~d 343 (434)
...... ......++..|+|||++.+..++.++|||||||++|||++++.|.............+........ ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 332211 112345677899999998888999999999999999999987764321110000000000000000 0000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..............+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011111122346788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=329.04 Aligned_cols=252 Identities=25% Similarity=0.252 Sum_probs=198.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... ......+..|+.++..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999976 789999999975422 133456888999999999999999998743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC-
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW- 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~- 270 (434)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999754 678899999999999999999999 999999999999999999999999999998654332
Q ss_pred --------------------------cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch
Q 013927 271 --------------------------THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS 324 (434)
Q Consensus 271 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 324 (434)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001223456899999999999999999999999999999999999999764432
Q ss_pred hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC-HhHHHHH
Q 013927 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPK-MSQVVIL 382 (434)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~~ 382 (434)
......... . ..+...........+..++..||. +|.+||+ +.++++.
T Consensus 237 ~~~~~i~~~-~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYNKIINW-K--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHhcc-C--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211100000 0 000000001123567778899997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.88 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=198.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||.|...++..||||.+..... ....+.+|+.++++++||||+++++++. +..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35778889999999999999887777799998875432 2346899999999999999999999754 3679999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.+|+|.+++......+++..++.++.|++.||.|||+ ++++|+||||.||+++.++.+||+|||+++........ .
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 9999999997655578999999999999999999998 99999999999999999999999999998765432111 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||............. .. ... .....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~-----~~~----~~~~~ 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS---QG-----LRL----YRPHL 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh---cC-----CCC----CCCCC
Confidence 112235678999999988889999999999999999998 999997644322111000 00 000 00111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
....+.+++.+||+.+|.+||++.+|+..|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2357788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=310.10 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=202.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||.+..... ......+.+|+.+++.++||||++++++. .+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46889999999999999999976 789999998865322 23345688999999999999999999863 45788999
Q ss_pred EEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+++|+|.+++.. ....++...+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 33557888999999999999999998 9999999999999999999999999999886643
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........+... +.....+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------~~~~~~~~--- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK------IEQCDYPP--- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH------HhcCCCCC---
Confidence 211 1223457889999999988889999999999999999999999986533221111100 00000111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11122335678899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.75 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=197.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~ 187 (434)
..|...+.||.|+||.|..+..+ +|..||||++..... .-...+..+|+.+|++++|+||+.++++.. .++
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 45666788999999999999876 899999999974432 233456889999999999999999999622 268
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
|+|+|+|+ .+|..++.. ...++......+.+|+++||.|+|+ .+|+||||||.|+|++.+..+||+|||+|+...
T Consensus 102 YiV~elMe-tDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred EEehhHHh-hHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence 99999995 689999974 3448888888899999999999999 899999999999999999999999999999876
Q ss_pred CCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhh---hhhc-cccCccccccc-
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---IWAK-PLLDSNDIREL- 341 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~~~~-~~~~~~~~~~~- 341 (434)
........+..+.|.+|+|||++.. ..|+...||||.|||+.||++|+..|.+.+.... +... +......+..+
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 5422334466778999999999865 4699999999999999999999999976432211 1110 00001111111
Q ss_pred -------cCCc-CCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 -------VDPS-LGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 -------~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+... .....+ +......++++.+||..||.+|+|++|.++
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1000 000111 112256678999999999999999999974
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=312.85 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=189.0
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec-----cC--CcEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-----SD--GIHLV 190 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----~~--~~~lv 190 (434)
|...+++|.|+||.||+|... +++.||||++-.+..-. .+|+.+|..++|||||++.-++ .+ ...+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 666789999999999999966 67999999987655422 3499999999999999997751 12 35689
Q ss_pred EEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEecccccccc
Q 013927 191 FQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWL 266 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~ 266 (434)
|||++. +|..++.. .+..++...+.-+..||.+||.|||+ .+|+||||||+|+|||.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999995 78888863 34566666777789999999999999 999999999999999977 89999999999988
Q ss_pred CCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccch---hhh---hhccc-------
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQS---VVI---WAKPL------- 332 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~---~~~---~~~~~------- 332 (434)
..+... . ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|+..|.+.... ..+ ...|.
T Consensus 177 ~~~epn--i-SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN--I-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc--e-eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 665332 2 23458899999999876 4999999999999999999999999773221 111 11111
Q ss_pred ---cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 ---LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.....+....+...+......+.++++.++|..+|.+|.++.|++.
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111111111122333467788999999999999999999873
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=324.61 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=209.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeeccC--C-cEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G-IHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~-~~lv~ 191 (434)
++|...+++|+|+||.++.++++ ++..|++|.+......+ ......+|+.+++++.|||||.+.+.+.+ . +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46888899999999999999877 67899999998765533 33478899999999999999999997433 4 78999
Q ss_pred EEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 192 QLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+||+||+|.+.+...+ ..+++..+..++.|++.|+.|||+ ++|+|||||+.||+++.++.|+|+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998765 678999999999999999999998 999999999999999999999999999999887553
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+....+.. .. +......
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k-------i~-----~~~~~Pl 226 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK-------IN-----RGLYSPL 226 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH-------Hh-----hccCCCC
Confidence 234567899999999999999999999999999999999999999987554332211 01 1112223
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+.....++..++..|+..+|..||++.+++..
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 34455678888999999999999999999855
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.62 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=196.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||++... +|+.||||++..... ......+..|+.+++.++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999876 789999999986432 223446788999999999999999998743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999998665778999999999999999999999 9999999999999999999999999999986643321
Q ss_pred ccceeccccccccccCCccc------cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCc
Q 013927 272 HHNVSKFEGTFGYFAPEYFM------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... .... .. ....
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~-~~---~~~~--- 228 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-NNIM-NF---QRFL--- 228 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-HHHH-cC---CCcc---
Confidence 1 223346899999999986 456789999999999999999999999754322111 0000 00 0000
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...........+..++..||+ +|.+||++.+++.
T Consensus 229 -~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 -KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000011123456778889997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.44 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=211.7
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~~~ 195 (434)
|.+..+||+|+||.||++.++ .|+.||||.+.. +...+.+..|+.+|.++++|++|++||. -...+++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 666778999999999999977 899999998864 3456679999999999999999999995 3458999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
.|+..+++..++.++.+..+..|+...+.||+|||. ..-||||||+.|||++.+|.+||+|||.|..+... ....
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence 999999999889999999999999999999999999 88999999999999999999999999999876543 2334
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
.+..||+.|||||++..-.|+.++||||||++..||..|++||..+.+...++..|......+ ..+..-.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF----------~KPE~WS 256 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF----------KKPEEWS 256 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC----------CChHhhh
Confidence 567799999999999999999999999999999999999999998887766655544322221 1223445
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.++.+++..||-.+|++|-|+-++++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 67889999999999999999999875
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=307.73 Aligned_cols=246 Identities=30% Similarity=0.420 Sum_probs=197.1
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLA 200 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~ 200 (434)
++||.|+||.||+|...++..||+|.+...........+.+|+.++++++||||+++++++. +..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999876654444557899999999999999999999744 4688999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc
Q 013927 201 SILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 201 ~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
+++......+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.+||+|||++......... ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 9987656678999999999999999999998 89999999999999999999999999998754332111 1112234
Q ss_pred ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 281 t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
+..|+|||++..+.++.++||||||+++|++++ |..||............ .... ....+......+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~--------~~~~----~~~~~~~~~~~~~ 224 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV--------EKGY----RMSCPQKCPDDVY 224 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------HcCC----CCCCCCCCCHHHH
Confidence 667999999988889999999999999999998 99999764332211000 0000 0011122335788
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 360 LTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+++.+||+.+|++||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=316.01 Aligned_cols=258 Identities=21% Similarity=0.319 Sum_probs=191.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhC---CCCCeeeEeeecc------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYV---DHPNTAKLVGCDS------ 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~------ 184 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 4688999998754332 2223466777777665 6999999999642
Q ss_pred -CCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccc
Q 013927 185 -DGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262 (434)
Q Consensus 185 -~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl 262 (434)
...++||||++ ++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 35789999997 6888888643 3458899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-----ccccCccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----KPLLDSND 337 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-----~~~~~~~~ 337 (434)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ........
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9865432 222345689999999999888899999999999999999999999976432211100 00000000
Q ss_pred -----c-ccccCCcCCC---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 -----I-RELVDPSLGD---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 -----~-~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+ ...+.+.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 000112245678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=311.81 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=194.7
Q ss_pred CCCCCeecccCcEEEEEEEeCC-Cc--EEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------CC
Q 013927 119 FSSENLIGKGGYAEVYKGCLRD-GT--LVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------DG 186 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~~ 186 (434)
|.+.+.||+|+||.||+|.+.. +. .||+|.+..... ......+..|+.+++.++||||+++++++. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999998763 33 699998876432 334557889999999999999999998631 14
Q ss_pred cEEEEEEcCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 187 IHLVFQLSPLGSLASILHG-----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
.+++|||+.+|+|.+++.. ....+++.....++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999987732 23457899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccccc
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||........ +.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~--~~~~~~-- 232 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-YDY--LRQGNR-- 232 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH--HHcCCC--
Confidence 9987643322111122345678999999998889999999999999999999 7889876433211 110 000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
..........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 233 -------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00111233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=326.97 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=188.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|...+.||+|+||.||+|... +|+.||||++...........+.+|+.+++.++|+||+++++++. +..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566788999999999999876 789999999976554445567899999999999999999999754 3688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.+|+|... .......+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 99998653 234567778899999999999998 8999999999999999999999999999986543211 1
Q ss_pred eeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 275 VSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||....... |... ..... ......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~------~~~~~-~~~~~~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASL------MCAIC-MSQPPE 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH------HHHHh-ccCCCC
Confidence 234568999999998743 224568999999999999999999997322111 0000 00000 000011
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
........+.+++.+||+.+|++||++.||++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223567889999999999999999999864
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=309.20 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~ 195 (434)
++|.+.+.||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++|+|+++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecC
Confidence 45888899999999999999988888899999876443 2346899999999999999999999743 46899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+++|.+++... ...+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++..+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999998753 3458999999999999999999999 89999999999999999999999999999865433211 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||............ ........+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~ 227 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV------------ERGYRMPCPQD 227 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------------HcCCCCCCCCc
Confidence 122335678999999988889999999999999999999 88898764322111100 00001111122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 33568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.04 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=200.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
++|.+.+.||+|+||.||+|... .+..||||.+...........+.+|+.+++++ +||||+++++++. +..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999742 34579999987654444456789999999999 7999999999744 468
Q ss_pred EEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 188 HLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
++||||+++|+|.+++.... ..+++..+..++.+++.||.|||+ ++++|+||||+|||++.++.++|+|||+++.+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997533 348999999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
.............++..|+|||.+.++.++.++|||||||++|||++ |..||.......... ..+...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~-----------~~~~~~ 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-----------KLIKEG 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH-----------HHHHcC
Confidence 43322111223345778999999998889999999999999999998 999987643221110 001110
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.....+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1111111123567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=312.93 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=200.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||.||+|... .+..||+|.+...........+.+|+.+++.++||||++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46888899999999999999864 236899999876554444557889999999999999999999743 4689
Q ss_pred EEEEEcCCCCHHHHhccCC---------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEec
Q 013927 189 LVFQLSPLGSLASILHGSK---------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 259 (434)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999986421 246788999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccc
Q 013927 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
||+++.+.............++..|+|||.+.++.++.++|||||||++||+++ |..||............. ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~- 238 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---DGG- 238 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---cCC-
Confidence 999976543322222233456789999999988889999999999999999998 999986543222111000 000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 239 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 --------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00111122457788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=315.91 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=197.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC---------------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEee
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD---------------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g 181 (434)
++|.+.+.||+|+||.||++.... ...||||.+...........+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468889999999999999987532 23589999876544445567999999999999999999999
Q ss_pred ec--cCCcEEEEEEcCCCCHHHHhccCC-----------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEE
Q 013927 182 CD--SDGIHLVFQLSPLGSLASILHGSK-----------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNIL 248 (434)
Q Consensus 182 ~~--~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIl 248 (434)
++ .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 74 347899999999999999985421 236788999999999999999998 89999999999999
Q ss_pred ecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh--CCCccccccchhh
Q 013927 249 LTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT--GRRAVDHLQQSVV 326 (434)
Q Consensus 249 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~~ 326 (434)
++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543322111223345678999999998889999999999999999998 5667765432221
Q ss_pred hhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 327 IWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 327 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+-.............. ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1100000000000000 0011112357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.84 Aligned_cols=245 Identities=28% Similarity=0.383 Sum_probs=203.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|++++.||+|.||.||.|+.+ ++-.||+|++.+.... .....+.+|++|-+.|+||||+++|+++.| ..||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 46999999999999999999976 7889999999876542 334578899999999999999999998555 789999
Q ss_pred EEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 192 QLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
||.+.|+|...|... ...++......+..|+|.||.|+|. ++||||||||+|+|++..+.+||+|||-+..-+.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 999999999999754 4558888888999999999999998 9999999999999999999999999999876542
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....+.+||..|.+||...+..++..+|+|++|++.||++.|..||........ +. .+..-. ..+
T Consensus 177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Yk----------rI~k~~--~~~ 241 (281)
T KOG0580|consen 177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YK----------RIRKVD--LKF 241 (281)
T ss_pred --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HH----------HHHHcc--ccC
Confidence 234678999999999999999999999999999999999999999986442211 11 111100 111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+........++|+.|+..+|.+|.+..||+.
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1223356788999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=310.08 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=197.4
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
+|.+.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+.++++++||||+++++++. +..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4778889999999999999988777899999865432 2335888999999999999999998743 36889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++......... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-S 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-c
Confidence 999999997655678999999999999999999998 899999999999999999999999999987654321111 1
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ...... ..+...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------~~~~~~----~~~~~~ 226 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--------SAGYRL----YRPKLA 226 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH--------HcCCcC----CCCCCC
Confidence 11223457999999998889999999999999999999 88998764332211110 000111 111123
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
...+.+++.+||+.+|++||++.+|++.|
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 45788899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.98 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=201.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC-----------------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD-----------------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 179 (434)
++|.+.+.||+|+||.||+|.... +..||+|.+...........+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 468899999999999999987542 246899998876555556678999999999999999999
Q ss_pred eeecc--CCcEEEEEEcCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcE
Q 013927 180 VGCDS--DGIHLVFQLSPLGSLASILHGSK----------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247 (434)
Q Consensus 180 ~g~~~--~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI 247 (434)
++++. +..++++||+.+++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 99744 47899999999999999986432 268899999999999999999998 8999999999999
Q ss_pred EecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh--CCCccccccchh
Q 013927 248 LLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT--GRRAVDHLQQSV 325 (434)
Q Consensus 248 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~ 325 (434)
+++.++.++|+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543322222233446778999999988889999999999999999998 677886543222
Q ss_pred hhhhc-cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 326 VIWAK-PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 326 ~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
..... ....... .......+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11100 0000000 00000111122357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=309.29 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=194.9
Q ss_pred eecccCcEEEEEEEeC---CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCCC
Q 013927 124 LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLGS 198 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~gs 198 (434)
.||+|+||.||+|.++ ++..||+|++...... .....+..|+.+++.+.||||+++++++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999653 5788999998754432 33457889999999999999999999754 46789999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc-eec
Q 013927 199 LASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-VSK 277 (434)
Q Consensus 199 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~ 277 (434)
|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||.||+++.++.+||+|||++..+........ ...
T Consensus 82 L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 82 LNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999964 3468899999999999999999998 8999999999999999999999999999986643322111 112
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
..++..|+|||.+....++.++|||||||++|||++ |..||............ ........+.....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i------------~~~~~~~~~~~~~~ 225 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI------------ESGERMECPQRCPP 225 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------HCCCCCCCCCCCCH
Confidence 234578999999988889999999999999999998 99999764332211111 11111111122335
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+.+++.+||+.+|++||++.+|++.|++.
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=312.65 Aligned_cols=266 Identities=27% Similarity=0.353 Sum_probs=200.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~ 187 (434)
++|.+.+.||+|+||.||+|..+ ++..||||.+.... ......+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46888899999999999999742 57899999987543 334457889999999999999999998632 357
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++|+||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..+.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999997656678999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCcccce-eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC----cccccccc
Q 013927 268 RQWTHHNV-SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD----SNDIRELV 342 (434)
Q Consensus 268 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 342 (434)
........ ....++..|+|||++.+..++.++|||||||++|||++|..++................ ...+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 43221111 11223456999999988889999999999999999999987764322111100000000 00001111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
...............+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111122345688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=307.87 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=196.5
Q ss_pred CeecccCcEEEEEEEeC-C---CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-D---GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~g 197 (434)
++||+|+||.||+|.+. . +..||+|.+...........+..|+.+++.+.||||+++++++. +..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999754 2 26899999886654444567899999999999999999999754 4689999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc-ee
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-VS 276 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~ 276 (434)
+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 81 PLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 999999744 378999999999999999999998 8999999999999999999999999999986643322111 11
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||............. .. .....+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~~---------~~~~~~~~~~ 224 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---SG---------ERLPRPEECP 224 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cC---------CcCCCCCCCC
Confidence 1223567999999988889999999999999999998 999997644321110000 00 0001111223
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 56778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=326.25 Aligned_cols=252 Identities=24% Similarity=0.263 Sum_probs=190.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
.|...+.||+|+||+||+|... +++.||||++..... ......+..|+.++.+++||||+++++++. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999876 788999999976432 233456889999999999999999999744 46889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc-
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT- 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~- 271 (434)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999864 3467888888899999999999998 9999999999999999999999999999754311000
Q ss_pred --------------------------------------------ccceeccccccccccCCccccCCCCCcCcEEehhHH
Q 013927 272 --------------------------------------------HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVL 307 (434)
Q Consensus 272 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvi 307 (434)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123569999999999998889999999999999
Q ss_pred HHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHh--hhccCCCCCCCHhHHHHH
Q 013927 308 LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASL--CIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 308 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPs~~evl~~ 382 (434)
+|||++|..||............... ... +.-+ ....++ ..+.+++.+ |+..+|..||++.+|+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~-~~~---~~~~-~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINW-ENT---LHIP-PQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcc-ccc---cCCC-CCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999764432211110000 000 0000 000122 344556655 666777779999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.81 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=197.7
Q ss_pred cCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc---CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS---DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---~~ 186 (434)
++|.+.+.||+|+||.||+|.. .+++.||||++...........+.+|+.++.++ +||||+++++++. ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688999999999999999973 247889999997654444455788999999999 6899999998643 25
Q ss_pred cEEEEEEcCCCCHHHHhccCC-----------------------------------------------------------
Q 013927 187 IHLVFQLSPLGSLASILHGSK----------------------------------------------------------- 207 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 207 (434)
.+++|||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886421
Q ss_pred -------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc
Q 013927 208 -------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 208 -------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 235778888999999999999998 9999999999999999999999999999976533221112222345
Q ss_pred ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 281 t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
+..|+|||.+.+..++.++||||||+++|+|++ |..||............ . .... ...... .....+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~-~~~~-----~~~~~~----~~~~~~~ 312 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-L-KEGT-----RMRAPD----YTTPEMY 312 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-H-hccC-----CCCCCC----CCCHHHH
Confidence 678999999988889999999999999999997 89998754322111100 0 0000 000011 1123577
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 360 LTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+++..||+.+|++||++.+|++.|+.+.
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 8899999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.11 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~ 187 (434)
++|.+.++||+|+||.||+|.+. .+..||||++...........+.+|+.++.++. ||||+++++++. +..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778899999999999999853 346899999986544444457889999999997 999999999754 468
Q ss_pred EEEEEEcCCCCHHHHhccCC------------------------------------------------------------
Q 013927 188 HLVFQLSPLGSLASILHGSK------------------------------------------------------------ 207 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 207 (434)
++|+||+++|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 208 -------------------------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 208 -------------------------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..+++.....++.|++.||.|||+ ++++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 135677788899999999999998 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986533211111223346788999999988889999999999999999998 8889875432221110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+........+......+.+++.+||+.+|..||++.+|++.|+..
T Consensus 354 -----------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 354 -----------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -----------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0000011111122235778899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=310.50 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|.+.+.||+|+||.||+|... .++.||+|.+.... .....+.+|+.++..++||||+++++++. +..+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4777889999999999999876 68899999987543 23456889999999999999999999743 4688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999998653 3468999999999999999999998 89999999999999999999999999999865433211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||.+.+..++.++|||||||++|||++ |..||........ +... ........+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~-----------~~~~~~~~~~ 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELL-----------EKGYRMERPE 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHH-----------HCCCCCCCCC
Confidence 1112234568999999988889999999999999999998 8999875332211 1110 0000111112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.....+.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2235678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.99 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=191.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~~ 188 (434)
+|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||++++++.. ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999976 789999999875322 223346889999999999999999998632 1378
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999996 688888863 3468899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCc-ccceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhccc------c
Q 013927 269 QWT-HHNVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPL------L 333 (434)
Q Consensus 269 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~------~ 333 (434)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+. .
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 211 112234568999999999875 57899999999999999999999999653321100 00000 0
Q ss_pred CccccccccC---CcCCCCCC---HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 DSNDIRELVD---PSLGDNYD---AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 ~~~~~~~~~d---~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+. ........ +.....+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000 00000000 011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.48 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=194.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-C-CcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-D-GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+. . +..||+|++..... ......+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 35888899999999999999865 2 36899999875322 2334468889999999999999999997443 58899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 999999999999974 3468889999999999999999999 99999999999999999999999999999865432
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . +..... .+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-~----------i~~~~~--~~ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ-K----------ILEGII--YF 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-H----------HhcCCC--CC
Confidence 234568999999999998889999999999999999999999997644322111 0 000000 01
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRP-----KMSQVVIL 382 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~ 382 (434)
+......+..++.+||+.+|++|+ +++++++.
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111224567889999999999995 78888654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=309.93 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=201.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec-cCCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~lv~e~~~ 195 (434)
++|.+.+.||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++||||+++++.. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCC
Confidence 46889999999999999999887667899999876433 234688999999999999999999964 457889999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++..+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 99999999753 3457899999999999999999998 89999999999999999999999999999866433211 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||+..+..++.++|||||||++|+|++ |..||............ ...........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~ 227 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPCPPE 227 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------------hcCCCCCCccc
Confidence 122345678999999988889999999999999999999 88888654332211100 00000111223
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|++||++.++++.|+.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 34577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.32 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=214.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
....+.++||+|-||.|.++....+..||||.++.......+.+|.+|+.+|.+|+||||+.++|+| .+.+++++||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456678899999999999999878999999999887777778999999999999999999999975 45899999999
Q ss_pred CCCCHHHHhccCCCC-CCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.+++.....+ ..-.....||.||+.||+||.+ .++|||||.+.|||++.++++||+|||+++.+..+...+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999765322 3555667899999999999999 999999999999999999999999999999887776666
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh--CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT--GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....+-...|||||.+..++++.++|||+||+++||+++ ...||........+...-.+....-.. .....+
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~-----~~l~~P 769 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ-----VVLSRP 769 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc-----eeccCC
Confidence 6666777899999999999999999999999999999875 667987654433321111111111111 112233
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.-+...+.+++..||..+-++||+++++...|+.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 4456788899999999999999999999988864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=310.14 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=201.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
++|+..+.||+|+||.||+|... ++ ..+|+|.+...........+..|+.++++++||||++++++.. +..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999875 33 3799999876544445567899999999999999999999744 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999999997656678999999999999999999998 899999999999999999999999999997654332
Q ss_pred cccce-eccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 271 THHNV-SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||............ . .....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i--------~----~~~~~ 229 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI--------N----DGFRL 229 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--------h----cCCCC
Confidence 11111 11123457999999988889999999999999999997 99999653322111100 0 00011
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112335678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=325.63 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=193.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||.|+||+||+|... +|+.||||++..... ......+.+|+.++..++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999976 689999999975422 223346788999999999999999999744 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999999999874 3568899999999999999999999 9999999999999999999999999999875432110
Q ss_pred cc------------------------------------ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCC
Q 013927 272 HH------------------------------------NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315 (434)
Q Consensus 272 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~ 315 (434)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 001246899999999999889999999999999999999999
Q ss_pred CccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC---HhHHHH
Q 013927 316 RAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPK---MSQVVI 381 (434)
Q Consensus 316 ~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~evl~ 381 (434)
.||............... .. .+. ... .......+.+++.+|+. +|.+|++ +.+++.
T Consensus 237 ~Pf~~~~~~~~~~~i~~~-~~---~~~---~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETYRKIINW-KE---TLQ---FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHHHHHHcC-CC---ccC---CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999764432211100000 00 000 000 00112356677788886 9999998 777765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=314.95 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=200.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||+||++... ++..+|+|.+.... ......+.+|+.++++++||||+++++++. +..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46888899999999999999742 34569999886543 334457899999999999999999999744 4789
Q ss_pred EEEEEcCCCCHHHHhccCC------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 189 LVFQLSPLGSLASILHGSK------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986322 348999999999999999999998 9999999999999999999999
Q ss_pred EeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCc
Q 013927 257 ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDS 335 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 335 (434)
|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i---~~ 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---TQ 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc
Confidence 999999986543322122223345778999999988889999999999999999998 89998764432211100 00
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 336 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+.. ..... .....+.+++.+||+.+|.+||++.+|+..|+.+..
T Consensus 238 ~~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 238 GRV-----LQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCc-----CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 000 00111 122467889999999999999999999999976653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.39 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=201.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec-cCCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~lv~e~~~ 195 (434)
++|.+.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 46888899999999999999988889999999875443 234688999999999999999999974 447899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-c
Confidence 99999988653 3568899999999999999999998 89999999999999999999999999999766532111 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++....++.++||||||+++|||++ |+.||........... +....... ....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------~~~~~~~~----~~~~ 227 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN--------LERGYRMP----RPDN 227 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH--------HHcCCCCC----CCCC
Confidence 122345678999999988889999999999999999999 9999975432211100 00000001 1111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|++||++++++..|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 23468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.72 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=204.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCC-cEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeee----c--c---C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDG-TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGC----D--S---D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~----~--~---~ 185 (434)
.++++.+.|.+|||+.||+|....+ ..||+|++... .+.......+|+++|++|. |+|||.+++. . . -
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 3577788999999999999998755 99999999876 3455667899999999997 9999999993 1 1 1
Q ss_pred CcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
.++|.||||.+|.|-++|... ...+.+..+++|++++++|+.+||. +..+|||||||-+||||+.+|+.||||||.+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 467999999999999999752 3349999999999999999999997 44679999999999999999999999999986
Q ss_pred ccCCCC-ccccee------ccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC
Q 013927 265 WLPRQW-THHNVS------KFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 265 ~~~~~~-~~~~~~------~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 334 (434)
...... ...... ..--|+.|+|||++. +...++|+|||||||+||.|+....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 432221 111110 112489999999874 567899999999999999999999999864321
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+++........+.....+..||..||+.+|.+||++-||+..+..+.
T Consensus 265 -----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 -----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred -----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 233444433334567788999999999999999999999998886554
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.65 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=202.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
.+|.+.++||.|+||.||+|...++..+|+|.+..... .....+..|+.+++.++||||+++++++. +..++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46888899999999999999988889999999876543 23446888999999999999999999743 4688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++|.+++... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999753 4568999999999999999999998 89999999999999999999999999999766432111
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||............ ........+.
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~ 227 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI------------TAGYRMPCPA 227 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------------HhCCcCCCCC
Confidence 123345678999999988889999999999999999998 89999764422111000 0011111122
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.....+.+++.+||+.+|.+||++.++++.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 334567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=318.56 Aligned_cols=243 Identities=27% Similarity=0.392 Sum_probs=188.7
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHH---hhCCCCCeeeEeeecc--CCcEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGII---AYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~--~~~~lv 190 (434)
|.+.+.||+|+||.||+|... +|+.||||++.+... ......+..|+.++ ..++||||++++++.. +..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999876 689999999975421 12233566666554 5678999999999743 468999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|...+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 999999999988853 568999999999999999999999 99999999999999999999999999998753221
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||........... +..... .+
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~-----------i~~~~~--~~ 220 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-----------IVNDEV--RY 220 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCCC--CC
Confidence 1223456789999999999988999999999999999999999999976433221100 000000 01
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
+......+..++.+||+.+|.+||+ +.++++
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112345678999999999999995 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=317.42 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
.+|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.+ +||||+++++++. .
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 46888899999999999999731 24579999887654444456789999999999 8999999999744 3
Q ss_pred CcEEEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence 688999999999999998642 1346788899999999999999998 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 251 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 999999999999987654322222223345678999999988889999999999999999998 7888865432211100
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+........+......+..++.+||+.+|.+||++.+|++.|+.+..
T Consensus 252 ------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 252 ------------LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------------HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 00000001112233567789999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.99 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=196.9
Q ss_pred CCCCCeecccCcEEEEEEEeC-C---CcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-D---GTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------- 185 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 185 (434)
|.+.+.||+|+||.||+|... + +..||||.+...... .....+.+|+..++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 367999998764332 334578999999999999999999996322
Q ss_pred CcEEEEEEcCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 186 GIHLVFQLSPLGSLASILHGS-----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
..++++||+++|+|..++... ...+++.....++.|++.||.|||+ ++++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 268999999999999988532 2468899999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~---------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY---------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 99986643322221222334678999999988889999999999999999999 8889876443221100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.+. .....+......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 228 -~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -LRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 00011122345788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=309.85 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=199.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.|.+.+.||+|+||.||+|... ++ ..||||.+...........|..|+.+++.++||||++++++.. +..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999865 33 3699999876544455567999999999999999999999743 3678999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999997666678999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccee-ccc--cccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 272 HHNVS-KFE--GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 272 ~~~~~-~~~--gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
..... ... .+..|+|||++.+..++.++|||||||++||+++ |..||........... +.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~--------i~~~~----~ 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA--------IEQDY----R 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH--------HHcCC----c
Confidence 11111 111 1457999999998889999999999999999886 9999975432211100 00000 0
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
...+......+..++..||..+|.+||++.+|+..|+..
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011112234577899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=336.98 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=196.4
Q ss_pred CCCCCeecccCcEEEEEEEeC-C-CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-D-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++ .+..++||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 788899999999999999865 4 6788999775443 23334678899999999999999999974 34789999999
Q ss_pred CCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 195 PLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 195 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988753 24467888999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||............ . .+. .. ..+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~--~-~~~----~~-----~~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--L-YGK----YD-----PFP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-hCC----CC-----CCC
Confidence 22234567999999999999889999999999999999999999999764332211100 0 000 00 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++..||+.+|+.||++.+++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 122346788999999999999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.29 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=199.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
++|.+.+.||+|+||.||++... ++..||+|.+...........+..|+.+++++ +||||+++++++. +
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46889999999999999999753 23579999998654444455788899999999 7999999999743 4
Q ss_pred CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 6889999999999999996432 347889999999999999999998 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999876543211111122234568999999988889999999999999999998 8888865432211100
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+........+......+..++.+||+.+|.+||++.+|++.|+.+.
T Consensus 255 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 255 ------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ------------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 0000111112223357778999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.07 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=189.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCC-CeeeEeeec--cCCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHP-NTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~-niv~l~g~~--~~~~~lv~ 191 (434)
+|.+.+.||+|+||.||+|... +++.||||++.+... ......+..|..++..+.|+ +|+.++++. .+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999876 678999999976422 23345678899999999765 577787764 44689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 99999999998863 3567889999999999999999999 99999999999999999999999999998743211
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||............ .... ..++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i-----------~~~~--~~~~ 221 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI-----------MEHN--VSYP 221 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----------HcCC--CCCC
Confidence 12234467899999999999989999999999999999999999999764432221110 0000 0111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
......+.+++.+||+.+|.+||+.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1223467788999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=317.68 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=200.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
++|...+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||++++|++. ...+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 35778889999999999999864 444 579998876544444456889999999999999999999754 467799
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
++|+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 99999999999997666678999999999999999999998 899999999999999999999999999998765332
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhh-hhccccCccccccccCCcCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVI-WAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....... +.. .. ...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~---------~~~ 230 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE----KG---------ERL 230 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----CC---------CCC
Confidence 2212222345678999999988889999999999999999997 99999764322111 100 00 000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.........+..++..||..+|++||++.++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001112246778899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.80 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=197.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-----------------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-----------------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 179 (434)
++|++.+.||+|+||.||++... ++..||+|++...........+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 2447999998765444455679999999999999999999
Q ss_pred eeec--cCCcEEEEEEcCCCCHHHHhccCC----------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcE
Q 013927 180 VGCD--SDGIHLVFQLSPLGSLASILHGSK----------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247 (434)
Q Consensus 180 ~g~~--~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI 247 (434)
++++ .+..+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 9974 347899999999999999986422 236778899999999999999998 8999999999999
Q ss_pred EecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh--CCCccccccchh
Q 013927 248 LLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT--GRRAVDHLQQSV 325 (434)
Q Consensus 248 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~ 325 (434)
|++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322111222334678999999888889999999999999999998 678886543222
Q ss_pred hhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 326 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.................. ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhccccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111000000000000000 011122357788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=313.20 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=199.1
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG 186 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~ 186 (434)
..++|.+.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||++++++.. +.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3457999999999999999999753 245799998875543334456889999999999999999999743 46
Q ss_pred cEEEEEEcCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 187 IHLVFQLSPLGSLASILHGS---------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
.++||||+++|+|.+++... .....+..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 89999999999999999642 1334677888999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.........-
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-------- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-------- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------
Confidence 99999986543322222222345678999999998889999999999999999998 788886543221110
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+.+... ...+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 233 ---~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 ---FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0000000 001112235788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.79 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=188.5
Q ss_pred CeecccCcEEEEEEEe----CCCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+.||+|+||.||++.. ..++.||||++..... ......+..|+.+++.++||||+++++++. +..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 3578999999975322 122345778999999999999999998643 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T 155 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence 999999999864 3457778888899999999999999 999999999999999999999999999987532221 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+..... ..+..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~-----------~~~~~~~--~~~~~ 222 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID-----------KILKGKL--NLPPY 222 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH-----------HHHcCCC--CCCCC
Confidence 1234568999999999998889999999999999999999999997644322110 0100000 11112
Q ss_pred HHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 234677899999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.22 Aligned_cols=238 Identities=27% Similarity=0.352 Sum_probs=185.7
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhh-CCCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAY-VDHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
+.||+|+||.||+|... +++.||||++..... ......+..|..++.. .+||||++++++. .+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 688999999976432 2223345667777765 4899999999874 3468899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 999998864 3568888999999999999999999 999999999999999999999999999997543221 2234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............. . ..+. ++.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--------~-~~~~----~~~~~~~ 221 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--------N-DRPH----FPRWISK 221 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------c-CCCC----CCCCCCH
Confidence 5678999999999998889999999999999999999999997644322211100 0 0011 1111234
Q ss_pred HHHHHHHhhhccCCCCCCCHhHH
Q 013927 357 RAVLTASLCIEQSPILRPKMSQV 379 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~ev 379 (434)
.+..++.+||+.+|.+||++.+.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHH
Confidence 56788899999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.95 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=202.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
.+|.+.+.||+|+||.||+|... +|. .||+|.+...........+.+|+.++++++||||+++++++. ...++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 35788899999999999999865 333 689998876654445567889999999999999999999744 578899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+||+++|+|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.+....
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999999998766679999999999999999999998 999999999999999999999999999998765332
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........++..|+|||.+....++.++|+||||+++||+++ |+.||+......... .+.......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------~~~~~~~~~ 231 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD------------LLEKGERLP 231 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------------HHhCCCCCC
Confidence 2221122223568999999988889999999999999999998 999997643321110 000000001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+......+..++.+||..+|+.||++.+++..|+...
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112245778899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.57 Aligned_cols=251 Identities=20% Similarity=0.260 Sum_probs=193.1
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
..++|.+.+.||+|+||.||++... +++.||+|++.+... ......+.+|+.+++.++||||++++++.. +..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999976 688999999875321 123345788999999999999999999744 36899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++.. ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 121 v~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999964 357888889999999999999999 99999999999999999999999999999865432
Q ss_pred CcccceeccccccccccCCccccC----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCc
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHG----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.+..
T Consensus 196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~-----------~~i~~~~ 263 (370)
T cd05621 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY-----------SKIMDHK 263 (370)
T ss_pred Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCC
Confidence 11 122345799999999998653 3788999999999999999999999764322111 0111100
Q ss_pred --CCCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHHH
Q 013927 346 --LGDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVIL 382 (434)
Q Consensus 346 --l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~ 382 (434)
+...........+..++..||..++.+ ||++.++++.
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000111122345667788888755543 8899998765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.46 Aligned_cols=250 Identities=21% Similarity=0.238 Sum_probs=194.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv 190 (434)
.++|.+.+.||+|+||.||++... +++.||+|++.+... ......+..|+.+++.++||||++++++..+ ..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999876 688999999975321 1223457789999999999999999987543 58899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++.. ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999864 357778888899999999999999 999999999999999999999999999997654321
Q ss_pred cccceeccccccccccCCccccC----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC--
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHG----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP-- 344 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 344 (434)
. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... . .+...
T Consensus 197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~----------~i~~~~~ 264 (370)
T cd05596 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-S----------KIMDHKN 264 (370)
T ss_pred c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-H----------HHHcCCC
Confidence 1 112345699999999998653 4789999999999999999999999764332111 0 01100
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVIL 382 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~ 382 (434)
.+...........+.+++..||..+|.+ ||++.+++..
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000001122356778889999999988 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=326.34 Aligned_cols=252 Identities=23% Similarity=0.259 Sum_probs=191.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||.|+||+||++... +|+.||||++.+... ......+.+|+.++++++||||+++++++. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999866 789999999875322 223456788999999999999999999744 3689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999864 4567888888899999999999999 9999999999999999999999999999864321100
Q ss_pred c------------c---------------------------------ceeccccccccccCCccccCCCCCcCcEEehhH
Q 013927 272 H------------H---------------------------------NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGV 306 (434)
Q Consensus 272 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 306 (434)
. . ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246999999999999888999999999999
Q ss_pred HHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCC---CCHhHHHHH
Q 013927 307 LLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILR---PKMSQVVIL 382 (434)
Q Consensus 307 il~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~evl~~ 382 (434)
++|||++|..||............ .... ..+. +.. .......+.+++.+||. +|.+| |++.+++..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i-~~~~---~~~~---~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKI-INWR---ETLY---FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHH-HccC---CccC---CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999764332111000 0000 0000 000 00112456778889997 67765 588888754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.33 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=199.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~ 195 (434)
++|.+...||+|+||.||+|....+..||+|.+..... ....+.+|+.++++++|||+++++++.. +..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence 35788889999999999999988777899998865432 2346889999999999999999999744 46889999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|+|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence 99999999753 3457899999999999999999998 89999999999999999999999999999765432111 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++.+..++.++|||||||++|||++ |..||............ ..... ...+..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------~~~~~----~~~~~~ 227 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV--------ERGYR----MPCPQG 227 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCCC----CCCCcc
Confidence 122345678999999988889999999999999999999 89999764332111000 00000 011122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=324.73 Aligned_cols=202 Identities=27% Similarity=0.374 Sum_probs=171.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +++.||||++.+... ......+..|+.++.+++||||+++++...+ ..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999876 689999999975422 2233467889999999999999999997544 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999974 4568899999999999999999999 9999999999999999999999999999875432100
Q ss_pred c---------------------------------cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcc
Q 013927 272 H---------------------------------HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 272 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~ 318 (434)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012357999999999999989999999999999999999999999
Q ss_pred cccc
Q 013927 319 DHLQ 322 (434)
Q Consensus 319 ~~~~ 322 (434)
....
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.60 Aligned_cols=250 Identities=26% Similarity=0.335 Sum_probs=196.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|++.++||+|+||+||++... +++.||||++...... .....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 6899999998754322 22345778999999999999999998743 46899999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+.+|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888643 3568999999999999999999999 899999999999999999999999999998654321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .+...+.. ....++
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--------~~~~~~~~-~~~~~~ 225 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--------EVERRVKE-DQEEYS 225 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--------HHHHHhhh-cccccC
Confidence 1233468999999999998889999999999999999999999997633211100 00000000 001112
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVVIL 382 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~ 382 (434)
......+..++..||+.||++|| ++.+++..
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22345678899999999999999 77777543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.70 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=202.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|...+ ...||||.............+.+|+.++++++||||+++++++. +..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457888999999999999998643 24699998876554445567999999999999999999999754 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999999997655678999999999999999999998 8999999999999999999999999999986543311
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......++..|+|||.+....++.++||||||+++||+++ |..||............. .......
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--------~~~~~~~---- 229 (270)
T cd05056 163 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE--------NGERLPM---- 229 (270)
T ss_pred -eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------cCCcCCC----
Confidence 11122234568999999988889999999999999999986 999997654322111100 0000011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.......+..++.+||..+|.+||++.+++..|+....
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11223467889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=313.26 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=200.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.++++++||||+++++++. +..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 35778889999999999999742 355789998865432 33456889999999999999999999744 4689
Q ss_pred EEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC
Q 013927 189 LVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY 253 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~ 253 (434)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence 999999999999998642 2347899999999999999999998 9999999999999999999
Q ss_pred CeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccc
Q 013927 254 EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 254 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 332 (434)
.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--- 237 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--- 237 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence 999999999976543322122233446788999999998889999999999999999999 9999865433221100
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
....... .........+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 238 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0000000 0111223567889999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.70 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
.+|.+.+.||+|+||.||+|... .+..||+|.+...........+..|+.+++++ +||||+++++++. +
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45888899999999999999742 24579999987654444556788999999999 6999999999744 3
Q ss_pred CcEEEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 688999999999999998642 2357889999999999999999998 9999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||.........-.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986543221111122234567999999988889999999999999999999 8889876432211100
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.. .. .....+......+..++.+||+.+|++||++.++++.|+.+.
T Consensus 249 ~~---~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 249 LR---EG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH---cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 00 000111222346778999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.42 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=204.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----CcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~ 188 (434)
.|...+.||+|+||.||+|.+. ++..||||.+...........+.+|+.+++.+.||||+++++++.+ ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4677789999999999999854 3678999999866544345679999999999999999999987543 688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
++|||+++++|.+++......+++..+..++.|++.||.|||+ ++++||||||.||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999998666679999999999999999999998 8999999999999999999999999999987653
Q ss_pred CCccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC---ccccccccCC
Q 013927 269 QWTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD---SNDIRELVDP 344 (434)
Q Consensus 269 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---~~~~~~~~d~ 344 (434)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........+..+... ...+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 21111 1112234567999999988889999999999999999999999986532221111111000 0011111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
......+......+..++.+||+.+|.+||++.+|++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111222335788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.05 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=201.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-C---CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-D---GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
.+|.+.+.||+|+||.||+|... + +..+|+|.+...........+..|+.++++++||||+++++++ .+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999864 2 3479999987655445556789999999999999999999974 3478899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999997666678999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccc-eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 271 THHN-VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.... .....++..|+|||++.+..++.++|||||||++||+++ |..||............ .... ..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~--------~~~~----~~ 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI--------EEGY----RL 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH--------hCCC----cC
Confidence 2111 111223568999999998889999999999999999886 99999754322111000 0000 00
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.........+..++.+||+.+|.+||++.+|++.|+.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11112235678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=305.01 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=198.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch----hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD----EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
++|.+.+.||+|++|.||.|... +++.||+|.+...... .....+.+|+.++++++||||++++++.. +..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47899999999999999999865 6899999998754321 22346888999999999999999999743 47889
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|+||+++++|.+++.. ...++......++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999998864 3457888889999999999999999 89999999999999999999999999998765432
Q ss_pred Cccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 270 WTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.... ......|+..|+|||++.+..++.++||||||+++|||++|+.||............. ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~ 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----------TQPTNP 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-----------ccCCCC
Confidence 1111 1123457889999999998889999999999999999999999997643332211100 000011
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+......+..++.+||..+|.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1122233467789999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.31 Aligned_cols=240 Identities=24% Similarity=0.333 Sum_probs=188.9
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|... +++.||||++.+... ......+..|..++..+ +||||++++++.. +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 688999999976422 23344577888888866 7999999999743 468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|...+.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT 154 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence 999988864 3568888999999999999999999 89999999999999999999999999998754222 11233
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .++.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-----------i~~~~~--~~p~~~~~ 221 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES-----------ILHDDV--LYPVWLSK 221 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH-----------HHcCCC--CCCCCCCH
Confidence 45689999999999988999999999999999999999999976543222110 000000 00111224
Q ss_pred HHHHHHHhhhccCCCCCC-------CHhHHHH
Q 013927 357 RAVLTASLCIEQSPILRP-------KMSQVVI 381 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RP-------s~~evl~ 381 (434)
.+.+++..||+.+|++|| ++.+++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 677889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.08 Aligned_cols=248 Identities=29% Similarity=0.384 Sum_probs=196.7
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLA 200 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~ 200 (434)
++||.|+||.||++...+++.||+|.+...........+.+|+.++++++|+||+++++++. ...++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999987799999999876654445567899999999999999999999744 3688999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc
Q 013927 201 SILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 201 ~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
+++......+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++................+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997655678899999999999999999998 8999999999999999999999999999976542211111112223
Q ss_pred ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 281 t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
+..|+|||.+.++.++.++|||||||++|||++ |..||........... +........+......+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------------IESGYRMPAPQLCPEEIY 225 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH------------HhcCCCCCCCccCCHHHH
Confidence 567999999988889999999999999999999 8888866433211100 000000011112235688
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 360 LTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
+++.+||..+|.+||++.+|++.|+.
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHHHhhC
Confidence 89999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=305.44 Aligned_cols=250 Identities=27% Similarity=0.338 Sum_probs=187.9
Q ss_pred eecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCC
Q 013927 124 LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGS 198 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gs 198 (434)
.||+|+||.||+|... .+..+|+|.+...........+.+|+.++++++||||+++++++. ...++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999854 346799998876554344457889999999999999999999754 36889999999999
Q ss_pred HHHHhccC----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 199 LASILHGS----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 199 L~~~l~~~----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
|.+++... ....++..+..++.|++.||.|||+ ++++||||||+||+++.+++++|+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99998642 2345677788899999999999998 9999999999999999999999999999975433222111
Q ss_pred eeccccccccccCCccccC-------CCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcC
Q 013927 275 VSKFEGTFGYFAPEYFMHG-------IVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.....|+..|+|||++.+. .++.++||||||+++|||++ |+.||............ .........++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQLKLPKPRL 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhcccCCCCCCcc
Confidence 2234567889999998642 35789999999999999996 99999764332211100 0011111222222
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
... ..+.+.+++..|| .+|++||++.+|+..|+
T Consensus 236 ~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 211 2235667888999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=323.94 Aligned_cols=201 Identities=25% Similarity=0.301 Sum_probs=168.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
.|...++||+|+||.||+|... +++.||||++.+... ......+.+|+.++++++||||+++++.+. +..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999876 688999999875422 233456888999999999999999999754 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc-
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT- 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~- 271 (434)
|+++|+|.+++... ..++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998643 467888888899999999999999 8999999999999999999999999999753211000
Q ss_pred --------------------------------------------ccceeccccccccccCCccccCCCCCcCcEEehhHH
Q 013927 272 --------------------------------------------HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVL 307 (434)
Q Consensus 272 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvi 307 (434)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123468999999999998899999999999999
Q ss_pred HHHHHhCCCcccccc
Q 013927 308 LLELITGRRAVDHLQ 322 (434)
Q Consensus 308 l~elltG~~p~~~~~ 322 (434)
+|||++|+.||....
T Consensus 238 l~elltG~~Pf~~~~ 252 (382)
T cd05625 238 LYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.12 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=199.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--Cc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~ 187 (434)
.++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888999999999999999853 4678999998765544445678899999999999999999997543 68
Q ss_pred EEEEEEcCCCCHHHHhccCC---------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCc
Q 013927 188 HLVFQLSPLGSLASILHGSK---------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N 246 (434)
++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986321 246788889999999999999998 899999999999
Q ss_pred EEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchh
Q 013927 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSV 325 (434)
Q Consensus 247 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 325 (434)
|+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543221111122234667999999988889999999999999999997 888886543221
Q ss_pred hhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 326 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
..... ...... ..+......+.+++.+||+.+|.+||++.||++.|+.
T Consensus 241 ~~~~~---~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYV---RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHH---hcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11000 000000 0111223567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.85 Aligned_cols=235 Identities=27% Similarity=0.398 Sum_probs=186.1
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|..+ +++.||||++.+... ......+..|..++..+ +||||++++++.. +..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 688999999875421 23344677888888876 6999999999743 468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS 154 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence 999998864 3568889999999999999999998 99999999999999999999999999998753221 12234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ . ... .. .+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i-~--~~~------~~----~~~~~~~ 221 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-L--NDE------VV----YPTWLSQ 221 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-h--cCC------CC----CCCCCCH
Confidence 457899999999999888999999999999999999999999764432211000 0 000 00 1111234
Q ss_pred HHHHHHHhhhccCCCCCCCH
Q 013927 357 RAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~ 376 (434)
.+.+++.+||+.||++||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 67789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=308.65 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=193.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
+|.+.++||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++.+ .+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5778889999999999999865 78999999997654444455788999999999999999999964 34688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++..+... .
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~ 149 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----I 149 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----c
Confidence 999987553 46778888999999999999999 99999999999999999999999999999765432 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||........... .........+...........
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 225 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----PLQLLQCIVDEDPPVLPVGQF 225 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc----hHHHHHHHhccCCCCCCCCcC
Confidence 2345689999999999988899999999999999999999999975322110000 000000000000000001112
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2457788999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.18 Aligned_cols=248 Identities=24% Similarity=0.268 Sum_probs=190.4
Q ss_pred CCCCCCeecccCcEEEEEEEe----CCCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 118 NFSSENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
+|.+.+.||+|+||.||++.. .+++.||+|++.+... ......+..|+.++.++ +||||+.++++.. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999875 2578999999875322 12234577899999999 5999999998643 468
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 899999999999998863 4568889999999999999999998 999999999999999999999999999997653
Q ss_pred CCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchh--hhhhccccCccccccccCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSV--VIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~ 344 (434)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...... +. -.++
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~------~~-~~~~ 228 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR------IL-KCDP 228 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH------Hh-cCCC
Confidence 3221 122345799999999998765 47889999999999999999999996432111 000000 00 0111
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
.+. ......+..++.+||+.||++|| ++.++++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 PFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 12234567889999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.02 Aligned_cols=242 Identities=23% Similarity=0.303 Sum_probs=190.1
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
+.||+|+||.||++... +|..||+|++..... ......+..|+.++..++||||+++++++ .+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 789999999976432 22344678899999999999999998864 34689999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
+|..++.. ...+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 155 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKT 155 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccccc
Confidence 99988863 4568899999999999999999995 269999999999999999999999999998753322 112234
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ...+ +......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i~~~--------~~~~----p~~~~~~ 222 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILME--------EIRF----PRTLSPE 222 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHHhcC--------CCCC----CCCCCHH
Confidence 56999999999999889999999999999999999999999654322111 000000 0001 1112346
Q ss_pred HHHHHHhhhccCCCCCC-----CHhHHHHH
Q 013927 358 AVLTASLCIEQSPILRP-----KMSQVVIL 382 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RP-----s~~evl~~ 382 (434)
+..++.+||+.||++|+ ++.++++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 77889999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.32 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=196.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc--EEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||+|+||.||+|... ++. .+++|.+...........+.+|+.++.++ +||||+++++++. +..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999875 343 47888876443334455789999999999 7999999999754 368899
Q ss_pred EEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 191 FQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986422 247888999999999999999998 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||............
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~---- 231 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL---- 231 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 999999986432110 1111123457999999988889999999999999999997 99999764332211100
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
........+......+.+++.+||..+|.+||++.+|++.|+.+..
T Consensus 232 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 232 --------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred --------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000111111223567889999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.88 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=188.7
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|... +++.||||++.+... ......+..|..++..+ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999876 688999999986432 22334578899999988 7999999999754 468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS 154 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence 999988863 3578999999999999999999998 99999999999999999999999999998743211 12234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc-ccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI-RELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~ 355 (434)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||+........... ....+ ..+..... ..+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~p~~~~ 229 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN---TEDYLFQVILEKQI--RIPRSLS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc---chHHHHHHHHcCCC--CCCCCCC
Confidence 567999999999999989999999999999999999999999642211000000 00000 00111100 1111223
Q ss_pred HHHHHHHHhhhccCCCCCCC------HhHHH
Q 013927 356 DRAVLTASLCIEQSPILRPK------MSQVV 380 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs------~~evl 380 (434)
..+..++.+||+.+|.+||+ +.+++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 46778999999999999998 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=316.25 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=195.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||||.+...........+.+|+.++++++||||+++++++ .+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999876 68899999997654444444678899999999999999999974 3478899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++ +|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence 984 7888887666678899999999999999999998 999999999999999999999999999997543321 1
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhccc------cCc-cccc
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPL------LDS-NDIR 339 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~------~~~-~~~~ 339 (434)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ...+. ... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1233457899999998865 45889999999999999999999999754321110 00000 000 0000
Q ss_pred cccCCcCCC----CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGD----NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..-.+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.09 Aligned_cols=243 Identities=25% Similarity=0.304 Sum_probs=185.4
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|... +++.||+|++.+... ......+..|+.++.++ +||||++++++. .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 688999999986432 22334577888888776 799999999974 3468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTS 154 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccc
Confidence 999988863 3568899999999999999999999 99999999999999999999999999998753221 11223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc-ccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI-RELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~ 355 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+ ..+.... ..++....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---~~~~~~~~~i~~~~--~~~p~~~~ 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEKQ--IRIPRSLS 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc---ccHHHHHHHHhcCC--CCCCCCCC
Confidence 46789999999999999999999999999999999999999964221100000 000000 0000100 01122233
Q ss_pred HHHHHHHHhhhccCCCCCCCH
Q 013927 356 DRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
..+..++.+||+.||++||++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 567789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.52 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=189.5
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~ 191 (434)
+|.+.+.||+|+||.||+|... +++.||||++.+... ......+..|..++..+ +|++|+.+++++. +..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 678999999986432 22334567788888777 5889999988743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|...+.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 99999999998864 3568889999999999999999998 89999999999999999999999999998754321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.... ..++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~-----------i~~~~--~~~p 221 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----------IMEHN--VAYP 221 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCC--CCCC
Confidence 1123346789999999999999999999999999999999999999976443222110 00000 0111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
......+..++.+||+.+|.+|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1223567789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=301.35 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=200.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||+|++|.||+|... +++.|++|.+..... ......+.+|+.++++++||||+++++++. +..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777789999999999999876 689999999875432 344557889999999999999999999744 368999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++++|.+++... ...+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999764 4678899999999999999999998 8999999999999999999999999999886654321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||............. .. .. .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~----~~-----~~~~~ 223 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII---RG----VF-----PPVSQ 223 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---cC----CC-----CCCcc
Confidence 1233468899999999998889999999999999999999999997654322111100 00 00 11111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.....+..++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 233567889999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.69 Aligned_cols=251 Identities=23% Similarity=0.214 Sum_probs=189.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|.+.+.||+|+||.||+|... +++.||||++.+... ......+.+|+.++..++||||+++++.+. +..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6889999999999999999976 689999999865322 123346788999999999999999998743 46889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC--
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW-- 270 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~-- 270 (434)
|+++|+|.+++.. ...++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999964 3567888888899999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHH
Q 013927 271 ---------------------------------------THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311 (434)
Q Consensus 271 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~el 311 (434)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001234699999999999988999999999999999999
Q ss_pred HhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCC---CHhHHHHH
Q 013927 312 ITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRP---KMSQVVIL 382 (434)
Q Consensus 312 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---s~~evl~~ 382 (434)
++|+.||............... .. ....+. .... ...+.+++.+|+ .+|.+|+ ++.+++..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~-~~---~~~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINW-ET---TLHIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhcc-Cc---cccCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999764432211110000 00 000000 0111 234455666665 5999999 78888644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.93 Aligned_cols=247 Identities=31% Similarity=0.431 Sum_probs=200.2
Q ss_pred CeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
+.||+|+||.||+|.... +..||+|.+...........+..|+.++..++|+||+++++++. ...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998763 78899999987655444567899999999999999999999744 368899999999
Q ss_pred CCHHHHhccC--------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 197 GSLASILHGS--------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 197 gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
++|.+++... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865 4778999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
...........++..|+|||.+....++.++|||||||++|+|++ |..||........... +.. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-----------~~~-~~~ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-----------LRK-GYR 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----------HHc-CCC
Confidence 322222334557889999999988889999999999999999999 6999976533221110 000 001
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
...+......+..++.+||+.+|.+||++.+++..|+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111222457888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.24 Aligned_cols=243 Identities=26% Similarity=0.280 Sum_probs=190.9
Q ss_pred CeecccCcEEEEEEEe----CCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 123 NLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
+.||+|+||.||++.. .+|+.||+|++...... .....+..|+.++++++||||+++++++. +..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 35889999999764322 22345778999999999999999999743 46889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~ 155 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA 155 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence 9999999863 4568999999999999999999999 999999999999999999999999999987643321 122
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ..... ..+....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i-----------~~~~~--~~p~~~~ 222 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-----------LKAKL--GMPQFLS 222 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH-----------HcCCC--CCCCCCC
Confidence 3457899999999998888999999999999999999999999764332211110 00000 0111123
Q ss_pred HHHHHHHHhhhccCCCCCCCHhH--HHHHhc
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQ--VVILLR 384 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~e--vl~~L~ 384 (434)
..+..++.+||+.+|++||++.+ +.+.+.
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 46778899999999999999766 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.43 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=195.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc--EEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||+|+||.||+|.++ ++. .+|+|.+...........+.+|+.++.++ +||||+++++++. +..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999875 454 46788776544344455788999999999 8999999999744 468999
Q ss_pred EEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 191 FQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986422 357889999999999999999998 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||............+.
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-- 238 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 238 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence 999999986432110 0111223567999999988889999999999999999998 9999975433221110000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
......+......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 239 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 239 ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000011112345778999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=309.67 Aligned_cols=243 Identities=26% Similarity=0.322 Sum_probs=188.3
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||+|+||+||++... +|+.||||.+...... .....+..|+.+++.++||||+++.++.. +..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 7899999998754322 22345778999999999999999988643 368899999999999
Q ss_pred HHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 200 ASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 200 ~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
..++.. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 987743 34568899999999999999999999 9999999999999999999999999999976543321 123
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......... .++.....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~--~~~~~~~~ 226 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-------LKQRILNDSV--TYPDKFSP 226 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-------HHHhhcccCC--CCcccCCH
Confidence 45689999999999999999999999999999999999999975322110000 0000111100 11122335
Q ss_pred HHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 357 RAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
.+.+++.+||+.+|++|| ++.+++.
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 677889999999999999 5556653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.88 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=189.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||++... +++.||||.... ..+.+|+.++++++||||+++++++ ....++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 57999999999999999999876 789999996532 2467899999999999999999964 3467899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. ++|..++.. ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 165 ~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NAN 238 (391)
T ss_pred CC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccc
Confidence 86 678888763 3568899999999999999999999 89999999999999999999999999999753222 112
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccc----------hhhhhhc----ccc----Cc
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQ----------SVVIWAK----PLL----DS 335 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~----------~~~~~~~----~~~----~~ 335 (434)
......||+.|+|||++.+..++.++|||||||++|||++|+.||-.... ...+... |.. ..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345799999999999988999999999999999999999987643110 0000000 000 00
Q ss_pred ccccccc---------CCcCCCCC--CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDIRELV---------DPSLGDNY--DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.... .+...... .......+..++.+||+.||.+|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 0122356788999999999999999999974
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=331.58 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=187.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------C-
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------D- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~- 185 (434)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||++++++.. .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 357999999999999999999875 689999998865321 2456999999999999999977521 1
Q ss_pred -CcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEecc
Q 013927 186 -GIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDF 260 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DF 260 (434)
.+++||||+++ +|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 25689999985 66665532 35678899999999999999999999 9999999999999999665 7999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhh---h---hhcccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---I---WAKPLL 333 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~---~~~~~~ 333 (434)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+...... + ...|..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998664332 12235689999999998764 689999999999999999999999976432211 1 000100
Q ss_pred C-----ccccccc-----cCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 334 D-----SNDIREL-----VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 334 ~-----~~~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
. ......+ ....+...++......+.+++.+||..+|.+|||+.|++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0000000 000011111112235688899999999999999999997
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=302.80 Aligned_cols=246 Identities=29% Similarity=0.415 Sum_probs=199.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
++|.+.+.||.|+||.||+|... |+.||||.+..... ....+.+|+.+++.++|+||++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46888899999999999999876 78999999976543 455789999999999999999999974 45789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997543 368999999999999999999998 9999999999999999999999999999986633211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
...++..|+|||++..+.++.++||||||+++|+|++ |..||........... +........+.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~ 222 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH------------VEKGYRMEAPE 222 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH------------HhcCCCCCCcc
Confidence 2234667999999988889999999999999999997 9999875432211100 00000011111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
.....+.+++.+||..+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=302.45 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=203.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++++++|+|+++++++.. +..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 889999998864222 233457889999999999999999999643 4688999
Q ss_pred EEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+++|+|.+++.. ....+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 34557899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ .+. .....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~----~~~~~ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIE----KCDYP 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh------hhh----cCCCC
Confidence 321 122345788999999998888999999999999999999999998653321111100 000 00001
Q ss_pred CCC-HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 349 NYD-AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 349 ~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
..+ ......+.+++.+||..+|.+||++.+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 123456788999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.77 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=187.0
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhh-CCCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAY-VDHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
+.||+|+||+||+|... +++.||||++..... ......+..|..++.. ++||||++++++.. +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 678999999976422 2233456678888876 48999999999743 468899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC 154 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence 999999864 3568889999999999999999999 99999999999999999999999999998753221 11233
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ . ...+.. +.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i-~--------~~~~~~----~~~~~~ 221 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI-R--------MDNPCY----PRWLTR 221 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH-H--------hCCCCC----CccCCH
Confidence 456899999999999888999999999999999999999999764432211100 0 000111 111224
Q ss_pred HHHHHHHhhhccCCCCCCCHh-HHH
Q 013927 357 RAVLTASLCIEQSPILRPKMS-QVV 380 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~-evl 380 (434)
.+.+++.+||+.+|.+||++. ++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH
Confidence 567889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=307.26 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=188.6
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||+|+||.||++..+ +|+.||+|++...... .....+..|++++++++||||++++++.. ...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 6899999998653221 12234567999999999999999998743 368899999999999
Q ss_pred HHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecc
Q 013927 200 ASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278 (434)
Q Consensus 200 ~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 278 (434)
.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 988754 33468899999999999999999998 999999999999999999999999999997654321 22335
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRA 358 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 358 (434)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........... ............. .......+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~ 226 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-------LKRRTLEDEVKFE-HQNFTEES 226 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH-------HHHHhhccccccc-cccCCHHH
Confidence 689999999999988899999999999999999999999975322111000 0000010000000 01123457
Q ss_pred HHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 359 VLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 359 ~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
.+++..||+.+|++||++.|+++.+
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhh
Confidence 8899999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=303.07 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=196.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~~lv~e~ 193 (434)
.+|.+.+.||+|+||.||+|... |..||+|.+.... ....+.+|+.++++++|+|+++++++. .+..++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35888899999999999999876 7889999886543 234688999999999999999999863 2358899999
Q ss_pred cCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999987543 358899999999999999999998 899999999999999999999999999987543221
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||............. . .......
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~---------~~~~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---K---------GYKMDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c---------CCCCCCC
Confidence 12234668999999988889999999999999999997 999986533221110000 0 0001111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
......+..++.+||+.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12235677889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.35 Aligned_cols=239 Identities=26% Similarity=0.346 Sum_probs=186.9
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
+.||+|+||.||+|... +|..||||++..... ......+..|..++..+ +||||++++++.. +..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 688999999976432 22334567788887754 8999999999743 468899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||+++..... .....
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS 154 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence 999998864 3568888999999999999999999 99999999999999999999999999998743211 11234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..+.+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-~~~~~--------~~~~~~~----~~~~ 221 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-ESIRV--------DTPHYPR----WITK 221 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHh--------CCCCCCC----CCCH
Confidence 567899999999999989999999999999999999999999764332111 00000 0011111 1224
Q ss_pred HHHHHHHhhhccCCCCCCCHh-HHH
Q 013927 357 RAVLTASLCIEQSPILRPKMS-QVV 380 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~-evl 380 (434)
.+..++.+||+.||.+||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 567789999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=304.46 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=202.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||.|+||.||+|... ++..||||.+..... ......+.+|+.+++.++||||+++++++ .+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 36788899999999999999965 789999998865322 22345788999999999999999999864 34688999
Q ss_pred EEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+++++|.+++.. ....+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 34568899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||............ .+.....+...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~- 229 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEQCDYPPLP- 229 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh------hhhcCCCCCCC-
Confidence 321 122345889999999998888999999999999999999999999653322111111 01111111111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.......+..++.+||+.+|.+||||.+|++.++..
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 --SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112345678889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=308.75 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=196.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
.+|.....||+|+||.||++... ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++. +..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35777889999999999999632 35689999876543 344557999999999999999999999744 4688
Q ss_pred EEEEEcCCCCHHHHhccCC--------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 189 LVFQLSPLGSLASILHGSK--------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence 9999999999999986432 347889999999999999999998 99999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhcccc
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLL 333 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 333 (434)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||..............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ- 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc-
Confidence 99999999975543211111122335678999999998889999999999999999998 8999865433221111000
Q ss_pred CccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
... ...+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 240 -------~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 -------GRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -------Ccc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000 00111223457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=303.27 Aligned_cols=248 Identities=30% Similarity=0.406 Sum_probs=196.5
Q ss_pred CeecccCcEEEEEEEeCC--C--cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLRD--G--TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~g 197 (434)
+.||+|++|.||+|.+.+ + ..||||.+...........+.+|+.++++++||||+++++... ...++|+||+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 368999999999998642 3 3699999987665445567999999999999999999999643 5788999999999
Q ss_pred CHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc-e
Q 013927 198 SLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN-V 275 (434)
Q Consensus 198 sL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~ 275 (434)
+|.+++.... ..+++.....++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++..+........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999997654 578999999999999999999998 8999999999999999999999999999987654322111 1
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.............. .. .. ...+...
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~~--~~-------~~~~~~~ 226 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--EG--ER-------LERPEAC 226 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--cC--Cc-------CCCCccC
Confidence 23446788999999988889999999999999999998 9999965433221100000 00 00 0011122
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
...+..++.+||+.+|++||++.+|++.|.
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.56 Aligned_cols=257 Identities=23% Similarity=0.274 Sum_probs=193.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------C
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------D 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~ 185 (434)
.++|.+.+.||+|+||.||++... +|..||||++..... ......+.+|+.+++.++||||++++++.. .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467999999999999999999875 689999999975432 233456889999999999999999999742 1
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++||||+.+ +|...+. ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 36899999985 5666553 347788888999999999999999 9999999999999999999999999999975
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---h--------------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---W-------------- 328 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~-------------- 328 (434)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... .
T Consensus 173 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 4322 1223456899999999999989999999999999999999999999754321100 0
Q ss_pred ---------hccccCccccccccCCcC-C--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 329 ---------AKPLLDSNDIRELVDPSL-G--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 329 ---------~~~~~~~~~~~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+........++..... . ..........+.+++.+||+.||++|||+.|++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000000000 0 00011123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=313.83 Aligned_cols=236 Identities=25% Similarity=0.293 Sum_probs=183.8
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHH-HHhhCCCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIG-IIAYVDHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
++||+|+||+||+|... +|+.||||++...... .....+..|.. +++.++||||+++++.+ .+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 7899999999754221 12234555554 56789999999999864 3468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS 154 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence 999998864 4568888899999999999999998 99999999999999999999999999998753221 12234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|..||.......... .+..... ........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-----------~i~~~~~--~~~~~~~~ 221 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD-----------NILNKPL--RLKPNISV 221 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH-----------HHHcCCC--CCCCCCCH
Confidence 4578999999999999899999999999999999999999997643221110 0000000 00111234
Q ss_pred HHHHHHHhhhccCCCCCCCHh
Q 013927 357 RAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
.+.+++.+||+.+|.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 677889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=301.90 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=200.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~ 195 (434)
+.|.+.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.++++++|+||++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 4688899999999999999997777889999887542 23457889999999999999999999743 46789999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++..+..... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cc
Confidence 99999999753 4567888999999999999999998 8999999999999999999999999999976543211 11
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++..+.++.++|+|||||++|++++ |+.||............ ...........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~ 227 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL------------ERGYRMPRPEN 227 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------------hCCCCCCCccc
Confidence 122335678999999988889999999999999999999 89999764332111100 00000011112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+..++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 33567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.32 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=200.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CC
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DG 186 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~ 186 (434)
+|.+.+.||+|+||.||+|... .+..||+|.+...........+.+|+.+++++ +||||+++++++. +.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 5888999999999999999742 12369999887654444556789999999999 7999999999744 36
Q ss_pred cEEEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 187 IHLVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
.++++||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+|||++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcC
Confidence 88999999999999998642 2347888999999999999999998 99999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhc
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 330 (434)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 248 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 248 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence 99999999999976543221111222334567999999998899999999999999999998 8888876432211100
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
+........+......+..++.+||+.+|++||++.+++..|+.+....
T Consensus 249 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 249 -----------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -----------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 0000011111223356788999999999999999999999998776443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=304.17 Aligned_cols=250 Identities=28% Similarity=0.355 Sum_probs=190.9
Q ss_pred CeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCcEEEEEEcC
Q 013927 123 NLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGIHLVFQLSP 195 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~~lv~e~~~ 195 (434)
+.||+|+||.||+|... ++..||||.+...........+.+|+.+++.++||||+++++++ ....++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 24579999886543334456788999999999999999999963 224789999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc--c
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH--H 273 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~ 273 (434)
+|+|.+++.......++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997655667888889999999999999998 89999999999999999999999999999755322110 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhC-CCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG-RRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||.+.+..++.++|||||||++|||++| ..||......... .. .. .. ..+ ..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~-~~-~~-----~~~----~~~~ 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT-VY-LL-QG-----RRL----LQPE 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH-Hh-cC-----CCC----CCCC
Confidence 11123356789999999888899999999999999999995 5556543221111 00 00 00 000 0011
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.....+.+++..||+.+|++||++.+|+..|+...
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 12346788999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.37 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=211.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+.....+||.|-||.||.|.|+ -.-.||||.++.+.. ...+|+.|..+|+.++|||+|+++|+|. ..+|+|+|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3455678999999999999987 456799999986653 3557999999999999999999999864 3799999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
.+|.|.++|... +..+.-...+.+|.||+.|+.||.. +++|||||.+.|+||.++..||++||||++.+.......
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 999999999864 4556777788999999999999998 999999999999999999999999999999876542211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.. ...-...|.|||.+....++.|+|||+|||+||||.| |..||.+++.+.+ ..++....+.+-+.
T Consensus 423 HA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV------------Y~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 423 HA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------YGLLEKGYRMDGPE 489 (1157)
T ss_pred cc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH------------HHHHhccccccCCC
Confidence 11 1112567999999999999999999999999999997 8889887665443 23444555555555
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
-+...+++|+..||+++|.+||++.|+-+.++.+...
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 6677899999999999999999999999999887543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=313.33 Aligned_cols=240 Identities=26% Similarity=0.359 Sum_probs=189.6
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
+.||+|+||+||+|... +++.||||++.+... ......+..|..++..+ +||||++++++. .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 688999999986422 22344577888898888 699999999974 3468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTS 154 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCccc
Confidence 999988864 3568999999999999999999998 99999999999999999999999999998643221 11223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... . +..... .++.....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-~----------i~~~~~--~~~~~~~~ 221 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-S----------ILEDEV--RYPRWLSK 221 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-H----------HHcCCC--CCCCcCCH
Confidence 4568999999999999999999999999999999999999997643221110 0 000000 01112235
Q ss_pred HHHHHHHhhhccCCCCCCCH-----hHHHH
Q 013927 357 RAVLTASLCIEQSPILRPKM-----SQVVI 381 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~-----~evl~ 381 (434)
.+.+++.+||+.+|++||++ .+++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 67889999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.08 Aligned_cols=242 Identities=30% Similarity=0.430 Sum_probs=200.5
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
|.-++.||.|+||.||-+.+. +.+.||||++...... +.-++++.|+..|.+++|||+|.+-||+. ...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555667999999999999866 7899999999876543 44568999999999999999999999854 368899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|- ||-.+++.-.+.++-...+..|+.+.+.||.|||+ .+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 96 68888887778889999999999999999999999 99999999999999999999999999999765443
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
..++|||.|||||++. .|.|+-++|||||||+..||.-.++|+-..+.....+-. ..++...+-
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtLq-------- 246 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQ-------- 246 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCCC--------
Confidence 4678999999999985 477999999999999999999999998665543332211 111111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+-.+.+..++..||+.-|.+|||..+++.
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2345577889999999999999999998863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=304.10 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=184.6
Q ss_pred eecccCcEEEEEEEeCC---CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCC
Q 013927 124 LIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGS 198 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gs 198 (434)
.||+|+||.||+|...+ ...+|+|.+...........+.+|+.+++.++||||+++++.+. +..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997542 45788998765544444557889999999999999999999744 46899999999999
Q ss_pred HHHHhccCC----CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 199 LASILHGSK----DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 199 L~~~l~~~~----~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
|.+++.... ...++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999986532 234677888999999999999999 8999999999999999999999999999875433211111
Q ss_pred eeccccccccccCCcccc-------CCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcC
Q 013927 275 VSKFEGTFGYFAPEYFMH-------GIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||.............. .....+..+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence 123345678999998743 346789999999999999999 7788865433221111000 00011111222
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
. ......+..++..|| .+|++||++.+|++.|.
T Consensus 236 ~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 D----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 122345566778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.82 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=198.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|.+.+.||.|+||.||++... +++.||+|.+...........+..|+.+++.++|+||+++++... +..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999876 789999999875544444567888999999999999999998743 4688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.+++... ...++......++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988643 3457889999999999999999998 9999999999999999999999999999976543211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||............. .+... ..+..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~---------~~~~~ 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC---QGSYK---------PLPSH 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh---cCCCC---------CCCcc
Confidence 1234568899999999988889999999999999999999999997643322111110 00000 01111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....+.+++.+||+.+|++||++.+|+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22457788999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=306.23 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=195.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS-------- 184 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-------- 184 (434)
+++.|.+.+.||+|+||.||+|... +++.||+|.+..... ....+..|+.++.++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999876 688999999875432 234678899999998 6999999999642
Q ss_pred CCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
+..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||+|+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 2478999999999999998763 3568899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
....... .......|+..|+|||++. +..++.++|||||||++|||++|..||............+. ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~ 233 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPA 233 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCC
Confidence 7654321 1223456899999999986 33588899999999999999999999975443222211100 000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... .......+.+++.+||..+|.+||++.+|+.
T Consensus 234 ~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0111 1112346788999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=304.85 Aligned_cols=247 Identities=30% Similarity=0.441 Sum_probs=193.4
Q ss_pred CeecccCcEEEEEEEeCC-------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD-------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+.||+|+||.||+|...+ ++.||||.+...........+.+|+.+++.++||||+++++++. +..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 36799998876544445567899999999999999999999743 468999999
Q ss_pred cCCCCHHHHhccC------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-----CeEEecccc
Q 013927 194 SPLGSLASILHGS------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-----EPQICDFGL 262 (434)
Q Consensus 194 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-----~~kL~DFGl 262 (434)
+++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 2347889999999999999999998 8999999999999999887 899999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIREL 341 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 341 (434)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~------------ 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH------------ 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH------------
Confidence 976543322222223345778999999999999999999999999999998 9999865432211100
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 342 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+........+......+.+++.+||..+|.+||++.+|++.|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000001111223356788999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=323.64 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=206.5
Q ss_pred CCCCeecccCcEEEEEEEeC--CCc--EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEc
Q 013927 120 SSENLIGKGGYAEVYKGCLR--DGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLS 194 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~ 194 (434)
.+.++||+|.||.|++|.|. +|+ .||||.+..+.......+|++|+.+|.+|+|||++++||+.. ....+|+|++
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELa 192 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELA 192 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhc
Confidence 34478999999999999976 344 689999987766556778999999999999999999999866 4788999999
Q ss_pred CCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.+.|+. .+..+-......+|.|||.||.||.+ +++|||||...|+|+.....|||+||||.+-+.......
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999987 45667788888999999999999999 999999999999999999999999999999887654443
Q ss_pred cee-ccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 274 NVS-KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 274 ~~~-~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.+. ...-.+.|+|||.+.+..++.++|||+|||++|||+| |..||-+...... -+.+|..-+...+
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI------------L~~iD~~erLpRP 337 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI------------LKNIDAGERLPRP 337 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH------------HHhccccccCCCC
Confidence 332 1223567999999999999999999999999999998 7789977554322 2334433333445
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.+.+++++..||..+|++||++..|.+
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 667789999999999999999999999973
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=313.60 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=186.2
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
++||+|+||+||+|... +++.||||++.+... ......+..|+.++.++ +||||+.++++.. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 678999999986532 23344678899999888 6999999999743 468899999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS 154 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence 999988863 3568999999999999999999999 99999999999999999999999999998743221 12234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.........-.. ......+..... ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~--~~p~~~~~ 228 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE----DYLFQVILEKPI--RIPRFLSV 228 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH----HHHHHHHHhCCC--CCCCCCCH
Confidence 567999999999999999999999999999999999999999642211000000 000000000000 11112224
Q ss_pred HHHHHHHhhhccCCCCCCCHh
Q 013927 357 RAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
.+..++.+||+.||++||++.
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCC
Confidence 567889999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=301.20 Aligned_cols=252 Identities=28% Similarity=0.368 Sum_probs=201.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
.++|.+.+.||+|+||.||+|..++++.||||.+..... ....+.+|+.++++++|+||++++++.. ...++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357889999999999999999988788999999876443 2346889999999999999999999744 468999999
Q ss_pred cCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++++|.+++.... ..+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999997543 568999999999999999999998 8999999999999999999999999999986643211
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||............ .... ....+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~--------~~~~----~~~~~ 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--------ERGY----RMPRP 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------HcCC----CCCCC
Confidence 11112234568999999998889999999999999999998 99999654322111110 0000 00111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=306.05 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=189.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhC---CCCCeeeEeeecc-------C
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYV---DHPNTAKLVGCDS-------D 185 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~g~~~-------~ 185 (434)
+|.+.+.||+|+||+||+|... +|+.||+|.+....... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999876 78999999987543221 222456677777665 7999999998643 2
Q ss_pred CcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..+++|||+. ++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 3689999998 4788887653 3458999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---ccccC--cc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPLLD--SN 336 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~~~--~~ 336 (434)
...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......... .. .+... ..
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 664321 123346789999999999888999999999999999999999999654322110 00 00000 00
Q ss_pred cc---ccccCCcCC---CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 DI---RELVDPSLG---DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 ~~---~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .....+... ....+.....+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000 0001122356778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=319.43 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=193.4
Q ss_pred HHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CC
Q 013927 112 LQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG 186 (434)
Q Consensus 112 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~ 186 (434)
+....++|.+.+.||+|+||.||++... +++.||+|++.+... ......+.+|+.+++.++||||++++++.. +.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3344578999999999999999999977 688999999865321 122345778999999999999999998744 35
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+++|+|.+++.. ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 8899999999999999864 357888888899999999999999 99999999999999999999999999999866
Q ss_pred CCCCcccceeccccccccccCCccccC----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .... ....
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~-~~~~----- 264 (371)
T cd05622 193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SKIM-NHKN----- 264 (371)
T ss_pred CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-HHHH-cCCC-----
Confidence 43211 112345699999999998653 3789999999999999999999999764332111 0000 0000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHHHh
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVILL 383 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~L 383 (434)
.+...........+..++..||...+.+ ||++.+|++..
T Consensus 265 --~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 265 --SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000001122345677889999843432 67888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=308.39 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=200.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||++... +|+.||+|++...........+.+|+.+++.++||||+++++++. +..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35777789999999999999866 688999999876554445567899999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ...+++..+..++.+++.||.|||+ ..+++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999998864 3568899999999999999999996 2589999999999999999999999999986543221
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....|+..|+|||++.++.++.++|||||||++|+|++|+.||............+......+..+............
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 1235689999999999888899999999999999999999999975432110000000000000111111000000111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
....+.+++.+||+.+|++||++.||++..-
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 3356788999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=312.65 Aligned_cols=240 Identities=23% Similarity=0.272 Sum_probs=184.5
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHH-HHhhCCCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIG-IIAYVDHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
+.||+|+||+||+|... +++.||+|++...... .....+..|.. +++.++||||++++++. .+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 6789999999753221 12223444444 56789999999999874 4468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|.+++.. ...+.......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~ 154 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS 154 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence 999999874 3456777888899999999999999 99999999999999999999999999998753221 11234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........... +..... ........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----------i~~~~~--~~~~~~~~ 221 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-----------ILNKPL--QLKPNITN 221 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH-----------HHhCCc--CCCCCCCH
Confidence 56799999999999998999999999999999999999999976433221100 000000 01112234
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+..++.+||+.+|.+||++.+.+.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 6778889999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=319.21 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=192.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-------CcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------GIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~~ 188 (434)
+|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||++++++..+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 789999999865322 2233468899999999999999999997432 478
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+|+||+. ++|...+. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 57777775 34568899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-ccccCcccccc------
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-KPLLDSNDIRE------ 340 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~------ 340 (434)
.. ........++..|+|||++.+. .++.++|||||||++|||++|+.||.........-. ...........
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 21 1122334578999999998764 478999999999999999999999976432211100 00000000000
Q ss_pred -----ccC-----CcCC--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 341 -----LVD-----PSLG--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 341 -----~~d-----~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+.. +... ..........+.+++.+||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 0000 00111223567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.40 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=197.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
+|.+.+.||+|+||.||++... ++..+|+|.+...........+.+|+.++.+++||||+++++++ .+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 6888899999999999999876 68899999987654444455788999999999999999999974 45789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 999999999743 567889999999999999999997 258999999999999999999999999998755332 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--hhccc--cCcc-c------------
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--WAKPL--LDSN-D------------ 337 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~~~~~--~~~~-~------------ 337 (434)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... +.... .... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23456889999999998888999999999999999999999998643321111 10000 0000 0
Q ss_pred ----cccccCCcC---CCCCC-HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 338 ----IRELVDPSL---GDNYD-AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 338 ----~~~~~d~~l---~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+..+... ....+ ......+..++.+||..+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000 0123457889999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.62 Aligned_cols=246 Identities=30% Similarity=0.416 Sum_probs=199.5
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|.+.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++|+||++++++.. ...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5778889999999999999976 689999999876554444557889999999999999999999643 4688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+++.+.... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 999999999643 78999999999999999999998 899999999999999999999999999998765432 12
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ...+.+... ..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~---~~ 223 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK--------NNPPSLEGN---KF 223 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh--------cCCCCCccc---cc
Confidence 2345688899999999988899999999999999999999999976543222111110 011111111 02
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+..++.+||..+|++||++++++.
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 245777889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.35 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=190.5
Q ss_pred CeecccCcEEEEEEEeC-CCc--EEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|... ++. .+|+|.+...........+.+|+.++.++ +||||+++++++. +..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999976 343 57888887544444555788999999999 8999999999744 358899999999
Q ss_pred CCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 197 GSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 197 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
|+|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 247889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccccc
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||............+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~--------- 225 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--------- 225 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---------
Confidence 98632211 01111223567999999988889999999999999999997 999996543221110000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
..............+.+++.+||+.+|.+||++.+++..|+.+.
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00000111122346788999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=312.76 Aligned_cols=254 Identities=20% Similarity=0.203 Sum_probs=192.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||++... +++.||+|++.+... ......+..|..++..++|+||+.++++.. +..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 688999999875321 223345788999999999999999998743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999997655678889999999999999999998 9999999999999999999999999999976643321
Q ss_pred ccceeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||............ ......+ . +.+..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i-~~~~~~~-~-~p~~~ 233 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MNHEERF-Q-FPSHI 233 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH-HcCCCcc-c-CCCcc
Confidence 12234569999999999875 46788999999999999999999999764332211100 0000000 0 00000
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVIL 382 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~ 382 (434)
......+.+++.+|+...+.+ |+++.++++.
T Consensus 234 -----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 -----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 112346677888888865544 4577777643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=298.49 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=200.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++. ...++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 46888899999999999999987 488999999875432 557999999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 99999999997667788999999999999999999998 8999999999999999999999999999987654321
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.............. ...+. ...+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~--~~~~~~ 224 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------KPPPT--LSDPEK 224 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------CCCCC--CCchhh
Confidence 22334578899999999888899999999999999999999999976433221111000 00000 011112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2356788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=309.19 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=195.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||++++++.. +..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999876 688999999876544334446788999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. ++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence 98 58988887666678899999999999999999998 999999999999999999999999999997543221 1
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhcccc-------Cccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPLL-------DSNDIR 339 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~~-------~~~~~~ 339 (434)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||......... ...+.. ......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12234568899999988654 4788999999999999999999999754321110 000000 000000
Q ss_pred cccCCcCCCC----CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGDN----YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..-.+..... ........+.+++.+||+.||.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000110000 00112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.93 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=198.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
.+|.+.+.||.|+||.||+|.+.++..+|+|.+...... ...+..|+.++++++|||+++++++.. ...++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 357778899999999999998877889999988754432 346889999999999999999999743 3688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.+++|.+++......+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 9999999997656678899999999999999999998 89999999999999999999999999998755332111 1
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++.++.++.++||||||+++|||++ |..||............. .+ .....+. .
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~--~~~~~~~-------~ 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN---AG--FRLYKPR-------L 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh---CC--CCCCCCC-------C
Confidence 112234678999999988889999999999999999998 999987533222111100 00 0001111 1
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
....+.+++.+||+.+|++||++.+|++.|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=312.01 Aligned_cols=239 Identities=25% Similarity=0.275 Sum_probs=185.1
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHH-HHhhCCCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIG-IIAYVDHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
+.||+|+||+||+|... +|+.||||++.+... ......+..|.. +++.++||||+++++.+ .+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999876 789999999975422 122234555654 46779999999999864 3478999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT 154 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence 99998886 34568899999999999999999998 99999999999999999999999999998753221 11223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|..||........... +....+ ...+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-----------~~~~~~--~~~~~~~~ 221 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN-----------ILHKPL--VLRPGASL 221 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH-----------HHcCCc--cCCCCCCH
Confidence 45789999999999999999999999999999999999999976432221100 000000 00111234
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHH
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.+..++.+||+.+|.+||++.+.+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCH
Confidence 567789999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.23 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=196.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++.+ .+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 46899999999999999999975 788999999875432 2334578899999999999999999964 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 999999998863 4567899999999999999999998 8999999999999999999999999999986543211
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||............ ... .+..+....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~~---~~~~~~~~~-- 233 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SKS---NFQPPKLKD-- 233 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ecC---CCCCCCCcc--
Confidence 122346889999999874 345788999999999999999999998654322111000 000 000111110
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
.......+.+++.+||+.+|++||++.+|++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111235678899999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.97 Aligned_cols=250 Identities=21% Similarity=0.327 Sum_probs=202.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCC-CCCeeeEeee--ccCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVD-HPNTAKLVGC--DSDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~--~~~~~~lv~e 192 (434)
..|+++++||+||.+.||++...+.+.||+|++.....+ .....|.+|+..|.+|. |.+||+++++ .++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458889999999999999999988888999887654443 44568999999999995 9999999997 4456889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|-+ -+|..+|......+....+..+..|++.++.++|. .||||.||||.|+|+-. |.+||+|||+|..+....+.
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 865 48999998765555533777889999999999999 99999999999999975 58999999999999888777
Q ss_pred cceeccccccccccCCccccCC-----------CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccc
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI-----------VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 341 (434)
......+||+.||+||.+.... .+.++||||||||||+|+.|+.||........ .+..+
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a----------Kl~aI 585 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA----------KLHAI 585 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH----------HHHhh
Confidence 6667788999999999986433 45789999999999999999999987653321 22344
Q ss_pred cCCcCCCCCCH-HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 VDPSLGDNYDA-EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 ~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+|.....++. ....+++.++..||+.||++||++.++++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 55543333321 11233889999999999999999999985
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.49 Aligned_cols=201 Identities=27% Similarity=0.373 Sum_probs=170.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|...+.||+|+||.||++... +++.||||++..... ......+..|+.++..++||||+++++... +..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6888899999999999999876 689999999975321 233446788999999999999999998744 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999864 4568888999999999999999999 99999999999999999999999999998754321000
Q ss_pred ---------------------------------cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccc
Q 013927 273 ---------------------------------HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319 (434)
Q Consensus 273 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 319 (434)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113469999999999999999999999999999999999999997
Q ss_pred ccc
Q 013927 320 HLQ 322 (434)
Q Consensus 320 ~~~ 322 (434)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=302.35 Aligned_cols=249 Identities=25% Similarity=0.300 Sum_probs=201.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
.|++.+.||.|.-|+||++..+ ++..+|+|++.+.... ....+...|-+||+.++||.+..+|+..+ +..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4666788999999999999987 5689999999886543 33456788999999999999999999643 46889999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC---
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR--- 268 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~--- 268 (434)
||+||+|..+++.+ ...+++..+..+|..++-||+|||. .|||+|||||+||||-++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999999999864 5568888888899999999999998 9999999999999999999999999999754311
Q ss_pred ------------------------------CCcc---------------------cceeccccccccccCCccccCCCCC
Q 013927 269 ------------------------------QWTH---------------------HNVSKFEGTFGYFAPEYFMHGIVDE 297 (434)
Q Consensus 269 ------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 297 (434)
.... .....++||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0000 0012367999999999999999999
Q ss_pred cCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC--
Q 013927 298 KTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPK-- 375 (434)
Q Consensus 298 ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-- 375 (434)
++|+|+|||++|||+.|..||.+...... +..++...+.....+.....+.+||.+.|.+||.+|..
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T-----------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET-----------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh-----------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence 99999999999999999999988554322 22333333332223345567888999999999999998
Q ss_pred --HhHHH
Q 013927 376 --MSQVV 380 (434)
Q Consensus 376 --~~evl 380 (434)
+.||-
T Consensus 384 rGA~eIK 390 (459)
T KOG0610|consen 384 RGAAEIK 390 (459)
T ss_pred cchHHhh
Confidence 77775
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.66 Aligned_cols=236 Identities=25% Similarity=0.279 Sum_probs=183.1
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHH-HHhhCCCCCeeeEeeec--cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIG-IIAYVDHPNTAKLVGCD--SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~ 196 (434)
++||+|+||.||+|... +|+.||+|++.+.... .....+..|.. +++.++||||+++++++ .+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 6899999999754321 22234555554 57889999999999864 3468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|...+.. ...+....+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS 154 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence 999988863 4567788888899999999999998 89999999999999999999999999998753221 12234
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|..||.......... .+..... ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------~i~~~~~--~~~~~~~~ 221 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-----------NILHKPL--QLPGGKTV 221 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-----------HHhcCCC--CCCCCCCH
Confidence 4578999999999998889999999999999999999999997643221110 0000000 11122234
Q ss_pred HHHHHHHhhhccCCCCCCCHh
Q 013927 357 RAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
.+..++.+||+.+|.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 677899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=317.38 Aligned_cols=258 Identities=21% Similarity=0.247 Sum_probs=194.3
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------- 184 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------- 184 (434)
..++|.+.+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999865 688999999976433 233456788999999999999999999632
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 236899999975 5666664 347888889999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhc--------
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAK-------- 330 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~-------- 330 (434)
..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+....... ...
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65432 1223456899999999999888999999999999999999999999753321110 000
Q ss_pred ------------cccCcccccccc-CCcCC--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 331 ------------PLLDSNDIRELV-DPSLG--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 331 ------------~~~~~~~~~~~~-d~~l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+......+.... +.... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00000 00111123567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.73 Aligned_cols=260 Identities=21% Similarity=0.218 Sum_probs=187.2
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC------CCeeeEeeec
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH------PNTAKLVGCD 183 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~ 183 (434)
++...+++|.+.++||+|+||+||+|... .++.||||++.... .....+..|+.++..++| ++++.+++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 33445678999999999999999999875 68899999986432 222345567777776654 4578887764
Q ss_pred c---CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-------
Q 013927 184 S---DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY------- 253 (434)
Q Consensus 184 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~------- 253 (434)
. ...++||+++ +++|.+++.. ...+++..+..|+.||+.||.|||+ ..+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 3 3578888887 5678887763 3568899999999999999999996 14999999999999998765
Q ss_pred ---------CeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch
Q 013927 254 ---------EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS 324 (434)
Q Consensus 254 ---------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 324 (434)
.+||+|||++..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||+.....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 223467899999999999999999999999999999999999999764432
Q ss_pred hhhh--hccc--cC--------ccccccccCC--cCCCCCC---------------HHHHHHHHHHHHhhhccCCCCCCC
Q 013927 325 VVIW--AKPL--LD--------SNDIRELVDP--SLGDNYD---------------AEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 325 ~~~~--~~~~--~~--------~~~~~~~~d~--~l~~~~~---------------~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.... .... +. ......+++. .+..... ......+.+|+..||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1110 0000 00 0000000000 0000000 011245678999999999999999
Q ss_pred HhHHHH
Q 013927 376 MSQVVI 381 (434)
Q Consensus 376 ~~evl~ 381 (434)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=313.99 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=191.6
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------- 184 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------- 184 (434)
..++|.+.+.||.|+||.||+|... +++.||||++...... .....+.+|+.++++++||||++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467999999999999999999865 7889999998764322 23345778999999999999999998642
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
...+++++++ +++|..++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 2367888887 678988875 3468899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--hh----ccc-----
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--WA----KPL----- 332 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~~----~~~----- 332 (434)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +. .+.
T Consensus 167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 65432 234568999999999876 46889999999999999999999999653321110 00 000
Q ss_pred -cCccccccccCCcCCCCCCH--------HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 -LDSNDIRELVDPSLGDNYDA--------EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 -~~~~~~~~~~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........... .+. ..+. .....+.+++.+||+.||.+|||+.|++.
T Consensus 242 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 242 KISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000 0000 01234678999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.66 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=200.0
Q ss_pred cCHHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec-
Q 013927 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD- 183 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~- 183 (434)
.++.++....+.|.+.+.||.|+||.||+|... +++.||+|.+.... .....+..|+.+++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 455666667788999999999999999999975 68899999986543 2334578899999998 799999999974
Q ss_pred -------cCCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 184 -------SDGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 184 -------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
.+..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence 23578999999999999998653 3457888889999999999999999 899999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~ 330 (434)
+|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||++|..||....+.......
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 9999999875532211 123356889999999875 345788999999999999999999999764332221110
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+... .......+.+++.+||..+|.+||++.||+.
T Consensus 239 --------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 --------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011110 0112346788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=316.16 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=194.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------C
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------D 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~ 185 (434)
.++|.+.+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||++++++.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999876 688999999976432 233456888999999999999999998632 1
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 36899999975 6766664 347888889999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh-------------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA------------- 329 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~------------- 329 (434)
.... .......||..|+|||++.+..++.++|||||||++|+|++|+.||......... ..
T Consensus 176 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 5432 1223456899999999999989999999999999999999999999753321110 00
Q ss_pred ----------ccccCccccccccCCcC-C--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 330 ----------KPLLDSNDIRELVDPSL-G--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 330 ----------~~~~~~~~~~~~~d~~l-~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.+.........+..... . ..........+.+++.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000000 0 00011123467889999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=297.11 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=196.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--------hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCC
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--------EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDG 186 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~ 186 (434)
+|.+...||.|+||.||+|... +++.||+|.+...... .....+.+|+.++++++||||++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3778889999999999999865 6889999988754322 1224678899999999999999999974 447
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++++||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 8899999999999999964 3567888899999999999999998 89999999999999999999999999999866
Q ss_pred CCCCcc----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 267 PRQWTH----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 267 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........+... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~ 228 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENA 228 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccC
Confidence 422111 1112345788999999999888999999999999999999999999764432222110 0011
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+.+ +......+..++.+||+.+|.+||++.+|++
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 1223356778899999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=304.39 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=197.0
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
|...+.||.|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++. +..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455577999999999999865 678999999876554455567899999999999999999999743 46899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|.+++.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 9999999853 568889999999999999999998 999999999999999999999999999997654321 112
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
....|+..|+|||++.+..++.++|||||||++|||++|+.||............ .....+.+ .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~----~~~~~ 226 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI--------PKNSPPTL----EGQYS 226 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh--------hcCCCCCC----CcccC
Confidence 2345788999999999888999999999999999999999998754332211110 00011111 12233
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+.+++.+||+.+|++||++.+|++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 567889999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.84 Aligned_cols=254 Identities=21% Similarity=0.196 Sum_probs=190.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.++||+|+||.||++..+ +++.||+|++.+... ......+..|+.++..++|+||++++++.. +..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999976 678899999864321 122345788999999999999999998743 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999997656678999999999999999999999 9999999999999999999999999999875433211
Q ss_pred ccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 272 HHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.............. .. ....-+..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--~~--~~~~~p~~ 232 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--HK--ERFQFPAQ 232 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC--CC--ccccCCCc
Confidence 1223356899999999986 34588999999999999999999999976433221111000 00 00000000
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCC--CCCCHhHHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPI--LRPKMSQVVIL 382 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~--~RPs~~evl~~ 382 (434)
. ......+.+++.+|+..+++ .||++.++++.
T Consensus 233 ~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 V----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 11234566677777755444 36888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.11 Aligned_cols=254 Identities=21% Similarity=0.234 Sum_probs=189.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||++... +++.||||++.+... ......+..|+.++..++|+||+.+++++. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888999999999999999976 689999999875221 223345888999999999999999998744 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999997555678889999999999999999999 9999999999999999999999999999876543211
Q ss_pred ccceeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... .... .......+ .+ .
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-~~i~-~~~~~~~~-~~-~ 232 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-GKIM-NHKEHFQF-PP-D 232 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-HHHH-cCCCcccC-CC-c
Confidence 11223468999999999863 45788999999999999999999999764322111 0000 00000000 00 0
Q ss_pred CCCCCHHHHHHHHHHHHhhhcc--CCCCCCCHhHHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQ--SPILRPKMSQVVIL 382 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~--~P~~RPs~~evl~~ 382 (434)
.. .....+..++.+||.. ++..||++.+++..
T Consensus 233 ~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01 1223456666776654 33447888888755
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=298.60 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=193.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~ 187 (434)
.+|...+.||+|+||.||+|... ++..||+|++..... ......+.+|+.++++++||||++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999875 689999998865422 123346888999999999999999999743 346
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++++||+++++|.+++... ..+++.....++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++..+.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 7899999999999998643 457888899999999999999998 899999999999999999999999999987553
Q ss_pred CCC-cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQW-THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
... .........++..|+|||++.+..++.++|||||||++|||++|+.||........+..... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~-- 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-------QPTNP-- 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-------CCCCC--
Confidence 211 11112234578999999999888899999999999999999999999976543322211100 00011
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+......+..++ .||..+|++||++.+|+.
T Consensus 229 --~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 --QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11222223445555 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.31 Aligned_cols=254 Identities=29% Similarity=0.364 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||.|+||+||+|... ++..+|+|++...........+.+|+.+++.++|+||+++++.. .+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888999999999999999865 68899999997655444556789999999999999999999863 3468899999
Q ss_pred cCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGS--KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
+++++|.+++... ...+++.....++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999653 2468999999999999999999998 9999999999999999999999999999976654322
Q ss_pred cc--ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 HH--NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.||............... ..+.+..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--------DPPSLET 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--------CCCCcCC
Confidence 21 12334688999999998877 6899999999999999999999999764432211110000 0011111
Q ss_pred CC-CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NY-DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .......+.+++..||+.+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 0123456788999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.90 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=188.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~ 191 (434)
+|+..+.||+|+||.||+|... +|+.||||++.+... ......+..|..++..+. |++|++++++. .+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999999999876 789999999975422 233345778899998886 56777788764 34688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-- 154 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence 99999999998863 3568899999999999999999998 99999999999999999999999999998754322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-----------i~~~~~--~~p 221 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS-----------IMEHNV--SYP 221 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCCC--CCC
Confidence 1122345689999999999988899999999999999999999999976443221110 000000 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
......+..++.+||+.+|.+|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11234667889999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.98 Aligned_cols=245 Identities=27% Similarity=0.420 Sum_probs=196.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee-ccCCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC-DSDGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~-~~~~~~lv~e~~~ 195 (434)
++|.+.+.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++++++|||+++++++ ..+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence 3588889999999999999876 47889999986542 23468899999999999999999996 4457899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+++|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999754 3457899999999999999999998 999999999999999999999999999987543221
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+..|+|||.+.++.++.++|||||||++|+|++ |+.||............ ...........
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~ 221 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV------------EKGYRMEPPEG 221 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------------hCCCCCCCCCc
Confidence 12223567999999988889999999999999999997 99998764332211110 00000011112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+..++.+||+.+|+.||++.+|++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=304.30 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=193.4
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
|...+.||+|+||.||++... +++.||||.+...... .....+..|+.++++++|+||+.+++.+ .+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999876 7899999998754322 2234577899999999999999999864 3468899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988543 3458889999999999999999998 999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ...+... .......
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~--------~~~~~~~-~~~~~~~ 226 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE--------VERLVKE-VQEEYSE 226 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH--------HHhhhhh-hhhhcCc
Confidence 12234689999999999988899999999999999999999999976332111000 0000000 0000111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
.....+.+++..||+.+|++||+ +.|++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12345778899999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=300.26 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=199.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
++|.+...||.|+||.||+|..+ +.+.||+|.+...........+.+|+.++++++|+||+++++++.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999854 2467999988765444345679999999999999999999997544 689
Q ss_pred EEEEEcCCCCHHHHhccCC--------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 189 LVFQLSPLGSLASILHGSK--------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987433 158999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-------- 232 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-------- 232 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--------
Confidence 9987543221 112223346778999999988888999999999999999998 788886543322111100
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
...+...........+..++.+||+.+|.+||++.+++..|.
T Consensus 233 ---~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000111122357888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=304.09 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=197.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
.+|.+.+.||.|+||.||+|... +++.||+|.+....... ...+.+|+.+++.++||||+++++.+ .+..++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46888899999999999999865 78899999987654433 35688999999999999999999864 3478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++....... .
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred cCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999999853 457889999999999999999998 899999999999999999999999999987553321 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||............. .........+..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----------~~~~~~~~~~~~ 241 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------TNGTPELQNPEK 241 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----------cCCCCCCCCccc
Confidence 1233468899999999988889999999999999999999999997643321111000 000000001112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||..+|++||++.+|+.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 2356778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=297.20 Aligned_cols=237 Identities=19% Similarity=0.279 Sum_probs=184.3
Q ss_pred eecccCcEEEEEEEeCC-------------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 124 LIGKGGYAEVYKGCLRD-------------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
.||+|+||.||+|.... ...||+|.+.... ......+..|+.++..++||||+++++++. ...+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 58999999999998532 2358999876543 233446888999999999999999999744 3688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC-------eEEeccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-------PQICDFG 261 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~-------~kL~DFG 261 (434)
+||||+++|+|..++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999999987666678999999999999999999998 99999999999999987664 8999999
Q ss_pred cccccCCCCcccceeccccccccccCCccc-cCCCCCcCcEEehhHHHHHHH-hCCCccccccchhhhhhccccCccccc
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELI-TGRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----------- 220 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----------- 220 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----------
Confidence 98654322 2234788899999887 456899999999999999998 5888876532211110
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
+...... ........+..++.+||+.+|.+||++.+|++.|+
T Consensus 221 -~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 -FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000000 01112346788999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.80 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=200.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
.|...+.||.|+||.||+|... ++..||||.+...........+.+|+.++++++||||+++++++. +..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999876 688999999876554455567899999999999999999999744 4689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++.. ..+++.....++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 99999999863 467888999999999999999998 899999999999999999999999999997654322 11
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
.....++..|+|||++.+..++.++|+|||||++|||++|..||............ ............
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~ 225 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNPPTLTGEF 225 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------------hcCCCCCCchhh
Confidence 22345788999999998888999999999999999999999999754332211111 111111222344
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5678889999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=323.63 Aligned_cols=192 Identities=21% Similarity=0.270 Sum_probs=163.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
...|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|+.++++++|+||+++++++ .+..++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 347999999999999999999976 678999996432 2367899999999999999999974 346789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
++. ++|..++......+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 985 68888886555679999999999999999999998 89999999999999999999999999999865433222
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcc
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~ 318 (434)
.......||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2223456999999999999989999999999999999999988654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.97 Aligned_cols=251 Identities=28% Similarity=0.435 Sum_probs=195.8
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHh-hHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
|++.+.||+|+||+||++... +++.||+|.+.......... ....|+.++++++||||++++++. .+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 56789999998876543332 345699999999999999999974 45688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.+++|.+++. ....+++..+..++.|+++||.+||+ .+|+|+||||+||+++.++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN 154 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred cccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999997 45678999999999999999999999 8999999999999999999999999999975411 1223
Q ss_pred eeccccccccccCCccc-cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||++. +..++.++||||||+++|+|++|..||.................. ....... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~ 228 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR---PLPSSSQ---QSRE 228 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT---HHHHHTT---SHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc---ccccccc---ccch
Confidence 34566899999999998 778999999999999999999999999865211110000000000 0000000 0001
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++..||+.+|++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1267888999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=300.07 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=194.3
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~ 195 (434)
|++.+.||.|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++ .+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 566788999999999999976 57889999886543 33445788999999999999999999864 346889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|..++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 999999887656678999999999999999999999 899999999999999999999999999987553321 122
Q ss_pred eccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 276 SKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....|+..|+|||++. +..++.++|||||||++|+|++|+.||............... ....+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~------- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLAQ------- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc---CCCCCCC-------
Confidence 3456899999999984 345788999999999999999999999764432221111000 0000000
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122467788999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=298.14 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=185.3
Q ss_pred eecccCcEEEEEEEeCCC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCC
Q 013927 124 LIGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGS 198 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gs 198 (434)
.||+|+||.||+|...++ ..+++|.+...........+.+|+.+++.++||||+++++.+. ...++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 3567777765544444567999999999999999999999754 36899999999999
Q ss_pred HHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 199 LASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 199 L~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
|.+++... ....++.....++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998753 2345667778899999999999998 89999999999999999999999999998643221111112
Q ss_pred eccccccccccCCcccc-------CCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 276 SKFEGTFGYFAPEYFMH-------GIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||............ . .+....+.++.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~-~~~~~~~~~~~~~ 235 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--I-KDQQVKLFKPQLE 235 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--H-hhcccccCCCccC
Confidence 34557889999998753 235788999999999999997 56688654332211100 0 1111223334333
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
..++ ..+..++..|| .+|++||++.+|++.|.
T Consensus 236 ~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333 45666778899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=296.03 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=200.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+.++++++||||++++++. .+..+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46888899999999999999875 6788999999765433 456788999999999999999999963 4468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++......++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 99999999997665778999999999999999999998 8999999999999999999999999999876543211
Q ss_pred ceeccccccccccCCccccC---CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFMHG---IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.............. . .+..+.+ ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~---~---~~~~~~~--~~ 228 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK---S---NFPPPKL--KD 228 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c---cCCCccc--cc
Confidence 12334678899999998776 789999999999999999999999976443322111000 0 0000111 11
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+.+++.+||..+|.+||++.+|+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2233456888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.73 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=204.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCC-CCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVD-HPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~lv 190 (434)
..|.+.+.||.|.||.||++..+ +|+.+|+|.+.+..... ....+.+|+.+|+++. |||||.+++.+++ .+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 45888899999999999999977 59999999998765532 3357899999999998 9999999997544 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC----CCeEEecccccccc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED----YEPQICDFGLAKWL 266 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGla~~~ 266 (434)
||++.+|.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999988755 38999999999999999999999 999999999999999643 47999999999987
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.. .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+............ ..+ ..
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~---~~~------~f 257 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR---GDF------DF 257 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc---CCC------CC
Confidence 65 2345678899999999999999999999999999999999999999987553332211000 000 11
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....-......+-+++..|+..||..|+++.++++.
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111112224566778899999999999999999884
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=298.63 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=196.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch---------hhHhhHHHHHHHHhhCCCCCeeeEeeecc--C
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD---------EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D 185 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~ 185 (434)
+|...+.||.|+||.||+|... +|+.||||.+...... .....+..|+.+++.++|||++++++++. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778889999999999999865 6899999988643211 11235778999999999999999999744 4
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 688999999999999999754 568888999999999999999998 8999999999999999999999999999976
Q ss_pred cCCCCcccceeccccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
..............|+..|+|||.+.... ++.++|+||||+++|++++|..||............. .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 234 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---NKRSAPPIP 234 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh---ccccCCcCC
Confidence 54332222233456889999999987654 8899999999999999999999996544332221100 000000111
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..........+..++.+||+.+|..||++.+|++.
T Consensus 235 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 235 ----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111234577888999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=307.06 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=208.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
+-|.+.+.||+|.|+.|-++++- +|..||||++.+...+. ....+.+|+..|+-+.|||||++|.+. +..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34888899999999999999865 89999999998865543 334688999999999999999999974 458999999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~~~~ 271 (434)
+-.+|+|.+++-.....+.+....+++.||+.|+.|+|. ..+|||||||+|+.+-+ -|-|||.|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 999999999998888889999999999999999999998 99999999999998865 478999999999776554
Q ss_pred ccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....+.+|++.|-|||++.+..|+ +++||||||||||.|++|+.||...+.+. .+..++|-.+ -.
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------TLTmImDCKY--tv 238 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------TLTMIMDCKY--TV 238 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------hhhhhhcccc--cC
Confidence 456788999999999999999998 56899999999999999999998654432 2223344332 23
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.-...++.+||..||..||++|.+.++|+.
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4556688999999999999999999999974
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=300.43 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=195.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+.|.+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++ ....++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 46888899999999999999976 58999999987643 33455788899999999999999999963 3468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|..++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... .
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 99999998886656678999999999999999999998 899999999999999999999999999987543221 1
Q ss_pred ceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
......+++.|+|||++. ...++.++|||||||++|+|++|+.||.............. ...+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------~~~~~~-- 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------SEPPTL-- 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--------CCCccC--
Confidence 123345788999999985 34467899999999999999999999975432221111000 000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+......+..++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001122346778899999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=306.89 Aligned_cols=192 Identities=24% Similarity=0.379 Sum_probs=156.4
Q ss_pred CCeecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEEEEc
Q 013927 122 ENLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVFQLS 194 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~e~~ 194 (434)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||++++++.. ...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999864 467899999875432 234778999999999999999998642 2478999998
Q ss_pred CCCCHHHHhccC--------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----cCCCCeEEecccc
Q 013927 195 PLGSLASILHGS--------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL----TEDYEPQICDFGL 262 (434)
Q Consensus 195 ~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGl 262 (434)
. ++|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 7 4777776421 2357888899999999999999998 899999999999999 4567899999999
Q ss_pred ccccCCCCcc-cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 263 AKWLPRQWTH-HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 263 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
++.+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9876433211 122345689999999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.98 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=194.8
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
.+++++.....||+|+||.||+|... ++..||+|.+..... .....+.+|+.++++++|+||+++++++. +..++|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556666678999999999999866 678899998876543 33457889999999999999999999744 468899
Q ss_pred EEEcCCCCHHHHhccCCCCC--CHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccC
Q 013927 191 FQLSPLGSLASILHGSKDKP--DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLP 267 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~ 267 (434)
+||+++++|.+++......+ ++..+..++.|++.||.|||+ ++|+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997544444 788888999999999999998 99999999999999986 6799999999987654
Q ss_pred CCCcccceeccccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchhh-hhhccccCccccccccCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSVV-IWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~ 344 (434)
... .......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||........ .+.....
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF----------- 227 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----------
Confidence 321 1122345789999999986644 78899999999999999999999965432211 1111000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....++......+..++.+||+.+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011112223356788899999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=296.75 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=194.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc----hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~ 187 (434)
.+|.+.++||+|+||.||+|... +|..||||.+..... ......+.+|+.++++++||||++++++..+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999876 689999998864321 1234568889999999999999999997543 46
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
+++|||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 7899999999999998643 457888889999999999999998 899999999999999999999999999987653
Q ss_pred CCCc-ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQWT-HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-----------~~~~~ 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-----------ATQPT 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-----------hcCCC
Confidence 2111 11123345889999999998888999999999999999999999999754332221110 00001
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+......+..++.+||. +|++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111223344567778888984 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=298.32 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=196.6
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
+|.+.+.||.|+||.||+|...+|+.+|||.+..... ......+.+|+.++++++|+||+++++++. +..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998875432 122346888999999999999999999744 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999964 3467888999999999999999998 899999999999999999999999999987653211
Q ss_pred c----ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 271 T----HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 271 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
. ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............. . ....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~----~~~~~~~ 230 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--H----RGLMPRL 230 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh--c----cCCCCCC
Confidence 1 1112335688999999999888899999999999999999999999976433221110000 0 0001111
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .....+..++.+||+.+|.+||++.+++.
T Consensus 231 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 231 PD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 22356788999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=307.36 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=189.4
Q ss_pred CCCeeccc--CcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 121 SENLIGKG--GYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 121 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
+.++||+| +|++||++..+ +|+.||||++..... ......+..|+.+++.++||||+++++++ .+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 78999999876 789999999976543 23344677799999999999999999974 44688999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc-
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH- 272 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~- 272 (434)
++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998643 3458899999999999999999998 99999999999999999999999999875433211100
Q ss_pred ----cceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc-----cccCc------
Q 013927 273 ----HNVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK-----PLLDS------ 335 (434)
Q Consensus 273 ----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~-----~~~~~------ 335 (434)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ +....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 00122346778999999976 35889999999999999999999999754322111100 00000
Q ss_pred ccc-----ccccCCcC-----------------CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDI-----RELVDPSL-----------------GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~-----~~~~d~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+ ....+... ...........+.+++.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 00000000 00011122356788999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=296.40 Aligned_cols=237 Identities=23% Similarity=0.352 Sum_probs=187.2
Q ss_pred CeecccCcEEEEEEEeCC-C----------cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD-G----------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEE
Confidence 368999999999999763 3 25788877654322 557889999999999999999999643 678899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-------CeEEeccccc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-------EPQICDFGLA 263 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-------~~kL~DFGla 263 (434)
|||+++|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998655578999999999999999999998 9999999999999999887 7999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
..... .....++..|+|||++... .++.++|||||||++|+|++ |..||......... ....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~~~~------- 220 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--RFYQ------- 220 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--HHHh-------
Confidence 86543 1223467789999999876 68999999999999999999 57777654321110 0000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.... .+......+.+++.+||..+|.+||++.+|++.|+
T Consensus 221 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00111157788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.86 Aligned_cols=189 Identities=23% Similarity=0.328 Sum_probs=161.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
..+|.+.+.||+|+||.||+|... ++..||+|+.... ....|+.++++++||||+++++++. +..++|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 357999999999999999999976 5788999975432 2356899999999999999999743 46789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
++. ++|.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 986 68888887666779999999999999999999999 89999999999999999999999999999753221
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcc
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~ 318 (434)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1123456899999999999989999999999999999999866554
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=335.47 Aligned_cols=257 Identities=25% Similarity=0.263 Sum_probs=197.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.++||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++. +..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999976 689999999975432 223457899999999999999999999754 4688999
Q ss_pred EEcCCCCHHHHhccC----------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 192 QLSPLGSLASILHGS----------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 192 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
||+++|+|.+++... ....++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988631 1235667788999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCc----------------ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh
Q 013927 262 LAKWLPRQWT----------------HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV 325 (434)
Q Consensus 262 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 325 (434)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 001123569999999999999999999999999999999999999997633221
Q ss_pred hhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCC-CHhHHHHHhcCC
Q 013927 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRP-KMSQVVILLRGD 386 (434)
Q Consensus 326 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~L~~~ 386 (434)
..... .+.++.-.. ........+..++.+||+.+|++|| +++++++.|+..
T Consensus 239 i~~~~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYRD---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhh---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11110 000110000 0012234577889999999999996 566777776554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=295.77 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=197.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--C-CcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D-GIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~-~~~lv~e 192 (434)
+|.+.+.||.|++|.||++... +++.||+|.+..... ......+.+|+.++++++|+|++++++... + ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999976 678999999875433 233456888999999999999999998643 2 3689999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+++++|.+++... ...+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999988753 3458999999999999999999998 8999999999999999999999999999986643221
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||+..+......... ... . + ..+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~---~~~----~-~----~~~ 223 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII---EGK----L-P----PMP 223 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---hcC----C-C----CCc
Confidence 2234568899999999998889999999999999999999999997543222111100 000 0 0 111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 223356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=301.96 Aligned_cols=244 Identities=25% Similarity=0.333 Sum_probs=190.2
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
|...+.||.|+||+||+|... +++.||+|.+...... .....+.+|+.++++++|+||+.+++.. .+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999876 7899999998764322 2234578899999999999999998863 3468899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999888643 3468999999999999999999998 999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||............ ...+... .. .+..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~----~~~~~~~-~~----~~~~ 226 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV----DRRVLET-EE----VYSA 226 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHhhhcc-cc----ccCc
Confidence 122346899999999998888999999999999999999999999764332111000 0000000 00 1111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
.....+..++..||+.+|++||++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 2234567888999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=301.34 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=195.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
+|++.+.||+|+||.||++... +|..||+|.+...........+.+|+.++++++||||+++++++ .+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999976 78999999987654444456788999999999999999999963 44788999999
Q ss_pred CCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 195 PLGSLASILHGS--KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 195 ~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
++++|..++... ...+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999998753 3468999999999999999999996 2589999999999999999999999999987653321
Q ss_pred cceeccccccccccCCccccCC------CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI------VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.....|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.......... .+..+.+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------~~~~~~~~~- 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--------QLSAIVDGD- 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH--------HHHHHhhcC-
Confidence 12345788999999985443 5789999999999999999999996532211100 001111100
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+......+..++.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 01112223456778999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.58 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=199.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhC-CCCCeeeEeeeccC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 185 (434)
.-++|...+.||.|..+.|-+++.+ +|+.+|+|++...... ...+.-.+|+.||+++ .||+|+.+.++.+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888889999999999998876 7889999988653321 2234556799999998 59999999998654
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
-+++|++.|+.|.|.++|. +.-.+++....+|+.|+.+|+.|||. ++||||||||+|||++++-++||+|||++
T Consensus 95 ~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecccee
Confidence 4678999999999999997 45678888899999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCcccc------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMH------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
+.++++ ......+||++|+|||.+.. ..|+..+|+||+|||||-|+.|..||-+-.+........ ++.
T Consensus 171 ~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im---eGk 244 (411)
T KOG0599|consen 171 CQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM---EGK 244 (411)
T ss_pred eccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH---hcc
Confidence 988765 34567899999999998853 357888999999999999999999998765544321100 000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
-++-.|.. .+......+++++||+.||.+|.|++|+++
T Consensus 245 -yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 -YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01111111 112245677899999999999999999874
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=295.23 Aligned_cols=249 Identities=30% Similarity=0.421 Sum_probs=196.9
Q ss_pred CCCCCeecccCcEEEEEEEeCC-----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
|.+.+.||.|+||.||++.... +..||+|.+...........+..|+.++..++|+||+++++++. +..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566889999999999998763 38899999976654445667999999999999999999999744 4788999
Q ss_pred EEcCCCCHHHHhccCCCC-CCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 192 QLSPLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
||+++++|.+++...... +++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999764444 8999999999999999999998 899999999999999999999999999998665431
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.... ....+++.|+|||.+....++.++||||||+++|+|++ |..||............. ... ...
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~~~---------~~~ 224 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK---KGY---------RLP 224 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCC---------CCC
Confidence 1111 12236789999999988889999999999999999998 788886533221110000 000 001
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
........+.+++.+||..+|.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111345678899999999999999999998765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=298.51 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=194.7
Q ss_pred CCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------
Q 013927 119 FSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------- 185 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 185 (434)
|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999753 468899999876433 2345568899999999999999999996321
Q ss_pred CcEEEEEEcCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 186 GIHLVFQLSPLGSLASILHGS-----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
-.+++++|+.+|+|..++... ...+++.....++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 136888999999998876421 2247888999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |+.||.............. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--~~--- 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--GN--- 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc--CC---
Confidence 99986543221111122335678999999988889999999999999999999 8888875433211100000 00
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.. ..+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 233 ---~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 ---RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112335788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=346.06 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=205.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
..|...++||+|+||.||+|... +|..||||++...... ...|+..+++++|||||+++|++. +..++||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 45778889999999999999974 7899999988643321 234688999999999999999854 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++. .++|..+..|+.|+++||+|||..+..+|+||||||+||+++.++.+++. ||........
T Consensus 765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 99999999995 38999999999999999999997555899999999999999999888876 6655433211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc---cchhhhhhccccCccccccccCCcCCC--
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL---QQSVVIWAKPLLDSNDIRELVDPSLGD-- 348 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~-- 348 (434)
....||+.|+|||++.+..++.++|||||||++|||+||+.||+.. ......|............++++.+..
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 1235789999999999999999999999999999999999998642 122333444333333445566666543
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
..+.++..++.+++.+||+.+|++||+|.||++.|+.+..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2345667788999999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=315.64 Aligned_cols=255 Identities=22% Similarity=0.251 Sum_probs=192.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.+|.+.+.||.|+||.||++... .+..||||.+.... ...+|+.++++++||||+++++++. ...++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 57999999999999999999753 35789999886532 3567999999999999999998643 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|++. ++|..++. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.....
T Consensus 166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9986 67888773 45678999999999999999999998 8999999999999999999999999999986654333
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh------hhhh----cccc-Ccc---c
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV------VIWA----KPLL-DSN---D 337 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~------~~~~----~~~~-~~~---~ 337 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+.. .+.. ..+ .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 233335679999999999998899999999999999999999999996533210 0000 0000 000 0
Q ss_pred cccc---cCCcCCCCCCH-------HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 338 IREL---VDPSLGDNYDA-------EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 338 ~~~~---~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+... +.......+.. .....+..++.+||..+|++||++.+++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000000 112356778899999999999999999754
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.15 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=198.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~ 191 (434)
+|.+.+.||.|+||.||++... +|+.||+|.+..... ......+..|+.++++++||||++++++.. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 788999999875433 334456888999999999999999998532 2468999
Q ss_pred EEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccC--CCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 192 QLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGC--QKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 192 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
||+++++|.+++... ...+++..++.++.+++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998643 467899999999999999999999211 289999999999999999999999999999876
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........... +....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~ 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK------------IKEGK 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH------------HhcCC
Confidence 54321 12334689999999999888899999999999999999999999976442211100 00001
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+......+..++.+||+.+|++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11122233457888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=299.60 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=197.1
Q ss_pred HHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec----
Q 013927 110 SELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD---- 183 (434)
Q Consensus 110 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~---- 183 (434)
+.+..+.++|.+.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 344456678999999999999999999876 68899999876432 2234577899999999 699999999964
Q ss_pred ---cCCcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 184 ---SDGIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 184 ---~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEE
Confidence 1247999999999999998753 34567888899999999999999998 89999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 332 (434)
+|||+++.+..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||.............
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~- 242 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP- 242 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence 99999986543211 1223458999999998753 447889999999999999999999997644322111100
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
........++ ......+..++.+||+.+|++||++.+|++.
T Consensus 243 --~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 --RNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --ccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000011111 1112457789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=293.89 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=199.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|+..+.||.|+||.||.+... +++.+++|.+..... ......+.+|+.++++++|+||++++++.. +..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999865 688999999875432 344457889999999999999999999743 467899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 4568999999999999999999998 8999999999999999999999999999986644321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||............. ..... ....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~---~~~~~---------~~~~ 223 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV---QGNYT---------PVVS 223 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCCCC---------CCcc
Confidence 2234568999999999988888999999999999999999999997643322111100 00000 0111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
.....+..++.+||..+|.+||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2235677889999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=299.27 Aligned_cols=237 Identities=21% Similarity=0.320 Sum_probs=185.6
Q ss_pred eecccCcEEEEEEEeC-C-------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 124 LIGKGGYAEVYKGCLR-D-------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
.||.|+||.||+|... . ...||+|.+.... ......+..|+.+++.++||||+++++++ .+..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 5899999999999864 2 2348888875433 23345688899999999999999999974 3578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--------eEEeccccccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE--------PQICDFGLAKW 265 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~--------~kL~DFGla~~ 265 (434)
+++|+|.+++......+++..++.++.||+.||.|||+ ++|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998666678999999999999999999998 99999999999999987765 69999999865
Q ss_pred cCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCC-CccccccchhhhhhccccCccccccccC
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGR-RAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
.... ....++..|+|||++.+. .++.++|||||||++|+|++|. .||............ .
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------------~ 219 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------------E 219 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH------------H
Confidence 4322 234578899999999864 5789999999999999999995 565543332111000 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
. ....+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 220 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00111122246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=296.80 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=194.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++.. .+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35777788999999999999865 688999999876532 2334578899999999999999999963 4578899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 999999999863 4568899999999999999999998 899999999999999999999999999987654321 1
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......|+..|+|||++. ...++.++|||||||++|+|++|..||.........+.... . ....+.....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~---~---~~~~~~~~~~- 234 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK---S---NFQPPKLKDK- 234 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc---c---CCCCCccccc-
Confidence 223456899999999874 45588999999999999999999999865433222111000 0 0000111000
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||+.+|++||++.+|++
T Consensus 235 -~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 -MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 011235678899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=300.40 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=193.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||.|++|.||+|... +++.||||.+...........+.+|+.++++++|+||++++++.. +..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46888899999999999999976 689999999876543333345778999999999999999999744 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. ++|.+++......+++.....++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 98 48999887666678999999999999999999998 899999999999999999999999999987543211 1
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh----hh---ccccC-------cccc
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----WA---KPLLD-------SNDI 338 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~---~~~~~-------~~~~ 338 (434)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... +. .+... ....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346788999999875 45889999999999999999999999654311110 00 00000 0000
Q ss_pred cccc-----CCcCCCCC-CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELV-----DPSLGDNY-DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~-----d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... ...+.... .......+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000000 0011256678999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=300.20 Aligned_cols=258 Identities=29% Similarity=0.396 Sum_probs=200.1
Q ss_pred cCHHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc
Q 013927 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS 184 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 184 (434)
++..++..++++|.+.+.||.|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 445566666789999999999999999999875 78899999986532 2234577899999998 8999999999642
Q ss_pred -------CCcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 185 -------DGIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 185 -------~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
+..++|+||+++|+|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence 247899999999999998853 34568899999999999999999998 89999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccC-----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 329 (434)
+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...........
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 999999998765432111 1234578899999998543 368899999999999999999999976443222111
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
... .....+.+ .......+..++.+||+.+|++||++.++++
T Consensus 245 ~~~---~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPR---NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred Hhc---CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 100 00001111 1122346788999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.14 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=199.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
+|...+.||.|+||.||++... +++.||+|.+...........+.+|+.+++.++||||+++++.+ .+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777788999999999999977 68999999998765555566789999999999999999999864 34688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++......++......++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--- 156 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--- 156 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence 9999999997655778899999999999999999997 36999999999999999999999999999876532211
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH-
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE- 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~- 353 (434)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ...+........ ......
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~ 228 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI------FELLQYIVNEPP-PRLPSGK 228 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH------HHHHHHHhcCCC-CCCChhh
Confidence 12567889999999988889999999999999999999999996542100000 000001111100 001111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..++..||..+|++||++.+++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 3456788999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=298.61 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=189.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHH-HhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGI-IAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|..||||++...........+..|+.+ ++.++||||+++++++ .+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 7899999999765433334456667665 5667899999999974 347899999
Q ss_pred EcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 193 LSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 193 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
|++ |+|.+++.. ....+++..+..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 678777653 33568999999999999999999998 6 899999999999999999999999999976543
Q ss_pred CCcccceeccccccccccCCcccc----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMH----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||............ ...-..+
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~ 226 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-------VVEEPSP 226 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-------HHhcCCC
Confidence 21 1123457889999998864 34688999999999999999999999653321111000 0000001
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+.. ......+..++.+||..+|.+||++.+|++
T Consensus 227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 112356788999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=299.57 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... ++..||+|.+.... ......+..|+.++++++||||+++++.+ .+..++||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46888899999999999999975 68999999987543 33445788999999999999999999974 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++......+++..+..++.|++.||.|||+ ++|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 99999999997666678999999999999999999999 899999999999999999999999999987543321 1
Q ss_pred ceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
......|++.|+|||.+. ...++.++||||||+++|+|++|+.||.............. ...+.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~-- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--------SEPPTL-- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--------CCCCCc--
Confidence 123456899999999875 34477899999999999999999999976543221111000 000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+......+.+++..||+.+|.+||++.+|++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111123467788999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=299.93 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=192.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++++|.+.+.||+|+||.||+|... +|..||+|++...........+.+|+.+++.++|+||++++++.. +..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999865 688999999876543333345788999999999999999999744 3688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+. ++|.+.+......+.+..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 67776665445567888888999999999999998 899999999999999999999999999987543221
Q ss_pred ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh----hhc---cccC--------c
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----WAK---PLLD--------S 335 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~~---~~~~--------~ 335 (434)
.......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||+........ |.. |... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 112234578899999998754 4788999999999999999999999764332111 110 0000 0
Q ss_pred cccccccCCcCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDIRELVDPSLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
............... .......+.+++.+|+..+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011346778899999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=315.35 Aligned_cols=242 Identities=29% Similarity=0.419 Sum_probs=199.2
Q ss_pred eecccCcEEEEEEEeCC-CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-C-cEEEEEEcCCCCHH
Q 013927 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-G-IHLVFQLSPLGSLA 200 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~-~~lv~e~~~~gsL~ 200 (434)
+||+|.||+||-|++.+ ...+|||.+.... ....+.+..|+.+-++|+|.|||+++|++.+ + +-+.||-.+||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999999774 5578999886543 2345578899999999999999999998655 3 34789999999999
Q ss_pred HHhccCCCCC--CHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCCCCcccceec
Q 013927 201 SILHGSKDKP--DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 201 ~~l~~~~~~~--~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
++|...-+++ .+.+.-.+..||++||.|||+ +.|||||||-.|+||+. .|.+||+|||-++.+..- .....+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998765666 777888889999999999999 99999999999999974 589999999999877543 233467
Q ss_pred cccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 278 FEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
+.||+.|||||++..|. |...+|||||||++.||.||++||-.++.....+.+-.+. ...+.++.+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy----------KvHP~iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY----------KVHPPIPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce----------ecCCCCcHHHH
Confidence 88999999999998775 8899999999999999999999998765544433322111 12345566667
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+...++.+|+..+|..||++.++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 78888999999999999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=308.63 Aligned_cols=235 Identities=23% Similarity=0.265 Sum_probs=179.3
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhC---CCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYV---DHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
||+|+||+||+|... +|+.||||++.+.... .....+..|..++..+ +||||+.++++.. +..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 6899999998653221 2223455677777665 6999999998743 468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~ 154 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN 154 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence 999988863 4568899999999999999999999 999999999999999999999999999987532221 1223
Q ss_pred ccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .... .. ..+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~-~i~~--~~------~~~~~---~~~~ 222 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR-NIAF--GK------VRFPK---NVLS 222 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH-HHHc--CC------CCCCC---ccCC
Confidence 45799999999998764 48899999999999999999999997643221110 0000 00 00000 0112
Q ss_pred HHHHHHHHhhhccCCCCCCCHh
Q 013927 356 DRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
..+..++.+||+.+|.+||++.
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCC
Confidence 4567788999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=298.96 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=195.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++++++||||+++++++. +..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999977 6899999998754321 22345788999999999999999999754 36889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|..++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999888887753 4468999999999999999999999 9999999999999999999999999999987654321
Q ss_pred cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc-----cc-------cCccc-c
Q 013927 273 HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK-----PL-------LDSND-I 338 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~-----~~-------~~~~~-~ 338 (434)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||............ .. ..... .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 45789999999999999999999999754322111100 00 00000 0
Q ss_pred ccccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+..+......+ ......+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000111100001 011356788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=298.45 Aligned_cols=237 Identities=22% Similarity=0.273 Sum_probs=183.1
Q ss_pred eecccCcEEEEEEEeCC-------------------------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeee
Q 013927 124 LIGKGGYAEVYKGCLRD-------------------------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 178 (434)
.||+|+||.||+|.... ...||+|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997421 13588998865432 33346888999999999999999
Q ss_pred Eeeecc--CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---
Q 013927 179 LVGCDS--DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY--- 253 (434)
Q Consensus 179 l~g~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~--- 253 (434)
+++++. +..++||||+++|+|..++......+++..++.++.|++.||.|||+ ++|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 999754 36789999999999999997666678999999999999999999998 8999999999999997644
Q ss_pred ----CeEEeccccccccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHH-hCCCccccccchhhh
Q 013927 254 ----EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELI-TGRRAVDHLQQSVVI 327 (434)
Q Consensus 254 ----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~ell-tG~~p~~~~~~~~~~ 327 (434)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999998643221 12346788999998875 45899999999999999995 689998754322211
Q ss_pred hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 328 WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 328 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.. ..... ..+......+..++.+||+.+|++||++.+|++.|.
T Consensus 232 ~~------------~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RF------------YEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH------------HHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 00000 000111235778999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=299.36 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=196.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~e 192 (434)
+|...+.||.|++|.||+|... +++.||+|.+...........+.+|++++++++||||+++++++. +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999976 688999999886544445567899999999999999999999642 25789999
Q ss_pred EcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|+++++|.+++.. ....++......++.|++.||.|||+ .+++|+||+|.||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988653 34557888999999999999999998 99999999999999999999999999998754322
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch---hhhhhccccCccccccccCCcC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS---VVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~d~~l 346 (434)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..... ..+.....+.+
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~ 228 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL------SYIVNMPNPEL 228 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH------HHHhcCCchhh
Confidence 1 12345788999999998889999999999999999999999999764210 00000 00000000111
Q ss_pred CCCCC--HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYD--AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..... ......+.+++.+||..+|.+||++.||++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111 122456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=333.57 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=193.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~l 189 (434)
.++|.+.+.||.|+||+||+|... ++..||+|.+..... ......+..|+.++.+++|||||++++++. +.+++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 357999999999999999999976 678999999875433 234457889999999999999999999642 35889
Q ss_pred EEEEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccC----CCCeeecCCCCCcEEecC-----------
Q 013927 190 VFQLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGC----QKRIIHRDIKADNILLTE----------- 251 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~----~~~iiHrDlkp~NIll~~----------- 251 (434)
||||+++|+|..+|... ...+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998642 356899999999999999999999732 145999999999999964
Q ss_pred ------CCCeEEeccccccccCCCCcccceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccc
Q 013927 252 ------DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQ 323 (434)
Q Consensus 252 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 323 (434)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|..||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 2358999999998654321 1234568999999999864 4588999999999999999999999975432
Q ss_pred hhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 324 SVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
....... . ... +.+.. ......+..||..||..+|.+||++.|++
T Consensus 249 ~~qli~~-l------k~~--p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 249 FSQLISE-L------KRG--PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred HHHHHHH-H------hcC--CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 2111110 0 000 00100 01124677899999999999999999998
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.30 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=201.2
Q ss_pred CCCCCeecccCcEEEEEEEeCC-CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEee--eccCCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG--CDSDGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g--~~~~~~~lv~e~~~ 195 (434)
|.++..||.|+||+||++..++ +-..|-|++... .++...+|+-|++||..++||+||++++ ++.+.++++.|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 5566679999999999999874 445566777543 3455678999999999999999999998 36778999999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
||-.+.++-.-...+...++..+++|++.||.|||+ ++|||||||+.|||++.+|.++|+|||.+..... +....
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 999999988778899999999999999999999999 9999999999999999999999999999753322 12233
Q ss_pred eccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 276 SKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
..+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|-.......++..... .....++.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqP------ 258 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQP------ 258 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCc------
Confidence 5688999999999874 45799999999999999999999999877666554432211 122233322
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+-+++..||..||..||++.++++
T Consensus 259 -S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 -SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 223356778899999999999999999974
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=293.81 Aligned_cols=245 Identities=28% Similarity=0.437 Sum_probs=197.4
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
|...+.||.|+||.||+|... ++..||||.+...........+.+|+.++.+++||||+++++++. +..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999865 788999998875544444567889999999999999999999743 46889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|..++.. ..+++..+..++.+++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence 9999999853 468899999999999999999998 999999999999999999999999999987654321 112
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.............. .. .+. ......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-----~~~----~~~~~~ 226 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---NN-----PPT----LEGNYS 226 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc---CC-----CCC----CCcccC
Confidence 334678899999999888889999999999999999999999975433221111100 00 011 112223
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 567788999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.81 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=196.0
Q ss_pred CCCCCCeecccCcEEEEEEEeCC--CcEEEEEEeeCCC---------chhhHhhHHHHHHHHhh-CCCCCeeeEeeecc-
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRD--GTLVAVKRLTKGT---------VDEKTCGFLCEIGIIAY-VDHPNTAKLVGCDS- 184 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~- 184 (434)
+|.+.+.||+|+||.||+|.... ++.+|||.+.... .......+..|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999764 6889999886432 12233457788888865 79999999999643
Q ss_pred -CCcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 185 -DGIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 185 -~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
+..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||+|.||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 468899999999999988743 34568899999999999999999995 268999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
|++....... ......|+..|+|||.+.++.++.++||||||+++|+|++|+.||............ .. .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~---~~----~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI---VE----A 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH---hh----c
Confidence 9998654432 234456889999999999888999999999999999999999999654322111100 00 0
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
...+... ......+..++.+||+.+|++||++.||.++|+
T Consensus 229 ~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0011000 112346778899999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.34 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=191.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||.|+||.||+|... +|+.||+|.+...... .....+.+|+.++++++||||++++++.. +..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999976 7899999998754322 22345778999999999999999999744 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. ++|.+++......+++..+..++.||++||.|||+ ++++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence 97 57888776555678999999999999999999998 999999999999999999999999999997654321 1
Q ss_pred ceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc-------cccC-ccccccccC-
Q 013927 274 NVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK-------PLLD-SNDIRELVD- 343 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~-------~~~~-~~~~~~~~d- 343 (434)
......++..|+|||++.+.. ++.++|||||||++|+|++|+.|+............ +... -..+....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 123345788999999987654 789999999999999999999986432211110000 0000 000000000
Q ss_pred ---CcCCC-----CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 ---PSLGD-----NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ---~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.... ...+.....+.+++.+||+.+|.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 001122356778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.28 Aligned_cols=191 Identities=25% Similarity=0.389 Sum_probs=155.5
Q ss_pred CeecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec----cCCcEEEEEEcC
Q 013927 123 NLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD----SDGIHLVFQLSP 195 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----~~~~~lv~e~~~ 195 (434)
.+||+|+||+||+|... ++..||+|.+..... ...+.+|+.++++++||||+++++++ ....++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999865 357899998875432 23477899999999999999999964 235789999987
Q ss_pred CCCHHHHhcc--------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----cCCCCeEEeccccc
Q 013927 196 LGSLASILHG--------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL----TEDYEPQICDFGLA 263 (434)
Q Consensus 196 ~gsL~~~l~~--------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGla 263 (434)
+ +|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67666532 12357888899999999999999998 899999999999999 56679999999999
Q ss_pred cccCCCCcc-cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 264 KWLPRQWTH-HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 264 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
+........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 866433211 122345689999999998764 588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.12 Aligned_cols=246 Identities=27% Similarity=0.429 Sum_probs=196.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC---CCCeeeEeeecc--CCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD---HPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~--~~~~lv~ 191 (434)
.|...+.||.|+||.||+|... ++..||||.+...........+.+|+.+++.++ |||++++++++. +..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777789999999999999975 789999999876554445557888999999997 999999999744 3578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++.. ..+++.....++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999854 478899999999999999999998 999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........... +.....+.+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~- 225 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML--------IPKSKPPRLEDN- 225 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc--------cccCCCCCCCcc-
Confidence 122344688999999998754 478999999999999999999999976433221110 000011111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+++.+||+.+|++||++.+++.
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 13356788999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.61 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=196.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
.+|.+.+.||.|+||.||+|... +|+.||||.+..... .....+.+|+.+++.++||||+++++++ .+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 45888899999999999999865 789999999875443 2345688999999999999999999974 3478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|..++.. ..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999998853 458999999999999999999999 9999999999999999999999999999876543211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||............. ......+. .+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~-------~~~~ 240 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQ-------NPEK 240 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccC-------Cccc
Confidence 1233468899999999988889999999999999999999999997654322111000 00000000 0111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
....+..++.+||..+|.+||++.+|+
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 224577789999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.03 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=196.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 57899999999999999999964 7899999999764433 3346888999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999999853 457888999999999999999998 8999999999999999999999999999876543211
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||............ .... .+. ...+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~-----~~~--~~~~~~ 240 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNG-----TPE--LQNPER 240 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCC-----CCC--CCCccc
Confidence 123345788999999998888999999999999999999999999654321111000 0000 000 001112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||..+|++||++.+|+.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2345677889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=297.93 Aligned_cols=258 Identities=20% Similarity=0.273 Sum_probs=191.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|.+.+.||+|++|.||+|... +++.||||.+...... .....+.+|+.++..++||||++++++. .+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999976 7899999998754322 2234678899999999999999999974 3468999999
Q ss_pred cCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGS--KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
+. ++|.+++... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 6888887643 2568899999999999999999998 999999999999999999999999999987553221
Q ss_pred ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cccc-------Cccc
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLL-------DSND 337 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~-------~~~~ 337 (434)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+. .+.. ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112233568899999988654 478899999999999999999999975332111100 0000 0000
Q ss_pred cccccCCcCCCC---CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 IRELVDPSLGDN---YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 ~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
............ .......++.+++.+||+.||.+||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00112346678999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=289.14 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=196.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
+|...+.||+|+||+||+|... ++..|++|.+..... ......+.+|+.+++.++|+||+++++++. +..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677789999999999999976 789999999875432 223457889999999999999999999754 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998643 457899999999999999999998 899999999999999999999999999987654332
Q ss_pred cccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||.........+..... ... ..
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~---------~~ 222 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KEL---------PP 222 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccC---------CC
Confidence 223455889999999987766 899999999999999999999999764432222211110 000 01
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122356677899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.23 Aligned_cols=245 Identities=30% Similarity=0.444 Sum_probs=194.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
+.|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++. +..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999876 689999999865432 233456889999999999999999999743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+. |+|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 67777776555678999999999999999999998 89999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
....|+..|+|||++. .+.++.++||||||+++|||++|..||.............. .. .+.+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~-----~~~~~- 235 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---ND-----SPTLS- 235 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CC-----CCCCC-
Confidence 2345788999999874 35688999999999999999999999976443222111100 00 00110
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.......+..++.+||..+|++||++.+|+..
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11233567889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=293.49 Aligned_cols=250 Identities=30% Similarity=0.421 Sum_probs=196.6
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC-------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD------- 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------- 185 (434)
.+++|.+.+.||.|+||.||+|... +++.|++|++..... ....+.+|+.+++++ .|+||+++++++.+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999976 678999999876543 334688999999999 79999999997432
Q ss_pred -CcEEEEEEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 186 -GIHLVFQLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 368999999999999988642 3678899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCcccceeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcc
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||............. ..
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~ 233 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RN 233 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---cc
Confidence 987654321 12234558899999998753 346789999999999999999999997543222111100 00
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.+ .........+.+++.+||..||++||++.+|++
T Consensus 234 -----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 -----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00011 111123456788999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.72 Aligned_cols=250 Identities=25% Similarity=0.277 Sum_probs=197.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|...+.||.|+||.||+|... +++.||||.+....... ....+..|+.++..++||||+++++... +..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5888899999999999999876 58999999998754432 4456889999999999999999998744 36889999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+.+++|.+++... ...+++.....++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998753 3568999999999999999999998 8999999999999999999999999999875432111
Q ss_pred c---------------------------cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch
Q 013927 272 H---------------------------HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS 324 (434)
Q Consensus 272 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 324 (434)
. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 0112346788999999999888999999999999999999999999764432
Q ss_pred hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC----HhHHHH
Q 013927 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPK----MSQVVI 381 (434)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs----~~evl~ 381 (434)
.... .+................+.+++.+||+.+|++||+ +.+++.
T Consensus 239 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFS-----------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHH-----------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2111 011111110111113467888999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=288.87 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=195.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|...+.||+|+||.||++... +++.+|||.+..... ......+.+|+.+++.++||||+++++.. .+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 788999999876432 23445788999999999999999999863 3468899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~~~ 271 (434)
+++++|.+++... ...+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999754 3458899999999999999999998 8999999999999998654 689999999987654321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||............. ...... ..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~---------~~ 222 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM---SGTFAP---------IS 222 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---hcCCCC---------CC
Confidence 223457889999999998889999999999999999999999997643322111000 000000 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112346778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=299.50 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=194.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+.+++.++||||+++++++.+ ..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999986 6899999988654322 234468889999999999999999997543 6889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|..+... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 9999999887753 3458999999999999999999998 899999999999999999999999999998654332
Q ss_pred cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhh---hhh--cc-------ccCccc-c
Q 013927 273 HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---IWA--KP-------LLDSND-I 338 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~~~--~~-------~~~~~~-~ 338 (434)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ +.. .. ...... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233457889999999875 3478899999999999999999999864322110 000 00 000000 0
Q ss_pred ccccCCcCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+...... .+.....+..++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000011100000 0122356888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.56 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=199.3
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------CcEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------GIHL 189 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~l 189 (434)
|...+.||+|+||.||+|+++ +|..||||.+.........+...+|+++|++++|+|||+++++.++ ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455578999999999999966 8999999999886666667788999999999999999999998544 3468
Q ss_pred EEEEcCCCCHHHHhccC--CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec--CCC--CeEEeccccc
Q 013927 190 VFQLSPLGSLASILHGS--KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT--EDY--EPQICDFGLA 263 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~--~~~--~~kL~DFGla 263 (434)
|||||.+|+|..+|... ...+++...+.++.+++.||.|||+ ++|+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999863 4568999999999999999999998 9999999999999994 334 4799999999
Q ss_pred cccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccch----hhhhhccccCcccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQS----VVIWAKPLLDSNDI 338 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~----~~~~~~~~~~~~~~ 338 (434)
+.++.+. ....+.||..|.+||.+.. +.|+..+|.|||||++|+++||..||...... ..+|.........+
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9887653 5567889999999999984 88999999999999999999999999653322 12332211111111
Q ss_pred ccccCCcCC------------CCCCHHHHHHHHHHHHhhhccCCCCCC--CHhHHHHHhc
Q 013927 339 RELVDPSLG------------DNYDAEEIDRAVLTASLCIEQSPILRP--KMSQVVILLR 384 (434)
Q Consensus 339 ~~~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~~P~~RP--s~~evl~~L~ 384 (434)
.-...+... ..........+...+..+|..+|.+|- ...+....+.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 111111111 111122334566667778888999998 5554444443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=288.02 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=196.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||.|+||.||++... +|+.||+|.+..... ......+.+|+.++++++||||++++++.. +..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999865 789999999875432 233447889999999999999999999744 368899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+.+++|.+++... ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988653 3457889999999999999999998 8999999999999999999999999999976543221
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|++.|+|||++.+..++.++|+|||||++|+|++|+.||............ .... ....+.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~-----------~~~~-~~~~~~ 223 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-----------IRGS-YPPVSS 223 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH-----------hcCC-CCCCcc
Confidence 112345788999999998888999999999999999999999998653322111100 0000 001112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.+|.+||++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22356788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=296.83 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=195.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--c--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--S--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~--~~~~lv 190 (434)
++|.+.+.||.|+||.||+|... +++.||+|.+...... .....+.+|+.++.+++||||++++++. . +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 6889999999754432 2223567899999999999999999863 3 578999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+||+. ++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99998 58999887655678999999999999999999998 899999999999999999999999999998665431
Q ss_pred cccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhh--------------hh----cc
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--------------WA----KP 331 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------------~~----~~ 331 (434)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......... |. .+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1223345788999999987544 688999999999999999999999753321110 00 00
Q ss_pred ccCccccccccCCcCCCCCCHH-HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 LLDSNDIRELVDPSLGDNYDAE-EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..............+...++.. ..+.+.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000001111111111111 2456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=297.58 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=197.5
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|.+.+.||+|+||.||++... .++.||+|.+..... ......+.+|+.+++.++||||+++++... +..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888899999999999999976 678999999876532 223446788999999999999999999743 35789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc-
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT- 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~- 271 (434)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999643 568888899999999999999998 8999999999999999999999999999863211000
Q ss_pred ------------ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccc
Q 013927 272 ------------HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 272 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+........ .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~-~~~~-----~ 231 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-QVIS-----D 231 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh-----c
Confidence 001112457889999999988889999999999999999999999997543221110 0000 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
....+.... .....+..++.+||+.+|++||++.++.+.|+..
T Consensus 232 ~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 232 DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 001111111 1234577899999999999999988888878764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=289.62 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=197.3
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|.+.+.||+|+||.||+|... +++.||+|.+...... .....+..|+.++++++|+||++++++. .+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999865 7899999998765442 3556789999999999999999999974 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999743 457888999999999999999998 999999999999999999999999999998765432211
Q ss_pred c--eeccccccccccCCccccCC---CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 274 N--VSKFEGTFGYFAPEYFMHGI---VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 274 ~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
. .....++..|+|||++.... ++.++||||||+++|++++|+.||............... ...+.+..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~~ 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-------GHKPPIPD 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-------CCCCCCCc
Confidence 1 12345788999999998766 889999999999999999999999764322211100000 00111111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. ......+..++.+||+.+|.+||++.+++.
T Consensus 230 ~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 S--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 111345678899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.32 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=197.7
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
...+..||.|+-|.|+++..+ +|...|||.+.+....+...+++..+.++.+.+ +|.||+.+|++ ...+++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344467999999999999977 689999999998777777778888998887775 89999999974 34688889988
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
. ..+..++.....++++...-++...++.||.||.+ .++|+|||+||+|||+|+.|++||||||++..+-.. ..
T Consensus 174 s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kA 247 (391)
T KOG0983|consen 174 S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KA 247 (391)
T ss_pred H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---cc
Confidence 5 35666776667788888888999999999999998 589999999999999999999999999999876543 33
Q ss_pred eeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 275 VSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.+...|.+.|||||.+.- ..|+-++||||||+.|+||.||+.||.+.+.......+..- +....++....
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~g---- 320 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMG---- 320 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccC----
Confidence 355669999999999863 45899999999999999999999999885544433322111 11122222211
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..++..||..|+.+||...++++
T Consensus 321 --FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 321 --FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2346778889999999999999999975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.34 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=196.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++|+||+++++++. +..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6888899999999999999976 688999998875432 233456889999999999999999999743 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++.+..+.. ....+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 82 VERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 99877766554 44568999999999999999999998 8999999999999999999999999999987654422 1
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcc-------------ccCccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP-------------LLDSNDIR 339 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~-------------~~~~~~~~ 339 (434)
......++..|+|||++... .++.++||||||+++|+|++|+.||.........+... ........
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 22345678899999999887 78999999999999999999999997543221111100 00000000
Q ss_pred --cccCCc----CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 --ELVDPS----LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 --~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+.... ....++......+..++.+||..+|++||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000111122467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.63 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=190.3
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|.....||+|+||.||++... +++.||||.+...........+..|+.++.++. ||||++++++. .+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455578999999999999876 689999999876544445557889999999996 99999999964 3467899999
Q ss_pred cCCCCHHHHh---cc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 194 SPLGSLASIL---HG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 194 ~~~gsL~~~l---~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
+.. ++.++. .. ....+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||++..+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 444432 22 23568899999999999999999997 248999999999999999999999999999765432
Q ss_pred CcccceeccccccccccCCccccC---CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHG---IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.. .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||............ .. .. ..+.+
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~-~~-----~~~~~ 231 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ-VV-KG-----DPPIL 231 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhh-hc-CC-----CCCcC
Confidence 11 1233578899999998776 6899999999999999999999999764321111000 00 00 01111
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112234568889999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=290.41 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=195.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+|...+.||+|+||.||+|... +++.||+|++..... ......+..|+.++++++|+||+++++++. +..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999864 789999999875332 123457889999999999999999999754 46889
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPR 268 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~ 268 (434)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++|+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999864 3567889999999999999999999 8999999999999998776 599999999976654
Q ss_pred CCccc--ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 269 QWTHH--NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 269 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........... +........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~ 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--------IFKIASATT 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH--------HHHHhccCC
Confidence 31111 11234578899999999888899999999999999999999999964322110000 000000001
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+......+..++.+||..+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11222233456788999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=306.62 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=166.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-C-----CCeeeEeee--ccCCcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-H-----PNTAKLVGC--DSDGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~--~~~~~~ 188 (434)
+|.+.++||+|+||.|.+|.+. +++.||||++++.. ........|+.+|..|+ | -|+|+++++ +.++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 6788999999999999999866 79999999998754 33345677999999997 3 489999997 567999
Q ss_pred EEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC--CCeEEeccccccc
Q 013927 189 LVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED--YEPQICDFGLAKW 265 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFGla~~ 265 (434)
||+|++. .+|.+++..+ ...++...+..|+.||+.||.+||+ .+|||+||||+||||..- ..+||+|||.+..
T Consensus 265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999987 5899999764 4568999999999999999999998 999999999999999754 3799999999987
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL 321 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 321 (434)
...... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 654322 344578899999999999999999999999999999998888663
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.16 Aligned_cols=259 Identities=23% Similarity=0.292 Sum_probs=197.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||.|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||++++++.. +..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 789999999876543 233457889999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+ +++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 999999987666779999999999999999999998 8999999999999999999999999999986654321 1
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhcc------ccCc-cccc
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKP------LLDS-NDIR 339 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~------~~~~-~~~~ 339 (434)
......|+..|+|||.+.+. .++.++|||||||++|+|++|..||......... ...+ .... ....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 22345689999999998654 4689999999999999999998888653321110 0000 0000 0000
Q ss_pred cccCCcCC----CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLG----DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+..+... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 0000122367888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=287.96 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=200.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|.+.+.||.|++|.||+|... +++.||||++...........+.+|+..+.+++|+||+++++++. +..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 6888899999999999999977 589999999987654344567999999999999999999999743 4688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++... ..++...+..++.|+++||.|||+ ..+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999743 678999999999999999999996 279999999999999999999999999999866443221
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccc--hhhhhhccccCccccccccCCcCCCCCCH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQ--SVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... ..+..... ...+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----------~~~~~~~~-~~~~~ 225 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----------QAICDGPP-PSLPA 225 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----------HHHhcCCC-CCCCc
Confidence 1234578899999999888899999999999999999999999976542 11110 00000000 11111
Q ss_pred H-HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 E-EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~-~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. ....+..++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 3357888999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.58 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=197.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~ 187 (434)
+++|.+.+.||+|+||.||+|... +|+.||||++...........+..|+.++++++||||++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357999999999999999999865 789999999865433334456888999999999999999998632 236
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++++||+. ++|..++. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 89999997 57888774 3568899999999999999999999 899999999999999999999999999997654
Q ss_pred CCCccc-ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh-hcccc---Cccccccc
Q 013927 268 RQWTHH-NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW-AKPLL---DSNDIREL 341 (434)
Q Consensus 268 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~---~~~~~~~~ 341 (434)
...... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...... ....+ .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 322111 1223468899999998754 468899999999999999999999996532211000 00000 00011111
Q ss_pred cCCcC---------CCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCCCCc
Q 013927 342 VDPSL---------GDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGDEDN 389 (434)
Q Consensus 342 ~d~~l---------~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~~~~ 389 (434)
.+... ....+ +.....+.+++.+||+.+|++||++.+++.. ++...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 11000 00000 1123567889999999999999999999876 6555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=293.46 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=194.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|+.++++++||||++++++.. +..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999876 689999999875432 223456889999999999999999999743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++... ..++...+..++.|++.||.|||+ ++++||||+|.||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998643 568889999999999999999999 99999999999999999999999999999865433
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ...... .+ ...+ +
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~--~~------~~~~----~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKIL--EG------KVRF----P 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHh--cC------CccC----C
Confidence 234458899999999988888999999999999999999999997644211 111100 00 0011 1
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVV 380 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl 380 (434)
......+..++.+||..+|.+|| ++.+++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11235677889999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=301.56 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=195.0
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------- 184 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------- 184 (434)
..++|.+.+.||+|+||.||+|... +|+.||||.+.+... ......+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999976 789999999865432 233346778999999999999999998642
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
...++||||+. ++|.+.+... ++...+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 23689999997 5788877532 8888899999999999999998 899999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh---h---hhcc-------
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---I---WAKP------- 331 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~---~~~~------- 331 (434)
....... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... + ...|
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 6543311 2234578899999999998999999999999999999999999965332110 0 0000
Q ss_pred -------------ccCccccccccCCc----CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 332 -------------LLDSNDIRELVDPS----LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 332 -------------~~~~~~~~~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......+..+.... ............+.+++.+||+.||.+||++.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000011111110 0111111234567889999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=296.97 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=192.9
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~~~ 195 (434)
|.....||.|+||.||++... ++..||||.+.... ......+.+|+.+++.++||||+++++. ..+..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344467999999999999875 68899999986543 2334568899999999999999999986 3457899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++........ ..
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 9999998853 458889999999999999999999 8999999999999999999999999999875533211 12
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... +.....+.+... ....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~--~~~~ 245 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--------IRDNLPPRVKDS--HKVS 245 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhcCCCccccc--cccC
Confidence 334588999999999888899999999999999999999999975433221110 011111111110 1122
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+..++..||..+|.+||++.++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 356678899999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=292.04 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=199.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
+++|...+.||.|+||.||+|... ++..||+|++..... ....+..|+.+++.++|+|++++++++ .+..++++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 456888889999999999999987 788999999976543 345688999999999999999999963 457899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|.+++......+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999998654579999999999999999999998 9999999999999999999999999999875543211
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||.+.+..++.++|||||||++|+|++|..||............. ........ ...
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~-------~~~ 240 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLK-------NPE 240 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCc-------chh
Confidence 1223457889999999988889999999999999999999999997644322111100 00000000 011
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.+|..||++.+|+.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12356788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.19 Aligned_cols=247 Identities=32% Similarity=0.438 Sum_probs=200.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
.|...+.||.|++|.||++... +++.|++|++..... .....+.+|+.++++++|+|+++++++. .+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3777889999999999999976 789999999976543 3445788999999999999999999974 34788999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++......+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 9999999997655678999999999999999999998 9999999999999999999999999999987654321
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
.....|+..|+|||.+....++.++||||||+++|+|++|+.||.............. .....+.. ....
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~ 223 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRN-------PEKW 223 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCc-------cccc
Confidence 2345688999999999888899999999999999999999999976532221111000 00011110 0111
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 356788999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.99 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=200.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~ 191 (434)
+|...+.||+|++|.||+|... ++..|++|++..... ......+.+|+.++++++||||+++++... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999977 789999999876543 234557889999999999999999999744 4588999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997543 88999999999999999999999 8999999999999999999999999999987655432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........++..|+|||.+....++.++||||||+++|+|++|..||............ +.........+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~~~ 226 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK----------IGSSGEPPEIP 226 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh----------ccccCCCcCCC
Confidence 11123456789999999998888999999999999999999999999775422111100 01011111122
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 222467888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=289.44 Aligned_cols=246 Identities=26% Similarity=0.279 Sum_probs=197.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
+|.+.+.||.|+||.||+|... +++.||+|.+.+... ......+.+|+.++++++||||+++++++. +..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 689999999976432 134457899999999999999999998743 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.+++|..++... ..++...+..++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999643 578899999999999999999998 899999999999999999999999999988664432
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ... .....+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~-~~~~~~~ 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK---------QET-ADVLYPA 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH---------hcc-ccccCcc
Confidence 22335578899999999888899999999999999999999999986543111110000 000 0111122
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCH--hHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKM--SQVV 380 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~--~evl 380 (434)
.....+..++.+||..+|.+||++ ++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 233678889999999999999999 6653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.81 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=194.1
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
|...+.||+|+||.||+|... ++..||+|.+..... ......+..|+.++++++|||++++++++. +..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999865 689999999875432 233456888999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++ |+|.+++......+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 97 57777776556678999999999999999999998 89999999999999999999999999998754322
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....|+..|+|||++. .+.++.++|||||||++|+|++|+.||............ .........
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-----------~~~~~~~~~ 245 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----------AQNESPTLQ 245 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-----------HhccCCCCC
Confidence 2345788999999974 456889999999999999999999998764322211110 000000011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.......+..++.+||+.+|.+||++.+|++.+-..
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 112334678899999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=294.65 Aligned_cols=259 Identities=24% Similarity=0.304 Sum_probs=194.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch----hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD----EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
+|.+.+.||.|+||.||+|... +|+.||||.+...... .....+..|+.+++.++|+||+++++++. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3777889999999999999976 6899999999765432 12335678999999999999999999744 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+ +|+|.+++......+++..+..++.||++||.|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999997554478999999999999999999999 899999999999999999999999999998664432
Q ss_pred cccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---h---hccccC----ccccc
Q 013927 271 THHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---W---AKPLLD----SNDIR 339 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~---~~~~~~----~~~~~ 339 (434)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||......... . ..+... .....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 1 1223346788999998865 45788999999999999999998877653321110 0 000000 00000
Q ss_pred cccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 340 ELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 340 ~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...........+ ......+.+++.+||+.+|++||++.+|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000001111 1224677889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=295.24 Aligned_cols=243 Identities=20% Similarity=0.263 Sum_probs=192.2
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCCC
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLGS 198 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~gs 198 (434)
...||.|+||.||+|... +++.||||.+..... .....+.+|+.++..++||||+++++++ .+..++++||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 356999999999999875 789999999865433 2344688999999999999999999863 457899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecc
Q 013927 199 LASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278 (434)
Q Consensus 199 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 278 (434)
|..++.. ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..+..... .....
T Consensus 105 L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 105 LTDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred HHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 9998843 568899999999999999999998 8999999999999999999999999999875543321 12335
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRA 358 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 358 (434)
.|+..|+|||++.+..++.++|||||||++|||++|+.||............... . .+... ........+
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~-----~~~~~--~~~~~~~~l 247 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---P-----PPKLK--NAHKISPVL 247 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---C-----CCCcc--ccCCCCHHH
Confidence 6889999999998888999999999999999999999999754332221110000 0 00000 001122457
Q ss_pred HHHHHhhhccCCCCCCCHhHHHHH
Q 013927 359 VLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 359 ~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..++.+||+.+|.+||++.+|++.
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=291.59 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=190.0
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc----CCcEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS----DGIHLVFQ 192 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~----~~~~lv~e 192 (434)
|.+.+.||+|+||.||+|... +++.||+|.+..............|+.++.++. |+|++++++++. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999865 689999999876433333334567999999885 999999999743 45889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+. |+|.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||+++. +.+||+|||++..+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 57878776555678999999999999999999998 89999999999999999 9999999999986643321
Q ss_pred cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh-hhccc-----------cCccccc
Q 013927 273 HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI-WAKPL-----------LDSNDIR 339 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~~~~~-----------~~~~~~~ 339 (434)
.....++..|+|||++.. +.++.++|||||||++|||++|..||...+..... ..... .......
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 123457889999997654 45788999999999999999999999754322110 00000 0000000
Q ss_pred cccCCcCC-C---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLG-D---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~-~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+... . .........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 0 001123467889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.03 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=194.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC----chhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT----VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~ 187 (434)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++|+||++++++..+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999875 68999999875431 12334578899999999999999999997432 37
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++++||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 7999999999999998643 457888899999999999999998 899999999999999999999999999997653
Q ss_pred CCCc-ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQWT-HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~ 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK-----------IATQPT 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH-----------HHcCCC
Confidence 2111 1112335688999999999888899999999999999999999999976433221111 011111
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+....+.+.+++.+||. +|..||++.+++.
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222334567888999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.03 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=196.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||.|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++.+ .+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46888899999999999999865 688999999864332 2345688999999999999999999964 4478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999999853 457888999999999999999998 9999999999999999999999999999875543321
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......|++.|+|||.+.++.++.++|||||||++|++++|+.||.............. ...........
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~----------~~~~~~~~~~~ 240 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------NGTPELQNPEK 240 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc----------CCCCCCCCccc
Confidence 12334688899999999888899999999999999999999999976433221110000 00000011112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....+.+++.+||..+|.+||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23467789999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=294.48 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=191.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC---------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 185 (434)
++|.+.+.||+|+||.||+|... +++.||||.+...... .....+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46899999999999999999976 7899999998754322 222346789999999999999999986422
Q ss_pred -CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 -GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||||+. ++|.+.+......+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3489999997 47888887655678999999999999999999998 899999999999999999999999999997
Q ss_pred ccCCCCcc--cceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh--c------
Q 013927 265 WLPRQWTH--HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA--K------ 330 (434)
Q Consensus 265 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~--~------ 330 (434)
.+...... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||......... .. .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65432211 1122345788999999886644 788999999999999999999999754321110 00 0
Q ss_pred -cccCc----------cccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 331 -PLLDS----------NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 331 -~~~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.... ..........+... .....+.+++.+||..+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00000000000000 01245678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.85 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=200.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~ 191 (434)
.+.|.+.+.||+|.|++|.+|.+. ++..||||.+.+..... ..+.+.+|+.+|+.++|||||+++.+ ....+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457999999999999999999976 78999999998765543 33568899999999999999999997 456899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+.+|.+.+++.......+ .....++.|+++|++|||+ +.|||||||++|||++.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999986544444 7777788999999999999 99999999999999999999999999999887633
Q ss_pred ccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....++|++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++.. +.++-+..+.+.+
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------lk~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------LKELRPRVLRGKY 272 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------cccccchheeeee
Confidence 345678999999999999988765 78999999999999999999998622 1112222221111
Q ss_pred --CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 --DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 --~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.++|-.+|.+|++++++..
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1112245667889999999999999999964
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=294.96 Aligned_cols=259 Identities=25% Similarity=0.314 Sum_probs=192.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv 190 (434)
++|.+.+.||.|+||.||+|... +|+.||+|.+...... .....+.+|+.++++++|+||++++++.. +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 57899999999999999999976 6899999998754322 22234678999999999999999999742 347899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+. ++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99997 47888887656778999999999999999999999 899999999999999999999999999998664321
Q ss_pred cccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh------hccc------cCccc
Q 013927 271 THHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW------AKPL------LDSND 337 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~------~~~~------~~~~~ 337 (434)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..+. .....
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 11222345788999999865 457899999999999999999999997533221110 0000 00000
Q ss_pred -ccccc-CCcCCCCC---CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 -IRELV-DPSLGDNY---DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 -~~~~~-d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..... ........ .......+.+++.+||+.||++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00000000 0012355678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.82 Aligned_cols=241 Identities=24% Similarity=0.273 Sum_probs=190.7
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||.|+||.||+|... +++.||+|++.+.... .....+.+|+.+++.++||||+++++... +..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999976 5899999999765432 33457889999999999999999999743 468899999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 279 (434)
.+++... ..++...+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 9999743 457889999999999999999998 999999999999999999999999999998765432 122345
Q ss_pred cccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 280 gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...........++......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY---------NDILKGNGKLEFPNYIDKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH---------HHHhccCCCCCCCcccCHHHH
Confidence 78899999999888899999999999999999999999976442111000 011110111112222245788
Q ss_pred HHHHhhhccCCCCCCC-----HhHHHH
Q 013927 360 LTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
.++.+||+.+|++||+ +.|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 8999999999999999 566644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.33 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=214.1
Q ss_pred CCCeecccCcEEEEEEEeC-CC----cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEEEEc
Q 013927 121 SENLIGKGGYAEVYKGCLR-DG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLS 194 (434)
Q Consensus 121 ~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~e~~ 194 (434)
..++||.|+||+||+|.+- .| -+||||++...........++.|+-+|.+++|||+++++|++.. ...||++|+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 4578999999999999853 33 47999999887766667789999999999999999999998654 578999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++...+..+-....+.++.|||+||.|||+ ++++||||.++|+||..-..+||.|||+++.+........
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9999999999888899999999999999999999998 9999999999999999999999999999998876544443
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....-.+.|||-|.+....|+.++|||||||++||++| |..|++++... +|..++....+...++.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------eI~dlle~geRLsqPpi 924 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------EIPDLLEKGERLSQPPI 924 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------HhhHHHhccccCCCCCC
Confidence 333334678999999999999999999999999999998 99999875543 23334433333344555
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
....+.-++.+||..|+..||+++++...+..+..+.
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 6677888999999999999999999998886664443
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.35 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=193.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+|.+.+.||.|++|.||+|... +|..||||++...........+.+|+.++++++||||+++++++. +..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999986 689999999986554444456788999999999999999999744 4689999999
Q ss_pred CCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 195 PLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 195 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
++ +|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 84 7888775433 468999999999999999999998 8999999999999999999999999999975543211
Q ss_pred cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhh------hhhccccCccccccccC-C
Q 013927 273 HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV------IWAKPLLDSNDIRELVD-P 344 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~d-~ 344 (434)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .+..|.. .....+.+ +
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE--STWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh--hhHHHHhcCc
Confidence 11234568899999998664 478899999999999999999999975332111 0000100 00000000 0
Q ss_pred cCCC-----------CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGD-----------NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~-----------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+.. ...+.....+.+++.+||+.+|.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 001122356778999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=292.16 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=191.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|+..+.||.|++|.||+|... +|+.||||.+..... ......+.+|+.++++++||||++++++.. +..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999876 789999998875432 223346889999999999999999999743 478899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+. ++|.+++... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 96 6888888643 4568999999999999999999998 899999999999999999999999999987654321
Q ss_pred cceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-----ccccC------------
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----KPLLD------------ 334 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-----~~~~~------------ 334 (434)
.......++..|+|||++.+.. ++.++|||||||++|+|+||+.||........... .....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 1122334688999999887644 68899999999999999999999965332111100 00000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+.......+. .........+.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 000111245678899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=294.28 Aligned_cols=257 Identities=19% Similarity=0.190 Sum_probs=181.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhH----------hhHHHHHHHHhhCCCCCeeeEeee
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKT----------CGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
+.|.+.++||+|+||+||+|...+ +..+|+|+.......... .....+...+..+.|+|++.++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 569999999999999999998763 456677754332211100 112234445667789999999986
Q ss_pred ccC------CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 183 DSD------GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 183 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
... ..+++++++. .++.+.+.. ....++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 432 1245666654 356666543 2335677888999999999999998 8999999999999999999999
Q ss_pred EeccccccccCCCCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh-hhhc
Q 013927 257 ICDFGLAKWLPRQWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV-IWAK 330 (434)
Q Consensus 257 L~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~~~ 330 (434)
|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999865422111 111234699999999999988999999999999999999999999987532211 1100
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
. .+.+..+....+.. ....+.+.+++..||..+|++||++.++++.|.
T Consensus 247 ~---~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 K---CDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H---HHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 00001111111110 112356888999999999999999999998763
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.27 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=193.9
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC-chhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT-VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVFQ 192 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~e 192 (434)
|.+.+.||.|+||.||+|... +|+.||+|.+.... .......+.+|+.+++.++|||++++++++. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999976 58899999998754 2233446888999999999999999999743 45899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|++ ++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 998 48888887655678999999999999999999998 8999999999999999999999999999986654321
Q ss_pred cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hhc-cccCccccccc------
Q 013927 273 HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WAK-PLLDSNDIREL------ 341 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~~-~~~~~~~~~~~------ 341 (434)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ... ...........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 11223446788999998765 45789999999999999999999999754321110 000 00000000000
Q ss_pred --cCC------cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 --VDP------SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 --~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+ .+...+.......+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 0000000112457888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.99 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=191.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec-cC-CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SD-GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~-~~~lv~e 192 (434)
++|.+-+.||+|.|+.||++... +|+.+|+|.+..... ....+.+.+|+.|...|+||||+++.... .+ -.++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45777788999999999998765 799999998864322 23445788999999999999999999853 33 5789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla~~~~~~ 269 (434)
++.|++|..-+-.. ...++...-....||+++|.|+|. ++|||||+||+|+|+.. ..-+||+|||+|..+..+
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999988766432 445666677788999999999999 99999999999999964 346999999999987632
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh---hhhccccCccccccccCCcC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---IWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~d~~l 346 (434)
.....+.|||+|||||++...+|+..+|||+.|||||-|+.|..||-+..+... +.+... -+++..
T Consensus 167 ---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y--------d~~~~~ 235 (355)
T KOG0033|consen 167 ---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY--------DYPSPE 235 (355)
T ss_pred ---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc--------CCCCcc
Confidence 344567899999999999999999999999999999999999999977443321 111100 011100
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
- +...+...+|+.+||..||.+|.|+.|.+
T Consensus 236 w----~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 236 W----DTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred c----CcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 0 11124566788999999999999999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=288.10 Aligned_cols=245 Identities=22% Similarity=0.333 Sum_probs=193.7
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~~~ 195 (434)
|...+.||+|++|.||++... +++.||+|++..... .....+.+|+.+++.++||||++++++ ..+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444578999999999999865 788999998865432 334468899999999999999999996 3457899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|.+++.. ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 9999999865 568889999999999999999998 9999999999999999999999999998875543211 12
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
....|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ .....+.... .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~--~~~~~ 242 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI--------RDNLPPKLKN--LHKVS 242 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--------HhcCCCCCcc--cccCC
Confidence 2345889999999998888999999999999999999999998654322111000 0000011110 11123
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 46788999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=298.88 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=195.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc------CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~ 188 (434)
.+|.+.+.||.|+||.||+|... +|..||+|++..... ......+.+|+.++++++||||++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57899999999999999999866 689999999876432 223446778999999999999999988632 3578
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999996 689888864 3558999999999999999999998 8999999999999999999999999999976543
Q ss_pred CCcc--cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh------hccc------c
Q 013927 269 QWTH--HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW------AKPL------L 333 (434)
Q Consensus 269 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~------~~~~------~ 333 (434)
.... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 2211 11134568899999999865 458899999999999999999999996543221110 0000 0
Q ss_pred CccccccccCC-cCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 334 DSNDIRELVDP-SLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 334 ~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....+....+. ....... ......+..++.+||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00001111100 0000011 1224678889999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.30 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=195.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||.|+||.||+|... +|..||+|.+...... .....+.+|+.++++++|+||+++++++. +..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999976 6889999998764221 23346788999999999999999999744 368899999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~~~ 271 (434)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998653 3357899999999999999999998 8999999999999999886 469999999986643321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......|++.|+|||++.+..++.++||||||+++|+|++|..||............. .. .+.+ ..
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~----~~~~-----~~ 223 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC---QG----YFAP-----IS 223 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---cc----cCCC-----CC
Confidence 1223458899999999988889999999999999999999999997543322221110 00 0100 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||..+|++||++.+|+.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 122346778899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=289.75 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=191.6
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
|.+.+.||.|++|.||+|... +|..||||++...... .....+.+|+.+++.++|||++++++++. +..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 7999999998765322 22346888999999999999999999744 4688999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+ ++|.+++.... ..+++..+..++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 6 68999886543 468999999999999999999998 8999999999999999999999999999975532211
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh---c---ccc--------Ccc--
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA---K---PLL--------DSN-- 336 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~---~---~~~--------~~~-- 336 (434)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... . +.. ..+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223468899999988664 478999999999999999999999975432211100 0 000 000
Q ss_pred -ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 -DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 -~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+.. ..........+.+++.+||+.+|.+||++.+|+.
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0001112256788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.85 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=199.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|.+.+.||.|+||.||++... +++.||+|++...... .....+..|+++++.++|||++++++.. .+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999976 6899999999765432 4455788999999999999999999863 3578899999
Q ss_pred cCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+++++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764 3778999999999999999999998 899999999999999999999999999998665432
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||+........... . ... . ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~-~~~----~-----~~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--L-KGQ----Y-----PPI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--h-cCC----C-----CCC
Confidence 1223456889999999998888999999999999999999999999764322111100 0 000 0 111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++.+||..+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.16 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=191.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||.|+||.||+|... +++.||||.+...........+..|+.++.+.. ||||+++++++. ...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 46888899999999999999987 489999999976544444556777887777775 999999999744 36889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+. ++|.+++......+++..+..++.|++.||.|||+ ..+|+||||+|+||+++.++.+||+|||++..+.....
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 986 57777776545678999999999999999999996 25899999999999999999999999999876543211
Q ss_pred cceeccccccccccCCccccCC----CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI----VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||............... . .... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~-~~~~-----~~~ 241 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-E-EPPS-----LPP 241 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-C-CCCC-----CCC
Confidence 12334788999999987543 788999999999999999999999753322111110000 0 0000 000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 --NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123567889999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.23 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=189.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||.|++|.||+|... +|+.||||.+...... .....+.+|+.++++++||||++++++.. +..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 7899999988654332 23346788999999999999999999744 47899999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCCCC
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~~~ 270 (434)
|++ ++|.+.+... ....++.....++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 997 5777776543 3346788888999999999999998 89999999999999985 5579999999997654321
Q ss_pred cccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccCc----cccc
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLDS----NDIR 339 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~~----~~~~ 339 (434)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........... .+.... ..+.
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 112334578899999988664 578999999999999999999999975432211110 000000 0000
Q ss_pred cccC--CcCCCC----CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVD--PSLGDN----YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... +..... ........+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 01112345788999999999999999999975
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.49 Aligned_cols=240 Identities=24% Similarity=0.325 Sum_probs=192.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~ 191 (434)
++|..+++||+|.||+|.+++-+ +|+.+|+|++++.-. .+....-+.|-.+|+..+||.+..+--. ..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 57888999999999999999866 899999999988654 2334456778999999999999887443 456899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||..||.|.-+|.. ...+++.....+-..|+.||.|||+ ++||.||||.+|+|+|.+|++||+|||+++.-- ..
T Consensus 248 eyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KY 321 (516)
T ss_pred EEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--cc
Confidence 99999999998874 4556666666678899999999999 999999999999999999999999999998432 23
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....++++||+.|+|||++....|...+|.|.+|||+|||++|+.||...+.... +..... .++ .++
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeLIl~-----ed~-------kFP 388 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-FELILM-----EDL-------KFP 388 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-HHHHHh-----hhc-------cCC
Confidence 4556789999999999999999999999999999999999999999976433211 111010 011 112
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.....+...|+...|..||.+|..
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcC
Confidence 222345566788999999999953
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=292.41 Aligned_cols=255 Identities=23% Similarity=0.301 Sum_probs=188.0
Q ss_pred eeccc--CcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCC
Q 013927 124 LIGKG--GYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLG 197 (434)
Q Consensus 124 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~g 197 (434)
.||.| +||+||++.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++. +..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999875 799999999876433 334457888999999999999999999743 4688999999999
Q ss_pred CHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc---
Q 013927 198 SLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH--- 273 (434)
Q Consensus 198 sL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--- 273 (434)
+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++++|||.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999988753 3458889999999999999999998 899999999999999999999999998654332111100
Q ss_pred --ceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh---ccccCcc----------
Q 013927 274 --NVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA---KPLLDSN---------- 336 (434)
Q Consensus 274 --~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~---~~~~~~~---------- 336 (434)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||........... .+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01112346679999998764 478999999999999999999999976433221110 0000000
Q ss_pred ----------------ccc-----cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 ----------------DIR-----ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 ----------------~~~-----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+. ...+..+...........+.+++.+||+.+|++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 011111111222334567899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=289.48 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=193.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------- 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 185 (434)
..++|.+.+.||.|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467999999999999999999986 689999999975432 2233457789999999999999999986432
Q ss_pred -----CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 186 -----GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 186 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
..++|+||+++ ++...+......+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence 57899999986 6777776555678999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---cccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPLL 333 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~~ 333 (434)
|++..+..... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......... .. .+..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99986644321 111223457789999988654 4788999999999999999999999753321110 00 0000
Q ss_pred C-ccccccc-----cCC------cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 D-SNDIREL-----VDP------SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 ~-~~~~~~~-----~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. -..+... .++ ...... ......+.+++..||+.+|.+||++.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000000 000 000000 012356788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=278.81 Aligned_cols=246 Identities=29% Similarity=0.427 Sum_probs=199.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+|.+.+.||.|++|.||+|... +++.||+|.+...... .....+.+|++++.+++|||+++++++.. ...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 6789999999765432 34457899999999999999999998643 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998744 678999999999999999999998 89999999999999999999999999999876543221
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........+...... .+ ..+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~----~~~~~ 222 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--------HP----PLPEG 222 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC--------CC----CCCCC
Confidence 233457899999999988778999999999999999999999997654433332211100 00 11112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2356778899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=283.73 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=197.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+|.+.+.||+|+||.||++... +++.+|+|.+..... ......+..|+.++++++|+||++++++. .+..++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999865 788999999876432 23345678899999999999999998863 3478899999
Q ss_pred cCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
+++++|.+++.. ....+++..++.++.+++.||.|||+ .+++|+||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999998864 23568899999999999999999998 899999999999999999999999999998765431
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........... +........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~ 221 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK------------VQRGKYPPI 221 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HhcCCCCCC
Confidence 1234578899999999888899999999999999999999999976433211100 000111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2234466888999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.16 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=199.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~ 191 (434)
+-+|....+||.|.||.||-|... +|...|+|-+.-.... .......+|+.++..++|||+|+++|+ +.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 456788889999999999999854 7999999987654332 223457789999999999999999997 556899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC-
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW- 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~- 270 (434)
|||.+|+|.+++.. ....++.....+..|++.|+.|||+ .|||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999974 3344555555577899999999999 999999999999999999999999999998775442
Q ss_pred -cccceeccccccccccCCccccCC---CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 271 -THHNVSKFEGTFGYFAPEYFMHGI---VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 271 -~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
-........||+-|||||++.+.. -..++||||||||+.||+||++||...+....++..- ...-
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-----------~~gh 1458 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-----------AAGH 1458 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-----------hccC
Confidence 112334577999999999997644 4467899999999999999999999877766554321 1111
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
.+.++.....+-.+++..||..||++|-++.|+++.-
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2222333344556788999999999998888776543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=287.40 Aligned_cols=241 Identities=23% Similarity=0.247 Sum_probs=182.0
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHH---hhCCCCCeeeEeeec--cCCcEEEEEEcC
Q 013927 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGII---AYVDHPNTAKLVGCD--SDGIHLVFQLSP 195 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l---~~l~h~niv~l~g~~--~~~~~lv~e~~~ 195 (434)
+||+|+||.||++... +++.||||.+.+.... .....+.+|..++ ...+||||+.+++.. .+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6899999998765332 1122344444333 344799999998864 457889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 9999998863 3568999999999999999999999 899999999999999999999999999987553321 1
Q ss_pred eccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 276 SKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............. ........ .+...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~~~----~~~~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------MTLTVNVE----LPDSF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH------HhhcCCcC----Ccccc
Confidence 23458999999999864 458899999999999999999999997533211100000 00001111 12223
Q ss_pred HHHHHHHHHhhhccCCCCCC-----CHhHHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRP-----KMSQVVIL 382 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~ 382 (434)
...+..++.+||..+|.+|| ++.++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 35677889999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=296.06 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=194.2
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C--CcE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D--GIH 188 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~--~~~ 188 (434)
.++|.+.+.||.|+||.||+|... +|+.||||++..... ......+.+|+.+++++ +||||+++++++. + ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356888899999999999999976 688999998865322 22334577899999999 9999999999743 2 478
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||++ ++|..++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..+..
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999998 5898888643 78889999999999999999998 8999999999999999999999999999986644
Q ss_pred CCcc---cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh----hhccccCcc----
Q 013927 269 QWTH---HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----WAKPLLDSN---- 336 (434)
Q Consensus 269 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~~~~~~~~---- 336 (434)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 3221 12234568999999998765 45788999999999999999999999653321110 000000000
Q ss_pred ----ccccccCCcCC------CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 337 ----DIRELVDPSLG------DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 337 ----~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....+++.... ..........+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00001100000 00001123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=290.57 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=192.8
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC--chhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT--VDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
|...+.||.|+||.||+|... ++..||||.+.... .......+.+|+.+++.++|+|++++++++ .+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556678999999999999976 68899999987532 223345688899999999999999999973 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. |+|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 97 67887776555668899999999999999999998 89999999999999999999999999998765432
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
....|+..|+|||.+. .+.++.++|||||||++|+|++|..||.............. . ..+...
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~-----~~~~~~--- 235 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---N-----ESPALQ--- 235 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---c-----CCCCcC---
Confidence 2345788999999974 34578899999999999999999999865433221111100 0 001100
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.......+..++.+||+.+|++||++.+|+....-..
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1122345778899999999999999999987654333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.34 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=192.8
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||.|+||.||++... +|+.||+|.+...... .....+.+|+.++++++||||+++++... +..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 5899999998764332 34457888999999999999999998643 468899999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc------cc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT------HH 273 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~------~~ 273 (434)
.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999753 378999999999999999999998 8999999999999999999999999999875433211 11
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......++..|+|||.+....++.++||||||+++|+|++|..||........... +............
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~~~~~~~~ 225 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-----------ILNGKIEWPEDVE 225 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------HhcCCcCCCcccc
Confidence 22345578899999999888899999999999999999999999975433221110 0000000000001
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+..++.+||+.+|.+||++..|.+.|+.
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 23567889999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=286.15 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=191.8
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
|.+.+.||.|+||+||+|... +++.||||++.............+|+..+.+++ ||||+++++++ .+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999986 578999999876543333334567999999999 99999999974 34789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+|+|.+++.... ..+++..+..++.|++.||.|||+ ++++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 788988887543 578999999999999999999998 899999999999999999999999999997654321
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccc--------cCcccc
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPL--------LDSNDI 338 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~--------~~~~~~ 338 (434)
......++..|+|||++.. ..++.++|+||||+++|||++|+.||........... .+. .....+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1223457889999998854 4578999999999999999999999965432211100 000 000000
Q ss_pred ccccCCcCCC---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGD---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+...... .........+..++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 000111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.91 Aligned_cols=259 Identities=18% Similarity=0.237 Sum_probs=189.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCC-CCCeeeEeeeccC--C-----
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD--G----- 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~----- 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||.+...... .....+.+|+.+++.+. ||||++++++... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999976 7899999988654322 22346788999999995 6999999986432 2
Q ss_pred cEEEEEEcCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccc
Q 013927 187 IHLVFQLSPLGSLASILHGS----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFG 261 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFG 261 (434)
.++||||+++ +|.+++... ...+++..+..++.||+.||.|||+ ++|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999985 788877542 2457999999999999999999998 99999999999999998 8899999999
Q ss_pred cccccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccC
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLD 334 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~ 334 (434)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||........... .+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9876533211 1122346888999998865 4578999999999999999999999975332211100 00000
Q ss_pred c-cccccccC----CcCCC----CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 335 S-NDIRELVD----PSLGD----NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 335 ~-~~~~~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. .....+.+ +.... ...+.....+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000000 00000 000112356788999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=292.37 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=189.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC---CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~ 188 (434)
.|.+.+.||+|+||.||+|... ++..||||.+..... ......+.+|+.++++++||||+++++++. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777889999999999999975 378999999986431 222345788999999999999999999744 3588
Q ss_pred EEEEEcCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC----CCCeEEecc
Q 013927 189 LVFQLSPLGSLASILHG----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE----DYEPQICDF 260 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kL~DF 260 (434)
+||||+++ +|.+++.. ....++...+..++.|++.||.|||+ ++|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 56665542 12367888999999999999999998 89999999999999999 899999999
Q ss_pred ccccccCCCCc-ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhh------------
Q 013927 261 GLAKWLPRQWT-HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV------------ 326 (434)
Q Consensus 261 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~------------ 326 (434)
|++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643322 1122334678999999988764 578999999999999999999999975432210
Q ss_pred ---hhhcccc-------CccccccccCCcCCCCCC----H-------HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 327 ---IWAKPLL-------DSNDIRELVDPSLGDNYD----A-------EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 327 ---~~~~~~~-------~~~~~~~~~d~~l~~~~~----~-------~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+..+.. .........+......++ . .....+..++.+||+.+|++||++.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000000000000011 0 22346788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=286.34 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=195.2
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
|.+.+.||.|++|.||+|... +|+.+|+|.+...... .....+..|+.++++++|+||++++++. .+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999876 7899999998765432 2345688899999999999999999964 34789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++ +|.+++......+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 85 8888887655688999999999999999999998 899999999999999999999999999998765432 11
Q ss_pred eeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhccccCccccccccC----
Q 013927 275 VSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPLLDSNDIRELVD---- 343 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~~~~~~~~~~~d---- 343 (434)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......... ...+. ......+.+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD--PEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc--hHhcccchhhhhh
Confidence 2234578899999998776 6889999999999999999999999653321110 00000 000000000
Q ss_pred -----Cc----CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 -----PS----LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 -----~~----l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+. ............+.+++..||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 000011223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=284.47 Aligned_cols=239 Identities=26% Similarity=0.317 Sum_probs=185.1
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~gsL 199 (434)
||+|+||+||++... +|+.||+|.+..... ......+..|+.+++.++||||+++++.. .+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 789999999875432 12334567899999999999999999863 3468999999999999
Q ss_pred HHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecc
Q 013927 200 ASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278 (434)
Q Consensus 200 ~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 278 (434)
.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99987543 368899999999999999999998 89999999999999999999999999998765432 112234
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRA 358 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 358 (434)
.++..|+|||++.++.++.++|||||||++|+|++|+.||.......... .+...... .....+......+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~ 225 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--------ELKRRTLE-MAVEYPDKFSPEA 225 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--------HHHhcccc-ccccCCccCCHHH
Confidence 57889999999988889999999999999999999999997643211000 00000000 0001111223567
Q ss_pred HHHHHhhhccCCCCCCCHhH
Q 013927 359 VLTASLCIEQSPILRPKMSQ 378 (434)
Q Consensus 359 ~~l~~~Cl~~~P~~RPs~~e 378 (434)
..++.+||+.+|.+||+..+
T Consensus 226 ~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHccCChhHccCCCc
Confidence 78999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=295.80 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=196.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~ 187 (434)
+.|.+.+.||+|+||+||+|... +|..||||.+..... ......+..|+.+++.++|+||++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46888999999999999999865 789999999875422 223345778999999999999999998642 237
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 89999996 688888863 3568999999999999999999998 899999999999999999999999999998654
Q ss_pred CCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhccc------cC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPL------LD 334 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~------~~ 334 (434)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ...+. ..
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 160 EKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 321 11233457889999998865 45889999999999999999999999653211100 00000 00
Q ss_pred cccccccc-------CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCCCCc
Q 013927 335 SNDIRELV-------DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGDEDN 389 (434)
Q Consensus 335 ~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~~~~ 389 (434)
.......+ ++.... ........+.+++.+||+.+|++||++.++++. ++.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000000 000000 011233567889999999999999999999866 6554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.17 Aligned_cols=243 Identities=30% Similarity=0.445 Sum_probs=190.3
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
|...+.||+|+||+||+|... +|..||+|++..... ......+..|+.+++.++|||++++++++. +..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999875 688999999875432 233346888999999999999999999744 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+. |+|.+++......+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 57777776556678999999999999999999998 8999999999999999999999999999864322
Q ss_pred ceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||............... .. +...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~-----~~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DS-----PTLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CC-----CCCC---
Confidence 12346889999999984 456888999999999999999999998764432222111000 00 0000
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.......+..++.+||+.+|.+||++.+++..
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112357778999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=293.41 Aligned_cols=263 Identities=27% Similarity=0.380 Sum_probs=197.6
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhh--CCCCCeeeEeeecc------CCcEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY--VDHPNTAKLVGCDS------DGIHLV 190 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~------~~~~lv 190 (434)
..+..+||+|.||.||+|.+. ++.||||++.. ...+.|+.|-+|.+- +.|+||+++++... -.++||
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 344467999999999999997 69999999864 445678888887765 57999999999732 268999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC------CCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC------QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~------~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
++|.+.|+|.++|. ...++|....+|+..+++||+|||+.. ..+|+|||||+.||||..|+++.|+|||+|.
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999995 478999999999999999999999742 4579999999999999999999999999999
Q ss_pred ccCCCCcccceeccccccccccCCccccCC-CC-----CcCcEEehhHHHHHHHhCCCcccc--ccchhhhhhccccCcc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-VD-----EKTDVYSFGVLLLELITGRRAVDH--LQQSVVIWAKPLLDSN 336 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDvwSlGvil~elltG~~p~~~--~~~~~~~~~~~~~~~~ 336 (434)
.+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||++....++. .++....+........
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 887654444445578999999999997653 22 357999999999999998765531 1111111111111111
Q ss_pred cc---cccc-CCcCCCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 337 DI---RELV-DPSLGDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 337 ~~---~~~~-d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.+ .+++ ....++.++. ..+.-+.+.+..||..||+.|.|+.=|-+++..+..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11 1111 1111222221 345678889999999999999999988888765543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.36 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=182.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---------- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 185 (434)
.+|+...+||+||||.||+++++ ||+.||||+|...........+.+|+.++++|+|||||++|..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 46888889999999999999998 9999999999877655555678999999999999999998652100
Q ss_pred --------------------------------------------------------------------------------
Q 013927 186 -------------------------------------------------------------------------------- 185 (434)
Q Consensus 186 -------------------------------------------------------------------------------- 185 (434)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred -------------------------------CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCC
Q 013927 186 -------------------------------GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234 (434)
Q Consensus 186 -------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~ 234 (434)
-+|+=||||+..+|.++++.+...-.....++++.+|++||.|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~--- 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD--- 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---
Confidence 0123356666555555554322211355677899999999999999
Q ss_pred CCeeecCCCCCcEEecCCCCeEEeccccccccC----------C------CCcccceeccccccccccCCccccC---CC
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLP----------R------QWTHHNVSKFEGTFGYFAPEYFMHG---IV 295 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~---~~ 295 (434)
+|||||||||.||++++++.|||+|||+|+... . .......+..+||.-|+|||++.+. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 899999999999999999999999999998621 0 0111133567899999999999764 49
Q ss_pred CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC--CCHHHHHHHHHHHHhhhccCCCCC
Q 013927 296 DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN--YDAEEIDRAVLTASLCIEQSPILR 373 (434)
Q Consensus 296 ~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~R 373 (434)
+.|+|+|||||||+||+. ||...-....+. ..+.++.+..+ +.......=..+|.++++.||.+|
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL----------~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASIL----------TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHH----------HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 999999999999999986 565422221111 11222222211 222333444668899999999999
Q ss_pred CCHhHHH
Q 013927 374 PKMSQVV 380 (434)
Q Consensus 374 Ps~~evl 380 (434)
||+.|++
T Consensus 863 PtA~eLL 869 (1351)
T KOG1035|consen 863 PTATELL 869 (1351)
T ss_pred CCHHHHh
Confidence 9999996
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=280.27 Aligned_cols=243 Identities=25% Similarity=0.281 Sum_probs=185.9
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHH-hhCCCCCeeeEeeecc--CCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGII-AYVDHPNTAKLVGCDS--DGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~h~niv~l~g~~~--~~~~lv~e~~~~ 196 (434)
+.||.|+||.||+|... +|+.||||++.+.... .....+..|..++ ...+|+|++++++++. +..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 6899999998754321 1222344555444 4558999999999754 468999999999
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|.||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 999999964 3467889999999999999999999 8999999999999999999999999999875432 12
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...|+..|+|||.+.+..++.++||||||+++|+|++|..||......... .... .... ............
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~--~~~~------~~~~~~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-DNIL--SRRI------NWPEEVKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHH--hccc------CCCCcccccCCH
Confidence 345788999999998888899999999999999999999999754332211 1000 0000 000011112235
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.+..++.+||+.+|++||++.++.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 6788999999999999999887766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=291.38 Aligned_cols=246 Identities=27% Similarity=0.365 Sum_probs=195.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCCCCCeeeEee-e-ccCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHPNTAKLVG-C-DSDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g-~-~~~~~~lv~ 191 (434)
+.|..-++||+||||.||-+..+ +|+.+|.|.+.+..... ...-.++|-.+|.+++.+.||.+-- + ..+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888899999999999998865 79999999887654422 2335788999999999999999854 3 456899999
Q ss_pred EEcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 192 QLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
..|+||+|.-+|.. ....+++.....+|.+|+.||++||. .+||.|||||+|||+|+.|++.|+|.|+|..++...
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999988875 34678999999999999999999998 999999999999999999999999999999887653
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
. ....+||.+|||||+++++.|+...|+|||||+||||+.|+.||......... ..+...+-. -...+
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------eEvdrr~~~-~~~ey 409 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------EEVDRRTLE-DPEEY 409 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--------HHHHHHHhc-chhhc
Confidence 3 33457999999999999999999999999999999999999999764332211 011111100 00112
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
+....++...+....|+.||++|...+
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCC
Confidence 222334566677888999999997654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=281.35 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=189.6
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhC---CCCCeeeEeeecc--CC-----
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYV---DHPNTAKLVGCDS--DG----- 186 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~--~~----- 186 (434)
|.+.+.||.|+||.||+|... +++.||||++...... .....+.+|+.++.++ +|||++++++++. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999987 5899999999754332 2233566788777666 6999999999743 23
Q ss_pred cEEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
.+++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 789999998 47888886532 368999999999999999999999 8999999999999999999999999999976
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--hhccccCcc--c---c
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--WAKPLLDSN--D---I 338 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~~~~~~~~~--~---~ 338 (434)
+.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ......... . .
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 64331 112334788999999999888999999999999999999999998753321110 000000000 0 0
Q ss_pred ----ccccCCcCC---CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 ----RELVDPSLG---DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111123466788999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=287.64 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=185.8
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCC-chhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGT-VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
+.+|.|+++.||++.. +++.||||++.... .......+..|+.+++.++||||++++++.. +..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555444 58999999998652 3344567899999999999999999999743 468899999999999
Q ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc-----cc
Q 013927 200 ASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT-----HH 273 (434)
Q Consensus 200 ~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~-----~~ 273 (434)
.+++... ...+++.....++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+..+..... ..
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999753 3568888999999999999999998 8999999999999999999999999999875432211 11
Q ss_pred ceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc------cccCccc-------c
Q 013927 274 NVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK------PLLDSND-------I 338 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~------~~~~~~~-------~ 338 (434)
......++..|+|||++... .++.++|||||||++|||++|..||............ ....... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 11234567889999998763 5889999999999999999999999764432221110 0000000 0
Q ss_pred c----cccCCcCC----CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 R----ELVDPSLG----DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~----~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. ...++... ..........+..++.+||+.+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 00011000 1111222356788999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=289.22 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=192.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeeccC--------
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 185 (434)
.++|.+.+.||.|+||.||+|... +++.||||++....... ....+.+|+.+++.++||||++++++..+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 357999999999999999999976 68999999987543322 22357789999999999999999885321
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
..++|++|+.. +|...+......+++..+..++.|+++||.|||+ ++|+||||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35899999874 6777776556679999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCcc---------cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchh---hhhh-
Q 013927 264 KWLPRQWTH---------HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VIWA- 329 (434)
Q Consensus 264 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~~~- 329 (434)
......... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432111 111234578889999988654 48899999999999999999999997533211 1110
Q ss_pred --ccccC----ccccccccCCcCCCCCC-------HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 330 --KPLLD----SNDIRELVDPSLGDNYD-------AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 330 --~~~~~----~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+... ...+....+.......+ ......+.+++.+||+.+|.+||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 00000000000000000 111256788999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=293.98 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=192.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------G 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.. .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67999999999999999999965 7899999998754322 223457889999999999999999987432 3
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++|++|+. ++|..++. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++..
T Consensus 95 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 589999986 46776653 357889999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hhccccCcccc----
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WAKPLLDSNDI---- 338 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~~~~~~~~~~---- 338 (434)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... +.........+
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 322 223457889999999876 45889999999999999999999999764321111 10000000000
Q ss_pred -----ccccC--Cc-CCCCCC---HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCCCC
Q 013927 339 -----RELVD--PS-LGDNYD---AEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGDED 388 (434)
Q Consensus 339 -----~~~~d--~~-l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~~~ 388 (434)
...+. +. ...... +.....+.+++.+||+.+|++||++.+++.. ++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00 000000 0123457789999999999999999999843 655543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=291.61 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=199.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-------CcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------GIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~~ 188 (434)
+|.+.+.||.|+||.||+|... +|+.||||++..... ......+..|+.+++.++||||++++++..+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999976 589999999876542 2334578899999999999999999997432 478
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
++|+|++ ++|.+++... ..+++..+..++.+++.||.|||+ ++|+||||||.|||++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 5788888643 478999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcc-cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh------hhcccc------C
Q 013927 269 QWTH-HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI------WAKPLL------D 334 (434)
Q Consensus 269 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------~~~~~~------~ 334 (434)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......... ...+.. .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 3210 112334578899999999887 7899999999999999999999999754321110 000000 0
Q ss_pred ccccccccCC-cCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCCC
Q 013927 335 SNDIRELVDP-SLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~~ 387 (434)
.......+.. ...... .......+.+++.+||+.+|.+||++.+++.. +++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000000 000000 01123567889999999999999999999863 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=300.55 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=189.4
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEE---EEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----CcEEEEEE
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAV---KRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GIHLVFQL 193 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vav---K~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~lv~e~ 193 (434)
..+||+|+|-+||+|.+. +|..||= |.-.........+.|..|+.+|+.|+||||+++|..+.+ ...+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999976 6766653 222222233455789999999999999999999997443 36789999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~~~~~~~ 272 (434)
+..|+|..|+.. -...+...+..++.||++||.|||+.. .+|||||||-.||+|+.+ |.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 999999999973 456788899999999999999999843 689999999999999865 799999999999875442
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcccc--CccccccccCCcCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLL--DSNDIRELVDPSLGDNY 350 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~~ 350 (434)
.....|||.|||||++. ..|++.+||||||++|+||+|+..||..-.....++.+-.- ....+...-|
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------- 270 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------- 270 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC-------
Confidence 22367999999999986 77999999999999999999999999876555555432111 0111111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.++..+|.+||.. ..+||++.|++.
T Consensus 271 -----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 -----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3567788999999 999999999974
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.26 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=195.7
Q ss_pred CHHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-
Q 013927 108 TLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS- 184 (434)
Q Consensus 108 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~- 184 (434)
...++...+++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++.+++||||++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566777889999999999999999999865 7899999998764322 23346788999999999999999998642
Q ss_pred -------CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 185 -------DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 185 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence 2356777776 6789888853 458899999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hhc---
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WAK--- 330 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~~--- 330 (434)
+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ...
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754322 223457889999998866 46889999999999999999999999643321110 000
Q ss_pred ------cccCcccccccc---CCcCCCCC---CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 331 ------PLLDSNDIRELV---DPSLGDNY---DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 331 ------~~~~~~~~~~~~---d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+..........+ .......+ .......+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000 00000000 00123457889999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=280.91 Aligned_cols=240 Identities=24% Similarity=0.275 Sum_probs=181.9
Q ss_pred eecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHH---HHHhhCCCCCeeeEeeec--cCCcEEEEEEcC
Q 013927 124 LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEI---GIIAYVDHPNTAKLVGCD--SDGIHLVFQLSP 195 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~ 195 (434)
+||+|+||.||+|... +++.||+|.+.+.... .....+..|. .++....||||+.+++.. .+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 6889999998764332 1112233443 344556899999998863 347889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+|+|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++..+.... .
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 9999998863 4568999999999999999999999 899999999999999999999999999987554321 1
Q ss_pred eccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 276 SKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||............ .........+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~----~~ 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------RMTLTMAVELPD----SF 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH------HHhhccCCCCCC----cC
Confidence 234689999999998755 5899999999999999999999999764221110000 000001111111 12
Q ss_pred HHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 355 IDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
...+.+++.+||..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 35677888999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=311.53 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=205.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC----C----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR----D----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 185 (434)
..++..+.+.||+|+||.|++|... . ...||||.+...........+..|+.+|+.+ .|+||+.++|++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3345556679999999999999743 1 4579999998776666677899999999998 59999999997654
Q ss_pred --CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEE
Q 013927 186 --GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNIL 248 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIl 248 (434)
..++|+||+..|+|.++|...+ ..+.....+.++.|||.|++||++ .++|||||.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEE
Confidence 6889999999999999998655 348888999999999999999999 89999999999999
Q ss_pred ecCCCCeEEeccccccccCCCCcccceecccc--ccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchh
Q 013927 249 LTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG--TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSV 325 (434)
Q Consensus 249 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 325 (434)
++.+..+||+|||+|+......... ...-.| ...|||||.+....|+.++|||||||+||||+| |..||.+.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 9999999999999998654432221 111112 345999999999999999999999999999998 778887633221
Q ss_pred hhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 326 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..+ +.+....+...+..+..++..++..||+.+|++||++.++++.|+..
T Consensus 530 ~l~-----------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELL-----------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHH-----------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 12333333334444567888999999999999999999999999874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=278.99 Aligned_cols=245 Identities=23% Similarity=0.276 Sum_probs=185.9
Q ss_pred HHHHHhcCCCCCCee--cccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhh-CCCCCeeeEeeec--c
Q 013927 111 ELQTATKNFSSENLI--GKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY-VDHPNTAKLVGCD--S 184 (434)
Q Consensus 111 ~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~--~ 184 (434)
+.....++|.+.+.+ |.|+||.||++... ++..+|+|.+........ |+..... .+||||+++++.+ .
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecC
Confidence 444445677777776 99999999999875 788999999875432111 2222222 2799999999874 4
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLA 263 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla 263 (434)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 5789999999999999999754 388999999999999999999999 8999999999999999998 9999999998
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
...... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||............ +.....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~ 224 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES-------LLKRQQ 224 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH-------HHHhhc
Confidence 765432 2235789999999999888999999999999999999999999753322110000 000000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCC-HhHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPK-MSQVV 380 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl 380 (434)
... .........+.+++.+||+.+|.+||+ +++++
T Consensus 225 ~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 225 KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 000 011123356788899999999999996 58886
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.27 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=193.7
Q ss_pred HHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCc
Q 013927 113 QTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGI 187 (434)
Q Consensus 113 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~ 187 (434)
...+++|.+.+.||.|+||.||+|... +|..||||++.+... ......+..|+.++..++||||+++++++ ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999866 789999998865322 22344677899999999999999999964 2358
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++++||+. ++|..++.. ..++......++.|+++||.|||+ ++|+||||+|.||+++.++.++|+|||++....
T Consensus 86 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELLG-TDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehhc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 89999984 689888853 457788888899999999999999 899999999999999999999999999987543
Q ss_pred CCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhh--hh-----------hcccc
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV--IW-----------AKPLL 333 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~-----------~~~~~ 333 (434)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .. .....
T Consensus 160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 22 123457889999998766 4689999999999999999999999965332110 00 00000
Q ss_pred CccccccccCCcCCCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 334 DSNDIRELVDPSLGDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......-+.........+. .....+.+++.+||+.+|++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000111111 123578889999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.48 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=197.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||.|+||.||+|... +|+.||+|++..... ......+..|+.++.++. ||||++++++.. +..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 789999999876322 233456888999999999 999999998743 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999743 478999999999999999999998 899999999999999999999999999998654332
Q ss_pred cc------------------cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc
Q 013927 271 TH------------------HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 271 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 332 (434)
.. .......|+..|+|||.+....++.++||||||++++++++|+.||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---- 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ---- 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----
Confidence 11 12234567899999999988889999999999999999999999997644221110
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCH----hHHHH
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKM----SQVVI 381 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~evl~ 381 (434)
.... .....+......+..++.+||+.+|.+||++ .+++.
T Consensus 233 -------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 -------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 0011112224567889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=283.79 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=189.7
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEEcCCCCH
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL 199 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~~~~gsL 199 (434)
.+||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++|+||++++++ ..+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999875 78999999886433 2334568899999999999999999986 34578999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 279 (434)
.+++.. ..+++.....++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ......
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 998853 457889999999999999999999 8999999999999999999999999999876543211 123345
Q ss_pred cccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 280 gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... +.....+.+.. .......+.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~--------~~~~~~~~~~~--~~~~~~~l~ 247 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------IRDNLPPKLKN--LHKVSPSLK 247 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhhCCcccCC--cccCCHHHH
Confidence 78999999999888889999999999999999999999975432211100 00001111100 011223567
Q ss_pred HHHHhhhccCCCCCCCHhHHHH
Q 013927 360 LTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.++.+||+.+|.+||++.+|+.
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 7889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.08 Aligned_cols=262 Identities=20% Similarity=0.232 Sum_probs=178.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC--CCcEEEEEEee--------------CC--CchhhHhhHHHHHHHHhhCCCCCee
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLT--------------KG--TVDEKTCGFLCEIGIIAYVDHPNTA 177 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~--------------~~--~~~~~~~~~~~E~~~l~~l~h~niv 177 (434)
.++|.+.+.||+|+||+||++..+ .+..+++|.+. +. ........+.+|+.+|.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754 22222222111 00 0112234578899999999999999
Q ss_pred eEeeec--cCCcEEEEEEcCCCCHHHHhccC----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 178 KLVGCD--SDGIHLVFQLSPLGSLASILHGS----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 178 ~l~g~~--~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
+++++. .+..++|++++. ++|..++... ...........|+.||+.||.|||+ ++||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 999974 346888999886 4666665432 1223355667899999999999998 99999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCc-cccccch--hh--
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA-VDHLQQS--VV-- 326 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p-~~~~~~~--~~-- 326 (434)
++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ +...... ..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999876543211 12245689999999999998999999999999999999998854 4321110 00
Q ss_pred -hhhccccCccc-------cccccCCc-CC--CCCCH------HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 327 -IWAKPLLDSND-------IRELVDPS-LG--DNYDA------EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 327 -~~~~~~~~~~~-------~~~~~d~~-l~--~~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+.......... +...++.. +. ..... .....+..++.+||+.||++||++.|++..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 00000000 00 00000 011345667899999999999999999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=283.51 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=203.3
Q ss_pred cCHHHHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhh--CCCCCeeeEeeecc
Q 013927 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY--VDHPNTAKLVGCDS 184 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~ 184 (434)
.++.-..+..+...+.+.||+|.||+||+|.++ |..||||++.... +..+.+|.+|... |+|+||+.+++...
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 444444555577888899999999999999998 8999999997532 3357788888765 59999999998732
Q ss_pred ------CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhcc-----CCCCeeecCCCCCcEEecCCC
Q 013927 185 ------DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG-----CQKRIIHRDIKADNILLTEDY 253 (434)
Q Consensus 185 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~-----~~~~iiHrDlkp~NIll~~~~ 253 (434)
..++||.+|.+.|||.++|. ...++....++++..+|.||++||.. ....|.|||||+.||||..++
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 25889999999999999995 47899999999999999999999962 245699999999999999999
Q ss_pred CeEEeccccccccCCCCcc--cceeccccccccccCCccccCC----CC--CcCcEEehhHHHHHHHhCC----------
Q 013927 254 EPQICDFGLAKWLPRQWTH--HNVSKFEGTFGYFAPEYFMHGI----VD--EKTDVYSFGVLLLELITGR---------- 315 (434)
Q Consensus 254 ~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~~--~ksDvwSlGvil~elltG~---------- 315 (434)
.+.|+|+|||......... ......+||.+|||||++.... ++ ..+||||||.|+||+.-..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999766543221 1234568999999999986542 22 3589999999999997632
Q ss_pred Cccccccc---hhhhhhccccCccccccccCCcCCCCC-CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 316 RAVDHLQQ---SVVIWAKPLLDSNDIRELVDPSLGDNY-DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 316 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.||.+.-+ +...+.+.. - .+-+.|.+.... +.+.+..+.+++..||..+|.-|-|+-.|...|..+..
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVV-C----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVV-C----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCcccCCCCCCCHHHHhcce-e----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 45543211 111110000 0 011122222222 34678999999999999999999999999888876654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.78 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=189.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---------- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 185 (434)
++|.+.+.||.|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++||||++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57889999999999999999876 689999999876543 334468889999999999999999875322
Q ss_pred ------CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-CCCCeEEe
Q 013927 186 ------GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQIC 258 (434)
Q Consensus 186 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~ 258 (434)
..++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.++|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 3689999997 588888853 458889999999999999999998 8999999999999997 45678999
Q ss_pred ccccccccCCCCcccc-eeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh----hhccc
Q 013927 259 DFGLAKWLPRQWTHHN-VSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----WAKPL 332 (434)
Q Consensus 259 DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~~~~ 332 (434)
|||++..+........ .....|+..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ...+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976543222111 122357889999998754 45788999999999999999999999754322111 00011
Q ss_pred cCcccccccc-------C-CcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 LDSNDIRELV-------D-PSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ~~~~~~~~~~-------d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+. . .......+ ......+.+++.+||+.+|.+||++.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000 0 00000000 112356778999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.05 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=192.0
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC------
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------ 185 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------ 185 (434)
...++|.+.+.||+|+||.||+|... +|..||||++...... .....+.+|+.++++++||||++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34568999999999999999999865 7899999998654322 233467899999999999999999986432
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
..++||+|+ +++|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 248999998 6789888853 568899999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhh---hhhccccC-----
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV---IWAKPLLD----- 334 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---~~~~~~~~----- 334 (434)
...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ +.......
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 765432 223457889999999876 3588899999999999999999999975332111 00000000
Q ss_pred ----ccccccccC--CcCC-C---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 335 ----SNDIRELVD--PSLG-D---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 335 ----~~~~~~~~d--~~l~-~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
......... +... . .........+.+++.+|++.+|.+||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000000000 0000 0 00011234577899999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.04 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=193.7
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
|...+.||+|+||.||+|... +++.||+|.+..... ......+..|+.++++++|+|+++++++.. +..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999976 589999999986542 223346788999999999999999999743 4789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+ ++|.+++......+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 8 58999997654678999999999999999999999 8999999999999999999999999999976543221 1
Q ss_pred eeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh--------------hhccc-c--Ccc
Q 013927 275 VSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--------------WAKPL-L--DSN 336 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------------~~~~~-~--~~~ 336 (434)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......... |.... . ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233457789999998776 7899999999999999999999999653321110 00000 0 000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
............. .+.....+.+++..||..+|++||++.+|+.
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 0111456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=281.79 Aligned_cols=253 Identities=26% Similarity=0.271 Sum_probs=194.0
Q ss_pred CCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCch---hhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVD---EKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
+|.+.+.||+|+||.||++... ++..||||++.+.... .....+..|+.++.++ +||||++++++.. +..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999998742 5788999998754321 2234678899999999 5999999988643 467
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|.||+++.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 899999999999999864 3567888899999999999999998 999999999999999999999999999987654
Q ss_pred CCCcccceeccccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchh--hhhhccccCccccccccC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSV--VIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d 343 (434)
..... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ..... .+... .
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~------~~~~~-~ 228 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR------RILKS-K 228 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH------HHHcc-C
Confidence 33111 122345889999999987655 7889999999999999999999986422110 00000 00000 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+... ......+.+++.+||+.+|++|||+.+|.+.|+..
T Consensus 229 ~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 PPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111 11224567889999999999999999998888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=286.49 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=189.5
Q ss_pred CCC-CCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhh-------------HhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 118 NFS-SENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEK-------------TCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 118 ~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
+|. +.+.||.|+||+||+|... +++.||||.+........ ...+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 454 4577999999999999976 789999999875432210 1146789999999999999999997
Q ss_pred c--cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 183 D--SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 183 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
+ .+..++||||+. |+|.+++. ....+++.....++.|++.||.|||+ .+++||||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence 4 446889999997 68988886 34568889999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCC------------cccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhh
Q 013927 261 GLAKWLPRQW------------THHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327 (434)
Q Consensus 261 Gla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 327 (434)
|++....... .........++..|+|||.+.+.. ++.++|||||||++|+|++|..||.........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997654110 011122334688899999987644 688999999999999999999999764432111
Q ss_pred ---hh---ccccC---c-ccc------ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 328 ---WA---KPLLD---S-NDI------RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 328 ---~~---~~~~~---~-~~~------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .+... . ..+ .....+.... ........+.+++..||+.+|++||++.+++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00 00000 0 000 0000000000 00112356778999999999999999999975
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=279.93 Aligned_cols=248 Identities=26% Similarity=0.313 Sum_probs=188.0
Q ss_pred CCCCCCeecccCcEEEEEEEe----CCCcEEEEEEeeCCCch---hhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--Cc
Q 013927 118 NFSSENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVD---EKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GI 187 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~ 187 (434)
+|.+.+.||.|+||.||++.. .+|..||+|++...... .....+..|+.++.++ +|+||+.++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 36889999998754321 2234678899999999 59999999987443 57
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 899999999999999864 3567888888999999999999998 999999999999999999999999999997654
Q ss_pred CCCcccceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHhCCCccccccch--hhhhhccccCccccccccC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGRRAVDHLQQS--VVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d 343 (434)
.... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ......... . ..
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------~-~~ 228 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL------K-SE 228 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh------c-cC
Confidence 3211 112235588999999998753 4678999999999999999999998642211 110100000 0 00
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
+ .++......+..++.+||..+|++|| ++.+++.
T Consensus 229 ~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 11112234667889999999999997 5566543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=286.80 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=187.9
Q ss_pred CCCCCCeecccCcEEEEEEEeC-C--CcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc------CC
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-D--GTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS------DG 186 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~------~~ 186 (434)
+|.+.+.||+|+||.||++... . +..||||++..... ......+.+|+.+++++ +||||+++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999976 4 78999999875322 12344678899999999 5999999998521 24
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.+++++|+. ++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 678888886 68888886 34568899999999999999999998 89999999999999999999999999999865
Q ss_pred CCCCcc--cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh----hhccccCccccc
Q 013927 267 PRQWTH--HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----WAKPLLDSNDIR 339 (434)
Q Consensus 267 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~~~~~~~~~~~~ 339 (434)
...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..........+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432111 11233568999999998765 45889999999999999999999999753311000 000000000000
Q ss_pred cccCC-----------cCCC---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 340 ELVDP-----------SLGD---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 340 ~~~d~-----------~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.+..+ .-.. .........+..++.+||+.+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 0000 00011234678899999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=274.48 Aligned_cols=247 Identities=26% Similarity=0.340 Sum_probs=190.7
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeee--ccCCcEEEEEEcCCCC
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC--DSDGIHLVFQLSPLGS 198 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~--~~~~~~lv~e~~~~gs 198 (434)
..||.|+||+|++-.++ .|+..|||++.....+....+++.|.+...+- +.||||++||. .+...++.||+|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 46999999999998876 89999999999877666666888898866554 68999999995 4456889999997 46
Q ss_pred HHHHhcc----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 199 LASILHG----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 199 L~~~l~~----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
|+.+... .+..+++...-.|+..++.||.||.. ...|||||+||+|||++..|.+||||||++..+... ..
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iA 223 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IA 223 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH---HH
Confidence 6654432 45668888888899999999999998 489999999999999999999999999999876543 22
Q ss_pred eeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 275 VSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.+.-.|...|||||.+.. ..|+-++||||||++|||+.||..|+..+.........-. .++...+..+.- ..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~~~~----~~ 297 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLFDKE----CV 297 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecCccc----cc
Confidence 334468899999999863 3599999999999999999999999987655332221111 112222221111 12
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++..|+.+|-..||...++..
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 23456788889999999999999999854
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=273.95 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=188.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
+|.+.+.||+|+||.||++... .+..+++|.+..... ......+..|+.++++++||||++++++.. +..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3778889999999999999865 345566666543221 122335777999999999999999998643 468899
Q ss_pred EEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 191 FQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
+||+++++|.+++.. ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 34578999999999999999999998 99999999999999975 579999999987654
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... +.....+..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~--------~~~~~~~~~- 225 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR--------IVEGPTPSL- 225 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH--------HHcCCCCCC-
Confidence 3211 12334578899999999888889999999999999999999999964322111100 000001111
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||..+|++||++.++++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 ---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1223356778999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=289.45 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=191.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--C------
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D------ 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~------ 185 (434)
.++|.+...||.|++|.||+|... +++.||||++..... ......+.+|+.++++++||||++++++.. +
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 467999999999999999999976 688999998865422 223345778999999999999999988532 2
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 278999998 4689998864 468999999999999999999998 8999999999999999999999999999986
Q ss_pred cCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh---hc-ccc-------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW---AK-PLL------- 333 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~---~~-~~~------- 333 (434)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... .. ...
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 168 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 5432 223457889999999865 357899999999999999999999996533221100 00 000
Q ss_pred -CccccccccCC---cCCCCCC---HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 -DSNDIRELVDP---SLGDNYD---AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 -~~~~~~~~~d~---~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......++.. .....+. ......+.+++.+||+.+|.+|||+.+|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 0000000 012457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=269.31 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=164.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC---C--CcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR---D--GTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~ 187 (434)
..|+....||+|.||.||++.-. + ...+|||.+..... ........+|+.+++.++||||+.+..+. ...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35888999999999999999633 2 23799999875422 12233577899999999999999998863 3478
Q ss_pred EEEEEEcCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC----CCeEEec
Q 013927 188 HLVFQLSPLGSLASILHG----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED----YEPQICD 259 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL~D 259 (434)
+++++|.+. +|..+++. ....++-..+..|+.||+.|+.|||+ +-|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999985 78887753 23467888899999999999999999 889999999999999877 8999999
Q ss_pred cccccccCCCCccc-ceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 260 FGLAKWLPRQWTHH-NVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 260 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
||+++.+....... .....+.|.+|+|||.+.+.. |+.+.||||.|||+.||+|-.+.|.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999886553322 234556799999999998765 99999999999999999998877754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=267.73 Aligned_cols=235 Identities=28% Similarity=0.333 Sum_probs=188.0
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL 199 (434)
||.|+||.||++... +++.||+|.+...... .....+..|+.++++++||||+++++... +..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 6899999998765432 24457889999999999999999998643 468999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 279 (434)
.+++... ..+++.....++.|++.||.|||+ .+++|+||+|.||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 9999743 468899999999999999999998 999999999999999999999999999987654321 1123455
Q ss_pred cccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 280 gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
++..|+|||.+.+...+.++|+||||+++|+|++|..||........... +... ...++......+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-----------~~~~--~~~~~~~~~~~l~ 221 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK-----------ILKD--PLRFPEFLSPEAR 221 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----------HhcC--CCCCCCCCCHHHH
Confidence 78899999999888889999999999999999999999976443211100 0000 0111111235678
Q ss_pred HHHHhhhccCCCCCCCHhH
Q 013927 360 LTASLCIEQSPILRPKMSQ 378 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~e 378 (434)
+++.+||..+|++||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 8999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=246.10 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=193.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~ 193 (434)
+|...++||+|.||+||+|+.+ +++.||+|.+..+..+ ......++|+.+++.++|.|||+++++ ....+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999976 6899999999875543 334578999999999999999999997 33478899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|. .+|..+...-++.++......++.|+++||.|+|+ ++++|||+||+|+|++.+|++||+|||+++.+.-.. .
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv--r 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R 156 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence 97 47888888888899999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred ceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHh-CCCcccccc---chhhhh-h--ccccCc-cccccccCC
Q 013927 274 NVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELIT-GRRAVDHLQ---QSVVIW-A--KPLLDS-NDIRELVDP 344 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~ellt-G~~p~~~~~---~~~~~~-~--~~~~~~-~~~~~~~d~ 344 (434)
-.+..+.|.+|++|+++.+.. |+...|+||-|||+.|+.. |++.|.+.+ +...++ . .|..+. ..+..+.|-
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 234456799999999998765 8999999999999999997 555565422 111121 1 111110 122233333
Q ss_pred cCCCCCCHH-----HH----HHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAE-----EI----DRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~-----~~----~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....++.. .. ..=.+++...+.-+|.+|.+++..++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222222211 11 11244666777789999999988754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=265.00 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=190.0
Q ss_pred hcCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC------C
Q 013927 116 TKNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD------G 186 (434)
Q Consensus 116 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~ 186 (434)
+++|.+. ++||-|-.|+|-.+..+ +|+.+|+|++.... ...+|+++--.. .|||||.+++++.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4456554 47999999999998876 78999999886432 366788765544 59999999997433 4
Q ss_pred cEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEecccc
Q 013927 187 IHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGL 262 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGl 262 (434)
+.+|||.++||.|.+.+... ...+.+..+..|+.||+.|+.|||+ .+|.||||||+|+|.+. |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 77899999999999999764 4568999999999999999999999 99999999999999964 55799999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
|+.-.. .....+.+-|+.|.|||++....|+..+|+||+||++|-|++|-+||...... .+ ...++.-+
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-ai-------spgMk~rI 279 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AI-------SPGMKRRI 279 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cC-------ChhHHhHh
Confidence 986543 23445677899999999999899999999999999999999999999653221 00 11111111
Q ss_pred CCcCCCCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 343 DPSLGDNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 343 d~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..... .++. ...+...++|..+|..+|.+|.|+.+++.
T Consensus 280 ~~gqy-~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 280 RTGQY-EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hccCc-cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11111 1222 23456677889999999999999999964
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.96 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=205.9
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeee-------cc
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC-------DS 184 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-------~~ 184 (434)
..+.-|.+...||.|.+|.||++... +|+.+|||+.......+ .....|.++++.+ +|||++.++|+ ..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34456888999999999999999865 78999999887654332 2456688888777 69999999996 35
Q ss_pred CCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
|.++||||||.+||..+++... ...+.|..+..|+..++.||.+||. +.++|||||-.|||++.++.|||+|||++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeee
Confidence 6799999999999999998763 4568899999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccC-----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
..+... .....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+.++.+....+..|.....
T Consensus 171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP-- 246 (953)
T KOG0587|consen 171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP-- 246 (953)
T ss_pred eeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc--
Confidence 876543 2334567899999999998643 3778999999999999999999999888777665544432221
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+ .-+..-.+++.++|+.||..|-++||++.++++
T Consensus 247 -kL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 247 -KL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -cc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11 123344678999999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=275.09 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=191.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~~lv~ 191 (434)
+|..+.+||+|+||+|.++..+ +.+.+|||+++++-. .+..+.-+.|-.+|.-. +-|.+++++.+. .|.+++||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 5888899999999999999877 567899999988654 23333445677777655 467888888874 46899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+.+|+|--.+++ -+.+.+..+..+|..||-||-+||+ ++||.||||..|||++.+|++||+|||+++. .-..
T Consensus 430 EyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIFD 503 (683)
T ss_pred EEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc--cccC
Confidence 99999999988874 3456667777889999999999999 9999999999999999999999999999973 2233
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....+++||+.|+|||++...+|+..+|+|||||+||||+.|+.||++.+...... .+.+... .++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-----------aI~ehnv--syP 570 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-----------AIMEHNV--SYP 570 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------HHHHccC--cCc
Confidence 445678999999999999999999999999999999999999999999876544321 1111111 123
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.....+.+.+....|...|.+|..
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccC
Confidence 334466777888889999999954
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.25 Aligned_cols=144 Identities=28% Similarity=0.396 Sum_probs=126.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.++||.|+||+||+|.+. +++.||||++..... ......+..|+.++..++||||++++++. .+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999977 789999999975432 22335688899999999999999999864 34789999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
||+.+++|.+++.. ...+++..+..|+.||+.||.|||. ++|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999864 3457888899999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=284.00 Aligned_cols=237 Identities=27% Similarity=0.308 Sum_probs=186.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhh-CCCCCeeeEeeeccC--CcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY-VDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~--~~~lv~ 191 (434)
+..|.....+|.|+|+.|-.+... +++..+||++.+... +-.+|+.++.. -+||||+.+.+.+.+ ..++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 466888888999999999988765 788999999987622 23346655544 479999999998766 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe-cCCCCeEEeccccccccCCCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll-~~~~~~kL~DFGla~~~~~~~ 270 (434)
|++.++-|.+.+.... ... ..+..|+.+|+.|+.|||+ +|||||||||+|||+ +..++++|+|||.++..+..
T Consensus 396 e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999987766664322 222 6777899999999999999 999999999999999 68899999999999877654
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.||..-+....+..+... +.+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~--------------~~~ 531 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM--------------PKF 531 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC--------------Ccc
Confidence 22334588999999999899999999999999999999999999765444333222111 111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+....+...+|+.+||+.||.+||+|.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1223356677889999999999999999854
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.35 Aligned_cols=205 Identities=25% Similarity=0.309 Sum_probs=175.2
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-- 185 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 185 (434)
++.....+|.+.++||+|+||.|..++.+ +++.||+|++.+-.. ......|..|-.+|..-+.+=|+.++-.++|
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44445578999999999999999999976 789999999986321 1234468899999999999999999876554
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
++|+||+|++||+|-.+|..-. .++...+..++..|+-||.-||+ .|+|||||||+|||+|..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHh
Confidence 7999999999999999997655 67887777788899999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccceeccccccccccCCccc----c-CCCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFM----H-GIVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
+.... .......+|||-|++||++. + +.|+..+|+||+||++|||+.|..||..
T Consensus 225 m~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 225 MDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 76442 23345678999999999985 2 5689999999999999999999999964
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=271.43 Aligned_cols=255 Identities=29% Similarity=0.362 Sum_probs=194.4
Q ss_pred cCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCC--CchhhH----hhHHHHHHHHhhCCCCCeeeEeee---ccCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKG--TVDEKT----CGFLCEIGIIAYVDHPNTAKLVGC---DSDG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~----~~~~~E~~~l~~l~h~niv~l~g~---~~~~ 186 (434)
++|-++.+||+|||+.||++.+ ...+.||||+-... ..++.. ....+|..|-+.|+||.||++|++ ..+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4677788999999999999974 46788999976543 333222 346679999999999999999996 4568
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec---CCCCeEEeccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLA 263 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGla 263 (434)
+|-|+|||+|.+|+.+|. ....+++.....|+.||+.||.||.+. ..+|||-||||.|||+- .-|.+||.|||++
T Consensus 543 FCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 999999999999999997 456788899999999999999999973 46899999999999995 4478999999999
Q ss_pred cccCCCCccc-----ceeccccccccccCCccccC----CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC
Q 013927 264 KWLPRQWTHH-----NVSKFEGTFGYFAPEYFMHG----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 264 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 334 (434)
+.+....... ..+...||.+|++||.+.-+ ..+.|+||||+|||+|.++.|+.||.+......+...
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe---- 696 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE---- 696 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh----
Confidence 9886543332 23567899999999998644 3688999999999999999999999875544333322
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
+.|-.-.. +....-+....+...+|.+||++.-++|....++.
T Consensus 697 -NTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -NTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111000 00001112223556688999999999998777764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.38 Aligned_cols=218 Identities=22% Similarity=0.136 Sum_probs=171.5
Q ss_pred cCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCCCHHHHhc
Q 013927 128 GGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLGSLASILH 204 (434)
Q Consensus 128 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~gsL~~~l~ 204 (434)
|.+|.||++... +++.||+|.+.... .+..|...+....||||++++++. .+..+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999976 78999999997643 133455555666799999999864 347899999999999999886
Q ss_pred cCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccccccc
Q 013927 205 GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284 (434)
Q Consensus 205 ~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 284 (434)
.. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||.+....... ....++..|
T Consensus 78 ~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 78 KF-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred Hh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 43 458899999999999999999998 999999999999999999999999999886554321 223456789
Q ss_pred ccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHh
Q 013927 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASL 364 (434)
Q Consensus 285 ~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 364 (434)
+|||.+.+..++.++||||+|+++|||++|..|+........ ..... ..+......+..++.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~~~----~~~~~~~~~~~~li~~ 211 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THTTL----NIPEWVSEEARSLLQQ 211 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------ccccc----CCcccCCHHHHHHHHH
Confidence 999999888899999999999999999999988754221100 00000 1111123467788999
Q ss_pred hhccCCCCCCCHh
Q 013927 365 CIEQSPILRPKMS 377 (434)
Q Consensus 365 Cl~~~P~~RPs~~ 377 (434)
||+.||++||++.
T Consensus 212 ~l~~dp~~R~~~~ 224 (237)
T cd05576 212 LLQFNPTERLGAG 224 (237)
T ss_pred HccCCHHHhcCCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=275.18 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=194.0
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
.++||.|-||+||-|+++ +|+.||||++.+.... .....+.+|+.||.+++||.||.+...+ .+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999976 8999999999875432 3345788999999999999999998764 46899999999987
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC---CCeEEeccccccccCCCCcccc
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---YEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGla~~~~~~~~~~~ 274 (434)
-|..+|...++.+++.....++.||+.||.|||. ++|+|+||||+|||+... -++||||||+|+.++... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 7888888888889998888899999999999999 999999999999999754 379999999999887542 2
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC-HH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD-AE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~ 353 (434)
....+||+.|+|||++.+..|...-|+||.|||+|--++|..||..........+. ..++-| ..+ .+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------AaFMyP----p~PW~e 790 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------AAFMYP----PNPWSE 790 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc--------cccccC----CCchhh
Confidence 34567999999999999999999999999999999999999999753322211110 011111 111 12
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.....+++|...|+..-.+|-+....+
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 234567788888999889998877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.82 Aligned_cols=259 Identities=20% Similarity=0.204 Sum_probs=167.5
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-C----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEee--------
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-D----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-------- 181 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g-------- 181 (434)
..++|.+.+.||+|+||.||+|.+. + +..||||++......+ .+..+ .+....+.+++.++.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE---IWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH---HHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4568999999999999999999976 4 6899999876432211 11111 122222333222211
Q ss_pred eccCCcEEEEEEcCCCCHHHHhccCCCCC-------------------CHHHHHHHHHHHHHHhHhhhccCCCCeeecCC
Q 013927 182 CDSDGIHLVFQLSPLGSLASILHGSKDKP-------------------DWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242 (434)
Q Consensus 182 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl 242 (434)
...+..++|+||+.+++|.+++....... ....+..++.|++.||.|||+ ++|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence 12346899999999999999886432111 123355789999999999998 89999999
Q ss_pred CCCcEEecC-CCCeEEeccccccccCCCCcccceeccccccccccCCccccC----------------------CCCCcC
Q 013927 243 KADNILLTE-DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG----------------------IVDEKT 299 (434)
Q Consensus 243 kp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ks 299 (434)
||+|||++. ++.+||+|||+++.+..... .......|++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 57999999999986543221 223456789999999965322 234567
Q ss_pred cEEehhHHHHHHHhCCCccccccchhh-hhhccccCccccccccCCcCCC----CCC--HHHHHHHHHHHHhhhccCCCC
Q 013927 300 DVYSFGVLLLELITGRRAVDHLQQSVV-IWAKPLLDSNDIRELVDPSLGD----NYD--AEEIDRAVLTASLCIEQSPIL 372 (434)
Q Consensus 300 DvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~----~~~--~~~~~~l~~l~~~Cl~~~P~~ 372 (434)
|||||||+||||+++..+++....... ...............+.+.... .+. ........+|+.+||+.||++
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999998776543211100 0000000000000111111000 000 001123457999999999999
Q ss_pred CCCHhHHHHH
Q 013927 373 RPKMSQVVIL 382 (434)
Q Consensus 373 RPs~~evl~~ 382 (434)
|||+.++++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=258.13 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=194.0
Q ss_pred CHHHHHHHhcCCCCCCeecccCcEEEEEEE-eCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeeccC
Q 013927 108 TLSELQTATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD 185 (434)
Q Consensus 108 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 185 (434)
++.++...|+ ++||+|+||.|--+. ..+|..||||++.+.. ...+.+..+|++++.+.. |+||+.++.++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3456655554 579999999998876 5589999999998763 345567899999999985 9999999998654
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEecc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICDF 260 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DF 260 (434)
.+|||||-|.||+|.+.+.. ...+++...-.+..+|+.||.|||. +||.||||||+|||...-. -+||+||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred cceEEEEEecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 79999999999999999974 4567888888999999999999999 9999999999999997544 4899999
Q ss_pred ccccccCC--C---CcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc
Q 013927 261 GLAKWLPR--Q---WTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 261 Gla~~~~~--~---~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~ 330 (434)
.++.-+.. . .......+.+|+..|||||+.. ...|+.++|.||||||||-|++|-.||.+.-...-.|.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 88743221 1 1112234578999999999863 245899999999999999999999999763222222221
Q ss_pred cccCccccccccCCcCC--CCCCHHH----HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 331 PLLDSNDIRELVDPSLG--DNYDAEE----IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~--~~~~~~~----~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
-..-...-..++...-. -.++..+ ..+.-++++..+..+|.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11000000001110000 1122222 345566788889999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=259.53 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=191.8
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----------CC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----------DG 186 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------~~ 186 (434)
|....+||+|.||+||+++.+ +|+.||+|++..+.. +......++|+.+|..++|+|++.++.+|. ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 555578999999999999866 678899987654322 233346789999999999999999988632 13
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
+++||.+|+. +|.-+|......++...+.+++.++..||.|+|. +.|+|||+||.|+||+.+|.+||+|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 8899999984 7888998777789999999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCc--ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------------cc
Q 013927 267 PRQWT--HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------------KP 331 (434)
Q Consensus 267 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------------~~ 331 (434)
..... ...++..+.|++|++||.+.+. .|+++.|||+.|||+.||+||.+.+.+..+...+-. .|
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 43221 2224556679999999998875 599999999999999999999988876332211100 01
Q ss_pred ccCcccccccc--CCcCCCCCC--HHHH------HHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 LLDSNDIRELV--DPSLGDNYD--AEEI------DRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ~~~~~~~~~~~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.-.+..-+ .|.-.+.+. .+.+ +...+++..++..||.+||.+.+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11110000000 000000000 1111 25677889999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=281.03 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=193.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCc-EEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGT-LVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
.++.....||-||||.|=+++.++.. .+|+|.+++...- ........|-.+|...+.|.||++|..+.| .+|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999877333 4899998875543 233467889999999999999999987555 678899
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|-|-||.|..+|.. ++.++..+...++..+++|++|||. ++||.|||||+|++++.+|.+||.|||+|+.+..+
T Consensus 500 EaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 500 EACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred HhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 99999999999974 4556667777788899999999999 99999999999999999999999999999988654
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
...-+++||+.|.|||++.+...+..+|.||||+++|||++|.+||.+.++....- .|-.-+| ...++
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn--------~ILkGid---~i~~P 641 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN--------LILKGID---KIEFP 641 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH--------HHHhhhh---hhhcc
Confidence 34457899999999999999999999999999999999999999998866543210 0000011 11222
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
....+....++......+|.+|..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 333456677888889999999976
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=263.42 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=192.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC--C----CeeeEeee--ccCC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH--P----NTAKLVGC--DSDG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~g~--~~~~ 186 (434)
+++|.+..++|+|.||.|-.+.+. .+..||||+++. +....+..+-|+++|.++.+ | -+|.+.++ ...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 568999999999999999998765 578999998864 34455567889999999943 2 25556555 3457
Q ss_pred cEEEEEEcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC--------------
Q 013927 187 IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-------------- 251 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-------------- 251 (434)
.|+|+|.+. .|+.++|.. .-.+++...+..|+.|+++++.|||+ .+++|-||||+|||+..
T Consensus 166 iCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 899999883 488888876 35678899999999999999999999 99999999999999942
Q ss_pred ------CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh
Q 013927 252 ------DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV 325 (434)
Q Consensus 252 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 325 (434)
+..++|+|||.|+.-... .+..+.|..|+|||++.+-.++.++||||+||||.|+.||...|..-++..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 235899999999854322 255667999999999999999999999999999999999999997644222
Q ss_pred --hhhhcccc----------------Ccc-----------ccccccCCcCC----CCCCHHHHHHHHHHHHhhhccCCCC
Q 013927 326 --VIWAKPLL----------------DSN-----------DIRELVDPSLG----DNYDAEEIDRAVLTASLCIEQSPIL 372 (434)
Q Consensus 326 --~~~~~~~~----------------~~~-----------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~P~~ 372 (434)
..+.+... ..+ ......++... ......+...+.+|+..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 11111110 000 00111111110 1122345577999999999999999
Q ss_pred CCCHhHHHH
Q 013927 373 RPKMSQVVI 381 (434)
Q Consensus 373 RPs~~evl~ 381 (434)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=254.49 Aligned_cols=236 Identities=29% Similarity=0.388 Sum_probs=188.1
Q ss_pred CcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHHHHhcc
Q 013927 129 GYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLASILHG 205 (434)
Q Consensus 129 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~~~l~~ 205 (434)
+||.||+|... +|+.||+|++...........+.+|+..+++++|+||+++++++. ...++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 589999999986554332567999999999999999999999754 468899999999999999874
Q ss_pred CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccc
Q 013927 206 SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285 (434)
Q Consensus 206 ~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 285 (434)
.. .+++..+..++.+++.++.|||+ .+++|+||+|.||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 33 38899999999999999999999 899999999999999999999999999998765432 223455788999
Q ss_pred cCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH-HHHHHHHHHHHh
Q 013927 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA-EEIDRAVLTASL 364 (434)
Q Consensus 286 aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~ 364 (434)
+||.+.+..++.++||||||+++|+|++|..||............ +........... .....+..++.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK----------IGKPKPPFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH----------HhccCCCCccccccCCHHHHHHHHH
Confidence 999998888899999999999999999999999763222111110 000000000000 023578889999
Q ss_pred hhccCCCCCCCHhHHHH
Q 013927 365 CIEQSPILRPKMSQVVI 381 (434)
Q Consensus 365 Cl~~~P~~RPs~~evl~ 381 (434)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=238.45 Aligned_cols=198 Identities=27% Similarity=0.401 Sum_probs=163.5
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeee--ccCCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC--DSDGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~--~~~~~~lv~e~~ 194 (434)
...+..||+|++|.|-+-++. +|+..|+|.+............++|+.+..+. .+|.+|.+||. .....++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334466999999999888765 89999999998665555556788899887665 69999999995 345799999999
Q ss_pred CCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 195 PLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 195 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
. .||+.+... .....++..+-+||..+..||.|||+ +..+||||+||+|||++.+|+||+||||++..+....
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi- 203 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI- 203 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence 7 477766543 55678888889999999999999999 5899999999999999999999999999998775432
Q ss_pred ccceeccccccccccCCcccc----CCCCCcCcEEehhHHHHHHHhCCCcccccc
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH----GIVDEKTDVYSFGVLLLELITGRRAVDHLQ 322 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvil~elltG~~p~~~~~ 322 (434)
..+.-.|...|||||.+.. ..|+-++||||||+++.||.+++.||+...
T Consensus 204 --Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 --AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred --HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2233458889999998853 368999999999999999999999998644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=274.97 Aligned_cols=262 Identities=21% Similarity=0.205 Sum_probs=174.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEe-----------------CCCcEEEEEEeeCCCchh-------------hHhhHHHHH
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL-----------------RDGTLVAVKRLTKGTVDE-------------KTCGFLCEI 165 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E~ 165 (434)
.++|.+.++||+|+||+||+|.. ..++.||||++....... ....+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999964 235689999986543211 112234577
Q ss_pred HHHhhCCCCCe-----eeEeeec----------cCCcEEEEEEcCCCCHHHHhccCC-----------------------
Q 013927 166 GIIAYVDHPNT-----AKLVGCD----------SDGIHLVFQLSPLGSLASILHGSK----------------------- 207 (434)
Q Consensus 166 ~~l~~l~h~ni-----v~l~g~~----------~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 207 (434)
.++.+++|.|+ +.+++++ .+..++|+||+++|+|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777877654 4555542 235789999999999999987421
Q ss_pred CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccC
Q 013927 208 DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287 (434)
Q Consensus 208 ~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 287 (434)
..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 123567788899999999999998 89999999999999999999999999999765432111 11122347899999
Q ss_pred CccccCC--------------------C--CCcCcEEehhHHHHHHHhCCC-ccccccchhhhhhccccCccccccccCC
Q 013927 288 EYFMHGI--------------------V--DEKTDVYSFGVLLLELITGRR-AVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 288 E~~~~~~--------------------~--~~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
|.+.... | ..+.||||+||++|+|++|.. ||.................+..+.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9875432 1 134799999999999999985 6654211110000000000000000000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCC---CCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSP---ILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPs~~evl~ 381 (434)
...............+++.+||..+| .+|+|+.|++.
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00000111123456778888898765 78999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.75 Aligned_cols=262 Identities=22% Similarity=0.271 Sum_probs=212.9
Q ss_pred HHHHHHhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec
Q 013927 110 SELQTATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD 183 (434)
Q Consensus 110 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 183 (434)
.++.....++....++-+|.||.||.|.+. +.+.|-||.++.....-....++.|.-++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344555567888889999999999999754 34568888888777766777899999999999999999999973
Q ss_pred c---CCcEEEEEEcCCCCHHHHhcc-------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC
Q 013927 184 S---DGIHLVFQLSPLGSLASILHG-------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY 253 (434)
Q Consensus 184 ~---~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~ 253 (434)
. +..++++.++..|+|..+|.. ....+.-.+...++.|++.|++|||. ++|||.||.+.|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 3 357788899999999999972 12345667778899999999999998 9999999999999999999
Q ss_pred CeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccc
Q 013927 254 EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 254 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 332 (434)
++||+|=.+++.+-+...+......-....||+||.+.+..|+..+|||||||+||||+| |+.|+...++-..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 999999999997766655554444445678999999999999999999999999999998 8899877655332
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
...+....+...+..+++++..++.-||...|++||+++|++.-|...
T Consensus 508 ------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 508 ------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 222333333334455678899999999999999999999999888643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-33 Score=256.47 Aligned_cols=246 Identities=24% Similarity=0.326 Sum_probs=189.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv 190 (434)
++|.++.+||+|+|++|..++++ +.+.+|+|++++.... +.....+.|-.+..+. +||.+|.+..|++. .+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67999999999999999999976 6789999999876543 3344566777777665 79999999998554 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
.||.++|+|.-.+... ..+++.....+...|+-||.|||+ +|||.||||..|+|+|..|++||.|||+++.-- .
T Consensus 330 ieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l--~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--G 403 (593)
T ss_pred EEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC--C
Confidence 9999999998888744 556677777778899999999999 999999999999999999999999999997432 2
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc--cccccCCcCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND--IRELVDPSLGD 348 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~d~~l~~ 348 (434)
.....++++||+.|+|||.+.+..|...+|+|+|||+++||+.|+.||+..... .|....++ +.-++...++
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-----n~d~ntedylfqvilekqir- 477 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-----NPDMNTEDYLFQVILEKQIR- 477 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-----CcccchhHHHHHHHhhhccc-
Confidence 234567899999999999999999999999999999999999999999853211 00000000 0011111111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
++....-+...++..-|+.||.+|..
T Consensus 478 -iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 -IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11112233445667889999999854
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=265.81 Aligned_cols=200 Identities=27% Similarity=0.328 Sum_probs=165.4
Q ss_pred cCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.-|..++.||-|+||+|.+++. ++...||+|.+.+..+- ........|-.||...+.+=||+||-.++ +.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4578888999999999999984 46778999999876542 33445677999999999999999998754 4799999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC---
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR--- 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~--- 268 (434)
+|++||++-++|. ..+.+.+.....++..+..|+++.|. .|+|||||||.|||||.+|++||.||||+.-+..
T Consensus 709 dYIPGGDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999987 44566666666666789999999998 9999999999999999999999999999863210
Q ss_pred -----CCcccc--------------------------------eeccccccccccCCccccCCCCCcCcEEehhHHHHHH
Q 013927 269 -----QWTHHN--------------------------------VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311 (434)
Q Consensus 269 -----~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~el 311 (434)
...+.. ....+||+.|+|||++....|+..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000000 0124699999999999999999999999999999999
Q ss_pred HhCCCcccc
Q 013927 312 ITGRRAVDH 320 (434)
Q Consensus 312 ltG~~p~~~ 320 (434)
+.|+.||-.
T Consensus 865 ~~g~~pf~~ 873 (1034)
T KOG0608|consen 865 LVGQPPFLA 873 (1034)
T ss_pred hhCCCCccC
Confidence 999999954
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=276.52 Aligned_cols=240 Identities=27% Similarity=0.387 Sum_probs=180.7
Q ss_pred CCCCCeecccCcEE-EEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEEEEEc
Q 013927 119 FSSENLIGKGGYAE-VYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv~e~~ 194 (434)
|...+++|.|+.|+ ||+|.+. |+.||||++-.+. ..-..+|+..|..- .|||||++|+...+ -.|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44456789998875 8999997 8899999886432 33467899998877 59999999998655 578899999
Q ss_pred CCCCHHHHhccCCCCC---CHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---C--CCeEEecccccccc
Q 013927 195 PLGSLASILHGSKDKP---DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---D--YEPQICDFGLAKWL 266 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~---~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~--~~~kL~DFGla~~~ 266 (434)
. .+|.+++....... .-.....+..|++.||++||+ .+||||||||+||||+. + ..++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 7 48999997631111 113346678899999999999 99999999999999976 3 46899999999988
Q ss_pred CCCCccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhC-CCccccccchh-hhhhccccCccccccccC
Q 013927 267 PRQWTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG-RRAVDHLQQSV-VIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 267 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d 343 (434)
+.+.... ..+...||-+|+|||++....-+..+||||||||+|..++| ..||...-... .+.. ....+..+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~----~~~~L~~L-- 735 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT----GNYTLVHL-- 735 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc----Cccceeee--
Confidence 7543322 23567799999999999988888899999999999999986 78997632221 1110 00011111
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
... .+. +..+||.+|++.+|..||++.+|+
T Consensus 736 ---~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 ---EPL--PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ---ccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 111 111 667899999999999999999995
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=244.12 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=187.0
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC-------CcEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------GIHL 189 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------~~~l 189 (434)
....+.||-|+||.||.+.+. +|+.||+|++..-... -....+.+|+.+|.-++|.|++..+++-+. ..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 445578999999999999876 8999999988643221 223468899999999999999999987322 4667
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
++|++. .+|..++- +...++-..+.-+.+||++||.|||+ .+|+||||||.|+|++.|..+||||||+++.....
T Consensus 135 ~TELmQ-SDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHH-hhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 777775 56777665 45667777888889999999999999 89999999999999999999999999999875443
Q ss_pred CcccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchh---hh---hhccccC------cc
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VI---WAKPLLD------SN 336 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~---~~~~~~~------~~ 336 (434)
....++..+.|-.|+|||.+++.. |+...||||.|||+.||+..+-.|..-.+.. .+ ...|... ++
T Consensus 210 -~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 -DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred -hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 333455566789999999999865 9999999999999999998887775422211 11 1111110 00
Q ss_pred ccccccC-----CcCC---CCCC-HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 337 DIRELVD-----PSLG---DNYD-AEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 337 ~~~~~~d-----~~l~---~~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.-..++. |.+. .-.+ ...-.+.+.+...++..+|..|.+..+.+..+-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0000110 1100 0000 011123455677889999999999998876654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=228.67 Aligned_cols=210 Identities=34% Similarity=0.520 Sum_probs=180.5
Q ss_pred ecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEcCCCCHHH
Q 013927 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLSPLGSLAS 201 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~~~gsL~~ 201 (434)
||+|++|.||++... +++.+++|++...........+.+|+..++.+.|++|++++++... ..++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 4899999999876543234578999999999999999999997554 7889999999999999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCCCCcccceecccc
Q 013927 202 ILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPRQWTHHNVSKFEG 280 (434)
Q Consensus 202 ~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~g 280 (434)
++......+++..+..++.+++++|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 997544578899999999999999999999 89999999999999999 89999999999986654321 1233457
Q ss_pred ccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHH
Q 013927 281 TFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAV 359 (434)
Q Consensus 281 t~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 359 (434)
...|++||.+... .++.++|+|++|+++++| ..+.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~~ 191 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PELK 191 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHHH
Confidence 8889999999877 788999999999999999 4677
Q ss_pred HHHHhhhccCCCCCCCHhHHHHHh
Q 013927 360 LTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 360 ~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
+++..|++.+|.+||++.+++..|
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 788999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=242.58 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=187.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-----C---CCeeeEeeec----
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-----H---PNTAKLVGCD---- 183 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~---- 183 (434)
++|.+.++||.|.|++||++.+. +.+.||+|+.+.. ....+..+.|+.+|++++ | ..||++++.+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 57999999999999999999865 6789999998753 344557889999999984 3 4699998852
Q ss_pred --cCCcEEEEEEcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---------
Q 013927 184 --SDGIHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE--------- 251 (434)
Q Consensus 184 --~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~--------- 251 (434)
..++|+|+|++.. +|..++.. .-..++...+.+|+.||+.||.|||.. -+|||-||||+|||+..
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhhh
Confidence 2357888888743 55555543 556789999999999999999999995 49999999999999931
Q ss_pred --------------------------------------------------------------------------------
Q 013927 252 -------------------------------------------------------------------------------- 251 (434)
Q Consensus 252 -------------------------------------------------------------------------------- 251 (434)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred -------------------------C----------------------------------------------------CC
Q 013927 252 -------------------------D----------------------------------------------------YE 254 (434)
Q Consensus 252 -------------------------~----------------------------------------------------~~ 254 (434)
. -.
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 0 01
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccccc--------chhh
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ--------QSVV 326 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~--------~~~~ 326 (434)
|||+|||.|+++....+ .-..|..|+|||++.+..|+..+||||++|++|||+||...|+.-. ....
T Consensus 393 vKIaDlGNACW~~khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred EEEeeccchhhhhhhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 56777777776544322 2235788999999999999999999999999999999998885411 0000
Q ss_pred -hhh----ccc---cCccccccccCCc-------------C------CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHH
Q 013927 327 -IWA----KPL---LDSNDIRELVDPS-------------L------GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379 (434)
Q Consensus 327 -~~~----~~~---~~~~~~~~~~d~~-------------l------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev 379 (434)
+.. .|. +....-+++++.. + .-.++.++..++.+++.-||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 000 000 0001111111110 0 113567788999999999999999999999999
Q ss_pred HH
Q 013927 380 VI 381 (434)
Q Consensus 380 l~ 381 (434)
++
T Consensus 548 l~ 549 (590)
T KOG1290|consen 548 LK 549 (590)
T ss_pred hc
Confidence 74
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=257.30 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=198.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~e~ 193 (434)
.+|.+...+|.|.||.||++++. .+...|||+++.... +...-..+|+-+++..+||||+.++|. ..+.++++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 36888889999999999999976 799999999987653 334457789999999999999999995 56789999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|.+|+|.++.+ ....+++.++..++...++||.|||+ .+-+|||||-.|||+++.|.+|++|||.+..+.... .
T Consensus 94 cgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A 167 (829)
T ss_pred cCCCcccceee-ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence 99999999987 45778888999999999999999999 899999999999999999999999999987664322 2
Q ss_pred ceeccccccccccCCcc---ccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--hhccccCccccccccCCcCCC
Q 013927 274 NVSKFEGTFGYFAPEYF---MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--WAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~d~~l~~ 348 (434)
....+.||+.|||||+. ..+.|..++|||++|+...|+---+.|.....+.... +.+..+.... +-|+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~---lkDk---- 240 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT---LKDK---- 240 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc---ccCC----
Confidence 23467899999999986 3567999999999999999998888776554443322 2221111111 1111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..-..-+.++++.|+..+|++||++..+++
T Consensus 241 ---~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 ---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112245777889999999999999987754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=235.44 Aligned_cols=253 Identities=25% Similarity=0.286 Sum_probs=187.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--------CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~~ 186 (434)
.+|.-.+.+|.|+- .|..+-+. .++.||+|++...... .......+|+.++..++|+||++++.+.. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778898988 55555544 6899999988765332 22346788999999999999999998632 25
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++|||+|. .+|...+. ..++=.....|..|++.|+.|||+ .+|+||||||+||++..++.+||.|||+|+.-
T Consensus 96 ~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence 889999997 57888776 345667788899999999999999 99999999999999999999999999999854
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc----------------
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK---------------- 330 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~---------------- 330 (434)
... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.... ..|.+
T Consensus 169 ~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-dQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 169 DTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-DQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred Ccc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-HHHHHHHHHhcCCCHHHHHHh
Confidence 332 3456677899999999999888999999999999999999999888652211 11110
Q ss_pred -----------cccCccccccc-cCCcCCCC--CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 331 -----------PLLDSNDIREL-VDPSLGDN--YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 331 -----------~~~~~~~~~~~-~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
|....-.+.+. -|...... .+......+..++.+||..+|++|.+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00000011111 11111111 11123345677889999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=244.38 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=194.4
Q ss_pred cCHHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC------CCeeeE
Q 013927 107 FTLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH------PNTAKL 179 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l 179 (434)
..+.|+. -..|.+....|+|-|++|.+|... -|+.||||+|.....-. ..=+.|+++|++|+. -+++++
T Consensus 424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred Eehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3344443 357888889999999999999876 58899999998754322 235679999999963 467777
Q ss_pred eee--ccCCcEEEEEEcCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-C
Q 013927 180 VGC--DSDGIHLVFQLSPLGSLASILHG--SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-E 254 (434)
Q Consensus 180 ~g~--~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~ 254 (434)
+.. ..+++|||||.+. -.|.++|.. .+..+....+..++.|+.-||..|.. -+|+|.||||.||||++.. .
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 763 5568999999886 479998864 45567888899999999999999998 8999999999999999764 6
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh--hhh---
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV--IWA--- 329 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~~--- 329 (434)
+||||||.|...... ..+....+..|.|||++.+-.|+...|+||.||+||||.||+-.|.+..+... .+.
T Consensus 576 LKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 899999999766443 23344456679999999999999999999999999999999988876322211 100
Q ss_pred ---------c-----cccC---------------cccc--ccccCC------cC-----CCCCCHHHHHHHHHHHHhhhc
Q 013927 330 ---------K-----PLLD---------------SNDI--RELVDP------SL-----GDNYDAEEIDRAVLTASLCIE 367 (434)
Q Consensus 330 ---------~-----~~~~---------------~~~~--~~~~d~------~l-----~~~~~~~~~~~l~~l~~~Cl~ 367 (434)
+ ..++ ...+ ...+.| .+ ..+-....+..+..|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 0 0000 0000 000111 00 111223456788999999999
Q ss_pred cCCCCCCCHhHHHH
Q 013927 368 QSPILRPKMSQVVI 381 (434)
Q Consensus 368 ~~P~~RPs~~evl~ 381 (434)
.||++|.+..+.++
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999998864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=223.91 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=187.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeeccC----CcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD----GIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~----~~~l 189 (434)
.++|.+.+++|+|.+++||.|.. .+++.++||+++.- ....+.+|+.+|..|. ||||+.++++..| ...|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45788889999999999999984 47889999998752 2345889999999998 9999999998544 4679
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccccccCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPR 268 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~~~ 268 (434)
++||..+.+...+. ..+....+.....+++.||.|+|+ +||.|||+||.|+++|.. -.++|+|+|+|..+.+
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988877766 345556677788999999999999 999999999999999965 4799999999998765
Q ss_pred CCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCcccccc----chhhhhhccc-----------
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQ----QSVVIWAKPL----------- 332 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~----~~~~~~~~~~----------- 332 (434)
+. .....+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||-+-. +.+.+ ++-.
T Consensus 186 ~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI-akVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI-AKVLGTDELYAYLNK 261 (338)
T ss_pred Cc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH-HHHhChHHHHHHHHH
Confidence 42 23334567788999998764 48899999999999999999999985421 11111 1100
Q ss_pred ---cCccccccccCCcCCC----CCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 ---LDSNDIRELVDPSLGD----NYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ---~~~~~~~~~~d~~l~~----~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+++...+. ...+ -...+.++++...|..|-.+|||++|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0111122222111111 0110 11256788889999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=249.16 Aligned_cols=196 Identities=24% Similarity=0.331 Sum_probs=165.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhCC---CCCeeeEeeeccC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYVD---HPNTAKLVGCDSD 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 185 (434)
.+|...+.+|+|+||.|+.+.++ +...|+||.+.++..- ......-.|+.||..++ |+||+++++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35889999999999999999987 5678999999876541 12224567999999998 9999999998665
Q ss_pred --CcEEEEEEcC-CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccc
Q 013927 186 --GIHLVFQLSP-LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262 (434)
Q Consensus 186 --~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl 262 (434)
.++++||--. +-+|.+++. .+..+++.....|+.|++-|+++||+ .+|||||||-+|+.++.+|.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 5677777653 347888886 45678888899999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCcccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~ 320 (434)
+.....+ ....++||..|.|||++.+..|- ..-|||++|++||-++....||..
T Consensus 717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8765433 45678899999999999988775 557999999999999999988753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=224.36 Aligned_cols=198 Identities=32% Similarity=0.468 Sum_probs=168.8
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
|.+.+.||.|++|.||+|... +++.+|+|.+...........+.+|+..+.+++|+|+++++++.. +..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456688999999999999987 488999999987544324567889999999999999999999744 57889999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+++|.+++......+++.....++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 999999997544338899999999999999999998 8999999999999999999999999999987654321 122
Q ss_pred eccccccccccCCcc-ccCCCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 276 SKFEGTFGYFAPEYF-MHGIVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
....++..|++||.+ ....++.++|||+||+++++|++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345578889999998 566678899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=222.34 Aligned_cols=243 Identities=20% Similarity=0.351 Sum_probs=178.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeee---ccCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC---DSDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~---~~~~~~lv~ 191 (434)
+.|.+.+.||+|.||.+-++.++ +++.+++|.+..... ...+|.+|...--.| .|.||+..|.. ..+.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 45889999999999999999987 678999999887653 345788988765555 48999999885 345677999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-C-CCCeEEeccccccccCCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-E-DYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~-~~~~kL~DFGla~~~~~~ 269 (434)
||++.|+|.+-+.. ..+.+....+++.|+++||.|+|+ +++||||||.+||||- . ...+||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 99999999998853 557778888999999999999999 9999999999999993 3 34899999999875432
Q ss_pred CcccceeccccccccccCCcccc---CC--CCCcCcEEehhHHHHHHHhCCCccccc---cchhh---hhhccccCcccc
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMH---GI--VDEKTDVYSFGVLLLELITGRRAVDHL---QQSVV---IWAKPLLDSNDI 338 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~---~~--~~~ksDvwSlGvil~elltG~~p~~~~---~~~~~---~~~~~~~~~~~~ 338 (434)
.+....-+..|.+||.... +. ..+.+|||.||+++|.++||+.||... ++.-. .|.+... ...
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~~~ 249 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--PAL 249 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--ccC
Confidence 2233334678999998643 22 457889999999999999999999741 11111 1211110 011
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...+ ..+. ..++++..+-|..+|++|=...++...
T Consensus 250 P~~F-----~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 250 PKKF-----NPFS----EKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chhh-----cccC----HHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1111 1122 345556677889999999555555433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=262.12 Aligned_cols=194 Identities=16% Similarity=0.186 Sum_probs=137.0
Q ss_pred hCCC-CCeeeEeeec---------cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeee
Q 013927 170 YVDH-PNTAKLVGCD---------SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239 (434)
Q Consensus 170 ~l~h-~niv~l~g~~---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiH 239 (434)
.++| +||+++++.+ .+.+.+++|++ .++|.++|......+++..++.++.||++||.|||+ ++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3445 4666666642 23456778877 469999997656679999999999999999999998 99999
Q ss_pred cCCCCCcEEecC-------------------CCCeEEeccccccccCCCCc--------------ccceecccccccccc
Q 013927 240 RDIKADNILLTE-------------------DYEPQICDFGLAKWLPRQWT--------------HHNVSKFEGTFGYFA 286 (434)
Q Consensus 240 rDlkp~NIll~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a 286 (434)
|||||+||||+. ++.+||+|||+++....... ........||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566677777653211000 000112457899999
Q ss_pred CCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhh
Q 013927 287 PEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCI 366 (434)
Q Consensus 287 PE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 366 (434)
||++.+..|+.++|||||||+||||++|..|+............. .+.+.. .........++.+||
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~---------~~~~~~-----~~~~~~~~~~~~~~L 249 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR---------VLPPQI-----LLNWPKEASFCLWLL 249 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh---------hcChhh-----hhcCHHHHHHHHHhC
Confidence 999999999999999999999999999988876432211111100 011100 111233456778999
Q ss_pred ccCCCCCCCHhHHHH
Q 013927 367 EQSPILRPKMSQVVI 381 (434)
Q Consensus 367 ~~~P~~RPs~~evl~ 381 (434)
+.+|.+||+|.||++
T Consensus 250 ~~~P~~Rps~~eil~ 264 (793)
T PLN00181 250 HPEPSCRPSMSELLQ 264 (793)
T ss_pred CCChhhCcChHHHhh
Confidence 999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=207.27 Aligned_cols=167 Identities=22% Similarity=0.197 Sum_probs=125.6
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccccee
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|+|.+++...+..+++..+..|+.|++.||.|||+ ++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 78999998666779999999999999999999998 55 999999999999999 9998765432
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH-
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI- 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~- 355 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ...... ++... .......
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~---~~~~~~-~~~~~-~~~~~~~~ 137 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL---NGMPAD-DPRDR-SNLESVSA 137 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH---HHhccC-Ccccc-ccHHHHHh
Confidence 12588999999999999999999999999999999999999965332111100000 000000 00000 0111122
Q ss_pred -HHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 356 -DRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 356 -~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..+.+++.+||..+|.+||++.++++.+...
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2588899999999999999999999887644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=221.64 Aligned_cols=195 Identities=26% Similarity=0.386 Sum_probs=159.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeee--ccCCcE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGC--DSDGIH 188 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~--~~~~~~ 188 (434)
.+.|...++||+|.|++||++.+. ....||+|.+..... ......|+++|..+. +.||+++.++ ..+...
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 467899999999999999999743 367899999876433 345888999999985 9999999998 456899
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccccccC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLP 267 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~~ 267 (434)
+|+||++.....+++. .++...+..++..++.||.++|. +|||||||||+|+|.+.. +.-.|+|||+|....
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999988885 46678888899999999999999 999999999999999854 567899999997321
Q ss_pred CC-------C------cc-----------------------------cceeccccccccccCCccccCC-CCCcCcEEeh
Q 013927 268 RQ-------W------TH-----------------------------HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSF 304 (434)
Q Consensus 268 ~~-------~------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSl 304 (434)
.. . .. .......||++|+|||++.... -++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 0 00 0001245999999999998655 6788999999
Q ss_pred hHHHHHHHhCCCcccc
Q 013927 305 GVLLLELITGRRAVDH 320 (434)
Q Consensus 305 Gvil~elltG~~p~~~ 320 (434)
|||++.+++++.||-.
T Consensus 265 GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeehhhcccccccc
Confidence 9999999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=217.04 Aligned_cols=166 Identities=20% Similarity=0.179 Sum_probs=130.5
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC--CCcEEEEEEeeCCC----chhhHhhHHHHHHHHhhCCCCCeee-EeeeccCC
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGT----VDEKTCGFLCEIGIIAYVDHPNTAK-LVGCDSDG 186 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~ 186 (434)
...++|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.+|++++|+|++. +++. +.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--GK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--CC
Confidence 34467999999999999999999865 57888999876431 1223456899999999999999985 5443 46
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCC-CCCcEEecCCCCeEEeccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI-KADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFGla~~ 265 (434)
.++||||+++++|... . ... ...++.++++||.|||+ ++|+|||| ||+|||++.++.+||+|||+++.
T Consensus 93 ~~LVmE~~~G~~L~~~-~-~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R-PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred cEEEEEccCCCCHHHh-C-ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 8999999999999732 1 111 14577899999999999 99999999 99999999999999999999987
Q ss_pred cCCCCcccc------eeccccccccccCCcccc
Q 013927 266 LPRQWTHHN------VSKFEGTFGYFAPEYFMH 292 (434)
Q Consensus 266 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 292 (434)
+........ .....+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654432222 245678899999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=218.58 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=184.6
Q ss_pred HhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCe-eecCCCC
Q 013927 168 IAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI-IHRDIKA 244 (434)
Q Consensus 168 l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~i-iHrDlkp 244 (434)
|+.+.|.|+.+++|.+- ...+.|.+||..|+|.+.+......+++.....+..+|+.||.|||+ ..| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence 45789999999999743 46888999999999999998878889999999999999999999998 344 9999999
Q ss_pred CcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCC-------CCCcCcEEehhHHHHHHHhCCCc
Q 013927 245 DNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-------VDEKTDVYSFGVLLLELITGRRA 317 (434)
Q Consensus 245 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDvwSlGvil~elltG~~p 317 (434)
.|++++..+.+||+|||+.................-...|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987664311111112222356799999987642 35679999999999999999999
Q ss_pred cccccchhhh--hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcchh--h
Q 013927 318 VDHLQQSVVI--WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQS--V 393 (434)
Q Consensus 318 ~~~~~~~~~~--~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~~--~ 393 (434)
|+........ ...+. .+.-...+.|.+.... +....+..++..||..+|++||++.+|-..++.+...... .
T Consensus 158 ~~~~~~~~~~~eii~~~--~~~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~n 233 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRV--KKGGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGN 233 (484)
T ss_pred cccccccCChHHHHHHH--HhcCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccch
Confidence 9763322110 00000 0001111222221111 3334688899999999999999999998888766543210 0
Q ss_pred ---------------------------hhhhcccccccc------------chhcccccccCc-chhhhhHHHHHHHhhC
Q 013927 394 ---------------------------KESQKQTHRRTY------------SEELFDAQEYNS-TRYLSDISRFKEIALG 433 (434)
Q Consensus 394 ---------------------------~~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~d~~~~~~~~~~ 433 (434)
.+++.......+ .....+++.|.+ |+|+|||.+|+.++..
T Consensus 234 l~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~fsDiv~fT~l~~~ 313 (484)
T KOG1023|consen 234 LMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIYFSDIVGFTVLSSN 313 (484)
T ss_pred hHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeeeeHHHHHHHHHHhc
Confidence 001111000000 156677788888 9999999999999875
Q ss_pred C
Q 013927 434 S 434 (434)
Q Consensus 434 ~ 434 (434)
+
T Consensus 314 ~ 314 (484)
T KOG1023|consen 314 S 314 (484)
T ss_pred C
Confidence 3
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=206.05 Aligned_cols=257 Identities=22% Similarity=0.228 Sum_probs=186.5
Q ss_pred CCCCCCeecccCcEEEEEEEeCCC--cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC----CCeeeEeeec---cCCcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDG--TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH----PNTAKLVGCD---SDGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~---~~~~~ 188 (434)
+|.+.+.||+|+||.||.|..... ..+|+|........... .+..|..++..+.. +++..+++.. .+..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 699999999999999999997643 57999988765332222 57778888888862 5777777765 22467
Q ss_pred EEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-----CCeEEecccc
Q 013927 189 LVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-----YEPQICDFGL 262 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-----~~~kL~DFGl 262 (434)
+||+.+ +.+|.++.... ...++..+.+.|+.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 888876 46899988544 4789999999999999999999999 999999999999999865 3689999999
Q ss_pred cc--ccCCCCc-----ccc-eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC
Q 013927 263 AK--WLPRQWT-----HHN-VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 263 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~ 334 (434)
++ .+..... ... ...+.||..|+++..+.+...+.+.|+||++.++.|++.|..||.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 98 3211111 111 234669999999999999999999999999999999999999997654322111000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.......... .....+. .+..+...+-..+...+|....+...|+...
T Consensus 251 ~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 251 KDPRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHhhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0000111111 1112223 3444444455589999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=201.37 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=185.6
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~~ 195 (434)
..+..+|.+...|+.|+|+++ |..+++|++.-... .....+|..|.-.|+.+.||||+.++|.|.. ++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 334456888999999999998 55667787764333 2334579999999999999999999998654 6788999999
Q ss_pred CCCHHHHhccCCC-CCCHHHHHHHHHHHHHHhHhhhccCCCCee-ecCCCCCcEEecCCCCeEEe--ccccccccCCCCc
Q 013927 196 LGSLASILHGSKD-KPDWSKRYRIALGTANGLTYLHEGCQKRII-HRDIKADNILLTEDYEPQIC--DFGLAKWLPRQWT 271 (434)
Q Consensus 196 ~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~gL~yLH~~~~~~ii-HrDlkp~NIll~~~~~~kL~--DFGla~~~~~~~~ 271 (434)
.|+|.++|++... ..+-.+..++|.++|+|++|||+- .+++ ---|.+..+++|++.+++|+ |--++....
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfqe~---- 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---- 344 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeeecc----
Confidence 9999999997543 467788899999999999999984 3344 34788999999999888774 433222111
Q ss_pred ccceeccccccccccCCccccCCCC---CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD---EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
...-.+.||+||.+...+-+ ..+|+|||++++|||.|...||....+..-.+. +.-..++.
T Consensus 345 -----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-----------ialeglrv 408 (448)
T KOG0195|consen 345 -----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-----------IALEGLRV 408 (448)
T ss_pred -----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-----------hhhccccc
Confidence 11125789999999876643 578999999999999999999987665433221 11122333
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+++-....+.+++.-|++.||.+||.+..|+-+|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 344444567788899999999999999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-25 Score=225.97 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=182.3
Q ss_pred CCCCeecccCcEEEEEEEeC-CCcEEEEEEee----CCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 120 SSENLIGKGGYAEVYKGCLR-DGTLVAVKRLT----KGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
....++|.|++|.|+..... ....++.|... ...... ....+..|+.+-..++|||++..+....+ ...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977776543 34444444332 221111 12236678888888999999887765332 344449
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|||++ +|..++... ..+....+..+..|++.|+.|+|+ .||.|||+|++|++++.+|.+||+|||.+..+...+.
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99998 999988633 467777788889999999999999 9999999999999999999999999999988776655
Q ss_pred c--cceeccccccccccCCccccCCCCCc-CcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 H--HNVSKFEGTFGYFAPEYFMHGIVDEK-TDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
. .....++|+-.|+|||++.+..|++. .||||.|+++..|++|+.||........... ............ -..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~~~~~~~~~~~~---~~~ 551 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-TNNYSDQRNIFE---GPN 551 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-hhcccccccccc---ChH
Confidence 5 55667889999999999999999864 7999999999999999999975333221110 000000000000 000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+...++.++|+.+|.+|.++.+|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111233456677889999999999999999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=195.92 Aligned_cols=256 Identities=31% Similarity=0.371 Sum_probs=193.7
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh--hHhhHHHHHHHHhhCCCC-CeeeEeeeccC--CcEEEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE--KTCGFLCEIGIIAYVDHP-NTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~g~~~~--~~~lv~e~ 193 (434)
|.+...||.|+||.||++... ..+|+|.+....... ....+.+|+.++..+.|+ +++.+.+.... ..++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 789999998765543 356799999999999988 79999987543 35899999
Q ss_pred cCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~~ 270 (434)
+.++++.+++.... ..+.......++.+++.++.|+|. .+++|||+||+||+++..+ .++++|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776433 268888999999999999999999 8999999999999999988 79999999998655432
Q ss_pred ccc----ceeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccc---hhhhhhccccCcccccc
Q 013927 271 THH----NVSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQ---SVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 271 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~ 340 (434)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||..... ....+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2356779999999999987 5788899999999999999999999766442 11111100000000
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.................+..++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467778899999999999999887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=192.65 Aligned_cols=199 Identities=21% Similarity=0.268 Sum_probs=166.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeeccCC--cEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSDG--IHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~lv~e~ 193 (434)
+|.++++||+|+||.++.|..= +++.||||.-..... .-.+..|....+.|. .+.|..++-+.+++ ..||+++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 6999999999999999999843 799999997654332 224677888888885 68888887776654 5588887
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-----CCeEEeccccccccCC
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-----YEPQICDFGLAKWLPR 268 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-----~~~kL~DFGla~~~~~ 268 (434)
+ |.||.++..-....++..++..||.|++.-++|+|+ +.+|.|||||+|+||..- ..+.|+|||+|+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 7 579999998888999999999999999999999999 999999999999999643 3588999999998765
Q ss_pred CCcccc-----eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccc
Q 013927 269 QWTHHN-----VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQ 323 (434)
Q Consensus 269 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 323 (434)
..+... .....||..||+=....+..-+.+.|+-|||-+++..|-|..||.++..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 433322 2456799999999999999999999999999999999999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=182.31 Aligned_cols=202 Identities=22% Similarity=0.271 Sum_probs=163.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEe-CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC-CCeeeEeee--ccCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL-RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGC--DSDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~--~~~~~~lv~ 191 (434)
.+.|.+.++||.|+||.+|.|.. .+|..||||+-...... ..+..|..+...|.+ ..|..+..+ ..+...+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 36799999999999999999984 58999999987654322 246778888888875 344444333 445677999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC---CCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---YEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGla~~~~~ 268 (434)
++. +.||.+++.-....++..+++-+|-|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||+|+.+-.
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 987 579999988777889999999999999999999998 999999999999999754 3688999999987643
Q ss_pred CCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch
Q 013927 269 QWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS 324 (434)
Q Consensus 269 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 324 (434)
..+. .......||..|.+-..+.+..-+.+.|+-|+|.+|..+.-|..||.++...
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3222 1224567999999988877777788999999999999999999999986544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=181.12 Aligned_cols=140 Identities=18% Similarity=0.080 Sum_probs=109.1
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh--------H-----------------hhHHHHHHHHhhCCCCCe
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK--------T-----------------CGFLCEIGIIAYVDHPNT 176 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~-----------------~~~~~E~~~l~~l~h~ni 176 (434)
...||+|+||.||+|...+|+.||||++........ . .....|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988899999999976532110 0 122349999999987776
Q ss_pred eeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhh-hccCCCCeeecCCCCCcEEecCCCCe
Q 013927 177 AKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL-HEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 177 v~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yL-H~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
.....+.....++||||++++++..... ....++......++.|++.+|.|| |+ .+|+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCcE
Confidence 4433333334589999999887765432 235678889999999999999999 67 8999999999999998 4789
Q ss_pred EEecccccccc
Q 013927 256 QICDFGLAKWL 266 (434)
Q Consensus 256 kL~DFGla~~~ 266 (434)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=172.28 Aligned_cols=142 Identities=19% Similarity=0.108 Sum_probs=111.6
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh-------------------------hHhhHHHHHHHHhhCCCCCe
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE-------------------------KTCGFLCEIGIIAYVDHPNT 176 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~~l~h~ni 176 (434)
...||+|+||.||+|...+|+.||||++....... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999998653210 01123578999999999987
Q ss_pred eeEeeeccCCcEEEEEEcCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 177 AKLVGCDSDGIHLVFQLSPLGSLAS-ILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 177 v~l~g~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
.....+.....++||||++++++.. .+. ...++......++.+++.+|.+||+ ..||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCCE
Confidence 5444333334589999999875443 342 3456778889999999999999996 37999999999999999 7899
Q ss_pred EEeccccccccCC
Q 013927 256 QICDFGLAKWLPR 268 (434)
Q Consensus 256 kL~DFGla~~~~~ 268 (434)
+|+|||++...+.
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=178.72 Aligned_cols=170 Identities=11% Similarity=0.032 Sum_probs=130.2
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh--Hhh------HHHHHHHHhhCCCCCeeeEeeecc---
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK--TCG------FLCEIGIIAYVDHPNTAKLVGCDS--- 184 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~------~~~E~~~l~~l~h~niv~l~g~~~--- 184 (434)
.++|...++||.|+||.||+... ++..+|||++........ ... +.+|+..+.++.|++|..+.++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999666 577899999975543221 122 578999999999999999877522
Q ss_pred -------CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 185 -------DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 185 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
...++||||++|.+|.++.. ++. ....+++.+|..+|. .+++|||++|+||+++.+| ++|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEE
Confidence 24789999999999988742 222 245589999999998 9999999999999999998 999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt 313 (434)
+|||.......... .. .++....|..++|+|+||+++.-+..
T Consensus 176 iDfg~~~~~~e~~a---~d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKA---KD-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhh---HH-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 99998865432110 00 03344456678999999999876643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=198.43 Aligned_cols=245 Identities=18% Similarity=0.161 Sum_probs=179.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC---CCCeeeEee--eccCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD---HPNTAKLVG--CDSDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g--~~~~~~~lv~ 191 (434)
..|.+.+.||+|+||+||+|...+|+.||+|+-......+. .--.+++.+|+ -+-|..+.. ...+..++|+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 56788889999999999999988899999999887665432 22234555666 122333333 2678899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-------CCCeEEecccccc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-------DYEPQICDFGLAK 264 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-------~~~~kL~DFGla~ 264 (434)
+|.+.|+|.++++ ....+++..++.++.|++..+..||. .+||||||||+|+||.. ..-++|+|||.+-
T Consensus 774 ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999998 66789999999999999999999999 99999999999999942 3358999999986
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
-+.--.........++|-.+-.+|...+..++..+|.|.|+-+++-||.|+..- . .+.-...++.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------~-------~~g~~~~~~~ 914 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------V-------KNGSSWMVKT 914 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------h-------cCCcceeccc
Confidence 443322334456677889999999999999999999999999999999997421 0 0111111222
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+..-...+. +.++...+|+.+-..=|...++...|++..
T Consensus 915 ~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 915 NFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred cchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 1111111222 333445566655555578888877776554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=203.36 Aligned_cols=249 Identities=21% Similarity=0.206 Sum_probs=174.6
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHH--HhhCCCCCeeeEeee--ccCCcEEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGI--IAYVDHPNTAKLVGC--DSDGIHLVFQL 193 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~--~~~~~~lv~e~ 193 (434)
++...+.||.+.|=+|.+|+++.|. |+||++.+....-....|.+++.- ...+++||++++.-. .....++|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4666678999999999999999887 899999876543333334433332 455689999998765 22356677777
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc--CCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL--PRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~--~~~~~ 271 (434)
.. .+|.+.+. .+..+......-|+.|++.||.-+|. .||+|||||.+||||+.-+.+.|+||...+.. +.. .
T Consensus 103 vk-hnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD-N 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED-N 176 (1431)
T ss_pred Hh-hhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC-C
Confidence 65 47888885 45567777778899999999999999 99999999999999999999999999887643 222 1
Q ss_pred ccceecc----ccccccccCCccccC----------C-CCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhc-cccC
Q 013927 272 HHNVSKF----EGTFGYFAPEYFMHG----------I-VDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAK-PLLD 334 (434)
Q Consensus 272 ~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~-~~~~ 334 (434)
......+ ..-.+|+|||.+... . .+++-||||+||++.||++ |++||+-. +....... ....
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-QL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-QLLAYRSGNADDP 255 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-HHHhHhccCccCH
Confidence 1222222 223579999987531 1 4567899999999999998 56777532 11111000 0000
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+.-++.+-| ..+.+++..|++.||.+|.++++.++.-+|.
T Consensus 256 e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 256 EQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 011111222 2466788999999999999999999876555
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=164.63 Aligned_cols=185 Identities=16% Similarity=0.066 Sum_probs=135.7
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh---HhhHHHHHHHHhhCC-CCCeeeEeeeccCCcEEEEEEcC
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK---TCGFLCEIGIIAYVD-HPNTAKLVGCDSDGIHLVFQLSP 195 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~lv~e~~~ 195 (434)
.+...|++|+||+||.+.. .+..++.+.+........ ...+.+|+.+|++|. |+++.+++++ ++.+++|+|+.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~ 81 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLA 81 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeec
Confidence 3457899999999997766 577888777765433111 124788999999995 5789999886 46799999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCC-CCCcEEecCCCCeEEeccccccccCCCCcc--
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI-KADNILLTEDYEPQICDFGLAKWLPRQWTH-- 272 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFGla~~~~~~~~~-- 272 (434)
+.+|...+.. ....++.+++.+|.++|. .||+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9898765421 113467789999999999 99999999 799999999999999999999865433210
Q ss_pred ----cce-----eccccccccccCCccccC-CCC-CcCcEEehhHHHHHHHhCCCcc
Q 013927 273 ----HNV-----SKFEGTFGYFAPEYFMHG-IVD-EKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 273 ----~~~-----~~~~gt~~y~aPE~~~~~-~~~-~ksDvwSlGvil~elltG~~p~ 318 (434)
... .....++.|++|+...-- ..+ ...+.++-|+-+|.++||+.+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 000 011246677777643221 222 3458889999999999998775
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-20 Score=187.57 Aligned_cols=234 Identities=26% Similarity=0.239 Sum_probs=172.9
Q ss_pred eecccCcEEEEEEE----eCCCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEEEEcC
Q 013927 124 LIGKGGYAEVYKGC----LRDGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVFQLSP 195 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~e~~~ 195 (434)
.+|.|+||.|+++. .+.|..+|+|++.+..... .......|..++...+ ||.+|.+.-.. ....++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 3357889999887754421 1114555778888887 99999998763 347899999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccce
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~ 275 (434)
+|.|...+... ..+++.........++-+++++|+ .+++|||+|++||+++.+|++++.|||+++..-..
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------ 150 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------ 150 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhh------
Confidence 99998888643 334444555556678899999998 99999999999999999999999999999865332
Q ss_pred eccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 276 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
...+||..|||||++. .....+|.||||++++||+||..||.. .....+ ... ...++.+..
T Consensus 151 ~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~I--------------l~~--~~~~p~~l~ 211 (612)
T KOG0603|consen 151 KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRI--------------LKA--ELEMPRELS 211 (612)
T ss_pred hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHH--------------hhh--ccCCchhhh
Confidence 1228999999999997 567789999999999999999999986 111111 110 111223333
Q ss_pred HHHHHHHHhhhccCCCCCCCH--hHHHHHhcCC
Q 013927 356 DRAVLTASLCIEQSPILRPKM--SQVVILLRGD 386 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~--~evl~~L~~~ 386 (434)
.....++..++..+|..|-.. .-+.++++..
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~ 244 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE 244 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence 445566778888899999766 4555555433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=168.99 Aligned_cols=229 Identities=18% Similarity=0.196 Sum_probs=143.6
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCC----------CC------eeeE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDH----------PN------TAKL 179 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h----------~n------iv~l 179 (434)
+.....||.|+++.||.+.+. +|+.+|||+...... ......+.+|.-....+.+ -. ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344568999999999999987 689999998875442 2334456666544444322 11 1222
Q ss_pred ee------ecc--C-----CcEEEEEEcCCCCHHHHhcc---CC---CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeec
Q 013927 180 VG------CDS--D-----GIHLVFQLSPLGSLASILHG---SK---DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240 (434)
Q Consensus 180 ~g------~~~--~-----~~~lv~e~~~~gsL~~~l~~---~~---~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHr 240 (434)
-+ ... . +.+++|+-+. ++|..++.. .. ..+....++.+..|+++.+++||. .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 011 0 2355666653 677776542 11 124455667788999999999999 999999
Q ss_pred CCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCcccc--------CCCCCcCcEEehhHHHHHHH
Q 013927 241 DIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH--------GIVDEKTDVYSFGVLLLELI 312 (434)
Q Consensus 241 Dlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvil~ell 312 (434)
||+|+|++++.+|.++|+||+........ ......+..|.+||.... -.++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654332 111234577899997643 24788899999999999999
Q ss_pred hCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCC
Q 013927 313 TGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILR 373 (434)
Q Consensus 313 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R 373 (434)
+|+.||+........ .. .+. .+. +..+.+..+|..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~-----------~~----~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP-----------EW----DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS-----------GG----GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc-----------cc----cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999864321110 00 111 122 445677788899999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-19 Score=163.44 Aligned_cols=143 Identities=19% Similarity=0.132 Sum_probs=111.8
Q ss_pred CCCCCCeecccCcEEEEEEE--eCCCcEEEEEEeeCCCchh-----------------------hHhhHHHHHHHHhhCC
Q 013927 118 NFSSENLIGKGGYAEVYKGC--LRDGTLVAVKRLTKGTVDE-----------------------KTCGFLCEIGIIAYVD 172 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 172 (434)
.|.+.+.||+|+||.||+|. ..+|+.||||++....... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 4589999999987543210 1123567999999997
Q ss_pred CC--CeeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC-eeecCCCCCcEEe
Q 013927 173 HP--NTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR-IIHRDIKADNILL 249 (434)
Q Consensus 173 h~--niv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~-iiHrDlkp~NIll 249 (434)
+. .+..+++. ...++||||+++++|...+.. ...........++.|++.+|.+||+ .+ ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEE
Confidence 53 34455544 345899999999888765432 2345556667899999999999999 88 9999999999999
Q ss_pred cCCCCeEEeccccccccC
Q 013927 250 TEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 250 ~~~~~~kL~DFGla~~~~ 267 (434)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 7899999999987544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=159.51 Aligned_cols=134 Identities=18% Similarity=0.227 Sum_probs=101.4
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-----CCCCeeeEeeeccCC-----cE-
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-----DHPNTAKLVGCDSDG-----IH- 188 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~-----~~- 188 (434)
.-..+||+|+||.||. .-.++.. +||++..... .....+.+|+.+++.+ .||||++++|+..+. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 3234444 7998876432 2345689999999999 679999999975443 23
Q ss_pred EEEEE--cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHh-HhhhccCCCCeeecCCCCCcEEecC----CCCeEEeccc
Q 013927 189 LVFQL--SPLGSLASILHGSKDKPDWSKRYRIALGTANGL-TYLHEGCQKRIIHRDIKADNILLTE----DYEPQICDFG 261 (434)
Q Consensus 189 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL-~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kL~DFG 261 (434)
+|+|| +++|+|.+++... .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 68999 5579999999642 35544 34567778777 99999 99999999999999974 3479999954
Q ss_pred cc
Q 013927 262 LA 263 (434)
Q Consensus 262 la 263 (434)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=156.46 Aligned_cols=144 Identities=19% Similarity=0.107 Sum_probs=112.3
Q ss_pred HHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch---------------------hhHhhHHHHHHHHhh
Q 013927 112 LQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD---------------------EKTCGFLCEIGIIAY 170 (434)
Q Consensus 112 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~ 170 (434)
+......|.+.+.||.|+||.||++...+|+.||||++...... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333348888999999999999999888999999987654310 011135678889999
Q ss_pred CCCCC--eeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEE
Q 013927 171 VDHPN--TAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNIL 248 (434)
Q Consensus 171 l~h~n--iv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIl 248 (434)
+.|++ +...++. ...++||||+++++|..+... .....++.+++.++.++|+ .+|+||||+|.||+
T Consensus 90 l~~~~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil 157 (198)
T cd05144 90 LYEEGFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL 157 (198)
T ss_pred HHHcCCCCCceeec--CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence 98874 4444443 456899999999998776431 2345688899999999999 99999999999999
Q ss_pred ecCCCCeEEeccccccccC
Q 013927 249 LTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 249 l~~~~~~kL~DFGla~~~~ 267 (434)
+++++.++|+|||++....
T Consensus 158 l~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EcCCCcEEEEECCccccCC
Confidence 9999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-19 Score=186.17 Aligned_cols=209 Identities=23% Similarity=0.336 Sum_probs=141.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccCCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~lv~e~~~ 195 (434)
.+|+.+++|..|+||.||.++++ ..+.+|+| +.+... +++- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee------------------
Confidence 47899999999999999999987 67889994 443221 1111 23233333333
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc----
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT---- 271 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~---- 271 (434)
|+-...+.. .+.+.. +++.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+++..-....
T Consensus 136 -gDc~tllk~-~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 333333332 122222 22678999999 9999999999999999999999999999875321110
Q ss_pred ---------ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 272 ---------HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 272 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
.......+||+.|+|||++....|...+|+|++|+|+||.+-|+.||.+.-+....- .++
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg-----------~vi 271 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-----------QVI 271 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh-----------hhh
Confidence 011134689999999999999999999999999999999999999998743221110 000
Q ss_pred CCcC-CCCCCHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 343 DPSL-GDNYDAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 343 d~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
...+ -.+-+.....+..+++.+.|..+|..|--.
T Consensus 272 sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 272 SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 0000 001122233567778899999999999543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=162.61 Aligned_cols=180 Identities=21% Similarity=0.215 Sum_probs=121.0
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe--cCCC--CeEEecccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL--TEDY--EPQICDFGL 262 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll--~~~~--~~kL~DFGl 262 (434)
+|+||.-.+ .+|..++.. ...+.....-|+.|+++|+.|||. ++|.|||+|++|||+ |+|+ .+.|+|||.
T Consensus 318 lylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 318 LYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred EEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 567777665 478888853 345556666688899999999998 999999999999999 4444 467899998
Q ss_pred ccccCCCC----cccceeccccccccccCCccccCC------CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc
Q 013927 263 AKWLPRQW----THHNVSKFEGTFGYFAPEYFMHGI------VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 263 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 332 (434)
+---.... ........-|...-||||+....+ .-.|+|.|+.|.+.||+++...||..-.........
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-- 469 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-- 469 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--
Confidence 74221110 111112344788899999986432 236899999999999999999999763322111100
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
..+..+ |.+.. .....+.+++...|+.||.+||+..-....|
T Consensus 470 Yqe~qL-----Palp~----~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 470 YQESQL-----PALPS----RVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhC-----CCCcc----cCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 111111 22222 2234566677889999999999976554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.6e-18 Score=153.33 Aligned_cols=133 Identities=20% Similarity=0.278 Sum_probs=108.8
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhCCCCCeeeEee--eccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYVDHPNTAKLVG--CDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g--~~~~~~~lv~e~ 193 (434)
+.||+|++|.||+|.. .|..|+||+....... .....+.+|+.++..+.|+++..... ...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 4778999986543221 11235778999999999988765443 356678999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
+++++|.+++.... . .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986422 1 778899999999999998 9999999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=151.51 Aligned_cols=129 Identities=22% Similarity=0.327 Sum_probs=104.9
Q ss_pred eecccCcEEEEEEEeCCCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhCCCCC--eeeEeeeccCCcEEEEEEc
Q 013927 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYVDHPN--TAKLVGCDSDGIHLVFQLS 194 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~lv~e~~ 194 (434)
+||+|+||.||+|.+. |..|++|+....... .....+.+|+.++..+.|++ +..++....+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 788999986543211 11245778999999998775 4455666667789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
++++|.+++..... .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998753211 788999999999999 9999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.9e-19 Score=172.51 Aligned_cols=173 Identities=23% Similarity=0.341 Sum_probs=128.1
Q ss_pred CcEEEEEEcCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 GIHLVFQLSPLGSLASILHG--SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
.+++.|++|...+|.++|.. .....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 47789999999999999964 34567888899999999999999 58999999999999999999999999998
Q ss_pred cccCCCC----cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccc
Q 013927 264 KWLPRQW----THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 264 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
....... .....+...||..||+||.+.+..|+.++||||||+||+|+++ =..++.... .+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~--------------t~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA--------------TL 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH--------------hh
Confidence 7665443 2234456789999999999999999999999999999999997 222222111 11
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev 379 (434)
..+-+..+...+-.+.. .-..++.+++...|.+||++.++
T Consensus 470 ~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 TDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 11222222111111111 12347789999999999944433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=169.73 Aligned_cols=136 Identities=21% Similarity=0.268 Sum_probs=108.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCC-Cch------hhHhhHHHHHHHHhhCCCCCeeeEeee--ccCC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKG-TVD------EKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~ 186 (434)
...|...+.||+|+||+||+|.+..+ .+++|+.... ... .....+.+|+.++..++|++++....+ ..+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34567788999999999999987643 3444443221 111 122468899999999999998775543 4457
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
.++||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 889999999999999884 356789999999999999 999999999999999 577999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=141.06 Aligned_cols=138 Identities=21% Similarity=0.149 Sum_probs=98.0
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh-Hhh----------------------HHHHHHHHhhCCCC--Ce
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK-TCG----------------------FLCEIGIIAYVDHP--NT 176 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~E~~~l~~l~h~--ni 176 (434)
.+.||+|+||.||+|...+|+.||||++........ ... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999876432111 111 12455566665443 24
Q ss_pred eeEeeeccCCcEEEEEEcCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 177 AKLVGCDSDGIHLVFQLSPLGSLAS-ILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 177 v~l~g~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. ..+|+||||||+||+++ ++.+
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCcE
Confidence 444443 35689999999854321 111110 11 4567789999999999996 37999999999999999 8899
Q ss_pred EEeccccccccC
Q 013927 256 QICDFGLAKWLP 267 (434)
Q Consensus 256 kL~DFGla~~~~ 267 (434)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=173.60 Aligned_cols=250 Identities=23% Similarity=0.250 Sum_probs=181.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC--CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCC-CCCeeeEeeec--cCCcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--~~~~~lv~ 191 (434)
.|.+.+.||+|+|+.|-..... ....+|+|.+..... .........|..+-+.+. |+|++.+++.. .+..++.+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 3666677999999999887754 345577776654431 222223444777777776 99999999974 44678999
Q ss_pred EEcCCCCHHHHh-ccCCCCCCHHHHHHHHHHHHHHhHhhh-ccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCC
Q 013927 192 QLSPLGSLASIL-HGSKDKPDWSKRYRIALGTANGLTYLH-EGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~gL~yLH-~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~ 268 (434)
+|..+|++.+.+ .......+....-.+..|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999888 443324445555667889999999999 7 8999999999999999999 999999999998876
Q ss_pred -CCcccceecccc-ccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCc
Q 013927 269 -QWTHHNVSKFEG-TFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 269 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
..........+| ++.|+|||.+.+. ......|+||.|+++.-+++|..||+......... ..+....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------~~~~~~~ 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------SSWKSNK 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------eeecccc
Confidence 445555566778 9999999999874 45678899999999999999999997644332110 1111110
Q ss_pred CC--CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 346 LG--DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 346 l~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.. ...-.........++..++..+|..|.+.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 000011123455677788889999999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.3e-16 Score=131.80 Aligned_cols=133 Identities=19% Similarity=0.129 Sum_probs=109.7
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC--CCeeeEeeecc--CCcEEEEEEcCCC
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH--PNTAKLVGCDS--DGIHLVFQLSPLG 197 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~--~~~~lv~e~~~~g 197 (434)
.+.||.|.++.||++...+ ..++||....... ...+..|+.++..+.| .++.++++... +..++++||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999864 7899998866443 3468889999999976 48888887644 3789999999987
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.+..+ +......++.+++++|.+||.....+++|+|++|.||+++..+.++++|||.+...
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 76543 45666778899999999999854457999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.4e-15 Score=137.34 Aligned_cols=134 Identities=14% Similarity=0.192 Sum_probs=103.1
Q ss_pred Ceec-ccCcEEEEEEEeCCCcEEEEEEeeCCCc------------hhhHhhHHHHHHHHhhCCCCCe--eeEeeecc--C
Q 013927 123 NLIG-KGGYAEVYKGCLRDGTLVAVKRLTKGTV------------DEKTCGFLCEIGIIAYVDHPNT--AKLVGCDS--D 185 (434)
Q Consensus 123 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~--~ 185 (434)
..|| .||.|+||.+... +..++||.+..... ......+.+|+.++.++.|++| +..+++.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998886 77899998854321 1222467889999999998775 55665421 1
Q ss_pred ----CcEEEEEEcCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 186 ----GIHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 186 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+ .||+||||||.|||++.++.++|+||
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 689988854 234433 35688999999999 99999999999999999999999999
Q ss_pred cccccc
Q 013927 261 GLAKWL 266 (434)
Q Consensus 261 Gla~~~ 266 (434)
|.+...
T Consensus 187 g~~~~~ 192 (239)
T PRK01723 187 DRGELR 192 (239)
T ss_pred CCcccC
Confidence 998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=142.65 Aligned_cols=141 Identities=21% Similarity=0.171 Sum_probs=100.2
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh---------------------------------------HhhHH
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK---------------------------------------TCGFL 162 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~ 162 (434)
.+.||.|++|.||+|.+.+|+.||||+...+..... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865431110 01345
Q ss_pred HHHHHHhhCC----CCCeee---EeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHH-HhHhhhccCC
Q 013927 163 CEIGIIAYVD----HPNTAK---LVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTAN-GLTYLHEGCQ 234 (434)
Q Consensus 163 ~E~~~l~~l~----h~niv~---l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-gL~yLH~~~~ 234 (434)
+|...+.++. +.+-+. ++.......++||||+++++|.++........+ +..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence 5665555552 322233 232233467899999999999887643212222 3446666665 4678887
Q ss_pred CCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
.|++|+|++|.||+++.++.++|+|||++..++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3e-13 Score=125.31 Aligned_cols=201 Identities=20% Similarity=0.215 Sum_probs=134.2
Q ss_pred HHHhhCCCCCeeeEeeeccC-------CcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCC
Q 013927 166 GIIAYVDHPNTAKLVGCDSD-------GIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQK 235 (434)
Q Consensus 166 ~~l~~l~h~niv~l~g~~~~-------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~ 235 (434)
.-|-++.|.|||+++.++.+ ...++.||+.-|++..+|.. ....+......+++.||+.||.|||+ |..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 34556679999999887443 35689999999999999975 23446667778899999999999998 568
Q ss_pred CeeecCCCCCcEEecCCCCeEEeccccccccC--CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh
Q 013927 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLP--RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313 (434)
Q Consensus 236 ~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt 313 (434)
.|+|+++.-.-|++..+|-+||.--.....-+ ........+.-.+.++|.|||+=.....+..+|||+||++.+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999988875321111000 0000111122346789999998777777888999999999999988
Q ss_pred CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 314 GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 314 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
|..--......... .....+.+..+-++.- ..++..|++..|..||+|++++..
T Consensus 278 lEiq~tnseS~~~~---ee~ia~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV---EENIANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceeeh---hhhhhhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 76321111000000 0000011111111111 124578999999999999998643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-12 Score=114.55 Aligned_cols=130 Identities=18% Similarity=0.041 Sum_probs=96.2
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEEcCCCCHHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQLSPLGSLAS 201 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~~~~gsL~~ 201 (434)
+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.++ .+++++..+..++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence 46889999999999876 77899998765432 12246778999988865544 3456665556789999999987754
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHhHhhhccC--CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 202 ILHGSKDKPDWSKRYRIALGTANGLTYLHEGC--QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 202 ~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
.. .....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 011235678999999999821 12369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=130.67 Aligned_cols=246 Identities=21% Similarity=0.218 Sum_probs=171.4
Q ss_pred CCCCCCeecc--cCcEEEEEEEe--C-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcE
Q 013927 118 NFSSENLIGK--GGYAEVYKGCL--R-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~ 188 (434)
.|.+..-+|. |.+|.||.+.. . ++..+|+|.-...... .....-.+|+....+++ |+|.++.+.... +..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3666778999 99999999876 3 6888999974433221 11223345666666664 899999776543 3577
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHH----HhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTAN----GLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLA 263 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla 263 (434)
+-+|++. .+|..+.+.....++......+..+... ||..+|. .+++|-|+||.||+...+ ..++++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCccee
Confidence 7778876 7888888866666777777788888888 9999999 999999999999999999 78999999999
Q ss_pred cccCCCCcccc---eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 264 KWLPRQWTHHN---VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 264 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
..+....-... .....|...|++||... +.++...|+|++|.++.+..+|..+...-. ...|.. ++.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--~~~W~~-------~r~ 340 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK--NSSWSQ-------LRQ 340 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC--CCCccc-------ccc
Confidence 88765532221 12236888999999764 567889999999999999999876542210 011110 011
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.. +..++...-...+...+..+++.+|..|++.+.+.
T Consensus 341 ~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 341 GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11 11111111112334477889999999999887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.4e-12 Score=127.96 Aligned_cols=145 Identities=17% Similarity=0.168 Sum_probs=94.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC-CcEEEEEEeeCCCch---------------------------------hhH----
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVD---------------------------------EKT---- 158 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~---- 158 (434)
..|+. +.||.|++|.||+|.+++ |+.||||+..++... +..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 689999999999999986 999999999765211 000
Q ss_pred --hhHHHHHHHHhhCC----CCCeeeEeee---ccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHH-hHh
Q 013927 159 --CGFLCEIGIIAYVD----HPNTAKLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG-LTY 228 (434)
Q Consensus 159 --~~~~~E~~~l~~l~----h~niv~l~g~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~g-L~y 228 (434)
-++.+|+..+.++. +.+.+.+-.+ ......+||||+.|+.+.++-.-.....+... ++...+.. +.-
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 13455555555542 3333433332 23467899999999999774221111222111 22211111 122
Q ss_pred hhccCCCCeeecCCCCCcEEecCCC----CeEEeccccccccCC
Q 013927 229 LHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAKWLPR 268 (434)
Q Consensus 229 LH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~~~~~ 268 (434)
+.. .|++|+|++|.||+++.++ .++++|||++..++.
T Consensus 276 if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 233 7999999999999999988 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-11 Score=120.60 Aligned_cols=231 Identities=16% Similarity=0.138 Sum_probs=145.8
Q ss_pred CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHH
Q 013927 139 RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSPLGSLASILHGSKDKPDWSKRY 216 (434)
Q Consensus 139 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 216 (434)
.++.+|.|........ .......+-+..|+.++||||++++.... ...|+|+|-+. .|..++.... .....
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 3688899998876554 34445677788999999999999999744 36799999873 5777775322 33444
Q ss_pred HHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCC
Q 013927 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296 (434)
Q Consensus 217 ~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 296 (434)
..+.||+.||.|||+ ..+++|++|...-|+|++.|..||++|.++.......... ....---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc--
Confidence 567899999999997 3689999999999999999999999999886443221100 0011122356666443222
Q ss_pred CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 297 EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 297 ~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
-..|.|-|||+++|++.|..+ ........-..| .....+.-..+.. ....... ..+++..|....+--|=.+
T Consensus 182 ~s~D~~~Lg~li~el~ng~~~--~~~~~~~~~~ip----k~~~~~~~k~~~~-~~~~r~n-~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSLL--TKTDLSNTGKIP----KALIELYCKKLGA-TELKRPN-KLRFILECRLLGGFFRNDF 253 (690)
T ss_pred cchhhhhHHHHHHHHhCcccC--cchhhhccCccc----hhHHHHHHHHhcc-ccccccc-hhhHHHHHHhccccccchH
Confidence 345999999999999999322 111110000000 0000000000000 0000001 4456677888788888888
Q ss_pred hHHHHHhcCCCCcc
Q 013927 377 SQVVILLRGDEDNA 390 (434)
Q Consensus 377 ~evl~~L~~~~~~~ 390 (434)
-+++..|+++.-..
T Consensus 254 vd~~~fLeel~lks 267 (690)
T KOG1243|consen 254 VDTLLFLEELRLKS 267 (690)
T ss_pred HHHHHHHHhcccCc
Confidence 88888887775443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1e-10 Score=104.40 Aligned_cols=137 Identities=14% Similarity=0.037 Sum_probs=97.7
Q ss_pred CeecccCcEEEEEEEeCC-------CcEEEEEEeeCCCch---------------------hhHhh----HHHHHHHHhh
Q 013927 123 NLIGKGGYAEVYKGCLRD-------GTLVAVKRLTKGTVD---------------------EKTCG----FLCEIGIIAY 170 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~---------------------~~~~~----~~~E~~~l~~ 170 (434)
..||.|--+.||.|...+ +..+|||+....... ..... ..+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 478999987543210 00112 2379999988
Q ss_pred CCC--CCeeeEeeeccCCcEEEEEEcCCCCHHH-HhccCCCCCCHHHHHHHHHHHHHHhHhh-hccCCCCeeecCCCCCc
Q 013927 171 VDH--PNTAKLVGCDSDGIHLVFQLSPLGSLAS-ILHGSKDKPDWSKRYRIALGTANGLTYL-HEGCQKRIIHRDIKADN 246 (434)
Q Consensus 171 l~h--~niv~l~g~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~gL~yL-H~~~~~~iiHrDlkp~N 246 (434)
+.. -++...+++ ..-++||||+.++.+.. .+. ...++......+..+++.+|..| |. .++|||||++.|
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence 853 455566654 57789999997653321 222 12334445567788999999999 77 899999999999
Q ss_pred EEecCCCCeEEeccccccccC
Q 013927 247 ILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 247 Ill~~~~~~kL~DFGla~~~~ 267 (434)
||+++ +.+.|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=8.6e-11 Score=101.66 Aligned_cols=130 Identities=24% Similarity=0.253 Sum_probs=100.4
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEee-CCCch----h--hHhhHHHHHHHHhhCC--CCCeeeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLT-KGTVD----E--KTCGFLCEIGIIAYVD--HPNTAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~----~--~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~lv~e~ 193 (434)
..+++|+-+.+|.+.+. |..+++|.-. +.-.. . ....-.+|+.++.++. --++..++++..+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 4456666433 22211 1 1235677999998886 356667788888899999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
.++..|.+++... ...++..+-.-+.-||. .+|+|+||+++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888643 24566777788889999 9999999999999998774 99999999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.4e-11 Score=108.02 Aligned_cols=141 Identities=17% Similarity=0.155 Sum_probs=108.1
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC--CCeeeEeeeccC-----CcEEEEEEcC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH--PNTAKLVGCDSD-----GIHLVFQLSP 195 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~-----~~~lv~e~~~ 195 (434)
+.||.|..+.||++...+|..+++|.............+..|+.++..+.+ .++.+++.+..+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876788999987654332234468889999999976 345667776443 4589999999
Q ss_pred CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC------------------------------------------
Q 013927 196 LGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC------------------------------------------ 233 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~------------------------------------------ 233 (434)
+.++...+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888775531 34667777788888888888888521
Q ss_pred -----------CCCeeecCCCCCcEEecC--CCCeEEeccccccc
Q 013927 234 -----------QKRIIHRDIKADNILLTE--DYEPQICDFGLAKW 265 (434)
Q Consensus 234 -----------~~~iiHrDlkp~NIll~~--~~~~kL~DFGla~~ 265 (434)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-11 Score=122.69 Aligned_cols=243 Identities=21% Similarity=0.212 Sum_probs=163.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--CCcEEEEEEeeCCCchhhHh-hHHHHHHHHhhC-CCCCeeeEeee--ccCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYV-DHPNTAKLVGC--DSDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l-~h~niv~l~g~--~~~~~~lv 190 (434)
.+|.....||.|.|+.|+....+ ++..|++|.+.+.......+ .-+.|+.+...+ .|.+++..+.. ..++.++-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 46788888999999999998754 67899999887765432221 234466555555 37777776653 23467788
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEeccccccccCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~~~~ 269 (434)
.||+.++++.... .....++...++.+..|++.++.++|+ +.++|+|++|+||++..+ +..++.|||....+.-
T Consensus 345 ~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 345 LEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred hhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccce-
Confidence 8999988766555 233456667788899999999999998 999999999999999886 7889999999864321
Q ss_pred Ccccceecccccccc-ccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 270 WTHHNVSKFEGTFGY-FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.......++..| .++.......+-.++|++|||.-+.+.++|...-....+...+.. +.. +.+.
T Consensus 420 ---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~------~~~-----p~~~- 484 (524)
T KOG0601|consen 420 ---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRS------GDT-----PNLP- 484 (524)
T ss_pred ---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeec------ccc-----cCCC-
Confidence 111112223334 345555556688999999999999999998643221111111110 000 0000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
...+.+..++..++..++..||.+.++....
T Consensus 485 ----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 485 ----GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ----chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 1113444456678899999999988875544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.9e-10 Score=97.20 Aligned_cols=140 Identities=23% Similarity=0.281 Sum_probs=101.7
Q ss_pred CCCeecccCcEEEEEEEeCCCcEEEEEEeeC-CCc----h--hhHhhHHHHHHHHhhCCCCC--eeeEeeeccCCcEEEE
Q 013927 121 SENLIGKGGYAEVYKGCLRDGTLVAVKRLTK-GTV----D--EKTCGFLCEIGIIAYVDHPN--TAKLVGCDSDGIHLVF 191 (434)
Q Consensus 121 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~-~~~----~--~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~lv~ 191 (434)
...+|-+|+-+.|+++.+. |+.+.||.-.. ... + -...+..+|+..|.++.--. ...++-+....-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999987 78877874332 211 1 12346778999998876332 2344555666889999
Q ss_pred EEcCC-CCHHHHhccCCCCCCHH-HHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEecccccc
Q 013927 192 QLSPL-GSLASILHGSKDKPDWS-KRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICDFGLAK 264 (434)
Q Consensus 192 e~~~~-gsL~~~l~~~~~~~~~~-~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGla~ 264 (434)
||.++ .++.+++.......... ....++..|-+.+.-||. ++||||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99986 36777776533332222 336788889999999999 9999999999999997655 45899999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.3e-11 Score=124.25 Aligned_cols=246 Identities=19% Similarity=0.176 Sum_probs=160.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeee--ccCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~--~~~~~~lv~ 191 (434)
..+.+.+-+-.|.++.++.+.-. .|...++|+...... .........+-.++-..++|-++..+-. +.....|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45666677888999999887643 454455554433211 1111222333333333456777765554 567899999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC---
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR--- 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~--- 268 (434)
+|..+++|...|+.....-....+. ....+..+++|||. ..+.|+|++|.|+|...++..+++|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs-~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARS-PILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccc-hhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999998654333333333 44467789999998 6699999999999999999999999984432110
Q ss_pred CCc----------------------c----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccccc
Q 013927 269 QWT----------------------H----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ 322 (434)
Q Consensus 269 ~~~----------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~ 322 (434)
... . .......||+.|.+||.+.+......+|+|++|++++|.++|..||+...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 000 0 00123568999999999999888899999999999999999999998644
Q ss_pred chhhhhhccccCccccccccCCcCCCC-CCHHHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 323 QSVVIWAKPLLDSNDIRELVDPSLGDN-YDAEEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
..... +.+......+. -+.+.......++...+..+|.+|-.|.
T Consensus 1040 pq~~f-----------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQIF-----------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhh-----------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 32221 11111111110 0111223444566677888999997776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-09 Score=95.12 Aligned_cols=127 Identities=20% Similarity=0.146 Sum_probs=82.6
Q ss_pred EEEEEEeCCCcEEEEEEeeCCCch-------------------------hhHhhHHHHHHHHhhCCCC--CeeeEeeecc
Q 013927 132 EVYKGCLRDGTLVAVKRLTKGTVD-------------------------EKTCGFLCEIGIIAYVDHP--NTAKLVGCDS 184 (434)
Q Consensus 132 ~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 184 (434)
.||.|...+|..+|||........ .......+|...|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999987643211 0112466799999999865 556666553
Q ss_pred CCcEEEEEEcC--CCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHh-hhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 185 DGIHLVFQLSP--LGSLASILHGSKDKPDWSKRYRIALGTANGLTY-LHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 185 ~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~y-LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
...+||||++ +..+..+.... ++......++.+++..+.. +|. .||+||||.+.|||++++ .+.|+|||
T Consensus 80 -~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 -RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp -TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--GT
T ss_pred -CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEecC
Confidence 5689999998 54554443321 1122334566677775555 567 899999999999999988 99999999
Q ss_pred cccccC
Q 013927 262 LAKWLP 267 (434)
Q Consensus 262 la~~~~ 267 (434)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.8e-08 Score=95.82 Aligned_cols=258 Identities=17% Similarity=0.143 Sum_probs=157.8
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeee--------EeeeccCC-cEE
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAK--------LVGCDSDG-IHL 189 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~g~~~~~-~~l 189 (434)
.....||+|+-+.+|-.--- +. .+-|+.......... +-+..|.+. .||-+.. ++|-.... .-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34567999999999964322 11 244777665432211 122333333 4554333 22322222 456
Q ss_pred EEEEcCCC-CHHHHhcc-----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 190 VFQLSPLG-SLASILHG-----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 190 v~e~~~~g-sL~~~l~~-----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
+|....+. ....++.. +....+|...++.+..++.+.+-||+ .|.+-+|+.++|+||.+++.|.|.|=...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 66666543 23333331 33457899999999999999999999 89999999999999999999999874332
Q ss_pred cccCCCCcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhC-CCccccccchhhhhhccccCccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITG-RRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
..-. ........+|...|.+||.-. +-.-+...|.|.||+++++++.| +.||.++...... |.-.+..
T Consensus 165 qi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a---p~p~E~~ 238 (637)
T COG4248 165 QINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA---PNPLETD 238 (637)
T ss_pred eecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC---CCcchhh
Confidence 2211 223345667899999999754 23346778999999999999987 8999885543211 0000000
Q ss_pred cc-----cccCCc--C---CCCCCH-HHHHHHHHHHHhhhccC--CCCCCCHhHHHHHhcCCCCcchh
Q 013927 338 IR-----ELVDPS--L---GDNYDA-EEIDRAVLTASLCIEQS--PILRPKMSQVVILLRGDEDNAQS 392 (434)
Q Consensus 338 ~~-----~~~d~~--l---~~~~~~-~~~~~l~~l~~~Cl~~~--P~~RPs~~evl~~L~~~~~~~~~ 392 (434)
|. .--+.. + ....+. .....+..+..+|+... +.-||+++..+..|....+..+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00 000000 0 011111 11234445567787764 56899999999999877665543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.4e-10 Score=114.23 Aligned_cols=149 Identities=15% Similarity=0.308 Sum_probs=101.4
Q ss_pred HHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC-------CcccceeccccccccccCCccccC
Q 013927 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-------WTHHNVSKFEGTFGYFAPEYFMHG 293 (434)
Q Consensus 221 ~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~ 293 (434)
+++.|+.|+|. ..++||++|.|++|.++.++..||++|+.+...... ++........-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45599999998 478999999999999999999999999987654331 111111122346689999999987
Q ss_pred CCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCC
Q 013927 294 IVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPIL 372 (434)
Q Consensus 294 ~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~ 372 (434)
..+.++|+||+||++|-+.. |+.-+........ .......+..-...++.....++.+=+.+++..++.-
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch---------hhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence 88899999999999999994 4444433222111 0111111111112222333456666668899999999
Q ss_pred CCCHhHHH
Q 013927 373 RPKMSQVV 380 (434)
Q Consensus 373 RPs~~evl 380 (434)
||++.++.
T Consensus 256 rp~~~~l~ 263 (700)
T KOG2137|consen 256 RPTLDLLL 263 (700)
T ss_pred Ccchhhhh
Confidence 99888774
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.5e-08 Score=92.94 Aligned_cols=138 Identities=16% Similarity=0.042 Sum_probs=96.7
Q ss_pred eecccCcEEEEEEEeCCCcEEEEEEeeCCCchh----------hHhhHHHHHHHHhhCC-----CCCeeeEeeec----c
Q 013927 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE----------KTCGFLCEIGIIAYVD-----HPNTAKLVGCD----S 184 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~-----h~niv~l~g~~----~ 184 (434)
.+-......|+++... |+.|.||......... ....+.+|...+.++. -|.+|.+.... .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3444444557777664 7889999775433211 1113778888887774 34443332111 2
Q ss_pred CCcEEEEEEcCCC-CHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-------CCCe
Q 013927 185 DGIHLVFQLSPLG-SLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-------DYEP 255 (434)
Q Consensus 185 ~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-------~~~~ 255 (434)
...++|+|++++. +|.+++... ....+......++.+++..+.-||. .||+|+|+++.|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 2477999999976 798887531 2344556677889999999999999 99999999999999975 4689
Q ss_pred EEeccccccc
Q 013927 256 QICDFGLAKW 265 (434)
Q Consensus 256 kL~DFGla~~ 265 (434)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2e-08 Score=99.11 Aligned_cols=165 Identities=20% Similarity=0.236 Sum_probs=122.5
Q ss_pred CcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-----C-CcEEEEEEcCC-CCHH
Q 013927 129 GYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-----D-GIHLVFQLSPL-GSLA 200 (434)
Q Consensus 129 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~-~~~lv~e~~~~-gsL~ 200 (434)
--.+.|++... +|..|++|++.-... ........-+++++++.|+|||++..+.. | .+++|+.|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34678898765 899999999943221 11212334578999999999999987532 2 57899999986 5787
Q ss_pred HHhccC--------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 201 SILHGS--------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 201 ~~l~~~--------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
++.... +...++..++.++.|+..||.++|+ .|+.-+-|.+.+||++.+-.++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 765431 2335678899999999999999999 89999999999999999989999999887665
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~ 316 (434)
.... .+| +. -..+-|.=.||.+++.|.||..
T Consensus 444 ~~d~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDP--------------TEP--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCC--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 4331 011 11 1124578889999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.3e-08 Score=91.82 Aligned_cols=136 Identities=21% Similarity=0.132 Sum_probs=96.1
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch---------------------hhHhhHHHHHHHHhhCCCC--C
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD---------------------EKTCGFLCEIGIIAYVDHP--N 175 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~--n 175 (434)
..++++||.|--+.||.|....|..+|||.-...... -......+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 5567889999999999999999999999965433211 1123467799999998765 6
Q ss_pred eeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 176 TAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 176 iv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
+.+.++. +.-.+||||..+-.|...-- +....-.|+..|++-+.-+-. .||||+|+++-||+++++|.+
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc--ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCE
Confidence 6666654 35679999999866544321 122222333344443333334 799999999999999999999
Q ss_pred EEeccccccc
Q 013927 256 QICDFGLAKW 265 (434)
Q Consensus 256 kL~DFGla~~ 265 (434)
.++||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.1e-07 Score=84.56 Aligned_cols=103 Identities=19% Similarity=0.181 Sum_probs=77.8
Q ss_pred hHHHHHHHHhhCCC-----CCeeeEeeecc---CCcEEEEEEcCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhh
Q 013927 160 GFLCEIGIIAYVDH-----PNTAKLVGCDS---DGIHLVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230 (434)
Q Consensus 160 ~~~~E~~~l~~l~h-----~niv~l~g~~~---~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH 230 (434)
.+.+|...+..|.. |..+.+...-. ...++|+|++++. +|.+++..... .+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH
Confidence 57778887777642 33333322111 2357999999874 79998874222 555667788999999999999
Q ss_pred ccCCCCeeecCCCCCcEEecCCC---CeEEecccccccc
Q 013927 231 EGCQKRIIHRDIKADNILLTEDY---EPQICDFGLAKWL 266 (434)
Q Consensus 231 ~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGla~~~ 266 (434)
. .||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 136 ~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 D---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred H---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9 9999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=7e-07 Score=80.12 Aligned_cols=137 Identities=15% Similarity=0.064 Sum_probs=100.2
Q ss_pred ecccCcEEEEEEEeCCCcEEEEEEeeCCCc-----hhhHhhHHHHHHHHhhCCCCC--eeeEe--eeccC----CcEEEE
Q 013927 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-----DEKTCGFLCEIGIIAYVDHPN--TAKLV--GCDSD----GIHLVF 191 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~n--iv~l~--g~~~~----~~~lv~ 191 (434)
-|+||-+.|+..... |+.+-+|.-..... ......|.+|+..|.+|..-+ +.+.. +.... ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 577999999997776 55788887652211 123457999999999985322 33332 22111 367899
Q ss_pred EEcCC-CCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--eEEeccccccc
Q 013927 192 QLSPL-GSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE--PQICDFGLAKW 265 (434)
Q Consensus 192 e~~~~-gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFGla~~ 265 (434)
|-+.+ -+|.+++... -...+...+..+..+++..+.-||+ .|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 96654 5898888542 3355677778899999999999999 99999999999999986666 99999987763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.3e-07 Score=92.61 Aligned_cols=140 Identities=20% Similarity=0.179 Sum_probs=92.0
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh---------------------------------------HhhHHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK---------------------------------------TCGFLC 163 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~ 163 (434)
+.|+.++-|.||+|.+++|+.||||+.+.+-.+.. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999999999999998866422110 012344
Q ss_pred HHHHHhhCC-----CCCeeeEeee---ccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHH-hHhhhccCC
Q 013927 164 EIGIIAYVD-----HPNTAKLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG-LTYLHEGCQ 234 (434)
Q Consensus 164 E~~~l~~l~-----h~niv~l~g~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~g-L~yLH~~~~ 234 (434)
|..-+.+++ .+++ .+-.+ ......++|||++|-.+.++..-.....+. ..++..++++ +.-+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~--- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLR--- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHh---
Confidence 555554442 2222 22222 234678999999998787774322234442 2233333332 122222
Q ss_pred CCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
.|++|.|..|.||+++.+|.+.+.|||+...++..
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 69999999999999999999999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.5e-06 Score=77.80 Aligned_cols=154 Identities=22% Similarity=0.151 Sum_probs=96.6
Q ss_pred cCHHHHHHHhcCCCCCCe---ecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhH-----------------------hh
Q 013927 107 FTLSELQTATKNFSSENL---IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKT-----------------------CG 160 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~ 160 (434)
.++..+........+... |+.|--+.||+|...++..+|||+.......... ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555555555554 4556667899999888999999998765432111 12
Q ss_pred HHHHHHHHhhCC--CCCeeeEeeeccCCcEEEEEEcCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCe
Q 013927 161 FLCEIGIIAYVD--HPNTAKLVGCDSDGIHLVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237 (434)
Q Consensus 161 ~~~E~~~l~~l~--h~niv~l~g~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~i 237 (434)
..+|+.-|+++. +-.+.+-+++ ....|||||+... .-.-.|.. -.+.......+..++++.+.-|-. ..++
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~--~~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--~a~L 188 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF--RNNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--EAGL 188 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee--cCCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--hcCc
Confidence 234666666553 2233333333 2567999998653 11112211 111222445556677777776664 3699
Q ss_pred eecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 238 IHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 238 iHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
||+||+.-|||+. ++.+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 7799999999987554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.8e-06 Score=87.96 Aligned_cols=139 Identities=19% Similarity=0.082 Sum_probs=90.8
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhh------------------------------------HhhHHHHHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEK------------------------------------TCGFLCEIG 166 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------------~~~~~~E~~ 166 (434)
+.||..+.|.||+|+.++|+.||||+-+.+-.... +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999999999999998765422110 013444554
Q ss_pred HHhh----CCCCC------eeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHH--hHhhhccCC
Q 013927 167 IIAY----VDHPN------TAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG--LTYLHEGCQ 234 (434)
Q Consensus 167 ~l~~----l~h~n------iv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~g--L~yLH~~~~ 234 (434)
-..+ +.|-+ |.+++--......|+|||++|..+.++-.-....++...+ +..+.++ -.-++
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~---- 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFK---- 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHh----
Confidence 3333 34555 3334433445788999999997666543323344444433 3223332 12233
Q ss_pred CCeeecCCCCCcEEecC----CCCeEEeccccccccCC
Q 013927 235 KRIIHRDIKADNILLTE----DYEPQICDFGLAKWLPR 268 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~----~~~~kL~DFGla~~~~~ 268 (434)
.|++|+|-.|.||++.. ++.+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 58999999999999984 66899999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.3e-06 Score=75.38 Aligned_cols=136 Identities=14% Similarity=0.075 Sum_probs=88.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhH--h------hHHHHHHHHhhCC---CCCeeeEeee--
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKT--C------GFLCEIGIIAYVD---HPNTAKLVGC-- 182 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~------~~~~E~~~l~~l~---h~niv~l~g~-- 182 (434)
.++|...+++-......|.+-..+ |..+.+|........... . ...+.+..+.++. -..++.++.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467888888887777777776665 788999987654321111 0 1122333333332 2223232221
Q ss_pred -----ccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 183 -----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 183 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
.....+++|||++|-.|.++.. ++. .++..+++++.-||. .|++|+|..|.|++++.+ .+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEE
Confidence 2234568999999988766542 111 244567788999999 999999999999999966 5999
Q ss_pred eccccccc
Q 013927 258 CDFGLAKW 265 (434)
Q Consensus 258 ~DFGla~~ 265 (434)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.7e-07 Score=94.71 Aligned_cols=180 Identities=21% Similarity=0.190 Sum_probs=127.5
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC-eeeEeee--ccCCcEEEEEEcCCC-C
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-TAKLVGC--DSDGIHLVFQLSPLG-S 198 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~--~~~~~~lv~e~~~~g-s 198 (434)
+-+++|+++++++.+-.-.+....+.+... ....-++++|.+++||| .+..++- .++..+++++++..+ +
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 347889999999876443333345655433 23455889999999999 5555553 234677899999877 3
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecc
Q 013927 199 LASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278 (434)
Q Consensus 199 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 278 (434)
-..........+...+...++.--+++++|||+ ..-+|+| ||+..+ +..+..||+....++... .....
T Consensus 322 ~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 322 SALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred ccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 322222222334444445566667789999997 4458998 777766 589999999988776543 34566
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccc
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 319 (434)
.+++.++|||+...+.+..+.|+|++|+--.++.-|-.|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 78999999999999999999999999987777777766643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=2e-05 Score=72.52 Aligned_cols=135 Identities=17% Similarity=0.186 Sum_probs=78.2
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC--eeeEeeec--cCCcEEEEEEcCCCC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN--TAKLVGCD--SDGIHLVFQLSPLGS 198 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~--~~~~~lv~e~~~~gs 198 (434)
..||.|..+.||+. . |..+++|....... .....+|.+++..+..-. +.+.+++. .+...+||++++|..
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999983 2 44577888765332 234677998888875432 34455553 335678999999853
Q ss_pred -HHHHh---------------------ccCC-CCCCHHHHHH-HHH----------HHHH-HhHhhhc-cCCCCeeecCC
Q 013927 199 -LASIL---------------------HGSK-DKPDWSKRYR-IAL----------GTAN-GLTYLHE-GCQKRIIHRDI 242 (434)
Q Consensus 199 -L~~~l---------------------~~~~-~~~~~~~~~~-i~~----------~i~~-gL~yLH~-~~~~~iiHrDl 242 (434)
+...+ |... .......... +.. .+.. ...+|.. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 1100 0111111000 000 0001 1122221 11245799999
Q ss_pred CCCcEEecCCCCeEEecccccc
Q 013927 243 KADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 243 kp~NIll~~~~~~kL~DFGla~ 264 (434)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=7e-06 Score=73.23 Aligned_cols=103 Identities=22% Similarity=0.196 Sum_probs=82.6
Q ss_pred HHHHHHHhhCCC-CCeeeEeeeccCCcEEEEEEcCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCee
Q 013927 162 LCEIGIIAYVDH-PNTAKLVGCDSDGIHLVFQLSPLGSLASILHG--SKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238 (434)
Q Consensus 162 ~~E~~~l~~l~h-~niv~l~g~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~ii 238 (434)
..|.-++..+.+ +++.+++|.| +.+++.||...+++...... .-...+|..+.+||.++++.+.+|+++....+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 347778888876 6999999998 55789999987766432100 123478999999999999999999986656688
Q ss_pred ecCCCCCcEEecCCCCeEEecccccccc
Q 013927 239 HRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 239 HrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
-.|++++|+-++++|.+|++|...+...
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchh
Confidence 8999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.5e-05 Score=73.15 Aligned_cols=139 Identities=19% Similarity=0.142 Sum_probs=80.3
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC--CeeeEeeec-----cCCcEEEEEEcC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP--NTAKLVGCD-----SDGIHLVFQLSP 195 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~-----~~~~~lv~e~~~ 195 (434)
+.|+.|..+.||++...+ ..+++|..... .....+..|..++..+... .+..++... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 468999999999999886 58999987653 3344577888888877533 344555521 113578999999
Q ss_pred CCCHHH----------------Hh---ccC---CCCCCHHH---------HHHH------------HHHHHH-HhHhhhc
Q 013927 196 LGSLAS----------------IL---HGS---KDKPDWSK---------RYRI------------ALGTAN-GLTYLHE 231 (434)
Q Consensus 196 ~gsL~~----------------~l---~~~---~~~~~~~~---------~~~i------------~~~i~~-gL~yLH~ 231 (434)
+..+.. .+ +.. ........ .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 877766 11 111 01111110 0000 011222 2333332
Q ss_pred ----cCCCCeeecCCCCCcEEec-CCCCeEEeccccccc
Q 013927 232 ----GCQKRIIHRDIKADNILLT-EDYEPQICDFGLAKW 265 (434)
Q Consensus 232 ----~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGla~~ 265 (434)
.....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1246799999999999999 666668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.4e-05 Score=67.71 Aligned_cols=128 Identities=20% Similarity=0.187 Sum_probs=89.3
Q ss_pred CCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeee-EeeeccCCcEEEEEEcCCCCH
Q 013927 121 SENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK-LVGCDSDGIHLVFQLSPLGSL 199 (434)
Q Consensus 121 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~lv~e~~~~gsL 199 (434)
..+.||+|.+|.||+|.+. |..+|+|+-..+. ....+..|+.+|..+.-.++.+ ++.+.. .++.|||..|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg~--~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYGE--DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEech--hhhhhhhhcCcch
Confidence 3467999999999999998 5689999776543 3446888999999998776654 444433 3445999998888
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCC-CCcEEecCCCCeEEeccccccc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIK-ADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlk-p~NIll~~~~~~kL~DFGla~~ 265 (434)
...-... +-... ..+++.-.-|-. .||-|+.|. |..+++..++.+.|+||.-|+.
T Consensus 100 ~~~~~~~----~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG----DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc----cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8766432 22233 344455444444 789998887 4444444455899999998874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.5e-05 Score=70.45 Aligned_cols=135 Identities=17% Similarity=0.129 Sum_probs=78.9
Q ss_pred ecccCc-EEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcEEEEEEcCCCCHH
Q 013927 125 IGKGGY-AEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIHLVFQLSPLGSLA 200 (434)
Q Consensus 125 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~lv~e~~~~gsL~ 200 (434)
|..|.+ +.||+.... +..+.||...... ......|+.++..+. +-.+.+++++.. +..++||++.+|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 344544 789998765 4678888775432 224667888887774 334555666543 3578999999987766
Q ss_pred HHh-------------------ccCC---CCCC--HHHHHHHHH--------------------HHHHHhHhhhc----c
Q 013927 201 SIL-------------------HGSK---DKPD--WSKRYRIAL--------------------GTANGLTYLHE----G 232 (434)
Q Consensus 201 ~~l-------------------~~~~---~~~~--~~~~~~i~~--------------------~i~~gL~yLH~----~ 232 (434)
... +... .... ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1110 0111 000000000 01111122211 1
Q ss_pred CCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 233 ~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12458999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00012 Score=80.27 Aligned_cols=76 Identities=11% Similarity=0.142 Sum_probs=53.7
Q ss_pred CeecccCcEEEEEEEeCCC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCe--eeEeeeccC-----CcEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNT--AKLVGCDSD-----GIHLVF 191 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~-----~~~lv~ 191 (434)
..|+.|.+..+|+....++ ..+++|+............+.+|+.+++.+. |+++ .++++++.+ ..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999876643 4677887654332222346788999999985 6654 677776543 478999
Q ss_pred EEcCCCC
Q 013927 192 QLSPLGS 198 (434)
Q Consensus 192 e~~~~gs 198 (434)
||+++..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.9e-06 Score=77.48 Aligned_cols=153 Identities=20% Similarity=0.199 Sum_probs=102.5
Q ss_pred ccccccccCHHHHHHHhcC---CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh--------------------
Q 013927 100 YRSSLKEFTLSELQTATKN---FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE-------------------- 156 (434)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~---~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------- 156 (434)
++-....+++..+.+..++ +.+++.||-|.-+.||.+-..+|++.++|.-.......
T Consensus 72 YRLTy~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly 151 (465)
T KOG2268|consen 72 YRLTYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY 151 (465)
T ss_pred eEeeeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence 3434445566666665533 67889999999999999999999999999644322110
Q ss_pred -hHhhHHHHHHHHhhCCC--CCeeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC
Q 013927 157 -KTCGFLCEIGIIAYVDH--PNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233 (434)
Q Consensus 157 -~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~ 233 (434)
.+-...+|...|+.|.. -.+.+.+++ +.-++|||+..+-.|..+-+- .+..+++ ..+..-+--|-.
T Consensus 152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~--~RH~Vvmelv~g~Pl~~v~~v----~d~~~ly---~~lm~~Iv~la~-- 220 (465)
T KOG2268|consen 152 LSRLAATKEFAFMKALYERGFPVPKPIDH--NRHCVVMELVDGYPLRQVRHV----EDPPTLY---DDLMGLIVRLAN-- 220 (465)
T ss_pred hHHHHHHHHHHHHHHHHHcCCCCCCcccc--cceeeHHHhhcccceeeeeec----CChHHHH---HHHHHHHHHHHH--
Confidence 11235668888888753 233444443 356789999988777665432 2223332 223333444554
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
+|+||+|..--||+|++++.++++||--..
T Consensus 221 -~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 221 -HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred -cCceecccchheeEEecCCCEEEeechHhh
Confidence 899999999999999999999999997654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00034 Score=62.81 Aligned_cols=133 Identities=18% Similarity=0.238 Sum_probs=89.6
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc---------------hhhHhhHHHHHHHHhhCC------CCCeeeEe
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV---------------DEKTCGFLCEIGIIAYVD------HPNTAKLV 180 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 180 (434)
...||.|+.-.||. +.+.....||+...... ........+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999996 55556688998877650 111235666777666665 78999999
Q ss_pred eeccC--CcEEEEEEcCC------CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC
Q 013927 181 GCDSD--GIHLVFQLSPL------GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252 (434)
Q Consensus 181 g~~~~--~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~ 252 (434)
|+.+. +.-+|+|.... -+|.+++.. ..++. .. ...+-+-..||-+ .+|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~---~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-EL---RQALDEFKRYLLD---HHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HH---HHHHHHHHHHHHH---cCCeecCCCcccEEEEec
Confidence 98443 77888888643 368888843 33443 22 2233344567776 899999999999999643
Q ss_pred C----CeEEec-cccccc
Q 013927 253 Y----EPQICD-FGLAKW 265 (434)
Q Consensus 253 ~----~~kL~D-FGla~~ 265 (434)
. .+.|+| ||....
T Consensus 155 ~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred CCCceEEEEEeCCCCccc
Confidence 2 467776 565443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=66.58 Aligned_cols=30 Identities=23% Similarity=0.406 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++|+|+.+.||+++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 458999999999999877556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.78 E-value=6.5e-05 Score=81.37 Aligned_cols=194 Identities=18% Similarity=0.151 Sum_probs=131.0
Q ss_pred HHHHHHHHhhCCCCCeeeEeeeccCC------cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCC
Q 013927 161 FLCEIGIIAYVDHPNTAKLVGCDSDG------IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234 (434)
Q Consensus 161 ~~~E~~~l~~l~h~niv~l~g~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~ 234 (434)
...|+..+.+..|+|++.++.+..+. ..+..+++..-++...+. .-...+..+...+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~--- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS--- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH---
Confidence 34477788899999999999874332 224457787777877776 44567778888889999999999998
Q ss_pred CCeeecCCCCC---cEEecCCCCeEEe--ccccccccCCCCcccceeccccccccccCCccccCCCCC--cCcEEehhHH
Q 013927 235 KRIIHRDIKAD---NILLTEDYEPQIC--DFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDE--KTDVYSFGVL 307 (434)
Q Consensus 235 ~~iiHrDlkp~---NIll~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDvwSlGvi 307 (434)
....|.-+... +--++.++.+.++ ||+..+.++..... ....-+..|.|||......++. ..|+|.+|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 55555544444 4455666677777 99888766543221 1122355688898887766554 4799999999
Q ss_pred HHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHh
Q 013927 308 LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383 (434)
Q Consensus 308 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L 383 (434)
+..+..|..+-.... .+..+++.... ..+......|+..++++|+++.+++...
T Consensus 382 ~~~~~~~~~i~~~~~--------------~~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA--------------VPVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCccccccc--------------chhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999998865432110 11111111110 0344566789999999999999998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00056 Score=61.11 Aligned_cols=124 Identities=21% Similarity=0.244 Sum_probs=86.8
Q ss_pred cCCCCCCeecccCc-EEEEEEEeCCCcEEEEEEeeC---CCc-------h----------hhHhhHHHHHHHHhhCC---
Q 013927 117 KNFSSENLIGKGGY-AEVYKGCLRDGTLVAVKRLTK---GTV-------D----------EKTCGFLCEIGIIAYVD--- 172 (434)
Q Consensus 117 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~-------~----------~~~~~~~~E~~~l~~l~--- 172 (434)
.++...+.||.|.. |.||++... |+.+|+|+... ... . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56788899999999 999999997 78999999321 100 0 12235788888877775
Q ss_pred CCCe--eeEeeec---cC-----------------CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhh
Q 013927 173 HPNT--AKLVGCD---SD-----------------GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230 (434)
Q Consensus 173 h~ni--v~l~g~~---~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH 230 (434)
+.++ |+++|+. .+ ...+|.+|.+... .+ ...-+.++.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHHH
Confidence 4455 8888861 00 1346777665432 11 2233456777888899
Q ss_pred ccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 231 ~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
. .||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---CCeeeccCcccccc-----CCEEEecccC
Confidence 8 99999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0011 Score=65.91 Aligned_cols=75 Identities=16% Similarity=0.020 Sum_probs=55.2
Q ss_pred CeecccCcEEEEEEEeCCC-cEEEEEEeeCCCc------hhhHhhHHHHHHHHhhCC---CCCeeeEeeeccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDG-TLVAVKRLTKGTV------DEKTCGFLCEIGIIAYVD---HPNTAKLVGCDSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~lv~e 192 (434)
+.||.|.+..||++...+| +.|+||.-..... .-....+..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999998876 5899997532110 123345677888887763 35678888888888899999
Q ss_pred EcCCC
Q 013927 193 LSPLG 197 (434)
Q Consensus 193 ~~~~g 197 (434)
+++..
T Consensus 112 ~L~~~ 116 (401)
T PRK09550 112 DLSDH 116 (401)
T ss_pred cCCCc
Confidence 98753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00034 Score=64.61 Aligned_cols=73 Identities=16% Similarity=0.104 Sum_probs=46.4
Q ss_pred CeecccCcEEEEEEEeCC--CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC-eeeEeeeccCCcEEEEEEcCCCCH
Q 013927 123 NLIGKGGYAEVYKGCLRD--GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-TAKLVGCDSDGIHLVFQLSPLGSL 199 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~lv~e~~~~gsL 199 (434)
+.|..|-...+|+....+ +..|++|....... ......+|+.++..+.... ..++++... ..++|||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcC
Confidence 356778888999987664 67888997654321 1123346888888875333 334444433 2479999987654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0014 Score=63.03 Aligned_cols=73 Identities=11% Similarity=-0.046 Sum_probs=51.2
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC---CCeeeEeeecc-----CCcEEEEEEc
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH---PNTAKLVGCDS-----DGIHLVFQLS 194 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~-----~~~~lv~e~~ 194 (434)
+.||.|..+.||.....++ .+.+|.... .. ....+..|...|+.+.- ..+.++++++. +..++|||++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARS-FS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecc-cc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 4699999999999876655 466776432 11 12357889999888753 35677776543 3489999999
Q ss_pred CCCCH
Q 013927 195 PLGSL 199 (434)
Q Consensus 195 ~~gsL 199 (434)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 87654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0004 Score=66.60 Aligned_cols=137 Identities=15% Similarity=0.107 Sum_probs=79.8
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC--CeeeEeee--------ccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP--NTAKLVGC--------DSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~--------~~~~~~lv~e 192 (434)
..|..|....+|+....+ ..+++|+.... .......|+.++..+.+. .+.+++.. ..+..+.+++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456778778999987664 46888987541 122455677777777432 24444332 1234578999
Q ss_pred EcCCCCHHH-----------H---hcc---C-C------CCCCHHHHH----------HHHHHHHHHhHhhhc----cCC
Q 013927 193 LSPLGSLAS-----------I---LHG---S-K------DKPDWSKRY----------RIALGTANGLTYLHE----GCQ 234 (434)
Q Consensus 193 ~~~~gsL~~-----------~---l~~---~-~------~~~~~~~~~----------~i~~~i~~gL~yLH~----~~~ 234 (434)
+++|..+.. . +|. . . ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998765421 0 111 0 0 011222111 011112333444442 123
Q ss_pred CCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0006 Score=63.97 Aligned_cols=136 Identities=13% Similarity=0.011 Sum_probs=76.5
Q ss_pred ecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEEcCCCCHHHH-
Q 013927 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQLSPLGSLASI- 202 (434)
Q Consensus 125 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~~~~gsL~~~- 202 (434)
+..|-.+.+|+... ++..+++|......... ..+...|..+++.+....+ .++++.. ...+|++|++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCccccccc
Confidence 45677788998874 46778888755432211 1235678888888864333 2334433 24789999987654321
Q ss_pred ----------------hccCC---CCCCHHHHH-HHHHH---------HHHHhHhhhc-----cCCCCeeecCCCCCcEE
Q 013927 203 ----------------LHGSK---DKPDWSKRY-RIALG---------TANGLTYLHE-----GCQKRIIHRDIKADNIL 248 (434)
Q Consensus 203 ----------------l~~~~---~~~~~~~~~-~i~~~---------i~~gL~yLH~-----~~~~~iiHrDlkp~NIl 248 (434)
+|... ..++....+ ....+ +...+..+-. .....++|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 12111 111221111 11101 1111111111 11246899999999999
Q ss_pred ecCCCCeEEeccccccc
Q 013927 249 LTEDYEPQICDFGLAKW 265 (434)
Q Consensus 249 l~~~~~~kL~DFGla~~ 265 (434)
+++++ +.|+||+.+..
T Consensus 160 ~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 160 VTPQG-LKLIDWEYASD 175 (256)
T ss_pred EeCCC-CEEEeccccCc
Confidence 99877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0031 Score=61.20 Aligned_cols=31 Identities=32% Similarity=0.463 Sum_probs=26.8
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999976556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0011 Score=63.87 Aligned_cols=137 Identities=24% Similarity=0.251 Sum_probs=79.6
Q ss_pred eecccCcEEEEEEEeCC-------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEEcC
Q 013927 124 LIGKGGYAEVYKGCLRD-------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQLSP 195 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~~~ 195 (434)
.|..|-...||+....+ +..+++|+...... ...+..+|..++..+....+ .+++++..+ ..|++|++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeC
Confidence 45566667899887654 57899998655331 22345678888887753333 344555443 35789988
Q ss_pred CCCHHHH-----------------hccCCCC--------CC--HHHHHH--------------------------HHHHH
Q 013927 196 LGSLASI-----------------LHGSKDK--------PD--WSKRYR--------------------------IALGT 222 (434)
Q Consensus 196 ~gsL~~~-----------------l~~~~~~--------~~--~~~~~~--------------------------i~~~i 222 (434)
|..+... +|..... .. +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 7654321 1111111 00 101000 01112
Q ss_pred HHHhHhhhc------cCCCCeeecCCCCCcEEecCC----CCeEEecccccc
Q 013927 223 ANGLTYLHE------GCQKRIIHRDIKADNILLTED----YEPQICDFGLAK 264 (434)
Q Consensus 223 ~~gL~yLH~------~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGla~ 264 (434)
...+.+|-. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222333331 134678999999999999985 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0044 Score=60.52 Aligned_cols=73 Identities=14% Similarity=0.079 Sum_probs=50.9
Q ss_pred eecccCcEEEEEEEeCCC-cEEEEEEeeC------CCchhhHhhHHHHHHHHhhCC--CC-CeeeEeeeccCCcEEEEEE
Q 013927 124 LIGKGGYAEVYKGCLRDG-TLVAVKRLTK------GTVDEKTCGFLCEIGIIAYVD--HP-NTAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~------~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~lv~e~ 193 (434)
.||.|....||++...+| +.|+||.-.. ....-...+..-|...|.... -| .+.+++.+..+...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 479999999999998754 5799996431 111222334556777776653 23 5777888888888899999
Q ss_pred cCC
Q 013927 194 SPL 196 (434)
Q Consensus 194 ~~~ 196 (434)
++.
T Consensus 82 L~~ 84 (370)
T TIGR01767 82 LSH 84 (370)
T ss_pred Ccc
Confidence 854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.017 Score=55.77 Aligned_cols=138 Identities=17% Similarity=0.150 Sum_probs=78.7
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC--CeeeEeee--------ccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP--NTAKLVGC--------DSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~--------~~~~~~lv~e 192 (434)
..++.|....+|+....+| .+++|+...... ......|++++..|... ++.+++.. ..+..+++++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 4567777788999876655 577887755322 12344566666666321 23444332 1234678999
Q ss_pred EcCCCCHH-----------HH---hccCCC-----------CCCHHHHHH------------HHHHHHHHhHhhhc----
Q 013927 193 LSPLGSLA-----------SI---LHGSKD-----------KPDWSKRYR------------IALGTANGLTYLHE---- 231 (434)
Q Consensus 193 ~~~~gsL~-----------~~---l~~~~~-----------~~~~~~~~~------------i~~~i~~gL~yLH~---- 231 (434)
|++|..+. .. +|.... ...|..... ....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99874321 11 111000 011211110 01122334554532
Q ss_pred cCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 232 ~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234789999999999999998777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0079 Score=58.24 Aligned_cols=139 Identities=17% Similarity=0.103 Sum_probs=90.8
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch---------------------h----hHhhHHHHHHHHhhCCCCCe
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD---------------------E----KTCGFLCEIGIIAYVDHPNT 176 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~----~~~~~~~E~~~l~~l~h~ni 176 (434)
...|..|--+.||.+...+|..+|||+++..... . .....-.|+.-|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3467788899999999999999999987532110 0 01123457777777765443
Q ss_pred eeEeeeccCCcEEEEEEcCCCCH-HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 177 AKLVGCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 177 v~l~g~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
.-.--+....-.|||+|+..... .-.| ....++...+..+-.+++.-+.-|... -++||.||.--|+|+.+ |.+
T Consensus 229 P~PePIlLk~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 229 PCPEPILLKNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCceeeecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-CEE
Confidence 22111222345689999864221 1122 223455555666667778888877774 47999999999999975 489
Q ss_pred EEeccccccc
Q 013927 256 QICDFGLAKW 265 (434)
Q Consensus 256 kL~DFGla~~ 265 (434)
.|+|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999887754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0091 Score=58.63 Aligned_cols=138 Identities=17% Similarity=0.206 Sum_probs=78.7
Q ss_pred eecccCcEEEEEEEeCC-----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCee-eEeeeccCCcEEEEEEcCCC
Q 013927 124 LIGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA-KLVGCDSDGIHLVFQLSPLG 197 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~lv~e~~~~g 197 (434)
.|..|-.-.+|++...+ +..|++|+..... .. .-+-.+|..+++.+..-++. ++++...++ .|.+|+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-EL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ce-eechHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 34457777899987532 3678999776543 22 12346688888887644433 445555444 688998775
Q ss_pred CHHHH-----------------hccCC----C-CCCHHHHHHHHHH-----------------HHHHhHhh----hc-cC
Q 013927 198 SLASI-----------------LHGSK----D-KPDWSKRYRIALG-----------------TANGLTYL----HE-GC 233 (434)
Q Consensus 198 sL~~~-----------------l~~~~----~-~~~~~~~~~i~~~-----------------i~~gL~yL----H~-~~ 233 (434)
+|... +|... . ..-+.....+..+ +...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 55311 12211 0 1112222122111 11111122 21 12
Q ss_pred CCCeeecCCCCCcEEecC-CCCeEEeccccccc
Q 013927 234 QKRIIHRDIKADNILLTE-DYEPQICDFGLAKW 265 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~ 265 (434)
...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 347899999999999986 46899999998864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.019 Score=55.34 Aligned_cols=133 Identities=17% Similarity=0.202 Sum_probs=75.5
Q ss_pred EEEEEEeCCCcEEEEEEeeC-CCchhhHhhHHHHHHHHhhCCC--CCeeeEeeeccCCc----EEEEEEcCCCCHHHHhc
Q 013927 132 EVYKGCLRDGTLVAVKRLTK-GTVDEKTCGFLCEIGIIAYVDH--PNTAKLVGCDSDGI----HLVFQLSPLGSLASILH 204 (434)
Q Consensus 132 ~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~----~lv~e~~~~gsL~~~l~ 204 (434)
.+|..... ++.+++. ... ...........+|..+++.+.- ..+...+++|.++. +.||+|+.+..+.+.+.
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34443333 7778888 321 2223344467778888888754 34445567777666 89999998732222111
Q ss_pred cCC-------------------------------------CCCCHHHHHHHHH--------HHHHHhHhhhcc-----CC
Q 013927 205 GSK-------------------------------------DKPDWSKRYRIAL--------GTANGLTYLHEG-----CQ 234 (434)
Q Consensus 205 ~~~-------------------------------------~~~~~~~~~~i~~--------~i~~gL~yLH~~-----~~ 234 (434)
... ....|...+..+. ....-..||+.. ..
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 000 0001111111000 111223344431 12
Q ss_pred CCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
..++|+|+.+.||+++.++-+=+.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 46899999999999999988999999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.043 Score=54.67 Aligned_cols=80 Identities=11% Similarity=-0.035 Sum_probs=54.4
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCc------hhhHhhHHHHHHHHhhCC---CCCeeeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV------DEKTCGFLCEIGIIAYVD---HPNTAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~lv~e~ 193 (434)
+.||.|....||+.... +..|+||.-..... .-...+...|...|..+. ..++.+++.++.+...++||+
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 46899999999998875 55688997652111 012333445666666553 357888999999989999999
Q ss_pred cCC--CCHHHHh
Q 013927 194 SPL--GSLASIL 203 (434)
Q Consensus 194 ~~~--gsL~~~l 203 (434)
+++ ..+...+
T Consensus 117 L~~~~~ilr~~L 128 (418)
T PLN02756 117 LEPPHIILRKGL 128 (418)
T ss_pred cCCcceehhhhh
Confidence 976 2344433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.02 Score=54.34 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=25.9
Q ss_pred CCeeecCCCCCcEEecCCCC-eEEeccccccc
Q 013927 235 KRIIHRDIKADNILLTEDYE-PQICDFGLAKW 265 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~-~kL~DFGla~~ 265 (434)
..++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.00021 Score=79.42 Aligned_cols=157 Identities=13% Similarity=-0.029 Sum_probs=111.6
Q ss_pred HHHHHHHHhhCCCCCeeeEeee----ccCCcEEEEEEcCCCCHHHHhccCCCC---CCHHHHHHHHHHHHHHhHhhhc--
Q 013927 161 FLCEIGIIAYVDHPNTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDK---PDWSKRYRIALGTANGLTYLHE-- 231 (434)
Q Consensus 161 ~~~E~~~l~~l~h~niv~l~g~----~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~i~~~i~~gL~yLH~-- 231 (434)
.+.|...++...|+++...+.- .....+.+++|+.+|.+.+++-.+... ++..-+.....+.+.+..-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445556667789999887663 334678899999999999988653322 2222222222222344444443
Q ss_pred cCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHH
Q 013927 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311 (434)
Q Consensus 232 ~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~el 311 (434)
+..+-.+|+++|+-|.++..+..+|++++|+.+...+. ........+++.|++|+....-.++.++|+|..|+-+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 22244799999999999999999999999999843332 1223456678899999998888899999999999999999
Q ss_pred HhCCCccc
Q 013927 312 ITGRRAVD 319 (434)
Q Consensus 312 ltG~~p~~ 319 (434)
..|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88887764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.015 Score=57.49 Aligned_cols=74 Identities=19% Similarity=0.103 Sum_probs=51.6
Q ss_pred CeecccCcEEEEEEEeCC-CcEEEEEEeeC-----CCchhhHhhHHHHHHHHhhCC--CC-CeeeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD-GTLVAVKRLTK-----GTVDEKTCGFLCEIGIIAYVD--HP-NTAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~lv~e~ 193 (434)
+.||.|.-.-||++...+ +..|+||.-.. ....-...+..-|.+.|+... .| .+.+++.+..+...+|||+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vMEd 114 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVMED 114 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHHh
Confidence 468999999999999753 56799985432 111223345666777777663 23 5777888888888899998
Q ss_pred cCC
Q 013927 194 SPL 196 (434)
Q Consensus 194 ~~~ 196 (434)
++.
T Consensus 115 L~~ 117 (409)
T PRK12396 115 LSD 117 (409)
T ss_pred Ccc
Confidence 853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.023 Score=51.39 Aligned_cols=152 Identities=14% Similarity=0.147 Sum_probs=86.3
Q ss_pred cCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccCCcEEEEEEcCCCCHHHHhccCC
Q 013927 128 GGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSK 207 (434)
Q Consensus 128 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~ 207 (434)
|+.++.-.|..+-|. ..+|++......-...-|..+..++.+++ .|+++..=..-.+-++.|.|.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i-------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI-------- 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc--------
Confidence 455555555544333 45565554333222334677888887764 3555542222246688898863211
Q ss_pred CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccC
Q 013927 208 DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287 (434)
Q Consensus 208 ~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 287 (434)
. ..-.|..+ +.+|.-.|+. ..+.+|||..|+||+-|..|.+||.|=+..- .. +..|.--
T Consensus 142 --~---~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------~V~~vN~ 200 (308)
T PF07387_consen 142 --N---FSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------QVNMVNI 200 (308)
T ss_pred --c---hhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh------------eeeEEee
Confidence 1 11112222 3667888853 3689999999999999999999999966432 11 1112221
Q ss_pred CccccCCCCCcCcEEehhHHHHHHHhC
Q 013927 288 EYFMHGIVDEKTDVYSFGVLLLELITG 314 (434)
Q Consensus 288 E~~~~~~~~~ksDvwSlGvil~elltG 314 (434)
|+ ...+.++.+-+|=.-++++...
T Consensus 201 ~Y---~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 201 EY---ESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred ec---cccChHHHHHHHHHHHHHHHHH
Confidence 11 2235566666666666666654
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.026 Score=55.10 Aligned_cols=138 Identities=20% Similarity=0.288 Sum_probs=75.6
Q ss_pred eecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCee-eEeeeccCCcEEEEEEcCCCC
Q 013927 124 LIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA-KLVGCDSDGIHLVFQLSPLGS 198 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~lv~e~~~~gs 198 (434)
.|..|-...+|+....+ +..|++|+...... ..-+-.+|..+++.+..-++. +++++..++ +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCCc--EeehhhcCCC
Confidence 34446667788886542 23788997765332 122345688888888654443 445554444 4888887654
Q ss_pred HHH-----------------HhccCC----CCC-CHHHHHHHHHH----------------------HHHHhHhhhc---
Q 013927 199 LAS-----------------ILHGSK----DKP-DWSKRYRIALG----------------------TANGLTYLHE--- 231 (434)
Q Consensus 199 L~~-----------------~l~~~~----~~~-~~~~~~~i~~~----------------------i~~gL~yLH~--- 231 (434)
|.. .+|... ... -|.....+..+ +..-+..+..
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 421 112111 111 12222111111 1111111111
Q ss_pred --cCCCCeeecCCCCCcEEecC-CCCeEEeccccccc
Q 013927 232 --GCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKW 265 (434)
Q Consensus 232 --~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~ 265 (434)
....-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11124799999999999975 56899999998853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.071 Score=51.47 Aligned_cols=32 Identities=16% Similarity=0.308 Sum_probs=28.7
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.061 Score=51.30 Aligned_cols=70 Identities=19% Similarity=0.193 Sum_probs=42.2
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC---CCCeeeEeee--ccCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD---HPNTAKLVGC--DSDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~--~~~~~~lv~e~~~~g 197 (434)
+.++.|....+|+.. .+++.+.||+-.. .....|..|..-|+.|. --.+.+++++ ..+..+|++||.+.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458889999999977 5578899998762 22335777888888773 3345566664 345679999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.22 Score=48.47 Aligned_cols=132 Identities=22% Similarity=0.302 Sum_probs=76.5
Q ss_pred CcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC---CC---eeeEee----eccC--CcEEEEEEcCC
Q 013927 129 GYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH---PN---TAKLVG----CDSD--GIHLVFQLSPL 196 (434)
Q Consensus 129 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~l~g----~~~~--~~~lv~e~~~~ 196 (434)
.-..||+....+|.. ++|+.... . .......|+..|..|.- += +..+-| .... ..+-+++|++|
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~--~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-W--TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-C--CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence 445689988887766 88988765 2 22345667777777742 11 222222 1233 56678999998
Q ss_pred CCHHH------------Hh---cc--CC---------CCCCHHH---H----------HHHHHHHHHHhHhhhcc----C
Q 013927 197 GSLAS------------IL---HG--SK---------DKPDWSK---R----------YRIALGTANGLTYLHEG----C 233 (434)
Q Consensus 197 gsL~~------------~l---~~--~~---------~~~~~~~---~----------~~i~~~i~~gL~yLH~~----~ 233 (434)
..+.. ++ +. .+ ....|.. . ......+...+..+.+. -
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 76662 11 10 00 1123331 0 01122333334444331 1
Q ss_pred CCC---eeecCCCCCcEEecCCCC-eEEecccccc
Q 013927 234 QKR---IIHRDIKADNILLTEDYE-PQICDFGLAK 264 (434)
Q Consensus 234 ~~~---iiHrDlkp~NIll~~~~~-~kL~DFGla~ 264 (434)
... +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 123 999999999999999885 8899999875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.17 Score=56.92 Aligned_cols=32 Identities=34% Similarity=0.473 Sum_probs=27.1
Q ss_pred CCCeeecCCCCCcEEecCCC--CeE-Eeccccccc
Q 013927 234 QKRIIHRDIKADNILLTEDY--EPQ-ICDFGLAKW 265 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~--~~k-L~DFGla~~ 265 (434)
..++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 36899999999999999875 555 999998864
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.1 Score=48.76 Aligned_cols=78 Identities=19% Similarity=0.142 Sum_probs=56.6
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccCCcEEEEEEc-CCCCHHH
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLS-PLGSLAS 201 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~lv~e~~-~~gsL~~ 201 (434)
..+..|..+.|+.+...+|..+++|+......... +. .....|...+-...|++++...+...+++|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~--E~-~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH--EA-RGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh--hh-hHHhHhheeCCCCceeeeccccccchhhhhhccCCCchhh
Confidence 34667899999999998999999998865432111 01 11245777777888999999888888889998 5557766
Q ss_pred Hh
Q 013927 202 IL 203 (434)
Q Consensus 202 ~l 203 (434)
+.
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 55
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.078 Score=51.54 Aligned_cols=54 Identities=20% Similarity=0.286 Sum_probs=46.6
Q ss_pred CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 209 KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 209 ~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
...+.+...|+.+.+..+.-+.. .-..-|||+.-.||||+ +|++.|+||-+++.
T Consensus 317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 45678888899888888877776 35789999999999999 89999999999984
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.018 Score=58.10 Aligned_cols=158 Identities=22% Similarity=0.285 Sum_probs=86.3
Q ss_pred hHHHHHHHHhhCCCCCeeeEeeecc---CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC
Q 013927 160 GFLCEIGIIAYVDHPNTAKLVGCDS---DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236 (434)
Q Consensus 160 ~~~~E~~~l~~l~h~niv~l~g~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~ 236 (434)
.++-...+++.+.|+|....+++.. ....+|+|++. .+|.+++..+. +. .. +++ . ++
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~------~~----s~~----~---~~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LK------DE----SLL----A---HG 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cc------hh----hhc----c---cc
Confidence 4556678889999999999998743 35778899886 58888875332 11 11 111 1 34
Q ss_pred eeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCC
Q 013927 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316 (434)
Q Consensus 237 iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~ 316 (434)
+.|- || .+++| -++.. | |-. ..+|+|||++|.++.++.-|..
T Consensus 88 ~~~~-----~~-------~~~td-~~~t~------------------~--~~~-----~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 VLHL-----NI-------IYITD-HFLTK------------------Y--PSP-----IGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccee-----hh-------hhccc-ccccc------------------C--CCC-----CCcchhhhhHHHHHHHHHHhhH
Confidence 4442 22 22333 11100 0 100 1148999999999999999987
Q ss_pred ccccccchhhh--hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhH
Q 013927 317 AVDHLQQSVVI--WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQ 378 (434)
Q Consensus 317 p~~~~~~~~~~--~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e 378 (434)
.+.....+... ..+-.........+.-. ..+..+..+.+..+...|+-..|..||...+
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 76543332211 11111111000000000 0112233456677888999999999985443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.61 E-value=1.4 Score=42.89 Aligned_cols=29 Identities=31% Similarity=0.457 Sum_probs=24.8
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 35789999999999995 4 57899999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.014 Score=58.68 Aligned_cols=68 Identities=25% Similarity=0.458 Sum_probs=58.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
..++|.....+|.|+||+|+.+... ++..+|||.|.....+......++|+.-+.++.|+++++++..
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha 115 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHA 115 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheec
Confidence 3467999999999999999999877 5568999999887777777788899999999999999998775
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.68 Score=46.11 Aligned_cols=73 Identities=15% Similarity=0.171 Sum_probs=43.1
Q ss_pred eecccCcEEEEEEEeCCC--cE-----EEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeee-EeeeccCCcEEEEEEcC
Q 013927 124 LIGKGGYAEVYKGCLRDG--TL-----VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK-LVGCDSDGIHLVFQLSP 195 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~lv~e~~~ 195 (434)
.|..|-...+|++...++ .. |.++.... . ....-+-.+|+.+++.+...++.+ +++... ..++.||++
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~--~g~l~efIe 132 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG--DFTIQEWVE 132 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccC-C-CceEeccHHHHHHHHHHHhCCCCCeEEEecC--CEEEEEEec
Confidence 455577888999875532 22 44443211 1 111123456889999987655544 455554 368999998
Q ss_pred CCCHH
Q 013927 196 LGSLA 200 (434)
Q Consensus 196 ~gsL~ 200 (434)
+.+|.
T Consensus 133 Gr~l~ 137 (383)
T PTZ00384 133 GNTMG 137 (383)
T ss_pred cccCC
Confidence 76543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.17 Score=49.99 Aligned_cols=62 Identities=16% Similarity=0.096 Sum_probs=39.7
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
...++-+|+++-++..++... ..++..+.+++.--++|+--+-- ..+++|.|+.|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 344566777777888877532 23334455566555555433322 158999999999999953
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.044 Score=44.90 Aligned_cols=43 Identities=26% Similarity=0.320 Sum_probs=32.9
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHh
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIA 169 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~ 169 (434)
..||.|+.|.||+|.+++|+.||||+.+.+.. ..+...+.+|.
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~----~~i~~Dl~~l~ 59 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPGIE----EQIEADLRILR 59 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchHHH----HHHHHHHHHHH
Confidence 57999999999999999999999999876432 23444555544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 434 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-62 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-60 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-33 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-20 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-19 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-19 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-19 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-19 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-19 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-135
Identities = 138/326 (42%), Positives = 191/326 (58%), Gaps = 19/326 (5%)
Query: 90 EDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRL 149
EDP++ + LK F+L ELQ A+ NFS++N++G+GG+ +VYKG L DGTLVAVKRL
Sbjct: 8 EDPEV-----HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 150 TKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSK 207
+ F E+ +I+ H N +L G LV+ GS+AS L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 208 DKP---DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264
+ DW KR RIALG+A GL YLH+ C +IIHRD+KA NILL E++E + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 265 WLPRQWTHHNVS-KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ- 322
+ + TH V+ GT G+ APEY G EKTDV+ +GV+LLELITG+RA D +
Sbjct: 183 LMDYKDTH--VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 323 -----QSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMS 377
++ W K LL + LVD L NY EE+++ + A LC + SP+ RPKMS
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 378 QVVILLRGDEDNAQSVKESQKQTHRR 403
+VV +L GD + + +++ R+
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-120
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 22/303 (7%)
Query: 102 SSLKEFTLSELQTATKNFSSE------NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD 155
+ F+ EL+ T NF N +G+GG+ VYKG + + T VAVK+L
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68
Query: 156 EKTCG---FLCEIGIIAYVDHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKP 210
F EI ++A H N +L+G SDG LV+ P GSL L P
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 211 --DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268
W R +IA G ANG+ +LHE IHRDIK+ NILL E + +I DFGLA+ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ--QSVV 326
S+ GT Y APE + G + K+D+YSFGV+LLE+ITG AVD + Q ++
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 327 IWAKPLL-DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385
+ + + I + +D + + D+ ++ AS C+ + RP + +V LL+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 386 DED 388
Sbjct: 304 MTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-119
Identities = 109/327 (33%), Positives = 166/327 (50%), Gaps = 26/327 (7%)
Query: 81 SREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRD 140
S+ + + L+ Y L +L+ AT NF + LIG G + +VYKG LRD
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 141 GTLVAVKRLTKGT---VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIH--LVFQLSP 195
G VA+KR T + ++E F EI +++ HP+ L+G + L+++
Sbjct: 63 GAKVALKRRTPESSQGIEE----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 196 LGSLASILHGSKDKP---DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
G+L L+GS W +R I +G A GL YLH IIHRD+K+ NILL E+
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175
Query: 253 YEPQICDFGLAKWLPRQ-WTHHNVS-KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
+ P+I DFG++K TH +S +GT GY PEYF+ G + EK+DVYSFGV+L E
Sbjct: 176 FVPKITDFGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 311 LITGRRAVDHL----QQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCI 366
++ R A+ ++ WA ++ + ++VDP+L D E + + TA C+
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 367 EQSPILRPKMSQVVILLRGD---EDNA 390
S RP M V+ L +++
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-74
Identities = 76/320 (23%), Positives = 117/320 (36%), Gaps = 37/320 (11%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGT 153
+ H +++ SS + L + + +G + V+K L VAVK
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD 59
Query: 154 VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLS------PLGSLASILHGSK 207
E+ + + H N + +G + G + L GSL+ L +
Sbjct: 60 KQSWQ--NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 208 DKPDWSKRYRIALGTANGLTYLHE-------GCQKRIIHRDIKADNILLTEDYEPQICDF 260
W++ IA A GL YLHE G + I HRDIK+ N+LL + I DF
Sbjct: 118 --VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-----VDEKTDVYSFGVLLLELITGR 315
GLA + + GT Y APE I + D+Y+ G++L EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 316 RAVDHLQQSV------VIWAKPLLDSNDIRELV-----DPSLGDNYDAEEIDRAVL-TAS 363
A D I P L+ D++E+V P L D + + T
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLE--DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 364 LCIEQSPILRPKMSQVVILL 383
C + R V +
Sbjct: 294 ECWDHDAEARLSAGCVGERI 313
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-58
Identities = 84/301 (27%), Positives = 128/301 (42%), Gaps = 42/301 (13%)
Query: 101 RSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTC 159
+S L +E++ E IGKGG+ V+KG ++D ++VA+K L G + +T
Sbjct: 10 KSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 160 G------FLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWS 213
F E+ I++ ++HPN KL G + +V + P G L L WS
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 214 KRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ-----ICDFGLAKWLPR 268
+ R+ L A G+ Y+ I+HRD+++ NI L E + DFGL+ +
Sbjct: 123 VKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----Q 177
Query: 269 QWTHHNVSKFEGTFGYFAPEYFM--HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV 326
Q H+VS G F + APE EK D YSF ++L ++TG D +
Sbjct: 178 QS-VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 327 IWAKPLLDSN---DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
+ + + I E P L R V+ C P RP S +V L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRL----------RNVIEL--CWSGDPKKRPHFSYIVKEL 284
Query: 384 R 384
Sbjct: 285 S 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-57
Identities = 73/319 (22%), Positives = 107/319 (33%), Gaps = 48/319 (15%)
Query: 106 EFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL--C 163
E SE N LIG+G Y VYKG L VAVK + F+
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQN----FINEK 56
Query: 164 EIGIIAYVDHPNTAKLVGCDSDGIH-------LVFQLSPLGSLASILHGSKDKPDWSKRY 216
I + ++H N A+ + D LV + P GSL L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSC 114
Query: 217 RIALGTANGLTYLHE------GCQKRIIHRDIKADNILLTEDYEPQICDFGLAK------ 264
R+A GL YLH + I HRD+ + N+L+ D I DFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-------VDEKTDVYSFGVLLLELITGRRA 317
+ + GT Y APE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 318 ------VDHLQQSVVIWAKPLLDSNDIRELVD-----PSLGDNYDAEEIDRAVL--TASL 364
V Q + D++ LV P + + + L T
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 365 CIEQSPILRPKMSQVVILL 383
C +Q R +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 29/285 (10%)
Query: 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL 162
SL E++ E ++G+G + V K R VA+K++ + + F+
Sbjct: 1 SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FI 49
Query: 163 CEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKP--DWSKRYRIAL 220
E+ ++ V+HPN KL G + + LV + + GSL ++LHG++ P + L
Sbjct: 50 VELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-PQICDFGLAKWLPRQWTHHNVSKFE 279
+ G+ YLH K +IHRD+K N+LL +ICDFG A + +++ +
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNK 164
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339
G+ + APE F EK DV+S+G++L E+IT R+ D + + N R
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHNGTR 222
Query: 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
P L N + I +++T C + P RP M ++V ++
Sbjct: 223 ----PPLIKNLP-KPI-ESLMTR--CWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-57
Identities = 86/324 (26%), Positives = 142/324 (43%), Gaps = 37/324 (11%)
Query: 67 KHLRTFHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIG 126
KH HP++ + ++ + D + + +L K IG
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDM--------DIPWCDLNIKEK-------IG 46
Query: 127 KGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLVGCDSD 185
G + V++ G+ VAVK L + + FL E+ I+ + HPN +G +
Sbjct: 47 AGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 186 GIHL--VFQLSPLGSLASILHGSKDKP--DWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
+L V + GSL +LH S + D +R +A A G+ YLH I+HR+
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRN 164
Query: 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
+K+ N+L+ + Y ++CDFGL++ T + GT + APE +EK+DV
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 302 YSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN-DIRELVDPSLGDNYDAEEIDRAVL 360
YSFGV+L EL T ++ +L + V+ A +I ++P + A I+
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV-----AAIIEG--- 274
Query: 361 TASLCIEQSPILRPKMSQVVILLR 384
C P RP + ++ LLR
Sbjct: 275 ----CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-55
Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 37/279 (13%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG---FLCEIGIIAYVDHPNTAK 178
E +IG GG+ +VY+ G VAVK ++ + E + A + HPN
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
L G + LV + + G L +L G + A+ A G+ YLH+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 237 IIHRDIKADNILLTEDYEPQ--------ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
IIHRD+K+ NIL+ + E I DFGLA R+W G + + APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPE 184
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348
+ + +DV+S+GVLL EL+TG + V + N + +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA---MNKLA----LPIPS 237
Query: 349 NYDAEEIDRAVLTASL---CIEQSPILRPKMSQVVILLR 384
A L C P RP + ++ L
Sbjct: 238 TCPEP-------FAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-54
Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLVG-C 182
IG G + VYKG G VAVK L + F E+G++ H N +G
Sbjct: 32 IGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 183 DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242
+ + +V Q SL LH S+ K + K IA TA G+ YLH K IIHRD+
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE---YFMHGIVDEKT 299
K++NI L ED +I DFGLA R H + G+ + APE ++
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 300 DVYSFGVLLLELITGR---RAVDHLQQSVVIWA------KPLLDSNDIRELVDPSLGDNY 350
DVY+FG++L EL+TG+ +++ Q +I P D + +R +
Sbjct: 207 DVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSP--DLSKVRSNCPKRMKR-- 260
Query: 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
L A C+++ RP +++ +
Sbjct: 261 ---------LMAE-CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-53
Identities = 56/275 (20%), Positives = 98/275 (35%), Gaps = 35/275 (12%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLV 180
+ + E++KG + G + VK L + F E + HPN ++
Sbjct: 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 181 GC----DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQK 235
G + L+ P GSL ++LH + D S+ + AL A G+ +LH +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH--- 292
I + + ++++ ED +I + + + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK----FSFQSPGRM---YAPAWVAPEALQKKPE 185
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
D++SF VLL EL+T L + L +R P++
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---EGLR----PTIPPGISP 238
Query: 353 EEIDRAVLTASL---CIEQSPILRPKMSQVVILLR 384
+ L C+ + P RPK +V +L
Sbjct: 239 H-------VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 62/283 (21%), Positives = 104/283 (36%), Gaps = 42/283 (14%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLV 180
LIGKG + +VY G G VA++ + +E F E+ H N +
Sbjct: 38 GELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 181 G-C-DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
G C + ++ L +L S++ +K D +K +IA G+ YLH K I+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE---GTFGYFAPEYFMHGIV 295
H+D+K+ N+ ++ + I DFGL K G + APE
Sbjct: 153 HKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 296 ---------DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----KPLLDSNDIREL 341
+ +DV++ G + EL +IW KP L +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL----SQIG 267
Query: 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ + D +L C RP ++++ +L
Sbjct: 268 MGKEISD----------ILLF--CWAFEQEERPTFTKLMDMLE 298
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-49
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 33/280 (11%)
Query: 122 ENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
++GKG + + K R+ G ++ +K L + +E FL E+ ++ ++HPN K +
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 181 G-CDSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
G D ++ + + G+L I+ + WS+R A A+G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE------------GTFGYFA 286
HRD+ + N L+ E+ + DFGLA+ + + T + G + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
PE DEK DV+SFG++L E+I A + + ++R +D
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NVRGFLDRYC 244
Query: 347 GDNYDAE--EIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
N I C + P RP ++ L
Sbjct: 245 PPNCPPSFFPI------TVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 69/293 (23%), Positives = 108/293 (36%), Gaps = 37/293 (12%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IGKG Y EV+ G R G VAVK +E + EI + H N +
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIA 98
Query: 182 CDSDGIHLVFQLS------PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE---- 231
D G QL GSL L D ++A + +GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 232 -GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS--KFEGTFGYFAPE 288
+ I HRD+K+ NIL+ ++ I D GLA ++ GT Y PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 289 ------YFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342
H D+YSFG++L E+ + +++ + + + ++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 343 D--------PSLGDNYDAEEIDRAVLTASL---CIEQSPILRPKMSQVVILLR 384
+ PS + + ++E R + L C +P R +V L
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQM--GKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-46
Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 37/300 (12%)
Query: 114 TATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
T ++ + +GKG Y EV++G + G VAVK + DEK+ E+ + H
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR--DEKSWFRETELYNTVMLRH 61
Query: 174 PNTAKLVGCDSDGIH------LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLT 227
N + D H L+ +GSL L D RI L A+GL
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLA 119
Query: 228 YLHE-----GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE--G 280
+LH + I HRD+K+ NIL+ ++ + I D GLA + +V G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 281 TFGYFAPEYFMHGIV------DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK---P 331
T Y APE I ++ D+++FG++L E+ + ++ +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 332 LLDSNDIRELVD-----PSLGDNYDAEEIDRAVLTASL---CIEQSPILRPKMSQVVILL 383
D+R++V P++ + + ++ ++ A L C Q+P R ++ L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL--AKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 37/293 (12%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+ IGKG + EV++G R G VAVK + +E++ EI + H N +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 103
Query: 182 CDSDGIHLVFQLS------PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
D+ QL GSL L+ + ++AL TA+GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 236 R-----IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE--GTFGYFAPE 288
I HRD+K+ NIL+ ++ I D GLA +++ GT Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 289 ------YFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342
H ++ D+Y+ G++ E+ + + + + + E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 343 D--------PSLGDNYDAEEIDRAVLTASL---CIEQSPILRPKMSQVVILLR 384
P++ + + + E R + A + C + R ++ L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKKTLS 332
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 122 ENLIGKGGYAEVYKGCLRDG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
++G G + VYKG VA+K L + T + L E ++A VD+P+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 177 AKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+L+G C + + L+ QL P G L + KD + A G+ YL + +
Sbjct: 80 CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---R 136
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL--------------PRQWTHHNVSKFEGT 281
R++HRD+ A N+L+ +I DFGLAK L P +W
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM---------- 186
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
A E +H I ++DV+S+GV + EL+T G +
Sbjct: 187 ----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 125 IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-- 181
IG+G + EV+ G LR D TLVAVK + + FL E I+ HPN +L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 182 CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
I++V +L G + L + ++ A G+ YL K IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRD 238
Query: 242 IKADNILLTEDYEPQICDFGLAKW--------------LPRQWTHHNVSKFEGTFGYFAP 287
+ A N L+TE +I DFG+++ +P +WT AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT--------------AP 284
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELIT 313
E +G ++DV+SFG+LL E +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 16/222 (7%)
Query: 122 ENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+G+G + +V G VAVK L + EI I+ + H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 177 AKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
K G +GI L+ + P GSL L +K+K + ++ + A+ G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF--APEYF 290
++ +HRD+ A N+L+ +++ +I DFGL K + ++ V + F APE
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD-DRDSPVFWYAPECL 201
Query: 291 MHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKP 331
M +DV+SFGV L EL+T + + +
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 122 ENLIGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+ +G G + V +G R VA+K L +GT T + E I+ +D+P +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 179 LVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
L+G C ++ + LV +++ G L L G +++ S + + G+ YL E K
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 131
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWL---------------PRQWTHHNVSKFEGTF 282
+HRD+ A N+LL + +I DFGL+K L P +W
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----------- 180
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE ++DV+S+GV + E ++ G++
Sbjct: 181 ---APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 122 ENLIGKGGYAEVYKGCLRDG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
++G G + V+KG V +K + + + + I +DH +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 177 AKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+L+G C + LV Q PLGSL + + + A G+ YL E
Sbjct: 78 VRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---H 134
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPR--QWTHHNVSKFEGTFGYFAPEYFMHG 293
++HR++ A N+LL + Q+ DFG+A LP + ++ +K + A E G
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--PIKWMALESIHFG 192
Query: 294 IVDEKTDVYSFGVLLLELIT-GRR 316
++DV+S+GV + EL+T G
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 59/218 (27%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 122 ENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCG--FLCEIGIIAYVDHPN 175
+G G + V +G VAVK L + + F+ E+ + +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 176 TAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G + + +V +L+PLGSL L + R A+ A G+ YL
Sbjct: 83 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES--- 139
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ---------------WTHHNVSKFE 279
KR IHRD+ A N+LL +I DFGL + LP+ W
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-------- 191
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE +D + FGV L E+ T G+
Sbjct: 192 ------APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 125 IGKGGYAEVYKGCLRDG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G G + VYKG VA+K L + T + L E ++A VD+P+ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 180 VG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
+G C + + L+ QL P G L + KD + A G+ YL + +R++
Sbjct: 83 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLV 139
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWL--------------PRQWTHHNVSKFEGTFGY 284
HRD+ A N+L+ +I DFGLAK L P +W
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------------- 186
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
A E +H I ++DV+S+GV + EL+T G +
Sbjct: 187 -ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-35
Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 43/238 (18%)
Query: 99 NYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTV 154
+++ + +IG+G + VY G L D AVK L + T
Sbjct: 10 ELVQAVQHVVIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 66
Query: 155 DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDG-IHLVFQLSPLGSLASILHGSKDKPD 211
+ FL E I+ HPN L+G S+G +V G L + + P
Sbjct: 67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 126
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW------ 265
L A G+ YL K+ +HRD+ A N +L E + ++ DFGLA+
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 266 ----------LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W A E K+DV+SFGVLL EL+T
Sbjct: 184 YSVHNKTGAKLPVKWM--------------ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 35/216 (16%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ IG G + V+ G + VA+K + +G + E+ F+ E ++ + HP
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKL 65
Query: 177 AKLVG-C-DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G C + I LV + G L+ L + + L G+ YL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 122
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGT 281
+IHRD+ A N L+ E+ ++ DFG+ ++ P +W
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------- 172
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
+PE F K+DV+SFGVL+ E+ + G+
Sbjct: 173 ----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-35
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 36/214 (16%)
Query: 122 ENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
++G+G + EVY+G + VAVK K + F+ E I+ +DHP+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 178 KLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
KL+G + + ++ +L P G L L +K+ +L + YL
Sbjct: 77 KLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGTFG 283
+HRDI NIL+ ++ DFGL+++ LP +W
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------------ 181
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
+PE +DV+ F V + E+++ G++
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 24/222 (10%)
Query: 125 IGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+G+G + +V C G +VAVK L + G+ EI I+ + H + K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 180 VGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
GC + + LV + PLGSL L + ++ A G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHA---Q 153
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF-----APEYF 290
IHRD+ A N+LL D +I DFGLAK +P ++ V G APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFWYAPECL 209
Query: 291 MHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKP 331
+DV+SFGV L EL+T + + + +
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 64/203 (31%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 122 ENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+GKG + V G +VAVK+L T + F EI I+ + H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNI 73
Query: 177 AKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
K G + L+ + P GSL L K++ D K + G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF--APEYF 290
KR IHRD+ NIL+ + +I DFGL K LP+ V + G F APE
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE-PGESPIFWYAPESL 189
Query: 291 MHGIVDEKTDVYSFGVLLLELIT 313
+DV+SFGV+L EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 58/290 (20%), Positives = 107/290 (36%), Gaps = 44/290 (15%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+F +G+GG+ V++ D A+KR+ + + E+ +A ++HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 176 TAKLVGCDSDG--------------IHLVFQLSPLGSLASILHGSKDK--PDWSKRYRIA 219
+ + +++ QL +L ++G + S I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL----------PRQ 269
L A + +LH K ++HRD+K NI T D ++ DFGL +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329
+ + GT Y +PE K D++S G++L EL+ +++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTL---- 237
Query: 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
D+R L P L E ++ + SP+ RP+ +
Sbjct: 238 ------TDVRNLKFPPLFTQKYPCE--YVMV--QDMLSPSPMERPEAINI 277
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 122 ENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
IG+G + +V++G VA+K T D FL E + DHP+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 178 KLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
KL+G + + ++ +L LG L S L K D + A + L YL KR
Sbjct: 80 KLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 136
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGTFG 283
+HRDI A N+L++ + ++ DFGL+++ LP +W
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------------ 184
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE +DV+ FGV + E++ G +
Sbjct: 185 --APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 64/262 (24%), Positives = 97/262 (37%), Gaps = 49/262 (18%)
Query: 75 LAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVY 134
L + + +P+ +++ + +IG+G + VY
Sbjct: 56 LYFQGANTVHIDLSALNPE------LVQAVQHVVIGPSSLIVH---FNEVIGRGHFGCVY 106
Query: 135 KGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDG-I 187
G L D AVK L + T + FL E I+ HPN L+G S+G
Sbjct: 107 HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247
+V G L + + P L A G+ +L K+ +HRD+ A N
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNC 223
Query: 248 LLTEDYEPQICDFGLAKW----------------LPRQWTHHNVSKFEGTFGYFAPEYFM 291
+L E + ++ DFGLA+ LP +W A E
Sbjct: 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM--------------ALESLQ 269
Query: 292 HGIVDEKTDVYSFGVLLLELIT 313
K+DV+SFGVLL EL+T
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
E +G+G + EV+ G T VA+K L GT+ + FL E ++ + H +L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYA 246
Query: 182 -CDSDGIHLVFQLSPLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I++V + GSL L G K + +A A+G+ Y+ +H
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPR-QWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
RD++A NIL+ E+ ++ DFGLA+ + ++T +KF + APE ++G K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 361
Query: 299 TDVYSFGVLLLELIT 313
+DV+SFG+LL EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 40/215 (18%)
Query: 122 ENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
+ +IGKG + VY G D A+K L++ T ++ FL E ++ ++HPN
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 178 KLVGC--DSDGIHL-VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L+G +G+ + G L + + P L A G+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW----------------LPRQWTHHNVSKF 278
++ +HRD+ A N +L E + ++ DFGLA+ LP +WT
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------- 195
Query: 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
A E K+DV+SFGVLL EL+T
Sbjct: 196 -------ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 67/203 (33%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 122 ENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+GKG + V G +VAVK+L T + F EI I+ + H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNI 104
Query: 177 AKLVG-CDSDG---IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
K G C S G + L+ + P GSL L K++ D K + G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF--APEYF 290
KR IHRD+ NIL+ + +I DFGL K LP+ ++ V + G F APE
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE-PGESPIFWYAPESL 220
Query: 291 MHGIVDEKTDVYSFGVLLLELIT 313
+DV+SFGV+L EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-34
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
E +G+G + EV+ G T VA+K L GT+ + FL E ++ + H +L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYA 329
Query: 182 -CDSDGIHLVFQLSPLGSLASILHGSKDK-PDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I++V + GSL L G K + +A A+G+ Y+ +H
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPR-QWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
RD++A NIL+ E+ ++ DFGLA+ + ++T +KF + APE ++G K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 444
Query: 299 TDVYSFGVLLLELIT 313
+DV+SFG+LL EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 64/249 (25%), Positives = 99/249 (39%), Gaps = 45/249 (18%)
Query: 122 ENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ +GKG + V G LVAVK+L D++ F EI I+ +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFI 86
Query: 177 AKLVG-CDSDG---IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
K G G + LV + P G L L + + D S+ + G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS- 145
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ---------------WTHHNVSK 277
+R +HRD+ A NIL+ + +I DFGLAK LP W
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY------ 197
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR--AVDHLQQSVVIWAKPLLD 334
APE I ++DV+SFGV+L EL T + + ++ + +
Sbjct: 198 --------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 335 SNDIRELVD 343
+ + EL++
Sbjct: 250 LSRLLELLE 258
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 65/286 (22%), Positives = 111/286 (38%), Gaps = 38/286 (13%)
Query: 49 RALTNWSRFFKLWKKKSTKHLRTFHPLAMP---KLSREKSRSTREDPDLTHIYNYRSSLK 105
R + ++ F + +K + P + R + S E D I + +
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378
Query: 106 EFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGF 161
+ + + + IG+G + +V++G VA+K T D F
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 162 LCEIGIIAYVDHPNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL 220
L E + DHP+ KL+G + + ++ +L LG L S L K D + A
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-------------LP 267
+ L YL KR +HRDI A N+L++ + ++ DFGL+++ LP
Sbjct: 499 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+W APE +DV+ FGV + E++
Sbjct: 556 IKWM--------------APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 46/215 (21%), Positives = 81/215 (37%), Gaps = 22/215 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPN 175
+ +S IG GG ++V++ + A+K + D +T + EI + + +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 176 TA--KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+L I++V + L S L K D +R + +H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH- 144
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
Q I+H D+K N L+ + ++ DFG+A + T GT Y PE
Sbjct: 145 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 292 -----------HGIVDEKTDVYSFGVLLLELITGR 315
+ K+DV+S G +L + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-34
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + V G R VA+K + +G++ E F+ E ++ + H +L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKLVQLYG 86
Query: 182 CDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I ++ + G L + L + + + + + YL K+ +H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 240 RDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGTFGYFA 286
RD+ A N L+ + ++ DFGL+++ P +W+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--------------P 189
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
PE M+ K+D+++FGVL+ E+ + G+
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + V G + VAVK + +G++ E F E + + HP K G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE--FFQEAQTMMKLSHPKLVKFYG 70
Query: 182 CDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
S I++V + G L + L + S+ + G+ +L + IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIH 127
Query: 240 RDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGTFGYFA 286
RD+ A N L+ D ++ DFG+ ++ P +W+ A
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--------------A 173
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
PE F + K+DV++FG+L+ E+ + G+
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 58/341 (17%), Positives = 122/341 (35%), Gaps = 39/341 (11%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPN 175
+ +S IG GG ++V++ + A+K + D +T + EI + + +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 176 TA--KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+L I++V + L S L K D +R + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH- 125
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
Q I+H D+K N L+ + ++ DFG+A + T GT Y PE
Sbjct: 126 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 292 -----------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR- 339
+ K+DV+S G +L + G+ + + + +++I
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 340 -ELVDPSLGD------NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQS 392
++ + L D D ++ R ++ + P ++ + V + +G + +
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQ--R--ISIPELL-AHPYVQIQTHPVNQMAKGTTEEMKY 297
Query: 393 VKESQKQTHR----RTYSEELFDAQEYNSTRYLSDISRFKE 429
V + ++ L++ + S F++
Sbjct: 298 VLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 338
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 122 ENLIGKGGYAEVYKGCLRDGT-----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ +IG G + EVYKG L+ + VA+K L G +++ FL E GI+ H N
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 177 AKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G S + ++ + G+L L + + + G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW---------------LPRQWTHHNVSKFE 279
+HRD+ A NIL+ + ++ DFGL++ +P +WT
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-------- 217
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE + +DV+SFG+++ E++T G R
Sbjct: 218 ------APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + EV+ G T VAVK L +G++ FL E ++ + H +L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75
Query: 182 -CDSDGIHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I+++ + GSL L K +K +A A G+ ++ E + IH
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPR-QWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
RD++A NIL+++ +I DFGLA+ + ++T +KF + APE +G K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIK 190
Query: 299 TDVYSFGVLLLELIT-GRR 316
+DV+SFG+LL E++T GR
Sbjct: 191 SDVWSFGILLTEIVTHGRI 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 65/313 (20%), Positives = 117/313 (37%), Gaps = 42/313 (13%)
Query: 24 SCFRGSESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFHPLAMPKLSRE 83
C + + +S + + + T ++ S + + P R
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 84 KSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG-- 141
T K+ L + +G G + V +G R
Sbjct: 308 MPMDTSVFES-PFSDPEELKDKKLFLKRDNLLIA----DIELGCGNFGSVRQGVYRMRKK 362
Query: 142 -TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CDSDGIHLVFQLSPLGSL 199
VA+K L +GT T + E I+ +D+P +L+G C ++ + LV +++ G L
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422
Query: 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259
L G +++ S + + G+ YL E K +HR++ A N+LL + +I D
Sbjct: 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISD 479
Query: 260 FGLAKWL---------------PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSF 304
FGL+K L P +W APE ++DV+S+
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWY--------------APECINFRKFSSRSDVWSY 525
Query: 305 GVLLLELIT-GRR 316
GV + E ++ G++
Sbjct: 526 GVTMWEALSYGQK 538
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 68/278 (24%), Positives = 107/278 (38%), Gaps = 50/278 (17%)
Query: 61 WKKKSTKHLRTFHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFS 120
S+ + +P+ T E+P RS +E S +
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPG----RAGRSFTREIEASRIHI------ 53
Query: 121 SENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
E +IG G EV G LR VA+K L G + + FL E I+ DHPN
Sbjct: 54 -EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 177 AKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G + G +V + GSL + L + + + G G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW---------------LPRQWTHHNVSKFE 279
+HRD+ A N+L+ + ++ DFGL++ +P +WT
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-------- 221
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE +DV+SFGV++ E++ G R
Sbjct: 222 ------APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
E +G G + EV+ T VAVK + G++ + FL E ++ + H KL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHA 250
Query: 182 -CDSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ I+++ + GSL L + K + A G+ ++ + + IH
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
RD++A NIL++ +I DFGLA+ + ++T +KF + APE G K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIK 365
Query: 299 TDVYSFGVLLLELIT-GRR 316
+DV+SFG+LL+E++T GR
Sbjct: 366 SDVWSFGILLMEIVTYGRI 384
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 64/262 (24%), Positives = 95/262 (36%), Gaps = 30/262 (11%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLVG 181
IG+G + VYKG VA L + + F E ++ + HPN +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 182 C------DSDGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
I LV +L G+L + L GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHT-R 148
Query: 234 QKRIIHRDIKADNILLT-EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
IIHRD+K DNI +T +I D GLA GT + APE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMYEE 204
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
DE DVY+FG+ +LE+ T Q + I+ + ++ ++ +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAIPEVK 260
Query: 353 EEIDRAVLTASLCIEQSPILRP 374
E I+ CI Q+ R
Sbjct: 261 EIIEG-------CIRQNKDERY 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 61/283 (21%), Positives = 110/283 (38%), Gaps = 48/283 (16%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+F LIG GG+ +V+K DG +KR+ + E+ +A +DH N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-----EVKALAKLDHVN 65
Query: 176 TAKLVGC------------------DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRY 216
GC + + + + G+L + + + D
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
+ G+ Y+H K++I+RD+K NI L + + +I DFGL L +
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---T 179
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN 336
+ +GT Y +PE ++ D+Y+ G++L EL+ S
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-------------TAFETSK 226
Query: 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+L D + D +D +E + +L + + P RP S++
Sbjct: 227 FFTDLRDGIISDIFDKKE--KTLL--QKLLSKKPEDRPNTSEI 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 122 ENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
+ ++G G + EV G L + VA+K L G +++ FL E I+ DHPN
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 178 KLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+L G + + +V + GSL S L + + + G A+G+ YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWL---------------PRQWTHHNVSKFEG 280
+HRD+ A NIL+ + ++ DFGL + L P +WT
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT--------- 217
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
+PE + +DV+S+G++L E+++ G R
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 59/249 (23%), Positives = 81/249 (32%), Gaps = 18/249 (7%)
Query: 71 TFHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGY 130
+ R S L S + F F + +G G Y
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-------FQRLSRLGHGSY 70
Query: 131 AEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYV-DHPNTAKLVGCDSDGI 187
EV+K DG L AVKR K L E+G V HP +L +G
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 188 HLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246
L Q SL ++ + T L +LH + ++H D+K N
Sbjct: 131 ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPAN 187
Query: 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGV 306
I L ++ DFGL L EG Y APE DV+S G+
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGE---VQEGDPRYMAPELLQGSY-GTAADVFSLGL 243
Query: 307 LLLELITGR 315
+LE+
Sbjct: 244 TILEVACNM 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 35/232 (15%)
Query: 99 NYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKT 158
++ EF S K IGKG + +V G R G VAVK + +
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA- 60
Query: 159 CGFLCEIGIIAYVDHPNTAKLVGC---DSDGIHLVFQLSPLGSLASILH-GSKDKPDWSK 214
FL E ++ + H N +L+G + G+++V + GSL L +
Sbjct: 61 --FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 215 RYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--------- 265
+ +L + YL +HRD+ A N+L++ED ++ DFGL K
Sbjct: 119 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 175
Query: 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
LP +WT APE K+DV+SFG+LL E+ + GR
Sbjct: 176 LPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 10/223 (4%)
Query: 100 YRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT 158
+ S + T + + + + IG+G + + DG +K + + K
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 159 CGFLC-EIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSK 214
E+ ++A + HPN + ++ +++V G L ++ K +
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ 126
Query: 215 RYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274
+ L ++H+ ++I+HRDIK+ NI LT+D Q+ DFG+A+ L T
Sbjct: 127 ILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVEL 181
Query: 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA 317
GT Y +PE + + K+D+++ G +L EL T + A
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 24/226 (10%)
Query: 110 SELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGII 168
+ K++ +G+GG++ V L DG A+KR+ ++ E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMH 80
Query: 169 AYVDHPNTAKLVGCDSDG------IHLVFQLSPLGSLASIL-HGSKDKPDWSKRY--RIA 219
+HPN +LV L+ G+L + + ++ +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-------WTH 272
LG GL +H K HRD+K NILL ++ +P + D G T
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 273 HNVSKFEGTFGYFAPEYF---MHGIVDEKTDVYSFGVLLLELITGR 315
+ + T Y APE F H ++DE+TDV+S G +L ++ G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 44/215 (20%), Positives = 80/215 (37%), Gaps = 22/215 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPN 175
+ +S IG GG ++V++ + A+K + D +T + EI + + +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 176 TA--KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+L I++V + L S L K W ++ + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH- 172
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
Q I+H D+K N L+ + ++ DFG+A + T G Y PE
Sbjct: 173 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 292 -----------HGIVDEKTDVYSFGVLLLELITGR 315
+ K+DV+S G +L + G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 39/213 (18%)
Query: 125 IGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLV 180
+G G + V KG + VAVK L D L E ++ +D+P +++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 181 G-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
G C+++ LV +++ LG L L ++ + + G+ YL E +H
Sbjct: 85 GICEAESWMLVMEMAELGPLNKYLQQNRHVK-DKNIIELVHQVSMGMKYLEE---SNFVH 140
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWL---------------PRQWTHHNVSKFEGTFGY 284
RD+ A N+LL + +I DFGL+K L P +W
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY------------- 187
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE + K+DV+SFGVL+ E + G++
Sbjct: 188 -APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ F+ IGKG + EV+KG R +VA+K + +++ EI +++ D P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 175 NTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYL 229
K G L + + GS +L IA GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYL 135
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
H ++ IHRDIKA N+LL+E E ++ DFG+A L N F GT + APE
Sbjct: 136 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 190
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
D K D++S G+ +EL G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 35/209 (16%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
IGKG + +V G R G VAVK + + FL E ++ + H N +L+G
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG 253
Query: 182 C---DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRI 237
+ G+++V + GSL L + +L + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKW---------LPRQWTHHNVSKFEGTFGYFAPE 288
+HRD+ A N+L++ED ++ DFGL K LP +WT APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APE 356
Query: 289 YFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
K+DV+SFG+LL E+ + GR
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 48/220 (21%)
Query: 125 IGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + VY+G + T VA+K + + + FL E ++ + + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYR---------IALGTANGLT 227
L+G S G ++ +L G L S L + + +A A+G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLPRQWTHH 273
YL+ + +HRD+ A N ++ ED+ +I DFG+ + LP +W
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+PE G+ +DV+SFGV+L E+ T
Sbjct: 208 ------------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 50/263 (19%), Positives = 93/263 (35%), Gaps = 65/263 (24%)
Query: 87 STREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG----- 141
E+P Y + + ++ + +G+G + +V+ +
Sbjct: 22 HIIENPQ----YFSDACVHHIKRRDIVLKWE-------LGEGAFGKVFLAECHNLLPEQD 70
Query: 142 -TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG--IHLVFQLSPLGS 198
LVAVK L + + + F E ++ + H + + G ++G + +VF+ G
Sbjct: 71 KMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 199 LASILHGSKDKPDWSKRYR--------------IALGTANGLTYLHEGCQKRIIHRDIKA 244
L L +A A G+ YL +HRD+
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLAT 186
Query: 245 DNILLTEDYEPQICDFGLAK--------------WLPRQWTHHNVSKFEGTFGYFAPEYF 290
N L+ + +I DFG+++ LP +W PE
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM--------------PPESI 232
Query: 291 MHGIVDEKTDVYSFGVLLLELIT 313
++ ++DV+SFGV+L E+ T
Sbjct: 233 LYRKFTTESDVWSFGVVLWEIFT 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVK--RLTKGTVDEKTCGFLCEIGIIAYVDH 173
NF E IG+G ++EVY+ CL DG VA+K ++ + + EI ++ ++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPD-------WSKRYRIALGTAN 224
PN K + + +++V +L+ G L+ ++ K + W ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGY 284
L ++H +R++HRDIK N+ +T ++ D GL ++ GT Y
Sbjct: 149 -LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 202
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344
+PE + K+D++S G LL E+ + + ++ L + P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYPP 257
Query: 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
D+Y E ++CI P RP ++ V
Sbjct: 258 LPSDHYSEELRQ----LVNMCINPDPEKRPDVTYV 288
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 54/249 (21%), Positives = 89/249 (35%), Gaps = 61/249 (24%)
Query: 102 SSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVD 155
LKE +LS ++ +G+ + +VYKG L VA+K L
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 156 EKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWS 213
F E + A + HPN L+G + + ++F G L L D
Sbjct: 54 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 214 KRYR---------------IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQIC 258
+ A G+ YL ++H+D+ N+L+ + +I
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKIS 170
Query: 259 DFGLAK--------------WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSF 304
D GL + LP +W APE M+G +D++S+
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWM--------------APEAIMYGKFSIDSDIWSY 216
Query: 305 GVLLLELIT 313
GV+L E+ +
Sbjct: 217 GVVLWEVFS 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 122 ENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
++ +G G Y EVY+G + VAVK L + T++ + FL E ++ + HPN +L+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 282
Query: 181 GCDSDG--IHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRI 237
G + +++ + G+L L + +A ++ + YL + K
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPR-QWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
IHR++ A N L+ E++ ++ DFGL++ + +T H +KF + APE +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS 397
Query: 297 EKTDVYSFGVLLLELIT 313
K+DV++FGVLL E+ T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 47/299 (15%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC----EIGIIAYVDHPNTAK 178
+G GG + VY VA+K + +++ L E+ + + H N
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEE--TLKRFEREVHNSSQLSHQNIVS 75
Query: 179 L--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
+ V + D +LV + +L+ + S +G+ + H R
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
I+HRDIK NIL+ + +I DFG+AK L + + GT YF+PE D
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 297 EKTDVYSFGVLLLELITGRR----------AVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
E TD+YS G++L E++ G A+ H+Q SV P + ++ V +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-----PNVTTD-----VRKDI 240
Query: 347 GDNYDAEEIDRAVLTASLCIEQSPILRPK-----MSQVVILLRGDEDNAQSVKESQKQT 400
+ + +L A E+ R K + +L + N + + +T
Sbjct: 241 -----PQSLSNVILRA---TEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKT 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTL-VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
++ +G G Y EVY+G + +L VAVK L + T++ + FL E ++ + HPN +L+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 181 GCDSDG--IHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
G + +++ + G+L L + + +A ++ + YL + K
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 132
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKW-------------LPRQWTHHNVSKFEGTFGY 284
IHRD+ A N L+ E++ ++ DFGL++ P +WT
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------------- 179
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRR 316
APE + K+DV++FGVLL E+ T G
Sbjct: 180 -APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 110 SELQTATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGII 168
E + + + +G+G + EV++ + G AVK++ + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVAC 104
Query: 169 AYVDHPNTAKLVGCDSDGIHL--VFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTA- 223
A + P L G +G + +L GSL ++ G + R
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED------RALYYLGQ 158
Query: 224 --NGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQWTHHNVSK--- 277
GL YLH +RI+H D+KADN+LL+ D +CDFG A L ++
Sbjct: 159 ALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316
GT + APE M D K D++S ++L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 41/280 (14%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVD-HP 174
+F ++++G G + + D VAVKR+ ++ E+ ++ D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHP 78
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
N + D ++ +L +L + + + T +GL +LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 233 CQKRIIHRDIKADNILLTEDYEPQ-----ICDFGLAKWL-PRQWTHHNVSKFEGTFGYFA 286
I+HRD+K NIL++ I DFGL K L + + S GT G+ A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 287 PEYF---MHGIVDEKTDVYSFGVLLLELITGRR---AVDHLQQSVVIWAKPLLDSNDIRE 340
PE D++S G + +I+ +Q+ ++ LD
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC----- 249
Query: 341 LVDPSLGDNYDAEE-IDRAVLTASLCIEQSPILRPKMSQV 379
+ P ++ A E I++ I P RP V
Sbjct: 250 -LHPEKHEDVIARELIEK-------MIAMDPQKRPSAKHV 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 69/259 (26%), Positives = 99/259 (38%), Gaps = 57/259 (22%)
Query: 88 TREDPD--LTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDG---- 141
+P+ + S LKE + +G G + EVY+G +
Sbjct: 6 HHHNPNYCFAGKTSSISDLKEVPRKNITL-------IRGLGHGAFGEVYEGQVSGMPNDP 58
Query: 142 --TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG--IHLVFQLSPLG 197
VAVK L + ++ FL E II+ +H N + +G ++ +L G
Sbjct: 59 SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 198 SLASILHGSKDKPDWSKR------YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251
L S L ++ +P +A A G YL E IHRDI A N LLT
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTC 175
Query: 252 DYEPQIC---DFGLAK--------------WLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
++ DFG+A+ LP +W PE FM GI
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM--------------PPEAFMEGI 221
Query: 295 VDEKTDVYSFGVLLLELIT 313
KTD +SFGVLL E+ +
Sbjct: 222 FTSKTDTWSFGVLLWEIFS 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 54/221 (24%), Positives = 81/221 (36%), Gaps = 49/221 (22%)
Query: 125 IGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKL 179
+GKG + V + L+ VAVK L + FL E + DHP+ AKL
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 180 VGCDSDG--------IHLVFQLSPLGSLASIL-----HGSKDKPDWSKRYRIALGTANGL 226
VG ++ G L + L + R + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--------------LPRQWTH 272
YL + IHRD+ A N +L ED + DFGL++ LP +W
Sbjct: 151 EYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
A E + +DV++FGV + E++T
Sbjct: 207 -------------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 58/285 (20%), Positives = 101/285 (35%), Gaps = 47/285 (16%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC-EIGIIAYVDHP 174
+++ IG G Y K DG ++ K L G++ E L E+ ++ + HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 175 NTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY-------RIALGTA 223
N + + +++V + G LAS++ + ++Y R+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE----RQYLDEEFVLRVMTQLT 121
Query: 224 NGLTYLHE--GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT 281
L H ++HRD+K N+ L ++ DFGLA+ L F GT
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGT 179
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341
Y +PE +EK+D++S G LL EL + +EL
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---------------FTAFSQKEL 224
Query: 342 VD-------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+ Y E + + RP + ++
Sbjct: 225 AGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-30
Identities = 64/213 (30%), Positives = 86/213 (40%), Gaps = 17/213 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
++ + +IG G A V C VA+KR+ L EI ++ HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 176 TAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRY----RIAL---GTANGL 226
L V +L GS+ I+ K + IA GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK---FEGTFG 283
YLH+ IHRD+KA NILL ED QI DFG++ +L F GT
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 284 YFAPEYFMHGIV-DEKTDVYSFGVLLLELITGR 315
+ APE D K D++SFG+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV 171
T+ + +++G+G A V++G + G L A+K + + E ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 172 DHPNTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY--RIALGTANG 225
+H N KL + L+ + P GSL ++L + + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWLPRQWTHHNVSKFEGT 281
+ +L E I+HR+IK NI+ + Q + DFG A+ L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGT 178
Query: 282 FGYFAPEYFMHGIV--------DEKTDVYSFGVLLLELITGR 315
Y P+ + ++ D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 46/223 (20%)
Query: 122 ENLIGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
+G+G + +++KG R+ T V +K L K + F +++ + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSH 71
Query: 174 PNTAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+ G G LV + GSL + L +K+ + + +A A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQ--------ICDFGLAKWL--------PRQWTHHNV 275
+IH ++ A NILL + + + + D G++ + W
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV---- 184
Query: 276 SKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELIT-GRR 316
PE + + TD +SFG L E+ + G +
Sbjct: 185 ----------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 49/224 (21%)
Query: 122 ENLIGKGGYAEVYKGCLRDG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTA 177
+++IG+G + +V K ++ A+KR+ + + F E+ ++ + HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 178 KLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY---------------RIAL 220
L+G ++L + +P G+L L S+ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK-----------WLPRQ 269
A G+ YL + K+ IHRD+ A NIL+ E+Y +I DFGL++ LP +
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
W A E + + +DV+S+GVLL E+++
Sbjct: 207 WM--------------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 34/228 (14%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+F ++G+G + +V K D A+K++ T L E+ ++A ++H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLNHQ 62
Query: 175 NTAKLVGCDSDGIHLVFQLSPL---------------GSLASILHGSKDKPDWSKRYRIA 219
+ + + V ++ + G+L ++H + +R+
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
L+Y+H + IIHRD+K NI + E +I DFGLAK + R +
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 280 ------------GTFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITG 314
GT Y A E G +EK D+YS G++ E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 48/223 (21%)
Query: 122 ENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNT 176
++G+G + V +G L+ VAVK + ++ FL E + HPN
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 177 AKLVGC-------DSDGIHLVFQLSPLGSLASIL-----HGSKDKPDWSKRYRIALGTAN 224
+L+G ++ G L + L + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--------------LPRQW 270
G+ YL + +HRD+ A N +L +D + DFGL+K +P +W
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
A E + K+DV++FGV + E+ T
Sbjct: 216 I--------------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 55/226 (24%)
Query: 125 IGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + +V+ + LVAVK L T+ + F E ++ + H + K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 81
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYR---------------IALG 221
G DG + +VF+ G L L + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------------WLP 267
A+G+ YL + +HRD+ N L+ + +I DFG+++ LP
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+W PE M+ ++DV+SFGV+L E+ T
Sbjct: 199 IRWM--------------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 46/232 (19%), Positives = 74/232 (31%), Gaps = 21/232 (9%)
Query: 100 YRSSLKEFTLSELQTATKNFSSENLIGKG--GYAEVYKG-CLRDGTLVAVKRLTKGTVDE 156
+ +L +S + +IGKG V G V V+R+
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 157 KTCGFLC-EIGIIAYVDHPNTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWS 213
+ FL E+ + +HPN L V GS ++
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG--M 125
Query: 214 KRYRIAL---GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270
IA G L Y+H +HR +KA +IL++ D + + +
Sbjct: 126 NELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 271 THHNV-----SKFEGTFGYFAPEYFMHGIV--DEKTDVYSFGVLLLELITGR 315
V + +PE + D K+D+YS G+ EL G
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 72/237 (30%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 101 RSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVK--RLTKGTVDEK 157
SL E LS L+ F L+G G Y +VYKG ++ G L A+K +T +E
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE- 66
Query: 158 TCGFLCEIGIIA-YVDHPNTAKLVGC--------DSDGIHLVFQLSPLGSLASILHGSKD 208
EI ++ Y H N A G D + LV + GS+ ++ +K
Sbjct: 67 ---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 209 KP---DWSKRYRIAL---GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262
+W IA GL++LH+ ++IHRDIK N+LLTE+ E ++ DFG+
Sbjct: 124 NTLKEEW-----IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 263 AKWLPRQWTHHNVSKFEGTFGYFAPE-----YFMHGIVDEKTDVYSFGVLLLELITG 314
+ L R N F GT + APE D K+D++S G+ +E+ G
Sbjct: 176 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 116 TKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ F +G+G Y VYK G +VA+K++ V+ + EI I+ D P
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQCDSP 84
Query: 175 NTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
+ K G L V + GS++ I+ + I T GL YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
R IHRDIKA NILL + ++ DFG+A L N GT + APE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQE 199
Query: 293 GIVDEKTDVYSFGVLLLELITG 314
+ D++S G+ +E+ G
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 31/225 (13%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTL---VAVKRLTKGTVDEKTCGFLC----EIGIIAYVDHP 174
L+G+GG +VY+ D VA+K +++ + F E + P
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPV--FRTRMQREARTAGRLQEP 94
Query: 175 NTAKL--VGCDSDGIH-LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+ + G DG + +L LA++L + + I + L H
Sbjct: 95 HVVPIHDFGEI-DGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAH- 151
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ-WTHHNVSKFEGTFGYFAPEYF 290
HRD+K +NIL++ D + DFG+A + T GT Y APE F
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERF 207
Query: 291 MHGIVDEKTDVYSFGVLLLELITGRR---------AVDHLQQSVV 326
+ D+Y+ +L E +TG H+ Q++
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 123 NLIGKGGYAEVYKG-CLRDGTLVAVK-----RLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+GKG + VY + ++A+K +L K V+ + E+ I +++ HPN
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL---RREVEIQSHLRHPNI 71
Query: 177 AKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G D+ ++L+ + +PLG++ L + AN L+Y H
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---S 127
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLP--RQWTHHNVSKFEGTFGYFAPEYFMH 292
KR+IHRDIK +N+LL E +I DFG + P R+ GT Y PE
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD------LCGTLDYLPPEMIEG 181
Query: 293 GIVDEKTDVYSFGVLLLELITGR 315
+ DEK D++S GVL E + G+
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV 171
T+ + +++G+G A V++G + G L A+K + + E ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 172 DHPNTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY--RIALGTANG 225
+H N KL + L+ + P GSL ++L + + + G
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWLPRQWTHHNVSKFEGT 281
+ +L E I+HR+IK NI+ + Q + DFG A+ L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGT 178
Query: 282 FGYFAPEYFMHGIV--------DEKTDVYSFGVLLLELITGR 315
Y P+ + ++ D++S GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 74/277 (26%), Positives = 105/277 (37%), Gaps = 61/277 (22%)
Query: 74 PLAMPKLSREKSRSTREDPDLTHIY------NYRSSLKEFTLSELQTATKNFSSENLIGK 127
L P+ K R++ D Y + S LKE + +G
Sbjct: 29 ELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITL-------IRGLGH 81
Query: 128 GGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
G + EVY+G + VAVK L + ++ FL E II+ +H N + +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 182 CDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKR------YRIALGTANGLTYLHEGC 233
++ +L G L S L ++ +P +A A G YL E
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-- 199
Query: 234 QKRIIHRDIKADNILLTEDYEPQIC---DFGLAK--------------WLPRQWTHHNVS 276
IHRDI A N LLT ++ DFG+A+ LP +W
Sbjct: 200 -NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM----- 253
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
PE FM GI KTD +SFGVLL E+ +
Sbjct: 254 ---------PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 62/234 (26%)
Query: 125 IGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
IG+G + V++ T+VAVK L + + F E ++A D+PN K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY-------------------- 216
L+G + G + L+F+ G L L S +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 217 ---RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK--------- 264
IA A G+ YL E ++ +HRD+ N L+ E+ +I DFGL++
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 265 -----WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+P +W PE + ++DV+++GV+L E+ +
Sbjct: 232 ADGNDAIPIRWM--------------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 54/243 (22%), Positives = 101/243 (41%), Gaps = 21/243 (8%)
Query: 76 AMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYK 135
+ +L ++ + R + LT + E + + + +G G V+K
Sbjct: 3 KLEELELDEQQRKRLEAFLTQK----QKVGELKDDDFEK-------ISELGAGNGGVVFK 51
Query: 136 GCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQ 192
+ G ++A K + + E+ ++ + P G I + +
Sbjct: 52 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
GSL +L + P+ +++ GLTYL E + +I+HRD+K NIL+
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSR 168
Query: 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELI 312
E ++CDFG++ L + V GT Y +PE ++D++S G+ L+E+
Sbjct: 169 GEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 313 TGR 315
GR
Sbjct: 225 VGR 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC----EIGIIAYVDHPNTAK 178
++G GG +EV+ LRD VAVK L + + F E A ++HP
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPS--FYLRFRREAQNAAALNHPAIVA 76
Query: 179 L--VGCDSDGIH----LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
+ G +V + +L I+H ++ + + L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ- 134
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEYFM 291
IIHRD+K NI+++ ++ DFG+A+ + + + GT Y +PE
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 292 HGIVDEKTDVYSFGVLLLELITGRR----------AVDHLQQSVV 326
VD ++DVYS G +L E++TG A H+++ +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 62/234 (26%)
Query: 125 IGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK 178
+G+G + +V K T VAVK L + + L E ++ V+HP+ K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 179 LVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY-------------------- 216
L G S + L+ + + GSL L S+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 217 ---RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-------- 265
A + G+ YL E +++HRD+ A NIL+ E + +I DFGL++
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 266 ------LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
+P +W A E I ++DV+SFGVLL E++T
Sbjct: 208 KRSQGRIPVKWM--------------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ + +G G + +VYK G L A K + + +E ++ EI I+A DHP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHP 76
Query: 175 NTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
KL+G L + + P G++ +I+ + + L +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-- 134
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
KRIIHRD+KA N+L+T + + ++ DFG++ + + F GT + APE M
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMC 191
Query: 293 GIV-----DEKTDVYSFGVLLLELITG 314
+ D K D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 47/220 (21%), Positives = 86/220 (39%), Gaps = 28/220 (12%)
Query: 122 ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIG----------IIAY 170
++ +GG+A VY+ + G A+KRL ++ + E+ I+ +
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQF 91
Query: 171 VDHPNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKR--YRIALGTANGLTY 228
+ K L+ G L L + + S +I T + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL----PRQWTHHNVSKFE----- 279
+H + IIHRD+K +N+LL+ ++CDFG A + W+ + E
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 280 -GTFGYFAPE---YFMHGIVDEKTDVYSFGVLLLELITGR 315
T Y PE + + + EK D+++ G +L L +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 56/287 (19%), Positives = 96/287 (33%), Gaps = 52/287 (18%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYV-D 172
T F IG G + V+K DG + A+KR K L E+ A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 173 HPNTAKLVGCDSDGIHLVFQLS--PLGSLASILHGSKDKPDW---SKRYRIALGTANGLT 227
H + + ++ H++ Q GSLA + + + ++ + L GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQ-------------------ICDFGLAKWLPR 268
Y+H ++H DIK NI ++ P I D G
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327
+ + V EG + A E K D+++ + ++ L ++
Sbjct: 183 RISSPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----PLPRNGDQ 236
Query: 328 WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRP 374
W + IR+ P + E + +L + I P RP
Sbjct: 237 WHE-------IRQGRLPRIPQVLSQEFTE--LL--KVMIHPDPERRP 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 67/276 (24%)
Query: 81 SREKSRSTREDPDLTHIYNYRSSLK---EFTLSELQTATKNFSSENLIGKGGYAEVYKGC 137
S +DP L + Y EF +L +G+G + +V
Sbjct: 3 SSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKP-------LGEGAFGQVVMAE 55
Query: 138 LRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSDG-- 186
VAVK L ++ + E+ ++ + H N L+G +
Sbjct: 56 AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115
Query: 187 IHLVFQLSPLGSLASIL---------------HGSKDKPDWSKRYRIALGTANGLTYLHE 231
++++ + + G+L L +++ + A G+ YL
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--------------LPRQWTHHNVSK 277
++ IHRD+ A N+L+TE+ +I DFGLA+ LP +W
Sbjct: 176 ---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------ 226
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
APE + ++DV+SFGVL+ E+ T
Sbjct: 227 --------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 53/228 (23%)
Query: 122 ENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HP 174
+G G + +V + VAVK L ++ + E+ I++++ H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 175 NTAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY-------------RIA 219
N L+G + G + ++ + G L + L + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-------------- 265
A G+ +L K IHRD+ A N+LLT + +I DFGLA+
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE + ++DV+S+G+LL E+ +
Sbjct: 228 LPVKWM--------------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 56/228 (24%)
Query: 125 IGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTA 177
+G+G + +V + VAVK L +G + + E+ I+ ++ H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 178 KLVGC--DSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYR---------------IA 219
L+G G + ++ + G+L++ L +++ K +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-------------- 265
A G+ +L ++ IHRD+ A NILL+E +ICDFGLA+
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE + ++DV+SFGVLL E+ +
Sbjct: 212 LPLKWM--------------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 61/317 (19%), Positives = 112/317 (35%), Gaps = 69/317 (21%)
Query: 42 SESPSKSRALTNWSRFFKLWKKKS-TKHLRTFHPLAMPKLSREKSR-STREDPDLTHIYN 99
A+ ++ L ++ + + + P + ST + P L +
Sbjct: 8 HHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSE 67
Query: 100 YRSSLK---EFTLSELQTATKNFSSENLIGKGGYAEVYKG--------CLRDGTLVAVKR 148
Y EF +L +G+G + +V ++ VAVK
Sbjct: 68 YELPEDPKWEFPRDKLTL-------GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM 120
Query: 149 LTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSDG--IHLVFQLSPLGSLASILHG 205
L ++ + E+ ++ + H N L+G + ++++ + + G+L L
Sbjct: 121 LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 180
Query: 206 SKDKPDWSKRY---------------RIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250
+ A G+ YL ++ IHRD+ A N+L+T
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237
Query: 251 EDYEPQICDFGLAKW--------------LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
E+ +I DFGLA+ LP +W APE +
Sbjct: 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM--------------APEALFDRVYT 283
Query: 297 EKTDVYSFGVLLLELIT 313
++DV+SFGVL+ E+ T
Sbjct: 284 HQSDVWSFGVLMWEIFT 300
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182
++GKG Y VY G L + +A+K + + + EI + ++ H N + +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 183 DSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTA---NGLTYLHEGCQKRI 237
S+ + + P GSL+++L +++ I T GL YLH+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHD---NQI 143
Query: 238 IHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV- 295
+HRDIK DN+L+ T +I DFG +K L F GT Y APE G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPRG 201
Query: 296 -DEKTDVYSFGVLLLELITGRR 316
+ D++S G ++E+ TG+
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 57/229 (24%)
Query: 125 IGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTA 177
+G G + +V + VAVK L + + E+ +++Y+ +H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 178 KLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY-----------------RI 218
L+G + G ++ + G L + L +D SK
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW------------- 265
+ A G+ +L K IHRD+ A NILLT +ICDFGLA+
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 266 -LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE + + ++DV+S+G+ L EL +
Sbjct: 208 RLPVKWM--------------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG--FLCEIGIIAYVDHPNTAKLV 180
+GKG + VY ++ ++A+K L K ++++ EI I +++ HPN ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 181 GC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
D I+L+ + +P G L L + + A+ L Y H ++++I
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH---ERKVI 136
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLP--RQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
HRDIK +N+L+ E +I DFG + P R+ T GT Y PE D
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT------MCGTLDYLPPEMIEGKTHD 190
Query: 297 EKTDVYSFGVLLLELITGR 315
EK D++ GVL E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 34/219 (15%)
Query: 124 LIGKGGYAEVYKGCLRDGTL----VAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAK 178
I GG +Y D + V +K L + D + + E +A V HP+ +
Sbjct: 87 CIAHGGLGWIYLA--LDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 179 L--VGCDSDGI-----HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
+ +D ++V + SL K ++ L L+YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS 200
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+++ D+K +NI+LTE+ + ++ D G + GT G+ APE
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAV----SRINSFGY--LYGTPGFQAPEIVR 250
Query: 292 HGIVDEKTDVYSFGVLLLELITGR-----RAVDHLQQSV 325
G TD+Y+ G L L R VD L +
Sbjct: 251 TGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
K ++ IG+G VY + G VA++++ +K + EI ++ +P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 175 NTAKLVGCDSDGIHL--VFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYL 229
N + G L V + GSL ++ + IA L +L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFL 132
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
H ++IHRDIK+DNILL D ++ DFG + + + + GT + APE
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEV 187
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 29/280 (10%), Positives = 64/280 (22%), Gaps = 46/280 (16%)
Query: 74 PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEV 133
+ E + + + + + S L + + G + V
Sbjct: 19 EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78
Query: 134 YKG-CLRDGTLVAVKRLTKGTVDEKT--------------------------CGFLCEIG 166
+ + A+K T G + ++ L
Sbjct: 79 FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138
Query: 167 IIAYVDHPNTAKLVGCDSDG----IHLVFQ-----LSPLGSLASILHGSKDKPDWSKRYR 217
+A P A+L D L+ L L S ++ + +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277
+ L K ++H DN+ + D + D +
Sbjct: 199 LTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPA 250
Query: 278 FEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGR 315
Y E+ + + G+ + +
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 39/218 (17%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 125 IGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLC----------------EIGII 168
+ +G + ++ C +D A+K+ K +++K E+ II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 169 AYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLAS-ILHGSKDKPDWSKRY------RIA 219
+ + G + D ++++++ S+ + +++ I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
N +Y+H +K I HRD+K NIL+ ++ ++ DFG ++++ +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----GSR 211
Query: 280 GTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGR 315
GT+ + PE+F + K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 40/244 (16%), Positives = 80/244 (32%), Gaps = 28/244 (11%)
Query: 96 HIYNYRSSLKEFTL-SELQTATKNFSSENLIGKGGYAEVYKGCLRD------GTLVAVKR 148
+ + ++ L +E Q +K +L+G+G +A+VY+ D +K
Sbjct: 43 NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV 102
Query: 149 LTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGS 206
E + + K +G LV +L G+L + ++
Sbjct: 103 QKPANPWEFYI-GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 207 KDKP----DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP------- 255
K+ P A+ + +H+ IIH DIK DN +L +
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 256 ----QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLEL 311
+ D G + + + T G+ E + + + D + + +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278
Query: 312 ITGR 315
+ G
Sbjct: 279 LFGT 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/259 (25%), Positives = 102/259 (39%), Gaps = 42/259 (16%)
Query: 70 RTFHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGG 129
+ AM + + +DPD+ ++ K F+ IG G
Sbjct: 19 NLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE------------IGHGS 66
Query: 130 YAEVYKG-CLRDGTLVAVKR--LTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDG 186
+ VY +R+ +VA+K+ + +EK + E+ + + HPNT + GC
Sbjct: 67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC---- 122
Query: 187 IHLVFQLSPL--------GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
+ GS + +L K + + G GL YLH +I
Sbjct: 123 ---YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMI 176
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE---YFMHGIV 295
HRD+KA NILL+E ++ DFG A + + F GT + APE G
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQY 230
Query: 296 DEKTDVYSFGVLLLELITG 314
D K DV+S G+ +EL
Sbjct: 231 DGKVDVWSLGITCIELAER 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 23/210 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVK-----RLTKGTVDEKTCGFLCEIGIIAY 170
+ + +GKGG+A+ ++ + A K L K EK EI I
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRS 97
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
+ H + G D+D + +V +L SL + K + RY G Y
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-YLRQIVLGCQY 156
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE---GTFGYF 285
LH + R+IHRD+K N+ L ED E +I DFGLA + ++ + + GT Y
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGTPNYI 208
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGR 315
APE + DV+S G ++ L+ G+
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVK-----RLTKGTVDEKTCGFLCEIGIIAY 170
++F NL+GKG +A VY+ + G VA+K + K + ++ E+ I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR---VQNEVKIHCQ 67
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRYRIALGTANG 225
+ HP+ +L DS+ ++LV ++ G + L ++ KP + ++ + + G
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQI--ITG 124
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE---GTF 282
+ YLH I+HRD+ N+LLT + +I DFGLA L K GT
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-----MPHEKHYTLCGTP 176
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
Y +PE ++DV+S G + L+ GR
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVK-----RLTKGTVDEKTCGFLCEIGIIAY 170
+ + +GKGG+A+ ++ + A K L K EK EI I
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRS 71
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGL 226
+ H + G D+D + +V +L SL + + +P+ ++ Y + G
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE-ARYYLRQI--VLGC 128
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
YLH + R+IHRD+K N+ L ED E +I DFGLA + V GT Y A
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIA 183
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELITGR 315
PE + DV+S G ++ L+ G+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 57/229 (24%)
Query: 125 IGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPN 175
+G+G + +V T VAVK L ++ + E+ ++ + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 176 TAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY---------------RI 218
L+G + ++++ + + G+L L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW------------- 265
A A G+ YL K+ IHRD+ A N+L+TED +I DFGLA+
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 266 -LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE I ++DV+SFGVLL E+ T
Sbjct: 254 RLPVKWM--------------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 116 TKNFSSENL-----IGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGII- 168
+ +++L +G+G Y V K G ++AVKR+ ++ L ++ I
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 169 AYVDHPNTAKLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY------RIA 219
VD P T G + D + + +L SL K D + +IA
Sbjct: 61 RTVDCPFTVTFYGALFREGD-VWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIA 115
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
+ L +LH + +IHRD+K N+L+ + ++CDFG++ +L
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDA 170
Query: 280 GTFGYFAPEYFMHGIV----DEKTDVYSFGVLLLELITGR 315
G Y APE + K+D++S G+ ++EL R
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 20/222 (9%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ + +G GG+ V + +D G VA+K+ + + + EI I+ ++HPN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 177 AKLVGC--------DSDGIHLVFQLSPLGSLASILHGSKDKPDWS-KRYRIALG-TANGL 226
+D L + G L L+ ++ R L ++ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQ---ICDFGLAKWLPRQWTHHNVSKFEGTFG 283
YLHE RIIHRD+K +NI+L + I D G AK L + ++F GT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQ 188
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV 325
Y APE D +SFG L E ITG R Q V
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 62/234 (26%)
Query: 125 IGKGGYAEVYKGCLRDG------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTA 177
+G G + +V VAVK L + + + E+ ++ + H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 178 KLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRY------------------- 216
L+G + I+L+F+ G L + L ++K +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 217 ---RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW-------- 265
A A G+ +L K +HRD+ A N+L+T +ICDFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 266 ------LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE GI K+DV+S+G+LL E+ +
Sbjct: 230 VRGNARLPVKWM--------------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 20/248 (8%)
Query: 73 HPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAE 132
H + + +TH ++++L+ S IG+G
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHE-QFKAALRMVVDQG--DPRLLLDSYVKIGEGSTGI 60
Query: 133 VYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHL-- 189
V G VAVK + + E+ I+ H N ++ G L
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIAL---GTANGLTYLHEGCQKRIIHRDIKADN 246
+ + G+L I+ + + IA L YLH + +IHRDIK+D+
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---AQGVIHRDIKSDS 171
Query: 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGV 306
ILLT D ++ DFG + + GT + APE + + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRK--SLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 307 LLLELITG 314
+++E++ G
Sbjct: 230 MVIEMVDG 237
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 53/229 (23%), Positives = 85/229 (37%), Gaps = 39/229 (17%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGI-IAYVDHPN 175
SE ++G G V G VAVKR+ D L EI + DHPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI----ALMEIKLLTESDDHPN 70
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY------RIALGTANGLT 227
+ +++ +L +L ++ + K + A+G+
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 228 YLHEGCQKRIIHRDIKADNILLT-------------EDYEPQICDFGLAKWLP--RQWTH 272
+LH +IIHRD+K NIL++ E+ I DFGL K L +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 273 HNVSKFEGTFGYFAPEYFMHGIV-------DEKTDVYSFGVLLLELITG 314
N++ GT G+ APE D++S G + +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 56/221 (25%), Positives = 84/221 (38%), Gaps = 24/221 (10%)
Query: 110 SELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGII 168
++ IG+G Y V K G ++AVKR+ +++ L ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 169 -AYVDHPNTAKLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY------RI 218
D P + G + D + +L S +I
Sbjct: 75 MRSSDCPYIVQFYGALFREGD-CWICMELMS-TSFDKFYK--YVYSVLDDVIPEEILGKI 130
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKF 278
L T L +L E +IIHRDIK NILL ++CDFG++ L
Sbjct: 131 TLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR---D 185
Query: 279 EGTFGYFAPEYFMHGIV----DEKTDVYSFGVLLLELITGR 315
G Y APE D ++DV+S G+ L EL TGR
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGII-AYVDHPNTAKLVGC 182
+G G +V+K + G ++AVK++ + E+ L ++ ++ D P + G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 183 --DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240
+ + + +L + P+ + + L YL E + +IHR
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-MTVAIVKALYYLKE--KHGVIHR 149
Query: 241 DIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV----- 295
D+K NILL E + ++CDFG++ L G Y APE
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR---SAGCAAYMAPERIDPPDPTKPDY 206
Query: 296 DEKTDVYSFGVLLLELITGR 315
D + DV+S G+ L+EL TG+
Sbjct: 207 DIRADVWSLGISLVELATGQ 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 30/254 (11%), Positives = 64/254 (25%), Gaps = 57/254 (22%)
Query: 110 SELQTATKNFSSENLIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKT---------- 158
SEL + ++G+ + G V
Sbjct: 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125
Query: 159 -----------------CGFLCEIGIIAYVDHPNTAKLVGCDSDGIHL-VFQLSPL--GS 198
F+ ++ ++ + D L F L P +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 199 LASIL-----HGSKDKP-DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
L + H S K R ++ L L LH ++H ++ +I+L +
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 242
Query: 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-----------GIVDEKTDV 301
+ F + + G+ PE ++ D
Sbjct: 243 GGVFLTGFEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 302 YSFGVLLLELITGR 315
++ G+++ +
Sbjct: 297 WALGLVIYWIWCAD 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 27/246 (10%)
Query: 84 KSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGT 142
+ +L + +++ F S+ ++ + +G G Y EV +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 143 LVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL 199
A+K + K +V L E+ ++ +DHPN KL D +LV + G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 200 ASILHGSKDKPDWSKRY------RIALGTANGLTYLHEGCQKRIIHRDIKADNILLT--- 250
D+ ++ I +G+TYLH + I+HRD+K +N+LL
Sbjct: 124 -------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKE 173
Query: 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLE 310
+D +I DFGL+ Q + + GT Y APE DEK DV+S GV+L
Sbjct: 174 KDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFI 229
Query: 311 LITGRR 316
L+ G
Sbjct: 230 LLAGYP 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 112 LQTATKNFSS----ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG--FLCE 164
+Q +T FS + ++GKG + EV G AVK ++K V +KT L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 165 IGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLAS--ILHGSKDKPDWSKRYRIAL 220
+ ++ +DHPN KL D +LV ++ G L I + D ++ R L
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSK 277
+G+TY+H + +I+HRD+K +N+LL +D +I DFGL+ +
Sbjct: 137 ---SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKD 187
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
GT Y APE HG DEK DV+S GV+L L++G
Sbjct: 188 KIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGC 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 57/233 (24%), Positives = 89/233 (38%), Gaps = 42/233 (18%)
Query: 112 LQTATKNFSS----ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC--- 163
++ +G G Y EV + A+K + K D+
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 164 ---------EIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDW 212
EI ++ +DHPN KL D +LV + G L ++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------FEQIIN 139
Query: 213 SKRY------RIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLA 263
++ I +G+ YLH + I+HRDIK +NILL +I DFGL+
Sbjct: 140 RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316
+ + + + GT Y APE +EK DV+S GV++ L+ G
Sbjct: 197 SFFSKDYKLRDRL---GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 29/236 (12%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKG 152
+ H +++ S + T + ++ ++GKG + EV K R AVK + K
Sbjct: 1 MHHHHHHSSGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 153 TV-DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDK 209
+ ++ T L E+ ++ +DHPN KL DS ++V +L G L D+
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-------FDE 111
Query: 210 PDWSKRY------RIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDF 260
KR+ RI +G+TY+H + I+HRD+K +NILL +D + +I DF
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316
GL+ + + GT Y APE G DEK DV+S GV+L L++G
Sbjct: 169 GLSTCFQQN---TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 44/210 (20%), Positives = 79/210 (37%), Gaps = 29/210 (13%)
Query: 182 CDSDGIHLVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+++ QL +L ++ S + + I + A + +LH K ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMH 187
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWL----PRQWTHHNVSKFE------GTFGYFAPEY 289
RD+K NI T D ++ DFGL + Q + + GT Y +PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349
K D++S G++L EL+ + + D+R L P L
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----------TDVRNLKFPLLFTQ 297
Query: 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+E ++ + SP RP+ + +
Sbjct: 298 KYPQE--HMMV--QDMLSPSPTERPEATDI 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 27/239 (11%), Positives = 59/239 (24%), Gaps = 56/239 (23%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKT------------------------ 158
++G+ + G V
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 159 ---CGFLCEIGIIAYVDHPNTAKLVGCDSDG-IHLVFQLSP-----LGSLASIL--HGSK 207
F+ ++ ++ + D + F L P L + +L H S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 208 DKP-DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266
K R ++ L L LH ++H ++ +I+L + + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 267 PRQWTHHNVSKFEGTFGYFAPEYFM----------HGIVDEKTDVYSFGVLLLELITGR 315
+ G+ PE ++ D ++ G+ + +
Sbjct: 260 ----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-22
Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 27/205 (13%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
K F ++G G ++EV+ R G L A+K + K + EI ++ + H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHE 66
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY------RIALGTANGL 226
N L + +LV QL G L D+ Y + + +
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGEL-------FDRILERGVYTEKDASLVIQQVLSAV 119
Query: 227 TYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG 283
YLHE I+HRD+K +N+L E+ + I DFGL+K GT G
Sbjct: 120 KYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPG 172
Query: 284 YFAPEYFMHGIVDEKTDVYSFGVLL 308
Y APE + D +S GV+
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 54/243 (22%), Positives = 81/243 (33%), Gaps = 55/243 (22%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTK----GTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
IG+G Y V + A+K + K + E+ ++ + HPN A+L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 180 VGC--DSDGIHLVFQLSPLGSL-------------ASILHGSKDKPDWSKRYRIALGTA- 223
D I LV +L G L + K +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 224 -------------------------NGLTYLHEGCQKRIIHRDIKADNILLT--EDYEPQ 256
+ L YLH + I HRDIK +N L + + +E +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 257 ICDFGLAKWLPRQWTHHNVSKFE--GTFGYFAPE--YFMHGIVDEKTDVYSFGVLLLELI 312
+ DFGL+K + GT + APE + K D +S GVLL L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 313 TGR 315
G
Sbjct: 271 MGA 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 59/259 (22%), Positives = 99/259 (38%), Gaps = 32/259 (12%)
Query: 79 KLSREKSRSTREDPD--LTHIYNYRSSLKEFTLSELQTATKNFSSE----NLIGKGGYAE 132
+ + K R + + L+ N + T+ + K E +G G E
Sbjct: 91 LVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 133 VYKGCLRD-GTLVAVKRLTK-------GTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-CD 183
V R VA++ ++K + EI I+ ++HP K+ D
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210
Query: 184 SDGIHLVFQLSPLGSLAS--ILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
++ ++V +L G L + + + + L + YLHE IIHRD
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHE---NGIIHRD 264
Query: 242 IKADNILLTEDYEPQ---ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV--- 295
+K +N+LL+ E I DFG +K L + GT Y APE +
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 296 DEKTDVYSFGVLLLELITG 314
+ D +S GV+L ++G
Sbjct: 322 NRAVDCWSLGVILFICLSG 340
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC------------------- 163
IGKG Y V D T A+K L+K + +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 164 ------EIGIIAYVDHPNTAKLV----GCDSDGIHLVFQLSPLGSLASILHGSKDKPDWS 213
EI I+ +DHPN KLV + D +++VF+L G + + D +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 214 KRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273
+ Y L G+ YLH ++IIHRDIK N+L+ ED +I DFG++
Sbjct: 140 RFYFQDL--IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DA 192
Query: 274 NVSKFEGTFGYFAPEYF--MHGIVD-EKTDVYSFGVLLLELITGR 315
+S GT + APE I + DV++ GV L + G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 28/200 (14%), Positives = 53/200 (26%), Gaps = 44/200 (22%)
Query: 124 LIGKGGYAEVYKGCLRDGTL---VAVKRL-TKGTVDEKTCG-FLCEIGIIAYVDHPNTAK 178
G + ++ D L VA+ + +G + + L ++ +D P A+
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 179 L--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
+ V G +V + GSL + S P R A H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
+ + ++ D G +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD-------AN 180
Query: 297 EKTDVYSFGVLLLELITGRR 316
+ D+ G L L+ R
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
F + +G G + +V+ R G +K + K EI ++ +DHP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRY--RIALGTANGLTYL 229
N K+ D +++V + G L I+ S+ Y + N L Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 230 HEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYF 285
H + ++H+D+K +NIL +I DFGLA+ + + + GT Y
Sbjct: 141 H---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA----GTALYM 193
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITG 314
APE F V K D++S GV++ L+TG
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-21
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ F E+ +G+G + VY+ + A+K L K TVD+K EIG++ + HP
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKI--VRTEIGVLLRLSHP 108
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
N KL I LV +L G L + G + D + + L + YLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL---EAVAYLH 165
Query: 231 EGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
E I+HRD+K +N+L D +I DFGL+K + Q V GT GY AP
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAP 219
Query: 288 EYFMHGIVDEKTDVYSFGVLL 308
E + D++S G++
Sbjct: 220 EILRGCAYGPEVDMWSVGIIT 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 22/206 (10%)
Query: 116 TKNFSSE----NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK-TCGFLCEIGIIA 169
+ FS +GKG ++ V + + G A K + + + E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 170 YVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANG 225
+ HPN +L + +LVF L G L + + D S + L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ES 117
Query: 226 LTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
+ Y H I+HR++K +N+LL + ++ DFGLA + F GT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTP 171
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLL 308
GY +PE + D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 50/248 (20%), Positives = 90/248 (36%), Gaps = 29/248 (11%)
Query: 85 SRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGC-LRDGTL 143
S N + K E + + L+G GG+ VY G + D
Sbjct: 11 SSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLP 70
Query: 144 VAVKRLTKGTVDEKTCGFLC-----EIGIIAYVDH--PNTAKL--VGCDSDGIHLVFQL- 193
VA+K + K + + E+ ++ V +L D L+ +
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130
Query: 194 SPLGSLAS--ILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQKRIIHRDIKADNILL 249
P+ L G + + ++ + ++ + + H ++HRDIK +NIL+
Sbjct: 131 EPVQDLFDFITERG-ALQEELARSFFWQVL----EAVRHCH---NCGVLHRDIKDENILI 182
Query: 250 -TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVL 307
E ++ DFG L F+GT Y PE+ + V+S G+L
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
Query: 308 LLELITGR 315
L +++ G
Sbjct: 239 LYDMVCGD 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKG 152
+ H +++ S + T + ++ ++GKG + EV K R AVK + K
Sbjct: 1 MHHHHHHSSGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 153 TVDEK-TCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSK 207
+ K T L E+ ++ +DHPN KL DS ++V +L G L I
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 208 DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAK 264
+ D ++ + +G+TY+H + I+HRD+K +NILL +D + +I DFGL+
Sbjct: 119 SEHDAARIIKQVF---SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
+ + GT Y APE + G DEK DV+S GV+L
Sbjct: 173 CFQQN---TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 67/226 (29%), Positives = 95/226 (42%), Gaps = 19/226 (8%)
Query: 100 YRSSLKEFTLSELQTATKN-FSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV--- 154
Y + ++ E Q TKN F ++GKGG+ EV +R G + A K+L K +
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 155 DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDW 212
+ L E I+ V+ L D + LV L G L H
Sbjct: 226 KGEAMA-LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAG 282
Query: 213 SKRYRIALGTAN---GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269
R A GL LH +RI++RD+K +NILL + +I D GLA +P
Sbjct: 283 FPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
Query: 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
T + GT GY APE + D ++ G LL E+I G+
Sbjct: 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 111 ELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEI 165
++++ K + + +G+G +A VYK +VA+K++ G E G L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 166 GIIAYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDK--PDWSKRYRIALG 221
++ + HPN L I LVF L I+ + P K Y +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT- 121
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKF 278
GL YLH Q I+HRD+K +N+LL E+ ++ DFGLAK R +TH V
Sbjct: 122 -LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--- 174
Query: 279 EGTFGYFAPEYFMH------GIVDEKTDVYSFGVLLLELITGR 315
T Y APE G+ D+++ G +L EL+
Sbjct: 175 --TRWYRAPELLFGARMYGVGV-----DMWAVGCILAELLLRV 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 19/192 (9%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC- 182
IG+G + EV + A K++ K V++ F EI I+ +DHPN +L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYETF 75
Query: 183 -DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
D+ I+LV +L G L + + D ++ + L + + Y H + + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL---SAVAYCH---KLNVAH 129
Query: 240 RDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
RD+K +N L D ++ DFGLA + GT Y +P+ G+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVL-EGLYG 185
Query: 297 EKTDVYSFGVLL 308
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 29/214 (13%)
Query: 110 SELQTATKNFSSE----NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCE 164
+L + F+ IG G Y+ + + AVK + K D E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----E 65
Query: 165 IGIIA-YVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRY--RI 218
I I+ Y HPN L D +++V +L G L IL + +S+R +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAV 121
Query: 219 ALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEP-QICDFGLAKWLPRQWTHHN 274
+ YLH + ++HRD+K NIL + E +ICDFG AK L + +
Sbjct: 122 LFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGL 176
Query: 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
+ T + APE D D++S GVLL
Sbjct: 177 LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 61/282 (21%), Positives = 106/282 (37%), Gaps = 29/282 (10%)
Query: 57 FFKLWKKKSTKHLRTFHPLAMPKLSREKSRSTREDP-DLTHIYNYRSSLKEFTLS----- 110
+ ++ + + + + ++ +EF S
Sbjct: 111 RAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLR 170
Query: 111 -------ELQTATKN-FSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKT 158
E Q ++ F ++G+GG+ EV+ ++ G L A K+L K +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 159 CGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY 216
+ E I+A V L + LV + G + ++ + +
Sbjct: 231 GA-MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 217 RIALGTAN---GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273
R TA GL +LH+ + II+RD+K +N+LL +D +I D GLA L
Sbjct: 290 RAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQT 344
Query: 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
+ GT G+ APE + D D ++ GV L E+I R
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 18/212 (8%)
Query: 106 EFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK-TCGFLC 163
EF ++ + N+ + +GKG ++ V + + G A K + + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 164 EIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIA 219
E I + HPN +L + +LVF L G L + + D S +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 137
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVS 276
L + Y H I+HR++K +N+LL + ++ DFGLA +
Sbjct: 138 L---ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWH 188
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
F GT GY +PE + D+++ GV+L
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 53/218 (24%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGI---IA 169
+ IG G Y VYK G VA+K + G + E+ + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 170 YVDHPNTAKL----VGCDSDG---IHLVFQLSPLGSLASILHGSKDK---PDWSKRYRIA 219
+HPN +L +D + LVF+ L + L + + K
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--LPRQWTHHNVSK 277
GL +LH I+HRD+K +NIL+T ++ DFGLA+ T V
Sbjct: 129 F--LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-- 181
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
T Y APE + D++S G + E+ +
Sbjct: 182 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 26/201 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTK-------GTVDEKTCGFLCEIGIIAYVDHPNT 176
+G G EV R VA+K ++K + EI I+ ++HP
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 177 AKLVGC-DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
K+ D++ ++V +L G L + + + + L + YLHE
Sbjct: 78 IKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHE-- 132
Query: 234 QKRIIHRDIKADNILLTEDYEPQ---ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
IIHRD+K +N+LL+ E I DFG +K L + GT Y APE
Sbjct: 133 -NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVL 188
Query: 291 MHGIV---DEKTDVYSFGVLL 308
+ + D +S GV+L
Sbjct: 189 VSVGTAGYNRAVDCWSLGVIL 209
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 21/208 (10%)
Query: 114 TATKNFSSE----NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEK-TCGFLCEIGI 167
F+ E +GKG ++ V + G A + + + E I
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 168 IAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTA 223
+ HPN +L + +L+F L G L + + D S + L
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL--- 120
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280
+ + H+ ++HR++K +N+LL + ++ DFGLA + + F G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAG 175
Query: 281 TFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
T GY +PE + D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 29/204 (14%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTK--------GTVDEKTCGFLCEIGIIAYVD-HP 174
+G+G + V + + AVK + V E L E+ I+ V HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
N +L + LVF L G L + + + K R L + LH
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL---EVICALH 141
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
+ I+HRD+K +NILL +D ++ DFG + L + + GT Y APE
Sbjct: 142 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEII 195
Query: 291 MHGIV------DEKTDVYSFGVLL 308
+ ++ D++S GV++
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFL-CEIGIIAYVDHPNTAKL--V 180
IGKG +A+V + G VA+K + K ++ + L E+ I+ ++HPN KL V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 181 GCDSDGIHLVFQLSPLGSLASIL--HGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
++L+ + + G + L HG + K ++ + +A + Y H QKRI+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSA--VQYCH---QKRIV 136
Query: 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-E 297
HRD+KA+N+LL D +I DFG + + F G Y APE F D
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 298 KTDVYSFGVLLLELITGR 315
+ DV+S GV+L L++G
Sbjct: 194 EVDVWSLGVILYTLVSGS 211
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 45/197 (22%), Positives = 72/197 (36%), Gaps = 18/197 (9%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG----FLCEIGIIAYVDHPNTAKL 179
IGKG ++ V + R+ G AVK + E I + HP+ +L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 180 VGC--DSDGIHLVFQLSPLGSLA-SILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQ 234
+ +++VF+ L I+ + +S+ L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 148
Query: 235 KRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
IIHRD+K +LL ++ FG+A L GT + APE
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVK 206
Query: 292 HGIVDEKTDVYSFGVLL 308
+ DV+ GV+L
Sbjct: 207 REPYGKPVDVWGCGVIL 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 29/210 (13%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC-----EIGIIAYVD----H 173
L+GKGG+ V+ G L D VA+K + + V + E+ ++ V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 174 PNTAKL--VGCDSDGIHLVFQLSPLGS--LASILHGSKDKPDWSKRY--RIALGTANGLT 227
P +L +G LV + I S+ + ++ +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAIQ 153
Query: 228 YLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
+ H + ++HRDIK +NIL+ ++ DFG L + F+GT Y
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYSP 206
Query: 287 PEYFMHGIVD-EKTDVYSFGVLLLELITGR 315
PE+ V+S G+LL +++ G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 61/210 (29%), Positives = 84/210 (40%), Gaps = 21/210 (10%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDH 173
+F IGKG + +V D + A+K + K +E E+ I+ ++H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN-VFKELQIMQGLEH 74
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA-LGTANGLTYLH 230
P L D + + +V L G L L + + + + I L A L YL
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDYLQ 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK-WLPRQWTHHNVSKFEGTFGYFAPEY 289
+RIIHRD+K DNILL E I DF +A GT Y APE
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT----TMAGTKPYMAPEM 185
Query: 290 FMHGIV---DEKTDVYSFGVLLLELITGRR 316
F D +S GV EL+ GRR
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 34/234 (14%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFS-----SENLIGKGGYAEVYKGCLRD-GTLVAVK 147
+ H +++ SS E + + S+ ++G G +V + R G A+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 148 RLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVG------CDSDGIHLVFQLSPLGSLA 200
L + E+ P+ ++ + ++ + G L
Sbjct: 61 LLYDSPKARQ------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 201 S-ILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYE 254
S I + +++R I + +LH I HRD+K +N+L T +D
Sbjct: 115 SRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAV 169
Query: 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308
++ DFG AK + + T Y APE D+ D++S GV++
Sbjct: 170 LKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGII 168
Q + + +G+G Y VYK G +VA+KR+ DE G + EI ++
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE---GIPSTAIREISLL 73
Query: 169 AYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGL 226
+ HPN L V + LVF+ L +L +K S+ G+
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFG 283
+ H Q RI+HRD+K N+L+ D ++ DFGLA+ R +TH V T
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLW 184
Query: 284 YFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
Y AP+ Y D++S G + E+ITG+
Sbjct: 185 YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 29/253 (11%)
Query: 78 PKLSREKSRSTREDPDLT-HIYNYRSSLKEFTLSELQTATKNFSS----ENLIGKGGYAE 132
K R + P + + Y K++ ++ + +G G +
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 133 VYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHL 189
V++ + G + K + +K EI I+ + HP L D + L
Sbjct: 67 VHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 190 VFQLSPLGSL-ASILHGSKDKPDWSKRY-----RIALGTANGLTYLHEGCQKRIIHRDIK 243
+ + G L I + S+ R A GL ++H + I+H DIK
Sbjct: 126 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQAC---EGLKHMH---EHSIVHLDIK 176
Query: 244 ADNILLT--EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDV 301
+NI+ + +I DFGLA L V T + APE V TD+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 302 YSFGVLLLELITG 314
++ GVL L++G
Sbjct: 234 WAIGVLGYVLLSG 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 25/205 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG-----FLCEIGIIAYVDHPNTAK 178
+G G +A V K + G A K + K G E+ I+ V H N
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 179 LVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L + + L+ +L G L S + + + + L +G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---DGVNYLH---T 133
Query: 235 KRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEY 289
K+I H D+K +NI+L + P + DFGLA + + GT + APE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----GTPEFVAPEI 189
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
+ + + D++S GV+ L++G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 8e-19
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV- 171
+FS +IG+GG+ EVY D G + A+K L K + +T L E +++ V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVS 247
Query: 172 --DHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLT 227
D P + D + + L G L L + R+ A GL
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLE 306
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
++H + +++RD+K NILL E +I D GLA ++ H GT GY AP
Sbjct: 307 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 359
Query: 288 EYFMHGIVDEKT-DVYSFGVLLLELITGR 315
E G+ + + D +S G +L +L+ G
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
S ++G G + +V+K G +A K + + +K EI ++ +DH N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANL 148
Query: 177 AKLVGC--DSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRY--RIALGTANGLTYLHE 231
+L + I LV + G L I+ + + ++ G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMH- 204
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPE 288
Q I+H D+K +NIL QI DFGLA+ PR+ + GT + APE
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPE 258
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITG 314
+ V TD++S GV+ L++G
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 71/303 (23%), Positives = 119/303 (39%), Gaps = 34/303 (11%)
Query: 29 SESEASFKENTTQSESPSKSRALTNWSRFFKLWKKKSTKHLRTFHPLAMPKLSREKSRST 88
+S +N E R + + + ++ + LR P L E +
Sbjct: 4 HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRD-DPSQSANLLAEAKKLN 62
Query: 89 REDPDLTHIYNYRSSLKEFTLSELQTATKNFSSE----NLIGKGGYAEVYKGCLRD-GTL 143
P T ++S E L + A K F + ++IG+G + V + R G
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPD-WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 144 VAVK-------RLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC--DSDGIHLVFQL 193
AVK RL+ ++E E I+ V HP+ L+ S + LVF L
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 194 SPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251
G L + + + R L +++LH I+HRD+K +NILL +
Sbjct: 182 MRKGELFDYLTEKVALSEKETRSIMRSLL---EAVSFLHA---NNIVHRDLKPENILLDD 235
Query: 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE------YFMHGIVDEKTDVYSFG 305
+ + ++ DFG + L + + GT GY APE H ++ D+++ G
Sbjct: 236 NMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 306 VLL 308
V+L
Sbjct: 293 VIL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDH 173
++F ++G+G ++ V A+K L K + + K E +++ +DH
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA-LGTANGLTYLH 230
P KL D + ++ + G L + + R+ A + +A L YLH
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
K IIHRD+K +NILL ED QI DFG AK L + + F GT Y +PE
Sbjct: 148 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-- 202
Query: 291 MHGIVDEK-----TDVYSFGVLLLELITGR 315
++ EK +D+++ G ++ +L+ G
Sbjct: 203 ---LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 63/319 (19%), Positives = 121/319 (37%), Gaps = 59/319 (18%)
Query: 75 LAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFT--LSELQTATKNFSSENLIGKGGYAE 132
L +L+++K ++ ++ + L E++ +F +IG+G ++E
Sbjct: 28 LGASELAQDK-----------YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSE 76
Query: 133 VYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDG 186
V ++ G + A+K + K + E +C F E ++ D +L D +
Sbjct: 77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQLHFAFQDENY 135
Query: 187 IHLVFQLSPLGSLASIL--HGSKDKPDWSKRY--RIALGTANGLTYLHEGCQKRIIHRDI 242
++LV + G L ++L G + + ++ Y I + + +H + +HRDI
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH---RLGYVHRDI 188
Query: 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVY 302
K DNILL ++ DFG L T ++ GT Y +PE T Y
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSY 247
Query: 303 -------SFGVLLLELITGR------------RAVDHLQQSVVIWAKPLLDSNDIRELV- 342
+ GV E+ G+ + H ++ + + + R+ +
Sbjct: 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQ 307
Query: 343 ----DPS--LGDNYDAEEI 355
P LG A +
Sbjct: 308 RLLCPPETRLGRG-GAGDF 325
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 23/212 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYV 171
+ + IG+G Y V+K +VA+KR+ DE G L EI ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKEL 58
Query: 172 DHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
H N +L V + LVF+ L D GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--LP-RQWTHHNVSKFEGTFGYFA 286
H + ++HRD+K N+L+ + E ++ +FGLA+ +P R ++ V T Y
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRP 169
Query: 287 PEYFMHGIV-DEKTDVYSFGVLLLELITGRRA 317
P+ + D++S G + EL R
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG-----FLCEIGIIAYVDHPNTAK 178
+G G +A V K + G A K + K + G E+ I+ + HPN
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 179 LVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L + + L+ +L G L S + + ++ + L +G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL---DGVHYLH---S 126
Query: 235 KRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEY 289
KRI H D+K +NI+L + P + DFG+A + GT + APE
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEI 182
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
+ + + D++S GV+ L++G
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVD 172
+ + IG+G Y VYK G A+K++ DE G + EI I+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELK 58
Query: 173 HPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
H N KL V + LVF+ L +L + + L NG+ Y H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--LP-RQWTHHNVSKFEGTFGYFAP 287
+R++HRD+K N+L+ + E +I DFGLA+ +P R++TH V T Y AP
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAP 169
Query: 288 EYFMHGIV-DEKTDVYSFGVLLLELITGR 315
+ M D++S G + E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 50/260 (19%), Positives = 94/260 (36%), Gaps = 18/260 (6%)
Query: 63 KKSTKHLRTFHPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSE 122
+ R + + + + D ++ + + ++
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH 162
Query: 123 NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + V++ R G A K + +K EI ++ + HP L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHD 221
Query: 182 C--DSDGIHLVFQLSPLGSL---ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
D + + ++++ G L + H + + + R GL ++HE
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC---KGLCHMHE---NN 275
Query: 237 IIHRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+H D+K +NI+ T ++ DFGL L +V GT + APE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 295 VDEKTDVYSFGVLLLELITG 314
V TD++S GVL L++G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC---EIGIIAYVDHPNTAKL 179
L+G+G Y +V + AVK L K + G EI ++ + H N +L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 180 V----GCDSDGIHLVFQLSPLGS---LASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
V + +++V + G L S+ + + Y L +GL YLH
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQL--IDGLEYLH-- 126
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM- 291
+ I+H+DIK N+LLT +I G+A+ L +G+ + PE
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 292 ----HGIVDEKTDVYSFGVLLLELITGR 315
G K D++S GV L + TG
Sbjct: 186 LDTFSG---FKVDIWSAGVTLYNITTGL 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 96 HIYNYRSSLKEFT--LSELQTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKG 152
+I Y K FT + +++ ++F +IG+G + EV L++ + A+K L K
Sbjct: 51 NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW 110
Query: 153 TV---DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSK 207
+ E C F E ++ D L D + ++LV G L ++L +
Sbjct: 111 EMLKRAETAC-FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 208 DK--PDWSKRY--RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263
D+ + ++ Y + + + +H Q +HRDIK DNIL+ + ++ DFG
Sbjct: 170 DRLPEEMARFYLAEMVIA----IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT-----DVYSFGVLLLELITGR 315
L T + GT Y +PE + D +S GV + E++ G
Sbjct: 223 LKLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 120 SSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTA 177
+ +G+G ++ K + AVK ++K EI + + HPN
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIV 69
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY--RIALGTANGLTYLHEGC 233
KL D LV +L G L K K +S+ I + ++++H+
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHD-- 124
Query: 234 QKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
++HRD+K +N+L T ++ E +I DFG A+ P + + T Y APE
Sbjct: 125 -VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELL 181
Query: 291 MHGIVDEKTDVYSFGVLL 308
DE D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 25/205 (12%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLC-----EIGIIAYVDHPNTAK 178
+G G +A V K + G A K + K G E+ I+ V HPN
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 179 LVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L + + L+ +L G L S + + + + L +G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---DGVNYLH---T 133
Query: 235 KRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWL-PRQWTHHNVSKFEGTFGYFAPEY 289
K+I H D+K +NI+L + P + DFGLA + GT + APE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEI 189
Query: 290 FMHGIVDEKTDVYSFGVLLLELITG 314
+ + + D++S GV+ L++G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGF----LCEIGI-- 167
+ IG+G Y +V+K RD G VA+KR+ T +E G + E+ +
Sbjct: 12 QYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEE---GMPLSTIREVAVLR 66
Query: 168 -IAYVDHPNTAKL----VGCDSDG---IHLVFQL--SPLGSLASILHGSKDKPDWSKRYR 217
+ +HPN +L +D + LVF+ L + + + K
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--LPRQWTHHNV 275
L GL +LH R++HRD+K NIL+T + ++ DFGLA+ T V
Sbjct: 127 FQL--LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
T Y APE + D++S G + E+ +
Sbjct: 182 -----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 55/197 (27%), Positives = 79/197 (40%), Gaps = 10/197 (5%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--V 180
+G+G Y EV VAVK + + EI I ++H N K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 181 GCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ + +L + G L I ++R+ L G+ YLH I H
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLH---GIGITH 128
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-EK 298
RDIK +N+LL E +I DFGLA ++K GT Y APE E
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 299 TDVYSFGVLLLELITGR 315
DV+S G++L ++ G
Sbjct: 189 VDVWSCGIVLTAMLAGE 205
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCG-----FLCEIGIIA 169
+ + +G G +A V K + G A K + K G E+ I+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 170 YVDHPNTAKLVGC--DSDGIHLVFQLSPLGSL--ASILHGSKDKPDWSKRYRIALGTANG 225
+ HPN L + + L+ +L G L S + + ++ + L NG
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL---NG 126
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWLPRQWTHHNVSKFEGT 281
+ YLH +I H D+K +NI+L + P+ I DFGLA + + GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG 314
+ APE + + + D++S GV+ L++G
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 50/223 (22%)
Query: 125 IGKGGYAEVYKGCLRD---GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL-- 179
+G+G Y VYK +D A+K++ + C EI ++ + HPN L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC---REIALLRELKHPNVISLQK 85
Query: 180 --VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTA--------NGLTYL 229
+ + L+F + L I+ + K ++ G +G+ YL
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWL---PRQWTHHN---VSKFE 279
H ++HRD+K NIL+ + + I D G A+ + + V
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV---- 197
Query: 280 GTFGYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
TF Y APE Y + D+++ G + EL+T
Sbjct: 198 -TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 121 SENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAK 178
E+++G+G +A V AVK + K ++ E+ ++ H N +
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLE 75
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQ 234
L+ + D +LVF+ GS+ S +H + +++ + A+ L +LH
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHN--- 129
Query: 235 KRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFE-----GTFGYFA 286
K I HRD+K +NIL + +ICDF L + +S E G+ Y A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 287 PEYFMHGIV-----DEKTDVYSFGVLL 308
PE D++ D++S GV+L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 101 RSSLKEFTLSELQTATK--NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEK 157
++S +AT + +G+G Y EVYK VA+KR+ +E
Sbjct: 16 TQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE- 74
Query: 158 TCGFLC----EIGIIAYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKD-KP 210
G E+ ++ + H N +L V + +HL+F+ + L + + D
Sbjct: 75 --GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131
Query: 211 DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ-----ICDFGLAKW 265
K + L NG+ + H +R +HRD+K N+LL+ + I DFGLA+
Sbjct: 132 RVIKSFLYQL--INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 266 --LP-RQWTHHNVSKFEGTFGYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
+P RQ+TH + T Y PE Y D++S + E++
Sbjct: 187 FGIPIRQFTHEII-----TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 19/232 (8%)
Query: 96 HIYNYRSSLKEFT--LSELQTATKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKG 152
+I N+ S K+ + +L+ +++ +IG+G + EV + + A+K L+K
Sbjct: 46 NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 105
Query: 153 TV---DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSK 207
+ + F E I+A+ + P +L D +++V + P G L +++
Sbjct: 106 EMIKRSDSAF-FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 164
Query: 208 DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267
W++ Y + A L +H IHRD+K DN+LL + ++ DFG +
Sbjct: 165 VPEKWARFYTAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 268 RQWTHHNVSKFEGTFGYFAPEYFM----HGIVDEKTDVYSFGVLLLELITGR 315
++ + GT Y +PE G + D +S GV L E++ G
Sbjct: 220 KEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 25/214 (11%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC-------EIGII 168
+ +S+ + +G G + V+ V VK + K V E EI I+
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 169 AYVDHPNTAKL--VGCDSDGIHLVFQLSPLGS--LASILHGSKDKPDWSKRY--RIALGT 222
+ V+H N K+ + + LV + G A I + + ++
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV--- 140
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
+ + YL K IIHRDIK +NI++ ED+ ++ DFG A +L R F GT
Sbjct: 141 -SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTI 193
Query: 283 GYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGR 315
Y APE M + +++S GV L L+
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 21/208 (10%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ + +G+G + V++ K + D+ EI I+ H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHR 61
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALG--TANGLTYL 229
N L + + ++F+ + I + ++R ++ L +L
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 230 HEGCQKRIIHRDIKADNILLT--EDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFA 286
H I H DI+ +NI+ +I +FG A+ L P N Y+A
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYA 171
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELITG 314
PE H +V TD++S G L+ L++G
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 55/197 (27%), Positives = 79/197 (40%), Gaps = 10/197 (5%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--V 180
+G+G Y EV VAVK + + EI I ++H N K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 181 GCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ + +L + G L I ++R+ L G+ YLH I H
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLH---GIGITH 128
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-EK 298
RDIK +N+LL E +I DFGLA ++K GT Y APE E
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 299 TDVYSFGVLLLELITGR 315
DV+S G++L ++ G
Sbjct: 189 VDVWSCGIVLTAMLAGE 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 44/254 (17%)
Query: 85 SRSTREDPDLTHIYNYRSSLKEFTLSELQTATKN------FSSENLIGKGGYAEVYKGCL 138
+ + ++ + + + + KE L + +T ++N F +G G + V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 139 RD-GTLVAVKRLTKGTVDEK-----TCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLV 190
++ G A+K L K V + T L E I+ V+ P KL D+ +++V
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHT---LNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 191 FQLSPLGSLASILHGSKDKP-DWSKRY--RIALGTANGLTYLHEGCQKRIIHRDIKADNI 247
+ G + S L ++ Y +I L YLH +I+RD+K +N+
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENL 172
Query: 248 LLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK-----TDV 301
L+ + Q+ DFG AK + R WT GT APE I+ K D
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEALAPE-----IILSKGYNKAVDW 221
Query: 302 YSFGVLLLELITGR 315
++ GVL+ E+ G
Sbjct: 222 WALGVLIYEMAAGY 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 33/207 (15%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLC----EIGIIAYVDHPNTAKL 179
IG+G Y V+K RD G +VA+K+ + D EI ++ + HPN L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP---VIKKIALREIRMLKQLKHPNLVNL 67
Query: 180 --VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
V +HLVF+ ++ L + I T + + H +
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNC 123
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYFAPEYFMH-- 292
IHRD+K +NIL+T+ ++CDFG A+ L + T Y +PE +
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-----TRWYRSPELLVGDT 178
Query: 293 ----GIVDEKTDVYSFGVLLLELITGR 315
+ DV++ G + EL++G
Sbjct: 179 QYGPPV-----DVWAIGCVFAELLSGV 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 34/242 (14%)
Query: 94 LTHIYNYRSSLKEFTLSELQTATKNFSS-----ENLIGKGGYAEVYKGCLRD-GTLVAVK 147
+ H +++ S + T + + +NF++ +G+G +A V + + G A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 148 -----RLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGC--DSDGIHLVFQLSPLGSL 199
R + E L EI ++ P L ++ I L+ + + G +
Sbjct: 61 FLKKRRRGQDCRAE----ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116
Query: 200 ----ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TED 252
L + D + + L G+ YLH+ I+H D+K NILL
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQIL---EGVYYLHQ---NNIVHLDLKPQNILLSSIYPL 170
Query: 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELI 312
+ +I DFG+++ + + + GT Y APE + + TD+++ G++ L+
Sbjct: 171 GDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227
Query: 313 TG 314
T
Sbjct: 228 TH 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGF----LCEIGIIAYVDHPNTAKL 179
IG+G + EV+K + G VA+K++ E GF L EI I+ + H N L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNL 81
Query: 180 ----------VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
I+LVF LA +L K S+ R+ NGL Y+
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA-------KWLPRQWTHHNVSKFEGTF 282
H + +I+HRD+KA N+L+T D ++ DFGLA P ++T+ V T
Sbjct: 141 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-----TL 192
Query: 283 GYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
Y PE Y D++ G ++ E+ T
Sbjct: 193 WYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 64/268 (23%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 70 RTFH----------PLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNF 119
RTFH A+ ++ + + D +S E L
Sbjct: 86 RTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV 145
Query: 120 SSEN-----LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAY 170
+ L+GKG + +V + G A+K L K + DE L E ++
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH-TLTENRVLQN 204
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI-ALGTANGLT 227
HP L D + V + + G L H S+++ R R + L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287
YLH +K +++RD+K +N++L +D +I DFGL K + F GT Y AP
Sbjct: 263 YLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 318
Query: 288 EYFMHGIVDEKTDVYSFGVLLLELITGR 315
E D + GV++ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC----EIGIIAYV 171
+ + + +G+G YA VYKG LVA+K + + G C E+ ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKDL 57
Query: 172 DHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
H N L + + LVF+ L L + + GL Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYFA 286
H +++++HRD+K N+L+ E E ++ DFGLA+ + + + V T Y
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRP 168
Query: 287 PEYFMHGIV-DEKTDVYSFGVLLLELITGR 315
P+ + + D++ G + E+ TGR
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 39/217 (17%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTVDEKTCGFLC----EIGIIAY 170
+ + L+G+G Y V K R+ G +VA+K+ + D+ EI ++
Sbjct: 26 KYENLGLVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDK---MVKKIAMREIKLLKQ 80
Query: 171 VDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
+ H N L V +LVF+ ++ L + D+ + NG+ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL---PRQWTHHNVSKFEGTFGYF 285
H IIHRDIK +NIL+++ ++CDFG A+ L + T Y
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-----TRWYR 191
Query: 286 APE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
APE Y + DV++ G L+ E+ G
Sbjct: 192 APELLVGDVKYGK-AV-----DVWAIGCLVTEMFMGE 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDH 173
+F +G G + V+ R G A+K L K V + E +++ V H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-TNDERLMLSIVTH 65
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKD-KPDWSKRY--RIALGTANGLTY 228
P ++ G D+ I ++ G L S+L S+ +K Y + L L Y
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEY 121
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP-RQWTHHNVSKFEGTFGYFAP 287
LH K II+RD+K +NILL ++ +I DFG AK++P +T GT Y AP
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGTPDYIAP 172
Query: 288 EYFMHGIVDEK-----TDVYSFGVLLLELITGR 315
E +V K D +SFG+L+ E++ G
Sbjct: 173 E-----VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 47/227 (20%)
Query: 114 TATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLC----EIGII 168
+++ F +G G YA VYKG G VA+K + + + G EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLM 57
Query: 169 AYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTA--- 223
+ H N +L V + + LVF+ L + + + + L
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYF 113
Query: 224 -----NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW--LP-RQWTHHNV 275
GL + H + +I+HRD+K N+L+ + + ++ DFGLA+ +P ++ V
Sbjct: 114 QWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 276 SKFEGTFGYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR 315
T Y AP+ Y D++S G +L E+ITG+
Sbjct: 171 -----TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 65/272 (23%), Positives = 109/272 (40%), Gaps = 39/272 (14%)
Query: 62 KKKSTKHLRTFHPLAMPK-LSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFS 120
+ ++T + P+ P K ++ +T + + +++
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ------EVSYT 57
Query: 121 SENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL 179
+IG G + VY+ G LVA+K++ + D++ E+ I+ +DH N +L
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFK--NRELQIMRKLDHCNIVRL 112
Query: 180 VGC--------DSDGIHLVFQLSPLGSLASILHGSKDK---PDWSKRYRIALGTANGLTY 228
D ++LV P H S+ K P + + L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAY 171
Query: 229 LHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWL--PRQWTHHNVSKFEGTFGYF 285
+H I HRDIK N+LL D ++CDFG AK L + S++ Y
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 223
Query: 286 APEYFMHGIVDEKT--DVYSFGVLLLELITGR 315
APE + G D + DV+S G +L EL+ G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKL 179
L+GKG + +V + G A+K L K + DE + E ++ HP L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH-TVTESRVLQNTRHPFLTAL 70
Query: 180 VGC--DSDGIHLVFQLSPLGSLASILHGSKD---KPDWSKRYR--IALGTANGLTYLHEG 232
D + V + + G L H S++ + ++ Y I L YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSA----LEYLHS- 123
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+ +++RDIK +N++L +D +I DFGL K + F GT Y APE
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE---- 175
Query: 293 GIVDEKT-----DVYSFGVLLLELITGR 315
++++ D + GV++ E++ GR
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 56/267 (20%), Positives = 104/267 (38%), Gaps = 37/267 (13%)
Query: 73 HPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAE 132
+ + +++ + S + + + S FT+ K + + IG G
Sbjct: 26 KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDS--TFTV------LKRYQNLKPIGSGAQGI 77
Query: 133 VYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYVDHPN--------TAKLV 180
V VA+K+L++ K E+ ++ V+H N T +
Sbjct: 78 VCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIISLLNVFTPQKT 135
Query: 181 GCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIAL-GTANGLTYLHEGCQKRIIH 239
+ ++LV +L + + L +R L G+ +LH IIH
Sbjct: 136 LEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIH 187
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT 299
RD+K NI++ D +I DFGLA+ T ++ + T Y APE + E
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 300 DVYSFGVLLLELITGR---RAVDHLQQ 323
D++S G ++ E++ + D++ Q
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQ 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 67/239 (28%), Positives = 101/239 (42%), Gaps = 43/239 (17%)
Query: 102 SSLKEFTLSELQTATK------NFSSENLIGKGGYAEVY---KGCLRD-GTLVAVKRLTK 151
S+KE ++ F ++G+G + +V+ K D L A+K L K
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK 62
Query: 152 GTV---DEKTCGFLCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGS 206
T+ D E I+ V+HP KL ++L+ G L S
Sbjct: 63 ATLKVRDRVRT--KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLS 118
Query: 207 KDK---PDWSKRYR--IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261
K+ + K Y +AL L +LH II+RD+K +NILL E+ ++ DFG
Sbjct: 119 KEVMFTEEDVKFYLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT-----DVYSFGVLLLELITGR 315
L+K F GT Y APE +V+ + D +SFGVL+ E++TG
Sbjct: 172 LSK--ESIDHEKKAYSFCGTVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 32/225 (14%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYV 171
K + S +G G Y V R G VA+K+L++ + K E+ ++ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA--YRELLLLKHM 80
Query: 172 DHPNTAKLVGCDS--------DGIHLVFQLSPLGS-LASILHGSKDKPDWSKRYRIALGT 222
H N L+ + +LV + + L I+ + +Y +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPF--MQTDLQKIMG--LKFSEEKIQY-LVYQM 135
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
GL Y+H ++HRD+K N+ + ED E +I DFGLA+ + T + V+++
Sbjct: 136 LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW---- 188
Query: 283 GYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
Y APE + ++ D++S G ++ E++TG+ + D+L Q
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 36/233 (15%)
Query: 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG-F---------LCEI 165
++ + I G Y V G +G VA+KR+ D +T L EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 166 GIIAYVDHPNTAKLVGCDS-------DGIHLVFQLSPLGS-LASILHGSKDK-PDWSKRY 216
++ + HPN L ++LV +L + + LA ++H + +Y
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL--MRTDLAQVIHDQRIVISPQHIQY 138
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVS 276
GL LHE ++HRD+ NILL ++ + ICDF LA+ N +
Sbjct: 139 -FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT---ADANKT 191
Query: 277 KFEGTFGYFAPE---YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
+ Y APE F + D++S G ++ E+ + R Q
Sbjct: 192 HYVTHRWYRAPELVMQFKG--FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 113 QTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD 172
+ +++ +IG G + V++ L + VA+K++ + + E+ I+ V
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVK 90
Query: 173 HPNTAKLVGC--------DSDGIHLVFQLSPLGSLASIL-HGSKDK----PDWSKRYRIA 219
HPN L D ++LV + P ++ H +K K K Y
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWL--PRQWTHHNVS 276
L L Y+H I HRDIK N+LL ++ DFG AK L + S
Sbjct: 150 L--LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204
Query: 277 KFEGTFGYFAPEYFMHGIVDEKT--DVYSFGVLLLELITGR 315
++ Y APE + G + T D++S G ++ EL+ G+
Sbjct: 205 RY-----YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 50/256 (19%), Positives = 90/256 (35%), Gaps = 34/256 (13%)
Query: 73 HPLAMPKLSREKSRSTREDPDLTHIYNYRSSLKEFTL-SELQTATKNFSSE-----NLIG 126
P P + P +F + S LQ + ++G
Sbjct: 12 VPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLG 71
Query: 127 KGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGII-AYVDHPNTAKLVG--- 181
G +V + + A+K L + E+ + P+ ++V
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 182 ---CDSDGIHLVFQLSPLGSLAS-ILHGSKDKPDWSKRY--RIALGTANGLTYLHEGCQK 235
+ +V + G L S I + +++R I + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS---I 180
Query: 236 RIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
I HRD+K +N+L T + ++ DFG AK +H++++ T Y APE
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---SHNSLTTPCYTPYYVAPEVLGP 237
Query: 293 GIVDEKTDVYSFGVLL 308
D+ D++S GV++
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 17/199 (8%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKL--V 180
IG G + LVAVK + +G ++ EI + HPN + V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNIVRFKEV 84
Query: 181 GCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ ++ + + G L I + + D ++ + L +G++Y H +I H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGVSYCH---SMQICH 139
Query: 240 RDIKADNILLTEDYEPQ--ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD- 296
RD+K +N LL P+ ICDFG +K H GT Y APE + D
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 297 EKTDVYSFGVLLLELITGR 315
+ DV+S GV L ++ G
Sbjct: 197 KIADVWSCGVTLYVMLVGA 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYV 171
+ +G G Y V R G VA+K+L + + K E+ ++ ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA--YRELRLLKHM 81
Query: 172 DHPNTAKLV--------GCDSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKR--YRIAL 220
H N L+ D +LV +G+ L ++ K D + Y++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHEKLGEDRIQFLVYQML- 138
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280
GL Y+H IIHRD+K N+ + ED E +I DFGLA+ + T + V+++
Sbjct: 139 ---KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-- 190
Query: 281 TFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
Y APE + + D++S G ++ E+ITG+ + DHL Q
Sbjct: 191 ---YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 31/225 (13%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYV 171
K + + IG G V VA+K+L++ K E+ ++ V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKCV 81
Query: 172 DHPN--------TAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRI--ALG 221
+H N T + + +++V +L +L ++ + Y + L
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQML- 137
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT 281
G+ +LH IIHRD+K NI++ D +I DFGLA+ T ++ + T
Sbjct: 138 --CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVT 189
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
Y APE + E D++S G ++ E+I G DH+ Q
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 124 LIGKGGYAEVY---KGCLRD-GTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPN 175
++GKGGY +V+ K + G + A+K L K + + E I+ V HP
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKAERNILEEVKHPF 82
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRYR--IALGTANGLTY 228
L+ ++L+ + G L + ++ D + Y I++ L +
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA----LGH 136
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
LH+ K II+RD+K +NI+L ++ DFGL K F GT Y APE
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPE 191
Query: 289 YFMHGIVDEKT-----DVYSFGVLLLELITGR 315
I+ D +S G L+ +++TG
Sbjct: 192 -----ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 31/110 (28%)
Query: 218 IALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW------------ 265
+ A G+ +L ++ IHRD+ A NILL+E +ICDFGLA+
Sbjct: 198 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 266 --LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT 313
LP +W APE + ++DV+SFGVLL E+ +
Sbjct: 255 ARLPLKWM--------------APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYV 171
+ + + + +G G Y V + G VAVK+L++ + K E+ ++ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHM 85
Query: 172 DHPNTAKLVGC--------DSDGIHLVFQLSPLGS-LASILHGSKDKPDWSK--RYRIAL 220
H N L+ + + ++LV L +G+ L +I+ K D + Y+I
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHL--MGADLNNIVKCQKLTDDHVQFLIYQIL- 142
Query: 221 GTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG 280
GL Y+H IIHRD+K N+ + ED E +I DFGLA+ + T +
Sbjct: 143 ---RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----- 191
Query: 281 TFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
T Y APE + ++ D++S G ++ EL+TGR DH+ Q
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 124 LIGKGGYAEVYKGC--LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV--------DH 173
+G G ++ V+ + + T VA+K + V + EI ++ V D
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADNTKEDS 82
Query: 174 PNTAKLVGC-DS------DGIH--LVFQLSPLG-SLASILHGSKDKPDWSKRYR-IALGT 222
++ D +G+H +VF++ LG +L +++ + + + I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEV--LGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ------ICDFGLAKWLPRQWTHHNVS 276
GL Y+H C IIH DIK +N+L+ P+ I D G A W +T+ +
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
+ Y +PE + D++S L+ ELITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 56/267 (20%), Positives = 97/267 (36%), Gaps = 65/267 (24%)
Query: 112 LQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY 170
L+T++K +S +G G + V + + G A+K++ + D + E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYK--NRELDIMKV 56
Query: 171 VDHPNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKR--------------- 215
+DH N KLV + + L G + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 216 --------YRIALGTAN-------------------GLTYLHEGCQKRIIHRDIKADNIL 248
+++ + ++H I HRDIK N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLL 173
Query: 249 L-TEDYEPQICDFGLAKWLPRQ--WTHHNVSKFEGTFGYFAPEYFMHGIVD--EKTDVYS 303
+ ++D ++CDFG AK L + S+F Y APE M G + D++S
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWS 227
Query: 304 FGVLLLELITGR---RAVDHLQQSVVI 327
G + ELI G+ + Q V I
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRI 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 15/199 (7%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHPNTAKL- 179
+G G + +V G G VAVK L + + EI + HP+ KL
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 180 -VGCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
V +V + G L I + + ++R + + + Y H + +
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI--LSAVDYCH---RHMV 132
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD- 296
+HRD+K +N+LL +I DFGL+ + + G+ Y APE +
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAPEVISGRLYAG 189
Query: 297 EKTDVYSFGVLLLELITGR 315
+ D++S GV+L L+ G
Sbjct: 190 PEVDIWSCGVILYALLCGT 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAK 178
++GKG + +V +++ G L AVK L K + D+ C + E I++ +HP +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC-TMTEKRILSLARNHPFLTQ 88
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRY--RIALGTANGLTYLHE 231
L C D + V + G L + H K + ++ Y I L +LH+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISA----LMFLHD 142
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
K II+RD+K DN+LL + ++ DFG+ K + F GT Y APE
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE--- 194
Query: 292 HGIVDEKT-----DVYSFGVLLLELITGR 315
I+ E D ++ GVLL E++ G
Sbjct: 195 --ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 64/254 (25%), Positives = 105/254 (41%), Gaps = 37/254 (14%)
Query: 77 MPKLSREKSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG 136
K+ + + + ++ + L+ +F+ ++GKG + +V
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT-------DFNFLMVLGKGSFGKVMLS 360
Query: 137 CLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAKLVGC--DSDGIHL 189
+ L AVK L K V D+ C + E ++A P +L C D ++
Sbjct: 361 ERKGTDELYAVKILKKDVVIQDDDVEC-TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419
Query: 190 VFQLSPLGSL-ASILHGSKDKPDWSKRYR--IALGTANGLTYLHEGCQKRIIHRDIKADN 246
V + G L I + K + Y IA+G L +L K II+RD+K DN
Sbjct: 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDN 472
Query: 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKT-----DV 301
++L + +I DFG+ K W F GT Y APE I+ + D
Sbjct: 473 VMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPE-----IIAYQPYGKSVDW 525
Query: 302 YSFGVLLLELITGR 315
++FGVLL E++ G+
Sbjct: 526 WAFGVLLYEMLAGQ 539
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 37/196 (18%), Positives = 78/196 (39%), Gaps = 21/196 (10%)
Query: 81 SREKSRSTREDPDLTHIYNYRSSLKEFTLSELQ-TATKNFSSENLIGKGGYAEVYKG-CL 138
++ ++++ ++ + +LIG G Y V +
Sbjct: 16 TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 139 RDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYVDHPNTAKLV-------GCDSDGIH 188
+ +VA+K++ + +D K L EI I+ ++H + K++ D ++
Sbjct: 76 LEKRVVAIKKILRVFEDLIDCKRI--LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 189 LVFQLSPLGS-LASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNI 247
+V ++ S + + + + G+ Y+H I+HRD+K N
Sbjct: 134 VVLEI--ADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHSA---GILHRDLKPANC 187
Query: 248 LLTEDYEPQICDFGLA 263
L+ +D ++CDFGLA
Sbjct: 188 LVNQDCSVKVCDFGLA 203
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 52/225 (23%), Positives = 86/225 (38%), Gaps = 42/225 (18%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
F E + G+G + V G G VA+K++ + L + +A + HP
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHP 79
Query: 175 NTAKLVGC-------DSDGI--HLVFQLSPLGSLASIL-HGSKDK---PDWSKRY----- 216
N +L D I ++V + P +L + + + P +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 217 -RIALGTANGLTYLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLP--RQWTH 272
R + LH + HRDIK N+L+ D ++CDFG AK L
Sbjct: 139 IR-------SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 273 HNVSKFEGTFGYFAPEYFMHGIVDEKT--DVYSFGVLLLELITGR 315
+ S++ Y APE + G T D++S G + E++ G
Sbjct: 191 YICSRY-----YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 68/266 (25%), Positives = 103/266 (38%), Gaps = 53/266 (19%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIA-YVDHPNTAK 178
+IGKG + +V + AVK L K + E+ + E ++ V HP
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH-IMSERNVLLKNVKHPFLVG 103
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKD---KPDWSKRY--RIALGTANGLTYLHE 231
L +D ++ V G L H ++ ++ Y IA L YLH
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASA----LGYLHS 157
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
I++RD+K +NILL + DFGL K + S F GT Y APE
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE--- 209
Query: 292 HGIVDEKT-----DVYSFGVLLLELITGR-----RAVDHLQQSVVIWAKPLL----DSND 337
++ ++ D + G +L E++ G R + + I KPL +N
Sbjct: 210 --VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN--ILNKPLQLKPNITNS 265
Query: 338 IRELV------DPS--LGDNYDAEEI 355
R L+ D + LG D EI
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEI 291
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAK 178
++GKG + +V+ + A+K L K V D+ C + E +++ +HP
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTH 82
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKD-KPDWSKRY--RIALGTANGLTYLHEGC 233
+ + + V + G L + + Y I LG L +LH
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLHS-- 136
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
K I++RD+K DNILL +D +I DFG+ K + F GT Y APE
Sbjct: 137 -KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE----- 188
Query: 294 IVDEKT-----DVYSFGVLLLELITGR 315
I+ + D +SFGVLL E++ G+
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 63/223 (28%), Positives = 92/223 (41%), Gaps = 43/223 (19%)
Query: 118 NFSSENLIGKGGYAEVY---KGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAY 170
NF ++G G Y +V+ K D G L A+K L K T+ + T E ++ +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 171 VDH-PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRY--RIALGT 222
+ P L +HL+ G L H S+ + + Y I L
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLA- 171
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK---WLPRQWTHHNVSKFE 279
L +LH+ II+RDIK +NILL + + DFGL+K + + F
Sbjct: 172 ---LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY----DFC 221
Query: 280 GTFGYFAPEYFMHGIVDEKT-------DVYSFGVLLLELITGR 315
GT Y AP+ IV D +S GVL+ EL+TG
Sbjct: 222 GTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLT--KGTVDEKTCGFLCEIGIIAYVD 172
+++ + IG+G Y V + VA+K+++ + + L EI I+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--LREIKILLRFR 83
Query: 173 HPNTAKLVGC-------DSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKRYRI--ALGT 222
H N + +++V L + + L +L ++ + Y + L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLK-TQHLSNDHICYFLYQIL-- 138
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV-SKFEGT 281
GL Y+H ++HRD+K N+LL + +ICDFGLA+ H +++ T
Sbjct: 139 -RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 282 FGYFAPE---YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
Y APE + D++S G +L E+++ R +L Q
Sbjct: 195 RWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVD-HPNTAK 178
++GKG + +V + L AVK L K V D+ C + E ++A P +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC-TMVEKRVLALPGKPPFLTQ 85
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKD---KPDWSKRYR--IALGTANGLTYLHE 231
L C D ++ V + G L + H + K + Y IA+G L +L
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQS 139
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
K II+RD+K DN++L + +I DFG+ K W F GT Y APE
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPE--- 191
Query: 292 HGIVDEKT-----DVYSFGVLLLELITGR 315
I+ + D ++FGVLL E++ G+
Sbjct: 192 --IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 36/233 (15%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLT--KGTVDEKTCGFLCEIGIIAYVD 172
+ +F ++L+G+G Y V G +VA+K++ + L EI I+ +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT--LREIKILKHFK 67
Query: 173 HPNTAKLV-------GCDSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKRYRI--ALGT 222
H N + + + ++++ +L + + L ++ D +Y I L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQEL--MQTDLHRVISTQMLSDD-HIQYFIYQTL-- 122
Query: 223 ANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
+ LH +IHRD+K N+L+ + + ++CDFGLA+ + ++ + +
Sbjct: 123 -RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 283 G--------YFAPEYFM-HGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
Y APE + DV+S G +L EL R D+ Q
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAK 178
+IG+G YA+V L+ + A++ + K V ++ E + +HP
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQASNHPFLVG 117
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRYR--IALGTANGLTYLHE 231
L C + V + G L + H + + + ++ Y I+L L YLHE
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE 171
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+ II+RD+K DN+LL + ++ D+G+ K S F GT Y APE
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE--- 223
Query: 292 HGIVDEKT-----DVYSFGVLLLELITGR 315
I+ + D ++ GVL+ E++ GR
Sbjct: 224 --ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 124 LIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAK 178
+IG+G YA+V L+ + A+K + K V ++ E + +HP
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASNHPFLVG 74
Query: 179 LVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRYR--IALGTANGLTYLHE 231
L C + V + G L + H + + + ++ Y I+L L YLHE
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE 128
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+ II+RD+K DN+LL + ++ D+G+ K S F GT Y APE
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE--- 180
Query: 292 HGIVDEKT-----DVYSFGVLLLELITGR 315
I+ + D ++ GVL+ E++ GR
Sbjct: 181 --ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHPNTAKL- 179
+G+G + +V + VA+K +++ + + EI + + HP+ KL
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 180 -VGCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
V I +V + + G L I+ + D +R+ + + Y H + +I
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQI--ICAIEYCH---RHKI 129
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD- 296
+HRD+K +N+LL ++ +I DFGL+ + + + G+ Y APE +
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 297 EKTDVYSFGVLLLELITGR 315
+ DV+S G++L ++ GR
Sbjct: 187 PEVDVWSCGIVLYVMLVGR 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 38/235 (16%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLT-KGTVDEKTCGFLCEIGIIAYVDH 173
+ +G GG V+ VA+K++ K L EI II +DH
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA--LREIKIIRRLDH 67
Query: 174 PNTAKLV----------------GCDSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKRY 216
N K+ + + +++V + + + LA++L + R
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY--METDLANVLE-QGPLLEEHARL 124
Query: 217 RIALGTANGLTYLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWLPRQWTHHNV 275
GL Y+H ++HRD+K N+ + TED +I DFGLA+ + ++H
Sbjct: 125 -FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 276 -SKFEGTFGYFAPE---YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQ 323
S+ T Y +P + + D+++ G + E++TG+ L+Q
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 55/250 (22%), Positives = 97/250 (38%), Gaps = 48/250 (19%)
Query: 98 YNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDE 156
++Y S + E+ + ++ +G+G Y+EV++ + + V VK L V +
Sbjct: 23 WDYESHVVEWGNQD------DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKK 74
Query: 157 KTCGFLCEIGIIAYV-DHPNTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPD 211
K EI I+ + PN L S LVF+ + D
Sbjct: 75 KK--IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI 132
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL-TEDYEPQICDFGLAKWL--PR 268
Y I L Y H I+HRD+K N+++ E + ++ D+GLA++ +
Sbjct: 133 RFYMYEIL----KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 269 QWTHHNVSKFEGTFGYFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGRRAV--- 318
++ S++ + PE Y D D++S G +L +I +
Sbjct: 186 EYNVRVASRY-----FKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 319 -DHLQQSVVI 327
D+ Q V I
Sbjct: 235 HDNYDQLVRI 244
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAYV 171
N+ ++LIG+G Y VY VA+K++ + +D K L EI I+ +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI--LREITILNRL 82
Query: 172 DHPNTAKLV-------GCDSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKRYRIALGTA 223
+L D +++V ++ S L + + + I
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEI--ADSDLKKLFKTPIFLTEEHIKT-ILYNLL 139
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263
G ++HE IIHRD+K N LL +D ++CDFGLA
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 15/199 (7%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLC--EIGIIAYVDHPNTAKL- 179
+G G + +V G G VAVK L + + EI + HP+ KL
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 180 -VGCDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRI 237
V I +V + G L I + S+R + +G+ Y H + +
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI--LSGVDYCH---RHMV 137
Query: 238 IHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD- 296
+HRD+K +N+LL +I DFGL+ + + G+ Y APE +
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAPEVISGRLYAG 194
Query: 297 EKTDVYSFGVLLLELITGR 315
+ D++S GV+L L+ G
Sbjct: 195 PEVDIWSSGVILYALLCGT 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 54/247 (21%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTK---GTVDEKTCGFLCEIGIIAY- 170
+ + +GKG Y V+K R G +VAVK++ + D + EI I+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT--FREIMILTEL 65
Query: 171 VDHPNTAKLVGC----DSDGIHLVFQLSPLGS-LASILHGSKDKPDWSKRYRIALGTANG 225
H N L+ + ++LVF + + L +++ + +P K+Y +
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDY--METDLHAVIRANILEPV-HKQY-VVYQLIKV 121
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFG-- 283
+ YLH G ++HRD+K NILL + ++ DFGL++ N
Sbjct: 122 IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 284 -----------------YFAPE-------YFMHGIVDEKTDVYSFGVLLLELITGR---R 316
Y APE Y + D++S G +L E++ G+
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCGKPIFP 232
Query: 317 AVDHLQQ 323
+ Q
Sbjct: 233 GSSTMNQ 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 37/198 (18%), Positives = 69/198 (34%), Gaps = 49/198 (24%)
Query: 125 IGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGI-IAYVDHPNTAKLVG- 181
+G G +V + + A+K L + E+ + P+ ++V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 182 -----CDSDGIHLVFQLSPLGSL-ASILHGSKDKPDWSKRY--RIALGTANGLTYLHEGC 233
+ +V + G L + I + +++R I + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS-- 135
Query: 234 QKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
I HRD+K +N+L T + ++ DFG AK + Y
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------KY------ 175
Query: 291 MHGIVDEKTDVYSFGVLL 308
D+ D++S GV++
Sbjct: 176 -----DKSCDMWSLGVIM 188
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 43/214 (20%)
Query: 124 LIGKGGYAEVYKGC--LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+IGKG + +V K + VA+K + + EI I+ L
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQA--AEEIRILE--------HLRK 152
Query: 182 CDSDGIH----------------LVFQLSPLG-SLASILHGSKDKPDWSKRYR-IALGTA 223
D D + F+L L +L ++ +K + R A
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFEL--LSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGT 281
L LH + RIIH D+K +NILL + I DFG + + ++ + S+F
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
Y APE + D++S G +L EL+TG
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 59/279 (21%), Positives = 93/279 (33%), Gaps = 93/279 (33%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-----DHPNTAK 178
+G G ++ V+ ++ VA+K + +T EI ++ V + PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREM 102
Query: 179 LVGC-DS------DGIH--LVFQLSPLG-SLASILHGSKDKP---DWSKRYRIALGTANG 225
+V D +G H +VF+ LG L + S + K+ I G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 226 LTYLHEGCQKRIIHRDIKADNILLT----------------------------------- 250
L YLH C+ IIH DIK +NILL+
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 251 --------------EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD 296
E + +I D G A W+ + +T T Y + E + +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYN 271
Query: 297 EKTDVYSFGVLLLELITGR------------RAVDHLQQ 323
D++S + EL TG R DH+
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 9e-10
Identities = 26/200 (13%), Positives = 45/200 (22%), Gaps = 53/200 (26%)
Query: 115 ATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGF------------- 161
T+ IG+G + EV++ D T VA+K + D
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 162 ---LCEIGIIAYVDHPNTAKLVGC--------------------------------DSDG 186
L + L D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246
+ +V + G + + I L + HRD+ N
Sbjct: 137 LFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 247 ILLTEDYEPQICDFGLAKWL 266
+LL + ++ K
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGT 281
L +L + IIH D+K +NILL I DFG + L ++ + S+F
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
Y +PE + D D++S G +L+E+ TG
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 18/150 (12%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGC 182
IG+G + +++G L + VA+K E + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 183 DSDGIH--LVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+G+H LV L LG SL +L K A + +HE K +++
Sbjct: 75 GQEGLHNVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 129
Query: 240 RDIKADNILLTEDYEPQ-----ICDFGLAK 264
RDIK DN L+ + DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/180 (17%), Positives = 56/180 (31%), Gaps = 44/180 (24%)
Query: 117 KNFSSENLIGKGGYAEVYKGC---------LRDGTLVAVKRLTKGTVDEKTCGFLCEIGI 167
+ + ++ + +Y+ ++K +D K E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNF 95
Query: 168 IAYVDHPNT----AKLVGCDSDGI--------------HLVFQLSPLG-SLASILHGSKD 208
P KL I LV LG SL S L S
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPK 153
Query: 209 KPDWSKR--YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAK 264
S+R ++A + L +LHE +H ++ A+NI + + + Q+ +G A
Sbjct: 154 HV-LSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 35/150 (23%), Positives = 56/150 (37%), Gaps = 18/150 (12%)
Query: 125 IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGC 182
IG G + E+ G L VA+K L + + E + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEP--MKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 183 DSDGIH--LVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
G + +V +L LG SL + IA+ + + Y+H K +I+
Sbjct: 74 GPCGKYNAMVLEL--LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIY 128
Query: 240 RDIKADNILLTEDYEPQ-----ICDFGLAK 264
RD+K +N L+ I DF LAK
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 33/173 (19%), Positives = 55/173 (31%), Gaps = 44/173 (25%)
Query: 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFL-CEIGIIAYVDHPNT----AK 178
IG+GG+ +Y + V V+ G L E+ P +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 179 LVGCDSDGI-----------------HLVFQLSPLG-SLASILHGSKDKPDWSKR----- 215
G+ ++ G L I + + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIY-------EANAKRFSRK 152
Query: 216 --YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAK 264
+++L + L Y+HE +H DIKA N+LL Q+ D+GLA
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 33/180 (18%), Positives = 54/180 (30%), Gaps = 61/180 (33%)
Query: 124 LIGKGGYAEVYKGC-LRDGTLVAV--------------------KRLTKGTVDEKTCGFL 162
IG GG+ +Y A +R+ K +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 163 CEIGIIAYVDHPNTAKLVGCDSDGIH---------LVFQLSPLG-SLASILHGSKDKPDW 212
+D+ G G+ +V + LG L I
Sbjct: 104 Q-------LDYLGIPLFYGS---GLTEFKGRSYRFMVMER--LGIDLQKIS-------GQ 144
Query: 213 SKR------YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI--CDFGLAK 264
+ ++ + + L Y+HE +H DIKA N+LL Q+ D+GL+
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 12/146 (8%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGC 182
IG G + ++Y G + G VA+K V K E I + + C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 183 DSDGIHLVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241
++G + V + LG SL + + K +A + + Y+H K IHRD
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRD 130
Query: 242 IKADNILLTEDYEPQ---ICDFGLAK 264
+K DN L+ + I DFGLAK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/149 (28%), Positives = 59/149 (39%), Gaps = 16/149 (10%)
Query: 125 IGKGGYAEVYKGC-LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGC 182
IG G + E+Y G ++ VA+K V K L E I + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 183 DSDGIH--LVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+G + LV L LG SL + + K +A N + ++H K +H
Sbjct: 72 GVEGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLH 126
Query: 240 RDIKADNILLTEDYEPQ---ICDFGLAKW 265
RDIK DN L+ I DFGLAK
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 37/115 (32%)
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ-------------------ICDFGLAK 264
+ L +LHE ++ H D+K +NIL + DFG A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV-----DEKTDVYSFGVLLLELITG 314
+ T ++ Y PE ++ + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVATRH-----YRPPE-----VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 24/122 (19%), Positives = 43/122 (35%), Gaps = 51/122 (41%)
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ-------------------ICDFGLAK 264
+ +LH ++ H D+K +NIL + + + DFG A
Sbjct: 129 KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 265 WLPRQWTHHN-------VSKFEGTFGYFAPEYFMHGIV-----DEKTDVYSFGVLLLELI 312
T+ + ++ Y APE ++ + DV+S G +L+E
Sbjct: 185 ------TYDDEHHSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYY 228
Query: 313 TG 314
G
Sbjct: 229 LG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 30/121 (24%), Positives = 44/121 (36%), Gaps = 43/121 (35%)
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ-------------------------IC 258
L YL + + H D+K +NILL + Y + +
Sbjct: 148 KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 259 DFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV-----DEKTDVYSFGVLLLELIT 313
DFG A + T Y APE ++ D +D++SFG +L EL T
Sbjct: 205 DFGCA-----TFKSDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYT 254
Query: 314 G 314
G
Sbjct: 255 G 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.85 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.91 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.09 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.78 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.69 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=435.04 Aligned_cols=259 Identities=29% Similarity=0.370 Sum_probs=203.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~ 194 (434)
+++.+.+.||+|+||+||+|.+++ .||||+++.... ......|.+|+.+|++++|||||+++|++. +..++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 457788899999999999998763 599999875432 344568999999999999999999999754 5789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.++|......+++..++.|+.|||.||.|||+ ++||||||||+|||+++++.+||+|||+|+..........
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 9999999998777789999999999999999999999 8999999999999999999999999999987654433344
Q ss_pred eeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 275 VSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+............ .....|.+. ..+
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~------~~~~~p~~~-~~~ 263 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG------RGYASPDLS-KLY 263 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------TTCCCCCST-TSC
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh------cCCCCCCcc-ccc
Confidence 456789999999999863 4589999999999999999999999987544322211000 001111111 112
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
......+.+++.+||+.+|++||||.||++.|+.++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 233457788999999999999999999999987554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=436.26 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=207.8
Q ss_pred CCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
+.+.+.||+|+||+||+|.+. +++.||||++...........|.+|+.++++++|||||+++|++. +..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455678999999999999863 468899999976554455568999999999999999999999864 368999
Q ss_pred EEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 191 FQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
||||++|+|.++|... ...++|..++.|+.|||.||.|||+ ++||||||||+||||++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 9999999999999642 2458999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+..........
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i---- 260 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI---- 260 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH----
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----
Confidence 9999999987654433333455679999999999999999999999999999999998 89999875543322110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
........+......+.+++.+||+.||++||||.||++.|+...
T Consensus 261 --------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 --------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 000111122334467888999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=431.47 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=206.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
++|.+.+.||+|+||+||+|.+. ++..||||++.... ......|.+|+.+|++++|||||+++|++.+ ..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 35778889999999999999863 47889999997653 3445679999999999999999999998654 689
Q ss_pred EEEEEcCCCCHHHHhccC------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 189 LVFQLSPLGSLASILHGS------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
+|||||++|+|.++|... ...++|..++.|+.|||.||.|||+ ++||||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 999999999999999642 3568999999999999999999999 9999999999999999999999
Q ss_pred EeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCc
Q 013927 257 ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDS 335 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 335 (434)
|+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+........... .
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~---~ 245 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT---Q 245 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---H
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---c
Confidence 999999987654333223334568999999999999999999999999999999998 899998755433221110 0
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 336 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+. ....+......+.+++.+||+.||++||||.+|++.|+.+
T Consensus 246 ~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 246 GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 0111222345778899999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=432.72 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=199.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~l 189 (434)
+|.+.++||+|+||+||+|.+. +++.||||++.... ......|.+|+.+|++++|||||+++|++.+ ..++
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4667788999999999999864 47899999997643 3445689999999999999999999998654 6899
Q ss_pred EEEEcCCCCHHHHhccC--------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 190 VFQLSPLGSLASILHGS--------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
||||+++|+|.+++... ...++|..++.|+.|||.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 99999999999999653 2458999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||............
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999987654433333455679999999999999999999999999999999999 89999875543322110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
..-. ....+......+.+++.+||+.||++||||.||++.|+.+.
T Consensus 274 ----~~g~----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 ----TQGR----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ----HHTC----CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----HcCC----CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 0000 11112223456788999999999999999999999997653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=428.90 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=213.2
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeCC------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC-CCeeeEeeec
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGCD 183 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~ 183 (434)
+.+...++|.+.+.||+|+||+||+|.+.. ++.||||++...........|.+|+.+|.+++| ||||+++|++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 334445679999999999999999998642 368999999877666666789999999999965 8999999975
Q ss_pred cC---CcEEEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCC
Q 013927 184 SD---GIHLVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKAD 245 (434)
Q Consensus 184 ~~---~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~ 245 (434)
.+ .+++|||||++|+|.++|... ...+++..++.|+.|||.||.|||+ ++||||||||+
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~ 214 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR 214 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcc
Confidence 32 589999999999999999642 3458999999999999999999999 99999999999
Q ss_pred cEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccch
Q 013927 246 NILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQS 324 (434)
Q Consensus 246 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~ 324 (434)
|||++.++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997765444444456779999999999999999999999999999999998 99999875432
Q ss_pred hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...... +.. ......+.....++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 295 ~~~~~~-------i~~----g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 295 EEFCRR-------LKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp HHHHHH-------HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-------HHc----CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 221110 000 0111112223356788999999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=422.25 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=198.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++.+... ......+.+|+.+|++++|||||++++++. +.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 47999999999999999999976 799999999987543 334567999999999999999999999744 46899999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||++|+|.+++... ...+++..+..|+.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999754 4557899999999999999999999 99999999999999999999999999999876432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+........... .... +.+..
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~~~~-----~~~~~--- 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---SGSF-----PPVSL--- 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCC-----CCCCT---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCCC-----CCCCc---
Confidence 112345689999999999999999999999999999999999999998754332221100 0000 11111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 -HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22346788999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=410.25 Aligned_cols=243 Identities=27% Similarity=0.344 Sum_probs=194.3
Q ss_pred CCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc------CCcEEEE
Q 013927 120 SSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------DGIHLVF 191 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~lv~ 191 (434)
.+.++||+|+||+||+|.+. ++..||||++..... ......|.+|+.+|++++|||||++++++. +.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999976 789999999976433 334567999999999999999999999743 2478999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEec-CCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLT-EDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFGla~~~~~ 268 (434)
|||++|+|.+++.. ...+++..+..|+.||+.||.|||+ ++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999974 4578999999999999999999998 66 99999999999998 478999999999986433
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||........+..... .+.... ..
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~--~~~~~~----~~-- 251 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPA----SF-- 251 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCCCG----GG--
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH--cCCCCC----CC--
Confidence 2 2345789999999998864 699999999999999999999999976443322211100 000000 01
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||+.||++|||+.|+++
T Consensus 252 --~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111235778899999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=417.39 Aligned_cols=247 Identities=22% Similarity=0.321 Sum_probs=203.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+.|.+.+.||+|+||+||+|.+. +|+.||||++..... .....+.+|+.+|++++|||||++++++ .+.+|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45888899999999999999986 799999999976433 2345688999999999999999999974 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|++|+|.+++.. ..+++..+..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence 999999999964 468999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......... +.....+.+. ....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------i~~~~~~~~~--~~~~ 295 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------IRDNLPPRLK--NLHK 295 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHSSCCCCS--CGGG
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------HHcCCCCCCC--cccc
Confidence 23567899999999999999999999999999999999999999976543322111 0000111110 1112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.||++|||+.|+++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2356788999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=415.33 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=204.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+... ......+.+|+.+|++++|||||+++++.. +.+++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35899999999999999999976 799999999976432 233457899999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999974 4578999999999999999999999 9999999999999999999999999999998765444
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ... .. ...+...+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-~i~--~~------~~~~p~~~- 257 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA-KII--KL------EYDFPEKF- 257 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHH--HT------CCCCCTTC-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH--cC------CCCCCccc-
Confidence 444567889999999999999999999999999999999999999997644332211 000 00 00111122
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
...+.+++.+||+.||++|||+.|++
T Consensus 258 ---s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 ---FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 34677899999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=416.15 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+.|.+.++||+|+||+||+|.+. +|+.||||++..... ..+|+.++++++|||||++++++. +.+++||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35777889999999999999976 799999999976432 346999999999999999999754 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999974 3568999999999999999999998 9999999999999999987 6999999999876543211
Q ss_pred c---ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 273 H---NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 273 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
. ....++||+.|||||++.+..|+.++|||||||++|||+||+.||............ ......+. .+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~~~~~~~~-----~~--- 278 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-ASEPPPIR-----EI--- 278 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-HHSCCGGG-----GS---
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-HcCCCCch-----hc---
Confidence 1 123467999999999999999999999999999999999999999764332211100 00000000 11
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+......+.+++.+||+.||++|||+.||++.|....
T Consensus 279 -~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 279 -PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1222356778899999999999999999998876443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=416.75 Aligned_cols=266 Identities=23% Similarity=0.278 Sum_probs=197.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~lv 190 (434)
++|.+.+.||+|+||+||+|.+. |+.||||++.... .....+..|+..+.+++|||||+++|++.+ .+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 34677789999999999999985 8999999996532 222223346666678999999999998542 36899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC-----CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC-----QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
|||+++|+|.++|+. ..++|..+..|+.|++.||.|||+.+ ..+||||||||+|||++.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999964 46899999999999999999999731 23999999999999999999999999999987
Q ss_pred cCCCCcc--cceeccccccccccCCccccC------CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc
Q 013927 266 LPRQWTH--HNVSKFEGTFGYFAPEYFMHG------IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 266 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
....... ......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.........+.........
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543221 122346799999999998754 36789999999999999999998876433221111100000000
Q ss_pred ---c-ccccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 338 ---I-RELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 338 ---~-~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+ .......+....+ .+..+.+.+++.+||+.||++||||.||++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1 1112222222222 345678899999999999999999999999997543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=419.10 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=203.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+.|.+.+.||+|+||+||+|.+. +|+.||||++..... .....+.+|+.+|++++|||||++++++ .+.+|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999986 799999999986543 3345689999999999999999999974 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
|++|+|.+++.. ..+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 999999999964 458999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......... +.....+.+.. ...
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------i~~~~~~~~~~--~~~ 372 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------IRDNLPPRLKN--LHK 372 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------HHHSCCCCCSC--TTS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------HHcCCCCCCcc--ccc
Confidence 23567899999999999999999999999999999999999999976543322111 00001111110 111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+|+.+||+.||++|||+.|+++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2346778999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=396.86 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=185.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+.... .....+.+|+.+|++++|||||+++++.. +..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999976 7999999999865432 33457899999999999999999999744 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999 5789998864 4579999999999999999999999 99999999999999999999999999999865433
Q ss_pred ccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......+||+.|+|||++.+..| +.++|||||||++|||+||+.||......... .... .. ...+...
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-~~i~--~~------~~~~p~~- 234 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-KNIS--NG------VYTLPKF- 234 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH--HT------CCCCCTT-
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHH--cC------CCCCCCC-
Confidence 22345789999999999988776 57999999999999999999999764332211 0000 00 0011111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.||++|||+.|+++
T Consensus 235 ---~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 ---LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2246778999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=400.30 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=187.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---------- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 185 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.+|++++|||||++++++.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999976 7999999999876655556679999999999999999999997421
Q ss_pred ----CcEEEEEEcCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEec
Q 013927 186 ----GIHLVFQLSPLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259 (434)
Q Consensus 186 ----~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 259 (434)
.+++|||||++|+|.+++.... ...++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 2689999999999999997543 235667788999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCcc----------cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh
Q 013927 260 FGLAKWLPRQWTH----------HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329 (434)
Q Consensus 260 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 329 (434)
||+|+.+...... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||...........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543211 11234679999999999999999999999999999999996 7764322211110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. +...... .........+..++.+||+.||++|||+.|+++
T Consensus 239 ~----------~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 D----------VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----------HHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----------HhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000000 001122345667999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=401.98 Aligned_cols=241 Identities=25% Similarity=0.266 Sum_probs=189.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~l 189 (434)
++|.+.+.||+|+||+||+|... +++.||||++.+.... .....+.+|+.+|++++|||||+++++. .+..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999852 4789999999765332 2234688899999999999999999974 347899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999974 4578999999999999999999999 99999999999999999999999999999865432
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.......... . .. ....
T Consensus 180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~--~~------~~~~--- 245 (304)
T 3ubd_A 180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-L--KA------KLGM--- 245 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-H--HC------CCCC---
T ss_pred C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-H--cC------CCCC---
Confidence 1 2234578999999999999999999999999999999999999999875433221110 0 00 0011
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
+......+.+++.+||+.||++|||+
T Consensus 246 -p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 246 -PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 11123467789999999999999995
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=396.59 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=198.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~~ 186 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++.+... ......+.+|+.+|++++|||||+++++.. +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46999999999999999999976 799999999976543 234457889999999999999999999732 35
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 799999997 679998874 4679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCC--cccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---ccccC---
Q 013927 267 PRQW--THHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPLLD--- 334 (434)
Q Consensus 267 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~~~--- 334 (434)
.... ........+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||.+....... .. .|...
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4321 12234567899999999998875 5789999999999999999999999764332211 10 00000
Q ss_pred ---ccccccccCCc-CCCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 335 ---SNDIRELVDPS-LGDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 335 ---~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+... .....+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 0000011 11246778999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=378.71 Aligned_cols=284 Identities=47% Similarity=0.756 Sum_probs=239.2
Q ss_pred cccccCHHHHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 103 SLKEFTLSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
.+..++..++....++|.+.+.||+|+||.||+|...+|+.||||++...........+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 36678899999999999999999999999999999888999999999876544444468999999999999999999997
Q ss_pred cc--CCcEEEEEEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 183 DS--DGIHLVFQLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 183 ~~--~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
+. +..++||||+.+|+|.+++... ...+++..+..|+.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 54 4689999999999999999753 234899999999999999999999932229999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc------cchhhhhhcc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL------QQSVVIWAKP 331 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~------~~~~~~~~~~ 331 (434)
+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||+.. ......|...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987654322 2234456999999999998888999999999999999999999999632 1222334455
Q ss_pred ccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 332 LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 332 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
......+..+.+..+...+.......+..++.+||+.+|.+|||+.+|++.|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 55566677778888888888899999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=380.51 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=165.3
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCc
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGI 187 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~ 187 (434)
..+.|.+.+.||+|+||+||+|..+ +++.||||++..... ...+.+|+.+|+.+ +||||++++++. .+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3467999999999999999999853 468899999876432 33578899999998 699999999974 4578
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEecccccccc
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWL 266 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~~~ 266 (434)
++||||+++|+|.+++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999994 48899999999999999999999 999999999999999877 79999999999865
Q ss_pred CCCCc--------------------------ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccc
Q 013927 267 PRQWT--------------------------HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVD 319 (434)
Q Consensus 267 ~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~ 319 (434)
..... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 43211 0112345799999999999876 48999999999999999999999995
Q ss_pred c
Q 013927 320 H 320 (434)
Q Consensus 320 ~ 320 (434)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=370.03 Aligned_cols=274 Identities=37% Similarity=0.618 Sum_probs=227.6
Q ss_pred HHHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCc
Q 013927 110 SELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 110 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~ 187 (434)
.++...+++|.+.+.||+|+||.||+|.+.+|+.||||++..... .....+.+|+.+++.++||||+++++++. +..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 344456678999999999999999999988899999998876543 34557899999999999999999999854 468
Q ss_pred EEEEEEcCCCCHHHHhccCC---CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 188 HLVFQLSPLGSLASILHGSK---DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999997532 358999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh----hhhhccccCcccccc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV----VIWAKPLLDSNDIRE 340 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~ 340 (434)
...............||+.|+|||++.++.++.++|||||||++|||++|+.||....... ..|.........+..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 6543322233344568999999999998999999999999999999999999997533211 112222223344556
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+++.+...........+.+++.+||+.||++||++.+|++.|+...
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 67777777778888999999999999999999999999999997553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=396.80 Aligned_cols=249 Identities=20% Similarity=0.249 Sum_probs=204.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|..+ +|+.||||++..... .....+.+|+.+|+.++|||||++++++. +.+++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57999999999999999999976 799999999987543 33457889999999999999999999754 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC--CCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED--YEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 99999999997666789999999999999999999999 999999999999999854 89999999999977543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+............. ...+ .......
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~-~~~~----~~~~~~~-- 382 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNM----DDSAFSG-- 382 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCCC----CSGGGTT--
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC-CCCC----CcccccC--
Confidence 2345568999999999999999999999999999999999999999875443221110000 0000 0000011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+|+.+||+.||.+||++.|+++
T Consensus 383 --~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 383 --ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1246778999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=394.54 Aligned_cols=244 Identities=24% Similarity=0.280 Sum_probs=193.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-----hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-----EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.++||+|+||+||+|... +|+.||||++.+.... ........++.+++.++|||||++++++. +.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999977 7999999999754321 11122334467778889999999999754 4789
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||++||+|..+|.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.+|++||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999974 4568999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchh--hhhhccccCccccccccCCc
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV--VIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~ 345 (434)
.. ....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+..... .+...... ....
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--------~~~~ 412 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAVE 412 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--------CCCC
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--------CCCC
Confidence 32 345689999999999975 479999999999999999999999997532211 11100000 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCC-----HhHHH
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPK-----MSQVV 380 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl 380 (434)
+... ....+.+++.+||+.||.+|++ +.||+
T Consensus 413 ~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 413 LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 1112 2346778999999999999998 57775
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=368.64 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=209.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
++|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.+++++ +||||+++++++. +
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56888999999999999999852 35679999998766555667899999999999 8999999999754 4
Q ss_pred CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 6899999999999999997532 357899999999999999999999 9999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654333233344557889999999999999999999999999999999 9999976443221110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+........+......+..++.+||+.+|.+||++.||++.|+.+..
T Consensus 318 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 318 ------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ------------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00011111222334578889999999999999999999999986543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=348.71 Aligned_cols=278 Identities=36% Similarity=0.574 Sum_probs=224.7
Q ss_pred ccccCHHHHHHHhcCCCCC------CeecccCcEEEEEEEeCCCcEEEEEEeeCCC---chhhHhhHHHHHHHHhhCCCC
Q 013927 104 LKEFTLSELQTATKNFSSE------NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGT---VDEKTCGFLCEIGIIAYVDHP 174 (434)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ 174 (434)
...|++.++..++++|... +.||+|+||.||+|... ++.||||++.... .......+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 5678999999999998877 89999999999999874 8899999987542 123455789999999999999
Q ss_pred CeeeEeeecc--CCcEEEEEEcCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 175 NTAKLVGCDS--DGIHLVFQLSPLGSLASILHG--SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 175 niv~l~g~~~--~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
||+++++++. +..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999854 478999999999999999864 24568999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--h
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--W 328 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~ 328 (434)
.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||......... +
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987654333333344678999999998764 5889999999999999999999999764332111 1
Q ss_pred -hccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 329 -AKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 329 -~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.........+...+++.+ ..........+..++.+||+.+|.+||++.+|++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 000111223344444443 2345667788999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=362.04 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=208.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+. .+..||||++...........+.+|+.++++++||||+++++++.+ ..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46888899999999999999975 3456999999876555666789999999999999999999998544 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999998766789999999999999999999999 999999999999999999999999999998765432
Q ss_pred cc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 271 TH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||............ ......
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------------~~~~~~ 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------------EEGYRL 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------------HTTCCC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------------HcCCCC
Confidence 21 12223446788999999998899999999999999999999 99999764433221110 000111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
..+......+..++..||+.+|.+||++.+|++.|+.+....
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 112223357888999999999999999999999998765443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=372.08 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=208.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|+.++++++||||+++++++. +..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356888899999999999999987 789999999986654555567999999999999999999999854 36899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999997655678999999999999999999999 99999999999999999999999999999865433211
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+++.|+|||.+.++.++.++|||||||++|||++ |..||........... +........+
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~------------~~~~~~~~~~ 337 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF------------VEKGGRLPCP 337 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH------------HHTTCCCCCC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCCCCCCC
Confidence 11122335778999999998899999999999999999998 9999987544322110 0000111112
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
......+..++.+||+.+|++|||+.+|++.|+.+
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 22335678899999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=362.05 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=202.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
++|.+.++||+|+||+||+|.+. +++ .||+|.+...........+.+|+.++++++||||+++++++. +..++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 35888899999999999999865 444 368888765544445567999999999999999999999754 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
++|+.+|+|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 99999999999998777789999999999999999999999 899999999999999999999999999998765543
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||......... ..+.......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------------~~~~~~~~~~ 239 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------SILEKGERLP 239 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------HHHHTTCCCC
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH------------HHHHcCCCCC
Confidence 3333344557889999999999999999999999999999999 99999865433221 1111111111
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
.+......+..++.+||+.+|.+||++.+|++.|+.+...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 2223345788899999999999999999999999876544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=365.98 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=211.9
Q ss_pred CHHHHHHHhcCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEe
Q 013927 108 TLSELQTATKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLV 180 (434)
Q Consensus 108 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 180 (434)
.........++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3444455567899999999999999999973 246899999998766555566799999999999 799999999
Q ss_pred eeccC---CcEEEEEEcCCCCHHHHhccCCC-------------------------------------------------
Q 013927 181 GCDSD---GIHLVFQLSPLGSLASILHGSKD------------------------------------------------- 208 (434)
Q Consensus 181 g~~~~---~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------- 208 (434)
+++.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 97543 48999999999999999975432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 209 ----------------KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 209 ----------------~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 28889999999999999999999 89999999999999999999999999999876544333
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||............ +........ +
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~~~~~~~~~----~ 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------LKEGTRMRA----P 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH-------HHHTCCCCC----C
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH-------HHcCCCCCC----C
Confidence 34455678999999999999999999999999999999998 99999764432221110 000000111 1
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
......+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 122346788899999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.66 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=199.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
.++|.+.+.||+|+||+||+|... |+.||||++..... ......+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 457888999999999999999875 88999999976543 3444578999999999999999999997543 6899999
Q ss_pred EcCCCCHHHHhccCCC--CCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 193 LSPLGSLASILHGSKD--KPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
|+++|+|.+++..... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999975432 38999999999999999999998 78 99999999999999999999999999975443
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ... .
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~~~----~ 258 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-------CKR----L 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS-------CCC----C
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------CCC----C
Confidence 21 1223457899999999999999999999999999999999999999875443322111000 000 1
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
..+......+..++.+||+.+|.+||++.+|++.|+......
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111222346788999999999999999999999998776554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=354.01 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=207.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++. +..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46888899999999999999976 68999999986543 345567999999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999998767789999999999999999999999 999999999999999999999999999998764332111
Q ss_pred ------------ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccc
Q 013927 274 ------------NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341 (434)
Q Consensus 274 ------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 341 (434)
......||+.|+|||++.+..++.++|||||||++|||++|..||.......... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~~~ 239 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVRGF 239 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHHHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhhcc
Confidence 1114579999999999999999999999999999999999999986532211110 0011111
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 342 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.+......+ ...+..++.+||+.||++||++.+|++.|+.+....
T Consensus 240 ~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 LDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111112 235778899999999999999999999998776443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=346.15 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=205.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhh------HhhHHHHHHHHhhCCCCCeeeEeeeccCCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEK------TCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~l 189 (434)
++|.+.+.||+|+||.||+|.+. +++.||||++........ ...+.+|+.++++++||||+++++++.+..++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 46888899999999999999975 789999999876443211 15688999999999999999999998888899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEecCCCC-----eEEecccc
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLTEDYE-----PQICDFGL 262 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~~~~~-----~kL~DFGl 262 (434)
||||+++|+|.+.+......+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 999999999999987777789999999999999999999998 78 999999999999988776 99999999
Q ss_pred ccccCCCCcccceeccccccccccCCccc--cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFM--HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||............ .
T Consensus 176 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---------~ 241 (287)
T 4f0f_A 176 SQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN---------M 241 (287)
T ss_dssp CBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH---------H
T ss_pred cccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH---------H
Confidence 975432 234567899999999984 455789999999999999999999999764332211100 0
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..........+......+.+++.+||+.||.+||++.+|++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0001111111222335788899999999999999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=359.39 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=202.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~lv 190 (434)
++|.+.++||+|+||+||+|.+. ++.||||++.... .....+..|+.++++++||||+++++++.+ ..++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46888999999999999999886 8999999996532 233356669999999999999999997443 25899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC----------CeeecCCCCCcEEecCCCCeEEecc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK----------RIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~----------~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999964 458999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccC-----CCCCcCcEEehhHHHHHHHhCCCccccccchhh-hhhcccc-
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-----IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV-IWAKPLL- 333 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~~~~~~- 333 (434)
|+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .+.....
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876554333333446799999999999763 456688999999999999999999976322111 0000000
Q ss_pred --Ccccccc-ccCCcCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 334 --DSNDIRE-LVDPSLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 334 --~~~~~~~-~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
....+.. .......... .......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000101 1111111111 1234567899999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=365.93 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=198.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv 190 (434)
++|.+.+.||+|+||.||+|... ++..||||++...........|.+|+.++++++||||+++++++.+ ..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46999999999999999999864 5678999999876555566689999999999999999999998544 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999998766789999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 271 THH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||........... +......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~------------i~~~~~~ 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA------------VDEGYRL 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH------------HHTTEEC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCCCC
Confidence 111 1122335778999999999999999999999999999998 9999976443222111 0000111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
..+......+..++.+||+.+|.+||++.+|++.|+.+...
T Consensus 270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11222345788899999999999999999999999877544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=348.92 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=201.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++ .+..++||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 57999999999999999999965 789999999875433 2344688999999999999999999974 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 999999999964 368899999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............... . .+ ....+..
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~-----~~--~~~~~~~ 241 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---G-----TP--ELQNPEK 241 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---C-----SC--CCSCGGG
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---C-----CC--CCCCccc
Confidence 234567999999999999999999999999999999999999999765433222110000 0 00 0011122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3356788999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=342.84 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=208.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|...++..||||++...... ...+.+|+.++.+++||||+++++++.+ ..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468888999999999999999988889999999765433 3468999999999999999999998544 688999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 9999999997666679999999999999999999999 9999999999999999999999999999986654321 12
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||................ ... .+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~-------~~~~ 229 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----RLY-------RPHL 229 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCC-------CCTT
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----CCC-------CCCc
Confidence 233446778999999998889999999999999999999 999997654432221110000 000 0111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
....+..++..||+.+|.+||++.+|++.|+.+.+..
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 2246778999999999999999999999999876553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.98 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=204.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcE----EEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTL----VAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+. +++. ||+|.+...........+.+|+.++++++||||+++++++. +..++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 35888899999999999999865 4543 88888765443344456788999999999999999999864 478899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+.+|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 99999999999998666678999999999999999999999 899999999999999999999999999999876554
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........||..|+|||++.++.++.++|||||||++|+|++ |+.||................. ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------~~ 237 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER------------LA 237 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB------------CC
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------CC
Confidence 4444455668889999999998999999999999999999999 9999987543322111000000 00
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.+......+..++.+||+.+|.+||++.+|++.|+.+....
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 01111224567889999999999999999999998765443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=355.89 Aligned_cols=252 Identities=24% Similarity=0.271 Sum_probs=199.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57899999999999999999977 7899999999765544445678999999999999999999998554 57899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999973 4568999999999999999999999 999999999999999999999999999998664333333
Q ss_pred ceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........+.. ............
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----------~~~~~~~~~~~~ 232 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----------WKEKKTYLNPWK 232 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH----------HHTTCTTSTTGG
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----------HhcccccCCccc
Confidence 3445679999999999987765 77899999999999999999999764432211110 000000000011
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.....+..++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 223566789999999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=358.41 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=205.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~ 186 (434)
.++|.+.+.||+|+||.||+|.. .++..||||++...........+.+|+.++.++ +||||+++++++. +.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46789999999999999999986 245689999998654444456799999999999 8999999999754 47
Q ss_pred cEEEEEEcCCCCHHHHhccCCC----------------------CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCC
Q 013927 187 IHLVFQLSPLGSLASILHGSKD----------------------KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKA 244 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp 244 (434)
.++||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 8999999999999999975432 37899999999999999999999 9999999999
Q ss_pred CcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccc
Q 013927 245 DNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQ 323 (434)
Q Consensus 245 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~ 323 (434)
+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987654433333345567889999999998999999999999999999998 9999976543
Q ss_pred hhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 324 SVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
...... .+........+......+..++.+||+.||.+||++.+|++.|+.+....
T Consensus 281 ~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 281 DANFYK-----------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SHHHHH-----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHH-----------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 221110 00011111112223356788999999999999999999999998776554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.62 Aligned_cols=259 Identities=27% Similarity=0.344 Sum_probs=207.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
++|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+ ..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46888999999999999999843 4678999999766555566679999999999999999999998544 689
Q ss_pred EEEEEcCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEec
Q 013927 189 LVFQLSPLGSLASILHGSK------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICD 259 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~D 259 (434)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997532 458999999999999999999999 9999999999999999555 599999
Q ss_pred cccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccc
Q 013927 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||.............
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------- 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------- 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 999976533222233345668999999999999999999999999999999998 999997654332211100
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.......+......+..++.+||+.+|.+||++.+|++.|+......
T Consensus 301 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 301 -----SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 00001111222346788999999999999999999999998765443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=357.31 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=210.2
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG 186 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~ 186 (434)
..++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++. +.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3467999999999999999999875 348899999987655555668999999999999999999999854 47
Q ss_pred cEEEEEEcCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCC
Q 013927 187 IHLVFQLSPLGSLASILHGSK-----------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIK 243 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlk 243 (434)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 899999999999999997532 568999999999999999999999 899999999
Q ss_pred CCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCcccccc
Q 013927 244 ADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQ 322 (434)
Q Consensus 244 p~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~ 322 (434)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986644322223344568899999999998899999999999999999999 999997654
Q ss_pred chhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 323 QSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
......... .... + ..+......+..++.+||+.+|.+||++.+|++.|+.+.+..
T Consensus 282 ~~~~~~~~~---~~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 HEEVIYYVR---DGNI-----L----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHHH---TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred hHHHHHHHh---CCCc-----C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 332211100 0000 0 111122356788999999999999999999999999876554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=351.45 Aligned_cols=268 Identities=26% Similarity=0.354 Sum_probs=205.1
Q ss_pred cCCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~ 187 (434)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4688899999999999999984 268899999997643 344557899999999999999999999742 358
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999998766679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCc----ccccccc
Q 013927 268 RQWTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS----NDIRELV 342 (434)
Q Consensus 268 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~----~~~~~~~ 342 (434)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+................. ..+...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43221 122334577889999999999999999999999999999999999865432211110000000 0011111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
........+......+..++.+||+.+|++||++.+|++.|+.+.+
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111112223334678889999999999999999999999986643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=360.92 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=210.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
++|.+.+.||+|+||.||+|... .+..||||++...........+.+|+.+++++ +||||+++++++. +
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 56888999999999999999852 24679999998776556667899999999999 9999999999754 3
Q ss_pred CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..++||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 6899999999999999997543 358999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987654433333344567889999999999999999999999999999999 9999976443221110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
+........+......+..++.+||+.+|++||++.+|++.|+.+....
T Consensus 306 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 306 ------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ------------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0000011111223356788999999999999999999999998775433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=343.03 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=206.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|.+.+++.||||++...... ...+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468888999999999999999988899999999865433 3468999999999999999999998544 689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence 9999999998777789999999999999999999999 9999999999999999999999999999986543211 11
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||............ ...... ..+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--------~~~~~~----~~~~~ 231 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRL----YKPRL 231 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCC----CCCTT
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--------hcCccC----CCCCc
Confidence 223456788999999998899999999999999999999 99999764433221110 000001 11111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
....+..++..||+.+|++||++.++++.|+.+.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 2356788999999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.05 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=204.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.+ ..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 46889999999999999999976 789999999865433 3344578999999999999999999998544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 91 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS- 165 (294)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence 99999999999974 3568999999999999999999999 999999999999999999999999999998664331
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||.+.+..++.++|||||||++|+|++|+.||...................... ...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~---- 237 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT----DVR---- 237 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH----HSC----
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch----hcc----
Confidence 122334569999999999999999999999999999999999999998754332211110000000000 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-CHhHHHHHhcCCCCcc
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-KMSQVVILLRGDEDNA 390 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~L~~~~~~~ 390 (434)
......+..++.+||+.+|.+|| ++.++.+.|+......
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 12235678899999999999998 9999999998876554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.64 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=201.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357999999999999999999975 899999999976533 234457889999999999999999999754 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 99999999999864 3568899999999999999999999 89999999999999999999999999999866433
Q ss_pred ccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......... +..... ..
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----------i~~~~~--~~ 233 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER-----------VLRGKY--RI 233 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHHCCC--CC
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCCC--CC
Confidence 223456799999999999888765 789999999999999999999986443221110 000000 01
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+......+.+++.+||+.||.+|||+.|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123467789999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=346.01 Aligned_cols=260 Identities=29% Similarity=0.419 Sum_probs=195.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|.+.. .||||++..... ......+.+|+.++++++||||++++++..+ ..++||||+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 568999999999999999998753 599999976543 3445678999999999999999999997544 689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 9999999998777789999999999999999999999 8999999999999999999999999999986554333333
Q ss_pred eeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 275 VSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....||+.|+|||++. +..++.++||||||+++|+|++|+.||.............. ... ..+.+ ....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~----~~~~~-~~~~ 251 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG--RGS----LSPDL-SKVR 251 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH--HTS----CCCCT-TSSC
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc--ccc----cCcch-hhcc
Confidence 44567999999999986 56688899999999999999999999976443322111000 000 00000 0111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
......+..++.+||+.+|.+||++.+|++.|+.+..
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2233578889999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=356.52 Aligned_cols=259 Identities=26% Similarity=0.407 Sum_probs=202.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv 190 (434)
++|.+.+.||+|+||.||+|.+. +++ .||+|.+...........+.+|+.++++++||||+++++++. +..++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 46889999999999999999965 454 357787765544455567999999999999999999999754 468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
++|+.+|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999999998777789999999999999999999999 899999999999999999999999999998765443
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......... .+.......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------------~~~~~~~~~ 239 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ILEKGERLP 239 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------------HHHTTCCCC
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------------HHHcCCCCC
Confidence 3333344557889999999999999999999999999999999 999998754332211 111111111
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.+......+..++.+||+.+|.+||++.+|++.|+.+....
T Consensus 240 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 240 QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 12223356788999999999999999999999998776554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=345.51 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=197.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+. .+..||||++...........+.+|+.++++++||||++++++.. +..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~ 94 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 94 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEE
Confidence 46888899999999999999864 245799999876655555667999999999999999999999754 4789999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 9999999999998766679999999999999999999999 8999999999999999999999999999987644321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||............ .. ......
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-----------~~-~~~~~~ 238 (281)
T 1mp8_A 172 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-----------EN-GERLPM 238 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----------HT-TCCCCC
T ss_pred -cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-----------Hc-CCCCCC
Confidence 12233456789999999998899999999999999999996 99999764432221110 00 000111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+......+..++.+||+.+|++||++.+|++.|+.+.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1223356788999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=349.58 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=208.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~ 187 (434)
.++|.+.+.||+|+||.||+|.. .++..||||++...........+.+|+.++++++||||+++++++. +..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 35688889999999999999985 2458899999987655556678999999999999999999999754 468
Q ss_pred EEEEEEcCCCCHHHHhccCC-----------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCC
Q 013927 188 HLVFQLSPLGSLASILHGSK-----------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKA 244 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp 244 (434)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 99999999999999997532 237899999999999999999999 8999999999
Q ss_pred CcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccc
Q 013927 245 DNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQ 323 (434)
Q Consensus 245 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~ 323 (434)
+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433223334557889999999998889999999999999999999 9999976443
Q ss_pred hhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 324 SVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...... +........+......+..++.+||+.||.+||++.+|++.|+.+.
T Consensus 259 ~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ERLFNL------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGHHHH------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221100 0000011111223356788999999999999999999999997553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=349.34 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=208.5
Q ss_pred cCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.+++++ +||||+++++++. +..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4688889999999999999985 256899999998765555566899999999999 9999999999754 478
Q ss_pred EEEEEEcCCCCHHHHhccCCC-----------------CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 188 HLVFQLSPLGSLASILHGSKD-----------------KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
++||||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999975432 48999999999999999999999 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 999999999999987655433333344567889999999999999999999999999999999 9999976443221110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
. +...... ..+......+..++.+||+.||.+||++.+|++.|+...
T Consensus 260 ~-------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 260 M-------IKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp H-------HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-------hccCCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 0 0000111 111122356788999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=369.48 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=209.5
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQL 193 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~ 193 (434)
..++|.+.+.||+|+||.||+|.+.++..||||++..... ....|.+|+.+|++++||||+++++++. +..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEee
Confidence 3457888899999999999999998889999999986542 3457999999999999999999999754 478999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-
Confidence 9999999999753 2367889999999999999999999 8999999999999999999999999999987643211
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+++.|+|||++..+.++.++|||||||++|||++ |+.||............ .. ......+
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--------~~----~~~~~~~ 407 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--------ER----GYRMPRP 407 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--------HH----TCCCCCC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------Hc----CCCCCCC
Confidence 11122346788999999998999999999999999999999 99999865433221110 00 0011111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
......+..++.+||+.+|++||++.+|+..|+.+....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 223457888999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=344.73 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=205.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~lv~ 191 (434)
++|.+.++||+|+||+||+|... +|+.||||++...........+.+|+.++++++||||+++++++.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888999999999999999987 6899999999765444445678899999999999999999997432 568999
Q ss_pred EEcCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----cCCCCeEEeccccccc
Q 013927 192 QLSPLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL----TEDYEPQICDFGLAKW 265 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGla~~ 265 (434)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997532 338999999999999999999999 899999999999999 7788899999999987
Q ss_pred cCCCCcccceeccccccccccCCccc--------cCCCCCcCcEEehhHHHHHHHhCCCccccccchh---hh----h-h
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFM--------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VI----W-A 329 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~----~-~ 329 (434)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||....... .. . .
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 65432 223456899999999986 4678999999999999999999999997432211 00 0 0
Q ss_pred ccccCcccccccc--------CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 330 KPLLDSNDIRELV--------DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 330 ~~~~~~~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
.|......+.... ...............+..++.+||+.||++||++.|+++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1100000000000 011122344566778889999999999999999999988775
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=350.12 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=200.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-----hHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-----KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
+.|.+.+.||+|+||.||+|... +|+.||||++.+..... ....+.+|+.++++++||||+++++++.+ ..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 46889999999999999999977 78999999998754321 23568899999999999999999997544 689
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC----CeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~ 264 (434)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++.
T Consensus 92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999964 4578999999999999999999999 9999999999999998877 79999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
.+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... +...
T Consensus 168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~-----------i~~~ 233 (361)
T 2yab_A 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-----------ITAV 233 (361)
T ss_dssp ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-----------HHTT
T ss_pred EcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhc
Confidence 765432 23456799999999999988999999999999999999999999976443221110 0000
Q ss_pred cCCCCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. ..++. .....+.+++.+||..||.+|||+.|+++
T Consensus 234 ~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 S--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00111 11246778999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.63 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=201.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +|+.||+|.+.... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 57889999999999999999977 68999999987543 33446889999999999999999999743 478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC--CCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE--DYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 99999999997666679999999999999999999999 99999999999999987 789999999999876543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +..... .++
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-----------i~~~~~--~~~ 223 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-----------IMNAEY--TFD 223 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------HHHTCC--CCC
T ss_pred -CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-----------HHcCCC--CCC
Confidence 223456789999999999988899999999999999999999999976443221110 000000 001
Q ss_pred H----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 A----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. .....+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 12356788999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.66 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=206.9
Q ss_pred ccCHHHHHHHhcC----------CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC
Q 013927 106 EFTLSELQTATKN----------FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174 (434)
Q Consensus 106 ~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 174 (434)
.++..++..+++. |...+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCC
Confidence 4566676666643 666678999999999999987 799999999976543 3345688999999999999
Q ss_pred CeeeEeeec--cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC
Q 013927 175 NTAKLVGCD--SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252 (434)
Q Consensus 175 niv~l~g~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~ 252 (434)
||+++++++ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999974 4578999999999999999853 568999999999999999999999 899999999999999999
Q ss_pred CCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc
Q 013927 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 253 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~ 332 (434)
+.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~--- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR--- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 9999999999987654321 22345799999999999999999999999999999999999999976443221110
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+.....+.+. ........+.+++.+||+.||++||++.+|++.
T Consensus 253 -----~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 -----LRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -----HHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----HhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111110 011223467789999999999999999999763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=344.05 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=196.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhh--CCCCCeeeEeeecc------CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY--VDHPNTAKLVGCDS------DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~------~~~ 187 (434)
.++|.+.+.||+|+||+||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++. ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 35799999999999999999988 4899999998643 23346667777766 79999999998632 247
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhh--------ccCCCCeeecCCCCCcEEecCCCCeEEec
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH--------EGCQKRIIHRDIKADNILLTEDYEPQICD 259 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH--------~~~~~~iiHrDlkp~NIll~~~~~~kL~D 259 (434)
++||||+++|+|.+++. ...+++..+..++.|++.||.||| + ++|+||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 89999999999999995 457899999999999999999999 7 8999999999999999999999999
Q ss_pred cccccccCCCCccc--ceeccccccccccCCccccC------CCCCcCcEEehhHHHHHHHhC----------CCccccc
Q 013927 260 FGLAKWLPRQWTHH--NVSKFEGTFGYFAPEYFMHG------IVDEKTDVYSFGVLLLELITG----------RRAVDHL 321 (434)
Q Consensus 260 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG----------~~p~~~~ 321 (434)
||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332211 12334799999999999876 445789999999999999999 6776542
Q ss_pred cchhh---hhhccccCccccccccCCcCCC-CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 322 QQSVV---IWAKPLLDSNDIRELVDPSLGD-NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 322 ~~~~~---~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..... ....... .....+.+.. ..+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHh-----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21110 0000000 0000111111 11234567899999999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.71 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=210.5
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD 183 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 183 (434)
......++|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3334456899999999999999999974 256899999998766555566799999999999 799999999974
Q ss_pred cC---CcEEEEEEcCCCCHHHHhccCCC---------------CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCC
Q 013927 184 SD---GIHLVFQLSPLGSLASILHGSKD---------------KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKAD 245 (434)
Q Consensus 184 ~~---~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~ 245 (434)
.+ ..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccc
Confidence 43 48999999999999999975433 27899999999999999999999 89999999999
Q ss_pred cEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccch
Q 013927 246 NILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQS 324 (434)
Q Consensus 246 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~ 324 (434)
||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999999987654433333345668899999999999999999999999999999998 99999764432
Q ss_pred hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...... +........ +......+..++.+||+.+|.+||++.+|++.|+.+.
T Consensus 258 ~~~~~~-------~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 258 EEFCRR-------LKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp HHHHHH-------HHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-------hccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211110 000000111 1112346788899999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=341.71 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=203.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|.+.++..||||++...... ...+.+|+.++.+++||||+++++++.+ ..++||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468888999999999999999988889999999865433 3468999999999999999999998544 689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-cc
Confidence 9999999998656779999999999999999999999 9999999999999999999999999999986543211 11
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............ ...... ..+..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--------~~~~~~----~~~~~ 245 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRL----YRPHL 245 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--------HTTCCC----CCCTT
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--------hcccCC----CCCCc
Confidence 223446788999999998899999999999999999998 99999865433221110 000001 11111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
....+..++.+||+.+|.+||++.++++.|+.+.
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 2256788999999999999999999999997543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=346.92 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=199.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46888999999999999999976 789999999976421 223446889999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 99999999999864 3568899999999999999999999 99999999999999999999999999999854322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. . ... ++
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-~~--~------~~~----~p 225 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LM--E------EIR----FP 225 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH--C------CCC----CC
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH-Hc--C------CCC----CC
Confidence 12234567999999999999999999999999999999999999999764332211000 00 0 001 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
......+..++.+||+.||++|| ++.+|++
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12234677899999999999999 8888874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=345.87 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=200.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccCCcEEEEEEcCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHLVFQLSPL 196 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~lv~e~~~~ 196 (434)
++|.+.+.||+|+||.||+|.+. ++.||||++... .....+.+|+.++++++||||+++++++.+..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCC
Confidence 45888899999999999999986 788999998643 33457899999999999999999999988899999999999
Q ss_pred CCHHHHhccCCC--CCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC-eEEeccccccccCCCCccc
Q 013927 197 GSLASILHGSKD--KPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-PQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 197 gsL~~~l~~~~~--~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~-~kL~DFGla~~~~~~~~~~ 273 (434)
|+|.+++..... .+++..++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999975432 4788999999999999999999854468999999999999998886 799999999755432
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh--hhhhccccCccccccccCCcCCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV--VIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..... ..+....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~--- 227 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--------TRPPLIK--- 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--------CCCCCBT---
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--------CCCCccc---
Confidence 223458999999999998899999999999999999999999997543221 11111000 0011111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
.....+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus 228 -~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred -ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 123467789999999999999999999999987765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=345.83 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=206.4
Q ss_pred CCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~ 188 (434)
.|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++. +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 478889999999999999983 3689999999986654445567899999999999999999999743 3478
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 9999999999999997666779999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc---cccccCC
Q 013927 269 QWTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND---IRELVDP 344 (434)
Q Consensus 269 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~d~ 344 (434)
.... .......||..|+|||++.+..++.++||||||+++|+|++|+.|+............+...... +...+..
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 3221 12234568889999999998889999999999999999999999875432221111111111111 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
......+......+..++.+||+.||.+||++.+|++.|+.+
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 112222233446788899999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=349.59 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=196.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---------- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 185 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999987 7999999999876555556689999999999999999999986421
Q ss_pred -------------------------------------------------CcEEEEEEcCCCCHHHHhccCC--CCCCHHH
Q 013927 186 -------------------------------------------------GIHLVFQLSPLGSLASILHGSK--DKPDWSK 214 (434)
Q Consensus 186 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~ 214 (434)
..++||||+++|+|.+++.... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 1689999999999999997532 3356677
Q ss_pred HHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc----------cceecccccccc
Q 013927 215 RYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH----------HNVSKFEGTFGY 284 (434)
Q Consensus 215 ~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~y 284 (434)
+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999 99999999999999999999999999999876543211 112345699999
Q ss_pred ccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHh
Q 013927 285 FAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASL 364 (434)
Q Consensus 285 ~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 364 (434)
+|||++.+..++.++|||||||++|||++|..|+............ ... ..........+..++.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~-------------~~~-~~~~~~~~~~~~~li~~ 308 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRN-------------LKF-PLLFTQKYPQEHMMVQD 308 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHT-------------TCC-CHHHHHHCHHHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhc-------------cCC-CcccccCChhHHHHHHH
Confidence 9999999989999999999999999999998776432211111000 000 00012223566789999
Q ss_pred hhccCCCCCCCHhHHHH
Q 013927 365 CIEQSPILRPKMSQVVI 381 (434)
Q Consensus 365 Cl~~~P~~RPs~~evl~ 381 (434)
||+.||++||++.|+++
T Consensus 309 ~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 309 MLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCSSGGGSCCHHHHHH
T ss_pred HccCCCCcCCCHHHHhh
Confidence 99999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=369.14 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=209.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
..+|.+.+.||+|+||.||+|.+. ++..||||++..... ....|.+|+.+|++++||||+++++++. +..++|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 345778889999999999999987 488999999976543 3457999999999999999999999854 46899999
Q ss_pred EcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+++|+|.+++.. ....+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999975 34568999999999999999999999 9999999999999999999999999999987643311
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||......... ..+........
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~------------~~~~~~~~~~~ 440 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------ELLEKDYRMER 440 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------HHHHTTCCCCC
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH------------HHHHcCCCCCC
Confidence 11223346788999999998899999999999999999999 99999765433211 11111111122
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
+......+..++.+||+.+|++||++.+|++.|+.+....
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 2233457788999999999999999999999999886543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.08 Aligned_cols=256 Identities=23% Similarity=0.333 Sum_probs=204.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+.. +..||||.+...........+.+|+.++++++||||++++++.. +..++||
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~ 91 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM 91 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEE
Confidence 568888999999999999998542 34699999987655556678999999999999999999999854 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999999998666779999999999999999999999 9999999999999999999999999999986654321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......+++.|+|||++.+..++.++||||||+++|+|++ |+.||............ ....... .
T Consensus 169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------~~~~~~~----~ 235 (281)
T 3cc6_A 169 -YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRLP----K 235 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH--------HHTCCCC----C
T ss_pred -cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH--------hcCCCCC----C
Confidence 12233457889999999988889999999999999999998 99999754332211000 0000000 1
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+......+..++.+||+.+|++||++.+|++.|+.+..
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11123467889999999999999999999999986643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=344.28 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=197.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|...+|+.||||++...... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 568899999999999999999988999999999765332 234568899999999999999999998544 68999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++ |+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 101 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 174 (311)
T 3niz_A 101 ME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--R 174 (311)
T ss_dssp CS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C
T ss_pred CC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--c
Confidence 98 57888887767779999999999999999999999 899999999999999999999999999998764321 2
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccCc----ccccccc
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLDS----NDIRELV 342 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~~----~~~~~~~ 342 (434)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+.... .......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2334568999999999876 5689999999999999999999999976433221100 000000 0000000
Q ss_pred CCcC--CCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 343 DPSL--GDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 343 d~~l--~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 00000 112256788999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=349.89 Aligned_cols=268 Identities=26% Similarity=0.364 Sum_probs=209.5
Q ss_pred CCCCCeecccCcEEEEEEEeC-----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHL 189 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~l 189 (434)
|.+.+.||+|+||+||++.+. +|+.||||++...........+.+|+.++++++||||+++++++. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998743 588999999987655555667999999999999999999999743 34789
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999964 348999999999999999999999 89999999999999999999999999999876543
Q ss_pred Ccc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccc---cCccccccccCCc
Q 013927 270 WTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL---LDSNDIRELVDPS 345 (434)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~---~~~~~~~~~~d~~ 345 (434)
... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.............. .....+...+...
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 221 122345578899999999988899999999999999999999999976432211110000 0000111222222
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
.....+......+.+++.+||+.+|.+||++.+|++.|+.+.+..+
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 2222233344678889999999999999999999999987665443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=342.86 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=192.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------------------------hhHhhHHHHHHHHhh
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------------------------EKTCGFLCEIGIIAY 170 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~ 170 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57889999999999999999976 7899999999765321 123468899999999
Q ss_pred CCCCCeeeEeeecc----CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCc
Q 013927 171 VDHPNTAKLVGCDS----DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADN 246 (434)
Q Consensus 171 l~h~niv~l~g~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N 246 (434)
++||||+++++++. +..++||||+++|+|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 99999999999753 35789999999999988763 4578999999999999999999999 899999999999
Q ss_pred EEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCC---CCCcCcEEehhHHHHHHHhCCCccccccc
Q 013927 247 ILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI---VDEKTDVYSFGVLLLELITGRRAVDHLQQ 323 (434)
Q Consensus 247 Ill~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~ 323 (434)
||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999998765432 2234567999999999997655 47789999999999999999999976432
Q ss_pred hhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 324 SVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........ .. .............+..++.+||+.||++||++.||++
T Consensus 246 ~~~~~~~~---~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCLHSKIK---SQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHHHH---HC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHh---cc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21110000 00 0000001112346788999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.64 Aligned_cols=262 Identities=23% Similarity=0.394 Sum_probs=209.9
Q ss_pred HHHHhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-
Q 013927 112 LQTATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS- 184 (434)
Q Consensus 112 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~- 184 (434)
.....++|.+.+.||+|+||.||+|.+. +++.||||.+...........+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3344567999999999999999999754 367899999987655555567999999999999999999999854
Q ss_pred -CCcEEEEEEcCCCCHHHHhccC---------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC
Q 013927 185 -DGIHLVFQLSPLGSLASILHGS---------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE 254 (434)
Q Consensus 185 -~~~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~ 254 (434)
+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCe
Confidence 4689999999999999998642 1457899999999999999999999 89999999999999999999
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhcccc
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLL 333 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~ 333 (434)
+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--- 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH---
Confidence 99999999986543322222234457889999999998899999999999999999999 88999765432221100
Q ss_pred CccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 334 DSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 334 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
..... ...+......+..++.+||+.+|.+||++.++++.|+....
T Consensus 254 --------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 --------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00000 01112223567889999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=348.71 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=207.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--D 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~ 185 (434)
++|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.+++++ +||||+++++++. +
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 56888999999999999999863 46789999998766555666799999999999 8999999999754 4
Q ss_pred CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 6899999999999999997543 248899999999999999999999 8999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 999999999999987654432222334457889999999988889999999999999999999 9999976443221110
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
. ...... ..+......+..++.+||+.+|.+||++.+|++.|+.+...
T Consensus 272 ~--------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 272 L--------KEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H--------HHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--------hcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000001 11122235678899999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.01 Aligned_cols=250 Identities=21% Similarity=0.262 Sum_probs=200.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-----hHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-----KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
+.|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++||||+++++++.+ ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35888999999999999999976 78999999998654321 24568899999999999999999997543 688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC----CeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~ 264 (434)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999963 4578999999999999999999999 9999999999999999887 79999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ......
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~---- 238 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFED---- 238 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT-CCCCCH----
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc-CCCcCc----
Confidence 765332 223456999999999999889999999999999999999999999764332211100000 000000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
... ......+.+++.+||+.||.+|||+.++++.
T Consensus 239 ~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 239 EYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0112467789999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=339.90 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=209.8
Q ss_pred CCCCCC-eecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEE
Q 013927 118 NFSSEN-LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e 192 (434)
+|.+.. .||+|+||.||+|.+. ++..||||++...........+.+|+.++++++||||+++++++. +..++|||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 89 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 89 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEE
Confidence 455555 8999999999999853 578899999987655556678999999999999999999999754 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 999999999998666779999999999999999999999 89999999999999999999999999999876533221
Q ss_pred -cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 273 -HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||............ .. ......
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i--------~~----~~~~~~ 234 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--------EQ----GKRMEC 234 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH--------HT----TCCCCC
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--------hc----CCcCCC
Confidence 11233456889999999988889999999999999999998 99999764432211100 00 001111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
+......+..++..||+.+|.+||++.+|++.|+.+.....
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 22334578889999999999999999999999987765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=349.85 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=206.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CC-----cEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~ 186 (434)
.++|.+.+.||+|+||.||+|... ++ ..||||.+...........+.+|+.+++++ +||||+++++++. +.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 467889999999999999999865 22 479999998766555566799999999999 8999999999754 47
Q ss_pred cEEEEEEcCCCCHHHHhccC-------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC
Q 013927 187 IHLVFQLSPLGSLASILHGS-------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY 253 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~ 253 (434)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 89999999999999998642 3457899999999999999999999 8999999999999999999
Q ss_pred CeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccc
Q 013927 254 EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPL 332 (434)
Q Consensus 254 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~ 332 (434)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK--- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH---
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH---
Confidence 999999999986644333223344567889999999998899999999999999999998 9999976433221111
Q ss_pred cCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 333 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+........+......+..++..||+.+|.+||++.+|++.|+...
T Consensus 279 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 --------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp --------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 00000001111112356788999999999999999999999997554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.90 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=185.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 56899999999999999999976 7899999999866544444568899999999999999999998543 68899999
Q ss_pred cCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 194 SPLGSLASILHGS-----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 194 ~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
++ |+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 98 6898888642 2458899999999999999999999 8999999999999999999999999999987643
Q ss_pred CCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhh---h---cccc---C----
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW---A---KPLL---D---- 334 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~---~---~~~~---~---- 334 (434)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... . .+.. .
T Consensus 161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 21 122345689999999998764 58999999999999999999999997643321110 0 0000 0
Q ss_pred ------------ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 335 ------------SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 335 ------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+...+.+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000111111111 2246788999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=354.81 Aligned_cols=267 Identities=15% Similarity=0.148 Sum_probs=205.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCC------CcEEEEEEeeCCCchhh----------HhhHHHHHHHHhhCCCCCeeeE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEK----------TCGFLCEIGIIAYVDHPNTAKL 179 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l 179 (434)
.++|.+.+.||+|+||.||+|.+.. ++.||||++........ ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3468899999999999999998764 47899999876542110 1134556677888899999999
Q ss_pred eeeccC------CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec--C
Q 013927 180 VGCDSD------GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT--E 251 (434)
Q Consensus 180 ~g~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~--~ 251 (434)
++++.. ..++||||+ +++|.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 997433 378999999 899999998766789999999999999999999999 8999999999999999 8
Q ss_pred CCCeEEeccccccccCCCCccc-----ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh
Q 013927 252 DYEPQICDFGLAKWLPRQWTHH-----NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV 326 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~ 326 (434)
++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 8999999999998765332111 11345599999999999998999999999999999999999999986322211
Q ss_pred -hhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 327 -IWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 327 -~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
...........+..++++.+... .....+..++..||+.+|.+||++.+|++.|+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 10011111123334444433211 1234677888999999999999999999999866543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=346.65 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=192.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCC-C---cEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C--
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRD-G---TLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G-- 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~-- 186 (434)
.++|.+.+.||+|+||.||+|.+.. + ..||||++..... ......+.+|+.++++++||||+++++++.+ .
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4579999999999999999998663 3 2799999976532 3445679999999999999999999997433 2
Q ss_pred ----cEEEEEEcCCCCHHHHhccC-----CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 187 ----IHLVFQLSPLGSLASILHGS-----KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 187 ----~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
.++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 28999999999999998532 2258999999999999999999999 89999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||............
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------ 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH------
Confidence 99999987654332223334456889999999999999999999999999999999 99999865433221100
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
... .....+......+..++.+||+.||.+||++.++++.|+.+....
T Consensus 253 -----~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 -----IGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -----HTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -----hcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 001111223356888999999999999999999999998775444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=335.82 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=192.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch---hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD---EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+. |+.||||++...... .....+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46888899999999999999986 889999998764332 223568899999999999999999997543 689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC---eeecCCCCCcEEecC--------CCCeEEecc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR---IIHRDIKADNILLTE--------DYEPQICDF 260 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~---iiHrDlkp~NIll~~--------~~~~kL~DF 260 (434)
||+++++|.+++. ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999995 4578999999999999999999999 77 999999999999986 678999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------- 226 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV---------- 226 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH----------
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh----------
Confidence 9998654332 22456899999999999888999999999999999999999999875443322111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.........+......+..++.+||+.+|.+||++.||++.|+.+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 -AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 001111111222335688899999999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=362.97 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=204.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLS 194 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~ 194 (434)
.++|.+.+.||+|+||.||+|.+.++..||||++..... ....|.+|+.+|++++||||+++++++. +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 456888899999999999999998788899999986543 2346999999999999999999999754 4789999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence 999999999742 3568999999999999999999999 9999999999999999999999999999986643211 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||++.++.++.++|||||||++|||++ |+.||.+.......... ........+.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i------------~~~~~~~~~~ 404 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPCPP 404 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH------------HTTCCCCCCT
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------HcCCCCCCCC
Confidence 1223446789999999998999999999999999999999 99999765433221110 0001111122
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.....+..++.+||+.+|++||++.+|++.|+.+....
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 33457788999999999999999999999999876554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=360.27 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=201.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--C-CcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D-GIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~-~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|.+. |+.||||++.... ....|.+|+.+|++++||||+++++++. + ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 356888899999999999999987 7899999997653 3456999999999999999999999742 2 5899999
Q ss_pred EcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999997643 347899999999999999999999 99999999999999999999999999999854322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||........... +........
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~------------i~~~~~~~~ 407 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------VEKGYKMDA 407 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH------------HHTTCCCCC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCCCCCC
Confidence 122356889999999999999999999999999999998 9999976543222110 001111112
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+......+..++.+||+.+|++||++.+|++.|+.+.
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2233457888999999999999999999999997543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=334.95 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.++ |+.||||++..... ......+.+|+.++++++||||+++++++. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999986 88999999986543 344457999999999999999999999743 3578999
Q ss_pred EEcCCCCHHHHhccCCC-CCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKD-KPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999986433 58999999999999999999998 78 99999999999999999999999988754322
Q ss_pred CCcccceeccccccccccCCccccCCCCC---cCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCc
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDE---KTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||............ ......+.
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-------~~~~~~~~ 231 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-------ALEGLRPT 231 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-------HHSCCCCC
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-------HhcCCCCC
Confidence 2345799999999998766554 799999999999999999999765433221110 00001111
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
. +......+..++..||+.+|++||++.+|++.|+.+.
T Consensus 232 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 I----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 1222356788999999999999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=337.31 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=196.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh-hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE-KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|...+|+.||||++....... ....+.+|+.++++++||||++++++.. +..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999889999999997654322 2346889999999999999999999753 478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++ +|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence 985 8999988766789999999999999999999999 899999999999999999999999999998654321 1
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccC-cccccc--ccC
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLD-SNDIRE--LVD 343 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~-~~~~~~--~~d 343 (434)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .+... -..... ..+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 22345689999999998764 589999999999999999999999976443221100 00000 000000 011
Q ss_pred CcCCC-------CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGD-------NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11100 001112356778999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=346.74 Aligned_cols=258 Identities=17% Similarity=0.153 Sum_probs=202.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+|+.+++++ +||||++++++.. +..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 57889999999999999999974 789999999876432 23588999999999 9999999999743 46789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC-----eEEeccccccccC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-----PQICDFGLAKWLP 267 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFGla~~~~ 267 (434)
|+ +++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 899999998666789999999999999999999999 89999999999999998887 9999999998764
Q ss_pred CCCccc-----ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 268 RQWTHH-----NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 268 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CC
Confidence 432211 124567999999999999999999999999999999999999999864322110000000000000 00
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...+... .. .+..++..||+.+|.+||++.+|++.|+...
T Consensus 241 ~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 IEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0000000 12 7888999999999999999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=348.44 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=193.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCC--CCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDH--PNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~--~~~lv~ 191 (434)
+.|.+.+.||+|+||.||+|...+++.||||++...... .....+.+|+.++.+++| |||+++++++.+ ..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468899999999999999999988999999999765432 344578999999999986 999999997543 678999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
| +.+|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 89 e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 89 E-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp C-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred e-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9 567899999974 4578899999999999999999999 8999999999999997 57899999999987654433
Q ss_pred ccceeccccccccccCCcccc-----------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH-----------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +..
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------~~~ 232 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------LHA 232 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------HHH
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----------HHH
Confidence 333345679999999999865 66889999999999999999999999764332211 111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.+++.....++......+..++..||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 222222222222223567889999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=373.42 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=200.4
Q ss_pred eecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCCCH
Q 013927 124 LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLGSL 199 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~gsL 199 (434)
.||+|+||.||+|.+. ++..||||++...........+.+|+.+|++++||||+++++++. +..++||||+++|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999864 466799999987654455668999999999999999999999754 478999999999999
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc-ceecc
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH-NVSKF 278 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~ 278 (434)
.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....... .....
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 99998777779999999999999999999999 999999999999999999999999999998764332111 11223
Q ss_pred ccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHH
Q 013927 279 EGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDR 357 (434)
Q Consensus 279 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 357 (434)
.+++.|+|||++.++.++.++|||||||++|||++ |+.||........... +........+......
T Consensus 500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~------------i~~~~~~~~p~~~~~~ 567 (613)
T 2ozo_A 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------IEQGKRMECPPECPPE 567 (613)
T ss_dssp --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH------------HHTTCCCCCCTTCCHH
T ss_pred CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH------------HHcCCCCCCCCcCCHH
Confidence 45689999999998999999999999999999998 9999987544322111 1111111122233467
Q ss_pred HHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 358 AVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 358 l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+..++..||+.+|++||++.+|++.|+...
T Consensus 568 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 568 LYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 888999999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.63 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=201.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC-----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
++|.+.+.||+|+||.||+|.... +..||||++...........+.+|+.++++++||||+++++++. +..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457778899999999999998652 24699999987655555667999999999999999999999854 46899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999998766789999999999999999999999 89999999999999999999999999999876433
Q ss_pred Ccc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 270 WTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............ . ....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-----------~-~~~~ 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-----------N-DGFR 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-----------H-TTCC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-----------H-CCCc
Confidence 211 11223346788999999998899999999999999999999 99999764432211100 0 0000
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
...+......+..++.+||+.+|.+||++.+|++.|+.+...
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111122335678899999999999999999999999866543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.24 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=200.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+ ..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999976 789999999986543 2344578899999999999999999997544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGla~~~~~ 268 (434)
||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999999998864 4568999999999999999999999 8999999999999998654 599999999987653
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ . .... ....+
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~--~~~~-~~~~~---- 252 (362)
T 2bdw_A 184 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-K--AGAY-DYPSP---- 252 (362)
T ss_dssp CC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-H--HTCC-CCCTT----
T ss_pred Cc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-H--hCCC-CCCcc----
Confidence 32 223467999999999999889999999999999999999999999764432211000 0 0000 00000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
........+.+++.+||+.||++||++.++++.
T Consensus 253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001123567889999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=348.88 Aligned_cols=250 Identities=20% Similarity=0.202 Sum_probs=202.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 57999999999999999999976 789999999976543 33446889999999999999999999754 368899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC--CCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE--DYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGla~~~~~~~~ 271 (434)
+.+|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999998666679999999999999999999999 89999999999999974 4689999999998765432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||++.+..++.++|||||||++|||++|..||.............. ... ..++...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~---~~~--~~~~~~~---- 274 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---CDW--EFDEDAF---- 274 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---CCC--CCCSSTT----
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCC--CCCcccc----
Confidence 23345699999999999998899999999999999999999999976443221110000 000 0011111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......+.+++.+||+.||.+||++.++++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1223567889999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.54 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=206.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.+.||+|+||.||+|...+++.||||++...... ...+.+|+.++++++||||+++++++. +..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468888999999999999999988899999999875433 346899999999999999999999754 4689999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++++|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence 9999999998766778999999999999999999999 999999999999999999999999999998654321 111
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....|++.|+|||++.+..++.++||||||+++|+|++ |+.||............ ...... ..+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i--------~~~~~~----~~~~~ 229 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--------STGFRL----YKPRL 229 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HTTCCC----CCCTT
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH--------hcCCcC----CCCcc
Confidence 223456788999999998889999999999999999999 89999764432221110 000000 01111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
....+..++.+||+.+|.+||++.++++.|+.+.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2356778999999999999999999999997653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.20 Aligned_cols=260 Identities=21% Similarity=0.202 Sum_probs=204.1
Q ss_pred HHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC-
Q 013927 110 SELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD- 185 (434)
Q Consensus 110 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~- 185 (434)
.++....++|.+.++||+|+||+||+|... +++.||||++.+.... .....+.+|+.++..++||||+++++++.+
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344455678999999999999999999987 5889999999753221 222358899999999999999999997544
Q ss_pred -CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 -GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||||+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 6889999999999999998656789999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
....... ......+||+.|+|||++. .+.|+.++|||||||++|||++|+.||............ .. ...
T Consensus 224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~---~~~ 298 (437)
T 4aw2_A 224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-MN---HKE 298 (437)
T ss_dssp ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HT---HHH
T ss_pred hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh-hh---ccc
Confidence 6644322 2233467999999999987 466899999999999999999999999764432211100 00 000
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHH
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~ 381 (434)
.+.-+...... ...+.+++.+||..+|++ ||++.||++
T Consensus 299 ~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00011111112 246777889999888888 999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.55 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=193.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv 190 (434)
++|.+.++||+|+||+||+|... +++.||||++.+.... .....+..|..++.++ +||||+++++++.+ ..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 46889999999999999999977 6889999999865322 2334678899999887 89999999997544 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 999999999999874 3568999999999999999999999 99999999999999999999999999999853222
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ......+.... ..+
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~--~~~~~~i~~~~--~~~ 281 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--DYLFQVILEKQ--IRI 281 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCH--HHHHHHHHHCC--CCC
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhH--HHHHHHHhccc--cCC
Confidence 1234567899999999999999999999999999999999999999964321110000000 00000000000 011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
+......+..++.+||+.||.+||++
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 12223567789999999999999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=336.74 Aligned_cols=257 Identities=26% Similarity=0.322 Sum_probs=202.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~~l 189 (434)
..|.+.+.||+|+||.||+|...+ +..||||.+...........+.+|+.++++++||||+++++++ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357788999999999999998642 2368999998765555667899999999999999999999973 236789
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999998777788999999999999999999999 99999999999999999999999999999866433
Q ss_pred Cc--ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcC
Q 013927 270 WT--HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 270 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.. ........||+.|+|||.+.+..++.++||||||+++|+|++ |..||............ ......
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGRRL-- 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--------HTTCCC--
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--------hcCCCC--
Confidence 21 112234557889999999998899999999999999999999 55566543322111000 000000
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
..+......+..++.+||+.+|.+||++.++++.|+.+..
T Consensus 252 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0011122467889999999999999999999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=338.44 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=205.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLS 194 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~ 194 (434)
.++|.+.+.||+|+||.||+|...++..||||.+..... ....+.+|+.++++++||||++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence 356888999999999999999988888999999976542 2456899999999999999999999754 4789999999
Q ss_pred CCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ .
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence 9999999996432 268999999999999999999999 9999999999999999999999999999987654321 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||.+.++.++.++||||||+++|||++ |+.||............ ....... .+.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--------~~~~~~~----~~~ 233 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------ERGYRMV----RPD 233 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--------HTTCCCC----CCT
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH--------hcccCCC----Ccc
Confidence 1223446788999999988889999999999999999999 99999764432221100 0000011 111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.....+..++..||+.+|++||++.+|++.|+....
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 223567889999999999999999999999986543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=350.17 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=194.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~l 189 (434)
.++|.+.+.||+|+||+||+|... +|+.||||++.+... ......+..|..++..+ +||||+++++++. +..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 357999999999999999999976 689999999976422 22344678899999988 7999999999754 46899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999964 3568999999999999999999999 99999999999999999999999999999854322
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .
T Consensus 178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-----------i~~~~~--~ 242 (353)
T 3txo_A 178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA-----------ILNDEV--V 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHHCCC--C
T ss_pred --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH-----------HHcCCC--C
Confidence 2233456799999999999988899999999999999999999999976543322110 000000 1
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCH------hHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKM------SQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~evl~ 381 (434)
++......+..++.+||+.+|.+||++ .+|++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111123467789999999999999998 66653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.84 Aligned_cols=250 Identities=19% Similarity=0.294 Sum_probs=193.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCC--CCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVD--HPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~--~~~~~lv~ 191 (434)
+.|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|+.++.++. ||||+++++++ .+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 35889999999999999999988899999999976543 344567899999999996 59999999874 34688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
| +.+++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5678999999754 478888999999999999999998 8999999999999996 57999999999987654433
Q ss_pred ccceeccccccccccCCcccc-----------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH-----------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----------~~~ 279 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------LHA 279 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----------HHH
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----------HHH
Confidence 223345679999999999865 36888999999999999999999999764322111 111
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
++++.....++......+.+++.+||+.||.+||++.||++.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 222222111222223567789999999999999999999853
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=353.15 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=199.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++++++||||+++++++.+ ..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 356999999999999999999876 7899999999876543 344578899999999999999999997544 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec---CCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGla~~~~~ 268 (434)
||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999998874 3568999999999999999999999 8999999999999998 467899999999986654
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .... .+..+..
T Consensus 166 ~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~~-~~~~~~~-- 237 (444)
T 3soa_A 166 EQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK---AGAY-DFPSPEW-- 237 (444)
T ss_dssp TC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCC-CCCTTTT--
T ss_pred CC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---hCCC-CCCcccc--
Confidence 32 22244679999999999998899999999999999999999999997644322211000 0000 0000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.||.+||++.|+++
T Consensus 238 ---~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 238 ---DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112346778999999999999999999976
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=339.14 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=208.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 356888899999999999999987 58899999997644 334568999999999999999999998543 6899999
Q ss_pred EcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+++++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 99999999999753 4568999999999999999999999 899999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......... .+........
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~------------~~~~~~~~~~ 233 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------------LLEKDYRMER 233 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------------HHHTTCCCCC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------HHhccCCCCC
Confidence 122334557889999999998899999999999999999999 999997644322111 0001111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
+......+..++..||+.+|.+||++.+|++.|+......
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1223356888999999999999999999999998765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.96 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=202.4
Q ss_pred CCCCCeecccCcEEEEEEEeC-C---CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CC-cEEEE
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-D---GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG-IHLVF 191 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~-~~lv~ 191 (434)
|.+.++||+|+||.||+|.+. + +..||+|.+...........+.+|+.++++++||||+++++++. +. .++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 556688999999999999853 2 23799999987655556678999999999999999999999853 33 48999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC-
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW- 270 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~- 270 (434)
||+.+|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999999999998767788999999999999999999999 899999999999999999999999999998654321
Q ss_pred -cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCc-cccccchhhhhhccccCccccccccCCcCCC
Q 013927 271 -THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA-VDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 271 -~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..| |.......... .+......
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~------------~~~~~~~~ 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH------------FLAQGRRL 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH------------HHHTTCCC
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH------------HhhcCCCC
Confidence 11122345678999999999998999999999999999999996655 44332221110 00000011
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
..+......+..++.+||+.+|.+||++.++++.|+.+...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11112235678899999999999999999999999866433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.85 Aligned_cols=259 Identities=20% Similarity=0.268 Sum_probs=196.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++ .+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999986 6899999999865433 3345788999999999999999999974 346889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.+ +|.+.+......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9985 5666665556789999999999999999999999 899999999999999999999999999998764321
Q ss_pred cceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhh----h---hccccC-ccccccccC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI----W---AKPLLD-SNDIRELVD 343 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~----~---~~~~~~-~~~~~~~~d 343 (434)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... . ..+... -.....+.+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2234456899999999998766 899999999999999999998886332211110 0 000000 000000000
Q ss_pred ---------CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 ---------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..............+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001111223456788999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.01 Aligned_cols=243 Identities=24% Similarity=0.262 Sum_probs=190.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.++||+|+||+||+|... +|+.||||++...... .....+..|+..+.++ +||||+++++++. +..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46999999999999999999987 7999999998764332 3333556666666555 8999999999754 3688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+ +++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 578999887666779999999999999999999999 899999999999999999999999999998664331
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+........... ... .+.+ .
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~------~~~----~~~~----~ 274 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ------GYL----PPEF----T 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT------TCC----CHHH----H
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc------cCC----Cccc----c
Confidence 2234568999999998875 789999999999999999999776654222111100 000 0000 0
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||+.||++||++.|+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112356788999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=351.62 Aligned_cols=256 Identities=26% Similarity=0.332 Sum_probs=194.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC--CC--cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec---cCCcEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR--DG--TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD---SDGIHLV 190 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~---~~~~~lv 190 (434)
.|.+.+.||+|+||.||+|.+. ++ ..||||.+...........+.+|+.++++++||||+++++++ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3666788999999999999864 22 468999987655455567899999999999999999999974 2367899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998777778999999999999999999999 899999999999999999999999999998654322
Q ss_pred cc--cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 271 TH--HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 271 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||............ .... .
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~--------~~~~----~ 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--------LQGR----R 314 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH--------HTTC----C
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH--------HcCC----C
Confidence 11 11233457889999999999999999999999999999999 67777654322111000 0000 0
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
...+......+..++.+||+.+|++||++.+|++.|+.+..
T Consensus 315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00111223567889999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.77 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=197.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.+... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999976 689999999975432 123456889999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp CCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 99999999999974 4568999999999999999999999 99999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
......+||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ..+... ..
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~--------~~~~~~--~~ 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV--------HTFETT--VV 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH--------HHHHHC--CC
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH--------HHHhhc--cc
Confidence 22345679999999999864 45899999999999999999999999753221110000 000000 00
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCC-HhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPK-MSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~ 381 (434)
.++......+..++.+||+.+|.+||+ +.+|..
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111222356788999999999999998 676653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=345.70 Aligned_cols=271 Identities=26% Similarity=0.324 Sum_probs=209.6
Q ss_pred cCCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~ 187 (434)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4688889999999999999984 368899999997654 344457899999999999999999999642 347
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 89999999999999997655679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC---ccccccccC
Q 013927 268 RQWTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD---SNDIRELVD 343 (434)
Q Consensus 268 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~---~~~~~~~~d 343 (434)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ...+...+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 432211 2233457888999999998889999999999999999999999987533221111000000 011111122
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
.......+......+..++.+||+.||.+||++.+|++.|+.+.....
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222222333445678889999999999999999999999998865543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.72 Aligned_cols=260 Identities=16% Similarity=0.145 Sum_probs=204.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+|+.++..+ +|+|+++++++.. ...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56899999999999999999964 78999999987543 223588899999999 7999999999744 46789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC-----eEEeccccccccC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-----PQICDFGLAKWLP 267 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFGla~~~~ 267 (434)
|+ +++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 899999998766779999999999999999999998 99999999999999987776 9999999998765
Q ss_pred CCCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 268 RQWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 268 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-Ccc
Confidence 43221 123456799999999999998999999999999999999999999976432111000000000000 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.+.+... ....+..++..||+.+|++||++.+|++.|+.+..
T Consensus 242 ~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 242 LRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0000111 22567889999999999999999999999986654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=343.25 Aligned_cols=250 Identities=20% Similarity=0.212 Sum_probs=197.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc----hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV----DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
+.|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++. +..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45889999999999999999976 789999999864321 113456899999999999999999999743 46899
Q ss_pred EEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC---eEEeccccc
Q 013927 190 VFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE---PQICDFGLA 263 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGla 263 (434)
||||+++|+|.+.+.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999887753 23458999999999999999999999 99999999999999987654 999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ... ...
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~----~~~--~~~ 252 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK----GKY--KMN 252 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH----TCC--CCC
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc----CCC--CCC
Confidence 8765432 12334579999999999999899999999999999999999999997643221110000 000 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.... .....+.+++.+||+.||++||++.++++
T Consensus 253 ~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 11256788999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.33 Aligned_cols=244 Identities=20% Similarity=0.289 Sum_probs=195.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++. +..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57899999999999999999975 7899999999753221 12346889999999999999999999754 3688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+ +|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999 6788888763 3568999999999999999999999 899999999999999999999999999998665432
Q ss_pred ccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+........ ..+.... ...
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------~~i~~~~--~~~ 227 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------KKVNSCV--YVM 227 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------CCCCSSC--CCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------HHHHcCC--CCC
Confidence 2345579999999999988776 68999999999999999999999763221110 0000000 011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||+.||.+|||+.|+++
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122356778999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=343.93 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=184.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
.+.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 457899999999999999999987 68899999997643 23457889999999999999999997543 6889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla~~~~~~ 269 (434)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999974 4568999999999999999999999 89999999999999975 889999999999865432
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..... ... .... .
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~--~~~-~~~~-----~ 273 (349)
T 2w4o_A 205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN--CEY-YFIS-----P 273 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT--TCC-CCCT-----T
T ss_pred ---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh--CCC-ccCC-----c
Confidence 1223467899999999999989999999999999999999999999764432211111000 000 0000 0
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+.+++.+||+.||++||++.++++
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122356788999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=332.75 Aligned_cols=251 Identities=24% Similarity=0.277 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.+++.++||||+++++++. +..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56889999999999999999976 789999999976544445567899999999999999999999754 457899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..+.......
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999863 4568999999999999999999999 999999999999999999999999999998664332222
Q ss_pred ceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.........+.. +...........
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~ 232 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----------WKEKKTYLNPWK 232 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH----------HHTTCTTSTTGG
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----------hhhcccccCchh
Confidence 3345678999999999987665 67899999999999999999999764432211110 000000000011
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.||.+||++.+|++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 22346778999999999999999999965
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.50 Aligned_cols=259 Identities=27% Similarity=0.347 Sum_probs=202.2
Q ss_pred cCCCCCCeecccCcEEEEEEEe------CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL------RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
++|.+.+.||+|+||.||+|.+ .++..||||++...........+.+|+.++++++||||+++++++.+ ..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 4699999999999999999983 25778999999766555556689999999999999999999998543 689
Q ss_pred EEEEEcCCCCHHHHhccCC------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEec
Q 013927 189 LVFQLSPLGSLASILHGSK------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICD 259 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~D 259 (434)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999997543 458899999999999999999999 89999999999999984 44699999
Q ss_pred cccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcccc
Q 013927 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------- 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------- 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-------
Confidence 999976543322223345567899999999998899999999999999999998 999997643322110000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
. ......+......+..++.+||+.+|.+||++.+|++.|+.+....
T Consensus 260 -~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 260 -S----GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -c----CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0 0000111122356788999999999999999999999998665443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.39 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=198.7
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
...++|.+.+.||+|+||.||+|..+ +|+.||||++.+... ......+..|..++..+ +||||+++++++. +..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34467999999999999999999986 789999999976422 22344677899999876 9999999999754 468
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 999999999999999974 3568999999999999999999999 899999999999999999999999999998543
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... .+.+.
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-~~~--------~~~~p 238 (345)
T 1xjd_A 170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMD--------NPFYP 238 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHC--------CCCCC
T ss_pred cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HhC--------CCCCC
Confidence 221 2234567999999999999989999999999999999999999999764432221100 000 01111
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHh-HHH
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMS-QVV 380 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl 380 (434)
......+..++.+||+.+|.+||++. +|+
T Consensus 239 ----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11234677899999999999999998 664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.10 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=187.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||++... +|+.||||++...... ...+.+|+.+++.++||||+++++++. +..++||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46889999999999999999987 7899999999865432 235889999999999999999999754 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--eEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE--PQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 98 ASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 999999999864 3468999999999999999999999 99999999999999987765 999999999743322
Q ss_pred ccceeccccccccccCCccccCCCCCc-CcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEK-TDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... ..+..+.........
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-------KTIQRILSVKYSIPD 243 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-------HHHHHHHTTCCCCCT
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-------HHHHHHhcCCCCCCC
Confidence 12234569999999999988887655 899999999999999999997643211100 000111111111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+..++.+||+.+|.+|||+.|+++
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1112356778999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=344.97 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=191.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++. +..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999987 789999999976544333345667999999999999999999754 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
++ |+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 98 58999888777789999999999999999999999 99999999999999999999999999999865432 12
Q ss_pred ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh--c--cccCccccccc-------
Q 013927 274 NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA--K--PLLDSNDIREL------- 341 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~--~--~~~~~~~~~~~------- 341 (434)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... . ...........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2334568999999999876 5689999999999999999999999976443221100 0 00000000000
Q ss_pred --cCCcCCCCC----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 --VDPSLGDNY----DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 --~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 0112256788999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=347.33 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=199.6
Q ss_pred cCCCCCCeeccc--CcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 117 KNFSSENLIGKG--GYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
++|.+.++||+| +||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++ .+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 468899999999 99999999987 799999999976543 23445688899999999999999999974 3468999
Q ss_pred EEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 191 FQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999998753 3568999999999999999999999 99999999999999999999999999998654221
Q ss_pred Cc-----ccceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 270 WT-----HHNVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 270 ~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .....+.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~~ 258 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN---GTVPCLL 258 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---CCCCccc
Confidence 11 111123468999999999987 5799999999999999999999999976443322211100 0000000
Q ss_pred CCc------------------------------------CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 343 DPS------------------------------------LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 343 d~~------------------------------------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0000111223568889999999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=338.93 Aligned_cols=243 Identities=26% Similarity=0.307 Sum_probs=198.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.+.... .....+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999976 7999999999764321 233467889999999999999999997544 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999999974 3568899999999999999999998 99999999999999999999999999999865432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ++...+ .++
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----------i~~~~~--~~p 223 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-----------ILNAEL--RFP 223 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------HHHCCC--CCC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------HHhCCC--CCC
Confidence 2345799999999999999999999999999999999999999976433221110 000000 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
......+..++.+||+.+|.+|| ++.+|++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12234677899999999999999 8888873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.16 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=195.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD---- 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---- 185 (434)
..++|.+.+.||+|+||.||+|... ++..||||++..... ......+.+|+.++++++||||+++++++.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3457889999999999999999754 345899999876543 3344578999999999999999999997433
Q ss_pred ---CcEEEEEEcCCCCHHHHhcc-----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEE
Q 013927 186 ---GIHLVFQLSPLGSLASILHG-----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257 (434)
Q Consensus 186 ---~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL 257 (434)
..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 24899999999999999842 34568999999999999999999998 89999999999999999999999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCcc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------- 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY------- 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-------
Confidence 99999987654322222334557889999999999899999999999999999999 8889976443221100
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+.. ......+......+..++.+||+.+|.+||++.+|++.|+.+..
T Consensus 262 ----~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 262 ----LLH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ----HHT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 00011112233568889999999999999999999999986543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.17 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=191.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C----c
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G----I 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~----~ 187 (434)
++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.++.+++||||+++++++.. . .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 46889999999999999999975 7899999999865432 334578899999999999999999997432 2 3
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 899999999999999974 3568999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQWTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+....... ......
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~---- 242 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPPSAR---- 242 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-CCHHHH----
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-CCcccc----
Confidence 33211 222345689999999999998999999999999999999999999987544332211100000 000000
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
.. .....+..++.+||+.||++||++.+++
T Consensus 243 ~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l 272 (311)
T 3ork_A 243 HE----GLSADLDAVVLKALAKNPENRYQTAAEM 272 (311)
T ss_dssp ST----TCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred cC----CCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence 01 1224677899999999999999766654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=344.65 Aligned_cols=245 Identities=28% Similarity=0.430 Sum_probs=197.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
+.|...+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++ .+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34888899999999999999974 789999999976533 23345789999999999999999999974 34688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+. |+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9998 68888886556789999999999999999999999 89999999999999999999999999999865432
Q ss_pred ccceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||.............. .. .+...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~---~~-----~~~~~- 274 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NE-----SPALQ- 274 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SC-----CCCCC-
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cC-----CCCCC-
Confidence 2456899999999984 56789999999999999999999999976443222111000 00 01111
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.......+..++.+||+.+|++||++.++++.
T Consensus 275 --~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122457788999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.50 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=208.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLS 194 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~ 194 (434)
.++|.+.+.||+|+||.||+|.+.++..||||++..... ....|.+|+.+|++++||||+++++++. +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 345777888999999999999998888899999986543 2346999999999999999999999754 4789999999
Q ss_pred CCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 195 PLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 195 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
.+|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-H
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-e
Confidence 999999999743 3568999999999999999999999 9999999999999999999999999999986643211 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......++..|+|||++.++.++.++|||||||+||||++ |+.||............ ........+.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i------------~~~~~~~~~~ 487 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPCPP 487 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH------------HTTCCCCCCT
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------HcCCCCCCCC
Confidence 1123346788999999998999999999999999999999 99999765433221110 0001111122
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.....+.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 23456788999999999999999999999999886554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=341.68 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=194.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.+... ......+.+|..++.++ +||||+++++++. +..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999986 689999999986532 23445688899999988 8999999999754 468999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 999999999999864 3568999999999999999999999 99999999999999999999999999999854322
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc-ccccCCcCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI-RELVDPSLGDN 349 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~ 349 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+ ..+..... .
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~i~~~~~--~ 237 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---TEDYLFQVILEKQI--R 237 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCC--C
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc---cHHHHHHHHHcCCC--C
Confidence 12234567999999999999989999999999999999999999999652211000000 00000 00000000 1
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKM 376 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 376 (434)
++......+..++.+||+.||.+||++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 112223567789999999999999996
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.66 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=203.5
Q ss_pred hcCCCCCC-eecccCcEEEEEEEeC---CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEE
Q 013927 116 TKNFSSEN-LIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHL 189 (434)
Q Consensus 116 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~l 189 (434)
.++|.+.+ .||+|+||.||+|.+. +++.||||++...... .....+.+|+.+++.++||||+++++++. +..++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 34677777 8999999999999642 4688999999765432 33557899999999999999999999754 46889
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999999975 3568999999999999999999999 89999999999999999999999999999876543
Q ss_pred Cccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 270 WTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. ....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------~~~~ 238 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------------KGER 238 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------------TTCC
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------------cCCC
Confidence 2211 1223346788999999988889999999999999999999 999998654332211100 0001
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
...+......+..++.+||+.||.+||++.+|++.|+.+.....
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11122233578889999999999999999999999987655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.16 Aligned_cols=260 Identities=21% Similarity=0.210 Sum_probs=202.6
Q ss_pred HHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC
Q 013927 109 LSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD 185 (434)
Q Consensus 109 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 185 (434)
+.++....++|.+.++||+|+||+||+|..+ +|+.||||++.+... ......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455678999999999999999999986 799999999975322 1233468899999999999999999997544
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
..++||||+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhh
Confidence 6889999999999999997655678999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccc-------cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFM-------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
+....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||............ ....
T Consensus 210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-~~~~- 286 (412)
T 2vd5_A 210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-VHYK- 286 (412)
T ss_dssp EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HTHH-
T ss_pred eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH-Hhcc-
Confidence 87654321 1223467999999999987 356899999999999999999999999764432211000 0000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCC---CCHhHHHH
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILR---PKMSQVVI 381 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~evl~ 381 (434)
..+..+..... ....+.+++.+||+ +|.+| |++.||++
T Consensus 287 --~~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 --EHLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp --HHCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred --cCcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00001111111 23467788999999 99998 58888864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=338.62 Aligned_cols=260 Identities=23% Similarity=0.273 Sum_probs=202.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc------CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~l 189 (434)
++|.+.+.||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++||||+++++++. ...++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46889999999999999999974 78999999987643 344557899999999999999999999743 25789
Q ss_pred EEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 190 VFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
||||+.+|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999998875 45678999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCCcc-------cceeccccccccccCCccccCC---CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcc
Q 013927 267 PRQWTH-------HNVSKFEGTFGYFAPEYFMHGI---VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 267 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||............
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------ 258 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL------ 258 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH------
Confidence 321111 0112345799999999987554 689999999999999999999999652211100000
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.................+..++.+||+.||.+||++.+|++.|+.+....
T Consensus 259 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 259 ----AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ----HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ----HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00000000111122356888999999999999999999999998876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=340.45 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=195.9
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC--CCCCeeeEeeecc------CC
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV--DHPNTAKLVGCDS------DG 186 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~------~~ 186 (434)
..++|.+.+.||+|+||.||+|... |+.||||++.... ...+..|.+++..+ +||||+++++++. ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3467999999999999999999987 8999999986432 23455566666554 8999999999733 35
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC--------CeeecCCCCCcEEecCCCCeEEe
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK--------RIIHRDIKADNILLTEDYEPQIC 258 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~--------~iiHrDlkp~NIll~~~~~~kL~ 258 (434)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999964 468999999999999999999998 6 99999999999999999999999
Q ss_pred ccccccccCCCCccc--ceeccccccccccCCccccCCCCCc------CcEEehhHHHHHHHhCCCccccccchhhhhhc
Q 013927 259 DFGLAKWLPRQWTHH--NVSKFEGTFGYFAPEYFMHGIVDEK------TDVYSFGVLLLELITGRRAVDHLQQSVVIWAK 330 (434)
Q Consensus 259 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDvwSlGvil~elltG~~p~~~~~~~~~~~~~ 330 (434)
|||++..+....... ......||+.|+|||++.+..++.. +|||||||++|||++|..|+.........+..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997664432211 1124579999999999988776665 99999999999999994444321111110000
Q ss_pred cccCc---ccccc-ccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 331 PLLDS---NDIRE-LVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 331 ~~~~~---~~~~~-~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
..... ..+.. ..........+ ......+..++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 00000 00000 01111112222 25667899999999999999999999999999865543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.25 Aligned_cols=243 Identities=21% Similarity=0.216 Sum_probs=198.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.+... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 789999999975432 123456888999999999999999999754 3689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999743 468999999999999999999999 99999999999999999999999999999876432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .++
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----------i~~~~~--~~p 258 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK-----------IVSGKV--RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHHCCC--CCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH-----------HHcCCC--CCC
Confidence 2345799999999999999999999999999999999999999976443221100 000000 011
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
......+..++.+||+.||.+||+ +.+|++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122356788999999999999998 788764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.81 Aligned_cols=266 Identities=19% Similarity=0.240 Sum_probs=207.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~lv~ 191 (434)
++|.+.++||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999987 6899999999765444445678899999999999999999997432 568999
Q ss_pred EEcCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----cCCCCeEEeccccccc
Q 013927 192 QLSPLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL----TEDYEPQICDFGLAKW 265 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGla~~ 265 (434)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997532 338999999999999999999999 899999999999999 7778899999999987
Q ss_pred cCCCCcccceeccccccccccCCcccc--------CCCCCcCcEEehhHHHHHHHhCCCccccccchh---hh----hh-
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMH--------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VI----WA- 329 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~----~~- 329 (434)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .. ..
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 65432 2234568999999999865 457789999999999999999999997532110 10 00
Q ss_pred ccccCcccccccc--------CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 330 KPLLDSNDIRELV--------DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 330 ~~~~~~~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.|...-..+.... +..............+..++..||+.||++||++.++++.|+.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1100000000000 0111223445667788899999999999999999999998876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=357.38 Aligned_cols=257 Identities=20% Similarity=0.261 Sum_probs=201.2
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-- 185 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 185 (434)
++....++|.+.++||+|+||+||+|... +++.||||++.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33445578999999999999999999987 689999999975321 1122358899999999999999999998554
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 58899999999999999964 458899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccceeccccccccccCCccccCC----CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccc
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGI----VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 341 (434)
..... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||............ . ... ..+
T Consensus 218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-~-~~~--~~~ 292 (410)
T 3v8s_A 218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-M-NHK--NSL 292 (410)
T ss_dssp CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-H-THH--HHC
T ss_pred eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH-H-hcc--ccc
Confidence 65432 11234567999999999997655 789999999999999999999999764432211000 0 000 000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHhhhccCCCC--CCCHhHHHHH
Q 013927 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPIL--RPKMSQVVIL 382 (434)
Q Consensus 342 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~evl~~ 382 (434)
.-+. .......+..++.+||+.+|.+ ||++.||++.
T Consensus 293 ~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 0112246778889999999988 9999999853
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.22 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=198.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 185 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457999999999999999999965 7899999999875431 133467889999999999999999998544
Q ss_pred CcEEEEEEcCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 GIHLVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||||+..| +|.+++.. ...+++..+..|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 578999999777 99999874 4568999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...
T Consensus 179 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------------~~~ 242 (335)
T 3dls_A 179 YLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA-------------AIH 242 (335)
T ss_dssp ECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT-------------CCC
T ss_pred ECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh-------------ccC
Confidence 765432 2234569999999999988776 78899999999999999999999764322110 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
+ +......+..++.+||+.+|++||++.++++.
T Consensus 243 ~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 P------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00122467889999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=337.90 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=194.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch----hhHhhHHHHHHHHhhC---CCCCeeeEeeeccC--
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD----EKTCGFLCEIGIIAYV---DHPNTAKLVGCDSD-- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-- 185 (434)
.++|.+.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.+++++ +||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 468999999999999999999975 7899999998743211 1123466777777666 49999999997432
Q ss_pred -----CcEEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEec
Q 013927 186 -----GIHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259 (434)
Q Consensus 186 -----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 259 (434)
..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEee
Confidence 3689999998 69999987543 348999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh---c-cccCc
Q 013927 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA---K-PLLDS 335 (434)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~---~-~~~~~ 335 (434)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... . .....
T Consensus 164 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 164 FGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999866433 223456789999999999999999999999999999999999999976443221100 0 00000
Q ss_pred cccc-------cccCCcCCC---CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDIR-------ELVDPSLGD---NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... ..+.+.... .........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 000000000 000122356788999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=351.04 Aligned_cols=256 Identities=21% Similarity=0.234 Sum_probs=192.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-------- 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 185 (434)
.++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 357999999999999999999876 789999999986432 2344578899999999999999999997532
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++||||+.++ |...+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 359999999865 666664 248899999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---cc--------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KP-------- 331 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~-------- 331 (434)
.... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....... .. .|
T Consensus 214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 5432 2234567999999999999999999999999999999999999999764322111 00 00
Q ss_pred ------------ccCccccccccCCcCCCCCC---HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 ------------LLDSNDIRELVDPSLGDNYD---AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ------------~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+...+...+..... ......+.+++.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000011111111000000 111456889999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=349.27 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=188.7
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--C--Cc
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--D--GI 187 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~--~~ 187 (434)
..++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++.++. ||||+++++++. + ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3468999999999999999999976 789999999875432 334457889999999997 999999999742 2 57
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+. |+|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 689998864 468899999999999999999999 899999999999999999999999999998653
Q ss_pred CCC-------------------cccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh
Q 013927 268 RQW-------------------THHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327 (434)
Q Consensus 268 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 327 (434)
... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 210 1112344679999999999976 56899999999999999999999999764322111
Q ss_pred ---hhccccC-cccccccc------------------CCcCCCCC------------CHHHHHHHHHHHHhhhccCCCCC
Q 013927 328 ---WAKPLLD-SNDIRELV------------------DPSLGDNY------------DAEEIDRAVLTASLCIEQSPILR 373 (434)
Q Consensus 328 ---~~~~~~~-~~~~~~~~------------------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~~P~~R 373 (434)
....... ...+..+. .......+ .......+.+++.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 0000000 00000000 00000000 00123467889999999999999
Q ss_pred CCHhHHHHH
Q 013927 374 PKMSQVVIL 382 (434)
Q Consensus 374 Ps~~evl~~ 382 (434)
||+.|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999765
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.56 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=179.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.+ ..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999975 7899999999753221 223568899999999999999999998544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999998766789999999999999999999999 8999999999999999999999999999986643211
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ........ ..+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~--~~~ 232 (278)
T 3cok_A 168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLADY--EMP 232 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC--CCC
T ss_pred --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhccc--CCc
Confidence 123456899999999999888999999999999999999999999753321110 00000000 111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.||++||++.+|++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122346778999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.51 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=208.1
Q ss_pred cCCCCCCeecccCcEEEEEEEe-----CCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC----Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-----RDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD----GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~ 187 (434)
++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4588889999999999999984 368899999997643 3445679999999999999999999997432 57
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++++|.+++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999998766779999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccC----cccccccc
Q 013927 268 RQWTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD----SNDIRELV 342 (434)
Q Consensus 268 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 342 (434)
...... ......++..|+|||.+.+..++.++|||||||++|||++|..||................ ...+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 432211 1123456788999999998889999999999999999999999986532211100000000 00011111
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
........+......+..++.+||+.+|++||++.+|++.|+.+.+
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111222334678889999999999999999999999986643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.59 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=190.0
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-------hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-C
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-------DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-D 185 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~ 185 (434)
..++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+|++++||||+++++++. +
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4578999999999999999999876 689999999975421 122235889999999999999999999754 4
Q ss_pred CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEecccc
Q 013927 186 GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICDFGL 262 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGl 262 (434)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 68899999999999998864 4578999999999999999999999 8999999999999997544 599999999
Q ss_pred ccccCCCCcccceeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 289 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~--------- 356 (419)
T 3i6u_A 289 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--------- 356 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH---------
T ss_pred ceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH---------
Confidence 9876532 22345679999999999863 56888999999999999999999999753322111000
Q ss_pred cccCCcCCCCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGDNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+..... ...+ .....+.+++.+||+.||.+||++.|+++
T Consensus 357 -i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 -ITSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HhcCCC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 0011 12356788999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.45 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=198.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CC-------cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DG-------TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~ 186 (434)
++|.+.+.||+|+||.||+|... ++ ..||+|++.... ......+.+|+.++++++||||+++++++. +.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 46888899999999999999865 33 479999986543 234457899999999999999999999854 46
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--------eEEe
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE--------PQIC 258 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~--------~kL~ 258 (434)
.++||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 899999999999999998766669999999999999999999999 99999999999999998887 9999
Q ss_pred ccccccccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCC-ccccccchhhhhhccccCcc
Q 013927 259 DFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRR-AVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~~~ 336 (434)
|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|.. ||.............. .
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--~- 234 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--R- 234 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT--T-
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc--c-
Confidence 99998754322 23458999999999987 668999999999999999999654 4444332211110000 0
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcch
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 391 (434)
..+.... ...+..++.+||+.||.+||++.++++.|+.+.....
T Consensus 235 -------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 235 -------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0000111 1246778899999999999999999999998876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.36 Aligned_cols=249 Identities=22% Similarity=0.250 Sum_probs=200.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-----hHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-----KTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++||||+++++++.+ ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45889999999999999999976 78999999998654321 24568999999999999999999997543 688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC----CeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~ 264 (434)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999974 4568999999999999999999999 8999999999999999888 79999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ... .++
T Consensus 168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~----~~~ 239 (321)
T 2a2a_A 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-SYD----FDE 239 (321)
T ss_dssp ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-CCC----CCH
T ss_pred ecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-ccc----cCh
Confidence 765432 223456899999999999889999999999999999999999999764332211100000 000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... .....+.+++.+||+.||++||++.++++
T Consensus 240 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 240 EFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0001 11246788999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=330.47 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=203.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
+.|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++ .+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 35888899999999999999875 78999999998765555566799999999999999999999974 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....... .
T Consensus 102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 99999999995 3568999999999999999999999 899999999999999999999999999998664432 1
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............. ...+.+...+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~--- 243 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--------NNPPTLEGNY--- 243 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------SCCCCCCSSC---
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc--------CCCCCCcccc---
Confidence 22345689999999999999999999999999999999999999976544322211110 0111112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
...+..++..||+.+|.+||++.+|++.
T Consensus 244 -~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 -SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2467889999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=340.84 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=200.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcE--EEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTL--VAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||+|+||.||+|... +|.. ||||.+...........+.+|+.++.++ +||||+++++++. +..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 36888899999999999999875 5664 4999988655445556799999999999 8999999999743 468899
Q ss_pred EEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 191 FQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 468999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||............
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---- 254 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 254 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----
Confidence 99999999743321 11223456889999999988889999999999999999998 99999765432221110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
... .....+......+..++.+||+.+|.+||++.++++.|+.+...
T Consensus 255 ----~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 ----PQG----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ----GGT----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----hcC----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 01111122235678899999999999999999999999866544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.68 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=197.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~l 189 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++.+... ......+..|..++..+ +||||++++++.. +..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 357999999999999999999987 588999999976432 12344678899999988 7999999999754 46899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999974 3468999999999999999999999 89999999999999999999999999999854322
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .
T Consensus 175 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-----------i~~~~~--~ 239 (353)
T 2i0e_A 175 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----------IMEHNV--A 239 (353)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHHCCC--C
T ss_pred --CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH-----------HHhCCC--C
Confidence 1223456799999999999999999999999999999999999999976443221110 000000 0
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCH-----hHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKM-----SQVV 380 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl 380 (434)
++......+..++.+||+.+|.+||++ .+|+
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 111223567889999999999999964 6665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.68 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=188.6
Q ss_pred cCCCCCCeecccCcEEEEEEEe----CCCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~ 187 (434)
++|.+.+.||+|+||.||+|.. .+|+.||||++.+... ......+.+|+.+++.++||||+++++++. +..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4688899999999999999986 4789999999986532 123345788999999999999999999754 478
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999999864 3568889999999999999999999 899999999999999999999999999997543
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +....
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----------i~~~~-- 237 (327)
T 3a62_A 173 HDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-----------ILKCK-- 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----------HHHTC--
T ss_pred cCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH-----------HHhCC--
Confidence 221 123456799999999999988899999999999999999999999976443221110 00000
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
...+......+.+++.+||+.+|.+|| ++.++++
T Consensus 238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 011112235678899999999999999 6667764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=344.92 Aligned_cols=244 Identities=21% Similarity=0.221 Sum_probs=191.7
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEEcCCCC
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQLSPLGS 198 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~~~~gs 198 (434)
.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 467999999999999875 789999999987543 344578999999999999999999997543 6899999999999
Q ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe--cCCCCeEEeccccccccCCCCccccee
Q 013927 199 LASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL--TEDYEPQICDFGLAKWLPRQWTHHNVS 276 (434)
Q Consensus 199 L~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll--~~~~~~kL~DFGla~~~~~~~~~~~~~ 276 (434)
|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+.... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence 999887666678999999999999999999999 899999999999999 567899999999998765432 223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEID 356 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 356 (434)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............... ... + ...... ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~---~-~~~~~~----~~~~ 317 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWD---L-EDEEFQ----DISE 317 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCC---S-CSGGGT----TSCH
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCC---C-Chhhhc----cCCH
Confidence 456999999999999888999999999999999999999999765432211100000 000 0 000001 1235
Q ss_pred HHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 357 RAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 357 ~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+.+++.+||+.+|.+||++.|+++
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6788999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=348.03 Aligned_cols=251 Identities=11% Similarity=0.021 Sum_probs=180.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC--CCCCeeeEeeecc-------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV--DHPNTAKLVGCDS------- 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~------- 184 (434)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++..+ +||||++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35888899999999999999976 789999999987653 23344677785444444 6999888552111
Q ss_pred -------------------CCcEEEEEEcCCCCHHHHhccCCCCCCHHHH------HHHHHHHHHHhHhhhccCCCCeee
Q 013927 185 -------------------DGIHLVFQLSPLGSLASILHGSKDKPDWSKR------YRIALGTANGLTYLHEGCQKRIIH 239 (434)
Q Consensus 185 -------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~gL~yLH~~~~~~iiH 239 (434)
...++||||++ |+|.+++......+.+..+ ..++.||+.||.|||+ ++|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 23799999999 8999999764444555566 7888999999999999 99999
Q ss_pred cCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCc
Q 013927 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRA 317 (434)
Q Consensus 240 rDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p 317 (434)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865422 224557799999999987 6799999999999999999999999
Q ss_pred cccccchhh-hhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 318 VDHLQQSVV-IWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 318 ~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
|........ .+...... ..................+.+++.+||+.||++||++.++++
T Consensus 293 f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLR-----VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCCBCCTT-----SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchhhhhhh-----hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 986533211 11111000 000111111111123457788999999999999999999963
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=332.15 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=193.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... ++..||+|++...........+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 35888899999999999999976 7899999999875544445678999999999999999999998544 67899999
Q ss_pred cCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccC
Q 013927 194 SPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 194 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~ 267 (434)
+++|+|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998853 24678999999999999999999999 899999999999999 456789999999998654
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.. .......||+.|+|||++. +.++.++|||||||++|+|++|+.||............... .... ....
T Consensus 179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~-----~~~~ 248 (285)
T 3is5_A 179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNY-----AVEC 248 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC-----CC--
T ss_pred Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-Cccc-----cccc
Confidence 33 1224456899999999875 56889999999999999999999999764432221110000 0000 0000
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. ....+..++.+||+.||++||++.||++
T Consensus 249 ~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1246778999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.72 Aligned_cols=265 Identities=23% Similarity=0.375 Sum_probs=195.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++ .+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 36888999999999999999975 789999999975332 33455789999999999999999999974 34688999
Q ss_pred EEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+.+|+|.+++.. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 45678999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||............. +.....+...
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~- 259 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------IEQCDYPPLP- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH------HHTTCSCCCC-
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH------hhcccCCCCc-
Confidence 32 12234568999999999998899999999999999999999999997533221111100 0000000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcchhhhh
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKE 395 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~ 395 (434)
.......+..++.+||+.||.+||++.+|++.|+.+.+..+.+.+
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 111234678899999999999999999999999887766554443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.47 Aligned_cols=245 Identities=28% Similarity=0.421 Sum_probs=195.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 56888999999999999999876 6789999998754322 223468899999999999999999998544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999999998643 568899999999999999999998 89999999999999999999999999998654432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||............ .. ... ..+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~-~~~----~~~ 227 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------SR-VEF----TFP 227 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--------HH-TCC----CCC
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH--------Hh-CCC----CCC
Confidence 223456899999999999888999999999999999999999999764332211100 00 000 111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......+..++.+||+.+|.+||++.||++.
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1123467789999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=332.98 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=193.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++. +..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999986 6899999998765433 33456889999999999999999999744 46889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 156 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-- 156 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence 9999999988863 4568999999999999999999999 899999999999999999999999999998765332
Q ss_pred cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc-----ccc--------Ccccc
Q 013927 273 HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK-----PLL--------DSNDI 338 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~-----~~~--------~~~~~ 338 (434)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ... .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 12234568999999999876 56899999999999999999999999764432211000 000 00000
Q ss_pred ccccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+....... ......+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000 112345788999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=332.14 Aligned_cols=262 Identities=21% Similarity=0.216 Sum_probs=200.7
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee---ccCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC---DSDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~---~~~~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +++.||||++..... ...+..|+.+++.++|+|++..++. ..+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 467999999999999999999974 789999998765432 2358889999999999888777664 334678999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~ 268 (434)
||+ +++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 899999998666789999999999999999999999 999999999999999 7889999999999987654
Q ss_pred CCccc-----ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 269 QWTHH-----NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 269 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...................... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hh
Confidence 32211 2235678999999999999899999999999999999999999997643221100000000000000 00
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
+.+...+ ...+..++..||+.+|++||++.+|++.|+.+...
T Consensus 240 ~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 240 EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0000111 25688899999999999999999999999866533
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=340.05 Aligned_cols=256 Identities=24% Similarity=0.236 Sum_probs=195.7
Q ss_pred HHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC----chhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-
Q 013927 112 LQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT----VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD- 185 (434)
Q Consensus 112 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~- 185 (434)
+....++|.+.+.||+|+||.||+|... ++..||||++.... .......+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445567999999999999999999976 78899999987532 12344578999999999999999999998544
Q ss_pred -CcEEEEEEcCCCCHHHHhccC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 013927 186 -GIHLVFQLSPLGSLASILHGS---------------------------------------KDKPDWSKRYRIALGTANG 225 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~g 225 (434)
..++||||+++|+|.+++... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 578999999999999998520 1123566778899999999
Q ss_pred hHhhhccCCCCeeecCCCCCcEEecCCC--CeEEeccccccccCCCCc--ccceeccccccccccCCcccc--CCCCCcC
Q 013927 226 LTYLHEGCQKRIIHRDIKADNILLTEDY--EPQICDFGLAKWLPRQWT--HHNVSKFEGTFGYFAPEYFMH--GIVDEKT 299 (434)
Q Consensus 226 L~yLH~~~~~~iiHrDlkp~NIll~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~ks 299 (434)
|.|||+ ++|+||||||+|||++.++ .+||+|||++..+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 899999999986543211 112345679999999999875 5689999
Q ss_pred cEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC--CCCHHHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 300 DVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD--NYDAEEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 300 DvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
|||||||++|||++|+.||............ ....... .........+.+++.+||+.+|.+||++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV-----------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH-----------HhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 9999999999999999999765443222110 0000000 00011235678899999999999999999
Q ss_pred HHHH
Q 013927 378 QVVI 381 (434)
Q Consensus 378 evl~ 381 (434)
++++
T Consensus 327 ~~l~ 330 (345)
T 3hko_A 327 RALQ 330 (345)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=344.88 Aligned_cols=201 Identities=24% Similarity=0.268 Sum_probs=172.5
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-----CCCeeeEeeec-
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-----HPNTAKLVGCD- 183 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~- 183 (434)
+.....++|.+.++||+|+||.||+|... +++.||||++... ......+..|+.+++.+. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 33344578999999999999999999975 7899999999743 233446788999999996 99999999974
Q ss_pred -cCCcEEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC----------
Q 013927 184 -SDGIHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---------- 251 (434)
Q Consensus 184 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---------- 251 (434)
.+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 45788999999 899999997543 458999999999999999999999 99999999999999975
Q ss_pred ---------------CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCC
Q 013927 252 ---------------DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR 316 (434)
Q Consensus 252 ---------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~ 316 (434)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999865432 234568999999999999999999999999999999999999
Q ss_pred cccccc
Q 013927 317 AVDHLQ 322 (434)
Q Consensus 317 p~~~~~ 322 (434)
||....
T Consensus 258 pf~~~~ 263 (360)
T 3llt_A 258 LFRTHE 263 (360)
T ss_dssp SCCCSS
T ss_pred CCCCCc
Confidence 997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.09 Aligned_cols=248 Identities=15% Similarity=0.135 Sum_probs=199.3
Q ss_pred hcCCCCCCeecccCcEEEEEEE------eCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC---CCCeeeEeeec--c
Q 013927 116 TKNFSSENLIGKGGYAEVYKGC------LRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD---HPNTAKLVGCD--S 184 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~--~ 184 (434)
.++|.+.++||+|+||.||+|. ..+++.||||++.... ...+..|+.++..++ |+||+.+++++ .
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4578899999999999999994 3468899999997643 335777888888887 99999999974 4
Q ss_pred CCcEEEEEEcCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---------
Q 013927 185 DGIHLVFQLSPLGSLASILHG----SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE--------- 251 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~--------- 251 (434)
+..++||||+++|+|.+++.. ....+++..+..|+.||+.||.|||+ ++|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccc
Confidence 578999999999999999974 35679999999999999999999999 89999999999999998
Q ss_pred --CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh
Q 013927 252 --DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329 (434)
Q Consensus 252 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 329 (434)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... +
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--C- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--E-
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--e-
Confidence 89999999999976543333334456779999999999999999999999999999999999999986532211 0
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCC-CCHhHHHHHhcCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILR-PKMSQVVILLRGDE 387 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~evl~~L~~~~ 387 (434)
.+...+.... ..+.+..++..||+.+|.+| |++.++.+.|+...
T Consensus 294 -----------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 294 -----------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -----------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -----------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0111111111 13455667889999999999 67888888887554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=331.85 Aligned_cols=261 Identities=19% Similarity=0.203 Sum_probs=195.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLV 190 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv 190 (434)
.++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++ .+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367999999999999999999976 7899999998764332 2345788999999999999999999974 3468899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999999974 3568999999999999999999999 899999999999999999999999999997654331
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||.............. ...... ....
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~----~~~~-- 259 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ--AIPRPS----TVRP-- 259 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS--CCCCGG----GTST--
T ss_pred -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc--CCCCcc----ccCC--
Confidence 1222345689999999999988999999999999999999999999986543321100000 000000 0111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCC-CHhHHHHHhcCCCCcch
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRP-KMSQVVILLRGDEDNAQ 391 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~L~~~~~~~~ 391 (434)
.....+..++.+||+.+|++|| ++.++++.|+.......
T Consensus 260 --~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 --GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1223677889999999999999 99999999987766554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=325.79 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=199.3
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++.+ ..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357899999999999999999976 689999999976443 3344578899999999999999999997544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC---eEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE---PQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGla~~~~~ 268 (434)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999888864 3568999999999999999999999 89999999999999986655 99999999976654
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............. ... ....+.
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~-~~~~~~--- 230 (284)
T 3kk8_A 161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA---GAY-DYPSPE--- 230 (284)
T ss_dssp SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCC-CCCTTT---
T ss_pred Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh---ccc-cCCchh---
Confidence 32 22345689999999999999999999999999999999999999976443222111000 000 000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+..++.+||+.+|++||++.|+++
T Consensus 231 --~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 --WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112346778999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=331.60 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=202.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeec----cCCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCD----SDGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~----~~~~~lv 190 (434)
++|.+.+.||+|+||.||+|... +|+.||+|.+..... ......+.+|+.++++++||||+++++++ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46888999999999999999986 789999999986543 34456789999999999999999999963 3468999
Q ss_pred EEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCCC-----eeecCCCCCcEEecCCCCeEEecccc
Q 013927 191 FQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQKR-----IIHRDIKADNILLTEDYEPQICDFGL 262 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~-----iiHrDlkp~NIll~~~~~~kL~DFGl 262 (434)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999864 23458999999999999999999998 67 99999999999999999999999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
+....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........... +....
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------i~~~~ 232 (279)
T 2w5a_A 163 ARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------IREGK 232 (279)
T ss_dssp HHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHTC
T ss_pred heeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH--------Hhhcc
Confidence 98664331 112345689999999999988899999999999999999999999986543221110 00000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.+.+. ......+..++.+||+.+|.+||++.+|++.+....
T Consensus 233 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 01111 122356788999999999999999999998775443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=351.23 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=199.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++. +..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888999999999999999987 7999999999754221 23346889999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 99999999999974 4568999999999999999999998 999999999999999999999999999998765431
Q ss_pred ccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||+......... .+.+... ..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-----------~i~~~~~--~~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-----------KICDGIF--YT 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-----------HHHTTCC--CC
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-----------HHhcCCc--CC
Confidence 2345679999999999988765 679999999999999999999997643322110 0000000 00
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||+.||.+|||+.+|++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1112246778999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=341.82 Aligned_cols=264 Identities=15% Similarity=0.121 Sum_probs=195.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchh----------hHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDE----------KTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
++|.+.+.||+|+||.||+|... ++..||||++....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 46888999999999999999975 57889999998654321 11246778899999999999999997
Q ss_pred c------cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC--C
Q 013927 183 D------SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY--E 254 (434)
Q Consensus 183 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~--~ 254 (434)
+ ....++||||+ +++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 3 23588999999 899999997543 78999999999999999999999 8999999999999999887 9
Q ss_pred eEEeccccccccCCCCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh-hh
Q 013927 255 PQICDFGLAKWLPRQWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV-IW 328 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~ 328 (434)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999999876432211 112345789999999999988899999999999999999999999965221111 10
Q ss_pred hccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 329 AKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 329 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
.........+...+...... ......+..++..||+.+|++||++.+|++.|+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 00000000011111000000 0123467889999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.43 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=173.9
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeeccC--CcEEEEEEcCCC
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD--GIHLVFQLSPLG 197 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~lv~e~~~~g 197 (434)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+ ..++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 378999999999999986 7899999999653 2345788999999997 9999999998554 588999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEEeccccccccCCCCcccc
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 99999974 4578999999999999999999999 9999999999999998765 89999999998654332 22
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC--H
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD--A 352 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~ 352 (434)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ....+..+.......... .
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS----AVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC----HHHHHHHHTTTCCCCCSHHHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc----HHHHHHHHHcCCCCCCccccc
Confidence 3456689999999999999999999999999999999999999976432110000 000000111111100000 1
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+++.+||+.||.+||++.++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 12357888999999999999999999963
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.08 Aligned_cols=262 Identities=21% Similarity=0.215 Sum_probs=202.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeee---ccCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC---DSDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~---~~~~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+|+.+++.++|++++..++. ..+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357999999999999999999974 799999999876543 2358899999999999887776654 334678999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~ 268 (434)
||+ +++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 899999998666789999999999999999999999 999999999999999 4888999999999987654
Q ss_pred CCccc-----ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 269 QWTHH-----NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 269 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cch
Confidence 32211 124557899999999999989999999999999999999999999764321100000000000000 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
+.+...+ ...+..++.+||+.+|.+||++.+|++.|+.+...
T Consensus 240 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 240 EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0001111 24678899999999999999999999999865433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.09 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=201.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----------- 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------- 184 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.... ..+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 46889999999999999999987 79999999997643 24678999999999999999998642
Q ss_pred -------CCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 185 -------DGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 185 -------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
...++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 2378999999999999999643 3578999999999999999999999 8999999999999999999999
Q ss_pred EeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcc
Q 013927 257 ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN 336 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 336 (434)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+.........
T Consensus 163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--------- 230 (284)
T 2a19_B 163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD--------- 230 (284)
T ss_dssp ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH---------
T ss_pred ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHH---------
Confidence 99999998765432 123456899999999999888999999999999999999999988543221111
Q ss_pred ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 337 DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 337 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
+....+...++ ..+..++.+||+.||.+||++.++++.|+.+....
T Consensus 231 ----~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 ----LRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ----HHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ----hhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11111112222 45678899999999999999999999998766544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=347.56 Aligned_cols=193 Identities=24% Similarity=0.394 Sum_probs=152.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~ 187 (434)
++|.+.++||+|+||+||+|... +|+.||||++...... .....+.+|+.+|++++||||+++++++. +..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999876 7899999999764332 33457889999999999999999999752 357
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+. |+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99999985 789998863 4668999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCcc-------------------------cceeccccccccccCCcc-ccCCCCCcCcEEehhHHHHHHHhC
Q 013927 268 RQWTH-------------------------HNVSKFEGTFGYFAPEYF-MHGIVDEKTDVYSFGVLLLELITG 314 (434)
Q Consensus 268 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvil~elltG 314 (434)
..... ......+||+.|+|||++ ....|+.++||||||||+|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 32111 123456789999999986 456699999999999999999993
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=328.00 Aligned_cols=245 Identities=27% Similarity=0.334 Sum_probs=194.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc------CCcEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------DGIHL 189 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~l 189 (434)
.|.+.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.++++++||||+++++++. ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3677788999999999999876 688999999876433 344567899999999999999999999632 23789
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEec-CCCCeEEecccccccc
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLT-EDYEPQICDFGLAKWL 266 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFGla~~~ 266 (434)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999964 3568899999999999999999998 77 99999999999998 7889999999999755
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||............... .. .....
T Consensus 183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~----~~~~~ 251 (290)
T 1t4h_A 183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GV----KPASF 251 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TC----CCGGG
T ss_pred ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--cC----Ccccc
Confidence 432 223456899999999886 45899999999999999999999999764433222111000 00 00000
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++..||+.+|.+||++.+|++
T Consensus 252 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111246788999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.34 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=196.5
Q ss_pred CeecccCcEEEEEEEeC---CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~e~~~~g 197 (434)
+.||+|+||.||+|.+. .++.||||++...... .....+.+|+.+|++++||||+++++++.+ ..++||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999653 4678999999764332 334579999999999999999999998544 688999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc-ccee
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH-HNVS 276 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~ 276 (434)
+|.+++.. ...+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 455 ~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 455 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999964 4568999999999999999999999 99999999999999999999999999999876543221 1223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......... +........+....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~------------i~~~~~~~~p~~~~ 598 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------LEKGERMGCPAGCP 598 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------HHTTCCCCCCTTCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCCCCCCCCCCC
Confidence 3456889999999999999999999999999999998 9999987544322111 00111111222334
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..+.+++..||+.||++||++.+|++.|+.+
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 6788899999999999999999999999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.33 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=192.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHH--HhhCCCCCeeeEeee-----ccC--Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGI--IAYVDHPNTAKLVGC-----DSD--GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~-----~~~--~~ 187 (434)
++|.+.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++. ..+ ..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 5688899999999999999987 48999999997532 2234445444 445899999999973 112 46
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC---------CeeecCCCCCcEEecCCCCeEEe
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK---------RIIHRDIKADNILLTEDYEPQIC 258 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~---------~iiHrDlkp~NIll~~~~~~kL~ 258 (434)
++||||+++|+|.+++.. ...++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence 899999999999999964 345888999999999999999998 6 99999999999999999999999
Q ss_pred ccccccccCCCCc------ccceeccccccccccCCcccc-------CCCCCcCcEEehhHHHHHHHhCCCccccccchh
Q 013927 259 DFGLAKWLPRQWT------HHNVSKFEGTFGYFAPEYFMH-------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV 325 (434)
Q Consensus 259 DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 325 (434)
|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653211 112234569999999999976 346678999999999999999988764321110
Q ss_pred ---hhhhccccCc---cccc-----cccCCcCCCC--CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 326 ---VIWAKPLLDS---NDIR-----ELVDPSLGDN--YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 326 ---~~~~~~~~~~---~~~~-----~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
..+....... ..+. ....+.+... ........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 0000000000 0000 0011111111 1234566799999999999999999999999999876533
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=344.15 Aligned_cols=198 Identities=25% Similarity=0.360 Sum_probs=164.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~ 187 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+|++++||||+++++++. +..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 47999999999999999999976 6889999999764332 34457899999999999999999999743 347
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 99999987 699999874 4568999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCcc--------------------cceeccccccccccCCcc-ccCCCCCcCcEEehhHHHHHHHhCCCccc
Q 013927 268 RQWTH--------------------HNVSKFEGTFGYFAPEYF-MHGIVDEKTDVYSFGVLLLELITGRRAVD 319 (434)
Q Consensus 268 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvil~elltG~~p~~ 319 (434)
..... ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 33211 123556799999999986 45569999999999999999998766554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.18 Aligned_cols=258 Identities=23% Similarity=0.268 Sum_probs=190.9
Q ss_pred cCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~~lv~ 191 (434)
+.|.+. ++||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +||||+++++++ .+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 357774 78999999999999965 789999999976532 3345788999999985 799999999974 34689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC---eEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE---PQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGla~~~~~ 268 (434)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999743 568899999999999999999999 89999999999999998776 99999999876532
Q ss_pred CCc-----ccceeccccccccccCCcccc-----CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcc--
Q 013927 269 QWT-----HHNVSKFEGTFGYFAPEYFMH-----GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSN-- 336 (434)
Q Consensus 269 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~-- 336 (434)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........|........
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 111234568999999999875 45889999999999999999999999764322111110000000
Q ss_pred --ccccccCCcCCCCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 337 --DIRELVDPSLGDNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 337 --~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..... .++. .....+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000000000 1111 12356788999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=330.64 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=194.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc---CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS---DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... |+.||||++.... ....+.+|+.++++++||||++++++.. +..++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46888899999999999999886 8899999987543 3456889999999999999999999732 268999999
Q ss_pred cCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999996432 237889999999999999999999 89999999999999999999999999998755432
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........... +........+
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~------------~~~~~~~~~~ 236 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------VEKGYKMDAP 236 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH------------HTTTCCCCCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HhcCCCCCCc
Confidence 123357889999999998899999999999999999998 9999976433221100 0000111112
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
......+..++.+||+.+|.+||++.++++.|+.+.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 223356788999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=342.96 Aligned_cols=247 Identities=18% Similarity=0.209 Sum_probs=186.0
Q ss_pred cCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHh-hCCCCCeeeEeeecc------CCc
Q 013927 117 KNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIA-YVDHPNTAKLVGCDS------DGI 187 (434)
Q Consensus 117 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~------~~~ 187 (434)
++|.+. ++||+|+||+||+|... +|+.||||++... ..+.+|+.++. ..+||||+++++++. +..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 356665 68999999999999976 7899999998642 24667888874 458999999999642 357
Q ss_pred EEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccc
Q 013927 188 HLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLA 263 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla 263 (434)
++||||+++|+|.+++... ...+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 8999999999999999764 3468999999999999999999999 99999999999999997 789999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~i~~ 281 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRM 281 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------CSHHHHHHH
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------HHHHHHHHc
Confidence 865432 2234567899999999999999999999999999999999999999753321100 000000000
Q ss_pred Cc--CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 344 PS--LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 344 ~~--l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.. ............+.+++.+||+.||++|||+.+|++.
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000001223567889999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=334.14 Aligned_cols=258 Identities=27% Similarity=0.358 Sum_probs=195.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--CCc--EEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--DGT--LVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~l 189 (434)
++|.+.+.||+|+||.||+|.+. +++ .||||++..... ......+.+|+.++++++||||++++++.. +..++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 46888899999999999999853 333 689999876432 244567899999999999999999999754 46899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|+||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999999997655678999999999999999999999 89999999999999999999999999999876543
Q ss_pred Cccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 270 WTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............ ......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-----------~~~~~~ 243 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-----------DKEGER 243 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-----------HTSCCC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH-----------HccCCC
Confidence 2221 1233457889999999988889999999999999999999 99999765433221110 000000
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
..........+..++.+||+.+|.+||++.+|++.|+....
T Consensus 244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01112233567889999999999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=335.93 Aligned_cols=262 Identities=25% Similarity=0.309 Sum_probs=195.0
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh----hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCc
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE----KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~ 187 (434)
..++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.+++.++||||+++++++. +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467999999999999999999976 68999999987543221 1246889999999999999999999754 478
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+.+ +|..++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999985 8988887666678889999999999999999999 899999999999999999999999999998764
Q ss_pred CCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---ccccC-ccccc
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPLLD-SNDIR 339 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~~~-~~~~~ 339 (434)
... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......... +. .+... -....
T Consensus 164 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 164 SPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp SCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred CCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 332 223445689999999998764 4889999999999999999999999764332111 11 00000 00000
Q ss_pred ---cccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 340 ---ELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 340 ---~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..+........+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000111 1123678889999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.01 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=190.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCC--chhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGT--VDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++. +..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 56899999999999999999976 78999999997532 1233346788999999999999999999743 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|..++.. ...+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-- 302 (446)
T ss_dssp CCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--
Confidence 99999999999864 3578999999999999999999995 268999999999999999999999999999854322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
........||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. . ... ++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-~~--~------~~~----~p 369 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LM--E------EIR----FP 369 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HH--C------CCC----CC
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-Hh--C------CCC----CC
Confidence 12234567999999999999999999999999999999999999999764432211100 00 0 000 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
......+..++.+||+.||.+|| ++.|+++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12235678899999999999999 9999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=342.59 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=199.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|.+. +|+.||+|++...........+.+|+.++++++||||+++++++ .+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888999999999999999987 78999999998765555566899999999999999999999974 3468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++.. ...+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999974 3468899999999999999999998 5 8999999999999999999999999998754321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcc--cc-----------------
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP--LL----------------- 333 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~--~~----------------- 333 (434)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ..
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1234568999999999999899999999999999999999999997643322110000 00
Q ss_pred --------Ccccc----ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 --------DSNDI----RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 --------~~~~~----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..... ..+................+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000 0000000000001112346788999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=338.99 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=194.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------G 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.. .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 46888999999999999999975 799999999966433 2334578899999999999999999997432 3
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 7899999864 568899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---ccc------c
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPL------L 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~------~ 333 (434)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....... .. .+. .
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 432 234568999999999877 67999999999999999999999999764322111 00 000 0
Q ss_pred Ccccc-------ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH--HhcCCC
Q 013927 334 DSNDI-------RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI--LLRGDE 387 (434)
Q Consensus 334 ~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~L~~~~ 387 (434)
..... .......+. .........+.+++.+||+.||.+|||+.++++ .++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00000 000000000 001122356788999999999999999999987 355443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.88 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++. +..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888899999999999999987 6899999998765433 33456789999999999999999999754 46789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++++|..++. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 105 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 105 FVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp CCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 999999988765 34568999999999999999999999 899999999999999999999999999997654321
Q ss_pred cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc-----ccc--------Ccccc
Q 013927 273 HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK-----PLL--------DSNDI 338 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~-----~~~--------~~~~~ 338 (434)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ... .....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 122345689999999999875 6899999999999999999999999764432211000 000 00000
Q ss_pred ccccCCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+..... +.....+.+++.+||+.||++||++.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111 122467888999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=325.28 Aligned_cols=243 Identities=26% Similarity=0.313 Sum_probs=196.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 46889999999999999999977 578999999976433 234578999999999999999999998544 57899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~~~ 270 (434)
+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999998864 3568999999999999999999999 999999999999999 788899999999998765432
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.............. ... ..
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~--~~ 226 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE-----------GTF--TF 226 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------CCC--CC
T ss_pred ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----------CCC--CC
Confidence 2234568999999998865 489999999999999999999999976443322111000 000 00
Q ss_pred CH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+. .....+..++.+||+.+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 12356788999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=341.92 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=189.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHH-HhhCCCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGI-IAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.+.||+|+||.||+|..+ +++.||||++.+.... .....+..|..+ ++.++||||+++++++. +..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46888999999999999999987 6889999999765432 223356667776 57789999999999754 468999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 999999999999874 3567888899999999999999999 99999999999999999999999999999854322
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .. ++...+ .+
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~----------i~~~~~--~~ 258 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DN----------ILNKPL--QL 258 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-HH----------HHHSCC--CC
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-HH----------HHhccc--CC
Confidence 12234577999999999999999999999999999999999999999764432211 00 000000 01
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++.+||+.||.+||++.+.+.
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1112346778899999999999999864433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=349.74 Aligned_cols=238 Identities=11% Similarity=0.047 Sum_probs=184.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHH---HHHhhCCCCCeeeEe-------eec
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEI---GIIAYVDHPNTAKLV-------GCD 183 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~ 183 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+ .++++++||||++++ ++.
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 56888899999999999999964 799999999975422 23445788999 556666899999988 332
Q ss_pred cC-------------------CcEEEEEEcCCCCHHHHhccCCC------CCCHHHHHHHHHHHHHHhHhhhccCCCCee
Q 013927 184 SD-------------------GIHLVFQLSPLGSLASILHGSKD------KPDWSKRYRIALGTANGLTYLHEGCQKRII 238 (434)
Q Consensus 184 ~~-------------------~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~i~~~i~~gL~yLH~~~~~~ii 238 (434)
.+ ..++||||+ +|+|.+++..... .+++..++.|+.||+.||.|||+ ++|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 22 278999999 5899999974322 23368888899999999999999 8999
Q ss_pred ecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccC-----------CCCCcCcEEehhHH
Q 013927 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-----------IVDEKTDVYSFGVL 307 (434)
Q Consensus 239 HrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGvi 307 (434)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999985432 2345567 999999999887 79999999999999
Q ss_pred HHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 308 LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 308 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+|||++|+.||......... ..+... ...+ ...+.+++.+||+.||++||++.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~-----------~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS-----------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS-----------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch-----------hhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999764321110 111110 0122 246778999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=325.43 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=196.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-----hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-----KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++||||+++++++. +..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888999999999999999987 78999999997654321 2457899999999999999999999754 3688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC----CeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~ 264 (434)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999964 3568999999999999999999999 8999999999999998877 89999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ... ..+
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~----~~~ 232 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-NYD----FDE 232 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCC----CCH
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc-ccC----Ccc
Confidence 664331 223456899999999999889999999999999999999999999764432211100000 000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
... ......+..++.+||+.+|.+||++.++++
T Consensus 233 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 112346788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=334.31 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=183.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeec--------cC-
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCD--------SD- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~--------~~- 185 (434)
.+|.+.++||+|+||.||+|.+. +|+.||||++.... ......+.+|+.++.++. ||||+++++++ .+
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 46888999999999999999976 78999999986653 344457889999999996 99999999874 11
Q ss_pred -CcEEEEEEcCCCCHHHHhcc--CCCCCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEecCCCCeEEecc
Q 013927 186 -GIHLVFQLSPLGSLASILHG--SKDKPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
..++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3689999997 789888864 45679999999999999999999998 78 999999999999999999999999
Q ss_pred ccccccCCCCccc----------ceeccccccccccCCcc---ccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh
Q 013927 261 GLAKWLPRQWTHH----------NVSKFEGTFGYFAPEYF---MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327 (434)
Q Consensus 261 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 327 (434)
|+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 9998765432111 11244589999999998 5566889999999999999999999999753322111
Q ss_pred hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 328 WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 328 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
...............+..++.+||+.+|.+||++.++++.|+.+..
T Consensus 263 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 263 ---------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000000011111346678899999999999999999999986654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.39 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=189.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------G 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57999999999999999999876 789999999986533 2344578899999999999999999997432 4
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+.+ +|.+++. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 6899999984 7888775 358899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc----------------
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK---------------- 330 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~---------------- 330 (434)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..........
T Consensus 178 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 432 1234467899999999999989999999999999999999999999764432111000
Q ss_pred ----------cccCccccccccCCcCCCCC---CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 331 ----------PLLDSNDIRELVDPSLGDNY---DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 331 ----------~~~~~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++........ .......+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000011100000000 0122467889999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.30 Aligned_cols=261 Identities=24% Similarity=0.311 Sum_probs=197.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS---------- 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~---------- 184 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 46889999999999999999985 7899999998665432 22346789999999999999999999743
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
+..++||||+.+ +|...+......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 247899999985 7777777666779999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCC--cccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-----ccc----
Q 013927 265 WLPRQW--THHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----KPL---- 332 (434)
Q Consensus 265 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-----~~~---- 332 (434)
.+.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 764321 1122345678999999999876 4589999999999999999999999976443211100 000
Q ss_pred ---cCccccccccCCcCCCCCC-HHH------HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 ---LDSNDIRELVDPSLGDNYD-AEE------IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ---~~~~~~~~~~d~~l~~~~~-~~~------~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.........+......... ... ...+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000000000011 111 235778999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.72 Aligned_cols=260 Identities=15% Similarity=0.145 Sum_probs=200.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC---------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeee---------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD---------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAK--------- 178 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 178 (434)
++|.+.+.||+|+||.||+|.... ++.||||++... ..+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 468899999999999999999763 789999999754 35888999999999999998
Q ss_pred ------Eeeec---cCCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEE
Q 013927 179 ------LVGCD---SDGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNIL 248 (434)
Q Consensus 179 ------l~g~~---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIl 248 (434)
++++. .+..++||||+ +++|.+++... ...+++..+..|+.||+.||.|||+ ++|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 34432 34678999999 89999999754 4679999999999999999999999 89999999999999
Q ss_pred ecCCC--CeEEeccccccccCCCCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccc
Q 013927 249 LTEDY--EPQICDFGLAKWLPRQWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHL 321 (434)
Q Consensus 249 l~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 321 (434)
++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876533211 1123457999999999999989999999999999999999999999875
Q ss_pred cch-hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 322 QQS-VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 322 ~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
... ................+.+..... ......+..++.+||+.||.+||++.+|++.|+.+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 311 111110000011111122111110 01125678889999999999999999999999866433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=333.21 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=201.1
Q ss_pred HHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhh--CCCCCeeeEeeeccC-----
Q 013927 113 QTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY--VDHPNTAKLVGCDSD----- 185 (434)
Q Consensus 113 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----- 185 (434)
....++|.+.+.||+|+||.||+|... |+.||||++... ....+.+|++++.. ++||||+++++++.+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567999999999999999999985 899999998643 23457788998887 789999999997432
Q ss_pred -CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhh--------ccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 186 -GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH--------EGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH--------~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+|
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEE
T ss_pred ceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEE
Confidence 57899999999999999964 46899999999999999999999 6 8999999999999999999999
Q ss_pred EeccccccccCCCCccc--ceeccccccccccCCccccCC------CCCcCcEEehhHHHHHHHhC----------CCcc
Q 013927 257 ICDFGLAKWLPRQWTHH--NVSKFEGTFGYFAPEYFMHGI------VDEKTDVYSFGVLLLELITG----------RRAV 318 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG----------~~p~ 318 (434)
|+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997664432211 123456899999999987653 33689999999999999999 6677
Q ss_pred ccccch---hhhhhccccCccccccccCCcCCCC-CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 319 DHLQQS---VVIWAKPLLDSNDIRELVDPSLGDN-YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 319 ~~~~~~---~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...... ...+.... ......+.+... ........+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCcCcccHHHHHHHH-----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 543211 00000000 000111111111 12356678999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.57 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=198.3
Q ss_pred CHHHHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeec--
Q 013927 108 TLSELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCD-- 183 (434)
Q Consensus 108 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-- 183 (434)
++.++....++|.+.+.||+|+||.||+|.+. +|+.||||++..... ....+.+|+.+++++ +||||+++++++
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33344445678999999999999999999975 789999999976432 234688999999999 799999999974
Q ss_pred ------cCCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeE
Q 013927 184 ------SDGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ 256 (434)
Q Consensus 184 ------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k 256 (434)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 34688999999999999999754 3568899999999999999999999 8999999999999999999999
Q ss_pred EeccccccccCCCCcccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcc
Q 013927 257 ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP 331 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~ 331 (434)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||............+
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 99999998654321 1223456899999999987 4568899999999999999999999997654433222111
Q ss_pred ccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH--HhcCC
Q 013927 332 LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI--LLRGD 386 (434)
Q Consensus 332 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~L~~~ 386 (434)
.. ...... ... ....+..++.+||+.+|.+||++.++++ .++..
T Consensus 248 ~~---~~~~~~----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 248 RN---PAPRLK----SKK----WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HS---CCCCCS----CSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cC---ccccCC----ccc----cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 10 000010 111 1246778999999999999999999986 44443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=339.76 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=198.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~~ 188 (434)
++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++.+++||||+++++++. ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 47999999999999999999976 788999999986555555567899999999999999999999743 2478
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+. |+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 107 iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9999998 589998864 458999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCccc-ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc----cccCcccccc--
Q 013927 269 QWTHH-NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK----PLLDSNDIRE-- 340 (434)
Q Consensus 269 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~----~~~~~~~~~~-- 340 (434)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .......+..
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 32211 1244579999999998754 45899999999999999999999999764322111000 0000000000
Q ss_pred ------cc-CCcCCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 341 ------LV-DPSLGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 341 ------~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. ........+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000001 112356788999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=365.98 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=206.3
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHL 189 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~l 189 (434)
..++|.+.+.||+|+||.||+|.+. .+..||||.+...........+.+|+.++++++||||+++++++. +..++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 3467888999999999999999864 246799999876655555668999999999999999999999754 47899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999998766679999999999999999999999 89999999999999999999999999999876443
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||............ ......
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i--------~~~~~~---- 611 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERL---- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--------HHTCCC----
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------HcCCCC----
Confidence 21 12233456789999999998899999999999999999997 99999865433221110 000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
..+......+..++.+||+.||.+||++.+|++.|+.+.
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111222356788999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=328.52 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=181.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHh-hHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.......... .+..+...++.++||||+++++++. +..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 56888999999999999999975 78999999997654433333 3444555688899999999999743 47899999
Q ss_pred EcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 193 LSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 193 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
|++ |+|.+++.. ....+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 998 588777653 45679999999999999999999998 7 999999999999999999999999999986644
Q ss_pred CCcccceeccccccccccCCcc----ccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYF----MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
.. ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||............ ....
T Consensus 163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~ 229 (290)
T 3fme_A 163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----------VVEE 229 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----------HHHS
T ss_pred cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----------Hhcc
Confidence 32 12334689999999996 4566889999999999999999999999753322211110 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.............+.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000001122346788999999999999999999965
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.43 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=197.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|... +|+.||||.+.... ....+.+|+.++++++||||+++++++ .+..++|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 357899999999999999999976 68999999997643 234688999999999999999999974 346899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999997556779999999999999999999999 9999999999999999999999999999976643321
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||................. +.. ..+.
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~--~~~~ 249 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--------PTF--RKPE 249 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------CCC--SSGG
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--------ccc--CCcc
Confidence 22345689999999999988899999999999999999999999976544332221110000 000 0111
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.||.+||++.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12356788999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=335.80 Aligned_cols=266 Identities=24% Similarity=0.302 Sum_probs=197.7
Q ss_pred HHHHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch----------hhHhhHHHHHHHHhhCCCCCeee
Q 013927 109 LSELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD----------EKTCGFLCEIGIIAYVDHPNTAK 178 (434)
Q Consensus 109 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~ 178 (434)
..++....++|.+.+.||+|+||.||+|...+|+.||||++...... .....+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998653321 11257899999999999999999
Q ss_pred Eeeec-----cC--CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 179 LVGCD-----SD--GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 179 l~g~~-----~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
+++++ .. ..++||||+. |+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcC
Confidence 99974 11 4689999998 68888887666789999999999999999999999 89999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh--
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW-- 328 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-- 328 (434)
++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 170 NNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999754332 12234568999999999877 668999999999999999999999997643221110
Q ss_pred ----hcccc------CccccccccCCcCCCC-------CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 329 ----AKPLL------DSNDIRELVDPSLGDN-------YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 329 ----~~~~~------~~~~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+.. ........+...+... ........+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000 0000001111111000 00112356788999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.94 Aligned_cols=259 Identities=29% Similarity=0.385 Sum_probs=182.2
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++ .+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467999999999999999999865 78999999987654444455788999999999999999999974 457899999
Q ss_pred EcCCCCHHHHhcc-------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 193 LSPLGSLASILHG-------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 193 ~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 34568999999999999999999999 8999999999999999999999999999976
Q ss_pred cCCCCc---ccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc-cc
Q 013927 266 LPRQWT---HHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI-RE 340 (434)
Q Consensus 266 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~ 340 (434)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 643211 111234568999999999876 5689999999999999999999999976543322111100000000 01
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..++.....+ ...+..++.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 251 VQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111222 246778999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=331.62 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=193.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-------hhhHhhHHHHHHHHhhCCCCCeeeEeeec-cCCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-------DEKTCGFLCEIGIIAYVDHPNTAKLVGCD-SDGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~ 187 (434)
++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||++++++. .+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 56999999999999999999976 689999999875432 12234688999999999999999999974 3468
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC---eEEecccccc
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE---PQICDFGLAK 264 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGla~ 264 (434)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 999999999999998863 4578999999999999999999999 89999999999999987664 9999999998
Q ss_pred ccCCCCcccceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL 341 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 341 (434)
..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.............. .....
T Consensus 166 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~-- 238 (322)
T 2ycf_A 166 ILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKYN-- 238 (322)
T ss_dssp ECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH--HTCCC--
T ss_pred ecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH--hCccc--
Confidence 76432 1223456899999999974 45688999999999999999999999975432211100000 00000
Q ss_pred cCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 342 VDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 342 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+... ......+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 112356788999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.19 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=191.7
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------- 184 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------- 184 (434)
...++|.+.+.||+|+||.||+|... +|+.||||++..... ...+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44568999999999999999999875 799999999876432 2346999999999999999998641
Q ss_pred ------------------------------C--CcEEEEEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhh
Q 013927 185 ------------------------------D--GIHLVFQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYL 229 (434)
Q Consensus 185 ------------------------------~--~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yL 229 (434)
+ ..++||||++ |+|.+.+.. ....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 2779999998 577776653 456789999999999999999999
Q ss_pred hccCCCCeeecCCCCCcEEec-CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCC-CCCcCcEEehhHH
Q 013927 230 HEGCQKRIIHRDIKADNILLT-EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVL 307 (434)
Q Consensus 230 H~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvi 307 (434)
|+ ++|+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||+
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 98 9999999999999998 68899999999998764432 223456899999999987654 8999999999999
Q ss_pred HHHHHhCCCccccccchhhhhh------cc----------ccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCC
Q 013927 308 LLELITGRRAVDHLQQSVVIWA------KP----------LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPI 371 (434)
Q Consensus 308 l~elltG~~p~~~~~~~~~~~~------~~----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~ 371 (434)
+|||++|+.||.+......... .| ......+..+....+...++......+.+++.+||+.+|.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999976432221100 00 0000000000000000001112335678899999999999
Q ss_pred CCCCHhHHHH
Q 013927 372 LRPKMSQVVI 381 (434)
Q Consensus 372 ~RPs~~evl~ 381 (434)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.13 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=200.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
.++|.+.++||+|+||.||+|... +|+.||||++.+... ......+.+|+.+|++++||||+++++++. +..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 367899999999999999999986 799999999975422 122346889999999999999999999754 468999
Q ss_pred EEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 191 FQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.+...
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999998754 3458999999999999999999999 89999999999999999999999999999876543
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh---hhhhccccCccccccccCCcC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---VIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~d~~l 346 (434)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+... +.. ...
T Consensus 340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~-------i~~-~~~-- 406 (576)
T 2acx_A 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-------VKE-VPE-- 406 (576)
T ss_dssp C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH-------HHH-CCC--
T ss_pred c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH-------hhc-ccc--
Confidence 2 2344579999999999999889999999999999999999999997643211 01000 000 001
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
.++......+..++.+||+.||.+|| ++.||++
T Consensus 407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11122235678899999999999999 6788864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.04 Aligned_cols=246 Identities=26% Similarity=0.298 Sum_probs=193.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.+... ...+|+.++.++ +||||+++++++.+ ..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 46999999999999999999977 789999999976542 245688888888 79999999998554 5789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC----CCeEEeccccccccCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED----YEPQICDFGLAKWLPR 268 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGla~~~~~ 268 (434)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999999874 4568999999999999999999999 899999999999998543 3599999999986643
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch--hhhhhccccCccccccccCCcC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS--VVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l 346 (434)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..... .... .+
T Consensus 173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~--~~~~------~~ 242 (342)
T 2qr7_A 173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--SGKF------SL 242 (342)
T ss_dssp TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--HCCC------CC
T ss_pred CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--cCCc------cc
Confidence 32 1234567899999999998888999999999999999999999999753211 11110000 0000 00
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...........+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111122356778999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.80 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46888899999999999999987 688999999876432 2345578899999999999999999998544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 95 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp ECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999999998863 3568999999999999999999999 8999999999999999999999999999986643221
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. . ...+..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~------~~~~~~--- 236 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK---N------EYSIPK--- 236 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---T------CCCCCT---
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---c------cCCCcc---
Confidence 22345689999999999988899999999999999999999999976433221110000 0 001111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.+|++||++.++++
T Consensus 237 -~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 -HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 12246778899999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=347.55 Aligned_cols=258 Identities=22% Similarity=0.251 Sum_probs=200.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCee-eEee--eccCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA-KLVG--CDSDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g--~~~~~~~lv~e 192 (434)
++|.+.++||+|+||.||+|.+. +++.||||++...... ..+..|+.++..+.|++.+ .+.. ...+..++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57999999999999999999975 7899999988764432 3588899999999875443 3333 34557889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~~ 269 (434)
|+ +++|.+++......+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 899999998667789999999999999999999999 999999999999999 68889999999999876543
Q ss_pred Cccc-----ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 270 WTHH-----NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 270 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...................+...+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE- 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH-
Confidence 2211 1235679999999999999999999999999999999999999998743321110000000000000000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+...+ ...+..++..||+.+|++||++.+|++.|+.+
T Consensus 239 ~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000111 25678899999999999999999999998766
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=336.18 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=188.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
.++|.+.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++ .+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457999999999999999999866 7899999999765432 2334678899999999999999999974 34688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-----CCCCeEEecccccccc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-----EDYEPQICDFGLAKWL 266 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-----~~~~~kL~DFGla~~~ 266 (434)
||+. |+|.+++... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 113 e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9998 5999988743 468999999999999999999999 8999999999999994 4556999999999866
Q ss_pred CCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccCc-ccc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLDS-NDI 338 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~~-~~~ 338 (434)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .+.... ...
T Consensus 188 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 188 GIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp C-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred CCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 4321 223445689999999999875 489999999999999999999999976433221110 000000 000
Q ss_pred c---cccC--CcCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 R---ELVD--PSLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~---~~~d--~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. .... +...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0000 0000000 0012356788999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.55 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=197.9
Q ss_pred HHHhcCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCC-CCCeeeEeeeccC--C
Q 013927 113 QTATKNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD--G 186 (434)
Q Consensus 113 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~ 186 (434)
....+.|.+. +.||+|+||.||+|... +|+.||||++...... .....+.+|+.++..+. ||||+++++++.+ .
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3344567776 78999999999999977 7899999999764332 33457889999999995 6999999998544 6
Q ss_pred cEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEecccc
Q 013927 187 IHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGL 262 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGl 262 (434)
.++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 88999999999999998643 4678999999999999999999999 89999999999999998 78999999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 249 (327)
T 3lm5_A 181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-------- 249 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--------
Confidence 98764331 2234568999999999999999999999999999999999999997644332211100000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..............+..++.+||+.+|.+||++.++++.
T Consensus 250 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 -VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 000011111223567789999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=323.94 Aligned_cols=241 Identities=21% Similarity=0.254 Sum_probs=193.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+..+..+ +||||+++++++ .+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56889999999999999999987 799999999986533 23455788999999999 999999999974 34688999
Q ss_pred EEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC----------------
Q 013927 192 QLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---------------- 252 (434)
Q Consensus 192 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---------------- 252 (434)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999753 2568999999999999999999999 899999999999999844
Q ss_pred ---CCeEEeccccccccCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhh
Q 013927 253 ---YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW 328 (434)
Q Consensus 253 ---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 328 (434)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++........+.
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~ 241 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH
T ss_pred CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH
Confidence 47999999999876543 123489999999999866 56689999999999999999988765432211111
Q ss_pred hccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 329 AKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 329 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. .. .+.+... ....+.+++.+||+.||++||++.++++
T Consensus 242 ~------~~-----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 242 Q------GR-----LPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp T------TC-----CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------CC-----CCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 00 0111112 2356788999999999999999999965
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.98 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=198.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++. +..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999976 6889999998753221 22346889999999999999999999754 3688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 999999999998743 468899999999999999999998 899999999999999999999999999987654321
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||........... +.... ..++
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----------~~~~~--~~~~ 232 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-----------IVNVD--LKFP 232 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-----------HHTTC--CCCC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-----------Hhccc--cCCC
Confidence 2345689999999999998999999999999999999999999976443221110 00000 0111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122356778999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=322.24 Aligned_cols=250 Identities=21% Similarity=0.217 Sum_probs=197.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhCCCCCeeeEeeec--c--CCc
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--S--DGI 187 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~--~~~ 187 (434)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++ . +..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999976 789999999975422 12345789999999999999999999974 2 367
Q ss_pred EEEEEEcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 188 HLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
++||||+.+| |.+++.. ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999977 6666654 35678999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCcccceeccccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||............. .. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~---~~------~~ 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG---KG------SY 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HC------CC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh---cC------CC
Confidence 5433333334566899999999987644 4779999999999999999999998643321110000 00 00
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.+. ......+..++.+||+.||.+||++.++++.
T Consensus 231 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 1223467789999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=349.29 Aligned_cols=248 Identities=26% Similarity=0.353 Sum_probs=198.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+ ..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999987 789999999976543 2344578999999999999999999998554 588999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~ 268 (434)
||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 106 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999998874 4568999999999999999999999 899999999999999 5678999999999987654
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.............. .... ...+
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~-~~~~---- 249 (484)
T 3nyv_A 182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK---GKYT-FELP---- 249 (484)
T ss_dssp CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCC-CCSG----
T ss_pred cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CCCC-CCCc----
Confidence 32 2344569999999999865 689999999999999999999999987543322111000 0000 0000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........+..++.+||+.+|.+|||+.|+++
T Consensus 250 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 -QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00122356788999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.00 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=194.9
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch------------hhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD------------EKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
.++|.+.+.||+|+||+||+|... +++.||||++...... .....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 357999999999999999999976 6889999999765322 224568899999999999999999998
Q ss_pred ccC--CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC---CeEE
Q 013927 183 DSD--GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY---EPQI 257 (434)
Q Consensus 183 ~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL 257 (434)
+.+ ..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 554 57899999999999998864 3568999999999999999999999 8999999999999998776 6999
Q ss_pred eccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc
Q 013927 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||............
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------- 259 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV------- 259 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------
Confidence 9999998765432 234456999999999986 56899999999999999999999999875433221100
Q ss_pred cccccCCcCCCCCCH----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 IRELVDPSLGDNYDA----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 ~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..... .++. .....+.+++.+||+.+|.+|||+.|+++
T Consensus 260 ----~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 ----EKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----HHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 0000 11256788999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=338.61 Aligned_cols=251 Identities=26% Similarity=0.307 Sum_probs=195.4
Q ss_pred cCCCCCCeecccCcEEEEEEEe----CCCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhC-CCCCeeeEeeec--cCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL----RDGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYV-DHPNTAKLVGCD--SDG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~--~~~ 186 (434)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+.++.++ +||||+++++++ .+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4688899999999999999987 3689999999875322 12234577899999999 699999999974 346
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 8899999999999999974 3468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcccceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHhCCCccccccchh--hhhhccccCcccccccc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGRRAVDHLQQSV--VIWAKPLLDSNDIRELV 342 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 342 (434)
..... .......||+.|+|||++.++ .++.++|||||||++|||++|+.||....... ....... .. .
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------~~-~ 281 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------LK-S 281 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH------HH-C
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH------hc-c
Confidence 43222 223456799999999999853 47899999999999999999999997532111 0000000 00 0
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCC-----CHhHHHHHh
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRP-----KMSQVVILL 383 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~~L 383 (434)
.+. ++......+..++.+||+.||.+|| ++.++++..
T Consensus 282 ~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 1122234677899999999999999 899997654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.92 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=199.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+ ..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46888899999999999999976 688999999876432 2345578899999999999999999998544 578999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 121 e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 121 ELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp CCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred ecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 99999999998864 3568999999999999999999999 899999999999999999999999999998764322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ . .. ...+...
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~--~~------~~~~~~~-- 263 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-K--KN------EYSIPKH-- 263 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-H--HT------CCCCCTT--
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-h--cC------CCCCCcc--
Confidence 1223456899999999999888999999999999999999999999764322211100 0 00 0011111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+..++.+||+.||++||++.++++
T Consensus 264 --~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 --INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2245778899999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.26 Aligned_cols=250 Identities=25% Similarity=0.401 Sum_probs=190.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec------------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD------------ 183 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~------------ 183 (434)
++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++++++||||+++++++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46889999999999999999976 7899999999642 34455789999999999999999999863
Q ss_pred ---cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecc
Q 013927 184 ---SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDF 260 (434)
Q Consensus 184 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF 260 (434)
.+..++||||+++|+|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 235789999999999999998666678889999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCc------------ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh
Q 013927 261 GLAKWLPRQWT------------HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327 (434)
Q Consensus 261 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 327 (434)
|++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 99986543210 1122345689999999999764 68999999999999999998 44322111111
Q ss_pred hhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 328 WAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 328 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
..... . ....+...++......+..++.+||+.||.+||++.++++.
T Consensus 238 ~~~~~-------~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLR-------S-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHH-------S-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhcc-------c-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 10000 0 01111222333344567889999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=331.03 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=199.6
Q ss_pred HHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhC-CCCCeeeEeeec
Q 013927 113 QTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYV-DHPNTAKLVGCD 183 (434)
Q Consensus 113 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 183 (434)
....++|.+.+.||.|+||.||+|.+. +|+.||||++...... .....+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567999999999999999999986 7999999999765421 1234678899999999 799999999975
Q ss_pred c--CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 184 S--DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 184 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
. ...++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence 3 468899999999999999863 3568999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCcccceeccccccccccCCcccc------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCc
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS 335 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~ 335 (434)
++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. .
T Consensus 246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~---~ 319 (365)
T 2y7j_A 246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM---E 319 (365)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H
T ss_pred cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---h
Confidence 998765432 2345679999999999863 358899999999999999999999997643322111000 0
Q ss_pred cccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 336 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... ...+.. . .....+..++.+||+.||++||++.++++
T Consensus 320 ~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 000000 0 11245788999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=339.21 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=195.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC--------CCCeeeEeeecc---
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD--------HPNTAKLVGCDS--- 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~--- 184 (434)
++|.+.++||+|+||+||+|... +++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 57999999999999999999875 7899999999753 234457889999999985 788999999643
Q ss_pred ---CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCC-------
Q 013927 185 ---DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDY------- 253 (434)
Q Consensus 185 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~------- 253 (434)
...++||||+.++.+..++......+++..+..|+.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 36889999995544444444444679999999999999999999999 7 999999999999999775
Q ss_pred ------------------------------------------CeEEeccccccccCCCCcccceeccccccccccCCccc
Q 013927 254 ------------------------------------------EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291 (434)
Q Consensus 254 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 291 (434)
.+||+|||++...... .....||+.|+|||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999876433 23446899999999999
Q ss_pred cCCCCCcCcEEehhHHHHHHHhCCCccccccchh---------hhhh--cc--------------cc-CccccccccCCc
Q 013927 292 HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV---------VIWA--KP--------------LL-DSNDIRELVDPS 345 (434)
Q Consensus 292 ~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~---------~~~~--~~--------------~~-~~~~~~~~~d~~ 345 (434)
+..++.++|||||||++|||++|+.||....... .+.. .+ .+ .......+.+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9899999999999999999999999997532110 0000 00 00 000000000000
Q ss_pred ---------CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 346 ---------LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 346 ---------l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
-....+......+.+++.+||+.||++|||+.||++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 011234566778999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.86 Aligned_cols=249 Identities=28% Similarity=0.365 Sum_probs=195.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46999999999999999999976 789999999865321 1234568899999999999999999998544 6889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec---CCCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGla~~~~~~ 269 (434)
|+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 102 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999998864 3568999999999999999999999 9999999999999995 4567999999999866433
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+............ .... ...+.
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~-~~~~~---- 245 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET---GKYA-FDLPQ---- 245 (486)
T ss_dssp -------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCC-SCSGG----
T ss_pred ---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCC-CCCcc----
Confidence 22344579999999999875 589999999999999999999999976443322111000 0000 00000
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
.......+..++.+||+.+|.+|||+.++++.
T Consensus 246 -~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 -WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01123567889999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=323.32 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=196.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46889999999999999999976 789999999986432 233468899999999999999999997543 67899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe---cCCCCeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---TEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGla~~~~~~~ 270 (434)
+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 999999998864 3468899999999999999999999 899999999999999 78889999999999754332
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ... ... ... .
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~-~~~-~~~----~ 230 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK---EGY-YEF-ESP----F 230 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HCC-CCC-CTT----T
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCC-CCC-Ccc----c
Confidence 2234568999999999999899999999999999999999999997643322110000 000 000 001 1
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122356788999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=346.02 Aligned_cols=248 Identities=26% Similarity=0.325 Sum_probs=192.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
+.|.+.+.||+|+||+||+|... ++..||||++..... ......+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 35889999999999999999987 789999999986543 2234568899999999999999999998554 6889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC---CCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---YEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGla~~~~~~ 269 (434)
|+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999988863 3568899999999999999999999 899999999999999764 45999999999876543
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
. ......||+.|+|||++. +.++.++|||||||++|+|++|..||.............. ... .+..+.. .
T Consensus 193 ~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~-~~~~~~~-~- 262 (494)
T 3lij_A 193 K---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK---GKY-TFDSPEW-K- 262 (494)
T ss_dssp B---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCC-CCCSGGG-T-
T ss_pred c---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCC-CCCchhc-c-
Confidence 2 234457999999999886 5699999999999999999999999976443322111000 000 0000000 1
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+..++.+||+.+|.+|||+.++++
T Consensus 263 ---~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 263 ---NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 12246778999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=327.26 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
+.|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++. +..++||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46889999999999999999987 689999999875432 33457889999999999999999999743 478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++++|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence 99999999987656779999999999999999999999 89999999999999999999999999997543211 01
Q ss_pred ceeccccccccccCCcc-----ccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 274 NVSKFEGTFGYFAPEYF-----MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~-----~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
......||+.|+|||++ .+..++.++||||||+++|+|++|+.||............... .....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~------- 242 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---DPPTL------- 242 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCC-------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc---CCccc-------
Confidence 12335689999999998 3567899999999999999999999999865433221110000 00000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+......+..++.+||+.+|.+||++.++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122356788999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.88 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=196.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.++||+|+||.||+|... +|+.||||++.+.... .....+..|+.++++++||||+++++++. +..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999986 7999999999764322 22346889999999999999999999754 3689999
Q ss_pred EEcCCCCHHHHhccC---CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGS---KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
||+++|+|..++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998653 3468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccch---hhhhhccccCccccccccCCc
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQS---VVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~~~d~~ 345 (434)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.. .+....
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----------~i~~~~ 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----------RVLEQA 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----------HHHHCC
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----------HHhhcc
Confidence 321 223457999999999999989999999999999999999999999764321 11100 000000
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHh
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMS 377 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 377 (434)
..++......+..++.+||+.||.+||++.
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 011122235677889999999999999763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=330.76 Aligned_cols=251 Identities=19% Similarity=0.290 Sum_probs=191.8
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCC--CCCeeeEeeecc--CCcEE
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVD--HPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~--~~~~l 189 (434)
..++|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|+.++.++. ||||+++++++. +..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 3456999999999999999999988899999999976543 334567899999999997 599999999744 35788
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||| +.+++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||+++ +.+||+|||++......
T Consensus 106 v~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 999 567899999974 3568899999999999999999999 89999999999999975 79999999999876543
Q ss_pred CcccceeccccccccccCCcccc-----------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMH-----------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
..........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---------- 249 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------- 249 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----------
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH----------
Confidence 33223345568999999999875 467889999999999999999999997643221111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+++.....++......+..++.+||+.+|.+||++.+|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111222111222222356788899999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=338.20 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=179.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--------CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~~ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++. ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 57999999999999999999865 789999999976433 234457889999999999999999999743 35
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++|++++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 78999998 5889988854 568999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---h---hccc------c
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---W---AKPL------L 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~---~~~~------~ 333 (434)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....... . ..|. .
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 234578999999999877 67899999999999999999999999764432111 0 0000 0
Q ss_pred CccccccccCCcC-CCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 DSNDIRELVDPSL-GDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 ~~~~~~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......++.... ...... .....+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000000 000010 11246788999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=326.69 Aligned_cols=251 Identities=17% Similarity=0.206 Sum_probs=194.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc----CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS----DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~----~~~~lv 190 (434)
++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+|+.++++++ ||||++++++.. ...++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46889999999999999999875 78999999987533 346889999999997 999999999753 357899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQ 269 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~ 269 (434)
|||+.+++|..++. .++...+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999985 38889999999999999999999 9999999999999999776 8999999999876543
Q ss_pred CcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh---c--------------c
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA---K--------------P 331 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~---~--------------~ 331 (434)
. ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||........... . .
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 2234568999999999877 6689999999999999999999999943221110000 0 0
Q ss_pred ccCccccccccC--------CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 LLDSNDIRELVD--------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ~~~~~~~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.........+.. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 00111111123467888999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=327.23 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=175.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHH-HHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIG-IIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...........+..|+. +++.++||||+++++++. +..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 46888899999999999999986 789999999987654444455666666 777889999999999743 46889999
Q ss_pred EcCCCCHHHHhcc----CCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 193 LSPLGSLASILHG----SKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 193 ~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 77777652 35678999999999999999999998 7 99999999999999999999999999998664
Q ss_pred CCCcccceeccccccccccCCcc----ccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYF----MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||............ ..... .
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~-----~ 247 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ--VVKGD-----P 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC--CCCSC-----C
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH--HhcCC-----C
Confidence 331 12334689999999998 4566899999999999999999999999764322111100 00000 0
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+.+...........+..++.+||+.||.+||++.+|++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111122356788999999999999999999965
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=320.67 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=192.5
Q ss_pred CCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~~ 195 (434)
|....+||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++||||+++++++. +..++||||++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 555568999999999999975 788999999976543 33456889999999999999999999754 46789999999
Q ss_pred CCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-CCCeEEeccccccccCCCCcc
Q 013927 196 LGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-DYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 196 ~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 999999997543 346788899999999999999999 89999999999999987 8999999999998664321
Q ss_pred cceeccccccccccCCccccCC--CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI--VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+|||++.++. ++.++||||||+++|+|++|+.||.............. .....+.+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~--- 248 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG------MFKVHPEIP--- 248 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH------HHCCCCCCC---
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc------ccccccccc---
Confidence 1223456899999999987654 78999999999999999999999976433221111000 000111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||+.+|++||++.++++
T Consensus 249 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 -ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222356778999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.38 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=186.3
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C-
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G- 186 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~- 186 (434)
......++|.+.+.||+|+||.||+|... +|+.||||++..... ....+..++..+..++||||+++++++.. .
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 44556678999999999999999999986 789999999876432 23357778888999999999999997421 1
Q ss_pred ------cEEEEEEcCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHhHhhh--ccCCCCeeecCCCCCcEEecC-CCC
Q 013927 187 ------IHLVFQLSPLGSLASILH---GSKDKPDWSKRYRIALGTANGLTYLH--EGCQKRIIHRDIKADNILLTE-DYE 254 (434)
Q Consensus 187 ------~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~gL~yLH--~~~~~~iiHrDlkp~NIll~~-~~~ 254 (434)
.++||||++++ |...+. .....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 78999999964 443332 24567889999999999999999999 7 89999999999999997 899
Q ss_pred eEEeccccccccCCCCcccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcc--
Q 013927 255 PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP-- 331 (434)
Q Consensus 255 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~-- 331 (434)
+||+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.............
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999998765432 223456899999999987654 8999999999999999999999997644322110000
Q ss_pred -ccCcccc-c---------cccC------CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 -LLDSNDI-R---------ELVD------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 -~~~~~~~-~---------~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....... . ...+ ..............+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 0 0000 00001112224567889999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=318.73 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=189.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++. +..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56889999999999999999987 799999999875322 122346889999999999999999999744 4688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 999999999999643 468899999999999999999999 899999999999999999999999999998664431
Q ss_pred ccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........... +.... ..+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~-~~~---- 230 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK--------IRGGV-FYI---- 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------HHHCC-CCC----
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH--------hhcCc-ccC----
Confidence 1234568999999999987765 5899999999999999999999976432211100 00000 001
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+..++.+||+.||.+||++.+|++
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112246778999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=330.08 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~~~ 188 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.++++++||||+++++++. ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 57889999999999999999976 789999999976554455567889999999999999999999743 3578
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+. |+|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 91 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 9999998 689998864 468999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCccc--------ceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh------hcccc
Q 013927 269 QWTHH--------NVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW------AKPLL 333 (434)
Q Consensus 269 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~------~~~~~ 333 (434)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ ..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 21111 1223568999999998765 678999999999999999999999997644221110 00000
Q ss_pred C-------ccccccccCCc-CCCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH--HhcCC
Q 013927 334 D-------SNDIRELVDPS-LGDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI--LLRGD 386 (434)
Q Consensus 334 ~-------~~~~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~L~~~ 386 (434)
. .......+... ...... ......+.+++.+||+.||++||++.++++ .++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 00000000000 000000 112356788999999999999999999986 34443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.63 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=199.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHL 189 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~l 189 (434)
.++|.+.++||+|+||.||+|... +++.||||++.+... ......+..|..++..+ +||||+.++++..+ .+++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999976 688999999975422 22334678899999987 79999999997554 6889
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999743 568999999999999999999999 99999999999999999999999999999854322
Q ss_pred CcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.......+||+.|+|||++.+..|+.++|||||||+||||++|+.||........... ++...+ .
T Consensus 496 --~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~-----------i~~~~~--~ 560 (674)
T 3pfq_A 496 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-----------IMEHNV--A 560 (674)
T ss_dssp --TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----------HHSSCC--C
T ss_pred --CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH-----------HHhCCC--C
Confidence 1234567899999999999999999999999999999999999999987543322111 111100 1
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCH-----hHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKM-----SQVV 380 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~evl 380 (434)
++......+..++..||+.||.+||++ .+|+
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 112233567889999999999999998 6665
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=340.68 Aligned_cols=252 Identities=25% Similarity=0.311 Sum_probs=189.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc------C--CcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------D--GIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~--~~~ 188 (434)
+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+.++++++||||+++++++. + ..+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4888899999999999999986 689999999975432 2346999999999999999988641 1 266
Q ss_pred EEEEEcCCCCHHHHhc---cCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEecccccc
Q 013927 189 LVFQLSPLGSLASILH---GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~ 264 (434)
+||||+++ +|..++. .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999985 5555543 245678999999999999999999998 999999999999999965 578999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhh---hh---ccccC---
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---WA---KPLLD--- 334 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~~---~~~~~--- 334 (434)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....... .. .|...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 7644321 2345689999999998765 6899999999999999999999999764322111 00 00000
Q ss_pred --ccccccccCCcCCC-----CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 335 --SNDIRELVDPSLGD-----NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 335 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..+.+.. .+.......+.+|+.+||+.||.+||++.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00001111111100 011122357888999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.16 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=197.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
.++|.+.+.||+|+||.||+|.... .||||++..... ......+.+|+.++++++||||+++++++. +..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4578899999999999999999863 399999875432 223346778999999999999999999754 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC--
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW-- 270 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~-- 270 (434)
|+++++|.+++......+++..+..++.|++.||.|||+ ++|+||||||+|||++ ++.+||+|||++.......
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999998766679999999999999999999999 8999999999999998 6799999999987543211
Q ss_pred -cccceeccccccccccCCcccc---------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccc
Q 013927 271 -THHNVSKFEGTFGYFAPEYFMH---------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE 340 (434)
Q Consensus 271 -~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 340 (434)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+.....
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------- 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG------- 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-------
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-------
Confidence 1122234568999999999864 34788999999999999999999999875443322211100
Q ss_pred ccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 341 LVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 341 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
..+.... ......+..++..||+.+|.+||++.+|++.|+.+....
T Consensus 259 -~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 -MKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -CCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -CCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0111100 011235778899999999999999999999999887654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=324.93 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=195.8
Q ss_pred hcCCCCCCeecccCcEEEEEEEe--CCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhC---CCCCeeeEeeecc-----
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCL--RDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYV---DHPNTAKLVGCDS----- 184 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----- 184 (434)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46799999999999999999997 36889999998754322 2223567788777766 8999999999743
Q ss_pred --CCcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 185 --DGIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 185 --~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCc
Confidence 35789999998 6999998754 3458999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh---h---hcccc--
Q 013927 262 LAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI---W---AKPLL-- 333 (434)
Q Consensus 262 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~---~---~~~~~-- 333 (434)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... . ..+..
T Consensus 166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99865432 1234456899999999999989999999999999999999999999764332111 0 00000
Q ss_pred -Cc-ccc-ccccCCc---CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 -DS-NDI-RELVDPS---LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 -~~-~~~-~~~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. ... ....... ............+..++.+||+.||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 0000000 000011122356778999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=332.49 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=192.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G------ 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~------ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57889999999999999999976 7899999999765432 334578899999999999999999997543 2
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 399999998 68888874 348999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cc------cc
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KP------LL 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~------~~ 333 (434)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+ ..
T Consensus 195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 432 234568999999999887 6789999999999999999999999976432211100 00 00
Q ss_pred Cccccccc---cCCcCCCC---CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 334 DSNDIREL---VDPSLGDN---YDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 334 ~~~~~~~~---~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
........ +....... ........+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 00000000 001123578889999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.53 Aligned_cols=258 Identities=17% Similarity=0.290 Sum_probs=198.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchh----------------hHhhHHHHHHHHhhCCCCCeeeEe
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDE----------------KTCGFLCEIGIIAYVDHPNTAKLV 180 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l~ 180 (434)
++|.+.+.||+|+||.||+|.. +|+.||||++....... ....+.+|+.++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5799999999999999999999 79999999987532211 115789999999999999999999
Q ss_pred eecc--CCcEEEEEEcCCCCHHHH------hccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 181 GCDS--DGIHLVFQLSPLGSLASI------LHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 181 g~~~--~~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
+++. +..++||||+++|+|.++ +... ...+++..+..++.|++.||.|||+ .++|+||||||+||+++.
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 9744 468899999999999998 6532 5678999999999999999999996 379999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccC-CCCC-cCcEEehhHHHHHHHhCCCccccccchhhhhh
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDE-KTDVYSFGVLLLELITGRRAVDHLQQSVVIWA 329 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwSlGvil~elltG~~p~~~~~~~~~~~~ 329 (434)
++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||...........
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999876433 23455689999999999877 5666 99999999999999999999976443111111
Q ss_pred ccccCcccc----ccccCCcCC---CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 330 KPLLDSNDI----RELVDPSLG---DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 330 ~~~~~~~~~----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......... .....+... ..........+..++.+||+.||.+||++.++++
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 000000000 0001222356788999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.30 Aligned_cols=255 Identities=22% Similarity=0.248 Sum_probs=190.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc------C--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------D--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~--~~~ 188 (434)
.+|.+.++||+|+||.||+|....+..||+|++...... ..+|+.+++.++||||+++++++. + ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 358889999999999999999886777999988754321 236999999999999999999741 1 167
Q ss_pred EEEEEcCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-CCCCeEEeccccccc
Q 013927 189 LVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQICDFGLAKW 265 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGla~~ 265 (434)
+||||++++.+..... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999999764444332 235678999999999999999999999 9999999999999999 789999999999987
Q ss_pred cCCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cc-------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KP------- 331 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~------- 331 (434)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......... .|
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 644322 2345689999999998765 589999999999999999999999976432211100 00
Q ss_pred ---ccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 332 ---LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 332 ---~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
......+.......+...+.......+.+++.+||+.||.+||++.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000000000111123578889999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=319.43 Aligned_cols=250 Identities=25% Similarity=0.302 Sum_probs=198.5
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--------hhhHhhHHHHHHHHhhCC-CCCeeeEeeeccC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--------DEKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 185 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 357899999999999999999986 789999999976531 122356889999999996 9999999998544
Q ss_pred --CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 186 --GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 186 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 58899999999999999974 3568999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccceeccccccccccCCccc------cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFM------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||............. ...
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~ 245 (298)
T 1phk_A 172 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---SGN 245 (298)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTC
T ss_pred hhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh---cCC
Confidence 8765432 223456899999999985 4568899999999999999999999997644322110000 000
Q ss_pred cccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
. .............+..++.+||+.+|.+||++.++++
T Consensus 246 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 0000001123356888999999999999999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.19 Aligned_cols=195 Identities=25% Similarity=0.313 Sum_probs=167.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC------CCCCeeeEeeec--cCCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV------DHPNTAKLVGCD--SDGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~--~~~~ 187 (434)
.+|.+.++||+|+||.||+|... +++.||||++.... .....+..|+.++..+ +|+||+.+++++ .+..
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 46999999999999999999876 68999999997542 3334677788888777 577999999974 4578
Q ss_pred EEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--eEEecccccc
Q 013927 188 HLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE--PQICDFGLAK 264 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFGla~ 264 (434)
++||||+. ++|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 89999997 68888887543 458999999999999999999999 89999999999999999987 9999999997
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccccc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ 322 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~ 322 (434)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 64432 234568999999999999899999999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=327.50 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=192.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------G 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 186 (434)
++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.+ .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46888899999999999999976 7899999999765432 334578899999999999999999997543 2
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+. |+|.+++. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 68888774 348999999999999999999999 89999999999999999999999999999765
Q ss_pred CCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccc------c
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPL------L 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~------~ 333 (434)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+. .
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 432 234568999999999877 6789999999999999999999999976442211100 000 0
Q ss_pred Cccc-------cccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 DSND-------IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 ~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.... +.....+.+. .........+.+++.+||+.||++||++.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000000000 111223457888999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.28 Aligned_cols=198 Identities=24% Similarity=0.349 Sum_probs=166.2
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CC-----CeeeEeeec--cCC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HP-----NTAKLVGCD--SDG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~--~~~ 186 (434)
.++|.+.+.||+|+||+||+|... +++.||||++... ......+..|+.++..++ |+ +|+.+++++ .+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 467999999999999999999976 7889999999753 233446778888888875 44 488988863 457
Q ss_pred cEEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec--CCCCeEEeccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT--EDYEPQICDFGLA 263 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFGla 263 (434)
.++||||+. |+|.+++.... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 899999997 59999887543 5689999999999999999999941 26899999999999995 4778999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQ 322 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~ 322 (434)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432 234568999999999999999999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=324.18 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=195.2
Q ss_pred cCCCCCCeecccCcEEEEEEEe-C-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC------eeeEeeec--cCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCL-R-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN------TAKLVGCD--SDG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~--~~~ 186 (434)
++|.+.+.||+|+||.||+|.. . +|+.||||++... ......+.+|+.++..++|+| ++++++++ .+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 4789999999999999999986 3 6889999999753 234456888999999887654 89999874 346
Q ss_pred cEEEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC--------------
Q 013927 187 IHLVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-------------- 251 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-------------- 251 (434)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 89999999 789999887543 468899999999999999999999 89999999999999987
Q ss_pred -----CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh
Q 013927 252 -----DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV 326 (434)
Q Consensus 252 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~ 326 (434)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999865432 2345689999999999988999999999999999999999999976433211
Q ss_pred hhhc----cccCccc--------------------------cccccCCcC-CCCCCHHHHHHHHHHHHhhhccCCCCCCC
Q 013927 327 IWAK----PLLDSND--------------------------IRELVDPSL-GDNYDAEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 327 ~~~~----~~~~~~~--------------------------~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.... ....... ......+.. ...........+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 1000 0000000 000000000 01112344677889999999999999999
Q ss_pred HhHHHH
Q 013927 376 MSQVVI 381 (434)
Q Consensus 376 ~~evl~ 381 (434)
+.||++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.69 Aligned_cols=196 Identities=24% Similarity=0.379 Sum_probs=150.1
Q ss_pred CCC-CCeecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec----cCCcEEE
Q 013927 119 FSS-ENLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD----SDGIHLV 190 (434)
Q Consensus 119 ~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~----~~~~~lv 190 (434)
|.+ +++||+|+||+||+|... +++.||||++...... ..+.+|+.+|++++||||+++++++ ....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 554 458999999999999965 5789999999754332 3578899999999999999999975 3368899
Q ss_pred EEEcCCCCHHHHhcc--------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----cCCCCeEEe
Q 013927 191 FQLSPLGSLASILHG--------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL----TEDYEPQIC 258 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~--------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~ 258 (434)
|||+. |+|.+++.. ....+++..+..|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 477777642 12348999999999999999999999 899999999999999 677899999
Q ss_pred ccccccccCCCCc-ccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccc
Q 013927 259 DFGLAKWLPRQWT-HHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHL 321 (434)
Q Consensus 259 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~ 321 (434)
|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999987653211 1223456789999999999874 5899999999999999999999999653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=321.77 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=189.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-----------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----------- 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------- 184 (434)
++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 56888999999999999999987 58999999997653 344567899999999999999999998642
Q ss_pred -----CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-CCCCeEEe
Q 013927 185 -----DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQIC 258 (434)
Q Consensus 185 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~ 258 (434)
+..++||||+. |+|.+++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 35789999998 69999995 3568899999999999999999999 8999999999999997 56799999
Q ss_pred ccccccccCCCCc-ccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh----hccc
Q 013927 259 DFGLAKWLPRQWT-HHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW----AKPL 332 (434)
Q Consensus 259 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~----~~~~ 332 (434)
|||+++....... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987643211 112234567999999998865 678999999999999999999999997644321110 0011
Q ss_pred cCccccccccC-------CcCC-CCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 LDSNDIRELVD-------PSLG-DNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ~~~~~~~~~~d-------~~l~-~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......++.. .... ...+ ......+.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000000 0000 0000 112356788999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=324.10 Aligned_cols=254 Identities=18% Similarity=0.233 Sum_probs=191.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CC-cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC------eeeEeeec--cCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DG-TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN------TAKLVGCD--SDG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~--~~~ 186 (434)
++|.+.+.||+|+||+||+|... ++ +.||||++... ......+.+|+.+++.++|++ ++.++++. .+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 57999999999999999999975 44 78999999753 234456888999999987766 88888763 457
Q ss_pred cEEEEEEcCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEe----------------
Q 013927 187 IHLVFQLSPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILL---------------- 249 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll---------------- 249 (434)
.++||||+. ++|.+.+.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 889999995 556555543 34578999999999999999999998 899999999999999
Q ss_pred ---cCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhh
Q 013927 250 ---TEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV 326 (434)
Q Consensus 250 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~ 326 (434)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999864432 2345689999999999999999999999999999999999999976433211
Q ss_pred hhh--c--cccCcc------ccccccCCcC---------------------CCCCCHHHHHHHHHHHHhhhccCCCCCCC
Q 013927 327 IWA--K--PLLDSN------DIRELVDPSL---------------------GDNYDAEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 327 ~~~--~--~~~~~~------~~~~~~d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
... . ...... .......... ...........+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 100 0 000000 0000000000 00112234567889999999999999999
Q ss_pred HhHHHH
Q 013927 376 MSQVVI 381 (434)
Q Consensus 376 ~~evl~ 381 (434)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999973
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=315.91 Aligned_cols=249 Identities=27% Similarity=0.354 Sum_probs=196.0
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++. +..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457999999999999999999986 789999999975432 233457889999999999999999999754 3688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC---CCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED---YEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGla~~~~~ 268 (434)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.+ +.+||+|||++.....
T Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999988864 3468899999999999999999999 899999999999999764 4799999999986643
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
.. ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||............. ..... .+....
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~--~~~~~~- 246 (287)
T 2wei_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---TGKYA--FDLPQW- 246 (287)
T ss_dssp CS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCC--CCSGGG-
T ss_pred CC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---cCCCC--CCchhh-
Confidence 32 1234458999999998865 48999999999999999999999997644322111000 00000 000000
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+..++.+||+.+|.+||++.++++
T Consensus 247 ---~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 ---RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 112346788999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=319.88 Aligned_cols=248 Identities=20% Similarity=0.213 Sum_probs=168.2
Q ss_pred cCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcE
Q 013927 117 KNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIH 188 (434)
Q Consensus 117 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 188 (434)
++|.+. ++||+|+||.||+|... +|+.||||++.... . ........+..+.||||+++++++.. ..+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 467774 46999999999999987 78999999997532 1 12222334667799999999997432 378
Q ss_pred EEEEEcCCCCHHHHhccCC-CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSK-DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla~ 264 (434)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999997643 468999999999999999999999 89999999999999986 4559999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ..+.. ...
T Consensus 180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~-~~~ 250 (336)
T 3fhr_A 180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----RRIRL-GQY 250 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----Hhhhc-ccc
Confidence 65432 2234568999999999988889999999999999999999999997643221100000 00000 000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.............+.+++.+||+.||.+||++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011122356788999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=318.20 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=176.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhh-HHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|... +|+.||||++........... +..+..+++.++||||+++++++. +..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46888899999999999999986 789999999987654433333 444555788889999999999744 46889999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
|+ ++.+..+.......+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99 456666665445678999999999999999999998 5 99999999999999999999999999997654321
Q ss_pred ccceeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 272 HHNVSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||.........+..... .. .+.+
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~-----~~~~ 250 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE-----PPLL 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH--SC-----CCCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc--cC-----CCCC
Confidence 223456899999999984 456889999999999999999999999764332221111000 00 0001
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .......+..++.+||+.||.+||++.+|++
T Consensus 251 ~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Cc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0112246778899999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.85 Aligned_cols=254 Identities=22% Similarity=0.263 Sum_probs=194.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-----------CCCeeeEeeecc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-----------HPNTAKLVGCDS 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~ 184 (434)
++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++.++. ||||++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46889999999999999999975 78999999997532 33456888999998886 899999999743
Q ss_pred C------CcEEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCC-CeeecCCCCCcEEec------
Q 013927 185 D------GIHLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQK-RIIHRDIKADNILLT------ 250 (434)
Q Consensus 185 ~------~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~-~iiHrDlkp~NIll~------ 250 (434)
. ..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 2 578999999 78999998753 4568999999999999999999999 7 999999999999994
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh-----
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV----- 325 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~----- 325 (434)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4448999999999876432 233468999999999999999999999999999999999999997532110
Q ss_pred ----hhhh--c--c------------ccCc-cccccccCC---------cCCCCCCHHHHHHHHHHHHhhhccCCCCCCC
Q 013927 326 ----VIWA--K--P------------LLDS-NDIRELVDP---------SLGDNYDAEEIDRAVLTASLCIEQSPILRPK 375 (434)
Q Consensus 326 ----~~~~--~--~------------~~~~-~~~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs 375 (434)
.+.. . | .... .....+... .-...++......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0000 0 0 0000 000000000 0011344566788999999999999999999
Q ss_pred HhHHHH
Q 013927 376 MSQVVI 381 (434)
Q Consensus 376 ~~evl~ 381 (434)
+.||++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=343.09 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=197.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--------cCCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--------SDGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--------~~~~ 187 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++ .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999975 68999999998765555566799999999999999999999973 3357
Q ss_pred EEEEEEcCCCCHHHHhccCC--CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC---eEEecccc
Q 013927 188 HLVFQLSPLGSLASILHGSK--DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE---PQICDFGL 262 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGl 262 (434)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 89999999999999997533 358888999999999999999999 89999999999999997765 99999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccc-
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIREL- 341 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 341 (434)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ |.............
T Consensus 171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-WHGKVREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-SSTTCC------CCS
T ss_pred cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-hhhhhhcccchhhhh
Confidence 98765432 22345789999999999999999999999999999999999999975322211 11111000000000
Q ss_pred ---------cCC--cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHH
Q 013927 342 ---------VDP--SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379 (434)
Q Consensus 342 ---------~d~--~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ev 379 (434)
... .............+..++..||..||++||++.++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 11122344567889999999999999999999774
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.45 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=191.0
Q ss_pred HhcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-----hhHhhHHHHHHHHhhC----CCCCeeeEeeecc
Q 013927 115 ATKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-----EKTCGFLCEIGIIAYV----DHPNTAKLVGCDS 184 (434)
Q Consensus 115 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~g~~~ 184 (434)
..++|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3467999999999999999999875 7899999999765332 1233566799999998 8999999999753
Q ss_pred --CCcEEEEEE-cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-CCCCeEEecc
Q 013927 185 --DGIHLVFQL-SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQICDF 260 (434)
Q Consensus 185 --~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DF 260 (434)
+..++|+|+ +.+++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++ .++.+||+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 478999999 788999999974 3468999999999999999999999 8999999999999999 8899999999
Q ss_pred ccccccCCCCcccceeccccccccccCCccccCCCC-CcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccc
Q 013927 261 GLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVD-EKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339 (434)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 339 (434)
|++....... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||......... .
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~--------- 249 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA--E--------- 249 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT--C---------
T ss_pred chhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh--c---------
Confidence 9998765432 2345689999999998876664 5899999999999999999999764321110 0
Q ss_pred cccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 340 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..+ +......+..++.+||+.+|++||++.++++
T Consensus 250 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 250 ----LHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----cCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1112346778999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=330.37 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=181.4
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEEEEEcC
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLVFQLSP 195 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv~e~~~ 195 (434)
|.+.++||+|+||+||.+...+|+.||||++.... ...+.+|+.++.++ +||||++++++..+ ..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 55567899999999987766679999999987532 33578899999876 89999999997544 5789999996
Q ss_pred CCCHHHHhccCCCCC------CHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-------------CCeE
Q 013927 196 LGSLASILHGSKDKP------DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-------------YEPQ 256 (434)
Q Consensus 196 ~gsL~~~l~~~~~~~------~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-------------~~~k 256 (434)
|+|.+++....... .+..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997532211 222356799999999999999 899999999999999754 4899
Q ss_pred EeccccccccCCCCccc--ceeccccccccccCCcccc-------CCCCCcCcEEehhHHHHHHHh-CCCccccccchhh
Q 013927 257 ICDFGLAKWLPRQWTHH--NVSKFEGTFGYFAPEYFMH-------GIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVV 326 (434)
Q Consensus 257 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~ 326 (434)
|+|||+++.+....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 99999998765432211 2234579999999999875 568899999999999999999 9999975332211
Q ss_pred hhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 327 IWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 327 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
........ .+.............+.+++.+||+.||.+||++.+|++
T Consensus 249 ~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110000 011111123455678889999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=323.33 Aligned_cols=239 Identities=21% Similarity=0.347 Sum_probs=194.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh-----hHhhHHHHHHHHhhCC--CCCeeeEeeecc--C
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE-----KTCGFLCEIGIIAYVD--HPNTAKLVGCDS--D 185 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~g~~~--~ 185 (434)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ....+.+|+.++++++ ||||+++++++. +
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 467999999999999999999865 78999999997643221 2245778999999996 599999999754 4
Q ss_pred CcEEEEEEcCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec-CCCCeEEeccccc
Q 013927 186 GIHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQICDFGLA 263 (434)
Q Consensus 186 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGla 263 (434)
..++|+|++.. ++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 68899999976 899999874 4568899999999999999999999 9999999999999999 7789999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccccccc
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELV 342 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (434)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...
T Consensus 198 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~---------- 260 (320)
T 3a99_A 198 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---GQV---------- 260 (320)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH---CCC----------
T ss_pred cccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc---ccc----------
Confidence 876533 2234568999999999987665 6789999999999999999999976432111 000
Q ss_pred CCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 343 DPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 343 d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+ ...+..++.+||+.+|.+||++.+|++
T Consensus 261 --~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 --FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112 246778999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.33 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=182.0
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv~e~~ 194 (434)
+|.+.++||+|+||+||.....+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+ ..++||||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 5788889999999997655556799999999976432 2356799999999 79999999997543 578999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-----CCCeEEeccccccccCCC
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-----DYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFGla~~~~~~ 269 (434)
. |+|.+++...........+..++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++.+...
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 7 69999997665555555667899999999999999 89999999999999953 235889999999876533
Q ss_pred Ccc-cceeccccccccccCCccc---cCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCC
Q 013927 270 WTH-HNVSKFEGTFGYFAPEYFM---HGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||............. .... .
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~---~~~~-----~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG---ACSL-----D 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT---CCCC-----T
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhc---cCCc-----c
Confidence 211 2234567999999999997 3557889999999999999999 999996533222111000 0000 0
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. .........+.+++.+||+.||.+||++.+|++
T Consensus 249 ~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 011223445778999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.10 Aligned_cols=237 Identities=23% Similarity=0.258 Sum_probs=190.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--C-----c
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--G-----I 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~-----~ 187 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++.+++||||+++++++.+ . .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57999999999999999999975 6899999998765544555678999999999999999999997432 2 5
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++++|.+++.. .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999988753 78999999999999999999999 899999999999999986 99999999998764
Q ss_pred CCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 268 RQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 268 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.. ....||+.|+|||++.++. +.++|||||||++|+|++|..||...... .+. .
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~~----~ 286 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GLP----E 286 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SCC----T
T ss_pred cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------ccc----c
Confidence 32 3456899999999987654 88999999999999999999887642110 000 0
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCC-HhHHHHHhcCC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPK-MSQVVILLRGD 386 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~evl~~L~~~ 386 (434)
..........+..++.+||+.||.+||+ +.++.+.|.+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0001122356788999999999999995 66666666554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=300.22 Aligned_cols=230 Identities=13% Similarity=0.078 Sum_probs=178.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~ 191 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++.+++||||+++++++ .+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46888999999999999999986 589999999986544 23346789999999999999999999974 34689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++++|.+++... ........|+.|++.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999532 3555678899999999999999 999999999999999999999998543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhh-hccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW-AKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
|++| ++.++|||||||++|||++|+.||.......... ..... ....... ..+..
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~-- 230 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEP--ADIDR-- 230 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCH--HHHCT--
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCCh--hhccc--
Confidence 3332 6788999999999999999999998644321110 00000 0000000 00011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCc
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDN 389 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~ 389 (434)
.....+..++.+||+.||++| |+.++++.|+.....
T Consensus 231 --~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 231 --DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp --TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred --CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 123567889999999999999 999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.36 Aligned_cols=238 Identities=11% Similarity=0.027 Sum_probs=178.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCC-CCee---------------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDH-PNTA--------------- 177 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~niv--------------- 177 (434)
.+|...++||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++..+.| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777789999999999999965 7999999998744332 224568899999999987 2211
Q ss_pred eE------eeec-------cCCcEEEEEEcCCCCHHHHhc------cCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCee
Q 013927 178 KL------VGCD-------SDGIHLVFQLSPLGSLASILH------GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238 (434)
Q Consensus 178 ~l------~g~~-------~~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~ii 238 (434)
.+ +.+. ....+++|+++ +++|.+++. .....+++..++.|+.|++.||.|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 11 0110 11345566654 588998884 234557788999999999999999999 9999
Q ss_pred ecCCCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCcc----------ccCCCCCcCcEEehhHHH
Q 013927 239 HRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF----------MHGIVDEKTDVYSFGVLL 308 (434)
Q Consensus 239 HrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwSlGvil 308 (434)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998865432 345567 999999999 555688899999999999
Q ss_pred HHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 309 LELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 309 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
|||++|+.||........ ....+... ..+ ...+..++.+||+.+|++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~-----------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG-----------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC-----------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh-----------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999976432211 01111100 112 256788999999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=294.89 Aligned_cols=223 Identities=18% Similarity=0.232 Sum_probs=172.6
Q ss_pred cCCCCC-CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHH-hhCCCCCeeeEeeecc------CCc
Q 013927 117 KNFSSE-NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGII-AYVDHPNTAKLVGCDS------DGI 187 (434)
Q Consensus 117 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~------~~~ 187 (434)
++|.+. ++||+|+||.||+|... +++.||||++... ..+.+|+.++ +.++||||+++++++. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 356665 78999999999999975 7899999998642 2467788887 6669999999999742 357
Q ss_pred EEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccc
Q 013927 188 HLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLA 263 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla 263 (434)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 8999999999999999764 3468999999999999999999999 99999999999999998 789999999998
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
.... +..++.++|||||||++|||++|+.||............ ...+..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~~ 216 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRM 216 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSCT
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHhh
Confidence 6432 134677899999999999999999999754322110000 000000
Q ss_pred CcCCCCCC----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDNYD----AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.. ...+ ......+..++.+||+.||.+||++.|+++
T Consensus 217 ~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 217 GQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0111 112356888999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=300.24 Aligned_cols=239 Identities=15% Similarity=0.101 Sum_probs=181.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-------hhhHhhHHHHHHHHhhCC---------CCCeeeEe
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-------DEKTCGFLCEIGIIAYVD---------HPNTAKLV 180 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l~ 180 (434)
++|.+.+.||+|+||+||+|.. +|+.||||++..... ......+.+|+.+++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4688899999999999999998 589999999986532 122356888999988886 77777776
Q ss_pred eec--------------------------------cCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHh
Q 013927 181 GCD--------------------------------SDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228 (434)
Q Consensus 181 g~~--------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~y 228 (434)
++. .+..++||||+++|++.+.+. ...+++..+..|+.||+.||.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHHH
Confidence 641 457999999999997666663 2568999999999999999999
Q ss_pred hh-ccCCCCeeecCCCCCcEEecCCC--------------------CeEEeccccccccCCCCcccceeccccccccccC
Q 013927 229 LH-EGCQKRIIHRDIKADNILLTEDY--------------------EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAP 287 (434)
Q Consensus 229 LH-~~~~~~iiHrDlkp~NIll~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 287 (434)
|| + ++|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aP 246 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDE 246 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCS
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccCh
Confidence 99 8 8999999999999999887 8999999999866432 34689999999
Q ss_pred CccccCCCCCcCcEEehhHH-HHHHHhCCCccccccchhhhhhccccCcccccc-ccCCcCCCCCCHHHHHHHHHHHHhh
Q 013927 288 EYFMHGIVDEKTDVYSFGVL-LLELITGRRAVDHLQQSVVIWAKPLLDSNDIRE-LVDPSLGDNYDAEEIDRAVLTASLC 365 (434)
Q Consensus 288 E~~~~~~~~~ksDvwSlGvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~l~~~C 365 (434)
|++.+.. +.++||||||++ .+++++|..||............ .+.. .................+.+++.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK------MLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH------HHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh------hhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 9998665 889999998777 78889999999652110000000 0000 0000001111234567889999999
Q ss_pred hccCCCCCCCHhHHH
Q 013927 366 IEQSPILRPKMSQVV 380 (434)
Q Consensus 366 l~~~P~~RPs~~evl 380 (434)
|+.+ |+.|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-31 Score=274.22 Aligned_cols=184 Identities=15% Similarity=0.089 Sum_probs=127.9
Q ss_pred ecccCcEEEEEEEe-CCCcEEEEEEeeCCCc---------hhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--CcEEEE
Q 013927 125 IGKGGYAEVYKGCL-RDGTLVAVKRLTKGTV---------DEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 125 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~~lv~ 191 (434)
.+.|++|.+..++. ..|+.||||++.+... +.....|.+|+++|+++ .|+||++++++.++ ..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566665555442 2588999999986532 12335699999999999 79999999998654 699999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||++|++|.++|.. ...++.. .|+.||+.||.|||+ +|||||||||+|||++.+|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 99999999999974 3456654 478999999999999 999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcc
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~ 318 (434)
......+||+.|+|||++.+ .+..++|+||+|++++++.+|..++
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22345789999999999865 4677899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=253.53 Aligned_cols=184 Identities=18% Similarity=0.174 Sum_probs=145.9
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-------hhHhhHHHHHHHHhhCCCCCee--eEeeeccCCcEEE
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-------EKTCGFLCEIGIIAYVDHPNTA--KLVGCDSDGIHLV 190 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv--~l~g~~~~~~~lv 190 (434)
...++||+|+||.||+|... +..+|+|+....... .....+.+|+.++++++||||+ .++++..+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999554 788999987653321 1134589999999999999999 7777877889999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++++|.+++.. +..++.|+++||.|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999964 56799999999999999 99999999999999999 99999999999775432
Q ss_pred ccc-----ceeccccccccccCCcccc--CCCCCcCcEEehhHHHHHHHhCCCcc
Q 013927 271 THH-----NVSKFEGTFGYFAPEYFMH--GIVDEKTDVYSFGVLLLELITGRRAV 318 (434)
Q Consensus 271 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~ 318 (434)
... ......||+.|+|||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111 1235679999999999976 56888899999999988888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.7e-25 Score=209.22 Aligned_cols=152 Identities=15% Similarity=0.074 Sum_probs=119.4
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-----------------hhHhhHHHHHHHHhhCCC
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-----------------EKTCGFLCEIGIIAYVDH 173 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h 173 (434)
.+......|.+.+.||+|+||.||+|.+.+|+.||||++...... .....+.+|+.++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 333444567777999999999999999977999999999653321 124568899999999985
Q ss_pred CCeeeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC
Q 013927 174 PNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY 253 (434)
Q Consensus 174 ~niv~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~ 253 (434)
+++..+++ .+..++||||+++|+|.+ +.. .....++.|++.||.|||+ ++|+||||||+|||++ ++
T Consensus 164 ~~v~~~~~--~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYA--WEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEE--EETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TT
T ss_pred CCcCeEEe--ccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CC
Confidence 44444433 346799999999999998 521 1234689999999999999 9999999999999999 99
Q ss_pred CeEEeccccccccCCCCcccceeccccccccccCCccc
Q 013927 254 EPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291 (434)
Q Consensus 254 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 291 (434)
.+||+|||+++. +..|.|||++.
T Consensus 230 ~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999863 34467888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-21 Score=178.99 Aligned_cols=137 Identities=18% Similarity=0.097 Sum_probs=106.8
Q ss_pred CCCCCeecccCcEEEEEEEe-CCCcE--EEEEEeeCCCch-----------------------hhHhhHHHHHHHHhhCC
Q 013927 119 FSSENLIGKGGYAEVYKGCL-RDGTL--VAVKRLTKGTVD-----------------------EKTCGFLCEIGIIAYVD 172 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 172 (434)
|.+.+.||+|+||.||+|.. .+|+. ||||++...... .....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 57888 999987543211 01125788999999998
Q ss_pred CCCe--eeEeeeccCCcEEEEEEcCC-C----CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhh-ccCCCCeeecCCCC
Q 013927 173 HPNT--AKLVGCDSDGIHLVFQLSPL-G----SLASILHGSKDKPDWSKRYRIALGTANGLTYLH-EGCQKRIIHRDIKA 244 (434)
Q Consensus 173 h~ni--v~l~g~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH-~~~~~~iiHrDlkp 244 (434)
|+++ ..+++. +..++||||+.+ | +|.++... .++.....++.|++.||.||| + .+|+||||||
T Consensus 129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCST
T ss_pred hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCH
Confidence 8754 334443 478999999942 3 67776532 123456788999999999999 8 8999999999
Q ss_pred CcEEecCCCCeEEecccccccc
Q 013927 245 DNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 245 ~NIll~~~~~~kL~DFGla~~~ 266 (434)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999755
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9.6e-18 Score=163.91 Aligned_cols=139 Identities=16% Similarity=0.144 Sum_probs=99.6
Q ss_pred CCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-------------hhHhh--------HHHHHHHHhhCCCCCe
Q 013927 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-------------EKTCG--------FLCEIGIIAYVDHPNT 176 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~--------~~~E~~~l~~l~h~ni 176 (434)
-|.+...||.|+||.||+|...+|+.||||+++..... ..... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38889999999999999999989999999987643110 00111 2345555655544333
Q ss_pred eeEeeeccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC--
Q 013927 177 AKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE-- 254 (434)
Q Consensus 177 v~l~g~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~-- 254 (434)
....-+.....++||||+++++|..+... .....++.|++.+|.|||. .+||||||||.|||+++++.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCcc
Confidence 21111122345799999999888765431 1234578899999999998 89999999999999988763
Q ss_pred --------eEEecccccccc
Q 013927 255 --------PQICDFGLAKWL 266 (434)
Q Consensus 255 --------~kL~DFGla~~~ 266 (434)
+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=3.4e-11 Score=111.99 Aligned_cols=143 Identities=13% Similarity=0.054 Sum_probs=106.9
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc--CCcEEE
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--~~~~lv 190 (434)
.....|.+...+|.|+.+.||++... +..+++|+...... .....+.+|+.+++.+. +.++.+++++.. +..++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456877788888999999998765 68899999865211 12235888999999885 567777877643 357899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC-------------------------------------
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC------------------------------------- 233 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~------------------------------------- 233 (434)
||+++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999876421 1123467788999999999710
Q ss_pred -------------------CCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 234 -------------------QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 234 -------------------~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.8e-11 Score=112.00 Aligned_cols=134 Identities=14% Similarity=0.059 Sum_probs=95.0
Q ss_pred CCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC--eeeEeeecc--CCcEEEEEEc
Q 013927 119 FSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN--TAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 119 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~--~~~~lv~e~~ 194 (434)
+.+..+.+.|..+.||++...+|..++||..... ....+..|+.+++.+.+.+ +.+++++.. +..++||||+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 3333333456669999998777888999987653 1235778999998886544 445777643 3579999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC-----------------------------------------
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC----------------------------------------- 233 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~----------------------------------------- 233 (434)
++.+|. ... .+ ...++.++++.|..||...
T Consensus 98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998884 321 12 2256677888888888621
Q ss_pred --------------CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 234 --------------QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 234 --------------~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.5e-10 Score=110.31 Aligned_cols=140 Identities=14% Similarity=0.102 Sum_probs=102.5
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEee--CCCchhhHhhHHHHHHHHhhCC--CCCeeeEeeeccCC-----cEEEEE
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLT--KGTVDEKTCGFLCEIGIIAYVD--HPNTAKLVGCDSDG-----IHLVFQ 192 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~-----~~lv~e 192 (434)
.+.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+++.+. +.++.++++++.+. .++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999998876 4678888776 3322222346888999999987 45577788775543 789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC---------------------------------------
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC--------------------------------------- 233 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~--------------------------------------- 233 (434)
|+++..+.+.. ...++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99987774321 134667788889999999999999720
Q ss_pred ----------------CCCeeecCCCCCcEEecCCCC--eEEeccccccc
Q 013927 234 ----------------QKRIIHRDIKADNILLTEDYE--PQICDFGLAKW 265 (434)
Q Consensus 234 ----------------~~~iiHrDlkp~NIll~~~~~--~kL~DFGla~~ 265 (434)
...++|||+++.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=6.9e-10 Score=105.62 Aligned_cols=186 Identities=17% Similarity=0.117 Sum_probs=116.5
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCC--eeeEeeeccC-----CcEEEEEE
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPN--TAKLVGCDSD-----GIHLVFQL 193 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~-----~~~lv~e~ 193 (434)
.+.++.|....||+.. ..+++|+.... .....+.+|..++..+. +.. +..++....+ ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999853 45889976432 33456888999998873 322 3344444222 24789999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhcc-----------------------------------------
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG----------------------------------------- 232 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~----------------------------------------- 232 (434)
++|.+|..... ..++...+..++.+++..|..||..
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99887765332 2355666677777788777777751
Q ss_pred --------------CCCCeeecCCCCCcEEecC--CCCeEEeccccccccCCCCccccee------------cccccccc
Q 013927 233 --------------CQKRIIHRDIKADNILLTE--DYEPQICDFGLAKWLPRQWTHHNVS------------KFEGTFGY 284 (434)
Q Consensus 233 --------------~~~~iiHrDlkp~NIll~~--~~~~kL~DFGla~~~~~~~~~~~~~------------~~~gt~~y 284 (434)
....++|+|++|.||+++. +..+.|+||+.+..-.....-.... .+....++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1135899999999999998 4567899999987543211000000 00000011
Q ss_pred cc-CCccccCCCCCcCcEEehhHHHHHHHhCCCccc
Q 013927 285 FA-PEYFMHGIVDEKTDVYSFGVLLLELITGRRAVD 319 (434)
Q Consensus 285 ~a-PE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 319 (434)
.. |+.... .....+.|++|.++|.+.+|..+|-
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 111110 0112488999999999999988764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.6e-06 Score=79.90 Aligned_cols=133 Identities=17% Similarity=0.071 Sum_probs=87.4
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC---CeeeEeeec---cCCcEEEEEEcCC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP---NTAKLVGCD---SDGIHLVFQLSPL 196 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~---~~~~~lv~e~~~~ 196 (434)
..++.|....||+. |..++||+-.. ......+..|..+|..+.+. .+..++.+. .+..++||++++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899987 46688887422 23345688999999998752 234444443 2357899999998
Q ss_pred CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhcc--------------------------------------------
Q 013927 197 GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG-------------------------------------------- 232 (434)
Q Consensus 197 gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~-------------------------------------------- 232 (434)
..+....- ..++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 87765321 1123334444444444444444431
Q ss_pred -------------CCCCeeecCCCCCcEEecC---CCC-eEEeccccccc
Q 013927 233 -------------CQKRIIHRDIKADNILLTE---DYE-PQICDFGLAKW 265 (434)
Q Consensus 233 -------------~~~~iiHrDlkp~NIll~~---~~~-~kL~DFGla~~ 265 (434)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1245799999999999997 455 48999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.8e-06 Score=82.70 Aligned_cols=75 Identities=12% Similarity=0.020 Sum_probs=50.7
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc------hhhHhhHHHHHHHHhhCCC--C-CeeeEeeeccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV------DEKTCGFLCEIGIIAYVDH--P-NTAKLVGCDSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~lv~e 192 (434)
+.||.|..+.||++... ++..|+||....... ......+..|..++..+.. + .+.+++.+..+..++|||
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvmE 115 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 115 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEEE
Confidence 46899999999999754 468899998653221 0122356778888887742 3 344667776677899999
Q ss_pred EcCCC
Q 013927 193 LSPLG 197 (434)
Q Consensus 193 ~~~~g 197 (434)
++++.
T Consensus 116 ~l~g~ 120 (397)
T 2olc_A 116 DLSHL 120 (397)
T ss_dssp CCTTS
T ss_pred eCCCc
Confidence 99763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.1e-06 Score=83.12 Aligned_cols=78 Identities=8% Similarity=-0.058 Sum_probs=51.0
Q ss_pred Cee-cccCcEEEEEEEeC-------CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCC---CCeeeEeeeccC----
Q 013927 123 NLI-GKGGYAEVYKGCLR-------DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDH---PNTAKLVGCDSD---- 185 (434)
Q Consensus 123 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~---- 185 (434)
+.| +.|....+|+.... ++..+++|....... ......+..|+.+++.+.. ..+.++++++.+
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998754 266788997643220 0012357778888887742 346667766443
Q ss_pred -CcEEEEEEcCCCCHH
Q 013927 186 -GIHLVFQLSPLGSLA 200 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~ 200 (434)
..++|||++++..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 357999999886654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.9e-05 Score=73.03 Aligned_cols=132 Identities=16% Similarity=0.092 Sum_probs=86.1
Q ss_pred ecccCc-EEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeee--ccCCcEEEEEEcCCCCH
Q 013927 125 IGKGGY-AEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGC--DSDGIHLVFQLSPLGSL 199 (434)
Q Consensus 125 lG~G~~-g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~--~~~~~~lv~e~~~~gsL 199 (434)
+..|.. +.||+.... ++..++||+-... ....+..|...|+.+. +-.+.+++++ ..+..++||+++++.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 444544 469987765 5677899976532 3345778999888774 2234555554 33467899999998877
Q ss_pred HHHhccCCCCCCHHHHHHHHHHHHHHhHhhhcc-----------------------------------------------
Q 013927 200 ASILHGSKDKPDWSKRYRIALGTANGLTYLHEG----------------------------------------------- 232 (434)
Q Consensus 200 ~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~----------------------------------------------- 232 (434)
.+...... .....++.+++..|..||..
T Consensus 108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 76543211 11223444555555555531
Q ss_pred --------CCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 233 --------CQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 233 --------~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887777999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.1e-05 Score=74.08 Aligned_cols=32 Identities=22% Similarity=0.351 Sum_probs=28.5
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 47899999999999998888999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=72.75 Aligned_cols=78 Identities=18% Similarity=0.303 Sum_probs=48.4
Q ss_pred CCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceecccc--ccccccCCccccCCC---CCcCcEEehhHHH
Q 013927 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEG--TFGYFAPEYFMHGIV---DEKTDVYSFGVLL 308 (434)
Q Consensus 234 ~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~---~~ksDvwSlGvil 308 (434)
...++|||++|.|||++.++ +.|+||+.+..-+... ......+ ...|++|+......- ....++...+..+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 37899999999999999876 9999999987543221 1111111 234667665531111 1123445777778
Q ss_pred HHHHhCC
Q 013927 309 LELITGR 315 (434)
Q Consensus 309 ~elltG~ 315 (434)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00022 Score=66.69 Aligned_cols=76 Identities=18% Similarity=0.170 Sum_probs=54.1
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC---CCeeeEeeeccCCcEEEEEEcCC
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH---PNTAKLVGCDSDGIHLVFQLSPL 196 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~lv~e~~~~ 196 (434)
.-...+|.|..+.||+....+|+.|.||+...... .....|..|...|+.|.- -.+.++++. +..++||||.++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 33456899999999999999999999997654322 222347789998888742 234455554 356899999886
Q ss_pred CC
Q 013927 197 GS 198 (434)
Q Consensus 197 gs 198 (434)
+.
T Consensus 95 ~~ 96 (288)
T 3f7w_A 95 RP 96 (288)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00022 Score=67.11 Aligned_cols=71 Identities=11% Similarity=-0.025 Sum_probs=45.6
Q ss_pred CCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEEc-CCCCH
Q 013927 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQLS-PLGSL 199 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~~-~~gsL 199 (434)
.+.|+.|....+|+. ..+++|+...... .......|+.++..+....+ .++++...+..+++++|+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence 567888999999998 4588888765321 11234557777776642222 456666666678999999 55433
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00055 Score=65.33 Aligned_cols=139 Identities=10% Similarity=0.049 Sum_probs=71.3
Q ss_pred eecccCcEE-EEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC--CCeeeEeeeccCCcEEEEEEcCCCCHH
Q 013927 124 LIGKGGYAE-VYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH--PNTAKLVGCDSDGIHLVFQLSPLGSLA 200 (434)
Q Consensus 124 ~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~lv~e~~~~gsL~ 200 (434)
.|+.|+... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+..+..+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchH
Confidence 455554443 6676654466777775443210 224456666666532 234556665444457899998765554
Q ss_pred HHhccC---------------------C----CCCCHHHHH-------H-H------------HHHHHHHhHhhh---cc
Q 013927 201 SILHGS---------------------K----DKPDWSKRY-------R-I------------ALGTANGLTYLH---EG 232 (434)
Q Consensus 201 ~~l~~~---------------------~----~~~~~~~~~-------~-i------------~~~i~~gL~yLH---~~ 232 (434)
+.+... . ...+..... . + ...+...+..|. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 433211 0 111111100 0 0 001111122221 11
Q ss_pred CCCCeeecCCCCCcEEecCC----CCeEEecccccccc
Q 013927 233 CQKRIIHRDIKADNILLTED----YEPQICDFGLAKWL 266 (434)
Q Consensus 233 ~~~~iiHrDlkp~NIll~~~----~~~kL~DFGla~~~ 266 (434)
....++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23689999999999999875 67899999988653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00074 Score=64.01 Aligned_cols=133 Identities=17% Similarity=0.189 Sum_probs=84.4
Q ss_pred CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC---CCCeeeEeeec--cCCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD---HPNTAKLVGCD--SDGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~--~~~~~lv~e~~~~g 197 (434)
..|+.|....+|+.... +..++||+.... ....+..|...|+.|. ...+.++++.. .+..++|||++++.
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46899999999998764 678889987642 2345788988888774 35566676653 34689999999986
Q ss_pred CHH--------H---HhccCCC---------------------CCCHHHHH---HHHH----------------HHHHH-
Q 013927 198 SLA--------S---ILHGSKD---------------------KPDWSKRY---RIAL----------------GTANG- 225 (434)
Q Consensus 198 sL~--------~---~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~g- 225 (434)
.+. . .|+.... .-+|...+ ++.. .++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 532 1 1222111 12454322 1111 11111
Q ss_pred hHhhhc-cCCCCeeecCCCCCcEEecCCCCeEEeccc
Q 013927 226 LTYLHE-GCQKRIIHRDIKADNILLTEDYEPQICDFG 261 (434)
Q Consensus 226 L~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG 261 (434)
...|.. .....+||+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 1236799999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0041 Score=58.71 Aligned_cols=154 Identities=15% Similarity=0.118 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCCCC-----CeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC--eeeE
Q 013927 107 FTLSELQTATKNFSSE-----NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN--TAKL 179 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 179 (434)
++..++......|.+. +.|+.|....+|+....+| .+++|...... ....+..|+.++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4455565555556653 2366788889999887755 57899886531 1123556777776664211 2233
Q ss_pred eee--------ccCCcEEEEEEcCCCCHHH--------------Hhcc---C-CCC----C---CHHHHHHH--------
Q 013927 180 VGC--------DSDGIHLVFQLSPLGSLAS--------------ILHG---S-KDK----P---DWSKRYRI-------- 218 (434)
Q Consensus 180 ~g~--------~~~~~~lv~e~~~~gsL~~--------------~l~~---~-~~~----~---~~~~~~~i-------- 218 (434)
+.. ..+..+++++++++..+.. .++. . ... . .|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 1234578999998754311 0111 0 000 1 12221110
Q ss_pred ----HHHHHHHhHhhhcc----CCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 219 ----ALGTANGLTYLHEG----CQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 219 ----~~~i~~gL~yLH~~----~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
...+...+.++... ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133344444421 23579999999999999987666899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00077 Score=66.90 Aligned_cols=69 Identities=17% Similarity=0.152 Sum_probs=47.0
Q ss_pred CeecccCcEEEEEEEeCC--------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~ 193 (434)
+.|+.|....||++...+ +..+++|+...... ...+..|..++..+...++ .++++.+.++ +|++|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~g--~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSGG--RLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETTE--EEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCCC--EEEEE
Confidence 457888889999998653 47899998843221 1245578888888753333 5667765543 88999
Q ss_pred cCC
Q 013927 194 SPL 196 (434)
Q Consensus 194 ~~~ 196 (434)
+++
T Consensus 154 l~G 156 (429)
T 1nw1_A 154 IPS 156 (429)
T ss_dssp CCE
T ss_pred eCC
Confidence 875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0019 Score=64.54 Aligned_cols=72 Identities=13% Similarity=-0.059 Sum_probs=46.5
Q ss_pred CeecccCcEEEEEEEeCC-CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEEcCCCC
Q 013927 123 NLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQLSPLGS 198 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~~~~gs 198 (434)
+.|+.|-...+|++...+ +..+++|+..... . ...+...|..++..|...++ .++++++.+ .+|++|+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-D-EIINREREKKISCILYNKNIAKKIYVFFTN--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-C-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-h-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC--eEEEEeeCCcc
Confidence 457788889999998764 4788899875432 1 11123578888888875544 456776644 35999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0015 Score=63.63 Aligned_cols=138 Identities=18% Similarity=0.223 Sum_probs=79.0
Q ss_pred CeecccCcEEEEEEEeC--------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC-CeeeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP-NTAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~lv~e~ 193 (434)
+.|..|-...+|++... ++..|.+|+..... .....+.+|..+++.+.-. -..++++++.++ +|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g--~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPEG--RLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE--EEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc--cEEEE
Confidence 35666778889998864 24789999853321 2234566898888877422 235566766554 99999
Q ss_pred cCCCCHHH--------------H---hccCC----CCCC--HHHHHHHHHHHHH-------------------HhHhhhc
Q 013927 194 SPLGSLAS--------------I---LHGSK----DKPD--WSKRYRIALGTAN-------------------GLTYLHE 231 (434)
Q Consensus 194 ~~~gsL~~--------------~---l~~~~----~~~~--~~~~~~i~~~i~~-------------------gL~yLH~ 231 (434)
+++..|.. . ||... .... +..+.++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98744321 1 12111 1122 2333333332211 1222221
Q ss_pred -----cCCCCeeecCCCCCcEEecCC----CCeEEecccccc
Q 013927 232 -----GCQKRIIHRDIKADNILLTED----YEPQICDFGLAK 264 (434)
Q Consensus 232 -----~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGla~ 264 (434)
.....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123468999999999999876 789999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.012 Score=55.59 Aligned_cols=137 Identities=17% Similarity=0.080 Sum_probs=76.3
Q ss_pred eecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCC--CeeeEeee-------ccCCcEEEEEEc
Q 013927 124 LIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP--NTAKLVGC-------DSDGIHLVFQLS 194 (434)
Q Consensus 124 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~-------~~~~~~lv~e~~ 194 (434)
.|+ |....||+....+|+.+++|....... ....+..|..++..+... .+.+++.. ..+..+++++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 777899998777777899999864321 123456677777776421 23334332 122346789999
Q ss_pred CCCCHH-----H------H---hcc---C-----CCCCCHHHH----HHHH---------------HHHHHHhHhhhc--
Q 013927 195 PLGSLA-----S------I---LHG---S-----KDKPDWSKR----YRIA---------------LGTANGLTYLHE-- 231 (434)
Q Consensus 195 ~~gsL~-----~------~---l~~---~-----~~~~~~~~~----~~i~---------------~~i~~gL~yLH~-- 231 (434)
++..+. . . ++. . ....++... ..++ ..+...+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 1 1 111 0 011222211 0000 001111222221
Q ss_pred --cCCCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 232 --GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 232 --~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
.....++|||+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.002 Score=62.41 Aligned_cols=72 Identities=11% Similarity=0.048 Sum_probs=42.6
Q ss_pred CeecccCcEEEEEEEeCC---------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC-eeeEeeeccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD---------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-TAKLVGCDSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~lv~e 192 (434)
..|+.|....+|+....+ +..+++|+..... ........|..++..+...+ +.++++.. ..++||+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 356778888999988653 2678888765432 11123456888887775333 33556544 3478999
Q ss_pred EcCCCC
Q 013927 193 LSPLGS 198 (434)
Q Consensus 193 ~~~~gs 198 (434)
|+++..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0031 Score=55.90 Aligned_cols=100 Identities=15% Similarity=0.101 Sum_probs=66.5
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccceec
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK 277 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~ 277 (434)
+|.++|...+.++++.+++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 79999998889999999999999999998776210 1111333457899999999998764 1110
Q ss_pred cccccccccCCccccCCCCCcCcEEehhHHHHHHHhCC
Q 013927 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315 (434)
Q Consensus 278 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~ 315 (434)
.....+.|||... ...+.+.=|||||+++|.-+--.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0123467888763 33456778999999999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.043 Score=52.29 Aligned_cols=31 Identities=26% Similarity=0.327 Sum_probs=27.8
Q ss_pred CCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 235 ~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.27 E-value=0.18 Score=49.57 Aligned_cols=72 Identities=10% Similarity=0.048 Sum_probs=45.9
Q ss_pred CeecccCcEEEEEEEeCC--------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCC-eeeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN-TAKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~lv~e~ 193 (434)
+.|..|-...+|+....+ +..|++++..... ....+..+|..+++.+.-.+ ..++++.. ..++|++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--PEGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CCCEEEEE
Confidence 356677788899988753 5789999864432 11223456888887774322 34455543 34789999
Q ss_pred cCCCC
Q 013927 194 SPLGS 198 (434)
Q Consensus 194 ~~~gs 198 (434)
+++..
T Consensus 152 I~G~~ 156 (424)
T 3mes_A 152 IDGEP 156 (424)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.10 E-value=0.048 Score=53.30 Aligned_cols=30 Identities=30% Similarity=0.500 Sum_probs=25.2
Q ss_pred CeeecCCCCCcEEe------cCCCCeEEeccccccc
Q 013927 236 RIIHRDIKADNILL------TEDYEPQICDFGLAKW 265 (434)
Q Consensus 236 ~iiHrDlkp~NIll------~~~~~~kL~DFGla~~ 265 (434)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566799999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.09 E-value=0.82 Score=40.34 Aligned_cols=116 Identities=17% Similarity=0.233 Sum_probs=77.6
Q ss_pred CCCCCeeeEeeeccCCcEEEEEEcCCC-CHHHHhccCCCCCCHHHHHHHHHHHHHHhH-hhhccCCCCeeecCCCCCcEE
Q 013927 171 VDHPNTAKLVGCDSDGIHLVFQLSPLG-SLASILHGSKDKPDWSKRYRIALGTANGLT-YLHEGCQKRIIHRDIKADNIL 248 (434)
Q Consensus 171 l~h~niv~l~g~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~-yLH~~~~~~iiHrDlkp~NIl 248 (434)
..||.+..-+....|.+.+.++.-+.+ ++..+ ..++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 47 ~~~~~f~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 47 EVDPCIVRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp GSCSSSEEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred ccCCCCCeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 467877444445556666666665443 44433 35778889999999988777 5553 477889999999
Q ss_pred ecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 249 LTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 249 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
++.++.++|.-.|+-..+++.. +.+|-+ +-.+=+++..++.++..|+.
T Consensus 117 f~~~~~p~i~hRGi~~~lpP~e--------------~~ee~f----------l~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPPDE--------------WDDERL----------LREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTTBSSCS--------------CCHHHH----------HHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCcccCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHHH
Confidence 9999999999888754432211 111111 11455777888888887765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.78 E-value=0.86 Score=40.08 Aligned_cols=122 Identities=11% Similarity=0.080 Sum_probs=77.5
Q ss_pred HHHHHhhCCCCCeeeE-eeeccCCcEEEEEEcCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecC
Q 013927 164 EIGIIAYVDHPNTAKL-VGCDSDGIHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRD 241 (434)
Q Consensus 164 E~~~l~~l~h~niv~l-~g~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrD 241 (434)
|+.+| ...||+++.. +....|.+.+.++.... -++.. + ...+...+++++.+|+....+++. -+|--
T Consensus 36 el~LL-~~~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 36 LMYLL-EQHSPYFIDAELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp GGGGG-GSCCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred HHHHH-hccCCcccceEEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 44444 3478888855 22334444444444332 23333 2 357788899999999988866663 37888
Q ss_pred CCCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcccc
Q 013927 242 IKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDH 320 (434)
Q Consensus 242 lkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~ 320 (434)
|.|+||+++.++.+++.-.|+-..+++.. +.+|- =+-.+=+++..+++|+..|+.
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee~----------fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEAE----------FLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTBSCCC--------------CCHHH----------HHHHHHHHHHHHHCTTCCHHH
T ss_pred EecceEEEcCCCCEEEEEccCccCCCCCC--------------CCHHH----------HHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999999999888754433210 01111 112455778888999888864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.69 E-value=0.081 Score=52.75 Aligned_cols=59 Identities=10% Similarity=0.108 Sum_probs=16.4
Q ss_pred CCCeecccCcEEEEEEEeCC-CcEEEE------EEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 121 SENLIGKGGYAEVYKGCLRD-GTLVAV------KRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 121 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
+.+.|| ||.||+|.+.. ..+||| |....... .+....|.+|..++..++|||+++.+++
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 345666 99999999863 467888 76654332 2334468889999999999999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 434 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-65
Identities = 76/272 (27%), Positives = 114/272 (41%), Gaps = 17/272 (6%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPNT 176
+ IG G + VYKG VAVK L + F E+G++ H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 177 AKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
+G + + +V Q SL LH + K + K IA TA G+ YLH K
Sbjct: 67 LLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH--- 292
IIHRD+K++NI L ED +I DFGLA R H + G+ + APE
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
++DVY+FG++L EL+TG+ ++ I R + P L +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDL-SKVRS 236
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ C+++ RP Q++ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 65/269 (24%), Positives = 111/269 (41%), Gaps = 19/269 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ +G G + EV+ G T VAVK L +G++ FL E ++ + H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70
Query: 177 AKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEGCQ 234
+L + I+++ + GSL L +K +A A G+ ++ E
Sbjct: 71 VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+ IHRD++A NIL+++ +I DFGLA+ + + + + APE +G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGT 186
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
K+DV+SFG+LL E++T R + + + DN E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------LERGYRMVRPDNCPEEL 239
Query: 355 IDRAVLTASLCIEQSPILRPKMSQVVILL 383
LC ++ P RP + +L
Sbjct: 240 YQ----LMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-58
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 22/298 (7%)
Query: 111 ELQTATKNFSSENL-IGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIG 166
+L N ++ +G G + V +G R VA+K L +GT T + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 167 IIAYVDHPNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG 225
I+ +D+P +L+G C ++ + LV +++ G L L G +++ S + + G
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGY 284
+ YL +K +HRD+ A N+LL + +I DFGL+K L + S + +
Sbjct: 122 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178
Query: 285 FAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343
+APE ++DV+S+GV + E ++ G++ ++ V+ I +
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------IEQGKR 230
Query: 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQTH 401
E S C RP V +R + S E H
Sbjct: 231 MECPPECPPELYA----LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (483), Expect = 6e-58
Identities = 72/308 (23%), Positives = 124/308 (40%), Gaps = 36/308 (11%)
Query: 107 FTLSELQTATKNFSSE---------NLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGT 153
FT + A + F+ E +IG G + EV G L+ VA+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 154 VDEKTCGFLCEIGIIAYVDHPNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPD 211
+++ FL E I+ DHPN L V S + ++ + GSL S L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP---R 268
+ + G A G+ YL +HRD+ A NIL+ + ++ DFGL+++L
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW 328
T+ + + + APE + +DV+S+G+++ E+++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 329 AKPLLDSN--DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386
+P D D+ ++ + C ++ RPK Q+V L
Sbjct: 232 -RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
Query: 387 EDNAQSVK 394
N S+K
Sbjct: 291 IRNPNSLK 298
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-57
Identities = 56/270 (20%), Positives = 106/270 (39%), Gaps = 19/270 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+ IG G + V+ G + VA+K + +G + E+ F+ E ++ + HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--FIEEAEVMMKLSHPKL 62
Query: 177 AKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G + I LVF+ G L+ L + + L G+ +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEE 119
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+IHRD+ A N L+ E+ ++ DFG+ +++ + + + +PE F
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSR 178
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
K+DV+SFGVL+ E+ + + + + + DI
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTGFRLYKPRLASTHV 231
Query: 355 IDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ C ++ P RP S+++ L
Sbjct: 232 YQ----IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-56
Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 19/269 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
++ E +G+G + EV+ G T VA+K L GT+ + FL E ++ + H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKL 74
Query: 177 AKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPD-WSKRYRIALGTANGLTYLHEGCQ 234
+L + I++V + GSL L G K + +A A+G+ Y+ +
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+HRD++A NIL+ E+ ++ DFGLA+ + + + APE ++G
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGR 190
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
K+DV+SFG+LL EL T R P + + ++ + V+ E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPEC 239
Query: 355 IDRAVLTASLCIEQSPILRPKMSQVVILL 383
+ C + P RP + L
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-56
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 112 LQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY 170
++ +F + +G G V+K G ++A K + + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
+ P G I + + GSL +L + ++++ GLTY
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTY 119
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
L E + +I+HRD+K NIL+ E ++CDFG++ L + V GT Y +PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPE 173
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGRR 316
++D++S G+ L+E+ GR
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 6e-56
Identities = 49/266 (18%), Positives = 104/266 (39%), Gaps = 19/266 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
K+ + +G G + V G R VA+K + +G++ E F+ E ++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--FIEEAKVMMNLSHEKL 61
Query: 177 AKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
+L G I ++ + G L + L + + + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
K+ +HRD+ A N L+ + ++ DFGL++++ +V + + PE M+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSK 177
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
K+D+++FGVL+ E+ + + +++ E + L
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-----------MPYERFTNSETAEHIAQGLRLYRPHLA 226
Query: 355 IDRAVLTASLCIEQSPILRPKMSQVV 380
++ C + RP ++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 7e-55
Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 22/285 (7%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGT-----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVD 172
+ + +IG G + EVYKG L+ + VA+K L G +++ FL E GI+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
H N +L G + ++ + G+L L + + + G A G+ YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH-HNVSKFEGTFGYFAPEY 289
+HRD+ A NIL+ + ++ DFGL++ L + S + + APE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349
+ +DV+SFG+++ E++T L ++++ + ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYW-----------ELSNHEVMKAINDGFRLP 233
Query: 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVK 394
+ C +Q RPK + +V +L S+K
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-54
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 33/291 (11%)
Query: 122 ENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+ IGKG + EV++G R G VAVK + +E++ EI + H N +
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64
Query: 182 CDSDG------IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC-- 233
D+ + LV GSL L+ + ++AL TA+GL +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 234 ---QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV--SKFEGTFGYFAPE 288
+ I HRD+K+ NIL+ ++ I D GLA ++ + GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 289 YF------MHGIVDEKTDVYSFGVLLLELITGRRAVD--------HLQQSVVIWAKPLLD 334
H ++ D+Y+ G++ E+ + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 335 SNDIRELVDPSLGDNYDAEEIDRAVLT-ASLCIEQSPILRPKMSQVVILLR 384
+ + P++ + + + E R + C + R ++ L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-54
Identities = 64/270 (23%), Positives = 110/270 (40%), Gaps = 23/270 (8%)
Query: 122 ENLIGKGGYAEVYKGCLRD---GTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDHPNTA 177
+ +G G + V KG + VAVK L D L E ++ +D+P
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 178 KLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR 236
+++G C+++ LV +++ LG L L + + G+ YL +
Sbjct: 72 RMIGICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 237 IIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYFMHGIV 295
+HRD+ A N+LL + +I DFGL+K L ++ + ++APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 296 DEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
K+DV+SFGVL+ E + G++ ++ S V + + E
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM--------LEKGERMGCPAGCPREM 239
Query: 355 IDRAVLTASLCIEQSPILRPKMSQVVILLR 384
D +LC RP + V + LR
Sbjct: 240 YD----LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-53
Identities = 61/272 (22%), Positives = 99/272 (36%), Gaps = 27/272 (9%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
K IGKG + +V G R G VAVK + + FL E ++ + H N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 62
Query: 177 AKLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEG 232
+L+G + G+++V + GSL L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+HRD+ A N+L++ED ++ DFGL K + + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
K+DV+SFG+LL E+ + R + + + + D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMDAPDGCPP 227
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ C +RP Q+ L
Sbjct: 228 AVYE----VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 2e-52
Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 45/307 (14%)
Query: 109 LSELQTATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFL 162
L L+ N IG+G + V++ T+VAVK L + + F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 163 CEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---------- 210
E ++A D+PN KL+G + L+F+ G L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 211 -------------DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQI 257
+++ IA A G+ YL E ++ +HRD+ N L+ E+ +I
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 258 CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA 317
DFGL++ + + + PE + ++DV+++GV+L E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 318 VDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMS 377
+ + +R+ + +N E + LC + P RP
Sbjct: 242 PYYGMAHEEVIYY-------VRDGNILACPENCPLELYN----LMRLCWSKLPADRPSFC 290
Query: 378 QVVILLR 384
+ +L+
Sbjct: 291 SIHRILQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-52
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 25/274 (9%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPN 175
++ IG G Y K DG ++ K L G++ E + E+ ++ + HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 176 TAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKP---DWSKRYRIALGTANGLTY 228
+ + +++V + G LAS++ + D R+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 229 LHE--GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
H ++HRD+K N+ L ++ DFGLA+ L + F GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 287 PEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
PE +EK+D++S G LL EL Q + IRE +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK--------IREGKFRRI 234
Query: 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380
Y E + + + RP + +++
Sbjct: 235 PYRYSDELNE----IITRMLNLKDYHRPSVEEIL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-52
Identities = 64/271 (23%), Positives = 101/271 (37%), Gaps = 23/271 (8%)
Query: 122 ENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTA 177
+IG+G + VY G L D AVK L + T + FL E I+ HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 178 KLVGC---DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L+G +V G L + + P L A G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW--THHNVSKFEGTFGYFAPEYFMH 292
K+ +HRD+ A N +L E + ++ DFGLA+ + + + HN + + + A E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
K+DV+SFGVLL EL+T + I + + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGRRLLQPEYCPD 261
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
+ C +RP S++V +
Sbjct: 262 PLYE----VMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-52
Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 20/271 (7%)
Query: 119 FSSENLIGKGGYAEVYKGCLRD-----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
F ++G G + VYKG VA+K L + T + L E ++A VD+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 174 PNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
P+ +L+G C + + L+ QL P G L + KD + A G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--- 127
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+R++HRD+ A N+L+ +I DFGLAK L + ++ + + A E +H
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
I ++DV+S+GV + EL+T + +++I +++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGS-----------KPYDGIPASEISSILEKGERLPQPP 236
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
+ C RPK +++I
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-51
Identities = 67/268 (25%), Positives = 103/268 (38%), Gaps = 26/268 (9%)
Query: 122 ENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTC-GFLCEIGIIAYVDHPNTAKL 179
+ IG+G + VYKG + VA L + + F E ++ + HPN +
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 180 VGC------DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
I LV +L G+L + L K GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 234 QKRIIHRDIKADNILLT-EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
IIHRD+K DNI +T +I D GLA + + GT + APE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEE 187
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
DE DVY+FG+ +LE+ T Q + I+ + + V P+ D
Sbjct: 188 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAI 239
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVV 380
E+ + CI Q+ R + ++
Sbjct: 240 PEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 4e-51
Identities = 64/287 (22%), Positives = 125/287 (43%), Gaps = 21/287 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+ + ++ +G G Y EVY+G + VAVK L + T++ + FL E ++ + HPN
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 74
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEG 232
+L+G +++ + G+L L + +A ++ + YL
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+K IHRD+ A N L+ E++ ++ DFGL++ + T+ + + + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAY 190
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
K+DV++FGVLL E+ T + P +D + + EL++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYRMERPE 239
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNAQSVKESQKQ 399
++ C + +P RP +++ + E +K+
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 5e-51
Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 33/281 (11%)
Query: 105 KEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT--CGF 161
+++ L +F +GKG + VY + ++A+K L K +++
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 162 LCEIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIA 219
E+ I +++ HPN +L G D+ ++L+ + +PLG++ L K D +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYI 112
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
AN L+Y H KR+IHRDIK +N+LL E +I DFG + P
Sbjct: 113 TELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---- 165
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339
GT Y PE + DEK D++S GVL E + G+ + + +
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFP 224
Query: 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380
+ V D S ++ +P RP + +V+
Sbjct: 225 DFVTEGARD------------LISRLLKHNPSQRPMLREVL 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-51
Identities = 60/298 (20%), Positives = 104/298 (34%), Gaps = 46/298 (15%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV 171
N ++G G + +V VAVK L + + + E+ ++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 172 -DHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP------------------ 210
H N L+G S I+L+F+ G L + L ++K
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 211 ----DWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266
+ A A G+ +L K +HRD+ A N+L+T +ICDFGLA+ +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSV 325
+ + APE GI K+DV+S+G+LL E+ + G +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 326 VIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
+ +L+ + + + C RP + L
Sbjct: 275 NFY-----------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 24/265 (9%)
Query: 123 NLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG 181
+G G + +VYK L A K + + +E ++ EI I+A DHPN KL+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKLLD 76
Query: 182 C--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIH 239
+ + ++ + G++ +++ + S+ + T + L YLH+ +IIH
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 240 RDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-----HGI 294
RD+KA NIL T D + ++ DFG++ R + F GT + APE M
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDRP 191
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
D K DV+S G+ L+E+ L V+ + ++ L P + +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPTLAQP---SRWSSNF 245
Query: 355 IDRAVLTASLCIEQSPILRPKMSQV 379
D C+E++ R SQ+
Sbjct: 246 KD----FLKKCLEKNVDARWTTSQL 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-50
Identities = 58/295 (19%), Positives = 103/295 (34%), Gaps = 39/295 (13%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV 171
S +G G + +V + VAVK L + + E+ +++Y+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 172 -DHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP-----------------D 211
+H N L+G ++ + G L + L +D D
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271
+ A G+ +L K IHRD+ A NILLT +ICDFGLA+ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP 331
+ + APE + + ++DV+S+G+ L EL + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----------PYPG 250
Query: 332 LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386
+ + +++ C + P+ RP Q+V L+
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 1e-49
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 29/273 (10%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVD 172
K FS IG G + VY +R+ +VA+K+++ +EK + E+ + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLH 230
HPNT + GC LV + + + K + + G GL YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 231 EGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYF 290
+IHRD+KA NILL+E ++ DFG A + + F GT + APE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVI 183
Query: 291 M---HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347
+ G D K DV+S G+ +EL + + ++ ++ I + P+L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------IAQNESPALQ 235
Query: 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV 380
+ +E V C+++ P RP ++
Sbjct: 236 SGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 60/267 (22%), Positives = 95/267 (35%), Gaps = 18/267 (6%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
+++ +G+G Y EV VAVK + + EI I ++H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 176 TAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
K G +G +L + G L + R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG-- 121
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHG 293
I HRDIK +N+LL E +I DFGLA ++K GT Y APE
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 294 -IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
E DV+S G++L ++ G D S ++ + + D+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------KEKKTYLNPWKKIDS 234
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQV 379
+ + ++P R + +
Sbjct: 235 APLA----LLHKILVENPSARITIPDI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-49
Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 22/281 (7%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH 173
IG+G + +V++G VA+K T D FL E + DH
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 174 PNTAKLVGCDSDG-IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
P+ KL+G ++ + ++ +L LG L S L K D + A + L YL
Sbjct: 68 PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
KR +HRDI A N+L++ + ++ DFGL++++ T++ SK + + APE
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINF 183
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
+DV+ FGV + E++ ++ + + I + N
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGERLPMPPNCPP 236
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRG--DEDNAQ 391
+ C P RP+ +++ L +E+ AQ
Sbjct: 237 TLYS----LMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-49
Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 23/277 (8%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAY 170
K+ +G G + V +G VAVK L + + F+ E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 171 VDHPNTAKLVG-CDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
+DH N +L G + + +V +L+PLGSL L + R A+ A G+ YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE-GTFGYFAPE 288
KR IHRD+ A N+LL +I DFGL + LP+ H+ + + F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 289 YFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347
+D + FGV L E+ T G+ L S ++ +E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KIDKEGERLPRP 237
Query: 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
++ + + C P RP + L
Sbjct: 238 EDCPQDIYN----VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-47
Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 21/267 (7%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
K ++ IG+G VY + G VA++++ +K + EI ++ +P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
N + D + +V + GSL ++ + D + + L +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
++IHRDIK+DNILL D ++ DFG + S GT + APE
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
K D++S G++ +E+I G + ++ +N EL +P + A
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNP---EKLSA 244
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQV 379
D + C++ R ++
Sbjct: 245 IFRD----FLNRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-47
Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 38/289 (13%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLRDGTL---VAVKRLTKGTVDEKTCGFLCEIGIIAYV-D 172
+ +++IG+G + +V K ++ L A+KR+ + + F E+ ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 173 HPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKP---------------DWSKR 215
HPN L+G ++L + +P G+L L S+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 216 YRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNV 275
A A G+ YL QK+ IHRD+ A NIL+ E+Y +I DFGL++ Q +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183
Query: 276 SKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDS 335
+ + A E + + +DV+S+GVLL E+++ ++ K
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 238
Query: 336 NDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+ + N D E D C + P RP +Q+++ L
Sbjct: 239 --LPQGYRLEKPLNCDDEVYD----LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-46
Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 22/267 (8%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHP 174
+F ++G+G ++ V L A+K L K + + K E +++ +DHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
KL D + ++ + G L + + TA ++ L
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSALEYL 124
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
K IIHRD+K +NILL ED QI DFG AK L + + F GT Y +PE
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
+ +D+++ G ++ +L+ G + ++ I +L + + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK--------IIKL-EYDFPEKFFP 235
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQV 379
+ D + R ++
Sbjct: 236 KARD----LVEKLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-45
Identities = 58/287 (20%), Positives = 115/287 (40%), Gaps = 31/287 (10%)
Query: 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAY 170
+ + +G+G + VY+G + T VA+K + + + FL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 171 VDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKD---------KPDWSKRYRIA 219
+ + +L+G ++ +L G L S L + P SK ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 220 LGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFE 279
A+G+ YL + +HRD+ A N ++ ED+ +I DFG+ + + + K
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 280 GTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339
+ +PE G+ +DV+SFGV+L E+ T + + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-------VM 249
Query: 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386
E DN + +C + +P +RP +++ ++ +
Sbjct: 250 EGGLLDKPDNCPDMLFE----LMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-44
Identities = 63/292 (21%), Positives = 108/292 (36%), Gaps = 38/292 (13%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIA-Y 170
+G+G + +V + VAVK L +G + + E+ I+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 171 VDHPNTAKLVGC---DSDGIHLVFQLSPLGSLASILHG---------------SKDKPDW 212
H N L+G + ++ + G+L++ L KD
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 213 SKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272
+ A G+ +L ++ IHRD+ A NILL+E +ICDFGLA+ + + +
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPL 332
+ APE + ++DV+SFGVLL E+ + + + + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-- 248
Query: 333 LDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
++E D E T C P RP S++V L
Sbjct: 249 ----RLKEGTRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-43
Identities = 63/292 (21%), Positives = 105/292 (35%), Gaps = 40/292 (13%)
Query: 118 NFSSENLIGKGGYAEVYKGCLR--------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIA 169
+G+G + +V T VAVK L ++ + E+ ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 170 YV-DHPNTAKLVGCDSDG--IHLVFQLSPLGSLASILHGSKDKP---------------D 211
+ H N L+G + ++++ + + G+L L +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271
A A G+ YL K+ IHRD+ A N+L+TED +I DFGLA+ +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKP 331
+ + + APE I ++DV+SFGVLL E+ T + ++
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL- 249
Query: 332 LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILL 383
++E N E C P RP Q+V L
Sbjct: 250 ------LKEGHRMDKPSNCTNELYM----MMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (383), Expect = 1e-42
Identities = 53/267 (19%), Positives = 93/267 (34%), Gaps = 21/267 (7%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
++ +G G + V++ G A K + +K EI ++ + HP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVLRHPTL 85
Query: 177 AKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
L D + + ++++ G L + +K + GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142
Query: 235 KRIIHRDIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
+H D+K +NI+ T ++ DFGL L + + GT + APE
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 199
Query: 293 GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352
V TD++S GVL L++G + D N +D S
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-----MDDSAFSGISE 254
Query: 353 EEIDRAVLTASLCIEQSPILRPKMSQV 379
+ D + P R + Q
Sbjct: 255 DGKD----FIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (381), Expect = 2e-42
Identities = 61/297 (20%), Positives = 102/297 (34%), Gaps = 29/297 (9%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182
+G G + V++ G + K + +K EI I+ + HP L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQLHHPKLINLHDA 94
Query: 183 --DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240
D + L+ + G L + K ++ GL ++HE I+H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 241 DIKADNILLTEDYEPQI--CDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
DIK +NI+ + DFGLA L + T + APE V
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFY 208
Query: 299 TDVYSFGVLLLELITGRR---AVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355
TD+++ GVL L++G D L+ + D V P
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA--------- 259
Query: 356 DRAVLTASLCIEQSPILRPKMSQVV--ILLRGDEDNAQSVKESQKQTHRRTYSEELF 410
+ + +++ P R + + L+GD N S S + R +E +
Sbjct: 260 -KDFIKN--LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKY 313
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 1e-39
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 19/242 (7%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG-----FLCEIGIIAYV 171
+FS +IG+GG+ EVY G + A+K L K + K + +++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 172 DHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYL 229
D P + D + + L G L L + A GL ++
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHM 123
Query: 230 HEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
H + +++RD+K NILL E +I D GLA ++ H GT GY APE
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 176
Query: 290 FMHGI-VDEKTDVYSFGVLLLELITGRRAVDH--LQQSVVIWAKPLLDSNDIRELVDPSL 346
G+ D D +S G +L +L+ G + I L + ++ + P L
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 347 GD 348
Sbjct: 237 RS 238
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 44/267 (16%), Positives = 89/267 (33%), Gaps = 34/267 (12%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGC 182
+G+G + V++ K + D+ EI I+ H N L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNILHLHES 69
Query: 183 --DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHR 240
+ + ++F+ + ++ S + + + L +LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 241 DIKADNILLTEDYEPQ--ICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEK 298
DI+ +NI+ I +FG A+ L Y+APE H +V
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVSTA 183
Query: 299 TDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRA 358
TD++S G L+ L++G + +++++ + Y +E
Sbjct: 184 TDMWSLGTLVYVLLSGI---------------NPFLAETNQQIIENIMNAEYTFDEEAFK 228
Query: 359 VLTASL------CIEQSPILRPKMSQV 379
++ + + R S+
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 5e-39
Identities = 68/315 (21%), Positives = 124/315 (39%), Gaps = 31/315 (9%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+ +++G G ++EV R LVA+K + K ++ K EI ++ + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 175 NTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
N L ++L+ QL G L + K R+ + + YLH+
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 233 CQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEY 289
I+HRD+K +N+L ED + I DFGL+K +S GT GY APE
Sbjct: 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---PGSVLSTACGTPGYVAPEV 180
Query: 290 FMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346
+ D +S GV+ L+ G + + I + + + S
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVV--ILLRGDEDNAQSVKESQKQTHRRT 404
+ + +E+ P R Q + + GD +++ +S + ++
Sbjct: 241 ----------KDFIRH--LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKN 288
Query: 405 YSEELFDAQEYNSTR 419
+++ + Q +N+T
Sbjct: 289 FAKSKWK-QAFNATA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (351), Expect = 7e-39
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 17/240 (7%)
Query: 122 ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAYVDHPNTAK 178
++G GG +EV+ LR VAVK L + + F E A ++HP
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 179 LVGC------DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG 232
+ ++V + +L I+H + + L + H+
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ- 129
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSK-FEGTFGYFAPEYFM 291
IIHRD+K NI+++ ++ DFG+A+ + + GT Y +PE
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 292 HGIVDEKTDVYSFGVLLLELITGRR---AVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348
VD ++DVYS G +L E++TG + + + + + E + L
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 12/205 (5%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYV-DH 173
+F ++GKG + +V+ + A+K L K V D+ + E +++ +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
P + + + V + G L + S K D S+ A GL +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
K I++RD+K DNILL +D +I DFG+ K N F GT Y APE +
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILL 176
Query: 292 HGIVDEKTDVYSFGVLLLELITGRR 316
+ D +SFGVLL E++ G+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 2e-38
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 14/216 (6%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDH 173
++F +G G + V+ +G A+K L K V ++ E +++ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 174 PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
P ++ G D+ I ++ G L S+L S+ P+ ++ A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVCLALEY 119
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
K II+RD+K +NILL ++ +I DFG AK++P GT Y APE
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVS 174
Query: 292 HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI 327
++ D +SFG+L+ E++ G
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (345), Expect = 5e-38
Identities = 59/286 (20%), Positives = 98/286 (34%), Gaps = 46/286 (16%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTC--------GFLCEIGII 168
N+ + ++G+G + V + AVK + + L E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 169 AYV-DHPNTAKLVGCDSDGIH--LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANG 225
V HPN +L LVF L G L L K + +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 226 LTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
+ LH+ I+HRD+K +NILL +D ++ DFG + L V GT Y
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYL 176
Query: 286 APEYFM------HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIR 339
APE H ++ D++S GV++ L+ G P
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---------------PPFWHRKQM 221
Query: 340 ELVDPSLGDNYDAEEIDRAVLTASL------CIEQSPILRPKMSQV 379
++ + NY + + ++ + P R +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 33/292 (11%)
Query: 115 ATKNFSSENLIGKGGYAEVYKGCLR--DGTLVAVKRLTKGTVDEKTC-GFLCEIGI---I 168
A + + IG+G Y +V+K G VA+KR+ T +E + E+ + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 169 AYVDHPNTAKLVGCDSDG-------IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALG 221
+HPN +L + + LVF+ + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGT 281
GL +LH R++HRD+K NIL+T + ++ DFGLA+ Q + T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVT 178
Query: 282 FGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRA------VDHLQQSVVIWAKPLLDS 335
Y APE + D++S G + E+ + VD L + + + P +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 336 NDIRELVDPSLGDNYDAEEIDRAVLTAS--------LCIEQSPILRPKMSQV 379
+ + A+ I++ V C+ +P R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 8e-37
Identities = 60/274 (21%), Positives = 94/274 (34%), Gaps = 22/274 (8%)
Query: 122 ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
IG G + ++Y G + G VA+K T + E I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTI 68
Query: 181 G-CDSDGIHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRII 238
C ++G + V + L SL + + K +A + + Y+H K I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 239 HRDIKADNILLTE---DYEPQICDFGLAKWLPRQWTHHNVSKFE-----GTFGYFAPEYF 290
HRD+K DN L+ I DFGLAK TH ++ E GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 291 MHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350
+ + D+ S G +L+ G L+ + K S L Y
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMSTPIEVLCKGY 244
Query: 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
+E + C +P S + L R
Sbjct: 245 PSEFAT----YLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-37
Identities = 67/280 (23%), Positives = 105/280 (37%), Gaps = 29/280 (10%)
Query: 123 NLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG----FLCEIGIIAYVDHPNTA 177
+ +G+G +A VYK +VA+K++ G E G L EI ++ + HPN
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 178 KLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
L+ I LVF L I+ + S L T GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM-HGI 294
I+HRD+K +N+LL E+ ++ DFGLAK + T Y APE +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARM 177
Query: 295 VDEKTDVYSFGVLLLELITGRRA------VDHLQQSV-VIWAKPLLDSNDIRELVDPSLG 347
D+++ G +L EL+ +D L + + D+ L D
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 348 DNYDAEEIDRAVLTASL--------CIEQSPILRPKMSQV 379
++ + A +P R +Q
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 2e-36
Identities = 43/279 (15%), Positives = 88/279 (31%), Gaps = 20/279 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPN 175
++ IG+G + +++G L + VA+K + + + ++A
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 176 TAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
G + LV L +L K A + +H +K
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 236 RIIHRDIKADNILLTEDYEPQ-----ICDFGLAKWLPRQWTHHNVSKFE-----GTFGYF 285
+++RDIK DN L+ + DFG+ K+ T ++ E GT Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 286 APEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345
+ + + D+ + G + + + G L+ + + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-RE 239
Query: 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384
L + EE + + + P + L
Sbjct: 240 LCAGFP-EEFYKYM---HYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-36
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 10/204 (4%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPN 175
NF IG+G Y VYK G +VA+K++ T E + EI ++ ++HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
KL+ + ++LVF+ + + GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-- 120
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE-YFMH 292
R++HRD+K N+L+ + ++ DFGLA+ + T Y APE
Sbjct: 121 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVTLWYRAPEILLGC 177
Query: 293 GIVDEKTDVYSFGVLLLELITGRR 316
D++S G + E++T R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-35
Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 16/210 (7%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHP 174
+++ + IG+G Y V + VA+K+++ L EI I+ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 175 NTAKLVGCDSDG-------IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLT 227
N + ++LV L L +L GL
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLK--TQHLSNDHICYFLYQILRGLK 123
Query: 228 YLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL-PRQWTHHNVSKFEGTFGYFA 286
Y+H ++HRD+K N+LL + +ICDFGLA+ P ++++ T Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 287 PEYFMHGIVD-EKTDVYSFGVLLLELITGR 315
PE ++ + D++S G +L E+++ R
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-35
Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 24/212 (11%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRD-GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT 176
+++ +IG G + VY+ L D G LVA+K++ + + E+ I+ +DH N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNI 75
Query: 177 AKLVGC--------DSDGIHLVFQLSPLGSLASILHGSKDKP--DWSKRYRIALGTANGL 226
+L D ++LV P H S+ K L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 227 TYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYF 285
Y+H I HRDIK N+LL D ++CDFG AK L R + + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYR 189
Query: 286 APEYFMHGI-VDEKTDVYSFGVLLLELITGRR 316
APE DV+S G +L EL+ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 11/205 (5%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTC--GFLCEIGIIAYVDH 173
+F L+GKG + +V G A+K L K + K + E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 174 PNTAKL--VGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHE 231
P L D + V + + G L L + + R A ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGAEIVSALEY 120
Query: 232 GCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM 291
+ +++RDIK +N++L +D +I DFGL K F GT Y APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 292 HGIVDEKTDVYSFGVLLLELITGRR 316
D + GV++ E++ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 52/271 (19%), Positives = 94/271 (34%), Gaps = 44/271 (16%)
Query: 124 LIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVD-----EKTCGFLCEIGIIAYVD--HPN 175
L+G GG+ VY G + D VA+K + K + E+ ++ V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 176 TAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
+L+ D L+ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 234 QKRIIHRDIKADNILLTED-YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFM- 291
++HRDIK +NIL+ + E ++ DFG L F+GT Y PE+
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRY 183
Query: 292 HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLD---SNDIRELVDPSLGD 348
H V+S G+LL +++ G +H ++ +I + S++ + L+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQVFFRQRVSSECQHLI------ 235
Query: 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
C+ P RP ++
Sbjct: 236 --------------RWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (321), Expect = 2e-34
Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 22/280 (7%)
Query: 118 NFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHPNT 176
+ IG+G Y VYK G A+K++ DE + EI I+ + H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 177 AKLVGCDSDGIHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQK 235
KL LV L L +L + + L NG+ Y H+ +
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 236 RIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV 295
R++HRD+K N+L+ + E +I DFGLA+ + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 296 DEKTDVYSFGVLLLELITGRR------AVDHLQQSVVIWAKP----------LLDSNDIR 339
D++S G + E++ G D L + I P L +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 340 ELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+ +P +++ + + S ++ P R Q
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 46/270 (17%), Positives = 94/270 (34%), Gaps = 29/270 (10%)
Query: 122 ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKL 179
++G G +V + R A+K L + E+ + P+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 70
Query: 180 VGC------DSDGIHLVFQLSPLGSLASILHGSKDKP-DWSKRYRIALGTANGLTYLHEG 232
V + +V + G L S + D+ + I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 233 CQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMH 292
I HRD+K +N+L T I + +H++++ T Y APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 293 GIVDEKTDVYSFGVLLLELITGRR---AVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349
D+ D++S GV++ L+ G + L S + + + + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE- 246
Query: 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+ + + R ++ P R +++
Sbjct: 247 -EVKMLIRN------LLKTEPTQRMTITEF 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 9e-34
Identities = 54/244 (22%), Positives = 96/244 (39%), Gaps = 20/244 (8%)
Query: 84 KSRSTREDPDLTHIYNYRSSLKEFTLSELQTATKNFSSEN------LIGKGGYAEVYKG- 136
+ + ++ + + + + KE L + +T ++N + + +G G + V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 137 CLRDGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSDGIHL--VFQ 192
G A+K L K V ++ L E I+ V+ P KL D +L V +
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED 252
G + S L + A YLH +I+RD+K +N+L+ +
Sbjct: 122 YVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177
Query: 253 YEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELI 312
Q+ DFG AK + + GT APE + ++ D ++ GVL+ E+
Sbjct: 178 GYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 313 TGRR 316
G
Sbjct: 233 AGYP 236
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-33
Identities = 58/282 (20%), Positives = 98/282 (34%), Gaps = 37/282 (13%)
Query: 119 FSSENL---------IGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG-----FLC 163
F EN+ +G G +A V K G A K + K G
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 164 EIGIIAYVDHPNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALG 221
E+ I+ + HPN L + + L+ +L G L K+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQ 121
Query: 222 TANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQ----ICDFGLAKWLPRQWTHHNVSK 277
NG+ + +I H D+K +NI+L + P+ I DFGLA + N+
Sbjct: 122 ILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 177
Query: 278 FEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337
GT + APE + + + D++S GV+ L++G + +
Sbjct: 178 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------- 227
Query: 338 IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQV 379
+ V+ D Y + A + + P R +
Sbjct: 228 VSA-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-33
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 21/215 (9%)
Query: 118 NFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEK-TCGFLCEIGIIAYVDHPN 175
+ IG+G + EV+K + G VA+K++ E L EI I+ + H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 176 TAKLVGC----------DSDGIHLVFQLSPLGSLASIL-HGSKDKPDWSKRYRIALGTAN 224
L+ I+LVF + K KR L
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---- 126
Query: 225 GLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL--PRQWTHHNVSKFEGTF 282
L L+ + +I+HRD+KA N+L+T D ++ DFGLA+ + + + T
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 283 GYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRR 316
Y PE + D++ G ++ E+ T
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-32
Identities = 50/282 (17%), Positives = 92/282 (32%), Gaps = 22/282 (7%)
Query: 117 KNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKT-CGFLCEIGIIAYVDHP 174
+ + IG+G Y V+K +VA+KR+ DE L EI ++ + H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 175 NTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQ 234
N +L L S + + + L L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL--FQLLKGLGFCHS 119
Query: 235 KRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGI 294
+ ++HRD+K N+L+ + E ++ +FGLA+ ++ + + F +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKL 178
Query: 295 VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354
D++S G + EL R + + E PS+ D +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 355 IDRAVLTASL-----------------CIEQSPILRPKMSQV 379
T SL ++ +P+ R +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-30
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 20/247 (8%)
Query: 117 KNFSSENLIGKGGYAEVYKG----CLRDGTLVAVKRLTKGTVDEKTCG---FLCEIGIIA 169
+NF ++G G Y +V+ G L A+K L K T+ +K E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 170 YVDH-PNTAKLVGC--DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGL 226
++ P L +HL+ G L + L + + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIV 139
Query: 227 TYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFA 286
L + II+RDIK +NILL + + DFGL+K T F GT Y A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 198
Query: 287 PEYFMHGI--VDEKTDVYSFGVLLLELITGRR---AVDHLQQSVVIWAKPLLDSNDIREL 341
P+ G D+ D +S GVL+ EL+TG I + L +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 342 VDPSLGD 348
+ D
Sbjct: 259 MSALAKD 265
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-28
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 22/222 (9%)
Query: 107 FTLSELQTATKNFSS----ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG- 160
F E+ + +G G Y V R G VA+K+L + E
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 161 FLCEIGIIAYVDHPNTAKLVGCD------SDGIHLVFQLSPLGSLASILHGSKDKPDWSK 214
E+ ++ ++ H N L+ D + +G+ L +K +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDR 122
Query: 215 RYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274
+ GL Y+H IIHRD+K N+ + ED E +I DFGLA+ + T +
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY- 178
Query: 275 VSKFEGTFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGR 315
T Y APE + + D++S G ++ E+ITG+
Sbjct: 179 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 2e-27
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 26/230 (11%)
Query: 96 HIYNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTV 154
Y+ FT+ K + + IG G V VA+K+L++
Sbjct: 2 QFYSVEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 55
Query: 155 DEKTC-GFLCEIGIIAYVDHPNTAKLVGC--------DSDGIHLVFQLSPLGSLASILHG 205
++ E+ ++ V+H N L+ + ++LV +L I
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM- 114
Query: 206 SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265
+ D + + G+ +LH IHRD+K NI++ D +I DFGLA+
Sbjct: 115 ---ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
T ++ + T Y APE + E D++S G ++ E++ +
Sbjct: 169 ---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 4e-27
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 23/213 (10%)
Query: 122 ENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLV 180
+G G ++ V+ + + T VA+K + V + EI ++ V+ + K
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA--AEDEIKLLQRVNDADNTKED 75
Query: 181 GCDSDGI-----------------HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTA 223
++ I +VF++ LA I +I+
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 224 NGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTF 282
GL Y+H + IIH DIK +N+L+ D + +A W + + T
Sbjct: 136 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 283 GYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR 315
Y +PE + D++S L+ ELITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 3e-26
Identities = 44/227 (19%), Positives = 86/227 (37%), Gaps = 28/227 (12%)
Query: 98 YNYRSSLKEFTLSELQTATKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDE 156
++Y S + E+ + ++ +G+G Y+EV++ + + V VK L +
Sbjct: 22 WDYESHVVEWGNQD------DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK 75
Query: 157 KTCGFLCEIGIIAYV-DHPNTAKLVGC----DSDGIHLVFQLSPLGSLASILHGSKDKPD 211
EI I+ + PN L S LVF+ +
Sbjct: 76 ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLT 127
Query: 212 WSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT-EDYEPQICDFGLAKWLPRQW 270
L Y H I+HRD+K N+++ E + ++ D+GLA++
Sbjct: 128 DYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 271 THHNVSKFEGTFGYFAPEYFM-HGIVDEKTDVYSFGVLLLELITGRR 316
++ + + PE + + + D D++S G +L +I +
Sbjct: 185 EYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 17/245 (6%)
Query: 116 TKNFSSENLIGKGGYAEVYKG-CLRDGTLVAVKRLTKGTVDEKTCG-FLCEIGIIAYVDH 173
+ + + + +G G Y V + G VAVK+L++ E+ ++ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 174 PNTAKLVGCDSDGIHL-----VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTY 228
N L+ + L V+ ++ L K + GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 229 LHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPE 288
+H IIHRD+K N+ + ED E +I DFGLA+ + T + + +
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEI 189
Query: 289 YFMHGIVDEKTDVYSFGVLLLELITGR---RAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345
++ D++S G ++ EL+TGR DH+ Q +I ++ + +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 346 LGDNY 350
NY
Sbjct: 250 SARNY 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.9 bits (191), Expect = 2e-17
Identities = 23/151 (15%), Positives = 45/151 (29%), Gaps = 15/151 (9%)
Query: 123 NLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCG---------FLCEIGIIAYVDH 173
L+G+G + V+ VK G K F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 174 PNTAKLVGCDSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC 233
KL G ++ + L L + + + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAKFY--- 120
Query: 234 QKRIIHRDIKADNILLTEDYEPQICDFGLAK 264
+ I+H D+ N+L++ + I DF +
Sbjct: 121 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.38 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=414.03 Aligned_cols=260 Identities=29% Similarity=0.389 Sum_probs=203.6
Q ss_pred hcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQL 193 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~ 193 (434)
.++|.+.+.||+|+||+||+|.++ ..||||++..... ......|.+|+.+|++++|||||+++|++. +..++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 357999999999999999999875 3599999975433 344567999999999999999999999854 468999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++......+++..++.|+.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 99999999998777789999999999999999999999 899999999999999999999999999998765543334
Q ss_pred ceeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 274 NVSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......||+.|+|||++.+ +.|+.++|||||||++|||+||+.||.+............ . ....+.+ ...
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~--~----~~~~p~~-~~~ 234 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--R----GYLSPDL-SKV 234 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--H----TSCCCCG-GGS
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh--c----CCCCCcc-hhc
Confidence 4456779999999999864 3588999999999999999999999987544322211100 0 0001100 011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.....+.+.+++.+||+.+|++||||.||++.|+.+.
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1222357788999999999999999999999997543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-55 Score=409.00 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=200.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|++.+.||+|+||+||+|.+. +|+.||||++......+....+.+|+.++++++|||||+++++.. +..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46889999999999999999986 799999999987655455567999999999999999999999743 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 85 ~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999996 44678999999999999999999999 999999999999999999999999999998765443333
Q ss_pred ceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||............. ...........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----------~~~~~~~~~~~ 230 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------KEKKTYLNPWK 230 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----------HTTCTTSTTGG
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----------hcCCCCCCccc
Confidence 3456789999999999988776 578999999999999999999997644322211100 00000000011
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+++.+||+.||++|||+.||++
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12346678899999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=414.70 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CC---cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DG---TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.++||+|+||+||+|.++ +| ..||||.+...........|.+|+.+|++++|||||+++|++. +..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677789999999999999875 33 3689999887666666678999999999999999999999854 478999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++......+++..++.|+.||++||.|||+ ++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999999998777789999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccc---ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcC
Q 013927 271 THH---NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 271 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+......... +....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~------------i~~~~ 250 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA------------IEQDY 250 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------------HHTTC
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCC
Confidence 221 1123457899999999999999999999999999999998 8999976543322111 00111
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
....+......+.+++.+||+.||++||||.||++.|+.+..
T Consensus 251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111223344678889999999999999999999999976543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-55 Score=407.65 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=196.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.+.||+|+||+||+|.+.+++.||||++...... ...|.+|+.++++++|||||+++|++. +..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 467888999999999999999988899999999765433 346999999999999999999999754 5799999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++......+++..++.|+.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 9999999998777889999999999999999999999 9999999999999999999999999999987654322 22
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhC-CCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG-RRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....||+.|+|||++.+..|+.++|||||||++|||+|| ..||........... +... .....+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~--------i~~~----~~~~~p~~ 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------ISTG----FRLYKPRL 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH--------HHHT----CCCCCCTT
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH--------HHhc----CCCCCccc
Confidence 2345689999999999999999999999999999999995 555544332211110 0000 01111112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
....+.+++.+||+.||++||||+||++.|+.+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 235678899999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=407.93 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=208.7
Q ss_pred CCCCCCe-ecccCcEEEEEEEeC---CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEE
Q 013927 118 NFSSENL-IGKGGYAEVYKGCLR---DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e 192 (434)
+|.+.+. ||+|+||+||+|.++ ++..||||++...........|.+|+.+|++++|||||+++|++. +..++|||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE 88 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 88 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence 4555564 999999999999764 355799999987665566678999999999999999999999754 57899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++...+..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 89 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 999999999987777789999999999999999999999 99999999999999999999999999999877543221
Q ss_pred -cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 273 -HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 273 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+|||++.++.++.++|||||||++|||+| |+.||............ . .......
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i--------~----~~~~~~~ 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--------E----QGKRMEC 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH--------H----TTCCCCC
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH--------H----cCCCCCC
Confidence 22234568999999999999999999999999999999998 99999875433221110 0 0111112
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223345778899999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=405.62 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=203.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~ 195 (434)
++|.+.+.||+|+||+||+|.+++++.||||++..... ....|.+|+.++++++|||||+++|++. +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 46888899999999999999998888999999976543 2346999999999999999999999754 47899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|+|.+++... ...+++..++.|+.||++||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-EC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-cc
Confidence 99999988643 3468999999999999999999999 9999999999999999999999999999987754322 22
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCcc-ccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAV-DHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+ ......... .. +.....+ ..+..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~-------i~~~~~~----~~p~~ 234 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QN-------LERGYRM----VRPDN 234 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HH-------HHTTCCC----CCCTT
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH-HH-------HHhcCCC----CCccc
Confidence 33456899999999999999999999999999999999976654 332222111 10 0011111 11122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|++||||.+|++.|+.
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 33567889999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=396.21 Aligned_cols=251 Identities=19% Similarity=0.305 Sum_probs=210.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
++|.+.++||+|+||+||+|.+++++.||||++.+.... ...|++|+.++++++||||++++|++. +..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 579999999999999999999988889999999875543 346999999999999999999999854 4789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|..++......+++..++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 9999999988777889999999999999999999999 9999999999999999999999999999987654322 23
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||............ .. ......+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i--------~~----~~~~~~p~~ 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--------AQ----GLRLYRPHL 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------HT----TCCCCCCTT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------Hh----CCCCCCccc
Confidence 334668999999999999999999999999999999998 89999875543322111 00 011111222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
....+.+++.+||+.+|++|||+.+|++.|..
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 33578889999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-54 Score=407.12 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=208.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++..... ..+.|.+|+.+|++++|||||+++|++. +..++||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 45888899999999999999986 688999999876543 3446999999999999999999999754 478999999
Q ss_pred cCCCCHHHHhcc-CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHG-SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++.. ....+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 999999999864 45678999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.......||+.|+|||++.++.|+.++|||||||++|||++|..||........++ ..+........+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-----------~~i~~~~~~~~~~ 239 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------ELLEKDYRMERPE 239 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----------HHHHTTCCCCCCT
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-----------HHHhcCCCCCCCc
Confidence 22334568999999999999999999999999999999999777654322211111 1111111122222
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.....+.+++.+||+.||++||||.||++.|+.+....
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 33457888999999999999999999999998765443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=403.68 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=201.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCC-----cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDG-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~l 189 (434)
..|...++||+|+||+||+|.++.+ ..||||++...........|.+|+.++++++|||||+++|++. +..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3577789999999999999987632 4799999987666666667999999999999999999999754 47899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+.+|++.+++......+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999888777889999999999999999999999 99999999999999999999999999999876543
Q ss_pred Ccc-cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 270 WTH-HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
... .......||+.|+|||++.++.++.++|||||||++|||++|..|+........+. ..+......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-----------~~i~~~~~~ 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-----------KAINDGFRL 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----------HHHHTTCCC
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-----------HHHhccCCC
Confidence 221 12234568999999999999999999999999999999999766654322111111 111111122
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
..+......+.+++.+||+.+|++||+|.||++.|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2223344678889999999999999999999999976543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=410.57 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=203.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC-C-----cEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD-G-----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~ 187 (434)
++|.+.++||+|+||+||+|.+.. + ..||||.+...........+.+|+.++.++ +|||||+++|++. +..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 468888999999999999998652 2 369999987655445556789999999998 8999999999754 478
Q ss_pred EEEEEEcCCCCHHHHhccCC----------------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCC
Q 013927 188 HLVFQLSPLGSLASILHGSK----------------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKAD 245 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~ 245 (434)
++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999997543 347889999999999999999999 99999999999
Q ss_pred cEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccch
Q 013927 246 NILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQS 324 (434)
Q Consensus 246 NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~ 324 (434)
|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987665444334455678999999999999999999999999999999998 89999875433
Q ss_pred hhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhc
Q 013927 325 VVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLR 384 (434)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~ 384 (434)
..... ++........+....+.+.+++.+||+.+|++|||+.||++.|.
T Consensus 274 ~~~~~-----------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYK-----------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHH-----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH-----------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22211 11111111222233457888999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=398.27 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=202.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.++++++|||||++++++ .+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46999999999999999999975 799999999976432 2345689999999999999999999974 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+++|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 999999998864 468999999999999999999999 999999999999999999999999999998765432 2
Q ss_pred ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHH
Q 013927 274 NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAE 353 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 353 (434)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||............... . .+. ...+..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~-----~~~--~~~~~~ 241 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---G-----TPE--LQNPEK 241 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---C-----SCC--CSSGGG
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC---C-----CCC--CCCccc
Confidence 234567999999999999999999999999999999999999999764433222111000 0 000 011122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 354 EIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 354 ~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
....+.+++.+||+.||++|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2356788999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=400.08 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=192.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc----CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS----DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~lv 190 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... +.....+.+|+.++++++|||||++++++. +.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46889999999999999999976 789999999987654 334567899999999999999999999642 357899
Q ss_pred EEEcCCCCHHHHhcc---CCCCCCHHHHHHHHHHHHHHhHhhhccC--CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 191 FQLSPLGSLASILHG---SKDKPDWSKRYRIALGTANGLTYLHEGC--QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3467999999999999999999999821 13499999999999999999999999999987
Q ss_pred cCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCc
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 345 (434)
+.... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||............ ..... +.
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i---~~~~~-----~~ 233 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---REGKF-----RR 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHTCC-----CC
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH---HcCCC-----CC
Confidence 65432 1234567999999999999999999999999999999999999999865433221110 00011 11
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+... ..+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112 2346788999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=393.52 Aligned_cols=244 Identities=28% Similarity=0.415 Sum_probs=200.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|..+ +|+.||||++.+... ......+.+|+.++++++|||||++++++.+ ..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35888999999999999999986 789999999975432 1234568899999999999999999998544 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred eecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 99999999999974 3568999999999999999999999 99999999999999999999999999999866533
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ...... ... ++
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~~--------~~~----~p 224 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISRV--------EFT----FP 224 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTT--------CCC----CC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-HHHHcC--------CCC----CC
Confidence 234567999999999999999999999999999999999999999764432211 100000 001 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
......+.+++.+||+.||++|||+.||++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122356778999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=397.77 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=197.9
Q ss_pred CeecccCcEEEEEEEeC---CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEEEEcCCC
Q 013927 123 NLIGKGGYAEVYKGCLR---DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVFQLSPLG 197 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~e~~~~g 197 (434)
++||+|+||+||+|.++ .++.||||++..... ......|.+|+.+|++++|||||+++|++. +..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 46999999999999864 346899999975433 233457999999999999999999999864 4788999999999
Q ss_pred CHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc-cee
Q 013927 198 SLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH-NVS 276 (434)
Q Consensus 198 sL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~-~~~ 276 (434)
+|.+++.. ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 93 ~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 93 PLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred cHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999874 4668999999999999999999999 899999999999999999999999999998765432222 223
Q ss_pred ccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCCHHHH
Q 013927 277 KFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEI 355 (434)
Q Consensus 277 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 355 (434)
...||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+......... +........+....
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~------------i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------LEKGERMGCPAGCP 236 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------HHTTCCCCCCTTCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH------------HHcCCCCCCCcccC
Confidence 4568999999999999999999999999999999998 8999987544322111 00011111222233
Q ss_pred HHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 356 DRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 356 ~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 5678899999999999999999999988743
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=398.20 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=201.4
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEEc
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQLS 194 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~~ 194 (434)
.|++.+.||+|+||+||+|.+. +|+.||||++..... .....+.+|+.+|++++|||||++++++ .+..++||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5888899999999999999976 789999999976543 4456799999999999999999999974 45788999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 9999999987666779999999999999999999999 99999999999999999999999999999765322 112
Q ss_pred eeccccccccccCCccc-----cCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 275 VSKFEGTFGYFAPEYFM-----HGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
.....||+.|+|||++. +..|+.++|||||||++|||++|+.||.............. .....+ .
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~-------~ 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTL-------A 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCC-------S
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCC-------C
Confidence 23567999999999984 45589999999999999999999999977544322211000 000000 1
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223356788999999999999999999965
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=406.19 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=201.1
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
.++|.+.+.||+|+||+||+|... +|+.||||++...........+.+|+.+|++++|||||++++++.+ ..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999976 7899999999876555556679999999999999999999997544 6899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ .++|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999999974 3568999999999999999999997 148999999999999999999999999999865432
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc---------------
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND--------------- 337 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~--------------- 337 (434)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.................+.
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2245689999999999999999999999999999999999999997633221110000000000
Q ss_pred ----------------cccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 338 ----------------IRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 338 ----------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...+...............++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000000111246788999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=390.89 Aligned_cols=243 Identities=27% Similarity=0.339 Sum_probs=193.8
Q ss_pred CCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc-hhhHhhHHHHHHHHhhCCCCCeeeEeeecc------CCcEEEE
Q 013927 120 SSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV-DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------DGIHLVF 191 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~lv~ 191 (434)
...+.||+|+||+||+|.+. +++.||||++..... ......+.+|+++|++++|||||++++++. ..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999976 788999999976532 344557899999999999999999999742 2478999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCC--eeecCCCCCcEEec-CCCCeEEeccccccccCC
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKR--IIHRDIKADNILLT-EDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFGla~~~~~ 268 (434)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999974 4578999999999999999999998 67 99999999999996 578999999999986443
Q ss_pred CCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCC
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGD 348 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 348 (434)
. ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.........+..... +.. .+..
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~----~~~~-- 234 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVK----PASF-- 234 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCC----CGGG--
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCC----Cccc--
Confidence 2 2345679999999998865 5999999999999999999999999764433322211100 000 0001
Q ss_pred CCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 349 NYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 349 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112245778999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=402.89 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCc----EEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGT----LVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVF 191 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~ 191 (434)
+|++.++||+|+||+||+|.+. +|+ .||||++...........|.+|+.++++++|||||+++|++.+ ..++++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~ 89 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 89 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence 5888999999999999999875 444 5899988765444556679999999999999999999997554 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
+|+.+|+|.+.+......+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999999988778889999999999999999999999 8999999999999999999999999999997765444
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........||+.|+|||++.++.|+.++|||||||++|||+| |..||++........ .+........
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~------------~i~~~~~~~~ 234 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ILEKGERLPQ 234 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH------------HHHHTCCCCC
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH------------HHHcCCCCCC
Confidence 333445568999999999999999999999999999999998 788987654332110 1111111112
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+......+.+++.+||+.+|.+|||+.||++.|..+.
T Consensus 235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 2233457788999999999999999999999887543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=397.93 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=202.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEEEEEEcC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHLVFQLSP 195 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~lv~e~~~ 195 (434)
++|.+.+.||+|+||+||+|.+++++.||||++..... ....|.+|+.++++++|||||+++|++.+ ..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 46889999999999999999998888899999976543 23569999999999999999999997544 6899999999
Q ss_pred CCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 196 LGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 196 ~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
+|+|..++... ...+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++.+..... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence 99999988753 4568999999999999999999999 8999999999999999999999999999987643322 22
Q ss_pred eeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCHHH
Q 013927 275 VSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEE 354 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 354 (434)
.....||+.|+|||++..+.++.++|||||||++|||++|+.|+............ +........+...
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-----------i~~~~~~~~~~~~ 239 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----------VERGYRMPCPPEC 239 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----------HHTTCCCCCCTTS
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-----------HHhcCCCCCCccc
Confidence 34456899999999999999999999999999999999977665432221111110 0001111122233
Q ss_pred HHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCCcc
Q 013927 355 IDRAVLTASLCIEQSPILRPKMSQVVILLRGDEDNA 390 (434)
Q Consensus 355 ~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 390 (434)
.+.+.+++.+||+.||++||+|.+|++.|+......
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 456888999999999999999999999998876554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=397.45 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=198.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+... ......+.+|+.++++++||||+++++++. +..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 35889999999999999999976 799999999975432 223456899999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999998863 4578999999999999999999999 9999999999999999999999999999997764433
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... ... .. ... ++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-~i~--~~------~~~----~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-KII--KL------EYD----FP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHH--TT------CCC----CC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-HHH--cC------CCC----CC
Confidence 334455679999999999999999999999999999999999999998644322211 000 00 001 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVV 380 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl 380 (434)
......+.+++.+||+.||++|||+.|++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12234678899999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=393.86 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC----CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc-CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD----GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS-DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|.+.. +..||||.+...........|.+|+.+|++++|||||+++|++. +..++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 468888999999999999998652 35689999876665566678999999999999999999999754 4789999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++......+++..+..++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++.+....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~- 162 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 162 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc-
Confidence 9999999999987777789999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
........||+.|+|||++.++.++.++|||||||++|||++ |..||............. .+ .....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~---~~---------~~~~~ 230 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NG---------ERLPM 230 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TT---------CCCCC
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH---cC---------CCCCC
Confidence 222345568999999999999999999999999999999998 899998754433221100 00 00111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
+......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2223357888999999999999999999999997654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-52 Score=396.52 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=187.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e~ 193 (434)
+.|.+.+.||+|+||+||+|... +|+.||||++.+.........+.+|+.+|++++|||||+++++..+ ..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45889999999999999999976 7899999999876655555678899999999999999999997543 68899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec---CCCCeEEeccccccccCCCC
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT---EDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGla~~~~~~~ 270 (434)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+++.....
T Consensus 89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999999974 5679999999999999999999999 9999999999999995 5789999999999866433
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.......... .... .......
T Consensus 164 --~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-~~~~--------~~~~~~~ 232 (307)
T d1a06a_ 164 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAE--------YEFDSPY 232 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HTTC--------CCCCTTT
T ss_pred --CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-hccC--------CCCCCcc
Confidence 2234567999999999999999999999999999999999999999764432221100 0000 0000011
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH--HhcC
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMSQVVI--LLRG 385 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~L~~ 385 (434)
.......+.+++.+||+.||++|||+.|+++ .+++
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1122356788999999999999999999987 3554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-52 Score=397.15 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=209.6
Q ss_pred HHhcCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--C
Q 013927 114 TATKNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--D 185 (434)
Q Consensus 114 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~ 185 (434)
...++|.+.+.||+|+||+||+|.+. +++.||||++...........|.+|+.++++++||||+++++++. +
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34567999999999999999999864 357899999987665566678999999999999999999999754 4
Q ss_pred CcEEEEEEcCCCCHHHHhccC-----------------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCC
Q 013927 186 GIHLVFQLSPLGSLASILHGS-----------------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDI 242 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl 242 (434)
..+++|||+++|+|.+++... ...+++..++.|+.|++.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 789999999999999998632 2347889999999999999999999 99999999
Q ss_pred CCCcEEecCCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCC-Cccccc
Q 013927 243 KADNILLTEDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR-RAVDHL 321 (434)
Q Consensus 243 kp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~ 321 (434)
||+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..|+.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998765543444445567899999999999999999999999999999999996 567765
Q ss_pred cchhhhhhccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 322 QQSVVIWAKPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.......... .+. ....+......+..++.+||+.+|++||||.||++.|+.+.
T Consensus 247 ~~~e~~~~v~---~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYYVR---DGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHHHH---TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHHHH---cCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4433221100 000 01112223356788999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-52 Score=396.37 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=197.7
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e 192 (434)
.|+..+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+|++++|||||++++++ .+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999976 789999999987543 23445789999999999999999999974 447899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.+|+|..++. ....+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 999999877665 34678999999999999999999999 99999999999999999999999999999865432
Q ss_pred cceeccccccccccCCcccc---CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMH---GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDN 349 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 349 (434)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.............. .. .+.+.
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~---~~-----~~~~~-- 235 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NE-----SPALQ-- 235 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SC-----CCCCS--
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---CC-----CCCCC--
Confidence 34569999999999864 4589999999999999999999999976543322211100 00 01111
Q ss_pred CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 350 YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 350 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
+......+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112246778999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-51 Score=395.77 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=204.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+|++++|||||++++++ .+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 47999999999999999999976 799999999976543 3445789999999999999999999974 4478999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC--CCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE--DYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+++......+++..+..|+.||+.||.|||+ ++||||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 99999999997666779999999999999999999999 99999999999999964 578999999999876543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............. ...+ ... ..
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~----~~~----~~ 249 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNM----DDS----AF 249 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCS----CCG----GG
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC----Ccc----cc
Confidence 2234567999999999999999999999999999999999999999764432221110000 0000 000 00
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
....+.+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123567889999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-50 Score=393.86 Aligned_cols=254 Identities=21% Similarity=0.233 Sum_probs=206.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|... +|+.||||++..... .....+.+|+.+|++++|||||++++++. +..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36899999999999999999976 799999999987543 33456889999999999999999999754 468899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec--CCCCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT--EDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+.+......+++..+..|+.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 99999999887666779999999999999999999999 9999999999999998 5789999999999877543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+............. +........
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------~~~~~~~~~ 252 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------DWEFDEDAF 252 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC---------CCCCCSSTT
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------CCCCCcccc
Confidence 2234567999999999999999999999999999999999999999875443221110000 000001111
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGD 386 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~ 386 (434)
......+.+++.+||+.||.+|||+.|+++. +++.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1223467789999999999999999999873 5543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=393.13 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=195.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc---CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS---DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---~~ 186 (434)
++|.+.+.||+|+||.||+|.+. +++.||||++...........+..|..++.++ +|+||+.+++++. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 56888999999999999999853 34689999998766555566788888888877 6899999999743 25
Q ss_pred cEEEEEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC
Q 013927 187 IHLVFQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE 251 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~ 251 (434)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++||||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 89999999999999998642 2357899999999999999999999 99999999999999999
Q ss_pred CCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCC-Cccccccchhhhhhc
Q 013927 252 DYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR-RAVDHLQQSVVIWAK 330 (434)
Q Consensus 252 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~ 330 (434)
++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||............
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998765544444445567999999999999999999999999999999999875 577654332211110
Q ss_pred cccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 331 PLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 331 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+..-..+ ..+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 250 -------~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 250 -------LKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp -------HHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0000111 11122235678899999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=385.23 Aligned_cols=249 Identities=21% Similarity=0.258 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-----hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-----EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~ 188 (434)
+.|.+.+.||+|+||+||+|... +|+.||||++.+.... .....+.+|+.+|++++|||||++++++.+ ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46899999999999999999976 7999999999765432 234578999999999999999999998544 688
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC----CeEEecccccc
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY----EPQICDFGLAK 264 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGla~ 264 (434)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999974 3578999999999999999999999 9999999999999998776 49999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............. ........
T Consensus 166 ~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~-- 239 (293)
T d1jksa_ 166 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-NYEFEDEY-- 239 (293)
T ss_dssp ECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCCCHHH--
T ss_pred hcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc-CCCCCchh--
Confidence 765432 233456899999999999999999999999999999999999999865433222110000 00000000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.......+.+++.+||+.||++|||+.|+++
T Consensus 240 ------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 240 ------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112246778999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=388.45 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=196.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC--CC--cEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC-CcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR--DG--TLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD-GIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~l 189 (434)
++|++.+.||+|+||.||+|.+. ++ ..||||++.+... ......|.+|+.+|++++||||++++|++.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 46888899999999999999854 23 3789999876533 2344579999999999999999999997654 6899
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
||||+++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999999999887766779999999999999999999999 99999999999999999999999999999977544
Q ss_pred Cccc-ceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCC
Q 013927 270 WTHH-NVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLG 347 (434)
Q Consensus 270 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 347 (434)
.... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+......... +......
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~-----------i~~~~~~ 233 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-----------IDKEGER 233 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----------HHTSCCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH-----------HHhCCCC
Confidence 3222 2234567889999999999999999999999999999998 8999976544332211 1111111
Q ss_pred CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcC
Q 013927 348 DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRG 385 (434)
Q Consensus 348 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~ 385 (434)
...+......+.+++.+||+.||++||||.+|++.|+.
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11122223567889999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=380.60 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=195.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc---CCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS---DGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~~~lv~e~ 193 (434)
++|.+.+.||+|+||.||+|.++ |..||||++.... ..+.|.+|+.++++++||||++++|++. +..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35777889999999999999986 7899999997643 3346899999999999999999999753 358999999
Q ss_pred cCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 194 SPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 194 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
+++|+|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999653 3458999999999999999999999 99999999999999999999999999999865432
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||........... +........+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~------------i~~~~~~~~~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------VEKGYKMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH------------HTTTCCCCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH------------HHcCCCCCCC
Confidence 233457899999999999999999999999999999998 7888876443322111 1111122223
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.....++.+++.+||+.||++||||.+|++.|+.+
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 33345778899999999999999999999999754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=384.69 Aligned_cols=252 Identities=27% Similarity=0.333 Sum_probs=200.9
Q ss_pred CCeecccCcEEEEEEEeCCC----cEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc---CCcEEEEEEc
Q 013927 122 ENLIGKGGYAEVYKGCLRDG----TLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS---DGIHLVFQLS 194 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~---~~~~lv~e~~ 194 (434)
.++||+|+||+||+|.+.++ ..||||++...........|.+|+.+|++++||||++++|++. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999987532 3699999976555556678999999999999999999999742 3578999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc--
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH-- 272 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~-- 272 (434)
++|+|.+++.......++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998877888999999999999999999999 99999999999999999999999999999876543221
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.......||+.|+|||.+..+.++.++||||||+++|||+||+.||............ +.. ......+.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~----------i~~-g~~~~~p~ 257 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----------LLQ-GRRLLQPE 257 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH----------HHT-TCCCCCCT
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH----------HHc-CCCCCCcc
Confidence 1223356899999999999999999999999999999999988887653222111100 000 00011112
Q ss_pred HHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 353 EEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
...+.+.+++.+||+.||++||+|.||++.|+.+.
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22356788999999999999999999999997664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=386.09 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=208.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD--GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~--~~ 187 (434)
++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|+.+++++ +|||||+++|++.+ ..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 46788899999999999999852 45789999998766666666899999999999 69999999998654 68
Q ss_pred EEEEEEcCCCCHHHHhccCC-----------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 188 HLVFQLSPLGSLASILHGSK-----------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999986432 358899999999999999999999 9999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhC-CCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITG-RRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+ ..||.........+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~- 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY- 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH-
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence 9999999999999987655444444567899999999999999999999999999999999994 55555433322211
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.++........+......+.+++.+||+.||++||||.+|++.|+++.
T Consensus 259 ----------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 ----------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111112222223457888999999999999999999999997543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=385.32 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=200.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~ 191 (434)
++|.+.++||+|+||.||+|... +|+.||||++.+... ......+.+|+.+|++++||||+++++++.+ .+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46899999999999999999976 799999999976432 2234568899999999999999999997544 688999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 85 EYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp ECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred eccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 99999999999874 4567888899999999999999999 999999999999999999999999999998654322
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........ .... . ...+...+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~i~~--~------~~~~p~~~- 228 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-LILM--E------EIRFPRTL- 228 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHH--C------CCCCCTTS-
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH-HHhc--C------CCCCCccC-
Confidence 22345789999999999999999999999999999999999999998754332211 0000 0 00111122
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
...+.+++.+||+.||.+||+ +.|+++
T Consensus 229 ---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 245778999999999999995 777764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=385.88 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=203.9
Q ss_pred cCCCCCCeecccCcEEEEEEEeCC--------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeeccC--
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDSD-- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-- 185 (434)
++|.+.+.||+|+||.||+|.... +..||||++...........+.+|+..+.++ +|||||++++++.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 358888999999999999998531 3479999998877666667899999999888 79999999997543
Q ss_pred CcEEEEEEcCCCCHHHHhccCC---------------CCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEec
Q 013927 186 GIHLVFQLSPLGSLASILHGSK---------------DKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLT 250 (434)
Q Consensus 186 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~ 250 (434)
..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 6899999999999999996432 358999999999999999999999 9999999999999999
Q ss_pred CCCCeEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHh-CCCccccccchhhhhh
Q 013927 251 EDYEPQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELIT-GRRAVDHLQQSVVIWA 329 (434)
Q Consensus 251 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~~ 329 (434)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||...........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 999999999999987765544444455678999999999999999999999999999999998 7888876443322111
Q ss_pred ccccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 330 KPLLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 330 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
+........+......+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 250 ------------i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 250 ------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ------------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 001111111222335688899999999999999999999999755
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-49 Score=381.32 Aligned_cols=243 Identities=25% Similarity=0.288 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVF 191 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~ 191 (434)
++|.+.+.||+|+||+||+|..+ +|+.||||++.+... ......+.+|+.++++++|||||+++++.. +..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999976 799999999975432 223457889999999999999999999754 4689999
Q ss_pred EEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCc
Q 013927 192 QLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 192 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~ 271 (434)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999998874 4567888888899999999999998 99999999999999999999999999999876543
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............ . .. ... ++
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~--~~------~~~----~p 221 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-L--NA------ELR----FP 221 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-H--HC------CCC----CC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH-H--cC------CCC----CC
Confidence 23467999999999999999999999999999999999999999764433221110 0 00 001 11
Q ss_pred HHHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
......+.+++.+||..||.+|| +++++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11224677889999999999996 8889875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-50 Score=383.45 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=208.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC------CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR------DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.+.||+|+||+||+|.+. +++.||||++...........|.+|+.++++++||||++++|++. +..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 46788899999999999999863 357899999987655555567999999999999999999999743 5799
Q ss_pred EEEEEcCCCCHHHHhcc---------CCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEec
Q 013927 189 LVFQLSPLGSLASILHG---------SKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICD 259 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D 259 (434)
+||||+++|+|.+++.. ....+++..+..++.|+++||.|||+ ++|+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 99999999999998863 22457899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCC-CccccccchhhhhhccccCcccc
Q 013927 260 FGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGR-RAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
||+++.+.............||+.|+|||.+.++.++.++|||||||++|||+||. .||...........
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~--------- 247 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------- 247 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH---------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH---------
Confidence 99998765443333344556899999999999999999999999999999999985 67766443322111
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
+.+.. ....+......+.+++.+||+.+|++||||.+|++.|+...+
T Consensus 248 --i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 --VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp --HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11110 011112223568889999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-49 Score=373.92 Aligned_cols=257 Identities=21% Similarity=0.228 Sum_probs=198.0
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHHHHHHHHhhCCCCCeeeEeeeccC------Cc
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GI 187 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 187 (434)
++|.+.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.+++.++||||++++++... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 46899999999999999999975 7999999999865442 344578999999999999999999997432 27
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccC
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLP 267 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~ 267 (434)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 899999999999998864 4578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcC
Q 013927 268 RQW-THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSL 346 (434)
Q Consensus 268 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 346 (434)
... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.........+..... ....... .
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~----~ 237 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-DPIPPSA----R 237 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCCGGG----T
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-CCCCCch----h
Confidence 322 122334567999999999999999999999999999999999999999875443322111000 0000001 1
Q ss_pred CCCCCHHHHHHHHHHHHhhhccCCCCCC-CHhHHHHHhcCC
Q 013927 347 GDNYDAEEIDRAVLTASLCIEQSPILRP-KMSQVVILLRGD 386 (434)
Q Consensus 347 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~evl~~L~~~ 386 (434)
... ....+.+++.+||+.||.+|| +++++++.|..+
T Consensus 238 ~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 238 HEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111 224677899999999999999 899998887643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=383.82 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=199.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCc--EEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc--CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGT--LVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS--DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~--~~~~lv 190 (434)
++|.+.++||+|+||+||+|.++ +|. .||||++...........|.+|+.+|+++ +|||||+++|++. +..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 45888899999999999999876 444 57888887655555566899999999998 7999999999754 468999
Q ss_pred EEEcCCCCHHHHhccC---------------CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCe
Q 013927 191 FQLSPLGSLASILHGS---------------KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEP 255 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~ 255 (434)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999643 3578999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCC-ccccccchhhhhhccccC
Q 013927 256 QICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRR-AVDHLQQSVVIWAKPLLD 334 (434)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~~~~~~~ 334 (434)
||+|||+++...... ......||..|+|||.+.++.|+.++|||||||++|||++|.. ||............
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i---- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH----
Confidence 999999998654321 1234568999999999999999999999999999999999765 67654433221110
Q ss_pred ccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCCC
Q 013927 335 SNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDED 388 (434)
Q Consensus 335 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~~ 388 (434)
. .......+......+.+++.+||+.||++||||.||++.|+.+.+
T Consensus 240 ----~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 ----P----QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----G----GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----H----hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 011111222334578889999999999999999999999987643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=378.13 Aligned_cols=248 Identities=19% Similarity=0.195 Sum_probs=201.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++..... ....+.+|+.+|+.++|||||+++++. .+.+++||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 56899999999999999999976 789999999987543 334588999999999999999999974 4578999999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC--CCeEEeccccccccCCCCc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED--YEPQICDFGLAKWLPRQWT 271 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFGla~~~~~~~~ 271 (434)
+++|+|.+++......+++..+..|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999998666679999999999999999999999 999999999999999854 48999999999876433
Q ss_pred ccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCC
Q 013927 272 HHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYD 351 (434)
Q Consensus 272 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 351 (434)
.......||+.|+|||.+.+..|+.++|||||||++|+|++|+.||............ ......+..... .
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~----~--- 228 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MNAEYTFDEEAF----K--- 228 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HHTCCCCCHHHH----T---
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCChhhc----c---
Confidence 2234567899999999999999999999999999999999999999765433221110 000000000000 0
Q ss_pred HHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 352 AEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 352 ~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.....+.+++.+||+.||++|||+.|+++
T Consensus 229 -~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 -EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11245788999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=380.96 Aligned_cols=266 Identities=24% Similarity=0.282 Sum_probs=196.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~lv 190 (434)
+.|.+.+.||+|+||.||+|.++ |+.||||++.... .....+..|+..+.+++|||||+++|++.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 34677789999999999999975 8999999986432 222123335555567899999999997532 36899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccC-----CCCeeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGC-----QKRIIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
|||+++|+|.+++.. ..++|..++.++.|+|.||.|||+.+ .++||||||||+||||+.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999974 46899999999999999999999631 36999999999999999999999999999987
Q ss_pred cCCCCcc--cceeccccccccccCCccccCC------CCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccc
Q 013927 266 LPRQWTH--HNVSKFEGTFGYFAPEYFMHGI------VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSND 337 (434)
Q Consensus 266 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 337 (434)
....... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||.........+.........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6543222 1234567999999999987543 5678999999999999999998875433221111110000011
Q ss_pred ----cccccCCcCCCCC-----CHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCCC
Q 013927 338 ----IRELVDPSLGDNY-----DAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGDE 387 (434)
Q Consensus 338 ----~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~~ 387 (434)
.....+..+.... +.+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0112222222222 2245567889999999999999999999999997543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-49 Score=382.48 Aligned_cols=242 Identities=21% Similarity=0.208 Sum_probs=198.8
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHhhCCCCCeeeEeeeccC--CcEEEEE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--GIHLVFQ 192 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~lv~e 192 (434)
+|.+.+.||+|+||+||+|.++ +|+.||||++.+... ......+.+|+.+|+.++|||||+++++..+ ..++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 6888999999999999999976 799999999975332 1234468899999999999999999997443 6789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.+|+|..++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 122 ~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 9999999999864 3568999999999999999999999 99999999999999999999999999999876533
Q ss_pred cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCCCH
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNYDA 352 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 352 (434)
.....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.......... . .. .... +.
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~--~~------~~~~----p~ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-V--SG------KVRF----PS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-H--HC------CCCC----CT
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-h--cC------CCCC----Cc
Confidence 23467999999999999999999999999999999999999999764432221100 0 00 0011 11
Q ss_pred HHHHHHHHHHHhhhccCCCCCC-----CHhHHHH
Q 013927 353 EEIDRAVLTASLCIEQSPILRP-----KMSQVVI 381 (434)
Q Consensus 353 ~~~~~l~~l~~~Cl~~~P~~RP-----s~~evl~ 381 (434)
.....+.+++.+||+.||.+|+ ++.++++
T Consensus 260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2234677899999999999994 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-49 Score=369.66 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=200.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--------hhHhhHHHHHHHHhhCC-CCCeeeEeeeccC-
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--------EKTCGFLCEIGIIAYVD-HPNTAKLVGCDSD- 185 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~- 185 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+.... .....+.+|+.++++++ ||||++++++..+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999975 7899999999865432 12346889999999997 9999999998544
Q ss_pred -CcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 186 -GIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 186 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 68999999999999999974 4578999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccceeccccccccccCCcccc------CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCcccc
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMH------GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDI 338 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 338 (434)
.+.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............. ....
T Consensus 159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~---~~~~ 232 (277)
T d1phka_ 159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---SGNY 232 (277)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTCC
T ss_pred EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH---hCCC
Confidence 876532 2345679999999999853 347889999999999999999999998754433211100 0000
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.............+.+++.+||+.+|.+||++.||++
T Consensus 233 ------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 ------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111123356788999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=368.99 Aligned_cols=254 Identities=25% Similarity=0.276 Sum_probs=190.1
Q ss_pred CCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchh----hHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEEEc
Q 013927 122 ENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDE----KTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQLS 194 (434)
Q Consensus 122 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e~~ 194 (434)
+++||+|+||+||+|.+. +|+.||||++....... ....+.+|+.++++++|||||++++++. +..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999976 79999999987643321 2346889999999999999999999744 4789999999
Q ss_pred CCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcccc
Q 013927 195 PLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHHN 274 (434)
Q Consensus 195 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~ 274 (434)
.++++..+.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A 156 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence 9887766654 55678888999999999999999999 9999999999999999999999999999987654322 2
Q ss_pred eeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccCc-cccccccC---
Q 013927 275 VSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLDS-NDIRELVD--- 343 (434)
Q Consensus 275 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~~-~~~~~~~d--- 343 (434)
.....||+.|+|||++..+ .|+.++|||||||++|||++|+.||........... .+.... ........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 2345799999999998755 579999999999999999999999976433221100 000000 00000000
Q ss_pred CcCCCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
-......+. .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000001111 12356888999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-49 Score=383.42 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=193.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch--hhHhhHH---HHHHHHhhCCCCCeeeEeeecc--CCcE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD--EKTCGFL---CEIGIIAYVDHPNTAKLVGCDS--DGIH 188 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~---~E~~~l~~l~h~niv~l~g~~~--~~~~ 188 (434)
++|.+.++||+|+||+||+|... +|+.||||++.+.... .....+. .|+.+++.++|||||++++++. +..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999976 7999999998753221 1122233 3477788889999999999744 4689
Q ss_pred EEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCC
Q 013927 189 LVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPR 268 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~ 268 (434)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999974 4567889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhh--hhhccccCccccccccCCc
Q 013927 269 QWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVV--IWAKPLLDSNDIRELVDPS 345 (434)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~d~~ 345 (434)
.. .....||+.|+|||++..+ .|+.++|||||||++|||+||+.||........ +...... ....
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~ 227 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAVE 227 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--------CCCC
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------CCCC
Confidence 32 2345799999999999754 589999999999999999999999976432211 1100000 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 346 LGDNYDAEEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 346 l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
....+ ...+.+++.+||+.||++||| ++|+++
T Consensus 228 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11122 346788999999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=377.74 Aligned_cols=246 Identities=18% Similarity=0.193 Sum_probs=193.9
Q ss_pred cCCCCCC-eecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhC-CCCCeeeEeeecc------CCc
Q 013927 117 KNFSSEN-LIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYV-DHPNTAKLVGCDS------DGI 187 (434)
Q Consensus 117 ~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~------~~~ 187 (434)
++|.+.. +||+|+||+||+|.+. +|+.||||++... ..+.+|+.++.++ +|||||++++++. ..+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4687764 6999999999999975 7899999998642 2467899987655 8999999999743 347
Q ss_pred EEEEEEcCCCCHHHHhccC-CCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccc
Q 013927 188 HLVFQLSPLGSLASILHGS-KDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLA 263 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla 263 (434)
++|||||++|+|.+++... ...+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 9999999999999999754 3568999999999999999999999 99999999999999985 557999999999
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.......... ...+..
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-------~~~i~~ 231 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRM 231 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCS
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-------HHHHhc
Confidence 8765432 234567999999999999989999999999999999999999999764332111000 000000
Q ss_pred CcCCCC--CCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDN--YDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...... ........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001000 01123467888999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=377.00 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=198.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCc--hhhHhhHHHHHHHHh-hCCCCCeeeEeeeccC--CcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTV--DEKTCGFLCEIGIIA-YVDHPNTAKLVGCDSD--GIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~--~~~lv 190 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++.+... ......+..|..++. .++|||||+++++..+ ..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47889999999999999999986 799999999975432 223345667777765 6899999999998544 68999
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQW 270 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~ 270 (434)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999999974 4568889999999999999999999 999999999999999999999999999998654332
Q ss_pred cccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCCcCCCCC
Q 013927 271 THHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDPSLGDNY 350 (434)
Q Consensus 271 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 350 (434)
.......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.......... ... .+....
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~--------~~~~p~-- 224 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMD--------NPFYPR-- 224 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHC--------CCCCCT--
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-HcC--------CCCCCc--
Confidence 2234567999999999999999999999999999999999999999864433221111 000 111111
Q ss_pred CHHHHHHHHHHHHhhhccCCCCCCCHh-HHHH
Q 013927 351 DAEEIDRAVLTASLCIEQSPILRPKMS-QVVI 381 (434)
Q Consensus 351 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-evl~ 381 (434)
.....+.+++.+||+.||++||++. +|++
T Consensus 225 --~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 --WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1234678899999999999999996 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=370.12 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=198.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++|||||++++++. +..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47889999999999999999975 7999999999765432 23457899999999999999999999743 46899999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
|+.++.+..........+++..+..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 998665555544456779999999999999999999999 999999999999999999999999999998764432
Q ss_pred cceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cccc-CccccccccC-
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLL-DSNDIRELVD- 343 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~-~~~~~~~~~d- 343 (434)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+......... .+.. .........+
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 2233457999999999987665 57899999999999999999999976443222111 0000 0000000000
Q ss_pred -CcCC--CCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCC
Q 013927 344 -PSLG--DNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGD 386 (434)
Q Consensus 344 -~~l~--~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~ 386 (434)
.... .... ......+.+++.+||+.||++|||+.|+++. |+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 0000 0112567889999999999999999999863 5443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=369.20 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=196.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-C-CcEEEEEEeeCCCch-hhHhhHHHHHHHHhhC---CCCCeeeEeeecc------
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-D-GTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYV---DHPNTAKLVGCDS------ 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~------ 184 (434)
++|.+.+.||+|+||+||+|.+. + ++.||||++...... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 57999999999999999999974 4 678999998754332 2233567788877665 7999999998742
Q ss_pred -CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccc
Q 013927 185 -DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLA 263 (434)
Q Consensus 185 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla 263 (434)
...+++|||+.+|.+..........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 25789999999887776666667789999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cccc----
Q 013927 264 KWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLL---- 333 (434)
Q Consensus 264 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~---- 333 (434)
+..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......... .+..
T Consensus 164 ~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 164 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 765432 233456799999999999999999999999999999999999999976433221100 0000
Q ss_pred Cccccc-cccCCcC---CCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 334 DSNDIR-ELVDPSL---GDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 334 ~~~~~~-~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
...... ....... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000000 00011112346778899999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-47 Score=362.80 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=195.4
Q ss_pred cCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec--cCCcEEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD--SDGIHLVFQL 193 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~lv~e~ 193 (434)
++|.+.+.||+|+||+||+|.+++|+.||||++...... .....+.+|+.+|++++||||+++++++ .+..+++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 478889999999999999999999999999999765432 2345789999999999999999999974 4478899999
Q ss_pred cCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCccc
Q 013927 194 SPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTHH 273 (434)
Q Consensus 194 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~~ 273 (434)
+.++.+..+.. ....+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence 98766666654 56789999999999999999999999 899999999999999999999999999998764432 2
Q ss_pred ceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccccC-cccccccc--C
Q 013927 274 NVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPLLD-SNDIRELV--D 343 (434)
Q Consensus 274 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~~~-~~~~~~~~--d 343 (434)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||........... .+... -....... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 22345689999999998754 578999999999999999999999976432221110 00000 00000000 0
Q ss_pred CcC--C-----CCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSL--G-----DNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l--~-----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
... . ..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 0011112356788999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=365.07 Aligned_cols=238 Identities=21% Similarity=0.345 Sum_probs=192.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-----hhHhhHHHHHHHHhhCC--CCCeeeEeeecc--CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-----EKTCGFLCEIGIIAYVD--HPNTAKLVGCDS--DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~g~~~--~~ 186 (434)
++|.+.++||+|+||+||+|... +|+.||||++.+.... .....+.+|+.++++++ |||||+++++.. +.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46999999999999999999976 7899999999754321 11234678999999997 899999999754 46
Q ss_pred cEEEEEEcCC-CCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCC-CCeEEecccccc
Q 013927 187 IHLVFQLSPL-GSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTED-YEPQICDFGLAK 264 (434)
Q Consensus 187 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGla~ 264 (434)
.++||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 8999999976 577777753 4578999999999999999999999 999999999999999854 799999999998
Q ss_pred ccCCCCcccceeccccccccccCCccccCCC-CCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccC
Q 013927 265 WLPRQWTHHNVSKFEGTFGYFAPEYFMHGIV-DEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVD 343 (434)
Q Consensus 265 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 343 (434)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~---~~~----------- 221 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR---GQV----------- 221 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH---CCC-----------
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhh---ccc-----------
Confidence 65433 2345679999999999987765 5678999999999999999999976432111 000
Q ss_pred CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 222 -~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111222 46778899999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=365.63 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=195.2
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeeccC------CcEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDSD------GIHL 189 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~l 189 (434)
.+|.+.++||+|+||+||+|... +|+.||||++.+.........+++|+.+|++++||||+++++++.. ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46889999999999999999875 8999999999876555556678999999999999999999997432 2356
Q ss_pred EEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCC
Q 013927 190 VFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 190 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~ 269 (434)
+++|+.+|+|.+++.. ..+++..+..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+++.....
T Consensus 88 l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 6677888999999964 468999999999999999999999 99999999999999999999999999999866433
Q ss_pred Ccc-cceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhc----cccCccc------
Q 013927 270 WTH-HNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAK----PLLDSND------ 337 (434)
Q Consensus 270 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~----~~~~~~~------ 337 (434)
... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.........+.. .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 221 22345679999999999855 45789999999999999999999999764322111100 0000000
Q ss_pred --ccc-ccCCcCCCCCCH-----HHHHHHHHHHHhhhccCCCCCCCHhHHHHH
Q 013927 338 --IRE-LVDPSLGDNYDA-----EEIDRAVLTASLCIEQSPILRPKMSQVVIL 382 (434)
Q Consensus 338 --~~~-~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~ 382 (434)
... ..........+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000111 111457789999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=359.59 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=192.1
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeec----------c
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCD----------S 184 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~----------~ 184 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++||||+++++++ .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 57889999999999999999975 8999999998655332 2345688999999999999999999863 2
Q ss_pred CCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 185 DGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 185 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
+..++||||+.++.+..... ....+....+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 35789999998776665543 56678889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcc--cceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhh------hccc---
Q 013927 265 WLPRQWTH--HNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIW------AKPL--- 332 (434)
Q Consensus 265 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~------~~~~--- 332 (434)
.+...... .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+........ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 66533211 122345799999999998765 68999999999999999999999997643222110 0000
Q ss_pred ---cCccccccccCCcCCCCCCH-HH------HHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 333 ---LDSNDIRELVDPSLGDNYDA-EE------IDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 333 ---~~~~~~~~~~d~~l~~~~~~-~~------~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.................... +. ...+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00000000000000111111 11 235677999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=362.67 Aligned_cols=253 Identities=25% Similarity=0.283 Sum_probs=189.6
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEeeecc------C--CcE
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVGCDS------D--GIH 188 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~--~~~ 188 (434)
.|...++||+|+||+||+|.+. +|+.||||++..... .+.+|+.+|++++||||+++++++. + .++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 3777789999999999999986 799999999976532 2346999999999999999998631 1 367
Q ss_pred EEEEEcCCCCHHHHhc--cCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccc
Q 013927 189 LVFQLSPLGSLASILH--GSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKW 265 (434)
Q Consensus 189 lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~ 265 (434)
+||||+++|.+..+.. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998765444432 255679999999999999999999998 9999999999999999775 899999999987
Q ss_pred cCCCCcccceeccccccccccCCcccc-CCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------cc-------
Q 013927 266 LPRQWTHHNVSKFEGTFGYFAPEYFMH-GIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KP------- 331 (434)
Q Consensus 266 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~------- 331 (434)
+.... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||........... .+
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 65432 2234578999999998765 4689999999999999999999999976432221110 00
Q ss_pred ---ccCccccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 ---LLDSNDIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ---~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..........................+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000000011122346788999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=360.75 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=192.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeeccC--------C
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDSD--------G 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 186 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++.+.... .....+.+|+.+|++++|||||++++++.. .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 47999999999999999999976 7999999999765432 344578899999999999999999997432 4
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
+++||||+ +++|..++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 4678777753 468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccceeccccccccccCCccccC-CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhh------ccc------c
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG-IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA------KPL------L 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~------~~~------~ 333 (434)
... .+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......... .+. .
T Consensus 172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 543 2445689999999998764 578999999999999999999999976433221100 000 0
Q ss_pred Ccc-------ccccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHH--hcCCCC
Q 013927 334 DSN-------DIRELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVIL--LRGDED 388 (434)
Q Consensus 334 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~--L~~~~~ 388 (434)
... .........+. .........+.+|+.+||..||.+|||+.|+++. |+.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 000 00000000000 0001112456789999999999999999999874 665543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-46 Score=354.08 Aligned_cols=258 Identities=22% Similarity=0.236 Sum_probs=194.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCeeeEee-e--ccCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNTAKLVG-C--DSDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~--~~~~~~lv~e 192 (434)
++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+..|+.+++.++|+|++..++ + ..+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46999999999999999999975 789999999876532 235788999999998877665544 3 3346788999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC---CCCeEEeccccccccCCC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE---DYEPQICDFGLAKWLPRQ 269 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGla~~~~~~ 269 (434)
|+. |+|...+......+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+|+.+...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 985 56777766667789999999999999999999999 99999999999999864 457999999999876543
Q ss_pred Ccc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 270 WTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 270 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................... ...+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChh
Confidence 221 1234567999999999999989999999999999999999999999764332211100000000000 0000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.+...+ ..++.+++..||+.+|++||++.++.+.|+..
T Consensus 239 ~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011112 24678889999999999999999999888744
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=345.44 Aligned_cols=259 Identities=20% Similarity=0.245 Sum_probs=197.3
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--CCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--DGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++||||+++++++. +..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46889999999999999999976 7899999999765433 34567899999999999999999999754 46789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEeccccccccCCCCcc
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWLPRQWTH 272 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~~~~~~~ 272 (434)
++.+++|..++. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 999988888776 45678899999999999999999999 9999999999999999999999999999987654322
Q ss_pred cceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhh-------hhccccCc-cccccccC
Q 013927 273 HNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI-------WAKPLLDS-NDIRELVD 343 (434)
Q Consensus 273 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-------~~~~~~~~-~~~~~~~d 343 (434)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||......... +..+.... .......+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 223345788999999987665 689999999999999999999997432211110 00000000 00000000
Q ss_pred ---------CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 344 ---------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 344 ---------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
..............+.+++.+||+.||.+|||++||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111222356778899999999999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-45 Score=351.26 Aligned_cols=251 Identities=17% Similarity=0.189 Sum_probs=192.7
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeeecc----CCcEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGCDS----DGIHLV 190 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~----~~~~lv 190 (434)
++|.+.++||+|+||+||+|... +|+.||||++.... ...+.+|+.+|+++. ||||+++++++. ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 47999999999999999999975 79999999997543 345889999999995 999999999742 358899
Q ss_pred EEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCC-CeEEeccccccccCCC
Q 013927 191 FQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDY-EPQICDFGLAKWLPRQ 269 (434)
Q Consensus 191 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGla~~~~~~ 269 (434)
|||+.+|+|..+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987764 458999999999999999999999 9999999999999998655 6999999999876543
Q ss_pred CcccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhh-----------------cc
Q 013927 270 WTHHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA-----------------KP 331 (434)
Q Consensus 270 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~-----------------~~ 331 (434)
. ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||........... ..
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 234556899999999987654 79999999999999999999999965332211000 00
Q ss_pred ccCccccccccC--------CcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 332 LLDSNDIRELVD--------PSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 332 ~~~~~~~~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
............ .............++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001100 00011111122356788999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.7e-45 Score=345.86 Aligned_cols=254 Identities=17% Similarity=0.184 Sum_probs=199.8
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC-CCeeeEeeec--cCCcEEEEE
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH-PNTAKLVGCD--SDGIHLVFQ 192 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~--~~~~~lv~e 192 (434)
++|.+.+.||+|+||+||+|.+. +|+.||||++..... ...+.+|+.+++.+.| +|++.++++. ....++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57999999999999999999976 789999999865432 2357789999999976 8998888864 446789999
Q ss_pred EcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecC-----CCCeEEeccccccccC
Q 013927 193 LSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTE-----DYEPQICDFGLAKWLP 267 (434)
Q Consensus 193 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFGla~~~~ 267 (434)
|+ +++|.+++......++...+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 98 589999998777789999999999999999999999 99999999999999974 5689999999998764
Q ss_pred CCCcc-----cceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhcccc----Ccccc
Q 013927 268 RQWTH-----HNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLL----DSNDI 338 (434)
Q Consensus 268 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~----~~~~~ 338 (434)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 33211 1234567999999999999999999999999999999999999999764332111000000 00011
Q ss_pred ccccCCcCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhHHHHHhcCC
Q 013927 339 RELVDPSLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQVVILLRGD 386 (434)
Q Consensus 339 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~~L~~~ 386 (434)
.++ ...++ +++..++..|+..+|++||+++.+.+.|+.+
T Consensus 238 ~~l-----~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 238 REL-----CAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHH-----TTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHh-----cCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 11222 4677788999999999999999998888654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=349.46 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=187.5
Q ss_pred cCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc--------CC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS--------DG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------~~ 186 (434)
++|.+.++||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56999999999999999999976 7999999999876443 34457889999999999999999999742 35
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.++||||+.++.+. .+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 78999999866554 443 457899999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchhhh--------------hh---
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVI--------------WA--- 329 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------------~~--- 329 (434)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....... |.
T Consensus 170 ~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 433 2334567899999999999999999999999999999999999999653322110 00
Q ss_pred ---------ccccCccccccccCCcCCCCC---CHHHHHHHHHHHHhhhccCCCCCCCHhHHHH
Q 013927 330 ---------KPLLDSNDIRELVDPSLGDNY---DAEEIDRAVLTASLCIEQSPILRPKMSQVVI 381 (434)
Q Consensus 330 ---------~~~~~~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~ 381 (434)
.+................... .......+.+|+.+||+.||++|||++||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000011111111111111 1223567889999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=350.60 Aligned_cols=251 Identities=25% Similarity=0.280 Sum_probs=193.6
Q ss_pred cCCCCCCeecccCcEEEEEEEeC----CCcEEEEEEeeCCCc---hhhHhhHHHHHHHHhhCCC-CCeeeEeeec--cCC
Q 013927 117 KNFSSENLIGKGGYAEVYKGCLR----DGTLVAVKRLTKGTV---DEKTCGFLCEIGIIAYVDH-PNTAKLVGCD--SDG 186 (434)
Q Consensus 117 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~--~~~ 186 (434)
++|.+.+.||+|+||+||+|... +|+.||||++.+... ......+.+|+.++++++| |||++++++. .+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 46999999999999999999852 588999999865432 1234468889999999976 8999999974 447
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.+++|||+.+|+|.+++... ..+.......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 88999999999999999743 456678888899999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccceeccccccccccCCccccC--CCCCcCcEEehhHHHHHHHhCCCccccccchhhhhhccccCccccccccCC
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHG--IVDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWAKPLLDSNDIRELVDP 344 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 344 (434)
..... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||............ .......
T Consensus 180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i-------~~~~~~~ 251 (322)
T d1vzoa_ 180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 251 (322)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-------HHHHHHC
T ss_pred ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HHhcccC
Confidence 54322 223456799999999998764 4788999999999999999999999764322111000 0000000
Q ss_pred cCCCCCCHHHHHHHHHHHHhhhccCCCCCCC-----HhHHHH
Q 013927 345 SLGDNYDAEEIDRAVLTASLCIEQSPILRPK-----MSQVVI 381 (434)
Q Consensus 345 ~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~evl~ 381 (434)
....+......+.+++.+||+.||++||+ ++|+++
T Consensus 252 --~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 --EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01111223457788999999999999995 778864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=350.65 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=194.4
Q ss_pred hcCCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCch-hhHhhHHHHHHHHhhCCCCCeeeEeeecc-------CC
Q 013927 116 TKNFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVD-EKTCGFLCEIGIIAYVDHPNTAKLVGCDS-------DG 186 (434)
Q Consensus 116 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~-------~~ 186 (434)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.+.... .....+.+|+.+|++++|||||+++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 357999999999999999999975 7999999999865432 33456889999999999999999998742 24
Q ss_pred cEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccccccc
Q 013927 187 IHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGLAKWL 266 (434)
Q Consensus 187 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~~~ 266 (434)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 5677888889999999953 569999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCcccceeccccccccccCCccccCC-CCCcCcEEehhHHHHHHHhCCCccccccchhhhhh---cccc---------
Q 013927 267 PRQWTHHNVSKFEGTFGYFAPEYFMHGI-VDEKTDVYSFGVLLLELITGRRAVDHLQQSVVIWA---KPLL--------- 333 (434)
Q Consensus 267 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~~---~~~~--------- 333 (434)
... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+......... ....
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 432 33456899999999877654 68899999999999999999999976432211100 0000
Q ss_pred CccccccccCCcC-CCCCC-----HHHHHHHHHHHHhhhccCCCCCCCHhHHHH--HhcCC
Q 013927 334 DSNDIRELVDPSL-GDNYD-----AEEIDRAVLTASLCIEQSPILRPKMSQVVI--LLRGD 386 (434)
Q Consensus 334 ~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~evl~--~L~~~ 386 (434)
............. ..... ......+.+++.+||+.||.+|||+.|+++ .|...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000000000000 00000 011245778999999999999999999986 45443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-39 Score=313.84 Aligned_cols=255 Identities=22% Similarity=0.252 Sum_probs=186.1
Q ss_pred CCCCCCeecccCcEEEEEEEeC-CCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-----------CCCeeeEeeecc-
Q 013927 118 NFSSENLIGKGGYAEVYKGCLR-DGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-----------HPNTAKLVGCDS- 184 (434)
Q Consensus 118 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~- 184 (434)
+|.++++||+|+||+||+|... +|+.||||++.+.. .....+.+|+.+++.++ |+||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4889999999999999999975 79999999997643 23346788999888875 477888887632
Q ss_pred ---CCcEEEEEEcCCCCHH-H-HhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCC-----
Q 013927 185 ---DGIHLVFQLSPLGSLA-S-ILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYE----- 254 (434)
Q Consensus 185 ---~~~~lv~e~~~~gsL~-~-~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~----- 254 (434)
...+++++++..+... . ........+.+..+..++.||+.||.|||+ ..+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 3456777776654322 2 223355678889999999999999999996 378999999999999986653
Q ss_pred -eEEeccccccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHHHHHHhCCCccccccchh--------
Q 013927 255 -PQICDFGLAKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLLLELITGRRAVDHLQQSV-------- 325 (434)
Q Consensus 255 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~-------- 325 (434)
++|+|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||.......
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999999865432 234568999999999999999999999999999999999999996432110
Q ss_pred h--hhh--c-------------cccCccccccccCC----------cCCCCCCHHHHHHHHHHHHhhhccCCCCCCCHhH
Q 013927 326 V--IWA--K-------------PLLDSNDIRELVDP----------SLGDNYDAEEIDRAVLTASLCIEQSPILRPKMSQ 378 (434)
Q Consensus 326 ~--~~~--~-------------~~~~~~~~~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~e 378 (434)
. ... . ...........+.. .............+.+++.+||+.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0 000 0 00000000000000 0022334566788999999999999999999999
Q ss_pred HHH
Q 013927 379 VVI 381 (434)
Q Consensus 379 vl~ 381 (434)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.2e-25 Score=197.03 Aligned_cols=170 Identities=15% Similarity=0.125 Sum_probs=120.5
Q ss_pred CCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCch-----------------hhHhhHHHHHHHHhhCCCCCeeeEeee
Q 013927 120 SSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVD-----------------EKTCGFLCEIGIIAYVDHPNTAKLVGC 182 (434)
Q Consensus 120 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 182 (434)
.+.++||+|+||+||+|...+|+.||||++...... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456889999999999999888999999987543211 011234568889999999999998876
Q ss_pred ccCCcEEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhccCCCCeeecCCCCCcEEecCCCCeEEecccc
Q 013927 183 DSDGIHLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEGCQKRIIHRDIKADNILLTEDYEPQICDFGL 262 (434)
Q Consensus 183 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl 262 (434)
. ..+++|||++++.+..+ +......++.|++.||.|||+ ++|+||||||+|||++++ .++|+|||+
T Consensus 83 ~--~~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 83 E--GNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp E--TTEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred c--CCEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEECCC
Confidence 4 34899999997655432 223345789999999999999 999999999999999976 589999999
Q ss_pred ccccCCCCcccceeccccccccccCCccccCCCCCcCcEEehhHHH
Q 013927 263 AKWLPRQWTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVYSFGVLL 308 (434)
Q Consensus 263 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil 308 (434)
|..........- ...+... -.+.+ ...|+.++|+||+.--+
T Consensus 149 a~~~~~~~~~~~---l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWREI---LERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHHHH---HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcHHH---HHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 976543211100 0000000 00111 35678889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.4e-06 Score=78.22 Aligned_cols=146 Identities=14% Similarity=0.081 Sum_probs=91.2
Q ss_pred HHHHHhcCCCCCCeecccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC-CCCeeeEeee--ccCCc
Q 013927 111 ELQTATKNFSSENLIGKGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD-HPNTAKLVGC--DSDGI 187 (434)
Q Consensus 111 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~--~~~~~ 187 (434)
++......|.+.+..+.++.+.||+.... ++.+.||+...... .....+.+|...+..+. +-.+.+++.+ ..+..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45555566776665555556789998754 56678887764322 22334677888877664 3234455554 23457
Q ss_pred EEEEEEcCCCCHHHHhccCCCCCCHHHHHHHHHHHHHHhHhhhcc-----------------------------------
Q 013927 188 HLVFQLSPLGSLASILHGSKDKPDWSKRYRIALGTANGLTYLHEG----------------------------------- 232 (434)
Q Consensus 188 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~gL~yLH~~----------------------------------- 232 (434)
++||++.++.++....... .. ...++.++++.+..||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999988776654211 11 122333444444444421
Q ss_pred ---------------------CCCCeeecCCCCCcEEecCCCCeEEecccccc
Q 013927 233 ---------------------CQKRIIHRDIKADNILLTEDYEPQICDFGLAK 264 (434)
Q Consensus 233 ---------------------~~~~iiHrDlkp~NIll~~~~~~kL~DFGla~ 264 (434)
....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987666799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.83 E-value=1.5e-05 Score=76.02 Aligned_cols=75 Identities=11% Similarity=-0.025 Sum_probs=50.3
Q ss_pred CeecccCcEEEEEEEeC-CCcEEEEEEeeCC------CchhhHhhHHHHHHHHhhCC---CCCeeeEeeeccCCcEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLR-DGTLVAVKRLTKG------TVDEKTCGFLCEIGIIAYVD---HPNTAKLVGCDSDGIHLVFQ 192 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~lv~e 192 (434)
+.||.|....||++... +++.|+||.-... .......+...|...|..+. ...+.+++.++.+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence 35899999999999866 4678999965321 11112234556887776653 24567788888888899999
Q ss_pred EcCCC
Q 013927 193 LSPLG 197 (434)
Q Consensus 193 ~~~~g 197 (434)
++.+.
T Consensus 112 ~L~~~ 116 (392)
T d2pula1 112 DLSHL 116 (392)
T ss_dssp CCTTS
T ss_pred ccCCc
Confidence 98764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=4.6e-05 Score=67.48 Aligned_cols=70 Identities=16% Similarity=0.164 Sum_probs=46.4
Q ss_pred cccC-cEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCC--CCeeeEeee--ccCCcEEEEEEcCCCCH
Q 013927 126 GKGG-YAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDH--PNTAKLVGC--DSDGIHLVFQLSPLGSL 199 (434)
Q Consensus 126 G~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~--~~~~~~lv~e~~~~gsL 199 (434)
..|. .+.||+...+++..+++|....... ..+..|...++.+.. -.+.+++++ ..+..++||+++++.++
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3443 4789999888888889997654432 246677777776643 234555654 33467899999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.0032 Score=57.15 Aligned_cols=62 Identities=11% Similarity=0.113 Sum_probs=38.4
Q ss_pred cCHHHHHHHhcCCCCCCeec-----ccCcEEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCC
Q 013927 107 FTLSELQTATKNFSSENLIG-----KGGYAEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVD 172 (434)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 172 (434)
++.+++.....+|.++++.. .|---+.|+....+|+ +++|+...... ......|+.++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE---KNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhh
Confidence 45677888888898876543 4555778998887665 89998865321 123444666666664
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0024 Score=58.46 Aligned_cols=131 Identities=18% Similarity=0.093 Sum_probs=72.3
Q ss_pred EEEEEEEeCCCcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe--eeEeee-------ccCCcEEEEEEcCCCCH--
Q 013927 131 AEVYKGCLRDGTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT--AKLVGC-------DSDGIHLVFQLSPLGSL-- 199 (434)
Q Consensus 131 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g~-------~~~~~~lv~e~~~~gsL-- 199 (434)
-.||++..++|+.|++|+....... ...+..|...+..|....+ +..+.. ..+..+.++++.+|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 5799999999999999998765322 2346678888777642221 111111 22235667888765221
Q ss_pred ---HH------Hh---c----c----CCCCCCHH----------------------HHHHHHHHHHHHhHh-hhccCCCC
Q 013927 200 ---AS------IL---H----G----SKDKPDWS----------------------KRYRIALGTANGLTY-LHEGCQKR 236 (434)
Q Consensus 200 ---~~------~l---~----~----~~~~~~~~----------------------~~~~i~~~i~~gL~y-LH~~~~~~ 236 (434)
.. .+ + . .....++. .....+..+...+.- +......+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 01 1 0 01111211 111222222222221 12223467
Q ss_pred eeecCCCCCcEEecCCCCeEEeccccccc
Q 013927 237 IIHRDIKADNILLTEDYEPQICDFGLAKW 265 (434)
Q Consensus 237 iiHrDlkp~NIll~~~~~~kL~DFGla~~ 265 (434)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.38 E-value=0.0046 Score=58.15 Aligned_cols=70 Identities=16% Similarity=0.106 Sum_probs=46.1
Q ss_pred CeecccCcEEEEEEEeCC--------CcEEEEEEeeCCCchhhHhhHHHHHHHHhhCCCCCe-eeEeeeccCCcEEEEEE
Q 013927 123 NLIGKGGYAEVYKGCLRD--------GTLVAVKRLTKGTVDEKTCGFLCEIGIIAYVDHPNT-AKLVGCDSDGIHLVFQL 193 (434)
Q Consensus 123 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~lv~e~ 193 (434)
+.|+.|-.-.+|++...+ +..|.+++... .. . .....+|..+++.+.-.++ .++++++.+ .+|++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC--ceEEEE
Confidence 457888889999998653 34577776542 21 1 2245678888888753344 467777654 678899
Q ss_pred cCCC
Q 013927 194 SPLG 197 (434)
Q Consensus 194 ~~~g 197 (434)
+++.
T Consensus 123 i~g~ 126 (395)
T d1nw1a_ 123 IPSR 126 (395)
T ss_dssp CCEE
T ss_pred eccc
Confidence 8764
|